| CAS No. | Saflık | Ürün Adı | BOSTON KODU |
|---|---|---|---|
| Cas.: 543683-48-3 | Purity: ≥95% | 2-(2-Bromo-4-nitrophenyl)acetonitrile | ESD-875989-250MG |
| Cas.: 543683-48-3 | Purity: ≥95% | 2-(2-Bromo-4-nitrophenyl)acetonitrile | ESD-875989-1G |
| Cas.: 66-98-8 | Purity: 97% | 4,4′-Biphenyldicarboxaldehyde | ESD-831339-25G |
| Cas.: 66-98-8 | Purity: 97% | 4,4′-Biphenyldicarboxaldehyde | ESD-831339-100G |
| Cas.: 94-46-2 | Purity: ≥98% | Isoamyl Benzoate | ESD-859100-100G |
| Cas.: 94-46-2 | Purity: ≥98% | Isoamyl Benzoate | ESD-859100-500G |
| Cas.: 80-30-8 | Purity: 99% | N-Cyclohexyl-p-toluenesulfonamide | ESD-871373-25G |
| Cas.: 80-30-8 | Purity: 99% | N-Cyclohexyl-p-toluenesulfonamide | ESD-871373-100G |
| Cas.: 39131-44-7 | Purity: ≥95% | 5-(Bromomethyl)furan-2-carbaldehyde | ESD-875990-250MG |
| Cas.: 39131-44-7 | Purity: ≥95% | 5-(Bromomethyl)furan-2-carbaldehyde | ESD-875990-1G |
| Cas.: 6228-73-5 | Purity: 98% | Cyclopropanecarboxamide | ESD-836643-5G |
| Cas.: 6228-73-5 | Purity: 98% | Cyclopropanecarboxamide | ESD-836643-25G |
| Cas.: 6228-73-5 | Purity: 98% | Cyclopropanecarboxamide | ESD-836643-100G |
| Cas.: 6228-73-5 | Purity: 98% | Cyclopropanecarboxamide | ESD-836643-500G |
| Cas.: 85233-16-5 | Purity: ≥95% | 2,4-Dinitro-6-fluorotoluene | ESD-875991-250MG |
| Cas.: 85233-16-5 | Purity: ≥95% | 2,4-Dinitro-6-fluorotoluene | ESD-875991-1G |
| Cas.: 62054-49-3 | Purity: 97% | Ethyl 3-methyl-4-oxocrotonate | ESD-808710-5ML |
| Cas.: 4857-70-9 | Purity: ≥95% | 2-(tert-Butyl)-5-hydroxycyclohexa-2,5-diene-1,4-dione | ESD-875992-250MG |
| Cas.: 4857-70-9 | Purity: ≥95% | 2-(tert-Butyl)-5-hydroxycyclohexa-2,5-diene-1,4-dione | ESD-875992-1G |
| Cas.: 140-08-9 | Purity: 85% | Tris(2-chloroethyl) Phosphite | ESD-875993-5ML |
| Cas.: 140-08-9 | Purity: 85% | Tris(2-chloroethyl) Phosphite | ESD-875993-1ML |
| Cas.: 61964-08-7 | Purity: ≥97% | 1,3-Dihydroisobenzofuran-5-Amine | ESD-860112-250MG |
| Cas.: 61380-96-9 | Purity: ≥95% | (3R,3aR,5R,6aR,7R)-7-Hydroxyhexahydro-2H-3,5-methanocyclopenta[b]furan-2-one | ESD-875994-250MG |
| Cas.: 61380-96-9 | Purity: ≥95% | (3R,3aR,5R,6aR,7R)-7-Hydroxyhexahydro-2H-3,5-methanocyclopenta[b]furan-2-one | ESD-875994-1G |
| Cas.: 409320-89-4 | Purity: ≥95% | 3,5-Dimethyl-4H-Pyrazole | ESD-875995-250MG |
| Cas.: 409320-89-4 | Purity: ≥95% | 3,5-Dimethyl-4H-Pyrazole | ESD-875995-1G |
| Cas.: 616-42-2 | Purity: 99% | Dimethyl sulfite | ESD-807066-5G |
| Cas.: 609-60-9 | Purity: 98% | 2,4-Dimethylbenzenesulfonylchloride | ESD-829358-25G |
| Cas.: 3244-54-0 | Purity: ≥95% | 3,6-Dinitro-9H-carbazole | ESD-875996-1G |
| Cas.: 3244-54-0 | Purity: ≥95% | 3,6-Dinitro-9H-carbazole | ESD-875996-5G |
| Cas.: 609-60-9 | Purity: 98% | 2,4-Dimethylbenzenesulfonylchloride | ESD-829358-5G |
| Cas.: 609-60-9 | Purity: 98% | 2,4-Dimethylbenzenesulfonylchloride | ESD-829358-1G |
| Cas.: 827-19-0 | Purity: ≥95% | Sodium 2,5-dimethylbenzenesulfonate | ESD-875997-1G |
| Cas.: 827-19-0 | Purity: ≥95% | Sodium 2,5-dimethylbenzenesulfonate | ESD-875997-5G |
| Cas.: 827-19-0 | Purity: ≥95% | Sodium 2,5-dimethylbenzenesulfonate | ESD-875997-25G |
| Cas.: 6068-72-0 | Purity: 98% | 4-Cyanobenzoyl chloride | ESD-829811-1G |
| Cas.: 6068-72-0 | Purity: 98% | 4-Cyanobenzoyl chloride | ESD-829811-100G |
| Cas.: 594-44-5 | Purity: 98% | Ethanesulfonyl chloride | ESD-830291-25G |
| Cas.: 594-44-5 | Purity: 98% | Ethanesulfonyl chloride | ESD-830291-100G |
| Cas.: 594-44-5 | Purity: 98% | Ethanesulfonyl chloride | ESD-830291-500G |
| Cas.: 5763-61-1 | Purity: 97% | 3,4-Dimethoxybenzylamine | ESD-807567-100G |
| Cas.: 5653-62-3 | Purity: 98% | 2,3-Dimethoxybenzonitrile | ESD-863498-50G |
| Cas.: 551-62-2 | Purity: 97% | 1,2,3,4-Tetrafluorobenzene | ESD-831074-25G |
| Cas.: 944401-65-4 | Purity: ≥95% | 5-Bromo-6-fluoropyridin-2-amine | ESD-875998-1G |
| Cas.: 944401-65-4 | Purity: ≥95% | 5-Bromo-6-fluoropyridin-2-amine | ESD-875998-250MG |
| Cas.: 87794-64-7 | Purity: 90% | 3-aminopropyltris(methoxyethoxyethoxy)silane | ESD-824628-1G |
| Cas.: 54879-20-8 | Purity: 97% | 2-Bromo-3-methylaniline | ESD-804068-1G |
| Cas.: 54879-20-8 | Purity: 97% | 2-Bromo-3-methylaniline | ESD-804068-25G |
| Cas.: 181630-15-9 | Purity: 99% | Picoplatin | ESD-873342-50MG |
| Cas.: 181630-15-9 | Purity: 99% | Picoplatin | ESD-873342-250MG |
| Cas.: 54446-36-5 | Purity: 97% | 4-Bromodiphenylamine | ESD-802074-25G |
| Cas.: 54446-36-5 | Purity: 97% | 4-Bromodiphenylamine | ESD-802074-100G |
| Cas.: 3025-95-4 | Purity: 97% | N-Acetyl-b-alanine | ESD-842887-5G |
| Cas.: 3025-95-4 | Purity: 97% | N-Acetyl-b-alanine | ESD-842887-25G |
| Cas.: 3025-95-4 | Purity: 97% | N-Acetyl-b-alanine | ESD-842887-100G |
| Cas.: 5372-81-6 | Purity: 99% | Dimethyl aminoterephthalate | ESD-838752-10G |
| Cas.: 51-80-9 | Purity: ≥95% | N,N,N’,N’-TETRAMETHYLDIAMINOMETHANE | ESD-876000-25ML |
| Cas.: 51-80-9 | Purity: ≥95% | N,N,N’,N’-TETRAMETHYLDIAMINOMETHANE | ESD-876000-100ML |
| Cas.: 51-80-9 | Purity: ≥95% | N,N,N’,N’-TETRAMETHYLDIAMINOMETHANE | ESD-876000-500ML |
| Cas.: 119-26-6 | Purity: 98%(HPLC) | 2,4-Dinitrophenylhydrazine | ESD-824171-5G |
| Cas.: 870-72-4 | Purity: 97% | Formaldehyde-sodium bisulfite adduct | ESD-810150-2.5KG |
| Cas.: 51-80-9 | Purity: 98% | N,N,N’,N’-TETRAMETHYLDIAMINOMETHANE | ESD-830982-25ML |
| Cas.: 14937-45-2 | Purity: 98% | Tributylhexadecylphosphonium bromide | ESD-838603-100G |
| Cas.: 2800-80-8 | Purity: indicator grade | Bromophenol red | ESD-876001-1G |
| Cas.: 2800-80-8 | Purity: indicator grade | Bromophenol red | ESD-876001-5G |
| Cas.: 2800-80-8 | Purity: indicator grade | Bromophenol red | ESD-876001-25G |
| Cas.: 2800-80-8 | Purity: indicator grade | Bromophenol red | ESD-876001-100G |
| Cas.: 1211441-98-3 | Purity: 98% | Ribociclib (LEE011) | ESD-856445-100MG |
| Cas.: 1211441-98-3 | Purity: 98% | Ribociclib (LEE011) | ESD-856445-1G |
| Cas.: 1188226-62-1 | Purity: ≥95% | 2,6-Dibromo-4-fluorobenzo[d]thiazole | ESD-876002-100MG |
| Cas.: 1188226-62-1 | Purity: ≥95% | 2,6-Dibromo-4-fluorobenzo[d]thiazole | ESD-876002-500MG |
| Cas.: 1427399-19-6 | Purity: ≥95% | 2-Bromo-4-fluorobenzo[d]thiazole-6-carbonitrile | ESD-876003-100MG |
| Cas.: 1427399-19-6 | Purity: ≥95% | 2-Bromo-4-fluorobenzo[d]thiazole-6-carbonitrile | ESD-876003-500MG |
| Cas.: 58130-03-3 | Purity: Mn~25000 | Methacryloxypropyl Terminated Polydimethylsiloxanes | ESD-876004-5G |
| Cas.: 58130-03-3 | Purity: Mn~25000 | Methacryloxypropyl Terminated Polydimethylsiloxanes | ESD-876004-25G |
| Cas.: 58130-03-3 | Purity: Mn~25000 | Methacryloxypropyl Terminated Polydimethylsiloxanes | ESD-876004-100G |
| Cas.: 58130-03-3 | Purity: Mn~25000 | Methacryloxypropyl Terminated Polydimethylsiloxanes | ESD-876004-1G |
| Cas.: 1427426-59-2 | Purity: ≥95% | 2,5-Dibromo-4-fluorobenzo[d]thiazole | ESD-876005-100MG |
| Cas.: 1427426-59-2 | Purity: ≥95% | 2,5-Dibromo-4-fluorobenzo[d]thiazole | ESD-876005-500MG |
| Cas.: 112-30-1 | Purity: 98% | n-Decyl alcohol | ESD-806661-100ML |
| Cas.: 383131-45-1 | Purity: ≥95% | 2-Amino-6-bromo-4-fluorobenzothiazole | ESD-876006-100MG |
| Cas.: 383131-45-1 | Purity: ≥95% | 2-Amino-6-bromo-4-fluorobenzothiazole | ESD-876006-500MG |
| Cas.: 124-11-8 | Purity: 95% | 1-Nonene | ESD-814757-25ML |
| Cas.: 124-11-8 | Purity: 90% | 1-Nonene | ESD-814781-100ML |
| Cas.: 124-11-8 | Purity: 90% | 1-Nonene | ESD-814781-500ML |
| Cas.: 1427383-09-2 | Purity: ≥95% | 5-Bromo-4-fluorobenzo[d]thiazol-2-amine | ESD-876007-100MG |
| Cas.: 1427383-09-2 | Purity: ≥95% | 5-Bromo-4-fluorobenzo[d]thiazol-2-amine | ESD-876007-500MG |
| Cas.: 124-11-8 | Purity: 95% | 1-Nonene | ESD-814757-100ML |
| Cas.: 1427448-37-0 | Purity: ≥95% | 2-Amino-4-fluorobenzo[d]thiazole-6-carbonitrile | ESD-876008-100MG |
| Cas.: 1427448-37-0 | Purity: ≥95% | 2-Amino-4-fluorobenzo[d]thiazole-6-carbonitrile | ESD-876008-500MG |
| Cas.: 618-27-9 | Purity: 98% | Cis-4-Hydroxy-L-proline | ESD-811191-5G |
| Cas.: 618-27-9 | Purity: 98% | Cis-4-Hydroxy-L-proline | ESD-811191-25G |
| Cas.: 7440-44-0 | Purity: 6-16 Mesh, pH: 5-6 | Water activated carbon | ESD-871993-250G |
| Cas.: 5402-20-0 | Purity: 96% | 4-Pyridinesulfonic acid | ESD-871776-50MG |
| Cas.: 3674-54-2 | Purity: 99% | Tetrabutylammonium Thiocyanate | ESD-857136-5G |
| Cas.: 3674-54-2 | Purity: 99% | Tetrabutylammonium Thiocyanate | ESD-857136-25G |
| Cas.: 5402-20-0 | Purity: 96% | 4-Pyridinesulfonic acid | ESD-871776-10MG |
| Cas.: 585-86-4 | Purity: BR | Lactitol | ESD-873708-100MG |
| Cas.: 585-86-4 | Purity: BR | Lactitol | ESD-873708-500MG |
| Cas.: 585-86-4 | Purity: BR | Lactitol | ESD-873708-1G |
| Cas.: 138-30-7 | Purity: ≥95% | 3-Hydrazinylbenzenesulfonic acid | ESD-875999-250MG |
| Cas.: 138-30-7 | Purity: ≥95% | 3-Hydrazinylbenzenesulfonic acid | ESD-875999-1G |
| Cas.: 1068977-22-9 | Purity: ≥95% | Ethyl [2,2′-bipyrimidine]-5-carboxylate | ESD-876010-100MG |
| Cas.: 1068977-22-9 | Purity: ≥95% | Ethyl [2,2′-bipyrimidine]-5-carboxylate | ESD-876010-500MG |
| Cas.: 74169-52-1 | Purity: ≥95% | 3,4-Dimethyl-1-phenylpyrano[2,3-c]pyrazol-6(1H)-one | ESD-876009-250MG |
| Cas.: 74169-52-1 | Purity: ≥95% | 3,4-Dimethyl-1-phenylpyrano[2,3-c]pyrazol-6(1H)-one | ESD-876009-1G |
| Cas.: 1346602-84-3 | Purity: ≥95% | 3-Vinylphenyl ethyl(methyl)carbamate | ESD-876011-100MG |
| Cas.: 1346602-84-3 | Purity: ≥95% | 3-Vinylphenyl ethyl(methyl)carbamate | ESD-876011-500MG |
| Cas.: 74169-54-3 | Purity: ≥95% | 1-(4-Chlorophenyl)-3,4-dimethylpyrano[2,3-c]pyrazol-6(1H)-one | ESD-876012-250MG |
| Cas.: 74169-54-3 | Purity: ≥95% | 1-(4-Chlorophenyl)-3,4-dimethylpyrano[2,3-c]pyrazol-6(1H)-one | ESD-876012-1G |
| Cas.: 513-35-9 | Purity: ≥99% | 2-Methyl-2-butene | ESD-876013-500ML |
| Cas.: 1174046-90-2 | Purity: ≥95% | 4-Ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxylic acid | ESD-876014-250MG |
| Cas.: 513-35-9 | Purity: ≥99% | 2-Methyl-2-butene | ESD-876013-100ML |
| Cas.: 1174046-90-2 | Purity: ≥95% | 4-Ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxylic acid | ESD-876014-1G |
| Cas.: 351335-29-0 | Purity: ≥95% | Methyl 4-((2-formylphenoxy)methyl)benzoate | ESD-876015-250MG |
| Cas.: 351335-29-0 | Purity: ≥95% | Methyl 4-((2-formylphenoxy)methyl)benzoate | ESD-876015-1G |
| Cas.: 513-35-9 | Purity: ≥99% | 2-Methyl-2-butene | ESD-876013-25ML |
| Cas.: 10380-41-3 | Purity: ≥95% | 2-Cyano-3,3-diphenylacrylic acid | ESD-876016-250MG |
| Cas.: 10380-41-3 | Purity: ≥95% | 2-Cyano-3,3-diphenylacrylic acid | ESD-876016-1G |
| Cas.: 16353-27-8 | Purity: ≥95% | 6-Iodoquinazoline-2,4(1H,3H)-dione | ESD-876017-250MG |
| Cas.: 16353-27-8 | Purity: ≥95% | 6-Iodoquinazoline-2,4(1H,3H)-dione | ESD-876017-1G |
| Cas.: 863250-72-0 | Purity: ≥95% | Ethyl 6-fluorobenzofuran-3-carboxylate | ESD-876018-500MG |
| Cas.: 863250-72-0 | Purity: ≥95% | Ethyl 6-fluorobenzofuran-3-carboxylate | ESD-876018-100MG |
| Cas.: 976-71-6 | Purity: ≥98% | Canrenone | ESD-859169-5G |
| Cas.: 976-71-6 | Purity: ≥98% | Canrenone | ESD-859169-25G |
| Cas.: 2897-60-1 | Purity: ≥98% | Diethoxy(3-glycidyloxypropyl)methylsilane | ESD-834055-500ML |
| Cas.: 16066-35-6 | Purity: ≥95% | 4-Isopropylbenzenesulfonic acid | ESD-876019-1G |
| Cas.: 3789-75-1 | Purity: GR | Scarlet 808 | ESD-873724-25MG |
| Cas.: 16066-35-6 | Purity: ≥95% | 4-Isopropylbenzenesulfonic acid | ESD-876019-5G |
| Cas.: 3789-75-1 | Purity: GR | Scarlet 808 | ESD-873724-100MG |
| Cas.: 7182-86-7 | Purity: ≥99% | Tetrabutylammoniump-toluenesulfonate | ESD-857039-100G |
| Cas.: 2090542-75-7 | Purity: ≥95% | 4-Fluoro-2-methoxy-3-nitroaniline | ESD-876020-1G |
| Cas.: 2090542-75-7 | Purity: ≥95% | 4-Fluoro-2-methoxy-3-nitroaniline | ESD-876020-250MG |
| Cas.: 876665-00-8 | Purity: ≥95% | 2,5-Dimethoxybenzyl 3-methylbutanoate | ESD-876021-1G |
| Cas.: 876665-00-8 | Purity: ≥95% | 2,5-Dimethoxybenzyl 3-methylbutanoate | ESD-876021-5G |
| Cas.: 58-61-7 | Purity: 99%biotech grade | Adenoside | ESD-6219-2.5KG |
| Cas.: 58-61-7 | Purity: 99%biotech grade | Adenoside | ESD-6219-500G |
| Cas.: 7501-02-2 | Purity: ≥95% | 2-([1,1′-Biphenyl]-2-yloxy)ethanol | ESD-876022-1G |
| Cas.: 7501-02-2 | Purity: ≥95% | 2-([1,1′-Biphenyl]-2-yloxy)ethanol | ESD-876022-5G |
| Cas.: 50604-01-8 | Purity: ≥95% | Methyl 2-ethylbenzoate | ESD-876023-1G |
| Cas.: 50604-01-8 | Purity: ≥95% | Methyl 2-ethylbenzoate | ESD-876023-250MG |
| Cas.: 626-95-9 | Purity: 98% | 1,4-Pentanediol | ESD-864415-25G |
| Cas.: 626-95-9 | Purity: 98% | 1,4-Pentanediol | ESD-864415-100G |
| Cas.: 28056-87-3 | Purity: ≥95% | 2-Ethyl-N,N-dimethylhexan-1-amine | ESD-876024-1G |
| Cas.: 28056-87-3 | Purity: ≥95% | 2-Ethyl-N,N-dimethylhexan-1-amine | ESD-876024-250MG |
| Cas.: 1118-02-1 | Purity: ≥80% | Trimethylsilyl isocyanate | ESD-831216-100G |
| Cas.: 696-82-2 | Purity: 98% | 2,4,6-Trifluoropyrimidine | ESD-839129-5G |
| Cas.: 177325-75-6 | Purity: 98% | 2,4-Bis(phenylsulfonyl)phenol | ESD-876025-5G |
| Cas.: 177325-75-6 | Purity: 98% | 2,4-Bis(phenylsulfonyl)phenol | ESD-876025-1G |
| Cas.: 60676-86-0 | Purity: For Resin | Silicon dioxide | ESD-876026-500G |
| Cas.: 53316-57-7 | Purity: ≥95% | 6-Amino-3-methyl-1,4-diphenyl-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile | ESD-876027-250MG |
| Cas.: 53316-57-7 | Purity: ≥95% | 6-Amino-3-methyl-1,4-diphenyl-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile | ESD-876027-1G |
| Cas.: 13641-96-8 | Purity: 98% | 2-Isocyanatoethyl Acrylate (stabilized with BHT) | ESD-829758-5G |
| Cas.: 528-43-8 | Purity: ≥98%(HPLC) | Magnolol | ESD-813635-5G |
| Cas.: 528-43-8 | Purity: ≥98%(HPLC) | Magnolol | ESD-813635-1G |
| Cas.: 203866-18-6 | Purity: 97% | N-Boc-|trans|-4-fluoro-L-proline methyl ester | ESD-803337-5G |
| Cas.: 528-43-8 | Purity: ≥98%(HPLC) | Magnolol | ESD-813635-25G |
| Cas.: 78-84-2 | Purity: 99% (GC) | Isobutyraldehyde | ESD-811834-2.5L |
| Cas.: 78-84-2 | Purity: 99% (GC) | Isobutyraldehyde | ESD-811834-4L |
| Cas.: 327-78-6 | Purity: 98% | 4-Chloro-3-(trifluoromethyl)phenyl isocyanate | ESD-831059-25G |
| Cas.: 327-78-6 | Purity: 98% | 4-Chloro-3-(trifluoromethyl)phenyl isocyanate | ESD-831059-1G |
| Cas.: 79-63-0 | Purity: 50% | Lanosterol | ESD-868732-1G |
| Cas.: 79-63-0 | Purity: 50% | Lanosterol | ESD-868732-25G |
| Cas.: 9004-67-5 | Purity: 50000mPa.s | Methyl cellulose | ESD-876028-100G |
| Cas.: 9004-67-5 | Purity: 50000mPa.s | Methyl cellulose | ESD-876028-500G |
| Cas.: 109-59-1 | Purity: Standard for GC, ≥99.9%(GC) | 2-Isopropoxyethanol | ESD-876029-5ML |
| Cas.: 138112-76-2 | Purity: 98%(HPLC) | AGOMELATINE | ESD-821874-250MG |
| Cas.: 138112-76-2 | Purity: 98%(HPLC) | AGOMELATINE | ESD-821874-1G |
| Cas.: 138112-76-2 | Purity: 98%(HPLC) | AGOMELATINE | ESD-821874-25G |
| Cas.: 7365-44-8 | Purity: 99% | 2-[Tris(hydroxymethyl)methylamino]-1-ethanesulfonic acid (TES) | ESD-818968-5G |
| Cas.: 34540-22-2 | Purity: 90% | Madecassoside | ESD-876030-250MG |
| Cas.: 34540-22-2 | Purity: 90% | Madecassoside | ESD-876030-1G |
| Cas.: 34540-22-2 | Purity: 90% | Madecassoside | ESD-876030-5G |
| Cas.: 5746-86-1 | Purity: 98% | (±)-Nornicotine | ESD-814870-1G |
| Cas.: 142-91-6 | Purity: 97% | Isopropyl palmitate | ESD-811771-2.5L |
| Cas.: 5746-86-1 | Purity: 98% | (±)-Nornicotine | ESD-814870-5G |
| Cas.: 5746-86-1 | Purity: 98% | (±)-Nornicotine | ESD-814870-25G |
| Cas.: 5746-86-1 | Purity: 98% | (±)-Nornicotine | ESD-814870-250MG |
| Cas.: 5746-86-1 | Purity: 98% | (±)-Nornicotine | ESD-814870-100MG |
| Cas.: 97-85-8 | Purity: 98% | isobutyl isobutyrate | ESD-811761-2.5L |
| Cas.: 26590-05-6 | Purity: 10 wt. % in H2O | Poly(acrylamide-co-diallyldimethylammonium chloride) solution | ESD-815473-5L |
| Cas.: 26590-05-6 | Purity: 10 wt. % in H2O | Poly(acrylamide-co-diallyldimethylammonium chloride) solution | ESD-815473-1L |
| Cas.: 18282-40-1 | Purity: 98% | 2-Ethyliodobenzene | ESD-858529-25G |
| Cas.: 18282-40-1 | Purity: 98% | 2-Ethyliodobenzene | ESD-858529-100G |
| Cas.: 51628-12-7 | Purity: 98% | 2-(4-Iodophenyl)acetonitrile | ESD-840579-5G |
| Cas.: 51628-12-7 | Purity: 98% | 2-(4-Iodophenyl)acetonitrile | ESD-840579-25G |
| Cas.: 71277-78-6 | Purity: ≥65%(HPLC) | Glycyrrhizic Acid Trisodium Salt Hydrate | ESD-876031-100G |
| Cas.: 71277-78-6 | Purity: ≥65%(HPLC) | Glycyrrhizic Acid Trisodium Salt Hydrate | ESD-876031-25G |
| Cas.: 130723-54-5 | Purity: ≥96%(GC) | 3-Iodobenzyl Cyanide | ESD-862502-5G |
| Cas.: 71277-78-6 | Purity: ≥65%(HPLC) | Glycyrrhizic Acid Trisodium Salt Hydrate | ESD-876031-5G |
| Cas.: 175278-12-3 | Purity: 97% | 4-Bromo-2-(trifluoromethoxy)iodobenzene | ESD-829092-1G |
| Cas.: 175278-12-3 | Purity: 97% | 4-Bromo-2-(trifluoromethoxy)iodobenzene | ESD-829092-5G |
| Cas.: 175278-12-3 | Purity: 97% | 4-Bromo-2-(trifluoromethoxy)iodobenzene | ESD-829092-25G |
| Cas.: 25309-64-2 | Purity: 98% | 1-Ethyl-4-iodobenzene | ESD-858377-25G |
| Cas.: 72373-82-1 | Purity: 97% | 3-Chloro-2-fluoroiodobenzene | ESD-838017-5G |
| Cas.: 72373-82-1 | Purity: 97% | 3-Chloro-2-fluoroiodobenzene | ESD-838017-25G |
| Cas.: 755027-18-0 | Purity: ≥98% | 2-Bromo-5-iodoanisole | ESD-858772-5G |
| Cas.: 755027-18-0 | Purity: ≥98% | 2-Bromo-5-iodoanisole | ESD-858772-25G |
| Cas.: 755027-18-0 | Purity: ≥98% | 2-Bromo-5-iodoanisole | ESD-858772-100G |
| Cas.: 459424-72-7 | Purity: ≥97% | 1-Iodo-2,3,4-Trifluorobenzene | ESD-858634-5G |
| Cas.: 459424-72-7 | Purity: ≥97% | 1-Iodo-2,3,4-Trifluorobenzene | ESD-858634-25G |
| Cas.: 41860-63-3 | Purity: 98% | 1,3,5-Trifluoro-2-iodobenzene | ESD-838964-5G |
| Cas.: 41860-63-3 | Purity: 98% | 1,3,5-Trifluoro-2-iodobenzene | ESD-838964-25G |
| Cas.: 202865-73-4 | Purity: 98% | 2-Bromo-4-fluoro-1-iodobenzene | ESD-831054-25G |
| Cas.: 202865-73-4 | Purity: 98% | 2-Bromo-4-fluoro-1-iodobenzene | ESD-831054-100G |
| Cas.: 13697-89-7 | Purity: 98% | 1,3-Difluoro-2-iodobenzene | ESD-835344-25G |
| Cas.: 13697-89-7 | Purity: 98% | 1,3-Difluoro-2-iodobenzene | ESD-835344-100G |
| Cas.: 29898-32-6 | Purity: 98% | 2,4-Dichloro-1-iodobenzene | ESD-870233-25G |
| Cas.: 29898-32-6 | Purity: 98% | 2,4-Dichloro-1-iodobenzene | ESD-870233-100G |
| Cas.: 2265-92-1 | Purity: 97% | 1,4-Difluoro-2-iodobenzene | ESD-835194-25G |
| Cas.: 156150-67-3 | Purity: 98% | 3-Chloro-4-fluoroiodobenzene | ESD-856395-5G |
| Cas.: 4426-47-5 | Purity: 98% | Butylboronic acid | ESD-801878-100G |
| Cas.: 71-23-8 | Purity: 99,99% | Propanol | ESD-876032-500ML |
| Cas.: 71-23-8 | Purity: 99,99% | Propanol | ESD-876032-100ML |
| Cas.: 491-38-3 | Purity: 98% | benzo-γ-pyrone | ESD-831487-5G |
| Cas.: 491-38-3 | Purity: 98% | benzo-γ-pyrone | ESD-831487-25G |
| Cas.: 491-38-3 | Purity: 98% | benzo-γ-pyrone | ESD-831487-100G |
| Cas.: 134450-56-9 | Purity: 95% | 4,5-Difluorophthalonitrile | ESD-869094-1G |
| Cas.: 134450-56-9 | Purity: 95% | 4,5-Difluorophthalonitrile | ESD-869094-5G |
| Cas.: 15541-60-3 | Purity: ≥99% | Melamine Pyrophosphate | ESD-859616-500G |
| Cas.: 156150-67-3 | Purity: 98% | 3-Chloro-4-fluoroiodobenzene | ESD-856395-100G |
| Cas.: 14281-83-5 | Purity: 97% | Glycine Zinc Salt Monohydrate | ESD-836166-100G |
| Cas.: 15541-60-3 | Purity: ≥99% | Melamine Pyrophosphate | ESD-859616-2.5KG |
| Cas.: 14281-83-5 | Purity: 97% | Glycine Zinc Salt Monohydrate | ESD-836166-500G |
| Cas.: 25014-41-9 | Purity: average Mw 50,000 | Polyacrylonitrile | ESD-876033-10G |
| Cas.: 25014-41-9 | Purity: average Mw 50,000 | Polyacrylonitrile | ESD-876033-50G |
| Cas.: 25014-41-9 | Purity: average Mw 50,000 | Polyacrylonitrile | ESD-876033-250G |
| Cas.: 544-17-2 | Purity: 98% | Calcium format | ESD-876034-500G |
| Cas.: 544-17-2 | Purity: 98% | Calcium format | ESD-876034-2.5KG |
| Cas.: 64-18-6 | Purity: 90% | Formic acid | ESD-876035-500G |
| Cas.: 64-18-6 | Purity: 90% | Formic acid | ESD-876035-5KG |
| Cas.: 99946-04-0 | Purity: 95% | Isoboonein | ESD-876036-5MG |
| Cas.: 99933-32-1 | Purity: 98% | Bullatantriol | ESD-876037-5MG |
| Cas.: 99891-77-7 | Purity: 95% | Isoboonein acetate | ESD-876038-5MG |
| Cas.: 99697-24-2 | Purity: 98% | 24-Norursodeoxycholic acid | ESD-876039-1MG |
| Cas.: 99697-24-2 | Purity: 98% | 24-Norursodeoxycholic acid | ESD-876039-5MG |
| Cas.: 99694-90-3 | Purity: 95% | Scholaricine | ESD-876040-5MG |
| Cas.: 99633-05-3 | Purity: 95% | 14-Benzoylneoline | ESD-876041-5MG |
| Cas.: 99624-92-7 | Purity: 98% | Uncinatone | ESD-876042-5MG |
| Cas.: 99624-39-2 | Purity: 95% | ent-3β,18-Dihydroxylabda-8(17),13E-dien-15-oic acid | ESD-876043-5MG |
| Cas.: 99624-27-8 | Purity: 98% | Kazinol B | ESD-876044-5MG |
| Cas.: 99353-00-1 | Purity: 97% | Methyl rosmarinate | ESD-876045-5MG |
| Cas.: 99340-07-5 | Purity: 97% | Kadsurin A | ESD-876046-5MG |
| Cas.: 99217-75-1 | Purity: 95% | Mulberrofuran G pentaacetate | ESD-876047-5MG |
| Cas.: 99217-63-7 | Purity: 95% | Kushenol A | ESD-876048-5MG |
| Cas.: 99173-00-9 | Purity: 93% | 1,6,8-Trideoxyshanzhigenin | ESD-876049-5MG |
| Cas.: 99132-99-7 | Purity: 98% | Dehydrobruceantinol | ESD-876050-5MG |
| Cas.: 99132-97-5 | Purity: 97% | Yadanzioside L | ESD-876051-5MG |
| Cas.: 99132-95-3 | Purity: 96% | Yadanzioside I | ESD-876052-5MG |
| Cas.: 99026-99-0 | Purity: 97% | Limonexin | ESD-876053-5MG |
| Cas.: 989-61-7 | Purity: 96% | Limonol | ESD-876054-5MG |
| Cas.: 98770-70-8 | Purity: 95% | 3-(4-Hydroxy-3-methoxyphenyl)propyl tetracosanoate | ESD-876055-1G |
| Cas.: 98755-25-0 | Purity: 98% | Isothymusin | ESD-876056-5MG |
| Cas.: 98751-79-2 | Purity: 98% | Paeonilactone A | ESD-876057-5MG |
| Cas.: 98751-78-1 | Purity: 98% | Paeonilactone B | ESD-876058-5MG |
| Cas.: 98751-77-0 | Purity: 97% | Paeonilactone C | ESD-876059-5MG |
| Cas.: 98717-15-8 | Purity: ≥99% | Ropivacaine hydrochloride | ESD-876060-10MG |
| Cas.: 98717-15-8 | Purity: ≥99% | Ropivacaine hydrochloride | ESD-876060-50MG |
| Cas.: 98665-65-7 | Purity: 95% | Dregeoside Da1 | ESD-876061-5MG |
| Cas.: 98665-16-8 | Purity: 96% | Lucidenic acid D | ESD-876062-5MG |
| Cas.: 98665-12-4 | Purity: 98% | Methyl lucidenate E2 | ESD-876063-5MG |
| Cas.: 98665-09-9 | Purity: 96% | Methyl lucidenate D | ESD-876064-5MG |
| Cas.: 98633-61-5 | Purity: 98% | Sarmentocymarin | ESD-876065-5MG |
| Cas.: 98570-81-1 | Purity: 98% | Cryptanoside A | ESD-876066-5MG |
| Cas.: 97938-31-3 | Purity: 96% | Leachianone A | ESD-876067-5MG |
| Cas.: 97938-30-2 | Purity: 98% | Sophoraflavone G | ESD-876068-5MG |
| Cas.: 97931-41-4 | Purity: 98% | Methyl 3-carbazolecarboxylate | ESD-876069-5MG |
| Cas.: 97914-19-7 | Purity: 95% | 3,4′-Dihydroxy-3′,5,7-trimethoxyflavan | ESD-876070-250MG |
| Cas.: 97867-34-0 | Purity: 98% | Norfloxacin lactate | ESD-876071-5MG |
| Cas.: 97856-19-4 | Purity: 95% | 8,9-Didehydro-7-hydroxydolichodial | ESD-876072-5MG |
| Cas.: 97763-17-2 | Purity: 98% | Jasmoside | ESD-876073-5MG |
| Cas.: 97761-91-6 | Purity: 95% | 2,6-Dimethyl-3-O-methyl-4-(2-methylbutyryl)phloroglucinol | ESD-876074-5MG |
| Cas.: 97761-90-5 | Purity: 95% | 2,6-Dimethyl-3-O-methyl-4-isobutyrylphloroglucinol | ESD-876075-1MG |
| Cas.: 977-32-2 | Purity: 98% | Boldenone propionate | ESD-876076-5MG |
| Cas.: 975-77-9 | Purity: 95% | Pericyclivine | ESD-876077-1MG |
| Cas.: 97575-49-0 | Purity: 99% | 6-Methylgenistein | ESD-876078-5MG |
| Cas.: 97534-10-6 | Purity: 98% | 3-O-Caffeoyloleanolic acid | ESD-876079-5MG |
| Cas.: 97519-39-6 | Purity: 98% | Ceftibuten | ESD-876080-10MG |
| Cas.: 97519-39-6 | Purity: 98% | Ceftibuten | ESD-876080-50MG |
| Cas.: 97465-80-0 | Purity: 96% | Hedyotol D | ESD-876081-1MG |
| Cas.: 974-41-4 | Purity: 95% | 8-Benzyl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one | ESD-876082-1G |
| Cas.: 974-41-4 | Purity: 95% | 8-Benzyl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one | ESD-876082-5G |
| Cas.: 97411-50-2 | Purity: 97% | 2′,3′-Dehydrosalannol | ESD-876083-5MG |
| Cas.: 97399-96-7 | Purity: 98% | Cynatratoside A | ESD-876084-5MG |
| Cas.: 97399-95-6 | Purity: 97% | Paniculidine C | ESD-876085-5MG |
| Cas.: 97399-94-5 | Purity: 98% | Paniculidine B | ESD-876086-5MG |
| Cas.: 97399-93-4 | Purity: 97% | Paniculidine A | ESD-876087-5MG |
| Cas.: 97399-91-2 | Purity: 98% | Aristolactam AIIIa | ESD-876088-5MG |
| Cas.: 97399-90-1 | Purity: 95% | Aristolactam AIa | ESD-876089-1MG |
| Cas.: 97372-53-7 | Purity: 97% | 8β-Hydroxycadin-4-en-3-one | ESD-876090-5MG |
| Cas.: 97218-06-9 | Purity: 96% | Eriobofuran | ESD-876091-5MG |
| Cas.: 97191-42-9 | Purity: 98% | 18-Hydroxytritriacontan-16-one | ESD-876092-5MG |
| Cas.: 97169-44-3 | Purity: 98% | 6-Epi-8-O-acetylharpagide | ESD-876093-5MG |
| Cas.: 97145-43-2 | Purity: 98% | KKI-5 | ESD-876094-1MG |
| Cas.: 97145-43-2 | Purity: 98% | KKI-5 | ESD-876094-5MG |
| Cas.: 96917-26-9 | Purity: 95% | Artanin | ESD-876095-1MG |
| Cas.: 96895-25-9 | Purity: 98% | Nyasol | ESD-876096-5MG |
| Cas.: 96892-57-8 | Purity: ≥99% | Hepsulfam | ESD-876097-1MG |
| Cas.: 96892-57-8 | Purity: ≥99% | Hepsulfam | ESD-876097-5MG |
| Cas.: 96850-29-2 | Purity: 97% | Maoecrystal B | ESD-876098-5MG |
| Cas.: 96850-21-4 | Purity: 95% | 8β-Tigloyloxycostunolide | ESD-876099-5MG |
| Cas.: 96801-92-2 | Purity: 95% | Chlorovaltrate K | ESD-876100-5MG |
| Cas.: 96800-41-8 | Purity: 98% | DuP 105 | ESD-876101-1MG |
| Cas.: 96800-41-8 | Purity: 98% | DuP 105 | ESD-876101-5MG |
| Cas.: 967-80-6 | Purity: ≥98% | Sulfaquinoxaline sodium salt | ESD-876102-100MG |
| Cas.: 96684-81-0 | Purity: 96% | Viscidulin III tetraacetate | ESD-876103-5MG |
| Cas.: 96651-85-3 | Purity: 95% | 4-Spiroindane-piperidine hydrochloride | ESD-876104-500MG |
| Cas.: 96558-24-6 | Purity: ≥99% | RPH-2823 | ESD-876105-1MG |
| Cas.: 96552-59-9 | Purity: 95% | 5,7-Dihydroxy-2-isopropylchromone | ESD-876106-1MG |
| Cas.: 96552-41-9 | Purity: 97% | Cudraxanthone D | ESD-876107-5MG |
| Cas.: 96487-37-5 | Purity: ≥99% | Nuvenzepine | ESD-876108-1MG |
| Cas.: 96487-37-5 | Purity: ≥99% | Nuvenzepine | ESD-876108-5MG |
| Cas.: 96478-43-2 | Purity: 98% | Irindalone | ESD-876109-1MG |
| Cas.: 96478-43-2 | Purity: 98% | Irindalone | ESD-876109-5MG |
| Cas.: 96449-05-7 | Purity: 98% | Rispenzepine | ESD-876110-1MG |
| Cas.: 96449-05-7 | Purity: 98% | Rispenzepine | ESD-876110-5MG |
| Cas.: 96426-21-0 | Purity: ≥98% | Gly-Arg-Gly-Asp-Ser | ESD-876111-5MG |
| Cas.: 96422-53-6 | Purity: 95% | Goniodiol 7-acetate | ESD-876112-1MG |
| Cas.: 96422-52-5 | Purity: 98% | Goniodiol | ESD-876113-5MG |
| Cas.: 96405-62-8 | Purity: 95% | Goniotriol | ESD-876114-5MG |
| Cas.: 96392-15-3 | Purity: ≥99% | PD 117519 | ESD-876115-5MG |
| Cas.: 96392-15-3 | Purity: ≥99% | PD 117519 | ESD-876115-10MG |
| Cas.: 96382-91-1 | Purity: 96% | Neonuezhenide | ESD-876116-5MG |
| Cas.: 963-75-7 | Purity: 98% | Androst-2-en-17-one | ESD-876117-5MG |
| Cas.: 96287-41-1 | Purity: 96% | Methyl 8-hydroxy-3-(2-methoxy-2-oxoethyl)-6-methyl-9-oxo-9H-furo[3,4-b]chromene-1-carboxylate | ESD-876118-5MG |
| Cas.: 96087-10-4 | Purity: 97% | Massoniresinol | ESD-876119-5MG |
| Cas.: 960589-81-5 | Purity: 98% | ent-17-Hydroxykauran-3-one | ESD-876120-5MG |
| Cas.: 960365-65-5 | Purity: ≥98% | Silvestrol aglycone | ESD-876121-1MG |
| Cas.: 960294-16-0 | Purity: 95% | 2,6-Diazaspiro[4.5]decane-6-carboxylicacid tert-butyl ester | ESD-876122-100MG |
| Cas.: 960294-16-0 | Purity: 95% | 2,6-Diazaspiro[4.5]decane-6-carboxylicacid tert-butyl ester | ESD-876122-250MG |
| Cas.: 960294-14-8 | Purity: 95% | tert-Butyl 1,7-diazaspiro[4.5]decane-1-carboxylate | ESD-876123-250MG |
| Cas.: 960294-14-8 | Purity: 95% | tert-Butyl 1,7-diazaspiro[4.5]decane-1-carboxylate | ESD-876123-1G |
| Cas.: 960293-88-3 | Purity: ≥99% | BI605906 | ESD-876124-2MG |
| Cas.: 960293-88-3 | Purity: ≥99% | BI605906 | ESD-876124-5MG |
| Cas.: 960079-47-4 | Purity: 95% | 2-Phenyl-2,6-diazaspiro[3.3]heptan-1-one | ESD-876125-250MG |
| Cas.: 960079-47-4 | Purity: 95% | 2-Phenyl-2,6-diazaspiro[3.3]heptan-1-one | ESD-876125-500MG |
| Cas.: 959860-85-6 | Purity: ≥99% | cFMS Receptor Inhibitor II | ESD-876126-1MG |
| Cas.: 959860-85-6 | Purity: ≥99% | cFMS Receptor Inhibitor II | ESD-876126-5MG |
| Cas.: 959860-49-2 | Purity: 95% | Guajadial | ESD-876127-5MG |
| Cas.: 959746-77-1 | Purity: ≥99% | A-836339 | ESD-876128-1MG |
| Cas.: 959746-77-1 | Purity: ≥99% | A-836339 | ESD-876128-5MG |
| Cas.: 959579-91-0 | Purity: 95% | 7,8-dimethyl-1-azaspiro[4.4]nonane hydrochloride | ESD-876129-5MG |
| Cas.: 959579-91-0 | Purity: 95% | 7,8-dimethyl-1-azaspiro[4.4]nonane hydrochloride | ESD-876129-10MG |
| Cas.: 959421-20-6 | Purity: 95% | 5,7,4′-Trihydroxy-3,6-dimethoxy-3′-prenylflavone | ESD-876130-1MG |
| Cas.: 958885-86-4 | Purity: 97% | Epivitexolide D | ESD-876131-5MG |
| Cas.: 958631-84-0 | Purity: 95% | (E)-1-(4-Hydroxyphenyl)dec-1-en-3-one | ESD-876132-5MG |
| Cas.: 95853-92-2 | Purity: 98% | CGS 15435 | ESD-876133-1MG |
| Cas.: 95853-92-2 | Purity: 98% | CGS 15435 | ESD-876133-5MG |
| Cas.: 958451-84-8 | Purity: 95% | 1,4-Dithia-7-azaspiro[4.5]decane hydrochloride | ESD-876134-250MG |
| Cas.: 958451-84-8 | Purity: 95% | 1,4-Dithia-7-azaspiro[4.5]decane hydrochloride | ESD-876134-1G |
| Cas.: 958296-13-4 | Purity: 95% | Piperlotine D | ESD-876135-5MG |
| Cas.: 958295-17-5 | Purity: 98% | AGN 196996 | ESD-876136-25MG |
| Cas.: 958295-17-5 | Purity: 98% | AGN 196996 | ESD-876136-100MG |
| Cas.: 958002-33-0 | Purity: ≥99% | Beclabuvir | ESD-876137-1MG |
| Cas.: 958002-33-0 | Purity: ≥99% | Beclabuvir | ESD-876137-5MG |
| Cas.: 957890-42-5 | Purity: ≥99% | HIV-1 integration inhibitor 2 | ESD-876138-1MG |
| Cas.: 957890-42-5 | Purity: ≥99% | HIV-1 integration inhibitor 2 | ESD-876138-5MG |
| Cas.: 95732-59-5 | Purity: 97% | Hedyotisol A | ESD-876139-5MG |
| Cas.: 957230-65-8 | Purity: 98% | Afegostat D-Tartrate | ESD-876140-1MG |
| Cas.: 957209-68-6 | Purity: 98% | NVP-QAV-572 | ESD-876141-5MG |
| Cas.: 957209-68-6 | Purity: 98% | NVP-QAV-572 | ESD-876141-10MG |
| Cas.: 957187-37-0 | Purity: 95% | (R)-2-(6-(tert-Butoxycarbonyl)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]decan-9-yl)acetic acid | ESD-876142-250MG |
| Cas.: 957187-37-0 | Purity: 95% | (R)-2-(6-(tert-Butoxycarbonyl)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]decan-9-yl)acetic acid | ESD-876142-1G |
| Cas.: 957135-43-2 | Purity: ≥99% | SM-164 | ESD-876143-2MG |
| Cas.: 957135-43-2 | Purity: ≥99% | SM-164 | ESD-876143-5MG |
| Cas.: 957118-49-9 | Purity: ≥98% | MK-3207 | ESD-876144-5MG |
| Cas.: 957118-49-9 | Purity: ≥98% | MK-3207 | ESD-876144-10MG |
| Cas.: 957054-33-0 | Purity: ≥99% | Pictilisib dimethanesulfonate | ESD-876145-5MG |
| Cas.: 957054-33-0 | Purity: ≥99% | Pictilisib dimethanesulfonate | ESD-876145-10MG |
| Cas.: 956906-93-7 | Purity: ≥99% | PF-04217903 methanesulfonate | ESD-876146-5MG |
| Cas.: 956906-93-7 | Purity: ≥99% | PF-04217903 methanesulfonate | ESD-876146-10MG |
| Cas.: 956901-32-9 | Purity: 98% | Betamethasone hydrochloride | ESD-876147-100MG |
| Cas.: 956901-32-9 | Purity: 98% | Betamethasone hydrochloride | ESD-876147-500MG |
| Cas.: 956869-95-7 | Purity: 95% | Euscaphin B | ESD-876148-1MG |
| Cas.: 956590-23-1 | Purity: ≥99% | UNBS5162 | ESD-876149-10MG |
| Cas.: 956590-23-1 | Purity: ≥99% | UNBS5162 | ESD-876149-50MG |
| Cas.: 956437-13-1 | Purity: 95% | spiro[bicyclo[3.2.1]octane-8,2′-[1,3]dithiolane]-3-carboxylic acid | ESD-876150-1G |
| Cas.: 956437-13-1 | Purity: 95% | spiro[bicyclo[3.2.1]octane-8,2′-[1,3]dithiolane]-3-carboxylic acid | ESD-876150-2.5G |
| Cas.: 956384-55-7 | Purity: 95% | Demethylsonchifolin | ESD-876151-5MG |
| Cas.: 956369-21-4 | Purity: 95% | spiro[bicyclo[3.3.1]nonane-9,2′-[1,3]dithiolane]-3-carboxylic acid | ESD-876152-1MG |
| Cas.: 956274-94-5 | Purity: ≥99% | Mavatrep | ESD-876153-5MG |
| Cas.: 956274-94-5 | Purity: ≥99% | Mavatrep | ESD-876153-10MG |
| Cas.: 956136-95-1 | Purity: ≥98% | Pradigastat | ESD-876154-5MG |
| Cas.: 956136-95-1 | Purity: ≥98% | Pradigastat | ESD-876154-10MG |
| Cas.: 956025-47-1 | Purity: ≥99% | 1-Naphthyl PP1 hydrochloride | ESD-876155-5MG |
| Cas.: 956025-47-1 | Purity: ≥99% | 1-Naphthyl PP1 hydrochloride | ESD-876155-10MG |
| Cas.: 955135-37-2 | Purity: 98% | 8,3′-Diprenylapigenin | ESD-876156-5MG |
| Cas.: 955028-68-9 | Purity: 97% | 6-AZASPIRO[2.5]OCTAN-4-OL HCL | ESD-876157-1G |
| Cas.: 955028-68-9 | Purity: 97% | 6-AZASPIRO[2.5]OCTAN-4-OL HCL | ESD-876157-5G |
| Cas.: 95480-80-1 | Purity: 95% | 5-Hydroxy-7-acetoxy-8-methoxyflavone | ESD-876158-1G |
| Cas.: 95456-43-2 | Purity: 98% | Hydroxytuberosone | ESD-876159-5MG |
| Cas.: 95442-76-5 | Purity: 95% | 4-Azaspiro[2.4]heptane hemioxalate | ESD-876160-5MG |
| Cas.: 95442-76-5 | Purity: 95% | 4-Azaspiro[2.4]heptane hemioxalate | ESD-876160-10MG |
| Cas.: 954389-09-4 | Purity: 98% | JTK-853 | ESD-876161-1MG |
| Cas.: 954389-09-4 | Purity: 98% | JTK-853 | ESD-876161-5MG |
| Cas.: 954379-68-1 | Purity: 98% | Neotuberostemonone | ESD-876162-5MG |
| Cas.: 954240-14-3 | Purity: 95% | 2,8-Diazaspiro[5.5]undecane-2-carboxylicacid tert-butyl ester | ESD-876163-500MG |
| Cas.: 954240-14-3 | Purity: 95% | 2,8-Diazaspiro[5.5]undecane-2-carboxylicacid tert-butyl ester | ESD-876163-1G |
| Cas.: 95416-25-4 | Purity: 98% | 15-Hydroxy-7-oxodehydroabietic acid | ESD-876164-5MG |
| Cas.: 954126-98-8 | Purity: ≥98% | Danirixin | ESD-876165-1MG |
| Cas.: 954126-98-8 | Purity: ≥98% | Danirixin | ESD-876165-5MG |
| Cas.: 95360-22-8 | Purity: 98% | Hainanmurpanin | ESD-876166-5MG |
| Cas.: 95343-20-7 | Purity: ≥98% | Pirarubicin Hydrochloride | ESD-876167-10MG |
| Cas.: 95343-20-7 | Purity: ≥98% | Pirarubicin Hydrochloride | ESD-876167-50MG |
| Cas.: 953427-66-2 | Purity: 98% | 2-Hydroxy-5-(2-hydroxy-4-methoxybenzyl)-4-methoxybenzaldehyde | ESD-876168-5MG |
| Cas.: 95298-47-8 | Purity: 98% | Kaji-ichigoside F1 | ESD-876169-5MG |
| Cas.: 952849-76-2 | Purity: ≥98% | KKL-10 | ESD-876170-1MG |
| Cas.: 952849-76-2 | Purity: ≥98% | KKL-10 | ESD-876170-5MG |
| Cas.: 952681-82-2 | Purity: 95% | 2-(1′-(tert-Butoxycarbonyl)spiro[chroman-2,4′-piperidine]-4-yl)acetic acid | ESD-876171-250MG |
| Cas.: 95262-48-9 | Purity: 95% | Niga-ichigoside F1 | ESD-876172-5MG |
| Cas.: 95258-17-6 | Purity: 98% | Yadanzioside G | ESD-876173-5MG |
| Cas.: 95258-16-5 | Purity: 98% | Yadanzioside C | ESD-876174-5MG |
| Cas.: 95258-15-4 | Purity: 98% | Yadanzioside A | ESD-876175-5MG |
| Cas.: 95258-14-3 | Purity: 98% | Yadanziolide A | ESD-876176-5MG |
| Cas.: 95258-13-2 | Purity: 98% | Yadanziolide B | ESD-876177-5MG |
| Cas.: 95258-12-1 | Purity: 96% | Yadanziolide C | ESD-876178-5MG |
| Cas.: 95258-11-0 | Purity: 98% | Yadanzioside F | ESD-876179-5MG |
| Cas.: 952485-00-6 | Purity: 96% | Hydrangenoside A dimethyl acetal | ESD-876180-5MG |
| Cas.: 952480-32-9 | Purity: 95% | 2-(3-(tert-Butoxycarbonyl)-3-azaspiro-[5.5]undecan-9-yl)acetic acid | ESD-876181-250MG |
| Cas.: 952480-32-9 | Purity: 95% | 2-(3-(tert-Butoxycarbonyl)-3-azaspiro-[5.5]undecan-9-yl)acetic acid | ESD-876181-1G |
| Cas.: 952473-86-8 | Purity: 97% | Neocaesalpin L | ESD-876182-5MG |
| Cas.: 95232-68-1 | Purity: 98% | Tenosal | ESD-876183-1MG |
| Cas.: 95232-68-1 | Purity: 98% | Tenosal | ESD-876183-5MG |
| Cas.: 95195-98-5 | Purity: 95% | 3,4-Dihydro-2H-spiro[naphthalene-1,4′-piperidine] hydrochloride | ESD-876184-500MG |
| Cas.: 951884-04-1 | Purity: 95% | 2′,7′-Dibromospiro[cyclopent[3]ene-1,9′-fluorene] | ESD-876185-1G |
| Cas.: 951884-04-1 | Purity: 95% | 2′,7′-Dibromospiro[cyclopent[3]ene-1,9′-fluorene] | ESD-876185-5G |
| Cas.: 951884-03-0 | Purity: 95% | 2′,7′-Dibromo-2-vinylspiro[cyclopropane-1,9′-fluorene] | ESD-876186-250MG |
| Cas.: 951884-03-0 | Purity: 95% | 2′,7′-Dibromo-2-vinylspiro[cyclopropane-1,9′-fluorene] | ESD-876186-1G |
| Cas.: 95188-34-4 | Purity: 95% | Sibiricin | ESD-876187-1MG |
| Cas.: 951571-70-3 | Purity: ≥98% | Neurotoxin Inhibitor | ESD-876188-5MG |
| Cas.: 951571-70-3 | Purity: ≥98% | Neurotoxin Inhibitor | ESD-876188-10MG |
| Cas.: 951395-08-7 | Purity: ≥99% | Tafamidis meglumine | ESD-876189-5MG |
| Cas.: 951395-08-7 | Purity: ≥99% | Tafamidis meglumine | ESD-876189-10MG |
| Cas.: 951382-34-6 | Purity: 98% | Ipragliflozin L-Proline | ESD-876190-5MG |
| Cas.: 951382-34-6 | Purity: 98% | Ipragliflozin L-Proline | ESD-876190-10MG |
| Cas.: 95135-98-1 | Purity: 97% | Artemetin acetate | ESD-876191-5MG |
| Cas.: 951322-11-5 | Purity: ≥99% | Desformylflustrabromine hydrochloride | ESD-876192-5MG |
| Cas.: 951322-11-5 | Purity: ≥99% | Desformylflustrabromine hydrochloride | ESD-876192-10MG |
| Cas.: 951164-20-8 | Purity: 95% | 1-Oxaspiro[4.4]nonan-6-amine hydrochloride | ESD-876193-250MG |
| Cas.: 95066-33-4 | Purity: 97% | Delbonine | ESD-876194-5MG |
| Cas.: 950-31-2 | Purity: 95% | 1’H-SPIRO[CYCLOHEXANE-1,2′-QUINAZOLIN]-4′(3’H)-ONE | ESD-876195-250MG |
| Cas.: 950-31-2 | Purity: 95% | 1’H-SPIRO[CYCLOHEXANE-1,2′-QUINAZOLIN]-4′(3’H)-ONE | ESD-876195-1G |
| Cas.: 949912-58-7 | Purity: 98% | Remodelin | ESD-876196-5MG |
| Cas.: 949912-58-7 | Purity: 98% | Remodelin | ESD-876196-10MG |
| Cas.: 94942-49-1 | Purity: 96% | 6-Methoxynaringenin | ESD-876197-5MG |
| Cas.: 949095-98-1 | Purity: 98% | Duloxetine metabolite Para-Naphthol Duloxetine | ESD-876198-1MG |
| Cas.: 949095-98-1 | Purity: 98% | Duloxetine metabolite Para-Naphthol Duloxetine | ESD-876198-5MG |
| Cas.: 949081-09-8 | Purity: 98% | 8-Hydroxy-ar-turmerone | ESD-876199-5MG |
| Cas.: 949081-05-4 | Purity: 98% | 6-(4-Hydroxy-3-methylphenyl)-2-methylhept-2-en-4-one | ESD-876200-5MG |
| Cas.: 948884-38-6 | Purity: 98% | Acuminatanol | ESD-876201-5MG |
| Cas.: 948841-07-4 | Purity: 98% | TB5 | ESD-876202-2MG |
| Cas.: 948841-07-4 | Purity: 98% | TB5 | ESD-876202-5MG |
| Cas.: 94805-82-0 | Purity: 98% | Glycycoumarin | ESD-876203-5MG |
| Cas.: 948033-85-0 | Purity: 97% | tert-Butyl 5-methyl-3-oxo-2,3-dihydrospiro-[indene-1,4′-piperidine]-1′-carboxylate | ESD-876204-250MG |
| Cas.: 948033-85-0 | Purity: 97% | tert-Butyl 5-methyl-3-oxo-2,3-dihydrospiro-[indene-1,4′-piperidine]-1′-carboxylate | ESD-876204-500MG |
| Cas.: 947914-18-3 | Purity: ≥98% | ML365 | ESD-876205-2MG |
| Cas.: 947914-18-3 | Purity: ≥98% | ML365 | ESD-876205-5MG |
| Cas.: 947669-91-2 | Purity: ≥99% | WWL70 | ESD-876206-5MG |
| Cas.: 947669-91-2 | Purity: ≥99% | WWL70 | ESD-876206-10MG |
| Cas.: 947534-12-5 | Purity: 95% | 1,4-Dithia-8-azaspiro[4.6]undecane hydrochloride | ESD-876207-250MG |
| Cas.: 947534-12-5 | Purity: 95% | 1,4-Dithia-8-azaspiro[4.6]undecane hydrochloride | ESD-876207-1G |
| Cas.: 947529-92-2 | Purity: 97% | Ethyl (9Z,11E)-13-hydroxyoctadeca-9,11-dienoate | ESD-876208-5MG |
| Cas.: 94739-29-4 | Purity: 98% | Lemildipine | ESD-876209-1MG |
| Cas.: 94739-29-4 | Purity: 98% | Lemildipine | ESD-876209-5MG |
| Cas.: 947257-66-1 | Purity: 98% | D-3263 | ESD-876210-1MG |
| Cas.: 947257-66-1 | Purity: 98% | D-3263 | ESD-876210-5MG |
| Cas.: 946518-61-2 | Purity: ≥98% | LY2409881 | ESD-876211-2MG |
| Cas.: 946518-61-2 | Purity: ≥98% | LY2409881 | ESD-876211-5MG |
| Cas.: 946497-95-6 | Purity: 97% | TERT-BUTYL 3′-AMINO-1’H-SPIRO[CYCLOPROPANE-1,6′-PYRROLO[3,4-C]PYRAZOLE]-5′(4’H)-CARBOXYLATE | ESD-876212-50MG |
| Cas.: 946497-95-6 | Purity: 97% | TERT-BUTYL 3′-AMINO-1’H-SPIRO[CYCLOPROPANE-1,6′-PYRROLO[3,4-C]PYRAZOLE]-5′(4’H)-CARBOXYLATE | ESD-876212-250MG |
| Cas.: 946387-38-8 | Purity: 95% | 5-Bromo-3′-(4-ethoxyphenyl)spiro[indoline-3,2′-thiazolidine]-2,4′-dione | ESD-876213-2G |
| Cas.: 946387-38-8 | Purity: 95% | 5-Bromo-3′-(4-ethoxyphenyl)spiro[indoline-3,2′-thiazolidine]-2,4′-dione | ESD-876213-10G |
| Cas.: 946387-07-1 | Purity: ≥99% | RN-1734 | ESD-876214-5MG |
| Cas.: 946387-07-1 | Purity: ≥99% | RN-1734 | ESD-876214-10MG |
| Cas.: 94617-36-4 | Purity: 97% | Mulberrofuran K | ESD-876215-5MG |
| Cas.: 946150-57-8 | Purity: ≥98% | Remetinostat | ESD-876216-5MG |
| Cas.: 946150-57-8 | Purity: ≥98% | Remetinostat | ESD-876216-10MG |
| Cas.: 945976-76-1 | Purity: ≥99% | LX-1031 | ESD-876217-2MG |
| Cas.: 945976-76-1 | Purity: ≥99% | LX-1031 | ESD-876217-5MG |
| Cas.: 945976-43-2 | Purity: ≥98% | LP-533401 | ESD-876218-1MG |
| Cas.: 945976-43-2 | Purity: ≥98% | LP-533401 | ESD-876218-5MG |
| Cas.: 945966-46-1 | Purity: ≥98% | Apararenone | ESD-876219-5MG |
| Cas.: 945966-46-1 | Purity: ≥98% | Apararenone | ESD-876219-10MG |
| Cas.: 94596-27-7 | Purity: 96% | Senkyunolide H | ESD-876221-5MG |
| Cas.: 945771-74-4 | Purity: ≥99% | BNC105 | ESD-876223-5MG |
| Cas.: 945771-74-4 | Purity: ≥99% | BNC105 | ESD-876223-10MG |
| Cas.: 945531-77-1 | Purity: ≥99% | Ezutromid | ESD-876224-5MG |
| Cas.: 945531-77-1 | Purity: ≥99% | Ezutromid | ESD-876224-10MG |
| Cas.: 945526-43-2 | Purity: ≥99% | ISCK03 | ESD-876225-5MG |
| Cas.: 945526-43-2 | Purity: ≥99% | ISCK03 | ESD-876225-10MG |
| Cas.: 94535-50-9 | Purity: ≥99% | Levcromakalim | ESD-876226-2MG |
| Cas.: 94535-50-9 | Purity: ≥99% | Levcromakalim | ESD-876226-5MG |
| Cas.: 94530-87-7 | Purity: 98% | Oleana-9(11),12-dien-3β-ol | ESD-876227-5MG |
| Cas.: 94530-85-5 | Purity: 95% | Senkyunolide G | ESD-876228-5MG |
| Cas.: 94530-83-3 | Purity: 95% | Senkyunolide E | ESD-876229-5MG |
| Cas.: 94529-97-2 | Purity: 98% | 20-Deoxocarnosol | ESD-876230-5MG |
| Cas.: 945259-61-0 | Purity: 95% | 4-Hydroxy-2-methoxyphenol1-O-(6-O-syringoyl)glucoside | ESD-876231-1MG |
| Cas.: 94513-60-7 | Purity: 98% | 7-Prenyljacareubin | ESD-876233-5MG |
| Cas.: 945128-26-7 | Purity: ≥98% | CYM-5541 | ESD-876234-5MG |
| Cas.: 945128-26-7 | Purity: ≥98% | CYM-5541 | ESD-876234-10MG |
| Cas.: 944905-36-6 | Purity: 95% | 5-FLUOROSPIRO[INDOLINE-3,4′-PIPERIDINE] | ESD-876235-250MG |
| Cas.: 944905-36-6 | Purity: 95% | 5-FLUOROSPIRO[INDOLINE-3,4′-PIPERIDINE] | ESD-876235-1G |
| Cas.: 944824-29-7 | Purity: 95% | Isodaphnoretin B | ESD-876236-5MG |
| Cas.: 944808-88-2 | Purity: ≥99% | CAY10566 | ESD-876237-1MG |
| Cas.: 944808-88-2 | Purity: ≥99% | CAY10566 | ESD-876237-5MG |
| Cas.: 944804-58-4 | Purity: 97% | Rhuscholide A | ESD-876238-5MG |
| Cas.: 944795-06-6 | Purity: ≥99% | Lck inhibitor 2 | ESD-876239-5MG |
| Cas.: 944795-06-6 | Purity: ≥99% | Lck inhibitor 2 | ESD-876239-10MG |
| Cas.: 94451-48-6 | Purity: 96% | Syzalterin | ESD-876240-5MG |
| Cas.: 94424-50-7 | Purity: ≥99% | Quinagolide hydrochloride | ESD-876241-5MG |
| Cas.: 94424-50-7 | Purity: ≥99% | Quinagolide hydrochloride | ESD-876241-10MG |
| Cas.: 944153-47-3 | Purity: ≥98% | SMER18 | ESD-876242-2MG |
| Cas.: 944153-47-3 | Purity: ≥98% | SMER18 | ESD-876242-5MG |
| Cas.: 94410-22-7 | Purity: 95% | Isomartynoside | ESD-876243-5MG |
| Cas.: 943989-68-2 | Purity: 98% | Iriflophenone 2-O-rhamnoside | ESD-876244-5MG |
| Cas.: 943962-47-8 | Purity: ≥98% | BMS-303141 | ESD-876245-5MG |
| Cas.: 943962-47-8 | Purity: ≥98% | BMS-303141 | ESD-876245-10MG |
| Cas.: 94390-09-7 | Purity: 95% | Sebiferenic acid | ESD-876246-1MG |
| Cas.: 943764-99-6 | Purity: ≥99% | Acebilustat | ESD-876247-1MG |
| Cas.: 943764-99-6 | Purity: ≥99% | Acebilustat | ESD-876247-5MG |
| Cas.: 94367-21-2 | Purity: ≥98% | Suc-Leu-Leu-Val-Tyr-AMC | ESD-876248-1MG |
| Cas.: 94367-21-2 | Purity: ≥98% | Suc-Leu-Leu-Val-Tyr-AMC | ESD-876248-5MG |
| Cas.: 94361-06-5 | Purity: ≥98% | Cyproconazole | ESD-876249-500MG |
| Cas.: 94361-06-5 | Purity: ≥98% | Cyproconazole | ESD-876249-1G |
| Cas.: 943609-66-3 | Purity: ≥99% | Vedolizumab | ESD-876250-1MG |
| Cas.: 943609-66-3 | Purity: ≥99% | Vedolizumab | ESD-876250-5MG |
| Cas.: 94356-26-0 | Purity: 98% | Piceatannol 3′-O-glucoside | ESD-876251-5MG |
| Cas.: 943540-74-7 | Purity: ≥99% | JNJ-38877618 | ESD-876252-5MG |
| Cas.: 943540-74-7 | Purity: ≥99% | JNJ-38877618 | ESD-876252-10MG |
| Cas.: 94344-54-4 | Purity: 97% | Sappanchalcone | ESD-876253-5MG |
| Cas.: 943344-58-9 | Purity: 98% | Genz-123346 | ESD-876254-5MG |
| Cas.: 943344-58-9 | Purity: 98% | Genz-123346 | ESD-876254-10MG |
| Cas.: 943145-62-8 | Purity: 95% | 2-Phenyl-1,3,8-triazaspiro[4.5]dec-1-en-4-one hydrochloride | ESD-876255-1G |
| Cas.: 943136-39-8 | Purity: 95% | Chlorahololide D | ESD-876256-5MG |
| Cas.: 943134-39-2 | Purity: 98% | Danegaptide | ESD-876257-2MG |
| Cas.: 943134-39-2 | Purity: 98% | Danegaptide | ESD-876257-5MG |
| Cas.: 942999-61-3 | Purity: ≥95% | DGAT-1 inhibitor 2 | ESD-876258-5MG |
| Cas.: 942999-61-3 | Purity: ≥95% | DGAT-1 inhibitor 2 | ESD-876258-10MG |
| Cas.: 94285-22-0 | Purity: 98% | Acetyldihydromicromelin A | ESD-876259-5MG |
| Cas.: 94285-06-0 | Purity: 98% | Dihydromicromelin B | ESD-876260-5MG |
| Cas.: 942626-75-7 | Purity: 95% | 5-Hydroxy-7,8,2′,5′-tetramethoxyflavone 5-O-glucoside | ESD-876261-1MG |
| Cas.: 942609-65-6 | Purity: 98% | 1,5,15-Tri-O-methylmorindol | ESD-876262-5MG |
| Cas.: 942582-15-2 | Purity: 93% | Walsuronoid B | ESD-876263-5MG |
| Cas.: 942507-42-8 | Purity: ≥99% | AZ304 | ESD-876264-5MG |
| Cas.: 942507-42-8 | Purity: ≥99% | AZ304 | ESD-876264-10MG |
| Cas.: 942480-13-9 | Purity: 97% | Nemoralisin | ESD-876265-5MG |
| Cas.: 942474-81-9 | Purity: 95% | 8-[2-Nitro-4-(trifluoromethyl)phenyl]-1,4-dioxa-8-azaspiro-[4,5]-decane | ESD-876266-1G |
| Cas.: 942474-81-9 | Purity: 95% | 8-[2-Nitro-4-(trifluoromethyl)phenyl]-1,4-dioxa-8-azaspiro-[4,5]-decane | ESD-876266-2G |
| Cas.: 942474-71-7 | Purity: 95% | 8-[5-(Trifluoromethyl)pyridin-2-yl]-1,4-dioxa-8-azaspiro[4.5]decane | ESD-876267-1G |
| Cas.: 942474-71-7 | Purity: 95% | 8-[5-(Trifluoromethyl)pyridin-2-yl]-1,4-dioxa-8-azaspiro[4.5]decane | ESD-876267-2G |
| Cas.: 942474-61-5 | Purity: 95% | 8-[4-(Ethylsulfonyl)-2-nitrophenyl]-1,4-dioxa-8-azaspiro[4.5]decane | ESD-876268-250MG |
| Cas.: 942436-93-3 | Purity: ≥98% | AZD-6280 | ESD-876269-1MG |
| Cas.: 942436-93-3 | Purity: ≥98% | AZD-6280 | ESD-876269-5MG |
| Cas.: 942398-84-7 | Purity: ≥99% | Amiselimod hydrochloride | ESD-876270-1MG |
| Cas.: 942398-84-7 | Purity: ≥99% | Amiselimod hydrochloride | ESD-876270-5MG |
| Cas.: 94234-24-9 | Purity: 95% | 20-Dehydroeupatoriopicrin semiacetal | ESD-876271-5MG |
| Cas.: 942142-51-0 | Purity: 98% | VTP-27999 | ESD-876272-2MG |
| Cas.: 942142-51-0 | Purity: 98% | VTP-27999 | ESD-876272-5MG |
| Cas.: 942123-43-5 | Purity: ≥98% | Inarigivir soproxil | ESD-876273-5MG |
| Cas.: 942123-43-5 | Purity: ≥98% | Inarigivir soproxil | ESD-876273-10MG |
| Cas.: 941987-60-6 | Purity: ≥99% | H-151 | ESD-876274-5MG |
| Cas.: 941987-60-6 | Purity: ≥99% | H-151 | ESD-876274-10MG |
| Cas.: 94-16-6 | Purity: ≥99% | Aminohippurate sodium | ESD-876275-100MG |
| Cas.: 94-16-6 | Purity: ≥99% | Aminohippurate sodium | ESD-876275-200MG |
| Cas.: 941227-27-6 | Purity: 95% | 1,3,5-Cadinatriene-3,8-diol | ESD-876276-1MG |
| Cas.: 940908-79-2 | Purity: ≥99% | Mericitabine | ESD-876277-5MG |
| Cas.: 940908-79-2 | Purity: ≥99% | Mericitabine | ESD-876277-10MG |
| Cas.: 94071-26-8 | Purity: 98% | Cerebellin | ESD-876278-1MG |
| Cas.: 94071-26-8 | Purity: 98% | Cerebellin | ESD-876278-5MG |
| Cas.: 939983-14-9 | Purity: 98% | p53 and MDM2 proteins-interaction-inhibitor (racemic) | ESD-876279-10MG |
| Cas.: 939983-14-9 | Purity: 98% | p53 and MDM2 proteins-interaction-inhibitor (racemic) | ESD-876279-100MG |
| Cas.: 939981-37-0 | Purity: ≥97% | p53 and MDM2 proteins-interaction-inhibitor (chiral) | ESD-876280-10MG |
| Cas.: 939981-37-0 | Purity: ≥97% | p53 and MDM2 proteins-interaction-inhibitor (chiral) | ESD-876280-100MG |
| Cas.: 939805-30-8 | Purity: ≥97% | ACTB-1003 | ESD-876281-2MG |
| Cas.: 939805-30-8 | Purity: ≥97% | ACTB-1003 | ESD-876281-5MG |
| Cas.: 939793-21-2 | Purity: 95% | 1,7-Diazaspiro[4.5]decane-7-carboxylic acid tert-butyl ester | ESD-876282-250MG |
| Cas.: 939793-21-2 | Purity: 95% | 1,7-Diazaspiro[4.5]decane-7-carboxylic acid tert-butyl ester | ESD-876282-1G |
| Cas.: 93915-36-7 | Purity: 97% | Hirsutanool 5-O-glucoside | ESD-876283-5MG |
| Cas.: 939055-18-2 | Purity: ≥99% | FIPI | ESD-876284-5MG |
| Cas.: 939055-18-2 | Purity: ≥99% | FIPI | ESD-876284-10MG |
| Cas.: 93888-59-6 | Purity: 97% | 9-Oxo-2,7-bisaboladien-15-oic acid | ESD-876285-5MG |
| Cas.: 93859-63-3 | Purity: 97% | Isochamaejasmin | ESD-876286-5MG |
| Cas.: 938458-82-3 | Purity: 95% | (spiro[2.5]oct-1-ylmethyl)amine | ESD-876287-1G |
| Cas.: 938458-82-3 | Purity: 95% | (spiro[2.5]oct-1-ylmethyl)amine | ESD-876287-5G |
| Cas.: 938448-87-4 | Purity: ≥97% | Bucladesine calcium salt | ESD-876288-50MG |
| Cas.: 938448-87-4 | Purity: ≥97% | Bucladesine calcium salt | ESD-876288-100MG |
| Cas.: 93796-20-4 | Purity: 98% | 3-Prenyl-2,4,6-trihydroxybenzophenone | ESD-876289-5MG |
| Cas.: 937812-80-1 | Purity: 98% | gamma-Secretase Modulators | ESD-876290-5MG |
| Cas.: 937812-80-1 | Purity: 98% | gamma-Secretase Modulators | ESD-876290-10MG |
| Cas.: 937729-06-1 | Purity: 95% | 1,8-Diazaspiro[4.5]decane-8-carboxylicacid tert-butyl ester | ESD-876291-100MG |
| Cas.: 937729-06-1 | Purity: 95% | 1,8-Diazaspiro[4.5]decane-8-carboxylicacid tert-butyl ester | ESD-876291-250MG |
| Cas.: 93767-25-0 | Purity: 95% | Jangomolide | ESD-876292-5MG |
| Cas.: 93753-33-4 | Purity: 95% | Magnaldehyde D | ESD-876293-5MG |
| Cas.: 937270-47-8 | Purity: ≥99% | SB1317 | ESD-876294-5MG |
| Cas.: 937270-47-8 | Purity: ≥99% | SB1317 | ESD-876294-10MG |
| Cas.: 93710-27-1 | Purity: 97% | Leuconolam | ESD-876295-5MG |
| Cas.: 93697-42-8 | Purity: 98% | Magnolignan C | ESD-876296-5MG |
| Cas.: 936947-34-1 | Purity: 95% | 1-Oxa-6-azaspiro[3.3]heptane oxalate | ESD-876297-100MG |
| Cas.: 936947-34-1 | Purity: 95% | 1-Oxa-6-azaspiro[3.3]heptane oxalate | ESD-876297-1G |
| Cas.: 93675-96-8 | Purity: 95% | Campsiketalin | ESD-876298-5MG |
| Cas.: 93675-85-5 | Purity: 97% | Rengyol | ESD-876299-5MG |
| Cas.: 93674-97-6 | Purity: 98% | Arg-Gly-Glu-Ser | ESD-876300-2MG |
| Cas.: 93674-97-6 | Purity: 98% | Arg-Gly-Glu-Ser | ESD-876300-5MG |
| Cas.: 93673-81-5 | Purity: 95% | Magnoligna A | ESD-876301-5MG |
| Cas.: 936648-40-7 | Purity: 95% | 6-FLUOROSPIRO[CHROMAN-2,4′-PIPERIDIN]-4-ONE HCL | ESD-876302-1G |
| Cas.: 936648-40-7 | Purity: 95% | 6-FLUOROSPIRO[CHROMAN-2,4′-PIPERIDIN]-4-ONE HCL | ESD-876302-5G |
| Cas.: 936648-38-3 | Purity: 95% | N-Boc-7-Bromo-4-oxo-3,4-dihydro-1’H-spiro[chromene-2,4′-piperidine] | ESD-876303-1G |
| Cas.: 936648-38-3 | Purity: 95% | N-Boc-7-Bromo-4-oxo-3,4-dihydro-1’H-spiro[chromene-2,4′-piperidine] | ESD-876303-5G |
| Cas.: 936563-87-0 | Purity: 98% | Ibrutinib Racemate | ESD-876304-5MG |
| Cas.: 936563-87-0 | Purity: 98% | Ibrutinib Racemate | ESD-876304-10MG |
| Cas.: 936490-38-9 | Purity: 0.25M in Tetrahydrofuran | 4-[8-(1,4-Dioxa-8-azaspiro[4.5]decyl)methyl]phenylmagnesium bromide 0.25 M in Tetrahydrofuran | ESD-876305-100ML |
| Cas.: 936446-61-6 | Purity: ≥99% | NRC-2694 | ESD-876306-1MG |
| Cas.: 936446-61-6 | Purity: ≥99% | NRC-2694 | ESD-876306-5MG |
| Cas.: 936006-11-0 | Purity: 96% | 5-(6-Hydroxybenzofuran-2-yl)-2-(3-methylbut-1-enyl)benzene-1,3-diol | ESD-876307-5MG |
| Cas.: 935863-26-6 | Purity: 98% | Aspyridone A | ESD-876308-5MG |
| Cas.: 935525-13-6 | Purity: 98% | BMS 433796 | ESD-876309-1MG |
| Cas.: 935525-13-6 | Purity: 98% | BMS 433796 | ESD-876309-5MG |
| Cas.: 935467-97-3 | Purity: ≥98% | TH-237A | ESD-876310-5MG |
| Cas.: 935467-97-3 | Purity: ≥98% | TH-237A | ESD-876310-10MG |
| Cas.: 935293-70-2 | Purity: 95% | (4→2)-Abeo-16-hydroxycleroda-2,13-dien-15,16-olide-3-al | ESD-876311-5MG |
| Cas.: 934828-12-3 | Purity: ≥99% | CXD101 | ESD-876312-1MG |
| Cas.: 934828-12-3 | Purity: ≥99% | CXD101 | ESD-876312-5MG |
| Cas.: 934826-68-3 | Purity: ≥98% | Visomitin | ESD-876313-5MG |
| Cas.: 934826-68-3 | Purity: ≥98% | Visomitin | ESD-876313-10MG |
| Cas.: 934809-60-6 | Purity: 98% | SA72 | ESD-876314-1MG |
| Cas.: 934809-60-6 | Purity: 98% | SA72 | ESD-876314-5MG |
| Cas.: 934739-29-4 | Purity: 95% | Karavilagenin D | ESD-876315-5MG |
| Cas.: 934664-22-9 | Purity: 95% | 1-Oxa-5-azaspiro[2.3]hexane-5-carboxylicacid phenylmethyl ester | ESD-876316-100MG |
| Cas.: 934664-22-9 | Purity: 95% | 1-Oxa-5-azaspiro[2.3]hexane-5-carboxylicacid phenylmethyl ester | ESD-876316-250MG |
| Cas.: 934662-91-6 | Purity: ≥99% | Cobimetinib racemate | ESD-876317-2MG |
| Cas.: 934662-91-6 | Purity: ≥99% | Cobimetinib racemate | ESD-876317-5MG |
| Cas.: 93460-55-0 | Purity: 97% | 8-Deacetylyunaconitine | ESD-876318-5MG |
| Cas.: 934554-40-2 | Purity: 95% | 3,4-dihydrospiro[1-benzopyran-2,1′-cyclobutane]-4-one | ESD-876319-10MG |
| Cas.: 934554-40-2 | Purity: 95% | 3,4-dihydrospiro[1-benzopyran-2,1′-cyclobutane]-4-one | ESD-876319-50MG |
| Cas.: 934554-38-8 | Purity: 95% | 3,4-dihydrospiro[1-benzopyran-2,1′-cyclobutane]-4-amine | ESD-876320-10MG |
| Cas.: 934554-38-8 | Purity: 95% | 3,4-dihydrospiro[1-benzopyran-2,1′-cyclobutane]-4-amine | ESD-876320-50MG |
| Cas.: 934369-14-9 | Purity: ≥99% | TY-52156 | ESD-876321-5MG |
| Cas.: 934369-14-9 | Purity: ≥99% | TY-52156 | ESD-876321-10MG |
| Cas.: 934269-17-7 | Purity: 95% | 2,7-Dibromo-2′,3′,5′,6′-tetrahydrospiro-[fluorene-9,4′-pyran] | ESD-876322-250MG |
| Cas.: 934269-17-7 | Purity: 95% | 2,7-Dibromo-2′,3′,5′,6′-tetrahydrospiro-[fluorene-9,4′-pyran] | ESD-876322-1G |
| Cas.: 93413-00-4 | Purity: 98% | Chamaechromone | ESD-876323-5MG |
| Cas.: 93395-30-3 | Purity: 98% | 8-Epicrepiside E | ESD-876324-5MG |
| Cas.: 93372-87-3 | Purity: 95% | 20-Hydroxy-3-oxolupan-28-oic acid | ESD-876325-250MG |
| Cas.: 933716-21-3 | Purity: 95% | 9-methyl-6,9-diazaspiro[4.5]decane | ESD-876326-1G |
| Cas.: 933716-21-3 | Purity: 95% | 9-methyl-6,9-diazaspiro[4.5]decane | ESD-876326-2.5G |
| Cas.: 93363-11-2 | Purity: 98% | 48740 RP | ESD-876327-1MG |
| Cas.: 93363-11-2 | Purity: 98% | 48740 RP | ESD-876327-5MG |
| Cas.: 933-41-5 | Purity: 95% | 1-Thia-4-azaspiro[4.5]decane hydrochloride | ESD-876328-1G |
| Cas.: 933-41-5 | Purity: 95% | 1-Thia-4-azaspiro[4.5]decane hydrochloride | ESD-876328-5G |
| Cas.: 932924-40-8 | Purity: 95% | 5-methylspiro[1,3-dioxane-2,2′-tricyclo[3.3.1.1~3,7~]decane]-5-carboxylic acid | ESD-876329-1G |
| Cas.: 932749-62-7 | Purity: ≥99% | Histone Acetyltransferase Inhibitor II | ESD-876330-5MG |
| Cas.: 932749-62-7 | Purity: ≥99% | Histone Acetyltransferase Inhibitor II | ESD-876330-10MG |
| Cas.: 932737-65-0 | Purity: ≥98% | FITM | ESD-876331-2MG |
| Cas.: 932737-65-0 | Purity: ≥98% | FITM | ESD-876331-5MG |
| Cas.: 932730-51-3 | Purity: ≥99% | CDDO-EA | ESD-876332-1MG |
| Cas.: 932730-51-3 | Purity: ≥99% | CDDO-EA | ESD-876332-5MG |
| Cas.: 932372-01-5 | Purity: ≥99% | Asapiprant | ESD-876333-1MG |
| Cas.: 932372-01-5 | Purity: ≥99% | Asapiprant | ESD-876333-5MG |
| Cas.: 932108-20-8 | Purity: 98% | RSV604 R enantiomer | ESD-876334-2MG |
| Cas.: 932108-20-8 | Purity: 98% | RSV604 R enantiomer | ESD-876334-5MG |
| Cas.: 931359-26-1 | Purity: 97% | tert-Butyl 2-(4-chlorophenyl)-3-oxo-1,4,8-triazaspiro[4.5]dec-1-ene-8-carboxylate | ESD-876335-500MG |
| Cas.: 931359-26-1 | Purity: 97% | tert-Butyl 2-(4-chlorophenyl)-3-oxo-1,4,8-triazaspiro[4.5]dec-1-ene-8-carboxylate | ESD-876335-1G |
| Cas.: 93135-89-8 | Purity: 98% | Nafocare B1 | ESD-876336-1MG |
| Cas.: 93135-89-8 | Purity: 98% | Nafocare B1 | ESD-876336-5MG |
| Cas.: 93129-94-3 | Purity: 98% | Tacalcitol monohydrate | ESD-876337-1MG |
| Cas.: 93129-94-3 | Purity: 98% | Tacalcitol monohydrate | ESD-876337-5MG |
| Cas.: 931116-24-4 | Purity: 95% | (R,E)-Deca-2-ene-4,6-diyne-1,8-diol | ESD-876338-1MG |
| Cas.: 931114-98-6 | Purity: 95% | (S,E)-Deca-2,9-diene-4,6-diyne-1,8-diol | ESD-876339-1MG |
| Cas.: 93078-83-2 | Purity: 97% | 8-O-Demethyl-7-O-methyl-3,9-dihydropunctatin | ESD-876340-5MG |
| Cas.: 929915-58-2 | Purity: ≥99% | DG051 | ESD-876341-1MG |
| Cas.: 929915-58-2 | Purity: ≥99% | DG051 | ESD-876341-5MG |
| Cas.: 929895-45-4 | Purity: ≥98% | Phen-DC3 Trifluoromethanesulfonate | ESD-876342-1MG |
| Cas.: 929895-45-4 | Purity: ≥98% | Phen-DC3 Trifluoromethanesulfonate | ESD-876342-5MG |
| Cas.: 929881-46-9 | Purity: 98% | Cucumegastigmane I | ESD-876343-5MG |
| Cas.: 929828-30-8 | Purity: 95% | 1′-Propyl-3,5,6,7-tetrahydrospiro[imidazo[4,5-c]-pyridine-4,4′-piperidine] | ESD-876344-500MG |
| Cas.: 929809-29-0 | Purity: 95% | 1′-Isopropyl-3,5,6,7-tetrahydrospiro[imidazo-[4,5-c]pyridine-4,4′-piperidine] | ESD-876345-500MG |
| Cas.: 929637-35-4 | Purity: 95% | Sessilifoline A | ESD-876346-5MG |
| Cas.: 929622-09-3 | Purity: 98% | Bavisant dihydrochloride | ESD-876347-2MG |
| Cas.: 929622-09-3 | Purity: 98% | Bavisant dihydrochloride | ESD-876347-5MG |
| Cas.: 929622-08-2 | Purity: 98% | Bavisant | ESD-876348-2MG |
| Cas.: 929622-08-2 | Purity: 98% | Bavisant | ESD-876348-5MG |
| Cas.: 929621-79-4 | Purity: ≥99% | Ac-Leu-Arg-AMC | ESD-876349-1MG |
| Cas.: 929621-79-4 | Purity: ≥99% | Ac-Leu-Arg-AMC | ESD-876349-5MG |
| Cas.: 92953-10-1 | Purity: ≥99% | Clofilium tosylate | ESD-876350-10MG |
| Cas.: 92953-10-1 | Purity: ≥99% | Clofilium tosylate | ESD-876350-50MG |
| Cas.: 929301-99-5 | Purity: 91% | tert-Butyl 7-benzyl-2,7-diazaspiro[3.5]nonane-2-carboxylate | ESD-876351-250MG |
| Cas.: 928783-29-3 | Purity: ≥99% | Fluxametamide | ESD-876352-5MG |
| Cas.: 928783-29-3 | Purity: ≥99% | Fluxametamide | ESD-876352-10MG |
| Cas.: 928659-70-5 | Purity: ≥99% | Eliglustat hemitartrate | ESD-876353-1MG |
| Cas.: 928659-70-5 | Purity: ≥99% | Eliglustat hemitartrate | ESD-876353-5MG |
| Cas.: 928333-30-6 | Purity: ≥97% | IRAK inhibitor 2 | ESD-876354-5MG |
| Cas.: 928333-30-6 | Purity: ≥97% | IRAK inhibitor 2 | ESD-876354-10MG |
| Cas.: 928165-59-7 | Purity: 98% | 3-Chloro-1-(4-octylphenyl)-1-propanone | ESD-876355-5MG |
| Cas.: 928160-90-1 | Purity: 95% | (6-(1,4-Dioxa-8-azaspiro[4.5]decan-8-yl)pyridin-3-yl)boronic acid | ESD-876356-250MG |
| Cas.: 928160-90-1 | Purity: 95% | (6-(1,4-Dioxa-8-azaspiro[4.5]decan-8-yl)pyridin-3-yl)boronic acid | ESD-876356-1G |
| Cas.: 928151-78-4 | Purity: 95% | Tenacissoside F | ESD-876357-1MG |
| Cas.: 927812-23-5 | Purity: 98% | Glochicoccin D | ESD-876358-5MG |
| Cas.: 92691-35-5 | Purity: 96% | Germacrone 4,5-epoxide | ESD-876359-5MG |
| Cas.: 92631-66-8 | Purity: 98% | Deltatsine | ESD-876360-5MG |
| Cas.: 92609-77-3 | Purity: 98% | O-Demethylforbexanthone | ESD-876361-5MG |
| Cas.: 925932-10-1 | Purity: 95% | Secaubrytriol | ESD-876363-5MG |
| Cas.: 925932-08-7 | Purity: 98% | Secaubryenol | ESD-876364-5MG |
| Cas.: 925705-36-8 | Purity: 95% | 3-Isomangostin hydrate formate | ESD-876365-5MG |
| Cas.: 92519-95-4 | Purity: 98% | Viscidulin I | ESD-876366-5MG |
| Cas.: 92510-91-3 | Purity: ≥99% | F 16915 | ESD-876367-1MG |
| Cas.: 92510-91-3 | Purity: ≥99% | F 16915 | ESD-876367-5MG |
| Cas.: 924910-83-8 | Purity: 95% | 21-Deoxyneridienone B | ESD-876368-1MG |
| Cas.: 924901-58-6 | Purity: 98% | Rupesin E | ESD-876369-5MG |
| Cas.: 924775-38-2 | Purity: 95% | 1′-Acetyl-7,8-dihydroxyspiro[chromene-2,4′-piperidin]-4(3H)-one | ESD-876370-500MG |
| Cas.: 924775-34-8 | Purity: 95% | 1′-Acetyl-7-hydroxyspiro[chromene-2,4′-piperidin]-4(3H)-one | ESD-876371-500MG |
| Cas.: 924769-64-2 | Purity: 95% | 1′-Acetyl-3,4-dihydrospiro[chromene-2,4′-piperidin]-7-ol | ESD-876372-500MG |
| Cas.: 924740-45-4 | Purity: 95% | [(1′-Acetyl-4-oxo-3,4-dihydrospiro[chromene-2,4′-piperidin]-7-yl)oxy]acetic acid | ESD-876373-500MG |
| Cas.: 92466-31-4 | Purity: 97% | 4,5-Epoxyartemisinic acid | ESD-876374-5MG |
| Cas.: 923975-81-9 | Purity: 90% | 3-(4-Chlorophenyl)-1,4-diazaspiro-[4.5]dec-3-en-2-one | ESD-876375-500MG |
| Cas.: 923975-81-9 | Purity: 90% | 3-(4-Chlorophenyl)-1,4-diazaspiro-[4.5]dec-3-en-2-one | ESD-876375-1G |
| Cas.: 923950-05-4 | Purity: 95% | 3-Acetoxy-4-cadinen-8-one | ESD-876376-1MG |
| Cas.: 923009-54-5 | Purity: 95% | tert-Butyl 5-oxo-4,10-diazaspiro[5.5]undecane-10-carboxylate | ESD-876377-250MG |
| Cas.: 923009-54-5 | Purity: 95% | tert-Butyl 5-oxo-4,10-diazaspiro[5.5]undecane-10-carboxylate | ESD-876377-500MG |
| Cas.: 923009-50-1 | Purity: 95% | tert-Butyl 4-oxo-3,9-diazaspiro[4.5]decane-9-carboxylate | ESD-876378-250MG |
| Cas.: 923009-50-1 | Purity: 95% | tert-Butyl 4-oxo-3,9-diazaspiro[4.5]decane-9-carboxylate | ESD-876378-1G |
| Cas.: 92282-70-7 | Purity: 98% | 3-O-Methyl-3-methoxymaxterone | ESD-876379-5MG |
| Cas.: 92280-12-1 | Purity: 95% | Sanggenon N | ESD-876380-1MG |
| Cas.: 922522-15-4 | Purity: 95% | Daphnilongeridine | ESD-876381-5MG |
| Cas.: 92233-55-1 | Purity: 98% | Syringin pentaacetate | ESD-876382-5MG |
| Cas.: 922169-96-8 | Purity: 98% | 5,6-Desmethylenedioxy-5-methoxyaglalactone | ESD-876383-5MG |
| Cas.: 921769-65-5 | Purity: 98% | Capecitabine-2′,3′-cyclic carbonate | ESD-876384-5MG |
| Cas.: 921760-85-2 | Purity: 95% | tert-Butyl 6-carboxy-4-oxospiro[chroman-2,4′-piperidine]-1′-carboxylate | ESD-876385-1G |
| Cas.: 921760-85-2 | Purity: 95% | tert-Butyl 6-carboxy-4-oxospiro[chroman-2,4′-piperidine]-1′-carboxylate | ESD-876385-5G |
| Cas.: 92134-98-0 | Purity: ≥98% | Fosphenytoin disodium | ESD-876386-5MG |
| Cas.: 92134-98-0 | Purity: ≥98% | Fosphenytoin disodium | ESD-876386-10MG |
| Cas.: 920502-42-7 | Purity: 95% | Tenacigenoside A | ESD-876387-1MG |
| Cas.: 92007-41-5 | Purity: 97% | 5,5-Dimethyl-3′,3’a,4′,6’a-tetrahydro-1’H-spiro[1,3-dioxane-2,2′-pentalene] | ESD-876388-500MG |
| Cas.: 92007-41-5 | Purity: 97% | 5,5-Dimethyl-3′,3’a,4′,6’a-tetrahydro-1’H-spiro[1,3-dioxane-2,2′-pentalene] | ESD-876388-1G |
| Cas.: 92007-37-9 | Purity: 95% | 5,5-Dimethyl-hexahydro-1’H-spiro-[1,3-dioxane-2,2′-pentalene]-5′-one | ESD-876389-500MG |
| Cas.: 92007-37-9 | Purity: 95% | 5,5-Dimethyl-hexahydro-1’H-spiro-[1,3-dioxane-2,2′-pentalene]-5′-one | ESD-876389-1G |
| Cas.: 919769-83-8 | Purity: 95% | Buergerin B | ESD-876390-5MG |
| Cas.: 919744-57-3 | Purity: 95% | 6′-Ethyl-10′-hydroxy-3′,4′-dihydro-8’H-spiro[cyclohexane-1,2′-pyrano[3,2-g]chromen]-8′-one | ESD-876391-500MG |
| Cas.: 91913-76-7 | Purity: 97% | 1-Methoxyindole-3-carboxylic acid | ESD-876392-5MG |
| Cas.: 919120-78-8 | Purity: 95% | ent-Labda-8(17),13-dien-16,15-olid-19-oic acid glucosyl ester | ESD-876393-1MG |
| Cas.: 918644-73-2 | Purity: 97% | 3-BOC-9-HYDROXY-3-AZASPIRO[5.5]UNDECANE | ESD-876394-250MG |
| Cas.: 918644-73-2 | Purity: 97% | 3-BOC-9-HYDROXY-3-AZASPIRO[5.5]UNDECANE | ESD-876394-1G |
| Cas.: 91800-48-5 | Purity: 95% | 8-Ethyl-1,3-diaza-spiro[4.5]decane-2,4-dione | ESD-876395-1G |
| Cas.: 91800-45-2 | Purity: 95% | 7,9-dimethyl-1,3-diazaspiro[4.5]decane-2,4-dione | ESD-876396-1G |
| Cas.: 917-13-5 | Purity: 98% | Enniatin B | ESD-876397-5MG |
| Cas.: 916918-84-8 | Purity: ≥99% | Ansofaxine hydrochloride | ESD-876398-1MG |
| Cas.: 916918-84-8 | Purity: ≥99% | Ansofaxine hydrochloride | ESD-876398-5MG |
| Cas.: 91679-27-5 | Purity: 98% | 10-Hydroxyoleoside dimethyl ester | ESD-876399-5MG |
| Cas.: 91653-75-7 | Purity: 98% | Coriatin | ESD-876400-5MG |
| Cas.: 91652-78-7 | Purity: 96% | Senkyunolide C | ESD-876401-5MG |
| Cas.: 916493-82-8 | Purity: ≥98% | PROTAC BET-binding moiety 2 | ESD-876402-5MG |
| Cas.: 916493-82-8 | Purity: ≥98% | PROTAC BET-binding moiety 2 | ESD-876402-10MG |
| Cas.: 916264-22-7 | Purity: 95% | Acetylvirolin | ESD-876403-5MG |
| Cas.: 916236-79-8 | Purity: 98% | Gopherenediol | ESD-876404-5MG |
| Cas.: 915924-46-8 | Purity: 95% | 1-oxaspiro[4.5]dec-3-ylamine | ESD-876405-1G |
| Cas.: 915921-61-8 | Purity: 95% | 1-phenylspiro[2.4]heptane-1-carboxylic acid | ESD-876406-1G |
| Cas.: 915920-80-8 | Purity: 95% | 1-oxaspiro[4.4]non-3-ylamine | ESD-876407-1G |
| Cas.: 915920-80-8 | Purity: 95% | 1-oxaspiro[4.4]non-3-ylamine | ESD-876407-5G |
| Cas.: 915795-01-6 | Purity: 95% | 7-AMINO-7-METHYL-5-AZASPIRO[2.4]HEPTAN-4-ONE HYDROCHLORIDE | ESD-876408-250MG |
| Cas.: 915795-01-6 | Purity: 95% | 7-AMINO-7-METHYL-5-AZASPIRO[2.4]HEPTAN-4-ONE HYDROCHLORIDE | ESD-876408-1G |
| Cas.: 914637-75-5 | Purity: 95% | 8-(4-Fluoro-2-nitrophenyl)-1,4-dioxa-8-azaspiro[4.5]decane | ESD-876409-1G |
| Cas.: 914637-75-5 | Purity: 95% | 8-(4-Fluoro-2-nitrophenyl)-1,4-dioxa-8-azaspiro[4.5]decane | ESD-876409-2G |
| Cas.: 913814-37-6 | Purity: 95% | 2,6-Dibenzhydryl-2,6-diazaspiro[3.3]heptane | ESD-876410-250MG |
| Cas.: 913814-37-6 | Purity: 95% | 2,6-Dibenzhydryl-2,6-diazaspiro[3.3]heptane | ESD-876410-1G |
| Cas.: 913720-11-3 | Purity: 95% | 4′-FLUOROSPIRO[CYCLOPROPANE-1,3′-INDOLIN]-2′-ONE | ESD-876411-1G |
| Cas.: 913696-30-7 | Purity: 97% | 5,9-Dioxaspiro[3.5]non-7-ylmethanol | ESD-876412-1G |
| Cas.: 913556-40-8 | Purity: 97% | Lehmbachol D | ESD-876413-5MG |
| Cas.: 91269-84-0 | Purity: 95% | Melilotigenin B | ESD-876414-1MG |
| Cas.: 912445-05-7 | Purity: ≥99% | Veliparib dihydrochloride | ESD-876415-5MG |
| Cas.: 912445-05-7 | Purity: ≥99% | Veliparib dihydrochloride | ESD-876415-10MG |
| Cas.: 912329-03-4 | Purity: 96% | Karavilagenin A | ESD-876416-5MG |
| Cas.: 912288-64-3 | Purity: ≥98% | YHO-13351 free base | ESD-876417-5MG |
| Cas.: 912288-64-3 | Purity: ≥98% | YHO-13351 free base | ESD-876417-10MG |
| Cas.: 912287-56-0 | Purity: ≥98% | YHO-13177 | ESD-876418-5MG |
| Cas.: 912287-56-0 | Purity: ≥98% | YHO-13177 | ESD-876418-10MG |
| Cas.: 91216-38-5 | Purity: 95% | 7,7,9-Trimethyl-1,3-diaza-spiro[4.5]decane-2,4-dione | ESD-876419-25MG |
| Cas.: 91216-38-5 | Purity: 95% | 7,7,9-Trimethyl-1,3-diaza-spiro[4.5]decane-2,4-dione | ESD-876419-50MG |
| Cas.: 91188-26-0 | Purity: 95% | 2-Methyl-2,7-diazaspiro[4.4]nonane dihydrochloride | ESD-876420-1G |
| Cas.: 91188-26-0 | Purity: 95% | 2-Methyl-2,7-diazaspiro[4.4]nonane dihydrochloride | ESD-876420-5G |
| Cas.: 911715-90-7 | Purity: ≥98% | AZD8797 | ESD-876421-5MG |
| Cas.: 911715-90-7 | Purity: ≥98% | AZD8797 | ESD-876421-10MG |
| Cas.: 911714-91-5 | Purity: 95% | Chrysothol | ESD-876422-1MG |
| Cas.: 911714-45-9 | Purity: ≥99% | SP-420 | ESD-876423-2MG |
| Cas.: 911714-45-9 | Purity: ≥99% | SP-420 | ESD-876423-5MG |
| Cas.: 911212-25-4 | Purity: 98% | Cefoselis hydrochloride | ESD-876424-5MG |
| Cas.: 911212-25-4 | Purity: 98% | Cefoselis hydrochloride | ESD-876424-10MG |
| Cas.: 911110-93-5 | Purity: 98% | Adapalene sodium salt | ESD-876425-50MG |
| Cas.: 911110-93-5 | Purity: 98% | Adapalene sodium salt | ESD-876425-100MG |
| Cas.: 911004-72-3 | Purity: 95% | Furowanin A | ESD-876426-5MG |
| Cas.: 91095-51-1 | Purity: 97% | 3,6,19,23-Tetrahydroxy-12-ursen-28-oic acid | ESD-876427-5MG |
| Cas.: 910856-25-6 | Purity: 95% | Danshenol C | ESD-876428-5MG |
| Cas.: 910808-12-7 | Purity: 98% | Netupitant metabolite Monohydroxy Netupitant | ESD-876429-1MG |
| Cas.: 910808-12-7 | Purity: 98% | Netupitant metabolite Monohydroxy Netupitant | ESD-876429-5MG |
| Cas.: 910808-11-6 | Purity: 98% | Netupitant metabolite Netupitant N-oxide | ESD-876430-1MG |
| Cas.: 910808-11-6 | Purity: 98% | Netupitant metabolite Netupitant N-oxide | ESD-876430-5MG |
| Cas.: 910634-41-2 | Purity: ≥99% | Litronesib | ESD-876431-2MG |
| Cas.: 910634-41-2 | Purity: ≥99% | Litronesib | ESD-876431-5MG |
| Cas.: 910484-28-5 | Purity: ≥99% | TTA-Q6 | ESD-876432-5MG |
| Cas.: 910484-28-5 | Purity: ≥99% | TTA-Q6 | ESD-876432-10MG |
| Cas.: 910442-59-0 | Purity: 97% | tert-Butyl 6-methoxy-3-oxo-2,3-dihydrospiro-[indene-1,4′-piperidine]-1′-carboxylate | ESD-876433-250MG |
| Cas.: 910442-59-0 | Purity: 97% | tert-Butyl 6-methoxy-3-oxo-2,3-dihydrospiro-[indene-1,4′-piperidine]-1′-carboxylate | ESD-876433-500MG |
| Cas.: 910442-55-6 | Purity: 97% | 6-Fluoro-3-oxo-2,3-dihydrospiro[indene-1,4′-piperidine]-1′-carboxylic acid tert-butyl ester | ESD-876434-250MG |
| Cas.: 910442-55-6 | Purity: 97% | 6-Fluoro-3-oxo-2,3-dihydrospiro[indene-1,4′-piperidine]-1′-carboxylic acid tert-butyl ester | ESD-876434-500MG |
| Cas.: 91037-75-1 | Purity: 98% | GRGDSP | ESD-876435-1MG |
| Cas.: 91037-75-1 | Purity: 98% | GRGDSP | ESD-876435-5MG |
| Cas.: 910044-56-3 | Purity: ≥97% | Tertiapin-Q | ESD-876436-1MG |
| Cas.: 910044-56-3 | Purity: ≥97% | Tertiapin-Q | ESD-876436-5MG |
| Cas.: 90996-27-3 | Purity: 95% | 8-Methoxybonducellin | ESD-876437-1MG |
| Cas.: 909406-74-2 | Purity: 95% | ETHYL 6-OXASPIRO[2.5]OCTANE-1-CARBOXYLATE | ESD-876438-1G |
| Cas.: 909406-74-2 | Purity: 95% | ETHYL 6-OXASPIRO[2.5]OCTANE-1-CARBOXYLATE | ESD-876438-10G |
| Cas.: 909406-73-1 | Purity: 95% | 6-Oxaspiro[2.5]octane-1-carboxylic acid | ESD-876439-1G |
| Cas.: 90921-13-4 | Purity: 95% | Erythrocentauric acid | ESD-876440-5MG |
| Cas.: 909034-85-1 | Purity: 95% | SPIRO[ISOCHROMAN-4,4′-PIPERIDINE] | ESD-876441-250MG |
| Cas.: 909034-85-1 | Purity: 95% | SPIRO[ISOCHROMAN-4,4′-PIPERIDINE] | ESD-876441-1G |
| Cas.: 90902-21-9 | Purity: 96% | Broussonin E | ESD-876442-5MG |
| Cas.: 908601-49-0 | Purity: 98% | SB-616234A | ESD-876443-1MG |
| Cas.: 908601-49-0 | Purity: 98% | SB-616234A | ESD-876443-5MG |
| Cas.: 90852-99-6 | Purity: 97% | Ptelatoside B | ESD-876444-5MG |
| Cas.: 90851-50-6 | Purity: 98% | ent-Labda-8(17),13E-diene-3β,15,18-triol | ESD-876445-5MG |
| Cas.: 90851-28-8 | Purity: 98% | Goshonoside F5 | ESD-876446-5MG |
| Cas.: 90851-24-4 | Purity: 98% | Goshonoside F1 | ESD-876447-5MG |
| Cas.: 908098-80-6 | Purity: 95% | 6,8-Di-O-methylcitreoisocoumarin | ESD-876448-1MG |
| Cas.: 90807-98-0 | Purity: 98% | Ru-32514 | ESD-876449-1MG |
| Cas.: 90807-98-0 | Purity: 98% | Ru-32514 | ESD-876449-5MG |
| Cas.: 907583-51-1 | Purity: 98% | Musellactone | ESD-876450-5MG |
| Cas.: 90695-03-7 | Purity: 96% | (2Z,6Z,10E,14E,18E)-Farnesylfarnesol | ESD-876451-5MG |
| Cas.: 90686-12-7 | Purity: 90% | 5-Hydroxysophoranone | ESD-876452-5MG |
| Cas.: 90685-26-0 | Purity: 98% | Methyl 1,4-bisglucosyloxy-3-prenyl-2-naphthoate | ESD-876453-5MG |
| Cas.: 906805-42-3 | Purity: ≥99% | SCH 546738 | ESD-876454-1MG |
| Cas.: 906805-42-3 | Purity: ≥99% | SCH 546738 | ESD-876454-5MG |
| Cas.: 906794-57-8 | Purity: 96% | Parvifolixanthone B | ESD-876455-5MG |
| Cas.: 906794-56-7 | Purity: 95% | Parvifolixanthone A | ESD-876456-5MG |
| Cas.: 905929-95-5 | Purity: 98% | Scutebarbatine B | ESD-876457-5MG |
| Cas.: 90582-44-8 | Purity: 98% | Sorghumol | ESD-876458-5MG |
| Cas.: 90536-74-6 | Purity: 98% | Ethyl 2,4,6-trihydroxybenzoate | ESD-876459-5MG |
| Cas.: 9050-30-0 | Purity: 98% | Heparan Sulfate | ESD-876460-1MG |
| Cas.: 9050-30-0 | Purity: 98% | Heparan Sulfate | ESD-876460-5MG |
| Cas.: 904891-20-9 | Purity: 95% | Valeriotetrate C | ESD-876461-5MG |
| Cas.: 904763-27-5 | Purity: 98% | ATN-161 trifluoroacetate salt | ESD-876462-2MG |
| Cas.: 904763-27-5 | Purity: 98% | ATN-161 trifluoroacetate salt | ESD-876462-5MG |
| Cas.: 90468-72-7 | Purity: 95% | Maoyerabdosin | ESD-876463-1MG |
| Cas.: 904667-65-8 | Purity: 93% | Daturametelin I | ESD-876464-5MG |
| Cas.: 904665-71-0 | Purity: 93% | Daturataturin A aglycone | ESD-876465-5MG |
| Cas.: 90392-32-8 | Purity: 95% | 6,9-diazaspiro[4.5]decane-7,10-dione | ESD-876466-1G |
| Cas.: 90392-32-8 | Purity: 95% | 6,9-diazaspiro[4.5]decane-7,10-dione | ESD-876466-2.5G |
| Cas.: 903895-98-7 | Purity: ≥97% | FPR Agonist 43 | ESD-876467-5MG |
| Cas.: 903895-98-7 | Purity: ≥97% | FPR Agonist 43 | ESD-876467-10MG |
| Cas.: 903-67-3 | Purity: 98% | Pregn-5-ene-3β,17α,20S-triol | ESD-876468-5MG |
| Cas.: 903576-44-3 | Purity: ≥99% | Pitolisant hydrochloride | ESD-876469-10MG |
| Cas.: 903576-44-3 | Purity: ≥99% | Pitolisant hydrochloride | ESD-876469-50MG |
| Cas.: 903565-83-3 | Purity: 98% | Tofogliflozin | ESD-876470-2MG |
| Cas.: 903565-83-3 | Purity: 98% | Tofogliflozin | ESD-876470-5MG |
| Cas.: 90352-19-5 | Purity: 95% | 7-Xylosyltaxol B | ESD-876471-5MG |
| Cas.: 903519-82-4 | Purity: 95% | 10-O-Coumaroyl-10-O-deacetylasperuloside | ESD-876472-1MG |
| Cas.: 90341-45-0 | Purity: 95% | Seneciphylline | ESD-876473-1MG |
| Cas.: 90332-92-6 | Purity: 95% | Shizukolidol | ESD-876474-1MG |
| Cas.: 90332-66-4 | Purity: 98% | 7-xylosyltaxol | ESD-876475-5MG |
| Cas.: 90332-66-4 | Purity: 98% | 7-xylosyltaxol | ESD-876475-10MG |
| Cas.: 90332-65-3 | Purity: 97% | 7-Xylosyl-10-deacetyltaxol C | ESD-876476-5MG |
| Cas.: 90332-64-2 | Purity: 97% | 7-Xylosyl-10-deacetyltaxol B | ESD-876477-5MG |
| Cas.: 90332-63-1 | Purity: 98% | 10-Deacetyl-7-xylosyl paclitaxel | ESD-876478-10MG |
| Cas.: 90332-63-1 | Purity: 98% | 10-Deacetyl-7-xylosyl paclitaxel | ESD-876478-50MG |
| Cas.: 90207-55-9 | Purity: 95% | 2-Oxa-5-azaspiro[3.4]octane | ESD-876479-2.5MG |
| Cas.: 90207-55-9 | Purity: 95% | 2-Oxa-5-azaspiro[3.4]octane | ESD-876479-5MG |
| Cas.: 90-19-7 | Purity: 97% | Rhamnetin | ESD-876480-5MG |
| Cas.: 90-18-6 | Purity: 98% | Quercetagetin | ESD-876481-5MG |
| Cas.: 90-18-6 | Purity: 98% | Quercetagetin | ESD-876481-10MG |
| Cas.: 901245-65-6 | Purity: ≥98% | GSK-5959 | ESD-876484-5MG |
| Cas.: 901245-65-6 | Purity: ≥98% | GSK-5959 | ESD-876484-10MG |
| Cas.: 90087-86-8 | Purity: 95% | 1-thia-4-azaspiro[4.4]nonane-3-carboxylic acid hydrochloride | ESD-876485-1G |
| Cas.: 90087-86-8 | Purity: 95% | 1-thia-4-azaspiro[4.4]nonane-3-carboxylic acid hydrochloride | ESD-876485-5G |
| Cas.: 900814-48-4 | Purity: 98% | AVX 13616 | ESD-876486-2MG |
| Cas.: 900814-48-4 | Purity: 98% | AVX 13616 | ESD-876486-5MG |
| Cas.: 900573-88-8 | Purity: ≥99% | JI-101 | ESD-876487-5MG |
| Cas.: 900573-88-8 | Purity: ≥99% | JI-101 | ESD-876487-10MG |
| Cas.: 90039-63-7 | Purity: 95% | Ylangenyl acetate | ESD-876488-5MG |
| Cas.: 90038-21-4 | Purity: 97% | Tatsinine | ESD-876489-5MG |
| Cas.: 899926-67-1 | Purity: 95% | 3-(4-Fluorophenyl)-1,4-diazaspiro-[4.5]dec-3-ene-2-thione | ESD-876490-500MG |
| Cas.: 899926-67-1 | Purity: 95% | 3-(4-Fluorophenyl)-1,4-diazaspiro-[4.5]dec-3-ene-2-thione | ESD-876490-1G |
| Cas.: 899822-99-2 | Purity: 98% | 3-(Hydroxymethyl)-3-nitro-1-(4-octylphenyl)-1,4-butanediol | ESD-876491-5MG |
| Cas.: 899822-97-0 | Purity: 98% | 3-Nitro-1-(4-octylphenyl)-1-propanone | ESD-876492-5MG |
| Cas.: 899821-23-9 | Purity: ≥98% | ACP-105 | ESD-876493-5MG |
| Cas.: 899821-23-9 | Purity: ≥98% | ACP-105 | ESD-876493-10MG |
| Cas.: 899789-51-6 | Purity: 98% | Chrysocaulflavone I | ESD-876494-5MG |
| Cas.: 899713-86-1 | Purity: ≥99% | ML348 | ESD-876495-5MG |
| Cas.: 899713-86-1 | Purity: ≥99% | ML348 | ESD-876495-10MG |
| Cas.: 899710-30-6 | Purity: 95% | [(6-Ethoxy-3,4-dihydrospiro[chromene-2,1′-cyclohexan]-4-yl)thio]acetic acid | ESD-876496-500MG |
| Cas.: 899507-36-9 | Purity: ≥99% | A 438079 | ESD-876497-10MG |
| Cas.: 899507-36-9 | Purity: ≥99% | A 438079 | ESD-876497-50MG |
| Cas.: 89915-39-9 | Purity: 98% | β-Carboline-1-propanoic acid | ESD-876498-5MG |
| Cas.: 89913-53-1 | Purity: 95% | 3-Epichromolaenide | ESD-876499-5MG |
| Cas.: 898800-26-5 | Purity: ≥99% | AZ876 | ESD-876500-1MG |
| Cas.: 898800-26-5 | Purity: ≥99% | AZ876 | ESD-876500-5MG |
| Cas.: 898782-16-6 | Purity: 97% | ethyl 8-[4-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-8-oxooctanoate | ESD-876501-1G |
| Cas.: 898782-16-6 | Purity: 97% | ethyl 8-[4-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-8-oxooctanoate | ESD-876501-2G |
| Cas.: 898782-13-3 | Purity: 97% | ethyl 7-[4-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-7-oxoheptanoate | ESD-876502-1G |
| Cas.: 898782-13-3 | Purity: 97% | ethyl 7-[4-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-7-oxoheptanoate | ESD-876502-2G |
| Cas.: 898782-10-0 | Purity: 97% | ethyl 6-[4-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-6-oxohexanoate | ESD-876503-1G |
| Cas.: 898782-10-0 | Purity: 97% | ethyl 6-[4-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-6-oxohexanoate | ESD-876503-2G |
| Cas.: 898782-07-5 | Purity: 97% | ethyl 5-[4-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-5-oxovalerate | ESD-876504-1G |
| Cas.: 898782-07-5 | Purity: 97% | ethyl 5-[4-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-5-oxovalerate | ESD-876504-2G |
| Cas.: 898782-04-2 | Purity: 97% | ethyl 4-[4-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-4-oxobutyrate | ESD-876505-1G |
| Cas.: 898782-04-2 | Purity: 97% | ethyl 4-[4-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-4-oxobutyrate | ESD-876505-2G |
| Cas.: 898781-35-6 | Purity: 97% | ethyl 8-[2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-8-oxooctanoate | ESD-876506-1G |
| Cas.: 898781-35-6 | Purity: 97% | ethyl 8-[2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-8-oxooctanoate | ESD-876506-2G |
| Cas.: 898781-32-3 | Purity: 97% | ethyl 7-[2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-7-oxoheptanoate | ESD-876507-1G |
| Cas.: 898781-32-3 | Purity: 97% | ethyl 7-[2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-7-oxoheptanoate | ESD-876507-2G |
| Cas.: 898781-29-8 | Purity: 97% | ethyl 6-[2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-6-oxohexanoate | ESD-876508-1G |
| Cas.: 898781-29-8 | Purity: 97% | ethyl 6-[2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-6-oxohexanoate | ESD-876508-2G |
| Cas.: 898781-26-5 | Purity: 97% | ethyl 5-[2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-5-oxovalerate | ESD-876509-1G |
| Cas.: 898781-26-5 | Purity: 97% | ethyl 5-[2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-5-oxovalerate | ESD-876509-2G |
| Cas.: 898781-23-2 | Purity: 97% | ethyl 4-[2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-4-oxobutyrate | ESD-876510-1G |
| Cas.: 898781-23-2 | Purity: 97% | ethyl 4-[2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-4-oxobutyrate | ESD-876510-2G |
| Cas.: 898781-20-9 | Purity: 97% | cyclohexyl 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone | ESD-876511-1G |
| Cas.: 898781-20-9 | Purity: 97% | cyclohexyl 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone | ESD-876511-2G |
| Cas.: 898781-17-4 | Purity: 97% | cyclopentyl 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone | ESD-876512-1G |
| Cas.: 898781-17-4 | Purity: 97% | cyclopentyl 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone | ESD-876512-2G |
| Cas.: 898781-14-1 | Purity: 97% | cyclobutyl 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone | ESD-876513-1G |
| Cas.: 898781-14-1 | Purity: 97% | cyclobutyl 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone | ESD-876513-2G |
| Cas.: 898781-11-8 | Purity: 97% | cyclopropyl 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone | ESD-876514-1G |
| Cas.: 898781-11-8 | Purity: 97% | cyclopropyl 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone | ESD-876514-2G |
| Cas.: 898781-08-3 | Purity: 97% | 2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3,4,5-trifluorobenzophenone | ESD-876515-1G |
| Cas.: 898781-08-3 | Purity: 97% | 2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3,4,5-trifluorobenzophenone | ESD-876515-2G |
| Cas.: 898781-05-0 | Purity: 97% | 3,5-difluoro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876516-1G |
| Cas.: 898781-05-0 | Purity: 97% | 3,5-difluoro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876516-2G |
| Cas.: 898762-68-0 | Purity: 97% | ethyl 8-[3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-8-oxooctanoate | ESD-876517-1G |
| Cas.: 898762-68-0 | Purity: 97% | ethyl 8-[3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-8-oxooctanoate | ESD-876517-2G |
| Cas.: 898762-66-8 | Purity: 97% | ethyl 7-[3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-7-oxoheptanoate | ESD-876518-1G |
| Cas.: 898762-66-8 | Purity: 97% | ethyl 7-[3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-7-oxoheptanoate | ESD-876518-2G |
| Cas.: 898762-64-6 | Purity: 97% | ethyl 6-[3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-6-oxohexanoate | ESD-876519-1G |
| Cas.: 898762-64-6 | Purity: 97% | ethyl 6-[3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-6-oxohexanoate | ESD-876519-2G |
| Cas.: 898762-61-3 | Purity: 97% | ethyl 5-[3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-5-oxovalerate | ESD-876520-1G |
| Cas.: 898762-61-3 | Purity: 97% | ethyl 5-[3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-5-oxovalerate | ESD-876520-2G |
| Cas.: 898762-58-8 | Purity: 97% | ethyl 4-[3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-4-oxobutyrate | ESD-876521-1G |
| Cas.: 898762-58-8 | Purity: 97% | ethyl 4-[3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl]-4-oxobutyrate | ESD-876521-2G |
| Cas.: 898762-55-5 | Purity: 97% | cyclohexyl 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone | ESD-876522-1G |
| Cas.: 898762-55-5 | Purity: 97% | cyclohexyl 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone | ESD-876522-2G |
| Cas.: 898762-52-2 | Purity: 97% | cyclopentyl 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone | ESD-876523-1G |
| Cas.: 898762-52-2 | Purity: 97% | cyclopentyl 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone | ESD-876523-2G |
| Cas.: 898762-49-7 | Purity: 97% | cyclobutyl 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone | ESD-876524-1G |
| Cas.: 898762-49-7 | Purity: 97% | cyclobutyl 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone | ESD-876524-2G |
| Cas.: 898762-46-4 | Purity: 97% | cyclopropyl 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone | ESD-876525-1G |
| Cas.: 898762-46-4 | Purity: 97% | cyclopropyl 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone | ESD-876525-2G |
| Cas.: 898762-43-1 | Purity: 97% | 3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3,4,5-trifluorobenzophenone | ESD-876526-1G |
| Cas.: 898762-43-1 | Purity: 97% | 3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3,4,5-trifluorobenzophenone | ESD-876526-2G |
| Cas.: 898762-40-8 | Purity: 97% | 3,5-difluoro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876527-1G |
| Cas.: 898762-40-8 | Purity: 97% | 3,5-difluoro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876527-2G |
| Cas.: 898762-37-3 | Purity: 97% | 3,4-difluoro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876528-1G |
| Cas.: 898762-37-3 | Purity: 97% | 3,4-difluoro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876528-2G |
| Cas.: 898762-34-0 | Purity: 97% | 2,4-difluoro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876529-1G |
| Cas.: 898762-34-0 | Purity: 97% | 2,4-difluoro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876529-2G |
| Cas.: 898762-31-7 | Purity: 97% | 3,5-dichloro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876530-1G |
| Cas.: 898762-31-7 | Purity: 97% | 3,5-dichloro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876530-2G |
| Cas.: 898762-28-2 | Purity: 97% | 3,4-dichloro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876531-1G |
| Cas.: 898762-28-2 | Purity: 97% | 3,4-dichloro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876531-2G |
| Cas.: 898762-25-9 | Purity: 97% | 2,5-dichloro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876532-1G |
| Cas.: 898762-25-9 | Purity: 97% | 2,5-dichloro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876532-2G |
| Cas.: 898762-22-6 | Purity: 97% | 2,4-dichloro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876533-1G |
| Cas.: 898762-22-6 | Purity: 97% | 2,4-dichloro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876533-2G |
| Cas.: 898762-19-1 | Purity: 97% | 2,3-dichloro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876534-1G |
| Cas.: 898762-19-1 | Purity: 97% | 2,3-dichloro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876534-2G |
| Cas.: 898762-16-8 | Purity: 97% | 4-chloro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-fluorobenzophenone | ESD-876535-1G |
| Cas.: 898762-16-8 | Purity: 97% | 4-chloro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-fluorobenzophenone | ESD-876535-2G |
| Cas.: 898762-13-5 | Purity: 97% | 3-chloro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-5-fluorobenzophenone | ESD-876536-1G |
| Cas.: 898762-13-5 | Purity: 97% | 3-chloro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-5-fluorobenzophenone | ESD-876536-2G |
| Cas.: 898762-11-3 | Purity: 97% | 2-chloro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4-fluorobenzophenone | ESD-876537-1G |
| Cas.: 898762-11-3 | Purity: 97% | 2-chloro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4-fluorobenzophenone | ESD-876537-2G |
| Cas.: 898762-09-9 | Purity: 97% | 4-bromo-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-fluorobenzophenone | ESD-876538-1G |
| Cas.: 898762-09-9 | Purity: 97% | 4-bromo-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-fluorobenzophenone | ESD-876538-2G |
| Cas.: 898762-07-7 | Purity: 97% | 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4′-trifluorobenzophenone | ESD-876539-1G |
| Cas.: 898762-07-7 | Purity: 97% | 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4′-trifluorobenzophenone | ESD-876539-2G |
| Cas.: 898762-05-5 | Purity: 97% | 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3′-trifluorobenzophenone | ESD-876540-1G |
| Cas.: 898762-05-5 | Purity: 97% | 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3′-trifluorobenzophenone | ESD-876540-2G |
| Cas.: 898762-03-3 | Purity: 97% | 3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-trifluorobenzophenone | ESD-876541-1G |
| Cas.: 898762-03-3 | Purity: 97% | 3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-trifluorobenzophenone | ESD-876541-2G |
| Cas.: 898762-01-1 | Purity: 97% | 3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-fluorobenzophenone | ESD-876542-1G |
| Cas.: 898762-01-1 | Purity: 97% | 3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-fluorobenzophenone | ESD-876542-2G |
| Cas.: 898761-99-4 | Purity: 97% | 2-Chloro-3′-[8-(1,4-dioxa-8-azaspiro-[4.5]decyl)methyl]benzophenone | ESD-876543-1G |
| Cas.: 898761-99-4 | Purity: 97% | 2-Chloro-3′-[8-(1,4-dioxa-8-azaspiro-[4.5]decyl)methyl]benzophenone | ESD-876543-2G |
| Cas.: 898761-97-2 | Purity: 97% | 3-chloro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4-fluorobenzophenone | ESD-876544-1G |
| Cas.: 898761-97-2 | Purity: 97% | 3-chloro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4-fluorobenzophenone | ESD-876544-2G |
| Cas.: 898761-95-0 | Purity: 97% | 4-chloro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3-fluorobenzophenone | ESD-876545-1G |
| Cas.: 898761-95-0 | Purity: 97% | 4-chloro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3-fluorobenzophenone | ESD-876545-2G |
| Cas.: 898761-93-8 | Purity: 97% | 4′-bromo-3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3′-fluorobenzophenone | ESD-876546-1G |
| Cas.: 898761-93-8 | Purity: 97% | 4′-bromo-3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3′-fluorobenzophenone | ESD-876546-2G |
| Cas.: 898761-91-6 | Purity: 97% | 3,5-dimethyl-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876547-1G |
| Cas.: 898761-91-6 | Purity: 97% | 3,5-dimethyl-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876547-2G |
| Cas.: 898761-89-2 | Purity: 97% | 3,4-dimethyl-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876548-1G |
| Cas.: 898761-89-2 | Purity: 97% | 3,4-dimethyl-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876548-2G |
| Cas.: 898761-87-0 | Purity: 97% | 2,6-dimethyl-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876549-1G |
| Cas.: 898761-87-0 | Purity: 97% | 2,6-dimethyl-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876549-2G |
| Cas.: 898761-85-8 | Purity: 97% | 2,5-dimethyl-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876550-1G |
| Cas.: 898761-85-8 | Purity: 97% | 2,5-dimethyl-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876550-2G |
| Cas.: 898761-83-6 | Purity: 97% | 2,4-dimethyl-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876551-1G |
| Cas.: 898761-83-6 | Purity: 97% | 2,4-dimethyl-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876551-2G |
| Cas.: 898761-81-4 | Purity: 97% | 2,3-dimethyl-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876552-1G |
| Cas.: 898761-81-4 | Purity: 97% | 2,3-dimethyl-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876552-2G |
| Cas.: 898761-79-0 | Purity: 97% | 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4′-fluorobenzophenone | ESD-876553-1G |
| Cas.: 898761-79-0 | Purity: 97% | 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4′-fluorobenzophenone | ESD-876553-2G |
| Cas.: 898761-77-8 | Purity: 97% | 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3′-fluorobenzophenone | ESD-876554-1G |
| Cas.: 898761-77-8 | Purity: 97% | 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3′-fluorobenzophenone | ESD-876554-2G |
| Cas.: 898761-75-6 | Purity: 97% | 4′-chloro-3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benozphenone | ESD-876555-1G |
| Cas.: 898761-75-6 | Purity: 97% | 4′-chloro-3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benozphenone | ESD-876555-2G |
| Cas.: 898761-73-4 | Purity: 97% | 3-chloro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benozphenone | ESD-876556-1G |
| Cas.: 898761-73-4 | Purity: 97% | 3-chloro-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benozphenone | ESD-876556-2G |
| Cas.: 898761-71-2 | Purity: 97% | 4′-bromo-3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876557-1G |
| Cas.: 898761-71-2 | Purity: 97% | 4′-bromo-3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876557-2G |
| Cas.: 898761-69-8 | Purity: 97% | 3-bromo-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876558-1G |
| Cas.: 898761-69-8 | Purity: 97% | 3-bromo-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876558-2G |
| Cas.: 898761-67-6 | Purity: 97% | 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4′-thiomethyl benzophenone | ESD-876559-1G |
| Cas.: 898761-67-6 | Purity: 97% | 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4′-thiomethyl benzophenone | ESD-876559-2G |
| Cas.: 898761-65-4 | Purity: 97% | 3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-thiomethyl benzophenone | ESD-876560-1G |
| Cas.: 898761-65-4 | Purity: 97% | 3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-thiomethyl benzophenone | ESD-876560-2G |
| Cas.: 898761-62-1 | Purity: 97% | 4′-carboethoxy-3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876561-1G |
| Cas.: 898761-62-1 | Purity: 97% | 4′-carboethoxy-3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876561-2G |
| Cas.: 898761-59-6 | Purity: 97% | 3-carboethoxy-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876562-1G |
| Cas.: 898761-59-6 | Purity: 97% | 3-carboethoxy-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876562-2G |
| Cas.: 898761-56-3 | Purity: 97% | 2-carboethoxy-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876563-1G |
| Cas.: 898761-56-3 | Purity: 97% | 2-carboethoxy-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876563-2G |
| Cas.: 898761-53-0 | Purity: 97% | 4′-cyano-3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876564-1G |
| Cas.: 898761-53-0 | Purity: 97% | 4′-cyano-3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876564-2G |
| Cas.: 898761-50-7 | Purity: 97% | 3-cyano-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876565-1G |
| Cas.: 898761-50-7 | Purity: 97% | 3-cyano-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876565-2G |
| Cas.: 898761-47-2 | Purity: 97% | 2-cyano-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876566-1G |
| Cas.: 898761-47-2 | Purity: 97% | 2-cyano-3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876566-2G |
| Cas.: 898761-44-9 | Purity: 97% | 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4′-methoxybenzophenone | ESD-876567-1G |
| Cas.: 898761-44-9 | Purity: 97% | 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4′-methoxybenzophenone | ESD-876567-2G |
| Cas.: 898761-41-6 | Purity: 97% | 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3′-methoxybenzophenone | ESD-876568-1G |
| Cas.: 898761-41-6 | Purity: 97% | 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3′-methoxybenzophenone | ESD-876568-2G |
| Cas.: 898761-38-1 | Purity: 97% | 3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-methoxybenzophenone | ESD-876569-1G |
| Cas.: 898761-38-1 | Purity: 97% | 3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-methoxybenzophenone | ESD-876569-2G |
| Cas.: 898761-35-8 | Purity: 97% | 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4′-methyl benzophenone | ESD-876570-1G |
| Cas.: 898761-35-8 | Purity: 97% | 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4′-methyl benzophenone | ESD-876570-2G |
| Cas.: 898761-32-5 | Purity: 97% | 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3′-methyl benzophenone | ESD-876571-1G |
| Cas.: 898761-32-5 | Purity: 97% | 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3′-methyl benzophenone | ESD-876571-2G |
| Cas.: 898761-29-0 | Purity: 97% | 3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-methyl benzophenone | ESD-876572-1G |
| Cas.: 898761-29-0 | Purity: 97% | 3′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-methyl benzophenone | ESD-876572-2G |
| Cas.: 898761-26-7 | Purity: 97% | 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876573-1G |
| Cas.: 898761-26-7 | Purity: 97% | 3-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876573-2G |
| Cas.: 898758-64-0 | Purity: 97% | cyclohexyl 4-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone | ESD-876574-1G |
| Cas.: 898758-64-0 | Purity: 97% | cyclohexyl 4-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone | ESD-876574-2G |
| Cas.: 898758-61-7 | Purity: 97% | cyclopentyl 4-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone | ESD-876575-1G |
| Cas.: 898758-61-7 | Purity: 97% | cyclopentyl 4-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone | ESD-876575-2G |
| Cas.: 898758-58-2 | Purity: 97% | cyclobutyl 4-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone | ESD-876576-1G |
| Cas.: 898758-58-2 | Purity: 97% | cyclobutyl 4-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone | ESD-876576-2G |
| Cas.: 898758-55-9 | Purity: 97% | cyclopropyl 4-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone | ESD-876577-1G |
| Cas.: 898758-55-9 | Purity: 97% | cyclopropyl 4-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]phenyl ketone | ESD-876577-2G |
| Cas.: 898758-52-6 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3,4,5-trifluorobenzophenone | ESD-876578-1G |
| Cas.: 898758-52-6 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3,4,5-trifluorobenzophenone | ESD-876578-2G |
| Cas.: 898758-49-1 | Purity: 97% | 3,5-difluoro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876579-1G |
| Cas.: 898758-49-1 | Purity: 97% | 3,5-difluoro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876579-2G |
| Cas.: 898758-46-8 | Purity: 97% | 3,4-difluoro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876580-1G |
| Cas.: 898758-46-8 | Purity: 97% | 3,4-difluoro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876580-2G |
| Cas.: 898758-43-5 | Purity: 97% | 2,4-difluoro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876581-1G |
| Cas.: 898758-43-5 | Purity: 97% | 2,4-difluoro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876581-2G |
| Cas.: 898758-40-2 | Purity: 97% | 3,5-dichloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876582-1G |
| Cas.: 898758-40-2 | Purity: 97% | 3,5-dichloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876582-2G |
| Cas.: 898758-37-7 | Purity: 97% | 3,4-dichloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876583-1G |
| Cas.: 898758-37-7 | Purity: 97% | 3,4-dichloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876583-2G |
| Cas.: 898758-34-4 | Purity: 97% | 2,5-dichloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876584-1G |
| Cas.: 898758-34-4 | Purity: 97% | 2,5-dichloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876584-2G |
| Cas.: 898758-31-1 | Purity: 97% | 2,4-dichloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876585-1G |
| Cas.: 898758-31-1 | Purity: 97% | 2,4-dichloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876585-2G |
| Cas.: 898758-28-6 | Purity: 97% | 2,3-dichloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876586-1G |
| Cas.: 898758-28-6 | Purity: 97% | 2,3-dichloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876586-2G |
| Cas.: 898758-25-3 | Purity: 97% | 4-chloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-fluorobenzophenone | ESD-876587-1G |
| Cas.: 898758-25-3 | Purity: 97% | 4-chloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-fluorobenzophenone | ESD-876587-2G |
| Cas.: 898758-22-0 | Purity: 97% | 3-chloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-5-fluorobenzophenone | ESD-876588-1G |
| Cas.: 898758-22-0 | Purity: 97% | 3-chloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-5-fluorobenzophenone | ESD-876588-2G |
| Cas.: 898758-19-5 | Purity: 97% | 2-chloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4-fluorobenzophenone | ESD-876589-1G |
| Cas.: 898758-19-5 | Purity: 97% | 2-chloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4-fluorobenzophenone | ESD-876589-2G |
| Cas.: 898758-16-2 | Purity: 97% | 4-bromo-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-fluorobenzophenone | ESD-876590-1G |
| Cas.: 898758-16-2 | Purity: 97% | 4-bromo-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-fluorobenzophenone | ESD-876590-2G |
| Cas.: 898758-14-0 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4-trifluoromethylbenzophenone | ESD-876591-1G |
| Cas.: 898758-14-0 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4-trifluoromethylbenzophenone | ESD-876591-2G |
| Cas.: 898758-12-8 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3-trifluoromethylbenzophenone | ESD-876592-1G |
| Cas.: 898758-12-8 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3-trifluoromethylbenzophenone | ESD-876592-2G |
| Cas.: 898758-10-6 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-trifluoromethylbenzophenone | ESD-876593-1G |
| Cas.: 898758-10-6 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-trifluoromethylbenzophenone | ESD-876593-2G |
| Cas.: 898758-08-2 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-fluorobenzophenone | ESD-876594-1G |
| Cas.: 898758-08-2 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-fluorobenzophenone | ESD-876594-2G |
| Cas.: 898758-06-0 | Purity: 97% | 2-chloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876595-1G |
| Cas.: 898758-06-0 | Purity: 97% | 2-chloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876595-2G |
| Cas.: 898758-04-8 | Purity: 97% | 3-chloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4-fluorobenzophenone | ESD-876596-1G |
| Cas.: 898758-04-8 | Purity: 97% | 3-chloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4-fluorobenzophenone | ESD-876596-2G |
| Cas.: 898758-02-6 | Purity: 97% | 4-chloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3-fluorobenzophenone | ESD-876597-1G |
| Cas.: 898758-02-6 | Purity: 97% | 4-chloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3-fluorobenzophenone | ESD-876597-2G |
| Cas.: 898758-00-4 | Purity: 97% | 4-bromo-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3-fluorobenzophenone | ESD-876598-1G |
| Cas.: 898758-00-4 | Purity: 97% | 4-bromo-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3-fluorobenzophenone | ESD-876598-2G |
| Cas.: 898757-98-7 | Purity: 97% | 3,5-dimethyl-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876599-1G |
| Cas.: 898757-98-7 | Purity: 97% | 3,5-dimethyl-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876599-2G |
| Cas.: 898757-96-5 | Purity: 97% | 3,4-dimethyl-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876600-1G |
| Cas.: 898757-96-5 | Purity: 97% | 3,4-dimethyl-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876600-2G |
| Cas.: 898757-94-3 | Purity: 97% | 2,6-dimethyl-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876601-1G |
| Cas.: 898757-94-3 | Purity: 97% | 2,6-dimethyl-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876601-2G |
| Cas.: 898757-92-1 | Purity: 97% | 2,5-dimethyl-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876602-1G |
| Cas.: 898757-92-1 | Purity: 97% | 2,5-dimethyl-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876602-2G |
| Cas.: 898757-90-9 | Purity: 97% | 2,4-dimethyl-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876603-1G |
| Cas.: 898757-90-9 | Purity: 97% | 2,4-dimethyl-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876603-2G |
| Cas.: 898757-88-5 | Purity: 97% | 2,3-dimethyl-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876604-1G |
| Cas.: 898757-88-5 | Purity: 97% | 2,3-dimethyl-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876604-2G |
| Cas.: 898757-86-3 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4-fluorobenzophenone | ESD-876605-1G |
| Cas.: 898757-86-3 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4-fluorobenzophenone | ESD-876605-2G |
| Cas.: 898757-84-1 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3-fluorobenzophenone | ESD-876606-1G |
| Cas.: 898757-84-1 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3-fluorobenzophenone | ESD-876606-2G |
| Cas.: 898757-82-9 | Purity: 97% | 4-chloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benozphenone | ESD-876607-1G |
| Cas.: 898757-82-9 | Purity: 97% | 4-chloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benozphenone | ESD-876607-2G |
| Cas.: 898757-80-7 | Purity: 97% | 3-chloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benozphenone | ESD-876608-1G |
| Cas.: 898757-80-7 | Purity: 97% | 3-chloro-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benozphenone | ESD-876608-2G |
| Cas.: 898757-78-3 | Purity: 97% | 4-bromo-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876609-1G |
| Cas.: 898757-78-3 | Purity: 97% | 4-bromo-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876609-2G |
| Cas.: 898757-76-1 | Purity: 97% | 3-bromo-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876610-1G |
| Cas.: 898757-76-1 | Purity: 97% | 3-bromo-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876610-2G |
| Cas.: 898757-74-9 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4-thiomethyl benzophenone | ESD-876611-1G |
| Cas.: 898757-74-9 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4-thiomethyl benzophenone | ESD-876611-2G |
| Cas.: 898757-72-7 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-thiomethyl benzophenone | ESD-876612-1G |
| Cas.: 898757-72-7 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-thiomethyl benzophenone | ESD-876612-2G |
| Cas.: 898757-70-5 | Purity: 97% | 4-carboethoxy-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876613-1G |
| Cas.: 898757-70-5 | Purity: 97% | 4-carboethoxy-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876613-2G |
| Cas.: 898757-68-1 | Purity: 97% | 3-carboethoxy-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876614-1G |
| Cas.: 898757-68-1 | Purity: 97% | 3-carboethoxy-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876614-2G |
| Cas.: 898757-66-9 | Purity: 97% | 2-Carboethoxy-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876615-1G |
| Cas.: 898757-66-9 | Purity: 97% | 2-Carboethoxy-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876615-2G |
| Cas.: 898757-64-7 | Purity: 97% | 4-cyano-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876616-1G |
| Cas.: 898757-64-7 | Purity: 97% | 4-cyano-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876616-2G |
| Cas.: 898757-61-4 | Purity: 97% | 3-cyano-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876617-1G |
| Cas.: 898757-61-4 | Purity: 97% | 3-cyano-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876617-2G |
| Cas.: 898757-58-9 | Purity: 97% | 2-cyano-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876618-1G |
| Cas.: 898757-58-9 | Purity: 97% | 2-cyano-4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876618-2G |
| Cas.: 898757-55-6 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4-methoxybenzophenone | ESD-876619-1G |
| Cas.: 898757-55-6 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4-methoxybenzophenone | ESD-876619-2G |
| Cas.: 898757-52-3 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3-methoxybenzophenone | ESD-876620-1G |
| Cas.: 898757-52-3 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3-methoxybenzophenone | ESD-876620-2G |
| Cas.: 898757-49-8 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-methoxybenzophenone | ESD-876621-1G |
| Cas.: 898757-49-8 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-methoxybenzophenone | ESD-876621-2G |
| Cas.: 898757-46-5 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4-methyl benzophenone | ESD-876622-1G |
| Cas.: 898757-46-5 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4-methyl benzophenone | ESD-876622-2G |
| Cas.: 898757-43-2 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3-methyl benzophenone | ESD-876623-1G |
| Cas.: 898757-43-2 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3-methyl benzophenone | ESD-876623-2G |
| Cas.: 898757-40-9 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-methyl benzophenone | ESD-876624-1G |
| Cas.: 898757-40-9 | Purity: 97% | 4′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-methyl benzophenone | ESD-876624-2G |
| Cas.: 898757-37-4 | Purity: 97% | 4-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876625-1G |
| Cas.: 898757-37-4 | Purity: 97% | 4-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876625-2G |
| Cas.: 898756-66-6 | Purity: 97% | 3,4-difluoro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876626-1G |
| Cas.: 898756-66-6 | Purity: 97% | 3,4-difluoro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876626-2G |
| Cas.: 898756-63-3 | Purity: 97% | 2,4-difluoro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876627-1G |
| Cas.: 898756-63-3 | Purity: 97% | 2,4-difluoro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876627-2G |
| Cas.: 898756-60-0 | Purity: 97% | 3,5-dichloro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876628-1G |
| Cas.: 898756-60-0 | Purity: 97% | 3,5-dichloro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876628-2G |
| Cas.: 898756-57-5 | Purity: 97% | 3,4-dichloro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876629-1G |
| Cas.: 898756-57-5 | Purity: 97% | 3,4-dichloro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876629-2G |
| Cas.: 898756-54-2 | Purity: 97% | 2,5-dichloro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876630-1G |
| Cas.: 898756-54-2 | Purity: 97% | 2,5-dichloro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876630-2G |
| Cas.: 898756-51-9 | Purity: 97% | 2,4-dichloro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876631-1G |
| Cas.: 898756-51-9 | Purity: 97% | 2,4-dichloro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876631-2G |
| Cas.: 898756-48-4 | Purity: 97% | 2,3-dichloro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876632-1G |
| Cas.: 898756-48-4 | Purity: 97% | 2,3-dichloro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876632-2G |
| Cas.: 898756-45-1 | Purity: 97% | 4-chloro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-fluorobenzophenone | ESD-876633-1G |
| Cas.: 898756-45-1 | Purity: 97% | 4-chloro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-fluorobenzophenone | ESD-876633-2G |
| Cas.: 898756-42-8 | Purity: 97% | 3-chloro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-5-fluorobenzophenone | ESD-876634-1G |
| Cas.: 898756-42-8 | Purity: 97% | 3-chloro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-5-fluorobenzophenone | ESD-876634-2G |
| Cas.: 898756-39-3 | Purity: 97% | 2-chloro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4-fluorobenzophenone | ESD-876635-1G |
| Cas.: 898756-39-3 | Purity: 97% | 2-chloro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4-fluorobenzophenone | ESD-876635-2G |
| Cas.: 898756-36-0 | Purity: 97% | 4-bromo-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-fluorobenzophenone | ESD-876636-1G |
| Cas.: 898756-36-0 | Purity: 97% | 4-bromo-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-fluorobenzophenone | ESD-876636-2G |
| Cas.: 898756-33-7 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4′-trifluorobenzophenone | ESD-876637-1G |
| Cas.: 898756-33-7 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4′-trifluorobenzophenone | ESD-876637-2G |
| Cas.: 898756-30-4 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3′-trifluorobenzophenone | ESD-876638-1G |
| Cas.: 898756-30-4 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3′-trifluorobenzophenone | ESD-876638-2G |
| Cas.: 898756-27-9 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2′-trifluorobenzophenone | ESD-876639-1G |
| Cas.: 898756-27-9 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2′-trifluorobenzophenone | ESD-876639-2G |
| Cas.: 898756-24-6 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2′-fluorobenzophenone | ESD-876640-1G |
| Cas.: 898756-24-6 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2′-fluorobenzophenone | ESD-876640-2G |
| Cas.: 898756-22-4 | Purity: 97% | 2-chloro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876641-1G |
| Cas.: 898756-22-4 | Purity: 97% | 2-chloro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876641-2G |
| Cas.: 898756-20-2 | Purity: 97% | 3-chloro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4-fluorobenzophenone | ESD-876642-1G |
| Cas.: 898756-20-2 | Purity: 97% | 3-chloro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4-fluorobenzophenone | ESD-876642-2G |
| Cas.: 898756-19-9 | Purity: 97% | 4-chloro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3-fluorobenzophenone | ESD-876643-1G |
| Cas.: 898756-19-9 | Purity: 97% | 4-chloro-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3-fluorobenzophenone | ESD-876643-2G |
| Cas.: 898756-17-7 | Purity: 97% | 4-bromo-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3-fluorobenzophenone | ESD-876644-1G |
| Cas.: 898756-17-7 | Purity: 97% | 4-bromo-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3-fluorobenzophenone | ESD-876644-2G |
| Cas.: 898756-15-5 | Purity: 97% | 3′,5′-dimethyl-2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876645-1G |
| Cas.: 898756-15-5 | Purity: 97% | 3′,5′-dimethyl-2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876645-2G |
| Cas.: 898756-14-4 | Purity: 97% | 3′,4′-dimethyl-2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876646-1G |
| Cas.: 898756-14-4 | Purity: 97% | 3′,4′-dimethyl-2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876646-2G |
| Cas.: 898756-12-2 | Purity: 97% | 2,6-dimethyl-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876647-1G |
| Cas.: 898756-12-2 | Purity: 97% | 2,6-dimethyl-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876647-2G |
| Cas.: 898756-10-0 | Purity: 97% | 2,5-dimethyl-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876648-1G |
| Cas.: 898756-10-0 | Purity: 97% | 2,5-dimethyl-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876648-2G |
| Cas.: 898756-09-7 | Purity: 97% | 2,4-dimethyl-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876649-1G |
| Cas.: 898756-09-7 | Purity: 97% | 2,4-dimethyl-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876649-2G |
| Cas.: 898756-07-5 | Purity: 97% | 2,3-dimethyl-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876650-1G |
| Cas.: 898756-07-5 | Purity: 97% | 2,3-dimethyl-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876650-2G |
| Cas.: 898756-05-3 | Purity: 97% | 2-[8-(1,4-Dioxa-8-azaspiro[4.5]decyl)methyl]-4′-fluorobenzophenone | ESD-876651-1G |
| Cas.: 898756-05-3 | Purity: 97% | 2-[8-(1,4-Dioxa-8-azaspiro[4.5]decyl)methyl]-4′-fluorobenzophenone | ESD-876651-2G |
| Cas.: 898756-04-2 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3′-fluorobenzophenone | ESD-876652-1G |
| Cas.: 898756-04-2 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3′-fluorobenzophenone | ESD-876652-2G |
| Cas.: 898756-02-0 | Purity: 97% | 4′-chloro-2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benozphenone | ESD-876653-1G |
| Cas.: 898756-02-0 | Purity: 97% | 4′-chloro-2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benozphenone | ESD-876653-2G |
| Cas.: 898756-00-8 | Purity: 97% | 3′-chloro-2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benozphenone | ESD-876654-1G |
| Cas.: 898756-00-8 | Purity: 97% | 3′-chloro-2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benozphenone | ESD-876654-2G |
| Cas.: 898755-99-2 | Purity: 97% | 4′-bromo-2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876655-1G |
| Cas.: 898755-99-2 | Purity: 97% | 4′-bromo-2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876655-2G |
| Cas.: 898755-97-0 | Purity: 97% | 3′-bromo-2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876656-1G |
| Cas.: 898755-97-0 | Purity: 97% | 3′-bromo-2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876656-2G |
| Cas.: 898755-95-8 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4′-thiomethyl benzophenone | ESD-876657-1G |
| Cas.: 898755-95-8 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4′-thiomethyl benzophenone | ESD-876657-2G |
| Cas.: 898755-94-7 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2′-thiomethyl benzophenone | ESD-876658-1G |
| Cas.: 898755-94-7 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2′-thiomethyl benzophenone | ESD-876658-2G |
| Cas.: 898755-92-5 | Purity: 97% | 4′-carboethoxy-2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876659-1G |
| Cas.: 898755-92-5 | Purity: 97% | 4′-carboethoxy-2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876659-2G |
| Cas.: 898755-90-3 | Purity: 97% | 3′-carboethoxy-2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876660-1G |
| Cas.: 898755-90-3 | Purity: 97% | 3′-carboethoxy-2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876660-2G |
| Cas.: 898755-89-0 | Purity: 97% | 2-carboethoxy-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876661-1G |
| Cas.: 898755-89-0 | Purity: 97% | 2-carboethoxy-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876661-2G |
| Cas.: 898755-87-8 | Purity: 97% | 4′-cyano-2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876662-1G |
| Cas.: 898755-87-8 | Purity: 97% | 4′-cyano-2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876662-2G |
| Cas.: 898755-85-6 | Purity: 97% | 3′-cyano-2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876663-1G |
| Cas.: 898755-85-6 | Purity: 97% | 3′-cyano-2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876663-2G |
| Cas.: 898755-84-5 | Purity: 97% | 2-cyano-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876664-1G |
| Cas.: 898755-84-5 | Purity: 97% | 2-cyano-2′-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876664-2G |
| Cas.: 898755-82-3 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4′-methoxybenzophenone | ESD-876665-1G |
| Cas.: 898755-82-3 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4′-methoxybenzophenone | ESD-876665-2G |
| Cas.: 898755-80-1 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3′-methoxybenzophenone | ESD-876666-1G |
| Cas.: 898755-80-1 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3′-methoxybenzophenone | ESD-876666-2G |
| Cas.: 898755-79-8 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2′-methoxybenzophenone | ESD-876667-1G |
| Cas.: 898755-79-8 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2′-methoxybenzophenone | ESD-876667-2G |
| Cas.: 898755-77-6 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4′-methyl benzophenone | ESD-876668-1G |
| Cas.: 898755-77-6 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-4′-methyl benzophenone | ESD-876668-2G |
| Cas.: 898755-74-3 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3′-methyl benzophenone | ESD-876669-1G |
| Cas.: 898755-74-3 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-3′-methyl benzophenone | ESD-876669-2G |
| Cas.: 898755-72-1 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2′-methyl benzophenone | ESD-876670-1G |
| Cas.: 898755-72-1 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2′-methyl benzophenone | ESD-876670-2G |
| Cas.: 898755-69-6 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876671-1G |
| Cas.: 898755-69-6 | Purity: 97% | 2-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone | ESD-876671-2G |
| Cas.: 898563-00-3 | Purity: ≥98% | TP-10 | ESD-876672-5MG |
| Cas.: 898563-00-3 | Purity: ≥98% | TP-10 | ESD-876672-10MG |
| Cas.: 89845-16-9 | Purity: 98% | Gastrofensin AN 5 free base | ESD-876673-1MG |
| Cas.: 89845-16-9 | Purity: 98% | Gastrofensin AN 5 free base | ESD-876673-5MG |
| Cas.: 898280-07-4 | Purity: ≥99% | XL228 | ESD-876674-5MG |
| Cas.: 898280-07-4 | Purity: ≥99% | XL228 | ESD-876674-10MG |
| Cas.: 898230-59-6 | Purity: ≥98% | Morinidazole R enantiomer | ESD-876675-5MG |
| Cas.: 898230-59-6 | Purity: ≥98% | Morinidazole R enantiomer | ESD-876675-10MG |
| Cas.: 89786-84-5 | Purity: 98% | Myrianthic acid | ESD-876676-5MG |
| Cas.: 89786-83-4 | Purity: 98% | 2α,3α,24-Trihydroxyurs-12-en-28-oic acid | ESD-876677-5MG |
| Cas.: 89778-26-7 | Purity: 98% | Toremifene | ESD-876678-100MG |
| Cas.: 89778-26-7 | Purity: 98% | Toremifene | ESD-876678-500MG |
| Cas.: 897657-95-3 | Purity: ≥98% | MSX-122 | ESD-876679-5MG |
| Cas.: 897657-95-3 | Purity: ≥98% | MSX-122 | ESD-876679-10MG |
| Cas.: 897383-62-9 | Purity: 98% | Allitinib | ESD-876680-5MG |
| Cas.: 897383-62-9 | Purity: 98% | Allitinib | ESD-876680-10MG |
| Cas.: 89729-09-9 | Purity: 95% | 5,7-Dioxa-6-thiaspiro[2.5]octane 6-oxide | ESD-876681-1G |
| Cas.: 89729-09-9 | Purity: 95% | 5,7-Dioxa-6-thiaspiro[2.5]octane 6-oxide | ESD-876681-5G |
| Cas.: 89706-39-8 | Purity: 95% | 7-O-Acetyl-4-O-demethylpolysyphorin | ESD-876682-5MG |
| Cas.: 896662-50-3 | Purity: 95% | 6′,6′,8′-Trimethyl-5′,6′-dihydrospiro[cycloheptane-1,4′-pyrrolo[3,2,1-ij]quinoline]-1′,2′-dione | ESD-876683-500MG |
| Cas.: 896662-47-8 | Purity: 95% | 6′,6′-Dimethyl-5′,6′-dihydrospiro[cyclohexane-1,4′-pyrrolo[3,2,1-ij]quinoline]-1′,2′-dione | ESD-876684-500MG |
| Cas.: 89647-62-1 | Purity: 95% | 3-epi-Isocucurbitacin B | ESD-876685-5MG |
| Cas.: 896106-16-4 | Purity: 98% | Imiquimod maleate | ESD-876686-100MG |
| Cas.: 896106-16-4 | Purity: 98% | Imiquimod maleate | ESD-876686-200MG |
| Cas.: 89595-71-1 | Purity: 98% | Chamaejasmenin B | ESD-876687-5MG |
| Cas.: 89595-70-0 | Purity: 95% | Chamaejasmenin C | ESD-876688-5MG |
| Cas.: 895542-09-3 | Purity: 98% | Trifarotene | ESD-876689-1MG |
| Cas.: 895542-09-3 | Purity: 98% | Trifarotene | ESD-876689-5MG |
| Cas.: 895525-73-2 | Purity: 95% | tert-Butyl 6-bromo-4H-spiro[benzo[d][1,3]-dioxine-2,4′-piperidine]-1′-carboxylate | ESD-876690-250MG |
| Cas.: 895525-73-2 | Purity: 95% | tert-Butyl 6-bromo-4H-spiro[benzo[d][1,3]-dioxine-2,4′-piperidine]-1′-carboxylate | ESD-876690-1G |
| Cas.: 895519-91-2 | Purity: 98% | Flumatinib mesylate | ESD-876691-500MG |
| Cas.: 895519-90-1 | Purity: ≥99% | Flumatinib | ESD-876692-5MG |
| Cas.: 895519-90-1 | Purity: ≥99% | Flumatinib | ESD-876692-10MG |
| Cas.: 89498-91-9 | Purity: 97% | Picrasinol B | ESD-876693-1MG |
| Cas.: 894804-07-0 | Purity: ≥99% | JNK Inhibitor VIII | ESD-876694-1MG |
| Cas.: 894804-07-0 | Purity: ≥99% | JNK Inhibitor VIII | ESD-876694-5MG |
| Cas.: 894787-30-5 | Purity: ≥99% | ST 2825 | ESD-876695-1MG |
| Cas.: 894787-30-5 | Purity: ≥99% | ST 2825 | ESD-876695-5MG |
| Cas.: 894783-71-2 | Purity: ≥99% | BIBF 1202 | ESD-876696-1MG |
| Cas.: 894783-71-2 | Purity: ≥99% | BIBF 1202 | ESD-876696-5MG |
| Cas.: 894002-50-7 | Purity: ≥96% | LDN-212320 | ESD-876697-10MG |
| Cas.: 893990-34-6 | Purity: ≥99% | VU 0240551 | ESD-876698-5MG |
| Cas.: 893990-34-6 | Purity: ≥99% | VU 0240551 | ESD-876698-10MG |
| Cas.: 89391-50-4 | Purity: ≥99% | Imirestat | ESD-876699-1MG |
| Cas.: 89391-50-4 | Purity: ≥99% | Imirestat | ESD-876699-5MG |
| Cas.: 89388-38-5 | Purity: 98% | MDL 19301 | ESD-876700-1MG |
| Cas.: 89388-38-5 | Purity: 98% | MDL 19301 | ESD-876700-5MG |
| Cas.: 893780-26-2 | Purity: 95% | 8′-Fluoro-6′-methyl-5′,6′-dihydrospiro[cyclopen-tane-1,4′-pyrrolo[3,2,1-ij]quinoline]-1′,2′-dione | ESD-876701-500MG |
| Cas.: 893422-47-4 | Purity: ≥99% | Akt1 and Akt2-IN-1 | ESD-876702-5MG |
| Cas.: 893422-47-4 | Purity: ≥99% | Akt1 and Akt2-IN-1 | ESD-876702-10MG |
| Cas.: 893411-52-4 | Purity: 95% | Spiro[2.5]octane-5,7-dione | ESD-876703-250MG |
| Cas.: 893411-52-4 | Purity: 95% | Spiro[2.5]octane-5,7-dione | ESD-876703-1G |
| Cas.: 892711-75-0 | Purity: ≥99% | CDN1163 | ESD-876704-5MG |
| Cas.: 892711-75-0 | Purity: ≥99% | CDN1163 | ESD-876704-10MG |
| Cas.: 892664-04-9 | Purity: 98% | GSK-269984A | ESD-876705-1MG |
| Cas.: 892664-04-9 | Purity: 98% | GSK-269984A | ESD-876705-5MG |
| Cas.: 892549-43-8 | Purity: ≥98% | MF63 | ESD-876706-5MG |
| Cas.: 892549-43-8 | Purity: ≥98% | MF63 | ESD-876706-10MG |
| Cas.: 892546-37-1 | Purity: ≥98% | PH-064 | ESD-876707-5MG |
| Cas.: 892546-37-1 | Purity: ≥98% | PH-064 | ESD-876707-10MG |
| Cas.: 89239-35-0 | Purity: 98% | CI-943 | ESD-876708-1MG |
| Cas.: 89239-35-0 | Purity: 98% | CI-943 | ESD-876708-5MG |
| Cas.: 892299-50-2 | Purity: 97% | 8-Methyl-3-phenyl-1,4,8-triazaspiro-[4.5]dec-3-ene-2-thione | ESD-876709-500MG |
| Cas.: 892299-50-2 | Purity: 97% | 8-Methyl-3-phenyl-1,4,8-triazaspiro-[4.5]dec-3-ene-2-thione | ESD-876709-1G |
| Cas.: 892299-03-5 | Purity: 97% | 1’H-Spiro[cycloheptane-1,2′-quinazoline]-4′-thiol | ESD-876710-500MG |
| Cas.: 892299-03-5 | Purity: 97% | 1’H-Spiro[cycloheptane-1,2′-quinazoline]-4′-thiol | ESD-876710-1G |
| Cas.: 892289-95-1 | Purity: 97% | tert-Butyl 2-phenyl-3-thioxo-1,4,8-triazaspiro-[4.5]dec-1-ene-8-carboxylate | ESD-876711-500MG |
| Cas.: 892289-95-1 | Purity: 97% | tert-Butyl 2-phenyl-3-thioxo-1,4,8-triazaspiro-[4.5]dec-1-ene-8-carboxylate | ESD-876711-1G |
| Cas.: 892128-60-8 | Purity: ≥98% | LY2334737 | ESD-876712-2MG |
| Cas.: 892128-60-8 | Purity: ≥98% | LY2334737 | ESD-876712-5MG |
| Cas.: 89199-99-5 | Purity: 97% | Mulberrofuran H | ESD-876713-5MG |
| Cas.: 89199-94-0 | Purity: 98% | Fraxiresinol 1-O-glucoside | ESD-876714-5MG |
| Cas.: 891494-64-7 | Purity: ≥95% | SCH900776 S-isomer | ESD-876715-2MG |
| Cas.: 891494-64-7 | Purity: ≥95% | SCH900776 S-isomer | ESD-876715-5MG |
| Cas.: 89130-86-9 | Purity: 95% | Betulin caffeate | ESD-876716-5MG |
| Cas.: 89105-94-2 | Purity: 98% | Fibrinogen Binding Inhibitor Peptide | ESD-876717-1MG |
| Cas.: 89105-94-2 | Purity: 98% | Fibrinogen Binding Inhibitor Peptide | ESD-876717-5MG |
| Cas.: 89104-59-6 | Purity: 95% | 4-O-Demethylisokadsurenin D | ESD-876718-5MG |
| Cas.: 891025-25-5 | Purity: ≥99% | BAMB-4 | ESD-876719-2MG |
| Cas.: 891025-25-5 | Purity: ≥99% | BAMB-4 | ESD-876719-5MG |
| Cas.: 890928-81-1 | Purity: 95% | 24,25-Epoxytirucall-7-en-3,23-dione | ESD-876720-1MG |
| Cas.: 890819-86-0 | Purity: ≥98% | ML349 | ESD-876721-5MG |
| Cas.: 890317-92-7 | Purity: 96% | erythro-Guaiacylglycerol β-coniferyl ether | ESD-876722-5MG |
| Cas.: 89020-11-1 | Purity: 95% | Dregeoside A11 | ESD-876723-5MG |
| Cas.: 890129-26-7 | Purity: ≥98% | BGG463 | ESD-876724-5MG |
| Cas.: 890129-26-7 | Purity: ≥98% | BGG463 | ESD-876724-10MG |
| Cas.: 890087-21-5 | Purity: ≥99% | LUF6000 | ESD-876725-5MG |
| Cas.: 890087-21-5 | Purity: ≥99% | LUF6000 | ESD-876725-10MG |
| Cas.: 889944-54-1 | Purity: 95% | 2-Oxaspiro[3.3]heptane-6-carboxylic acid | ESD-876726-1G |
| Cas.: 889944-54-1 | Purity: 95% | 2-Oxaspiro[3.3]heptane-6-carboxylic acid | ESD-876726-2.5G |
| Cas.: 889139-52-0 | Purity: 95% | tert-Butyl 1H-spiro[isoquinoline-4,4′-piperidine]-2(3H)-carboxylate hydrochloride | ESD-876727-250MG |
| Cas.: 889139-52-0 | Purity: 95% | tert-Butyl 1H-spiro[isoquinoline-4,4′-piperidine]-2(3H)-carboxylate hydrochloride | ESD-876727-1G |
| Cas.: 88866-99-3 | Purity: 95% | Sprengerin A | ESD-876728-5MG |
| Cas.: 88861-91-0 | Purity: 98% | Sprengerin C | ESD-876729-5MG |
| Cas.: 888486-23-5 | Purity: 98% | Transdermal Peptide | ESD-876730-1MG |
| Cas.: 888486-23-5 | Purity: 98% | Transdermal Peptide | ESD-876730-5MG |
| Cas.: 888482-17-5 | Purity: 97% | 11,12-De(methylenedioxy)danuphylline | ESD-876731-5MG |
| Cas.: 88797-59-5 | Purity: 98% | Wallicoside | ESD-876732-5MG |
| Cas.: 887936-68-7 | Purity: ≥98% | Temanogrel | ESD-876733-1MG |
| Cas.: 887936-68-7 | Purity: ≥98% | Temanogrel | ESD-876733-5MG |
| Cas.: 88768-40-5 | Purity: 98% | Cilazapril | ESD-876734-10MG |
| Cas.: 88768-40-5 | Purity: 98% | Cilazapril | ESD-876734-50MG |
| Cas.: 887603-94-3 | Purity: ≥98% | ZSET1446 | ESD-876735-1MG |
| Cas.: 887603-94-3 | Purity: ≥98% | ZSET1446 | ESD-876735-5MG |
| Cas.: 887401-93-6 | Purity: ≥98% | INCB 3284 dimesylate | ESD-876736-10MG |
| Cas.: 887401-93-6 | Purity: ≥98% | INCB 3284 dimesylate | ESD-876736-50MG |
| Cas.: 887401-92-5 | Purity: ≥99% | INCB 3284 | ESD-876737-10MG |
| Cas.: 887401-92-5 | Purity: ≥99% | INCB 3284 | ESD-876737-50MG |
| Cas.: 887375-68-0 | Purity: 97% | 3,9-Dihydroeucomin | ESD-876738-5MG |
| Cas.: 887375-26-0 | Purity: ≥99% | Mapracorat | ESD-876739-5MG |
| Cas.: 887375-26-0 | Purity: ≥99% | Mapracorat | ESD-876739-10MG |
| Cas.: 887333-30-4 | Purity: 95% | Hebeirubescensin H | ESD-876740-5MG |
| Cas.: 88728-58-9 | Purity: 97% | Epiglobulol | ESD-876741-5MG |
| Cas.: 887258-94-8 | Purity: ≥98% | Vabicaserin hydrochloride | ESD-876742-5MG |
| Cas.: 887258-94-8 | Purity: ≥98% | Vabicaserin hydrochloride | ESD-876742-10MG |
| Cas.: 887220-99-7 | Purity: 97% | 3-(4-Methylphenyl)-1,4,8-triazaspiro-[4.5]dec-3-en-2-one | ESD-876743-500MG |
| Cas.: 887220-99-7 | Purity: 97% | 3-(4-Methylphenyl)-1,4,8-triazaspiro-[4.5]dec-3-en-2-one | ESD-876743-1G |
| Cas.: 887220-96-4 | Purity: 95% | 3-Phenyl-1,4,8-triaza-spiro[4.5]dec-3-en-2-one | ESD-876744-1G |
| Cas.: 887220-96-4 | Purity: 95% | 3-Phenyl-1,4,8-triaza-spiro[4.5]dec-3-en-2-one | ESD-876744-2.5G |
| Cas.: 88721-09-9 | Purity: 95% | Adynerigenin β-neritrioside | ESD-876745-5MG |
| Cas.: 887148-69-8 | Purity: ≥99% | Monepantel | ESD-876746-1MG |
| Cas.: 887148-69-8 | Purity: ≥99% | Monepantel | ESD-876746-5MG |
| Cas.: 887147-75-3 | Purity: 95% | 1α-Hydroxytorilin | ESD-876747-5MG |
| Cas.: 887118-43-6 | Purity: 95% | 2,7-Diazaspiro[4.5]decan-1-one | ESD-876748-1G |
| Cas.: 887118-43-6 | Purity: 95% | 2,7-Diazaspiro[4.5]decan-1-one | ESD-876748-5G |
| Cas.: 886989-88-4 | Purity: 97% | Piperlotine C | ESD-876749-5MG |
| Cas.: 886766-31-0 | Purity: 95% | tert-Butyl 5,8-diazaspiro[3.5]nonane-8-carboxylate | ESD-876750-1G |
| Cas.: 886766-31-0 | Purity: 95% | tert-Butyl 5,8-diazaspiro[3.5]nonane-8-carboxylate | ESD-876750-5G |
| Cas.: 886747-63-3 | Purity: 98% | Phoyunbene C | ESD-876751-5MG |
| Cas.: 886747-62-2 | Purity: 98% | Phoyunbene B | ESD-876752-5MG |
| Cas.: 886747-60-0 | Purity: 97% | Phoyunnanin E | ESD-876753-5MG |
| Cas.: 88668-99-9 | Purity: 98% | 8-Epideoxyloganic acid | ESD-876754-5MG |
| Cas.: 88664-09-9 | Purity: 97% | 14-Deoxycoleon U | ESD-876755-5MG |
| Cas.: 886449-72-5 | Purity: 95% | tert-Butyl 10-oxo-4,9-diazaspiro[4.5]decane-4-carboxylate | ESD-876756-250MG |
| Cas.: 886449-72-5 | Purity: 95% | tert-Butyl 10-oxo-4,9-diazaspiro[4.5]decane-4-carboxylate | ESD-876756-500MG |
| Cas.: 88642-46-0 | Purity: 97% | Cerebroside B | ESD-876757-5MG |
| Cas.: 886363-78-6 | Purity: 95% | 6-Acetylamino-2-spiro(N-Boc-piperidine-4-yl)-benzopyran | ESD-876758-1G |
| Cas.: 886363-78-6 | Purity: 95% | 6-Acetylamino-2-spiro(N-Boc-piperidine-4-yl)-benzopyran | ESD-876758-5G |
| Cas.: 886361-92-8 | Purity: 95% | 3-(1,3-Benzodioxol-5-yl)-3-(1,4-dioxa-8-azaspiro-[4.5]dec-8-yl)propanoic acid | ESD-876759-1G |
| Cas.: 886361-92-8 | Purity: 95% | 3-(1,3-Benzodioxol-5-yl)-3-(1,4-dioxa-8-azaspiro-[4.5]dec-8-yl)propanoic acid | ESD-876759-5G |
| Cas.: 886360-95-8 | Purity: 95% | tert-Butyl 1-oxa-4,8-diazaspiro[4.5]decane-8-carboxylate | ESD-876760-1G |
| Cas.: 886360-95-8 | Purity: 95% | tert-Butyl 1-oxa-4,8-diazaspiro[4.5]decane-8-carboxylate | ESD-876760-5G |
| Cas.: 886226-15-9 | Purity: 98% | Muricarpone B | ESD-876761-5MG |
| Cas.: 88585-86-8 | Purity: 95% | Isomexoticin | ESD-876762-1MG |
| Cas.: 88578-07-8 | Purity: ≥98% | Imoxiterol | ESD-876763-1MG |
| Cas.: 88578-07-8 | Purity: ≥98% | Imoxiterol | ESD-876763-5MG |
| Cas.: 885704-21-2 | Purity: ≥99% | c-Fms-IN-3 | ESD-876764-5MG |
| Cas.: 885704-21-2 | Purity: ≥99% | c-Fms-IN-3 | ESD-876764-10MG |
| Cas.: 885703-64-0 | Purity: ≥99% | c-Fms-IN-1 | ESD-876765-5MG |
| Cas.: 885703-64-0 | Purity: ≥99% | c-Fms-IN-1 | ESD-876765-10MG |
| Cas.: 885697-82-5 | Purity: 97% | 5”-O-Acetyljuglanin | ESD-876766-5MG |
| Cas.: 88546-96-7 | Purity: 98% | Minumicrolin | ESD-876767-5MG |
| Cas.: 88546-55-8 | Purity: 98% | Omeprazole metabolite Omeprazole sulfone | ESD-876768-5MG |
| Cas.: 88546-55-8 | Purity: 98% | Omeprazole metabolite Omeprazole sulfone | ESD-876768-10MG |
| Cas.: 885460-90-2 | Purity: 95% | 4-amino-5-cyano-2-mercapto-3-azaspiro[5.5]undeca-1,4-diene-1-carboxamide | ESD-876769-1G |
| Cas.: 885315-96-8 | Purity: 99% | Kongensin A | ESD-876770-5MG |
| Cas.: 885279-92-5 | Purity: 95% | tert-Butyl 1,8-diazaspiro[4.5]decane-1-carboxylate | ESD-876771-1G |
| Cas.: 885275-27-4 | Purity: 95% | 2-Benzyl-2,7-diaza-spiro[4.4]nonane | ESD-876772-1G |
| Cas.: 885272-17-3 | Purity: 95% | 2,6-Diaza-spiro[3.5]nonane-6-carboxylic acid tert-butyl ester hydrochloride | ESD-876773-250MG |
| Cas.: 885272-17-3 | Purity: 95% | 2,6-Diaza-spiro[3.5]nonane-6-carboxylic acid tert-butyl ester hydrochloride | ESD-876773-1G |
| Cas.: 885270-86-0 | Purity: 95% | 2,6-Diaza-spiro[3.4]octane-6-carboxylic acidtert-butyl ester | ESD-876774-250MG |
| Cas.: 885270-86-0 | Purity: 95% | 2,6-Diaza-spiro[3.4]octane-6-carboxylic acidtert-butyl ester | ESD-876774-1G |
| Cas.: 885270-84-8 | Purity: 95% | 2,6-Diaza-spiro[3.4]octane-2-carboxylic acidtert-butylester | ESD-876775-250MG |
| Cas.: 885270-84-8 | Purity: 95% | 2,6-Diaza-spiro[3.4]octane-2-carboxylic acidtert-butylester | ESD-876775-1G |
| Cas.: 885268-47-3 | Purity: 95% | 1,7-Diazaspiro[4.4]nonane-1-carboxylicacid tert-butyl ester | ESD-876776-100MG |
| Cas.: 885268-47-3 | Purity: 95% | 1,7-Diazaspiro[4.4]nonane-1-carboxylicacid tert-butyl ester | ESD-876776-250MG |
| Cas.: 885268-42-8 | Purity: 95% | tert-Butyl 2,7-diazaspiro[4.5]decane-2-carboxylate | ESD-876777-250MG |
| Cas.: 885268-42-8 | Purity: 95% | tert-Butyl 2,7-diazaspiro[4.5]decane-2-carboxylate | ESD-876777-1G |
| Cas.: 885220-61-1 | Purity: ≥99% | Verucerfont | ESD-876778-1MG |
| Cas.: 885220-61-1 | Purity: ≥99% | Verucerfont | ESD-876778-5MG |
| Cas.: 88515-58-6 | Purity: 95% | Rosamultin | ESD-876779-5MG |
| Cas.: 885060-09-3 | Purity: ≥99% | Filanesib | ESD-876780-5MG |
| Cas.: 885060-09-3 | Purity: ≥99% | Filanesib | ESD-876780-10MG |
| Cas.: 885060-08-2 | Purity: ≥98% | (R)-Filanesib | ESD-876781-5MG |
| Cas.: 885060-08-2 | Purity: ≥98% | (R)-Filanesib | ESD-876781-10MG |
| Cas.: 885044-12-2 | Purity: 95% | Farrerol 7-O-glucoside | ESD-876782-5MG |
| Cas.: 88478-44-8 | Purity: 98% | Murraxocin | ESD-876783-5MG |
| Cas.: 88478-14-2 | Purity: 98% | Heynic acid | ESD-876784-5MG |
| Cas.: 884049-52-9 | Purity: 95% | Spiro[piperidine-4,3′-pyrrolo[2,3-b]pyridin]-2′(1’H)-one | ESD-876785-250MG |
| Cas.: 884049-52-9 | Purity: 95% | Spiro[piperidine-4,3′-pyrrolo[2,3-b]pyridin]-2′(1’H)-one | ESD-876785-1G |
| Cas.: 883985-03-3 | Purity: 95% | 1H-SPIRO[[1,8]NAPHTHYRIDINE-4,4′-PIPERIDIN]-2(3H)-ONE | ESD-876786-50MG |
| Cas.: 883985-03-3 | Purity: 95% | 1H-SPIRO[[1,8]NAPHTHYRIDINE-4,4′-PIPERIDIN]-2(3H)-ONE | ESD-876786-250MG |
| Cas.: 883872-71-7 | Purity: 96% | 8α-(2-Methylacryloyloxy)-1-O-methylhirsutinolide 13-O-acetate | ESD-876787-5MG |
| Cas.: 883859-83-4 | Purity: 95% | 8-Lavandulylkaempferol | ESD-876788-5MG |
| Cas.: 88377-68-8 | Purity: ≥95% | Adrenorphin | ESD-876789-1MG |
| Cas.: 88377-68-8 | Purity: ≥95% | Adrenorphin | ESD-876789-5MG |
| Cas.: 883715-18-2 | Purity: 96% | N-Benzylinolenamide | ESD-876790-5MG |
| Cas.: 883550-05-8 | Purity: 95% | 4-(1,4-dioxa-8-azaspiro[4.5]dec-8-yl)-4-oxobutanoic acid | ESD-876791-1G |
| Cas.: 883550-05-8 | Purity: 95% | 4-(1,4-dioxa-8-azaspiro[4.5]dec-8-yl)-4-oxobutanoic acid | ESD-876791-5G |
| Cas.: 88352-44-7 | Purity: 98% | TA-1801 | ESD-876792-1MG |
| Cas.: 88352-44-7 | Purity: 98% | TA-1801 | ESD-876792-5MG |
| Cas.: 883031-03-6 | Purity: ≥99% | HC-067047 | ESD-876793-5MG |
| Cas.: 883031-03-6 | Purity: ≥99% | HC-067047 | ESD-876793-10MG |
| Cas.: 882697-00-9 | Purity: ≥99% | Anle138b | ESD-876794-5MG |
| Cas.: 882697-00-9 | Purity: ≥99% | Anle138b | ESD-876794-10MG |
| Cas.: 882663-88-9 | Purity: ≥98% | AMG-47a | ESD-876795-2MG |
| Cas.: 882663-88-9 | Purity: ≥98% | AMG-47a | ESD-876795-5MG |
| Cas.: 882531-87-5 | Purity: ≥98% | R1530 | ESD-876796-10MG |
| Cas.: 882531-87-5 | Purity: ≥98% | R1530 | ESD-876796-50MG |
| Cas.: 882506-05-0 | Purity: 98% | Alisporivir intermediate-1 | ESD-876797-1MG |
| Cas.: 882506-05-0 | Purity: 98% | Alisporivir intermediate-1 | ESD-876797-5MG |
| Cas.: 882405-89-2 | Purity: ≥99% | BBT594 | ESD-876798-5MG |
| Cas.: 882405-89-2 | Purity: ≥99% | BBT594 | ESD-876798-10MG |
| Cas.: 882366-16-7 | Purity: ≥99% | SBI-115 | ESD-876799-5MG |
| Cas.: 882366-16-7 | Purity: ≥99% | SBI-115 | ESD-876799-10MG |
| Cas.: 88200-01-5 | Purity: 97% | (-)-Chelidonine | ESD-876800-5MG |
| Cas.: 88191-84-8 | Purity: ≥99% | MDL-28170 | ESD-876801-5MG |
| Cas.: 88191-84-8 | Purity: ≥99% | MDL-28170 | ESD-876801-10MG |
| Cas.: 88191-14-4 | Purity: 97% | 3β,5α,9α-Trihydroxyergosta-7,22-dien-6-one | ESD-876802-5MG |
| Cas.: 881851-50-9 | Purity: ≥99% | Larazotide acetate | ESD-876803-1MG |
| Cas.: 881851-50-9 | Purity: ≥99% | Larazotide acetate | ESD-876803-5MG |
| Cas.: 881639-98-1 | Purity: ≥99% | G-1 | ESD-876804-1MG |
| Cas.: 881639-98-1 | Purity: ≥99% | G-1 | ESD-876804-5MG |
| Cas.: 88150-59-8 | Purity: 98% | UK51656 | ESD-876805-1MG |
| Cas.: 88150-59-8 | Purity: 98% | UK51656 | ESD-876805-5MG |
| Cas.: 88150-47-4 | Purity: ≥99% | Amlodipine maleate | ESD-876806-500MG |
| Cas.: 88150-47-4 | Purity: ≥99% | Amlodipine maleate | ESD-876806-1G |
| Cas.: 881388-87-0 | Purity: 98% | Daphniyunnine A | ESD-876808-5MG |
| Cas.: 881179-06-2 | Purity: ≥98% | α-2,3-sialyltransferase-IN-1 | ESD-876809-5MG |
| Cas.: 881179-06-2 | Purity: ≥98% | α-2,3-sialyltransferase-IN-1 | ESD-876809-10MG |
| Cas.: 881179-02-8 | Purity: ≥98% | Lith-O-Asp | ESD-876810-5MG |
| Cas.: 881179-02-8 | Purity: ≥98% | Lith-O-Asp | ESD-876810-10MG |
| Cas.: 88086-86-6 | Purity: 97% | 4-Hydroxybenzaldehyde rhamnoside | ESD-876811-5MG |
| Cas.: 880813-36-5 | Purity: 98% | PhiKan 083 | ESD-876812-5MG |
| Cas.: 880813-36-5 | Purity: 98% | PhiKan 083 | ESD-876812-10MG |
| Cas.: 880635-03-0 | Purity: ≥98% | GW 6471 | ESD-876813-5MG |
| Cas.: 880635-03-0 | Purity: ≥98% | GW 6471 | ESD-876813-10MG |
| Cas.: 880462-11-3 | Purity: 95% | 1-N-CBZ-4-(1,4-DIOXA-8-AZASPIRO[4.5]DEC-8-YL)PIPERIDINE | ESD-876814-1G |
| Cas.: 880462-11-3 | Purity: 95% | 1-N-CBZ-4-(1,4-DIOXA-8-AZASPIRO[4.5]DEC-8-YL)PIPERIDINE | ESD-876814-5G |
| Cas.: 880450-15-7 | Purity: 95% | 4-(4-fluorophenyl)-1,7$l^{6}-dithia-4-azaspiro[4.4]nonane-3,7,7-trione | ESD-876815-1G |
| Cas.: 880450-10-2 | Purity: 95% | 4-phenyl-1,7$l^{6}-dithia-4-azaspiro[4.4]nonane-3,7,7-trione | ESD-876816-1MG |
| Cas.: 880450-05-5 | Purity: 95% | 4-(4-methoxyphenyl)-1,7$l^{6}-dithia-4-azaspiro[4.4]nonane-3,7,7-trione | ESD-876817-1G |
| Cas.: 880155-70-4 | Purity: ≥98% | CNT2 inhibitor-1 | ESD-876818-5MG |
| Cas.: 880155-70-4 | Purity: ≥98% | CNT2 inhibitor-1 | ESD-876818-10MG |
| Cas.: 880090-88-0 | Purity: ≥97% | Neuropathiazol | ESD-876819-5MG |
| Cas.: 880090-88-0 | Purity: ≥97% | Neuropathiazol | ESD-876819-50MG |
| Cas.: 87980-68-5 | Purity: ≥98% | Ingenol-5,20-acetonide-3-O-angelate | ESD-876820-1MG |
| Cas.: 87980-68-5 | Purity: ≥98% | Ingenol-5,20-acetonide-3-O-angelate | ESD-876820-5MG |
| Cas.: 879642-15-6 | Purity: 95% | 4-phenyl-1$l^{6},7$l^{6}-dithia-4-azaspiro[4.4]nonane-1,1,3,7,7-pentone | ESD-876821-1G |
| Cas.: 879642-09-8 | Purity: 95% | 4-(2-methylphenyl)-1,7$l^{6}-dithia-4-azaspiro[4.4]nonane-3,7,7-trione | ESD-876822-1G |
| Cas.: 879642-03-2 | Purity: 95% | 4-(2-phenylethyl)-1,7$l^{6}-dithia-4-azaspiro[4.4]nonane-3,7,7-trione | ESD-876823-1G |
| Cas.: 879641-96-0 | Purity: 95% | 4-benzyl-1,7$l^{6}-dithia-4-azaspiro[4.4]nonane-3,7,7-trione | ESD-876824-1MG |
| Cas.: 879641-88-0 | Purity: 95% | 4-(4-chlorophenyl)-1,7$l^{6}-dithia-4-azaspiro[4.4]nonane-3,7,7-trione | ESD-876825-1MG |
| Cas.: 879641-80-2 | Purity: 95% | 4-(furan-2-ylmethyl)-1,7$l^{6}-dithia-4-azaspiro[4.4]nonane-3,7,7-trione | ESD-876826-1G |
| Cas.: 87952-00-9 | Purity: 95% | Ethyl 1-thia-4-azaspiro[4.5]decane-6-carboxylatehydrochloride | ESD-876827-500MG |
| Cas.: 879514-21-3 | Purity: 95% | 8-(Nitromethyl)-1,4-dioxaspiro[4.5]decan-8-ol | ESD-876828-1G |
| Cas.: 879487-87-3 | Purity: ≥99% | R-268712 | ESD-876829-2MG |
| Cas.: 879487-87-3 | Purity: ≥99% | R-268712 | ESD-876829-5MG |
| Cas.: 87940-60-1 | Purity: ≥99% | Eprobemide | ESD-876830-5MG |
| Cas.: 87940-60-1 | Purity: ≥99% | Eprobemide | ESD-876830-10MG |
| Cas.: 87932-34-1 | Purity: 98% | p-Hydroxyphenethyl anisate | ESD-876831-5MG |
| Cas.: 879319-16-1 | Purity: 95% | (2,5-dioxo-2′,3′-dihydro-1H-spiro[imidazolidine-4,1′-inden]-1-yl)acetic acid | ESD-876832-1G |
| Cas.: 878978-76-8 | Purity: ≥99% | ML-098 | ESD-876833-5MG |
| Cas.: 878978-76-8 | Purity: ≥99% | ML-098 | ESD-876833-10MG |
| Cas.: 878-46-6 | Purity: 95% | 1-methyl-1,3-diazaspiro[4.5]decane-2,4-dione | ESD-876834-1G |
| Cas.: 878-46-6 | Purity: 95% | 1-methyl-1,3-diazaspiro[4.5]decane-2,4-dione | ESD-876834-5G |
| Cas.: 878451-87-7 | Purity: ≥99% | RS-246204 | ESD-876835-5MG |
| Cas.: 878451-87-7 | Purity: ≥99% | RS-246204 | ESD-876835-10MG |
| Cas.: 878385-84-3 | Purity: ≥99% | AZD-5069 | ESD-876836-1MG |
| Cas.: 878385-84-3 | Purity: ≥99% | AZD-5069 | ESD-876836-5MG |
| Cas.: 87827-55-2 | Purity: 96% | Alismol | ESD-876837-5MG |
| Cas.: 878167-55-6 | Purity: 95% | tert-Butyl 5-bromospiro[indoline-3,4′-piperidine]-1′-carboxylate | ESD-876838-250MG |
| Cas.: 878167-55-6 | Purity: 95% | tert-Butyl 5-bromospiro[indoline-3,4′-piperidine]-1′-carboxylate | ESD-876838-1G |
| Cas.: 878167-12-5 | Purity: 95% | 5-Chloro-2H-spiro[1-benzofuran-3,4′-piperidine] hydrochloride | ESD-876839-1MG |
| Cas.: 87797-84-0 | Purity: 95% | 6β-Hydroxyipolamiide | ESD-876840-1MG |
| Cas.: 877875-96-2 | Purity: 98% | erythro-Guaiacylglycerol β-sinapyl ether | ESD-876841-5MG |
| Cas.: 877790-46-0 | Purity: 95% | 8-(5-Nitropyridin-2-yl)-1,4-dioxa-8-azaspiro[4.5]decane | ESD-876842-500MG |
| Cas.: 877201-35-9 | Purity: 95% | 6-Aminomethyl-spiro[2.5]octane | ESD-876843-250MG |
| Cas.: 877201-35-9 | Purity: 95% | 6-Aminomethyl-spiro[2.5]octane | ESD-876843-1G |
| Cas.: 877125-98-9 | Purity: 95% | 7-Aminomethyl-spiro[3.5]nonane | ESD-876844-250MG |
| Cas.: 877125-98-9 | Purity: 95% | 7-Aminomethyl-spiro[3.5]nonane | ESD-876844-1G |
| Cas.: 87686-86-0 | Purity: 97% | 6-Hydroxyrubiadin | ESD-876845-5MG |
| Cas.: 87679-37-6 | Purity: ≥98% | Trandopril | ESD-876846-10MG |
| Cas.: 87679-37-6 | Purity: ≥98% | Trandopril | ESD-876846-50MG |
| Cas.: 876761-75-0 | Purity: 95% | N-Boc-amino-(1,4-dioxa-spiro[4.5]dec-8-yl)-acetic acid | ESD-876847-250MG |
| Cas.: 876761-75-0 | Purity: 95% | N-Boc-amino-(1,4-dioxa-spiro[4.5]dec-8-yl)-acetic acid | ESD-876847-1G |
| Cas.: 876708-03-1 | Purity: ≥98% | RO-9187 | ESD-876848-5MG |
| Cas.: 876708-03-1 | Purity: ≥98% | RO-9187 | ESD-876848-10MG |
| Cas.: 876708-01-9 | Purity: 98% | Nucleoside-Analog-2 | ESD-876849-2MG |
| Cas.: 876708-01-9 | Purity: 98% | Nucleoside-Analog-2 | ESD-876849-5MG |
| Cas.: 876707-99-2 | Purity: 98% | Nucleoside-Analog-1 | ESD-876850-2MG |
| Cas.: 876707-99-2 | Purity: 98% | Nucleoside-Analog-1 | ESD-876850-5MG |
| Cas.: 876310-60-0 | Purity: ≥98% | RF9 | ESD-876851-1MG |
| Cas.: 876310-60-0 | Purity: ≥98% | RF9 | ESD-876851-5MG |
| Cas.: 87626-56-0 | Purity: 98% | LM985 | ESD-876852-1MG |
| Cas.: 87626-56-0 | Purity: 98% | LM985 | ESD-876852-5MG |
| Cas.: 87592-77-6 | Purity: 98% | Smyrindioloside | ESD-876853-1MG |
| Cas.: 87585-32-8 | Purity: 97% | (+)-Lyoniresinol 9′-O-glucoside | ESD-876854-5MG |
| Cas.: 875666-39-0 | Purity: 96% | cis-3,4-Dihydroxy-β-ionone | ESD-876855-5MG |
| Cas.: 87562-76-3 | Purity: 97% | Kelampayoside A | ESD-876856-5MG |
| Cas.: 87562-14-9 | Purity: 96% | Randaiol | ESD-876857-5MG |
| Cas.: 87549-36-8 | Purity: ≥99% | Parcetasal | ESD-876858-1MG |
| Cas.: 87549-36-8 | Purity: ≥99% | Parcetasal | ESD-876858-5MG |
| Cas.: 875455-82-6 | Purity: ≥98% | Rusalatide acetate | ESD-876859-1MG |
| Cas.: 875455-82-6 | Purity: ≥98% | Rusalatide acetate | ESD-876859-5MG |
| Cas.: 87530-30-1 | Purity: 98% | Lusianthridin | ESD-876860-5MG |
| Cas.: 875-11-6 | Purity: 95% | 1-Thia-4-azaspiro[4.6]undecane hydrochloride | ESD-876861-500MG |
| Cas.: 875071-97-9 | Purity: 95% | 5′-Bromospiro[cyclopropane-1,3′-indolin]-2′-one | ESD-876862-1G |
| Cas.: 875071-97-9 | Purity: 95% | 5′-Bromospiro[cyclopropane-1,3′-indolin]-2′-one | ESD-876862-5G |
| Cas.: 875051-72-2 | Purity: ≥99% | PF-01247324 | ESD-876863-5MG |
| Cas.: 875051-72-2 | Purity: ≥99% | PF-01247324 | ESD-876863-10MG |
| Cas.: 874902-19-9 | Purity: ≥99% | LY2183240 | ESD-876864-10MG |
| Cas.: 874902-19-9 | Purity: ≥99% | LY2183240 | ESD-876864-50MG |
| Cas.: 87480-84-0 | Purity: 97% | Dihydroajugapitin | ESD-876865-5MG |
| Cas.: 874758-58-4 | Purity: 98% | Ecteinascidin-Analog-1 | ESD-876866-2MG |
| Cas.: 874758-58-4 | Purity: 98% | Ecteinascidin-Analog-1 | ESD-876866-5MG |
| Cas.: 87441-73-4 | Purity: 97% | 11(13)-Dehydroivaxillin | ESD-876867-5MG |
| Cas.: 87440-75-3 | Purity: 93% | Viteralone | ESD-876868-1MG |
| Cas.: 87440-66-2 | Purity: 98% | 6-Dehydroxy-8-hydroxygaleopsisinolone | ESD-876869-5MG |
| Cas.: 87440-56-0 | Purity: 95% | Glepidotin B | ESD-876870-1MG |
| Cas.: 874303-34-1 | Purity: 95% | Millewanin H | ESD-876871-5MG |
| Cas.: 874303-33-0 | Purity: 95% | Millewanin G | ESD-876872-5MG |
| Cas.: 874201-05-5 | Purity: 97% | Daphnilongeranin A | ESD-876873-5MG |
| Cas.: 874101-00-5 | Purity: ≥99% | RO4987655 | ESD-876874-2MG |
| Cas.: 874101-00-5 | Purity: ≥99% | RO4987655 | ESD-876874-5MG |
| Cas.: 87402-91-3 | Purity: 97% | Euchrestaflavone B | ESD-876875-5MG |
| Cas.: 87402-88-8 | Purity: 97% | Denudatin B | ESD-876876-5MG |
| Cas.: 87402-72-0 | Purity: 98% | Eulophiol | ESD-876877-5MG |
| Cas.: 873999-88-3 | Purity: 97% | 2,3-Dihydroamentoflavone 7,4′-dimethyl ether | ESD-876878-5MG |
| Cas.: 873924-12-0 | Purity: 95% | 7-(tert-Butoxycarbonyl)-7-azaspiro-[3.5]nonane-2-carboxylic acid | ESD-876879-250MG |
| Cas.: 873924-12-0 | Purity: 95% | 7-(tert-Butoxycarbonyl)-7-azaspiro-[3.5]nonane-2-carboxylic acid | ESD-876879-1G |
| Cas.: 873924-08-4 | Purity: 95% | tert-butyl 9-oxo-3-azaspiro[5.5]undecane-3-carboxylate | ESD-876880-250MG |
| Cas.: 873867-94-8 | Purity: 95% | 3,4,5′-Trimethoxy-3′,4′-methylenedioxy-7,9′:7′,9-diepoxylignan | ESD-876881-5MG |
| Cas.: 873786-09-5 | Purity: ≥98% | PLX647 | ESD-876882-5MG |
| Cas.: 873786-09-5 | Purity: ≥98% | PLX647 | ESD-876882-10MG |
| Cas.: 873779-30-7 | Purity: 95% | 1′-Boc-5-Bromo-1,2-dihydro-2-oxo-spiro[3H-indole-3,4′-piperidine] | ESD-876883-500MG |
| Cas.: 873779-30-7 | Purity: 95% | 1′-Boc-5-Bromo-1,2-dihydro-2-oxo-spiro[3H-indole-3,4′-piperidine] | ESD-876883-1G |
| Cas.: 873779-29-4 | Purity: 95% | tert-Butyl 3,4-dihydro-2H-spiro[naphthalene-1,4′-piperidine]-1′-carboxylate | ESD-876884-250MG |
| Cas.: 873779-29-4 | Purity: 95% | tert-Butyl 3,4-dihydro-2H-spiro[naphthalene-1,4′-piperidine]-1′-carboxylate | ESD-876884-1G |
| Cas.: 873694-46-3 | Purity: 95% | Demethylcarolignan E | ESD-876885-5MG |
| Cas.: 87355-32-6 | Purity: 98% | Lupeolic acid | ESD-876886-5MG |
| Cas.: 87340-25-8 | Purity: 98% | Fortuneine | ESD-876887-5MG |
| Cas.: 87339-76-2 | Purity: 98% | 1,7-Dihydroxy-4-methoxyxanthone | ESD-876888-5MG |
| Cas.: 872729-34-5 | Purity: 95% | 3-Methoxyoxohernandaline | ESD-876889-5MG |
| Cas.: 872729-33-4 | Purity: 97% | 1,2,3,10-Tetramethoxy-9-(2-hydroxy-4,5-dimethoxybenzyloxy)oxoaporphine | ESD-876890-5MG |
| Cas.: 872-64-0 | Purity: 97% | 6-AZASPIRO[2.5]OCTANE | ESD-876891-1G |
| Cas.: 872-64-0 | Purity: 97% | 6-AZASPIRO[2.5]OCTANE | ESD-876891-5G |
| Cas.: 87261-77-6 | Purity: 97% | 7-Epi-5-eudesmene-1β,11-diol | ESD-876892-5MG |
| Cas.: 872141-30-5 | Purity: 95% | 7′-FLUOROSPIRO[CYCLOPROPANE-1,3′-INDOLIN]-2′-ONE | ESD-876893-1G |
| Cas.: 87193-98-4 | Purity: 95% | 2-Deacetoxydecinnamoyltaxinine J | ESD-876894-5MG |
| Cas.: 871727-04-7 | Purity: 95% | 6-TERT-BUTYL 1-METHYL 6-AZASPIRO[2.5]OCTANE-1,6-DICARBOXYLATE | ESD-876895-1G |
| Cas.: 87164-90-7 | Purity: 98% | ICI 153110 | ESD-876896-1MG |
| Cas.: 87164-90-7 | Purity: 98% | ICI 153110 | ESD-876896-5MG |
| Cas.: 87151-60-8 | Purity: 95% | 1-oxaspiro[4.5]decan-8-one | ESD-876897-1G |
| Cas.: 87151-60-8 | Purity: 95% | 1-oxaspiro[4.5]decan-8-one | ESD-876897-5G |
| Cas.: 870995-64-5 | Purity: 95% | 5-Methoxystrictamine | ESD-876898-1MG |
| Cas.: 87095-74-7 | Purity: 95% | 5-Hydroxy-1,7-diphenyl-6-hepten-3-one | ESD-876899-1MG |
| Cas.: 87085-00-5 | Purity: ≥90% | Mulberrofuran G | ESD-876900-5MG |
| Cas.: 870480-56-1 | Purity: 95% | Bis-5,5-nortrachelogenin | ESD-876901-5MG |
| Cas.: 870082-43-2 | Purity: 95% | 1-(2,8-Diazaspiro[4.5]decan-2-yl)ethanone hemioxalate | ESD-876902-100MG |
| Cas.: 870082-43-2 | Purity: 95% | 1-(2,8-Diazaspiro[4.5]decan-2-yl)ethanone hemioxalate | ESD-876902-500MG |
| Cas.: 86989-18-6 | Purity: 95% | Alpinumisoflavone acetate | ESD-876903-5MG |
| Cas.: 869880-32-0 | Purity: 95% | Formoxanthone A | ESD-876904-5MG |
| Cas.: 869807-57-8 | Purity: 98% | Andropanolide | ESD-876905-5MG |
| Cas.: 869799-76-8 | Purity: 97% | threo-Guaiacylglycerol β-coniferyl ether | ESD-876906-5MG |
| Cas.: 86940-46-7 | Purity: 95% | Praeroside II | ESD-876907-5MG |
| Cas.: 869384-82-7 | Purity: 95% | 14-Deoxy-17-hydroxyandrographolide | ESD-876908-5MG |
| Cas.: 86917-79-5 | Purity: 95% | Eudesma-3,11-dien-2-one | ESD-876909-5MG |
| Cas.: 868666-20-0 | Purity: 98% | 3′,5′-Dimethoxybiphenyl-3-ol | ESD-876910-5MG |
| Cas.: 868409-19-2 | Purity: 95% | (+)-Puerol B 2″-O-glucoside | ESD-876911-5MG |
| Cas.: 868405-37-2 | Purity: 95% | Protosappanin A dimethyl acetal | ESD-876912-5MG |
| Cas.: 86838-54-2 | Purity: 98% | 2,2,5,5-Tetramethylcyclohexane-1,4-dione | ESD-876913-5MG |
| Cas.: 868361-89-1 | Purity: 95% | 1′-Benzyl-7-methoxy-spiro[chromane-2,4′-piperidine]-4-one | ESD-876914-500MG |
| Cas.: 868361-89-1 | Purity: 95% | 1′-Benzyl-7-methoxy-spiro[chromane-2,4′-piperidine]-4-one | ESD-876914-1G |
| Cas.: 86831-53-0 | Purity: 98% | Rhodiolin | ESD-876915-5MG |
| Cas.: 867009-61-8 | Purity: 95% | 2-benzyl-2,8-diazaspiro[4.5]decane | ESD-876916-1G |
| Cas.: 867006-20-0 | Purity: 95% | 3,9-Diazaspiro[5.5]undecan-2-one | ESD-876917-1G |
| Cas.: 867006-20-0 | Purity: 95% | 3,9-Diazaspiro[5.5]undecan-2-one | ESD-876917-5G |
| Cas.: 86654-26-4 | Purity: 95% | 7-Hydroxy-3-prenylcoumarin | ESD-876918-250MG |
| Cas.: 86641-76-1 | Purity: 95% | 3,12-Bis(3-bromopropanoyl)-3,12-diaza-6,9-diazoniadispiro[5.2.5.2]hexadecane dichloride | ESD-876919-500MG |
| Cas.: 86641-76-1 | Purity: 95% | 3,12-Bis(3-bromopropanoyl)-3,12-diaza-6,9-diazoniadispiro[5.2.5.2]hexadecane dichloride | ESD-876919-1G |
| Cas.: 86630-23-1 | Purity: 96% | 3,5,3′-Trihydroxybibenzyl | ESD-876920-5MG |
| Cas.: 866111-14-0 | Purity: 97% | Clausine Z | ESD-876921-5MG |
| Cas.: 86606-14-6 | Purity: 98% | 6-Benzoyl-5,7-dihydroxy-2,2-dimethylchromane | ESD-876922-5MG |
| Cas.: 866028-06-0 | Purity: 95% | 1′-Boc-5-Fluoro-1,2-dihydro-2-oxo-spiro[3H-indole-3,4′-piperidine] | ESD-876923-1G |
| Cas.: 866028-06-0 | Purity: 95% | 1′-Boc-5-Fluoro-1,2-dihydro-2-oxo-spiro[3H-indole-3,4′-piperidine] | ESD-876923-5G |
| Cas.: 865887-46-3 | Purity: 96% | Oleuropeic acid 8-O-glucoside | ESD-876924-5MG |
| Cas.: 86583-19-9 | Purity: ≥98% | 3-Deazaadenosine hydrochloride | ESD-876925-1MG |
| Cas.: 86583-19-9 | Purity: ≥98% | 3-Deazaadenosine hydrochloride | ESD-876925-5MG |
| Cas.: 865626-62-6 | Purity: 95% | tert-Butyl 4-oxo-2-phenyl-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate | ESD-876926-1G |
| Cas.: 865543-37-9 | Purity: 95% | Ganoderic acid SZ | ESD-876927-5MG |
| Cas.: 86548-91-6 | Purity: 98% | Junipediol A | ESD-876928-5MG |
| Cas.: 86537-66-8 | Purity: 95% | N-Methylcalycinine | ESD-876929-5MG |
| Cas.: 86530-28-1 | Purity: 98% | β-Apo-13-carotenone D3 | ESD-876930-1MG |
| Cas.: 86530-28-1 | Purity: 98% | β-Apo-13-carotenone D3 | ESD-876930-5MG |
| Cas.: 865187-17-3 | Purity: 96% | Gelsempervine A | ESD-876931-5MG |
| Cas.: 864817-63-0 | Purity: 95% | Leojaponin | ESD-876932-5MG |
| Cas.: 864812-75-9 | Purity: 95% | 3,4-dihydro-2H-spiro[naphthalene-1,3′-piperidine] | ESD-876933-10MG |
| Cas.: 864812-75-9 | Purity: 95% | 3,4-dihydro-2H-spiro[naphthalene-1,3′-piperidine] | ESD-876933-50MG |
| Cas.: 864763-36-0 | Purity: 95% | (6′-Methyl-8′-oxo-3′,4′-dihydro-8’H-spiro[cyclohexane-1,2′-pyrano[3,2-g]chromen]-7′-yl)acetic acid | ESD-876934-500MG |
| Cas.: 864719-19-7 | Purity: 95% | Sequosempervirin D | ESD-876935-1MG |
| Cas.: 864719-17-5 | Purity: 95% | Sequosempervirin B | ESD-876936-1MG |
| Cas.: 864684-96-8 | Purity: 95% | tert-Butyl 1-oxa-7-azaspiro[3.5]nonane-7-carboxylate | ESD-876937-100MG |
| Cas.: 864684-96-8 | Purity: 95% | tert-Butyl 1-oxa-7-azaspiro[3.5]nonane-7-carboxylate | ESD-876937-500MG |
| Cas.: 864516-31-4 | Purity: 95% | Nigrolineaxanthone V | ESD-876938-1MG |
| Cas.: 86434-57-3 | Purity: 98% | Beperidium iodide | ESD-876939-1MG |
| Cas.: 86434-57-3 | Purity: 98% | Beperidium iodide | ESD-876939-5MG |
| Cas.: 86408-36-8 | Purity: ≥97% | Polymyxin B nonapeptide | ESD-876940-5MG |
| Cas.: 863971-24-8 | Purity: ≥97% | Mc-MMAE | ESD-876941-1MG |
| Cas.: 863971-24-8 | Purity: ≥97% | Mc-MMAE | ESD-876941-5MG |
| Cas.: 863971-19-1 | Purity: ≥99% | McMMAF | ESD-876942-1MG |
| Cas.: 863971-19-1 | Purity: ≥99% | McMMAF | ESD-876942-5MG |
| Cas.: 863971-12-4 | Purity: ≥96% | MMAF-OMe | ESD-876943-2MG |
| Cas.: 863971-12-4 | Purity: ≥96% | MMAF-OMe | ESD-876943-5MG |
| Cas.: 86384-98-7 | Purity: 98% | CV-159 | ESD-876944-1MG |
| Cas.: 86384-98-7 | Purity: 98% | CV-159 | ESD-876944-5MG |
| Cas.: 863774-58-7 | Purity: ≥98% | Dimethylenastron | ESD-876945-5MG |
| Cas.: 863774-58-7 | Purity: ≥98% | Dimethylenastron | ESD-876945-10MG |
| Cas.: 863-76-3 | Purity: 95% | α-Amyrin acetate | ESD-876946-5MG |
| Cas.: 863680-45-9 | Purity: ≥99% | GSK598809 | ESD-876947-5MG |
| Cas.: 863680-45-9 | Purity: ≥99% | GSK598809 | ESD-876947-10MG |
| Cas.: 863598-09-8 | Purity: ≥98% | Casein Kinase II Inhibitor IV | ESD-876948-5MG |
| Cas.: 863598-09-8 | Purity: ≥98% | Casein Kinase II Inhibitor IV | ESD-876948-10MG |
| Cas.: 863513-91-1 | Purity: ≥98% | Cebranopadol | ESD-876949-2MG |
| Cas.: 863513-91-1 | Purity: ≥98% | Cebranopadol | ESD-876949-5MG |
| Cas.: 863405-60-1 | Purity: ≥99% | JW74 | ESD-876950-5MG |
| Cas.: 863405-60-1 | Purity: ≥99% | JW74 | ESD-876950-10MG |
| Cas.: 863115-70-2 | Purity: 98% | MCHr1 antagonist 2 | ESD-876951-1MG |
| Cas.: 863115-70-2 | Purity: 98% | MCHr1 antagonist 2 | ESD-876951-5MG |
| Cas.: 86307-44-0 | Purity: ≥99% | Impurity C of Calcitriol | ESD-876952-1MG |
| Cas.: 86307-44-0 | Purity: ≥99% | Impurity C of Calcitriol | ESD-876952-5MG |
| Cas.: 863031-24-7 | Purity: 98% | Azilsartan medoxomil monopotassium | ESD-876953-2MG |
| Cas.: 863031-24-7 | Purity: 98% | Azilsartan medoxomil monopotassium | ESD-876953-5MG |
| Cas.: 86293-25-6 | Purity: 97% | Isoiridogermanal | ESD-876954-5MG |
| Cas.: 862812-98-4 | Purity: ≥98% | GSK319347A | ESD-876955-1MG |
| Cas.: 862812-98-4 | Purity: ≥98% | GSK319347A | ESD-876955-5MG |
| Cas.: 862309-06-6 | Purity: ≥99% | MK-0249 | ESD-876956-1MG |
| Cas.: 862309-06-6 | Purity: ≥99% | MK-0249 | ESD-876956-5MG |
| Cas.: 862261-25-4 | Purity: 95% | 8-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1,4-dioxa-8-azaspiro[4.5]decane | ESD-876957-250MG |
| Cas.: 862261-25-4 | Purity: 95% | 8-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1,4-dioxa-8-azaspiro[4.5]decane | ESD-876957-1G |
| Cas.: 862255-64-9 | Purity: 95% | Valeriotriate B | ESD-876958-5MG |
| Cas.: 862189-96-6 | Purity: ≥99% | Miridenafil dihydrochloride | ESD-876959-5MG |
| Cas.: 862189-96-6 | Purity: ≥99% | Miridenafil dihydrochloride | ESD-876959-10MG |
| Cas.: 862189-95-5 | Purity: 98% | mirodenafil | ESD-876960-5MG |
| Cas.: 862189-95-5 | Purity: 98% | mirodenafil | ESD-876960-10MG |
| Cas.: 862090-74-2 | Purity: 98% | Chymase-IN-1 | ESD-876961-1MG |
| Cas.: 862090-74-2 | Purity: 98% | Chymase-IN-1 | ESD-876961-5MG |
| Cas.: 861998-00-7 | Purity: ≥99% | Anamorelin hydrochloride | ESD-876962-5MG |
| Cas.: 861998-00-7 | Purity: ≥99% | Anamorelin hydrochloride | ESD-876962-10MG |
| Cas.: 861960-34-1 | Purity: 98% | 7-Methoxy-3,4-dihydro-1-naphthalenylacetonitrile | ESD-876963-5MG |
| Cas.: 861393-28-4 | Purity: ≥98% | A-740003 | ESD-876964-10MG |
| Cas.: 861393-28-4 | Purity: ≥98% | A-740003 | ESD-876964-50MG |
| Cas.: 861139-16-4 | Purity: ≥99% | RSV-IN-1 | ESD-876965-5MG |
| Cas.: 861139-16-4 | Purity: ≥99% | RSV-IN-1 | ESD-876965-10MG |
| Cas.: 86047-86-1 | Purity: 95% | 1,4-diazaspiro[5.5]undecan-5-one | ESD-876966-1G |
| Cas.: 86047-86-1 | Purity: 95% | 1,4-diazaspiro[5.5]undecan-5-one | ESD-876966-5G |
| Cas.: 86030-08-2 | Purity: ≥99% | BTB-1 | ESD-876967-5MG |
| Cas.: 86030-08-2 | Purity: ≥99% | BTB-1 | ESD-876967-10MG |
| Cas.: 860033-06-3 | Purity: ≥99% | L 888607 | ESD-876968-5MG |
| Cas.: 860033-06-3 | Purity: ≥99% | L 888607 | ESD-876968-10MG |
| Cas.: 859853-30-8 | Purity: ≥99% | BMS-690514 | ESD-876969-2MG |
| Cas.: 859853-30-8 | Purity: ≥99% | BMS-690514 | ESD-876969-5MG |
| Cas.: 859498-05-8 | Purity: 98% | AGN 205728 | ESD-876970-100MG |
| Cas.: 85916-47-8 | Purity: 98% | Katacalcin TFA | ESD-876971-1MG |
| Cas.: 858-98-0 | Purity: 98% | 3-O-Benzyl estrone | ESD-876972-5MG |
| Cas.: 85889-15-2 | Purity: 95% | prim-O-Glucosylangelicain | ESD-876973-5MG |
| Cas.: 858668-07-2 | Purity: ≥99% | EMD534085 | ESD-876974-1MG |
| Cas.: 858668-07-2 | Purity: ≥99% | EMD534085 | ESD-876974-5MG |
| Cas.: 85858-76-0 | Purity: 98% | FK-448 Free base | ESD-876975-1MG |
| Cas.: 85858-76-0 | Purity: 98% | FK-448 Free base | ESD-876975-5MG |
| Cas.: 858474-14-3 | Purity: ≥99% | NSC23925 | ESD-876976-5MG |
| Cas.: 858474-14-3 | Purity: ≥99% | NSC23925 | ESD-876976-10MG |
| Cas.: 858360-61-9 | Purity: 95% | Marsdenoside F | ESD-876977-1MG |
| Cas.: 858351-47-0 | Purity: 95% | 1-Boc-5-Fluorospiro[indoline-3,4′-piperidine] | ESD-876978-250MG |
| Cas.: 858351-47-0 | Purity: 95% | 1-Boc-5-Fluorospiro[indoline-3,4′-piperidine] | ESD-876978-1G |
| Cas.: 858351-40-3 | Purity: 95% | tert-Butyl 6-fluoro-1,2-dihydrospiro[indole-3,4′-piperidine]-1′-carboxylate | ESD-876979-1G |
| Cas.: 858128-57-1 | Purity: ≥98% | SPB | ESD-876980-5MG |
| Cas.: 858128-57-1 | Purity: ≥98% | SPB | ESD-876980-10MG |
| Cas.: 858102-78-0 | Purity: ≥99% | E-982 | ESD-876981-5MG |
| Cas.: 858102-78-0 | Purity: ≥99% | E-982 | ESD-876981-10MG |
| Cas.: 857898-70-5 | Purity: 95% | tert-Butyl 1H-spiro[isoquinoline-4,4′-piperidine]-2(3H)-carboxylate | ESD-876982-250MG |
| Cas.: 857898-70-5 | Purity: 95% | tert-Butyl 1H-spiro[isoquinoline-4,4′-piperidine]-2(3H)-carboxylate | ESD-876982-1G |
| Cas.: 857897-01-9 | Purity: 98% | 11,12-Di-O-acetyltenacigenin B | ESD-876983-5MG |
| Cas.: 857859-82-6 | Purity: 98% | Polygalaxanthone XI | ESD-876984-5MG |
| Cas.: 857730-15-5 | Purity: 95% | TERT-BUTYL 6′-CHLORO-1′,2′-DIHYDROSPIRO[PIPERIDINE-4,3′-PYRROLO[3,2-B]PYRIDINE]-1-CARBOXYLATE | ESD-876985-250MG |
| Cas.: 857730-15-5 | Purity: 95% | TERT-BUTYL 6′-CHLORO-1′,2′-DIHYDROSPIRO[PIPERIDINE-4,3′-PYRROLO[3,2-B]PYRIDINE]-1-CARBOXYLATE | ESD-876985-1G |
| Cas.: 857730-11-1 | Purity: 95% | TERT-BUTYL 1′,2′-DIHYDROSPIRO[PIPERIDINE-4,3′-PYRROLO[2,3-C]PYRIDINE]-1-CARBOXYLATE | ESD-876986-1G |
| Cas.: 85769-33-1 | Purity: 95% | Alstolenine | ESD-876987-5MG |
| Cas.: 857672-34-5 | Purity: 96% | Longistylumphylline A | ESD-876988-5MG |
| Cas.: 857652-30-3 | Purity: ≥99% | PSN632408 | ESD-876989-5MG |
| Cas.: 857652-30-3 | Purity: ≥99% | PSN632408 | ESD-876989-10MG |
| Cas.: 857402-63-2 | Purity: 98% | Retaspimycin Hydrochloride | ESD-876990-1MG |
| Cas.: 857402-63-2 | Purity: 98% | Retaspimycin Hydrochloride | ESD-876990-5MG |
| Cas.: 857402-23-4 | Purity: 98% | Retaspimycin | ESD-876991-5MG |
| Cas.: 857402-23-4 | Purity: 98% | Retaspimycin | ESD-876991-10MG |
| Cas.: 85734-02-7 | Purity: 97% | Isoflavidinin | ESD-876992-5MG |
| Cas.: 857297-90-6 | Purity: 97% | 3-Hydroxysarpagine | ESD-876993-5MG |
| Cas.: 857290-04-1 | Purity: ≥98% | PF-915275 | ESD-876994-5MG |
| Cas.: 857290-04-1 | Purity: ≥98% | PF-915275 | ESD-876994-10MG |
| Cas.: 857066-90-1 | Purity: ≥98% | TMC353121 | ESD-876995-5MG |
| Cas.: 857066-90-1 | Purity: ≥98% | TMC353121 | ESD-876995-10MG |
| Cas.: 85699-62-3 | Purity: 97% | α-Conidendrin | ESD-876996-5MG |
| Cas.: 856676-23-8 | Purity: ≥99% | Choline Fenofibrate | ESD-876997-10MG |
| Cas.: 856676-23-8 | Purity: ≥99% | Choline Fenofibrate | ESD-876997-100MG |
| Cas.: 856095-68-6 | Purity: ≥99% | OBA-09 | ESD-876998-5MG |
| Cas.: 856095-68-6 | Purity: ≥99% | OBA-09 | ESD-876998-10MG |
| Cas.: 856068-76-3 | Purity: 95% | 2-Phenyl-2-azaspiro[4.4]nonane-1,3-dione | ESD-876999-1G |
| Cas.: 856068-76-3 | Purity: 95% | 2-Phenyl-2-azaspiro[4.4]nonane-1,3-dione | ESD-876999-5G |
| Cas.: 85604-00-8 | Purity: ≥99% | Zaltidine | ESD-877000-2MG |
| Cas.: 85604-00-8 | Purity: ≥99% | Zaltidine | ESD-877000-5MG |
| Cas.: 855-96-9 | Purity: 98% | Eupatorin | ESD-877001-5MG |
| Cas.: 855715-40-1 | Purity: 95% | 2-chloro-N-spiro[1,3-benzodioxole-2,1′-cyclopentan]-5-ylacetamide | ESD-877002-1MG |
| Cas.: 85571-15-9 | Purity: 98% | Rhodionin | ESD-877003-5MG |
| Cas.: 855527-92-3 | Purity: ≥98% | NBI-74330 | ESD-877004-5MG |
| Cas.: 855527-92-3 | Purity: ≥98% | NBI-74330 | ESD-877004-10MG |
| Cas.: 855398-58-2 | Purity: 95% | 6-OXASPIRO[4.5]DECAN-9-OL | ESD-877005-250MG |
| Cas.: 855398-58-2 | Purity: 95% | 6-OXASPIRO[4.5]DECAN-9-OL | ESD-877005-1G |
| Cas.: 855398-57-1 | Purity: 95% | 6-OXASPIRO[4.5]DECAN-9-ONE | ESD-877006-1G |
| Cas.: 855398-57-1 | Purity: 95% | 6-OXASPIRO[4.5]DECAN-9-ONE | ESD-877006-5G |
| Cas.: 854601-70-0 | Purity: 98% | Naloxegol | ESD-877007-5MG |
| Cas.: 854601-70-0 | Purity: 98% | Naloxegol | ESD-877007-10MG |
| Cas.: 854464-95-2 | Purity: 98% | 3-(3-Hydroxybutyl)phenol | ESD-877008-5MG |
| Cas.: 85443-48-7 | Purity: 98% | Bencianol | ESD-877009-1MG |
| Cas.: 85443-48-7 | Purity: 98% | Bencianol | ESD-877009-5MG |
| Cas.: 854038-96-3 | Purity: 95% | Norcaesalpinin E | ESD-877010-5MG |
| Cas.: 85392-79-6 | Purity: 98% | Indanidine | ESD-877011-1MG |
| Cas.: 85392-79-6 | Purity: 98% | Indanidine | ESD-877011-5MG |
| Cas.: 85375-15-1 | Purity: ≥99% | SKF89976A hydrochloride | ESD-877012-5MG |
| Cas.: 85375-15-1 | Purity: ≥99% | SKF89976A hydrochloride | ESD-877012-10MG |
| Cas.: 853751-19-6 | Purity: 97% | 8-[(4-Methylbenzene)sulfonyl]-1,4-dioxa-8-azaspiro[4.5]decane | ESD-877013-500MG |
| Cas.: 853751-19-6 | Purity: 97% | 8-[(4-Methylbenzene)sulfonyl]-1,4-dioxa-8-azaspiro[4.5]decane | ESD-877013-1G |
| Cas.: 85372-72-1 | Purity: 95% | 5,19-Epoxy-19,25-dimethoxycucurbita-6,23-dien-3-ol | ESD-877014-5MG |
| Cas.: 85372-70-9 | Purity: 95% | 5,19-Epoxy-19,25-dimethoxycucurbita-6,23-dien-3-ol | ESD-877015-1MG |
| Cas.: 85371-64-8 | Purity: ≥99% | Pinacidil monohydrate | ESD-877016-5MG |
| Cas.: 85371-64-8 | Purity: ≥99% | Pinacidil monohydrate | ESD-877016-10MG |
| Cas.: 853574-48-8 | Purity: 95% | 4-(2,4-Dioxo-1,3-diaza-spiro[4.4]non-3-yl)-butyric acid | ESD-877017-1G |
| Cas.: 853400-76-7 | Purity: ≥98% | Trofinetide | ESD-877018-1MG |
| Cas.: 853400-76-7 | Purity: ≥98% | Trofinetide | ESD-877018-5MG |
| Cas.: 85329-59-5 | Purity: 98% | Trichorabdal A | ESD-877019-5MG |
| Cas.: 853267-91-1 | Purity: 98% | Hythiemoside A | ESD-877020-5MG |
| Cas.: 85287-60-1 | Purity: 97% | Sculponeatin A | ESD-877021-5MG |
| Cas.: 852875-96-8 | Purity: 97% | 2,3-Dihydropodocarpusflavone A | ESD-877022-5MG |
| Cas.: 852638-61-0 | Purity: 97% | Heteronoside | ESD-877023-5MG |
| Cas.: 852459-91-7 | Purity: 95% | Futokadsurin C | ESD-877024-5MG |
| Cas.: 852-42-6 | Purity: 98% | Guaiapate | ESD-877025-1MG |
| Cas.: 852-42-6 | Purity: 98% | Guaiapate | ESD-877025-5MG |
| Cas.: 852400-45-4 | Purity: 95% | 7-mercapto-10-(4-methyl-1,3-thiazol-2-yl)-9-oxo-8-azaspiro[4.5]dec-6-ene-6-carbonitrile | ESD-877026-1G |
| Cas.: 852400-33-0 | Purity: 95% | (1-methyl-2,4-dioxo-1,3-diazaspiro[4.5]dec-3-yl)acetic acid | ESD-877027-1G |
| Cas.: 852400-00-1 | Purity: 95% | 3-(2,4-Dioxo-1,3-diaza-spiro[4.4]non-3-yl)-propionic acid | ESD-877028-1G |
| Cas.: 852391-20-9 | Purity: ≥99% | Necrostatin 2 Senantiomer | ESD-877029-1MG |
| Cas.: 852391-20-9 | Purity: ≥99% | Necrostatin 2 Senantiomer | ESD-877029-5MG |
| Cas.: 852391-19-6 | Purity: ≥99% | Necrostatin 2 | ESD-877030-1MG |
| Cas.: 852391-19-6 | Purity: ≥99% | Necrostatin 2 | ESD-877030-5MG |
| Cas.: 852385-13-8 | Purity: 95% | 6-Methyl-7-O-methylaromadendrin | ESD-877031-5MG |
| Cas.: 852329-66-9 | Purity: 98% | Dutogliptin | ESD-877032-1MG |
| Cas.: 852329-66-9 | Purity: 98% | Dutogliptin | ESD-877032-5MG |
| Cas.: 852155-81-8 | Purity: ≥99% | HAEGT | ESD-877033-1MG |
| Cas.: 852155-81-8 | Purity: ≥99% | HAEGT | ESD-877033-5MG |
| Cas.: 852055-88-0 | Purity: 98% | L-Threonine derivative-1 | ESD-877034-1MG |
| Cas.: 852055-88-0 | Purity: 98% | L-Threonine derivative-1 | ESD-877034-5MG |
| Cas.: 851916-42-2 | Purity: ≥99% | MK-0812 Succinate | ESD-877035-2MG |
| Cas.: 851916-42-2 | Purity: ≥99% | MK-0812 Succinate | ESD-877035-5MG |
| Cas.: 85187-37-7 | Purity: ≥99% | Cloperastine fendizoate | ESD-877036-100MG |
| Cas.: 85187-10-6 | Purity: 98% | Sphingomyelin | ESD-877037-5MG |
| Cas.: 85187-10-6 | Purity: 98% | Sphingomyelin | ESD-877037-10MG |
| Cas.: 851776-28-8 | Purity: ≥98% | MK-0354 | ESD-877038-5MG |
| Cas.: 851776-28-8 | Purity: ≥98% | MK-0354 | ESD-877038-10MG |
| Cas.: 85175-67-3 | Purity: ≥98% | Zatebradine | ESD-877039-5MG |
| Cas.: 85175-67-3 | Purity: ≥98% | Zatebradine | ESD-877039-10MG |
| Cas.: 851722-03-7 | Purity: 95% | 2-chloro-N-spiro[1,3-benzodioxole-2,1′-cyclohexan]-5-ylacetamide | ESD-877040-1G |
| Cas.: 851546-61-7 | Purity: ≥99% | PSI-697 | ESD-877041-1MG |
| Cas.: 851546-61-7 | Purity: ≥99% | PSI-697 | ESD-877041-5MG |
| Cas.: 851325-42-3 | Purity: 95% | tert-Butyl 2,8-diazaspiro[4.5]decane-8-carboxylate hydrochloride | ESD-877042-1G |
| Cas.: 851325-42-3 | Purity: 95% | tert-Butyl 2,8-diazaspiro[4.5]decane-8-carboxylate hydrochloride | ESD-877042-5G |
| Cas.: 85122-21-0 | Purity: 98% | 2-Methoxystypandrone | ESD-877043-5MG |
| Cas.: 851207-99-3 | Purity: 95% | 4-imino-2-mercapto-5-(4-methyl-1,3-thiazol-2-yl)-3-azaspiro[5.5]undec-1-ene-1-carbonitrile | ESD-877044-1G |
| Cas.: 851175-93-4 | Purity: 95% | (7,7,9-trimethyl-2,4-dioxo-1,3-diazaspiro[4.5]dec-3-yl)acetic acid | ESD-877045-1G |
| Cas.: 851170-89-3 | Purity: 95% | (2′,5′-dioxo-2,3-dihydro-1’H-spiro[chromene-4,4′-imidazolidin]-1′-yl)acetic acid | ESD-877046-1G |
| Cas.: 851170-89-3 | Purity: 95% | (2′,5′-dioxo-2,3-dihydro-1’H-spiro[chromene-4,4′-imidazolidin]-1′-yl)acetic acid | ESD-877046-5G |
| Cas.: 851170-88-2 | Purity: 95% | (2,5-dioxo-3′,4′-dihydro-1H,2’H-spiro[imidazolidine-4,1′-naphthalen]-1-yl)acetic acid | ESD-877047-1G |
| Cas.: 851170-87-1 | Purity: 95% | (8-methyl-2,4-dioxo-1,3-diazaspiro[4.5]dec-3-yl)acetic acid | ESD-877048-1G |
| Cas.: 851170-86-0 | Purity: 95% | [8-(1,1-dimethylpropyl)-2,4-dioxo-1,3-diazaspiro[4.5]dec-3-yl]acetic acid | ESD-877049-1G |
| Cas.: 850875-62-6 | Purity: 95% | 2′,3′-dihydro-spiro[cyclobutane-1,4′(1’H)-isoquinoline] | ESD-877050-250MG |
| Cas.: 850875-62-6 | Purity: 95% | 2′,3′-dihydro-spiro[cyclobutane-1,4′(1’H)-isoquinoline] | ESD-877050-1G |
| Cas.: 85081-24-9 | Purity: 97% | Cinchonain Ia | ESD-877051-5MG |
| Cas.: 85081-23-8 | Purity: 97% | Cinchonain IIa | ESD-877052-5MG |
| Cas.: 85081-18-1 | Purity: ≥99% | NBI-98782 | ESD-877053-2MG |
| Cas.: 85081-18-1 | Purity: ≥99% | NBI-98782 | ESD-877053-5MG |
| Cas.: 850717-64-5 | Purity: ≥98% | BX517 | ESD-877054-5MG |
| Cas.: 850717-64-5 | Purity: ≥98% | BX517 | ESD-877054-10MG |
| Cas.: 850630-40-9 | Purity: 98% | Apigenin 5-O-neohesperidoside | ESD-877055-5MG |
| Cas.: 850608-87-6 | Purity: ≥99% | Riluzole hydrochloride | ESD-877056-50MG |
| Cas.: 850608-87-6 | Purity: ≥99% | Riluzole hydrochloride | ESD-877056-100MG |
| Cas.: 850567-90-7 | Purity: 96% | 1,4-Dioxaspiro[4,5]dec-7-en-8-boronic acid | ESD-877057-250MG |
| Cas.: 85051-41-8 | Purity: 95% | Norviburtinal | ESD-877058-1MG |
| Cas.: 85022-69-1 | Purity: 97% | Cinchonain Ib | ESD-877059-5MG |
| Cas.: 85022-68-0 | Purity: 90% | Cinchonain IIb | ESD-877060-5MG |
| Cas.: 850140-72-6 | Purity: ≥99% | afatinib | ESD-877061-10MG |
| Cas.: 850140-72-6 | Purity: ≥99% | afatinib | ESD-877061-50MG |
| Cas.: 85003-85-6 | Purity: 97% | Methyl 1,6-dihydroxy-3-methylxanthone-8-carboxylate | ESD-877062-5MG |
| Cas.: 850021-30-6 | Purity: 95% | 1,7′-dimethyl-5′,6′,7′,8′-tetrahydro-1’H-spiro[piperidine-4,2′-pyrido[3,4-d]pyrimidin]-4′(3′ H)-one | ESD-877063-1G |
| Cas.: 849928-22-9 | Purity: 95% | tert-butyl 3,4-dihydro-1’H-spiro[chromene-2,4′-piperidine]-1′-carboxylate | ESD-877064-1G |
| Cas.: 849928-22-9 | Purity: 95% | tert-butyl 3,4-dihydro-1’H-spiro[chromene-2,4′-piperidine]-1′-carboxylate | ESD-877064-2.5G |
| Cas.: 84-99-1 | Purity: 98% | Xanthoxyletin | ESD-877065-5MG |
| Cas.: 849699-55-4 | Purity: 98% | Rubicordifolin | ESD-877066-5MG |
| Cas.: 849643-15-8 | Purity: ≥99% | SU14813 maleate | ESD-877067-2MG |
| Cas.: 849643-15-8 | Purity: ≥99% | SU14813 maleate | ESD-877067-5MG |
| Cas.: 84957-30-2 | Purity: 98% | Cefquinome | ESD-877068-5MG |
| Cas.: 849550-67-0 | Purity: ≥99% | Cevipabulin fumarate | ESD-877069-5MG |
| Cas.: 849550-67-0 | Purity: ≥99% | Cevipabulin fumarate | ESD-877069-10MG |
| Cas.: 84955-05-5 | Purity: 95% | Cudraxanthone B | ESD-877070-1MG |
| Cas.: 849550-05-6 | Purity: ≥99% | Cevipabulin | ESD-877071-5MG |
| Cas.: 849550-05-6 | Purity: ≥99% | Cevipabulin | ESD-877071-10MG |
| Cas.: 849245-34-7 | Purity: 97% | Chinensine B | ESD-877072-5MG |
| Cas.: 849214-04-6 | Purity: ≥98% | cGAMP | ESD-877073-500ΜG |
| Cas.: 849214-04-6 | Purity: ≥98% | cGAMP | ESD-877073-1MG |
| Cas.: 849203-60-7 | Purity: 95% | tert-Butyl 1-oxo-7-azaspiro[3.5]nonane-7-carboxylate | ESD-877074-1G |
| Cas.: 849203-60-7 | Purity: 95% | tert-Butyl 1-oxo-7-azaspiro[3.5]nonane-7-carboxylate | ESD-877074-5G |
| Cas.: 849201-84-9 | Purity: 98% | Glaucogenin C mono-D-thevetoside | ESD-877075-5MG |
| Cas.: 84873-15-4 | Purity: 98% | p-Hydroxyphenethyl trans-ferulate | ESD-877076-5MG |
| Cas.: 848669-09-0 | Purity: 95% | Stigmasta-4,22,25-trien-3-one | ESD-877077-5MG |
| Cas.: 848669-08-9 | Purity: 95% | Stigmasta-4,25-dien-3-one | ESD-877078-1MG |
| Cas.: 848580-34-7 | Purity: 95% | 2-Methyl-2,8-diazaspiro[4.5]decan-1-onehydrochloride | ESD-877079-1G |
| Cas.: 84847-50-7 | Purity: 98% | Vasicinolone | ESD-877080-5MG |
| Cas.: 848463-13-8 | Purity: 98% | SSR128129E free acid | ESD-877081-10MG |
| Cas.: 848463-13-8 | Purity: 98% | SSR128129E free acid | ESD-877081-50MG |
| Cas.: 84845-75-0 | Purity: 98% | Niperotidine | ESD-877082-1MG |
| Cas.: 84845-75-0 | Purity: 98% | Niperotidine | ESD-877082-5MG |
| Cas.: 848344-36-5 | Purity: ≥98% | Bentamapimod | ESD-877083-5MG |
| Cas.: 848344-36-5 | Purity: ≥98% | Bentamapimod | ESD-877083-10MG |
| Cas.: 848301-94-0 | Purity: ≥99% | G3-C12 | ESD-877084-1MG |
| Cas.: 848301-94-0 | Purity: ≥99% | G3-C12 | ESD-877084-5MG |
| Cas.: 848259-27-8 | Purity: ≥99% | Pemafibrate | ESD-877085-1MG |
| Cas.: 848259-27-8 | Purity: ≥99% | Pemafibrate | ESD-877085-5MG |
| Cas.: 848258-31-1 | Purity: 98% | Pemafibrate racemate | ESD-877086-1MG |
| Cas.: 848258-31-1 | Purity: 98% | Pemafibrate racemate | ESD-877086-5MG |
| Cas.: 848217-00-5 | Purity: ≥99% | H4 Receptor antagonist 1 | ESD-877087-5MG |
| Cas.: 848217-00-5 | Purity: ≥99% | H4 Receptor antagonist 1 | ESD-877087-10MG |
| Cas.: 848193-69-1 | Purity: ≥98% | Selisistat R-enantiomer | ESD-877088-2MG |
| Cas.: 848193-69-1 | Purity: ≥98% | Selisistat R-enantiomer | ESD-877088-5MG |
| Cas.: 848031-94-7 | Purity: 95% | threo-1-(4-Hydroxy-3-methoxyphenyl)propane-1,2-diol | ESD-877089-5MG |
| Cas.: 84799-31-5 | Purity: 95% | 5- Epilithospermoside | ESD-877090-1MG |
| Cas.: 847991-34-8 | Purity: 98% | MARK Substrate | ESD-877091-1MG |
| Cas.: 847991-34-8 | Purity: 98% | MARK Substrate | ESD-877091-5MG |
| Cas.: 847950-09-8 | Purity: ≥98% | Lck Inhibitor | ESD-877092-5MG |
| Cas.: 847950-09-8 | Purity: ≥98% | Lck Inhibitor | ESD-877092-10MG |
| Cas.: 847871-99-2 | Purity: ≥99% | Lenalidomide (hemihydrate) | ESD-877093-50MG |
| Cas.: 847871-99-2 | Purity: ≥99% | Lenalidomide (hemihydrate) | ESD-877093-100MG |
| Cas.: 847835-17-0 | Purity: 98% | Tasumatrol L | ESD-877094-5MG |
| Cas.: 84783-01-7 | Purity: ≥98% | K-Ras-IN-1 | ESD-877095-5MG |
| Cas.: 84783-01-7 | Purity: ≥98% | K-Ras-IN-1 | ESD-877095-10MG |
| Cas.: 847728-01-2 | Purity: ≥99% | CJ-42794 | ESD-877096-10MG |
| Cas.: 847728-01-2 | Purity: ≥99% | CJ-42794 | ESD-877096-50MG |
| Cas.: 84746-43-0 | Purity: 98% | Small Cardioactive Peptide B SCPB | ESD-877097-1MG |
| Cas.: 84746-43-0 | Purity: 98% | Small Cardioactive Peptide B SCPB | ESD-877097-5MG |
| Cas.: 847460-34-8 | Purity: 98% | CRA-026440 | ESD-877098-1MG |
| Cas.: 847460-34-8 | Purity: 98% | CRA-026440 | ESD-877098-5MG |
| Cas.: 84745-95-9 | Purity: 98% | Eriocalyxin B | ESD-877099-5MG |
| Cas.: 847239-17-2 | Purity: ≥98% | UVI 3003 | ESD-877100-5MG |
| Cas.: 847239-17-2 | Purity: ≥98% | UVI 3003 | ESD-877100-10MG |
| Cas.: 84652-33-5 | Purity: 95% | Decinnamoyltaxinine J | ESD-877101-5MG |
| Cas.: 846-46-8 | Purity: 98% | 5α-Androstanedione | ESD-877102-5MG |
| Cas.: 84638-81-3 | Purity: 98% | ZK-90055 hydrochloride | ESD-877103-1MG |
| Cas.: 84638-81-3 | Purity: 98% | ZK-90055 hydrochloride | ESD-877103-5MG |
| Cas.: 84633-29-4 | Purity: ≥99% | Eurycomanone | ESD-877104-1MG |
| Cas.: 84633-29-4 | Purity: ≥99% | Eurycomanone | ESD-877104-5MG |
| Cas.: 84629-61-8 | Purity: 98% | Darenzepine | ESD-877105-1MG |
| Cas.: 84629-61-8 | Purity: 98% | Darenzepine | ESD-877105-5MG |
| Cas.: 845959-98-0 | Purity: 95% | Serrin A | ESD-877106-5MG |
| Cas.: 845959-50-4 | Purity: ≥98% | Mitoquinone mesylate | ESD-877107-5MG |
| Cas.: 84575-10-0 | Purity: 96% | Cleomiscosin C | ESD-877108-5MG |
| Cas.: 84573-16-0 | Purity: ≥99% | Rocaglamide | ESD-877109-200ΜG |
| Cas.: 84573-16-0 | Purity: ≥99% | Rocaglamide | ESD-877109-1MG |
| Cas.: 845714-00-3 | Purity: 98% | PHA-767491 | ESD-877110-10MG |
| Cas.: 845714-00-3 | Purity: 98% | PHA-767491 | ESD-877110-50MG |
| Cas.: 845614-12-2 | Purity: ≥95% | Bitopertin R enantiomer | ESD-877111-1MG |
| Cas.: 845290-58-6 | Purity: 95% | 2-methyl-2,8-diazaspiro[5.5]undecane | ESD-877112-1G |
| Cas.: 845290-58-6 | Purity: 95% | 2-methyl-2,8-diazaspiro[5.5]undecane | ESD-877112-5G |
| Cas.: 844903-58-8 | Purity: ≥99% | GSK163090 | ESD-877113-5MG |
| Cas.: 844903-58-8 | Purity: ≥99% | GSK163090 | ESD-877113-10MG |
| Cas.: 844882-93-5 | Purity: 98% | IFN alpha-IFNAR-IN-1 | ESD-877114-5MG |
| Cas.: 844882-93-5 | Purity: 98% | IFN alpha-IFNAR-IN-1 | ESD-877114-10MG |
| Cas.: 84468-24-6 | Purity: ≥99% | HA-100 | ESD-877115-5MG |
| Cas.: 84468-24-6 | Purity: ≥99% | HA-100 | ESD-877115-10MG |
| Cas.: 844639-57-2 | Purity: ≥99% | CAY10471 Racemate | ESD-877116-5MG |
| Cas.: 844639-57-2 | Purity: ≥99% | CAY10471 Racemate | ESD-877116-10MG |
| Cas.: 844637-85-0 | Purity: 95% | threo-Guaiacylglycerol-β-O-4′-dehydrodisinapyl ether | ESD-877117-5MG |
| Cas.: 844-26-8 | Purity: 98% | Bithionol sulfoxide | ESD-877118-500MG |
| Cas.: 84414-40-4 | Purity: 95% | 23-Hydroxybetulin | ESD-877119-5MG |
| Cas.: 84-39-9 | Purity: 98% | Stylopine | ESD-877120-5MG |
| Cas.: 84375-46-2 | Purity: 98% | Adoxosidic acid | ESD-877121-5MG |
| Cas.: 84299-80-9 | Purity: 96% | Pterosin D 3-O-glucoside | ESD-877122-5MG |
| Cas.: 84294-77-9 | Purity: 97% | Aliarin | ESD-877123-5MG |
| Cas.: 842148-40-7 | Purity: ≥98% | AKT Kinase Inhibitor | ESD-877124-5MG |
| Cas.: 842148-40-7 | Purity: ≥98% | AKT Kinase Inhibitor | ESD-877124-10MG |
| Cas.: 84108-17-8 | Purity: 97% | Triptotriterpenic acid A | ESD-877125-5MG |
| Cas.: 84104-80-3 | Purity: 95% | Wilforlide A acetate | ESD-877126-5MG |
| Cas.: 84060-09-3 | Purity: 95% | Spiro[4H-3,1-benzoxazine-4,4′-piperidin]-2(1H)-one | ESD-877127-250MG |
| Cas.: 84060-09-3 | Purity: 95% | Spiro[4H-3,1-benzoxazine-4,4′-piperidin]-2(1H)-one | ESD-877127-1G |
| Cas.: 840529-13-7 | Purity: ≥98% | Helioxanthin 8-1 | ESD-877128-2MG |
| Cas.: 840529-13-7 | Purity: ≥98% | Helioxanthin 8-1 | ESD-877128-5MG |
| Cas.: 840506-29-8 | Purity: ≥99% | Acelarin | ESD-877129-1MG |
| Cas.: 840506-29-8 | Purity: ≥99% | Acelarin | ESD-877129-5MG |
| Cas.: 839713-36-9 | Purity: ≥99% | Nelotanserin | ESD-877130-1MG |
| Cas.: 839713-36-9 | Purity: ≥99% | Nelotanserin | ESD-877130-5MG |
| Cas.: 839711-70-5 | Purity: 97% | 2,7-Dimethyl-1,4-dihydroxynaphthalene 1-O-glucoside | ESD-877131-5MG |
| Cas.: 83945-57-7 | Purity: 95% | 4-Epicommunic acid | ESD-877132-1MG |
| Cas.: 83-94-3 | Purity: 97% | Tabernanthine | ESD-877133-5MG |
| Cas.: 83925-00-2 | Purity: 97% | Flavidinin | ESD-877134-5MG |
| Cas.: 83924-98-5 | Purity: 98% | Flavidin | ESD-877135-5MG |
| Cas.: 83915-59-7 | Purity: 95% | 13-Hydroxylabda-8(17),14-dien-18-oic acid | ESD-877136-1MG |
| Cas.: 83907-40-8 | Purity: ≥98% | SPQ | ESD-877137-50MG |
| Cas.: 83907-40-8 | Purity: ≥98% | SPQ | ESD-877137-100MG |
| Cas.: 83905-81-1 | Purity: 97% | 12-Acetoxyabietic acid | ESD-877138-5MG |
| Cas.: 83881-51-0 | Purity: 98% | Cetirizine | ESD-877139-100MG |
| Cas.: 83881-51-0 | Purity: 98% | Cetirizine | ESD-877139-200MG |
| Cas.: 83864-70-4 | Purity: 95% | Angeloylisogomisin O | ESD-877140-5MG |
| Cas.: 83864-69-1 | Purity: 95% | Angeloylgomisin O | ESD-877141-5MG |
| Cas.: 83805-11-2 | Purity: ≥99% | Falecalcitriol | ESD-877142-1MG |
| Cas.: 83-74-9 | Purity: 96% | Ibogaine | ESD-877143-5MG |
| Cas.: 83725-41-1 | Purity: 94% | 3α-Acetoxy-20(29)-lupene-23,28-dioic acid | ESD-877144-5MG |
| Cas.: 83725-24-0 | Purity: 96% | Pomolic acid 28-O-β-D-glucopyranosyl ester | ESD-877145-5MG |
| Cas.: 83708-70-7 | Purity: 97% | Dihydrosesamin | ESD-877146-5MG |
| Cas.: 83688-84-0 | Purity: 98% | Tertatolol | ESD-877147-1MG |
| Cas.: 83688-84-0 | Purity: 98% | Tertatolol | ESD-877147-5MG |
| Cas.: 836683-15-9 | Purity: ≥99% | Acumapimod | ESD-877148-5MG |
| Cas.: 836683-15-9 | Purity: ≥99% | Acumapimod | ESD-877148-10MG |
| Cas.: 83625-35-8 | Purity: ≥98% | Amebucort | ESD-877149-1MG |
| Cas.: 83625-35-8 | Purity: ≥98% | Amebucort | ESD-877149-5MG |
| Cas.: 835904-51-3 | Purity: ≥99% | Synta66 | ESD-877150-5MG |
| Cas.: 835904-51-3 | Purity: ≥99% | Synta66 | ESD-877150-10MG |
| Cas.: 835621-07-3 | Purity: ≥99% | Regorafenib Hydrochloride | ESD-877151-5MG |
| Cas.: 835621-07-3 | Purity: ≥99% | Regorafenib Hydrochloride | ESD-877151-10MG |
| Cas.: 835619-41-5 | Purity: ≥99% | Indeglitazar | ESD-877152-1MG |
| Cas.: 835619-41-5 | Purity: ≥99% | Indeglitazar | ESD-877152-5MG |
| Cas.: 835616-60-9 | Purity: ≥98% | Thalidomide fluoride | ESD-877153-5MG |
| Cas.: 835616-60-9 | Purity: ≥98% | Thalidomide fluoride | ESD-877153-10MG |
| Cas.: 835598-94-2 | Purity: ≥99% | GLX351322 | ESD-877154-5MG |
| Cas.: 835598-94-2 | Purity: ≥99% | GLX351322 | ESD-877154-10MG |
| Cas.: 83529-71-9 | Purity: 98% | Anisofolin A | ESD-877155-5MG |
| Cas.: 83529-62-8 | Purity: 97% | Leucosceptoside A | ESD-877156-5MG |
| Cas.: 83507-02-2 | Purity: 98% | Org-10490 | ESD-877157-1MG |
| Cas.: 83507-02-2 | Purity: 98% | Org-10490 | ESD-877157-5MG |
| Cas.: 83474-08-2 | Purity: 98% | Fenmetozole Tosylate | ESD-877158-1MG |
| Cas.: 83474-08-2 | Purity: 98% | Fenmetozole Tosylate | ESD-877158-5MG |
| Cas.: 83461-56-7 | Purity: ≥99% | Mifamurtide | ESD-877159-1MG |
| Cas.: 83461-56-7 | Purity: ≥99% | Mifamurtide | ESD-877159-5MG |
| Cas.: 83459-37-4 | Purity: 98% | 2,4-Dihydroxy-6-methoxy-3-methylacetophenone | ESD-877160-5MG |
| Cas.: 83-45-4 | Purity: ≥99% | Stigmastanol | ESD-877161-5MG |
| Cas.: 83-45-4 | Purity: ≥99% | Stigmastanol | ESD-877161-10MG |
| Cas.: 834-45-7 | Purity: 95% | (2,4-dioxo-1,3-diazaspiro[4.5]dec-3-yl)acetic acid | ESD-877162-250MG |
| Cas.: 83419-49-2 | Purity: 95% | 6′-CHLOROSPIRO[CYCLOPROPANE-1,3′-INDOLIN]-2′-ONE | ESD-877163-1G |
| Cas.: 83419-48-1 | Purity: 95% | 6′-(TRIFLUOROMETHYL)SPIRO[CYCLOPROPANE-1,3′-INDOLIN]-2′-ONE | ESD-877164-250MG |
| Cas.: 83419-48-1 | Purity: 95% | 6′-(TRIFLUOROMETHYL)SPIRO[CYCLOPROPANE-1,3′-INDOLIN]-2′-ONE | ESD-877164-1G |
| Cas.: 83419-47-0 | Purity: 95% | 6′-METHYLSPIRO[CYCLOPROPANE-1,3′-INDOLIN]-2′-ONE | ESD-877165-1G |
| Cas.: 834153-87-6 | Purity: ≥98% | (R)-Elagolix | ESD-877166-2MG |
| Cas.: 834153-87-6 | Purity: ≥98% | (R)-Elagolix | ESD-877166-5MG |
| Cas.: 83373-60-8 | Purity: ≥98% | D609 | ESD-877167-5MG |
| Cas.: 83373-60-8 | Purity: ≥98% | D609 | ESD-877167-10MG |
| Cas.: 833-52-3 | Purity: 95% | 7-Hydroxycoumarin-6-carboxylic acid | ESD-877168-1MG |
| Cas.: 83348-22-5 | Purity: 95% | 10-O-Caffeoyl-6-epiferetoside | ESD-877169-5MG |
| Cas.: 833481-73-5 | Purity: ≥99% | 2OH-BNPP1 | ESD-877170-2MG |
| Cas.: 833481-73-5 | Purity: ≥99% | 2OH-BNPP1 | ESD-877170-5MG |
| Cas.: 83335-41-5 | Purity: 98% | Dynorphin B (1-13) | ESD-877171-1MG |
| Cas.: 83335-41-5 | Purity: 98% | Dynorphin B (1-13) | ESD-877171-5MG |
| Cas.: 83324-51-0 | Purity: 98% | 8(17), 13-Labdadien-15, 16-olide | ESD-877172-5MG |
| Cas.: 832741-02-3 | Purity: 97% | 3-Cyclopropyl-2-thioxo-1,3-diaza-spiro[4.5]decan-4-one | ESD-877173-1G |
| Cas.: 832741-02-3 | Purity: 97% | 3-Cyclopropyl-2-thioxo-1,3-diaza-spiro[4.5]decan-4-one | ESD-877173-5G |
| Cas.: 83217-89-4 | Purity: 95% | 1β-Hydroxy-β-eudesmol | ESD-877174-5MG |
| Cas.: 83182-58-5 | Purity: 95% | 8α-Tigloyloxyhirsutinolide 13-O-acetate | ESD-877175-5MG |
| Cas.: 83170-31-4 | Purity: 98% | Kaempferol 3-O-rhamninoside | ESD-877176-5MG |
| Cas.: 83162-84-9 | Purity: 98% | Bonducellin | ESD-877177-5MG |
| Cas.: 83150-97-4 | Purity: 98% | Carpalasionin | ESD-877178-5MG |
| Cas.: 83133-17-9 | Purity: 95% | 4′,5-Dihydroxy-3′,5′,6,7-tetramethoxyflavone | ESD-877179-5MG |
| Cas.: 831222-78-7 | Purity: 98% | 5-Hydroxymethyl-7-methoxybenzofuran | ESD-877180-5MG |
| Cas.: 830347-18-7 | Purity: 97% | Phlogacanthoside A | ESD-877181-5MG |
| Cas.: 830347-16-5 | Purity: 98% | Phlogacantholide B | ESD-877182-5MG |
| Cas.: 83013-86-9 | Purity: 98% | 6′-O-Galloylsalidroside | ESD-877183-5MG |
| Cas.: 83011-43-2 | Purity: 95% | Methyl 3-hydroxy-4,5-dimethoxybenzoate | ESD-877184-5G |
| Cas.: 82989-25-1 | Purity: ≥99% | Tazanolast | ESD-877185-1MG |
| Cas.: 82989-25-1 | Purity: ≥99% | Tazanolast | ESD-877185-5MG |
| Cas.: 82964-04-3 | Purity: ≥98% | Tolrestat | ESD-877186-5MG |
| Cas.: 82964-04-3 | Purity: ≥98% | Tolrestat | ESD-877186-10MG |
| Cas.: 82958-45-0 | Purity: 95% | 4-O-Galloylbergenin | ESD-877187-5MG |
| Cas.: 82958-44-9 | Purity: 98% | 11-O-Galloylbergenin | ESD-877188-5MG |
| Cas.: 82925-55-1 | Purity: 98% | 7,4′-Dihydroxy-8-methylflavan | ESD-877189-5MG |
| Cas.: 828935-47-3 | Purity: 95% | 3-Oxo-24,25,26,27-tetranortirucall-7-en-23,21-olide | ESD-877190-5MG |
| Cas.: 828923-27-9 | Purity: 96% | 2,3-Dihydroisoginkgetin | ESD-877191-5MG |
| Cas.: 82855-39-8 | Purity: 95% | 4′,5′-Dichloro-3′,6′-dihydroxy-2′,7′-dimethoxy-3-oxo-3H-spiro[isobenzofuran-1,9′-xanthene]-5-carboxylic acid | ESD-877192-250MG |
| Cas.: 82855-39-8 | Purity: 95% | 4′,5′-Dichloro-3′,6′-dihydroxy-2′,7′-dimethoxy-3-oxo-3H-spiro[isobenzofuran-1,9′-xanthene]-5-carboxylic acid | ESD-877192-1G |
| Cas.: 82834-16-0 | Purity: 98% | Perindopril | ESD-877193-100MG |
| Cas.: 82834-16-0 | Purity: 98% | Perindopril | ESD-877193-500MG |
| Cas.: 828288-98-8 | Purity: ≥98% | Asp-AMS | ESD-877194-5MG |
| Cas.: 828288-98-8 | Purity: ≥98% | Asp-AMS | ESD-877194-10MG |
| Cas.: 82749-70-0 | Purity: ≥99% | DCPIB | ESD-877195-5MG |
| Cas.: 82749-70-0 | Purity: ≥99% | DCPIB | ESD-877195-10MG |
| Cas.: 827319-50-6 | Purity: 95% | Perforatumone | ESD-877196-1MG |
| Cas.: 82683-51-0 | Purity: 95% | SPIRO[4.5]DECANE-7,9-DIONE | ESD-877197-1G |
| Cas.: 82683-51-0 | Purity: 95% | SPIRO[4.5]DECANE-7,9-DIONE | ESD-877197-5G |
| Cas.: 82652-20-8 | Purity: 95% | Picrasidine A | ESD-877198-1MG |
| Cas.: 82-57-5 | Purity: 97% | Visnagin | ESD-877200-1G |
| Cas.: 825658-06-8 | Purity: ≥99% | ML335 | ESD-877201-5MG |
| Cas.: 825658-06-8 | Purity: ≥99% | ML335 | ESD-877201-10MG |
| Cas.: 82513-70-0 | Purity: 96% | 10-Hydroxy-16-epiaffinine | ESD-877202-5MG |
| Cas.: 82508-37-0 | Purity: 98% | Deacetylpseudolaric acid A | ESD-877203-5MG |
| Cas.: 82508-36-9 | Purity: 98% | Deacetylpseudolaric acid C2 | ESD-877204-5MG |
| Cas.: 82508-34-7 | Purity: 98% | Methyl pseudolarate B | ESD-877205-5MG |
| Cas.: 82508-33-6 | Purity: 95% | Methyl pseudolarate A | ESD-877206-1MG |
| Cas.: 82467-50-3 | Purity: 99% | R(+)-Gomisin M1 | ESD-877207-5MG |
| Cas.: 82464-35-5 | Purity: 98% | 3-Oxotirucalla-7,24-dien-21-oic acid | ESD-877208-5MG |
| Cas.: 82462-67-7 | Purity: 99% | Hispanone | ESD-877209-5MG |
| Cas.: 82451-18-1 | Purity: 98% | Jasminoside | ESD-877210-5MG |
| Cas.: 82442-48-6 | Purity: 95% | Arteannuin A | ESD-877211-1MG |
| Cas.: 82427-77-8 | Purity: 97% | Maglifloenone | ESD-877212-5MG |
| Cas.: 82425-45-4 | Purity: 97% | Gomisin M2 | ESD-877213-5MG |
| Cas.: 82425-44-3 | Purity: 95% | Gomisin L2 | ESD-877214-5MG |
| Cas.: 82425-43-2 | Purity: 95% | Gomisin L1 | ESD-877215-5MG |
| Cas.: 82425-35-2 | Purity: 98% | 20-O-Acetylingenol-3-angelate | ESD-877216-5MG |
| Cas.: 82425-35-2 | Purity: 98% | 20-O-Acetylingenol-3-angelate | ESD-877216-10MG |
| Cas.: 82386-80-9 | Purity: 95% | 1,7-Diaza-spiro[4.4]nonane dihydrochloride | ESD-877217-250MG |
| Cas.: 82386-80-9 | Purity: 95% | 1,7-Diaza-spiro[4.4]nonane dihydrochloride | ESD-877217-1G |
| Cas.: 82375-30-2 | Purity: 96% | Humantenirine | ESD-877218-5MG |
| Cas.: 82375-29-9 | Purity: 95% | Humantenine | ESD-877219-5MG |
| Cas.: 82358-44-9 | Purity: 92% | (+)-Dalbergiphenol | ESD-877220-5MG |
| Cas.: 82354-38-9 | Purity: 96% | Humantenmine | ESD-877221-5MG |
| Cas.: 82344-82-9 | Purity: 98% | Coelonin | ESD-877222-5MG |
| Cas.: 823218-99-1 | Purity: ≥99% | SN 2 | ESD-877223-10MG |
| Cas.: 823218-99-1 | Purity: ≥99% | SN 2 | ESD-877223-50MG |
| Cas.: 823182-23-6 | Purity: 95% | Breyniaionoside A | ESD-877224-5MG |
| Cas.: 82266-85-1 | Purity: ≥99% | Impurity C of Alfacalcidol | ESD-877225-1MG |
| Cas.: 82235-82-3 | Purity: 95% | 6-Bromo-1,4-dioxaspiro[4.4]nonane | ESD-877226-1G |
| Cas.: 82235-82-3 | Purity: 95% | 6-Bromo-1,4-dioxaspiro[4.4]nonane | ESD-877226-5G |
| Cas.: 82209-76-5 | Purity: 96% | Andrographoside | ESD-877227-5MG |
| Cas.: 82209-72-1 | Purity: 98% | andropanoside | ESD-877228-5MG |
| Cas.: 821794-90-5 | Purity: ≥99% | CMK | ESD-877229-2MG |
| Cas.: 821794-90-5 | Purity: ≥99% | CMK | ESD-877229-5MG |
| Cas.: 821768-06-3 | Purity: ≥99% | JNJ-17203212 | ESD-877230-5MG |
| Cas.: 821768-06-3 | Purity: ≥99% | JNJ-17203212 | ESD-877230-10MG |
| Cas.: 82101-17-5 | Purity: 98% | Ipsalazide | ESD-877231-1MG |
| Cas.: 82101-17-5 | Purity: 98% | Ipsalazide | ESD-877231-5MG |
| Cas.: 82003-90-5 | Purity: 97% | Daurichromenic acid | ESD-877232-5MG |
| Cas.: 819870-23-0 | Purity: 97% | Macarangioside D | ESD-877233-5MG |
| Cas.: 819861-40-0 | Purity: 98% | Vitamin A | ESD-877234-5MG |
| Cas.: 81969-41-7 | Purity: 98% | Splendoside | ESD-877235-5MG |
| Cas.: 81968-62-9 | Purity: 95% | 4(15),5,10(14)-Germacratrien-1-ol | ESD-877236-1MG |
| Cas.: 81919-14-4 | Purity: ≥99% | Bendazac L-Lysine | ESD-877237-10MG |
| Cas.: 81919-14-4 | Purity: ≥99% | Bendazac L-Lysine | ESD-877237-50MG |
| Cas.: 81910-41-0 | Purity: 96% | Momordicoside I aglycone | ESD-877238-5MG |
| Cas.: 81910-39-6 | Purity: 95% | 5,19-Epoxy-25-methoxycucurbita-6,23-dien-3-ol | ESD-877239-5MG |
| Cas.: 81873-08-7 | Purity: 95% | Forskolin J | ESD-877240-1MG |
| Cas.: 81866-98-0 | Purity: 95% | 7-oxa-1,3-diazaspiro[4.4]nonane-2,4-dione | ESD-877241-1G |
| Cas.: 81861-74-7 | Purity: 98% | Magnosalin | ESD-877242-5MG |
| Cas.: 81840-58-6 | Purity: 98% | Spirendolol | ESD-877243-1MG |
| Cas.: 81840-58-6 | Purity: 98% | Spirendolol | ESD-877243-5MG |
| Cas.: 81840-15-5 | Purity: ≥96% | Vesnarinone | ESD-877244-1MG |
| Cas.: 81840-15-5 | Purity: ≥96% | Vesnarinone | ESD-877244-5MG |
| Cas.: 81742-10-1 | Purity: 97% | 3,6-Dichlorotrimellitic anhydride | ESD-877245-10MG |
| Cas.: 81742-10-1 | Purity: 97% | 3,6-Dichlorotrimellitic anhydride | ESD-877245-50MG |
| Cas.: 81732-65-2 | Purity: 98% | Bambuterol | ESD-877246-10MG |
| Cas.: 81732-65-2 | Purity: 98% | Bambuterol | ESD-877246-50MG |
| Cas.: 81720-08-3 | Purity: ≥98% | Rehmannioside D | ESD-877247-5MG |
| Cas.: 81720-08-3 | Purity: ≥98% | Rehmannioside D | ESD-877247-10MG |
| Cas.: 81720-05-0 | Purity: ≥98% | Rehmannioside A | ESD-877248-5MG |
| Cas.: 81686-22-8 | Purity: ≥98% | Sodium ionophore III | ESD-877249-10MG |
| Cas.: 81686-22-8 | Purity: ≥98% | Sodium ionophore III | ESD-877249-50MG |
| Cas.: 81678-46-8 | Purity: 98% | 3-Dehydro-15-deoxoeucosterol | ESD-877250-5MG |
| Cas.: 816456-90-3 | Purity: 95% | Canusesnol A | ESD-877251-1MG |
| Cas.: 81644-34-0 | Purity: 96% | Withaperuvin C | ESD-877252-5MG |
| Cas.: 815610-63-0 | Purity: ≥98% | ustekinumab | ESD-877253-1MG |
| Cas.: 815610-63-0 | Purity: ≥98% | ustekinumab | ESD-877253-5MG |
| Cas.: 81525-10-2 | Purity: 98% | Nafamostat | ESD-877254-10MG |
| Cas.: 81525-10-2 | Purity: 98% | Nafamostat | ESD-877254-50MG |
| Cas.: 81495-71-8 | Purity: 96% | 1-Hydroxypinoresinol 1-O-glucoside | ESD-877255-5MG |
| Cas.: 81489-69-2 | Purity: 95% | Taxagifine | ESD-877256-5MG |
| Cas.: 81485-25-8 | Purity: ≥98% | Peretinoin | ESD-877257-2MG |
| Cas.: 81485-25-8 | Purity: ≥98% | Peretinoin | ESD-877257-5MG |
| Cas.: 81446-29-9 | Purity: 97% | (-)-Pinoresinol | ESD-877258-5MG |
| Cas.: 81426-17-7 | Purity: 98% | 8-Hydroxypinoresinol | ESD-877259-5MG |
| Cas.: 81409-90-7 | Purity: ≥99% | Cabergoline | ESD-877260-5MG |
| Cas.: 81409-90-7 | Purity: ≥99% | Cabergoline | ESD-877260-10MG |
| Cas.: 81403-80-7 | Purity: ≥99% | Alfuzosin | ESD-877261-10MG |
| Cas.: 81403-80-7 | Purity: ≥99% | Alfuzosin | ESD-877261-50MG |
| Cas.: 81382-51-6 | Purity: ≥99% | Pentiapine | ESD-877262-1MG |
| Cas.: 81382-51-6 | Purity: ≥99% | Pentiapine | ESD-877262-5MG |
| Cas.: 81371-54-2 | Purity: 96% | Momordicoside G | ESD-877263-5MG |
| Cas.: 81342-13-4 | Purity: 98% | Amisulpride hydrochloride | ESD-877264-100MG |
| Cas.: 81342-13-4 | Purity: 98% | Amisulpride hydrochloride | ESD-877264-200MG |
| Cas.: 81329-71-7 | Purity: 98% | Modecainide | ESD-877265-1MG |
| Cas.: 81329-71-7 | Purity: 98% | Modecainide | ESD-877265-5MG |
| Cas.: 81286-16-0 | Purity: 98% | Somatostatin-28 1-12 | ESD-877266-1MG |
| Cas.: 81286-16-0 | Purity: 98% | Somatostatin-28 1-12 | ESD-877266-5MG |
| Cas.: 81264-00-8 | Purity: 96% | ent-6α,9α-Dihydroxy-15-oxokaur-16-en-19-oic acid | ESD-877267-5MG |
| Cas.: 81263-98-1 | Purity: 97% | ent-6α,9α-Dihydroxy-15-oxokaur-16-en-19-oic acid β-D-glucopyranosyl ester | ESD-877268-5MG |
| Cas.: 81263-96-9 | Purity: 97% | ent-9-Hydroxy-15-oxokaur-16-en-19-oic acid β-D-glucopyranosyl ester | ESD-877269-5MG |
| Cas.: 81241-53-4 | Purity: 96% | 15-Deoxoeucosterol | ESD-877271-5MG |
| Cas.: 81122-95-4 | Purity: 95% | (Z)-Lachnophyllum lactone | ESD-877272-5MG |
| Cas.: 81109-75-3 | Purity: 95% | 1′-benzyl-3,4-dihydrospiro[1-benzopyran-2,4′-piperidine]-4-ol | ESD-877273-1G |
| Cas.: 81066-45-7 | Purity: 98% | Kauniolide | ESD-877274-5MG |
| Cas.: 81066-45-7 | Purity: 98% | Kauniolide | ESD-877274-10MG |
| Cas.: 81053-49-8 | Purity: 99% | Methyl 4-prenyloxycinnamate | ESD-877275-5MG |
| Cas.: 81053-14-7 | Purity: 95% | 4-Hydroxy-4-(methoxycarbonylmethyl)cyclohexanone | ESD-877276-1MG |
| Cas.: 81045-50-3 | Purity: 98% | Pivalopril | ESD-877277-1MG |
| Cas.: 81045-50-3 | Purity: 98% | Pivalopril | ESD-877277-5MG |
| Cas.: 80-99-9 | Purity: ≥98% | Lathosterol | ESD-877278-5MG |
| Cas.: 80-99-9 | Purity: ≥98% | Lathosterol | ESD-877278-10MG |
| Cas.: 80971-60-4 | Purity: 97% | n-Butyl β-D-fructofuranoside | ESD-877279-1MG |
| Cas.: 80937-31-1 | Purity: 98% | Flosulide | ESD-877280-1MG |
| Cas.: 80937-31-1 | Purity: 98% | Flosulide | ESD-877280-5MG |
| Cas.: 80879-63-6 | Purity: ≥98% | Emiglitate | ESD-877281-1MG |
| Cas.: 80879-63-6 | Purity: ≥98% | Emiglitate | ESD-877281-5MG |
| Cas.: 808769-54-2 | Purity: 98% | 3α,22β-Dihydroxyolean-12-en-29-oic acid | ESD-877282-5MG |
| Cas.: 808732-98-1 | Purity: ≥98% | Rislenemdaz | ESD-877283-1MG |
| Cas.: 808732-98-1 | Purity: ≥98% | Rislenemdaz | ESD-877283-5MG |
| Cas.: 80832-44-6 | Purity: 98% | Pyracrenic acid | ESD-877284-5MG |
| Cas.: 808-26-4 | Purity: ≥98% | Sancycline | ESD-877285-5MG |
| Cas.: 808-26-4 | Purity: ≥98% | Sancycline | ESD-877285-10MG |
| Cas.: 80787-59-3 | Purity: 98% | 1-Hydroxycanthin-6-one | ESD-877286-5MG |
| Cas.: 80787-51-5 | Purity: 97% | 3-Acetylyunaconitine | ESD-877287-5MG |
| Cas.: 807640-87-5 | Purity: 98% | BGB-102 | ESD-877288-1MG |
| Cas.: 807640-87-5 | Purity: 98% | BGB-102 | ESD-877288-5MG |
| Cas.: 80751-65-1 | Purity: 98% | SKF 82958 | ESD-877289-5MG |
| Cas.: 80751-65-1 | Purity: 98% | SKF 82958 | ESD-877289-10MG |
| Cas.: 807372-38-9 | Purity: 95% | 4′-Demethoxypiperlotine C | ESD-877290-5MG |
| Cas.: 80734-02-7 | Purity: ≥98% | Lenampicillin hydrochloride | ESD-877291-2MG |
| Cas.: 80734-02-7 | Purity: ≥98% | Lenampicillin hydrochloride | ESD-877291-5MG |
| Cas.: 8067-24-1 | Purity: ≥98% | Dihydroergotoxine mesylate | ESD-877292-100MG |
| Cas.: 80621-54-1 | Purity: 98% | 8-Demethylsideroxylin | ESD-877293-5MG |
| Cas.: 80604-17-7 | Purity: 95% | 2′,5,6′,7-Tetraacetoxyflavanone | ESD-877294-5MG |
| Cas.: 80604-16-6 | Purity: 95% | 2′,5,6′,7-Tetrahydroxyflavanone | ESD-877295-5MG |
| Cas.: 80573-04-2 | Purity: ≥99% | Balsalazide | ESD-877296-10MG |
| Cas.: 80573-04-2 | Purity: ≥99% | Balsalazide | ESD-877296-50MG |
| Cas.: 80557-12-6 | Purity: 98% | Grifolic acid | ESD-877297-5MG |
| Cas.: 80554-58-1 | Purity: 95% | Schinifoline | ESD-877298-1MG |
| Cas.: 80537-98-0 | Purity: 97% | Vitexin 2”-O-(4”’-O-acetyl)rhamnoside | ESD-877299-5MG |
| Cas.: 80514-14-3 | Purity: 95% | 7β-(3-Ethyl-cis-crotonoyloxy)-1α-(2-methylbutyryloxy)-3,14-dehydro-Z-notonipetranone | ESD-877300-5MG |
| Cas.: 80510-09-4 | Purity: 97% | N-cis-Ferruloyltyramine | ESD-877301-5MG |
| Cas.: 80510-06-1 | Purity: 97% | Grossamide | ESD-877302-5MG |
| Cas.: 80508-42-5 | Purity: 95% | Tenacigenin B | ESD-877303-1MG |
| Cas.: 80489-65-2 | Purity: 98% | Rubifolic acid | ESD-877304-5MG |
| Cas.: 80456-55-9 | Purity: 98% | Vibunazole | ESD-877305-5MG |
| Cas.: 80456-55-9 | Purity: 98% | Vibunazole | ESD-877305-10MG |
| Cas.: 80454-42-8 | Purity: 98% | Paeoniflorigenone | ESD-877306-5MG |
| Cas.: 80453-44-7 | Purity: 98% | Padmatin | ESD-877307-5MG |
| Cas.: 80451-04-3 | Purity: 98% | Cecropin A | ESD-877308-1MG |
| Cas.: 80451-04-3 | Purity: 98% | Cecropin A | ESD-877308-5MG |
| Cas.: 80434-33-9 | Purity: 95% | γ-Diasarone | ESD-877309-1MG |
| Cas.: 804-30-8 | Purity: ≥99% | Fursultiamine | ESD-877310-5MG |
| Cas.: 804-30-8 | Purity: ≥99% | Fursultiamine | ESD-877310-10MG |
| Cas.: 80416-52-0 | Purity: 97% | 13-Op-Coumaroylplumieride | ESD-877311-1MG |
| Cas.: 80396-57-2 | Purity: 95% | Protoplumericin A | ESD-877312-1MG |
| Cas.: 80368-31-6 | Purity: 95% | 8β-Tigloyloxyreynosin | ESD-877313-5MG |
| Cas.: 80366-15-0 | Purity: 95% | 2′,6′-Dihydroxypinobanksin | ESD-877314-5MG |
| Cas.: 80306-38-3 | Purity: ≥99% | AR7 | ESD-877315-5MG |
| Cas.: 80306-38-3 | Purity: ≥99% | AR7 | ESD-877315-10MG |
| Cas.: 802909-72-4 | Purity: 95% | Dehydro-δ-tocopherol | ESD-877316-1MG |
| Cas.: 802906-73-6 | Purity: ≥99% | Basimglurant | ESD-877317-5MG |
| Cas.: 802906-73-6 | Purity: ≥99% | Basimglurant | ESD-877317-10MG |
| Cas.: 80288-49-9 | Purity: ≥99% | Furafylline | ESD-877318-1MG |
| Cas.: 80288-49-9 | Purity: ≥99% | Furafylline | ESD-877318-5MG |
| Cas.: 80251-32-7 | Purity: 98% | Nafamostat hydrochloride | ESD-877319-10MG |
| Cas.: 80251-32-7 | Purity: 98% | Nafamostat hydrochloride | ESD-877319-50MG |
| Cas.: 80225-53-2 | Purity: ≥97% | Rosmanol | ESD-877320-5MG |
| Cas.: 80225-53-2 | Purity: ≥97% | Rosmanol | ESD-877320-10MG |
| Cas.: 8015-61-0 | Purity: 97% | Aloin | ESD-877321-1MG |
| Cas.: 80151-89-9 | Purity: 95% | Methyl demethoxycarbonylchanofruticosinate | ESD-877322-5MG |
| Cas.: 800389-33-7 | Purity: 98% | Agatharesinol acetonide | ESD-877323-5MG |
| Cas.: 80012-43-7 | Purity: ≥98% | Epinastine | ESD-877324-50MG |
| Cas.: 80012-43-7 | Purity: ≥98% | Epinastine | ESD-877324-100MG |
| Cas.: 79995-67-8 | Purity: 99% | Blumeatin B | ESD-877325-5MG |
| Cas.: 79994-24-4 | Purity: 98% | Dynorphin A 1-10 | ESD-877326-1MG |
| Cas.: 79994-24-4 | Purity: 98% | Dynorphin A 1-10 | ESD-877326-5MG |
| Cas.: 79962-57-5 | Purity: 98% | 3′-(4-Chlorophenyl)spiro[indoline-3,2′-thiazolidine]-2,4′-dione | ESD-877327-2G |
| Cas.: 79962-57-5 | Purity: 98% | 3′-(4-Chlorophenyl)spiro[indoline-3,2′-thiazolidine]-2,4′-dione | ESD-877327-10G |
| Cas.: 79955-41-2 | Purity: 93% | Quinovic acid 3-O-glucoside | ESD-877328-5MG |
| Cas.: 79907-44-1 | Purity: 97% | Procyanidin B2 3,3′-di-O-gallate | ESD-877329-5MG |
| Cas.: 79848-61-6 | Purity: 98% | Ko-3290 | ESD-877331-1MG |
| Cas.: 79848-61-6 | Purity: 98% | Ko-3290 | ESD-877331-5MG |
| Cas.: 79756-69-7 | Purity: ≥98% | TPI-1 | ESD-877332-5MG |
| Cas.: 79756-69-7 | Purity: ≥98% | TPI-1 | ESD-877332-10MG |
| Cas.: 79714-31-1 | Purity: 98% | Risarestat | ESD-877333-1MG |
| Cas.: 79714-31-1 | Purity: 98% | Risarestat | ESD-877333-5MG |
| Cas.: 79700-61-1 | Purity: 98% | Dopropidil | ESD-877334-1MG |
| Cas.: 79700-61-1 | Purity: 98% | Dopropidil | ESD-877334-5MG |
| Cas.: 796854-35-8 | Purity: 98% | WAY-204688 | ESD-877335-1MG |
| Cas.: 796854-35-8 | Purity: 98% | WAY-204688 | ESD-877335-5MG |
| Cas.: 79662-82-1 | Purity: 95% | 4-amino-1,3-diazaspiro[4.4]non-3-en-2-one | ESD-877336-10MG |
| Cas.: 79-61-8 | Purity: ≥99% | Dichlorisone acetate | ESD-877337-10MG |
| Cas.: 79-61-8 | Purity: ≥99% | Dichlorisone acetate | ESD-877337-50MG |
| Cas.: 796073-69-3 | Purity: ≥98% | DM4 | ESD-877338-1MG |
| Cas.: 796073-69-3 | Purity: ≥98% | DM4 | ESD-877338-5MG |
| Cas.: 796067-46-4 | Purity: 95% | (8-tert-butyl-2,4-dioxo-1,3-diazaspiro[4.5]dec-3-yl)acetic acid | ESD-877339-1G |
| Cas.: 796067-45-3 | Purity: 95% | 5-cyano-4-mercapto-2-methyl-N-phenyl-3-azaspiro[5.5]undeca-1,4-diene-1-carboxamide | ESD-877340-1G |
| Cas.: 79561-22-1 | Purity: ≥99% | Alarelin Acetate | ESD-877341-10MG |
| Cas.: 79561-22-1 | Purity: ≥99% | Alarelin Acetate | ESD-877341-50MG |
| Cas.: 79491-71-7 | Purity: 95% | 9-Oxo-10,11-dehydroageraphorone | ESD-877342-5MG |
| Cas.: 794568-92-6 | Purity: ≥99% | BAY 73-6691 | ESD-877343-5MG |
| Cas.: 794568-92-6 | Purity: ≥99% | BAY 73-6691 | ESD-877343-10MG |
| Cas.: 794568-90-4 | Purity: ≥99% | BAY 73-6691 racemate | ESD-877344-1MG |
| Cas.: 794568-90-4 | Purity: ≥99% | BAY 73-6691 racemate | ESD-877344-5MG |
| Cas.: 79439-85-3 | Purity: 98% | Bruceantinoside A | ESD-877345-5MG |
| Cas.: 79439-84-2 | Purity: 97% | Yadanzioside P | ESD-877346-5MG |
| Cas.: 79421-40-2 | Purity: 95% | 4-(1,4-Dioxa-8-azaspiro[4.5]dec-8-yl)-benzenecarbaldehyde | ESD-877347-1G |
| Cas.: 79421-40-2 | Purity: 95% | 4-(1,4-Dioxa-8-azaspiro[4.5]dec-8-yl)-benzenecarbaldehyde | ESD-877347-5G |
| Cas.: 79406-13-6 | Purity: 98% | 3α-Cinnamoyloxypterokaurene L3 | ESD-877348-5MG |
| Cas.: 79406-11-4 | Purity: 98% | 3α-Angeloyloxypterokaurene L3 | ESD-877349-5MG |
| Cas.: 79406-10-3 | Purity: 97% | ent-3β-Cinnamoyloxykaur-16-en-19-oic acid | ESD-877350-5MG |
| Cas.: 79406-09-0 | Purity: 95% | ent-3β-Tigloyloxykaur-16-en-19-oic acid | ESD-877351-5MG |
| Cas.: 79338-84-4 | Purity: ≥99% | Tapinarof | ESD-877352-5MG |
| Cas.: 79338-84-4 | Purity: ≥99% | Tapinarof | ESD-877352-10MG |
| Cas.: 792957-74-5 | Purity: ≥98% | ER-000444793 | ESD-877353-1MG |
| Cas.: 792957-74-5 | Purity: ≥98% | ER-000444793 | ESD-877353-5MG |
| Cas.: 79243-10-0 | Purity: 98% | Somatostatin-28 1-14 | ESD-877354-1MG |
| Cas.: 79243-10-0 | Purity: 98% | Somatostatin-28 1-14 | ESD-877354-5MG |
| Cas.: 79233-15-1 | Purity: 98% | Deoxyandrographolide | ESD-877355-5MG |
| Cas.: 79233-15-1 | Purity: 98% | Deoxyandrographolide | ESD-877355-10MG |
| Cas.: 79157-36-1 | Purity: 98% | Latinone | ESD-877356-5MG |
| Cas.: 79114-77-5 | Purity: 97% | Lariciresinol acetate | ESD-877357-5MG |
| Cas.: 79082-64-7 | Purity: 98% | (-)-Corlumine | ESD-877358-5MG |
| Cas.: 790725-81-4 | Purity: 95% | (8-ethyl-2,4-dioxo-1,3-diazaspiro[4.5]dec-3-yl)acetic acid | ESD-877359-1MG |
| Cas.: 790704-73-3 | Purity: 95% | 5-Cbz-1-oxa-5-azaspiro[2.4]heptane | ESD-877360-1G |
| Cas.: 790186-68-4 | Purity: ≥99% | GW284543 | ESD-877361-5MG |
| Cas.: 790186-68-4 | Purity: ≥99% | GW284543 | ESD-877361-10MG |
| Cas.: 79004-25-4 | Purity: 98% | 4′-O-Methylnyasol | ESD-877362-5MG |
| Cas.: 78919-13-8 | Purity: ≥99% | Iloprost | ESD-877363-1MG |
| Cas.: 78916-55-9 | Purity: 98% | Deacetylnimbinene | ESD-877364-5MG |
| Cas.: 788812-21-5 | Purity: 97% | Spiro[isoindoline-1,4′-piperidin]-3-one hydrochloride | ESD-877365-250MG |
| Cas.: 788812-21-5 | Purity: 97% | Spiro[isoindoline-1,4′-piperidin]-3-one hydrochloride | ESD-877365-1G |
| Cas.: 78876-53-6 | Purity: 95% | 1-chloro-6-(5-ethynylthiophen-2-yl)hexa-3,5-diyn-2-ol | ESD-877366-1MG |
| Cas.: 78876-52-5 | Purity: 97% | 1-Chloro-6-(5-(prop-1-ynyl)thiophen-2-yl)hexa-3,5-diyn-2-ol | ESD-877367-5MG |
| Cas.: 78853-39-1 | Purity: 98% | Cyclodrine hydrochloride | ESD-877368-1MG |
| Cas.: 78853-39-1 | Purity: 98% | Cyclodrine hydrochloride | ESD-877368-5MG |
| Cas.: 78782-99-7 | Purity: ≥98% | Calcitriol D6 | ESD-877369-1MG |
| Cas.: 78782-98-6 | Purity: Abundance: 98atom%; Chemical purity: ≥95% | Calcifediol-D6 | ESD-877370-1MG |
| Cas.: 78782-98-6 | Purity: Abundance: 98atom%; Chemical purity: ≥95% | Calcifediol-D6 | ESD-877370-5MG |
| Cas.: 78771-13-8 | Purity: 98% | Sarmazenil | ESD-877371-1MG |
| Cas.: 78771-13-8 | Purity: 98% | Sarmazenil | ESD-877371-5MG |
| Cas.: 78749-47-0 | Purity: 95% | Shizukanolide C | ESD-877372-5MG |
| Cas.: 786701-13-1 | Purity: 98% | Emicerfont | ESD-877373-1MG |
| Cas.: 786701-13-1 | Purity: 98% | Emicerfont | ESD-877373-5MG |
| Cas.: 78606-95-9 | Purity: 99% | (S)-(-)-2-Amino-3-methyl-1,1-diphenyl-1-butanol | ESD-877374-5MG |
| Cas.: 785835-79-2 | Purity: ≥99% | JDTic dihydrochloride | ESD-877375-5MG |
| Cas.: 785835-79-2 | Purity: ≥99% | JDTic dihydrochloride | ESD-877375-10MG |
| Cas.: 785782-25-4 | Purity: 95% | 8-Benzyl-1,2,8-triazaspiro[4.5]decan-3-one | ESD-877376-1G |
| Cas.: 785782-25-4 | Purity: 95% | 8-Benzyl-1,2,8-triazaspiro[4.5]decan-3-one | ESD-877376-5G |
| Cas.: 785718-37-8 | Purity: ≥98% | NSC305787 | ESD-877377-5MG |
| Cas.: 785718-37-8 | Purity: ≥98% | NSC305787 | ESD-877377-10MG |
| Cas.: 78536-37-5 | Purity: 95% | Excisanin A | ESD-877378-5MG |
| Cas.: 78536-36-4 | Purity: 98% | Excisanin B | ESD-877379-5MG |
| Cas.: 78516-69-5 | Purity: 97% | Dulcioic acid | ESD-877380-5MG |
| Cas.: 78479-12-6 | Purity: 95% | 7-Epi-10-deacetylcephalomannine | ESD-877381-5MG |
| Cas.: 78454-17-8 | Purity: 95% | 7-Epi-10-deacetyltaxol | ESD-877382-5MG |
| Cas.: 78441-82-4 | Purity: 98% | BMY-25271 | ESD-877383-1MG |
| Cas.: 78441-82-4 | Purity: 98% | BMY-25271 | ESD-877383-5MG |
| Cas.: 78432-78-7 | Purity: 98% | 19-Hydroxybaccatin III | ESD-877384-5MG |
| Cas.: 784210-88-4 | Purity: ≥98% | RGB-286638 free base | ESD-877385-2MG |
| Cas.: 784210-88-4 | Purity: ≥98% | RGB-286638 free base | ESD-877385-5MG |
| Cas.: 784210-87-3 | Purity: ≥98% | RGB-286638 | ESD-877386-2MG |
| Cas.: 784210-87-3 | Purity: ≥98% | RGB-286638 | ESD-877386-5MG |
| Cas.: 78405-33-1 | Purity: 98% | 1,7-Dihydroxy-2,3-dimethoxyxanthone | ESD-877387-5MG |
| Cas.: 78343-62-1 | Purity: 98% | Pyranojacareubin | ESD-877388-5MG |
| Cas.: 783348-36-7 | Purity: ≥99% | MLN120B | ESD-877389-5MG |
| Cas.: 783348-36-7 | Purity: ≥99% | MLN120B | ESD-877389-10MG |
| Cas.: 78310-77-7 | Purity: ≥98% | Thymus factor X | ESD-877390-1MG |
| Cas.: 78310-77-7 | Purity: ≥98% | Thymus factor X | ESD-877390-5MG |
| Cas.: 78299-79-3 | Purity: 98% | FKK | ESD-877391-1MG |
| Cas.: 78299-79-3 | Purity: 98% | FKK | ESD-877391-5MG |
| Cas.: 78289-26-6 | Purity: 98% | Droxicainide | ESD-877392-1MG |
| Cas.: 78289-26-6 | Purity: 98% | Droxicainide | ESD-877392-5MG |
| Cas.: 782487-28-9 | Purity: ≥98% | Rosiptor | ESD-877393-5MG |
| Cas.: 782487-28-9 | Purity: ≥98% | Rosiptor | ESD-877393-10MG |
| Cas.: 781649-09-0 | Purity: ≥99% | Telcagepant | ESD-877394-2MG |
| Cas.: 781649-09-0 | Purity: ≥99% | Telcagepant | ESD-877394-5MG |
| Cas.: 781613-23-8 | Purity: ≥99% | Tesevatinib | ESD-877395-2MG |
| Cas.: 781613-23-8 | Purity: ≥99% | Tesevatinib | ESD-877395-5MG |
| Cas.: 78123-71-4 | Purity: ≥98% | DAMGO | ESD-877396-1MG |
| Cas.: 78123-71-4 | Purity: ≥98% | DAMGO | ESD-877396-5MG |
| Cas.: 78108-84-6 | Purity: 95% | 6-(2-CYANOETHYL)-1,4-DIOXASPIRO(4.5)DECANE | ESD-877397-1EA |
| Cas.: 78090-11-6 | Purity: 98% | Picoprazole | ESD-877398-1MG |
| Cas.: 78090-11-6 | Purity: 98% | Picoprazole | ESD-877398-5MG |
| Cas.: 7803-88-5 | Purity: ≥99% | 6-O-Methyl Guanosine | ESD-877399-50MG |
| Cas.: 78012-28-9 | Purity: 95% | 1,3-Diacetylvilasinin | ESD-877400-1MG |
| Cas.: 77988-07-9 | Purity: 96% | Secologanin dimethyl acetal | ESD-877401-5MG |
| Cas.: 77949-42-9 | Purity: 98% | Longikaurin E | ESD-877402-5MG |
| Cas.: 778576-62-8 | Purity: ≥96% | Oglemilast | ESD-877403-5MG |
| Cas.: 778576-62-8 | Purity: ≥96% | Oglemilast | ESD-877403-10MG |
| Cas.: 77844-93-0 | Purity: 92% | Euglobal Ia1 | ESD-877404-5MG |
| Cas.: 77836-86-3 | Purity: 95% | Nelumol A | ESD-877405-1MG |
| Cas.: 77794-63-9 | Purity: 96% | Euglobal Ia2 | ESD-877406-5MG |
| Cas.: 77784-22-6 | Purity: 98% | Dehydrocrebanine | ESD-877407-5MG |
| Cas.: 77741-58-3 | Purity: 98% | 1,7-Dihydroxy-3-methoxy-2-prenylxanthone | ESD-877408-5MG |
| Cas.: 77699-15-5 | Purity: 97% | (6R,9R)-3-Oxo-α-ionol glucoside | ESD-877409-5MG |
| Cas.: 77695-52-4 | Purity: 98% | Ecastolol | ESD-877410-1MG |
| Cas.: 77695-52-4 | Purity: 98% | Ecastolol | ESD-877410-5MG |
| Cas.: 77658-46-9 | Purity: 97% | ent-11α,16α-Epoxy-15α-hydroxykauran-19-oic acid | ESD-877411-5MG |
| Cas.: 77658-45-8 | Purity: 98% | ent-9-Hydroxy-15-oxokauran-19-oic acid | ESD-877412-5MG |
| Cas.: 77658-39-0 | Purity: 98% | ent-9-Hydroxy-15-oxokaur-16-en-19-oic acid | ESD-877413-5MG |
| Cas.: 77658-38-9 | Purity: 95% | Pterokaurene L3 | ESD-877414-5MG |
| Cas.: 776325-66-7 | Purity: 97% | 1,4,5,6-Tetrahydroxy-7,8-diprenylxanthone | ESD-877415-5MG |
| Cas.: 77614-16-5 | Purity: ≥99% | Dermorphin | ESD-877416-1MG |
| Cas.: 77614-16-5 | Purity: ≥99% | Dermorphin | ESD-877416-5MG |
| Cas.: 7759-35-5 | Purity: ≥99% | Nestoron | ESD-877417-10MG |
| Cas.: 7759-35-5 | Purity: ≥99% | Nestoron | ESD-877417-50MG |
| Cas.: 77573-44-5 | Purity: ≥98% | Ingenol-3,4,5,20-diacetonide | ESD-877418-1MG |
| Cas.: 77573-44-5 | Purity: ≥98% | Ingenol-3,4,5,20-diacetonide | ESD-877418-5MG |
| Cas.: 77573-43-4 | Purity: ≥99% | Ingenol-5,20-acetonide | ESD-877419-1MG |
| Cas.: 77573-43-4 | Purity: ≥99% | Ingenol-5,20-acetonide | ESD-877419-5MG |
| Cas.: 775351-91-2 | Purity: 95% | Corylifol C | ESD-877420-5MG |
| Cas.: 775351-65-0 | Purity: 98% | Imeglimin | ESD-877421-2MG |
| Cas.: 775351-65-0 | Purity: 98% | Imeglimin | ESD-877421-5MG |
| Cas.: 775351-61-6 | Purity: ≥98% | Imeglimin hydrochloride | ESD-877422-2MG |
| Cas.: 775351-61-6 | Purity: ≥98% | Imeglimin hydrochloride | ESD-877422-5MG |
| Cas.: 775294-82-1 | Purity: 98% | SBE13 | ESD-877423-10MG |
| Cas.: 775294-82-1 | Purity: 98% | SBE13 | ESD-877423-50MG |
| Cas.: 77529-42-1 | Purity: ≥99% | Glycolic acid oxidase inhibitor 1 | ESD-877424-5MG |
| Cas.: 77529-42-1 | Purity: ≥99% | Glycolic acid oxidase inhibitor 1 | ESD-877424-10MG |
| Cas.: 77472-98-1 | Purity: ≥98% | Pipequaline | ESD-877425-2MG |
| Cas.: 77472-98-1 | Purity: ≥98% | Pipequaline | ESD-877425-5MG |
| Cas.: 77469-98-8 | Purity: 98% | Pimobendan hydrochloride | ESD-877426-5MG |
| Cas.: 77469-98-8 | Purity: 98% | Pimobendan hydrochloride | ESD-877426-10MG |
| Cas.: 774549-97-2 | Purity: ≥99% | KM11060 | ESD-877427-10MG |
| Cas.: 774549-97-2 | Purity: ≥99% | KM11060 | ESD-877427-25MG |
| Cas.: 7745-40-6 | Purity: 98% | 5-Androsten-3β-ol-17-one ethyleneketal | ESD-877428-5MG |
| Cas.: 77449-31-1 | Purity: 95% | Episesartemin A | ESD-877429-5MG |
| Cas.: 77448-87-4 | Purity: 98% | Ro-15-2041 | ESD-877430-1MG |
| Cas.: 77448-87-4 | Purity: 98% | Ro-15-2041 | ESD-877430-5MG |
| Cas.: 77415-72-6 | Purity: 95% | 2,7-Dibenzyl-2,7-diazaspiro[4.4]nonane | ESD-877431-250MG |
| Cas.: 77415-72-6 | Purity: 95% | 2,7-Dibenzyl-2,7-diazaspiro[4.4]nonane | ESD-877431-1G |
| Cas.: 77394-27-5 | Purity: 98% | Sesartemin | ESD-877432-5MG |
| Cas.: 773899-29-9 | Purity: 97% | (2S)-Pinocembrin 7-O-[2”-O-(5”’-O-trans-cinnamoyl)-β-D-apiofuranosyl]-β-D-glucoside | ESD-877433-5MG |
| Cas.: 773850-91-2 | Purity: 95% | Drimiopsin D | ESD-877434-5MG |
| Cas.: 773850-90-1 | Purity: 95% | Drimiopsin C | ESD-877435-1MG |
| Cas.: 77376-98-8 | Purity: 95% | 3H-Spiro[1,3-benzothiazole-2,4′-oxane] | ESD-877436-1G |
| Cas.: 77376-98-8 | Purity: 95% | 3H-Spiro[1,3-benzothiazole-2,4′-oxane] | ESD-877436-5G |
| Cas.: 77353-57-2 | Purity: 96% | Triacetylpseurotin A | ESD-877437-5MG |
| Cas.: 7733-96-2 | Purity: ≥98% | HC-056456 | ESD-877438-5MG |
| Cas.: 7733-96-2 | Purity: ≥98% | HC-056456 | ESD-877438-10MG |
| Cas.: 77331-76-1 | Purity: 98% | Hyuganin D | ESD-877439-5MG |
| Cas.: 7727-79-9 | Purity: 97% | Zederone | ESD-877440-5MG |
| Cas.: 77264-89-2 | Purity: 95% | 1′-BENZYLSPIRO[CHROMAN-2,4′-PIPERIDIN]-4-ONE | ESD-877441-1G |
| Cas.: 77264-89-2 | Purity: 95% | 1′-BENZYLSPIRO[CHROMAN-2,4′-PIPERIDIN]-4-ONE | ESD-877441-5G |
| Cas.: 77263-11-7 | Purity: 95% | Abyssinone V | ESD-877442-5MG |
| Cas.: 77263-06-0 | Purity: 98% | Erythrabyssin II | ESD-877443-5MG |
| Cas.: 77225-15-1 | Purity: 95% | 3-methyl-1-oxa-3,8-diazaspiro[4.5]decan-2-one | ESD-877444-1G |
| Cas.: 77211-75-7 | Purity: 95% | Benzyl 1-oxa-6-azaspiro[2.5]octane-6-carboxylate | ESD-877445-500MG |
| Cas.: 77211-75-7 | Purity: 95% | Benzyl 1-oxa-6-azaspiro[2.5]octane-6-carboxylate | ESD-877445-1G |
| Cas.: 77211-58-6 | Purity: 95% | 3-Phenyl-1-oxa-3,8-diazaspiro[4.5]decan-2-one | ESD-877446-1G |
| Cas.: 77211-58-6 | Purity: 95% | 3-Phenyl-1-oxa-3,8-diazaspiro[4.5]decan-2-one | ESD-877446-5G |
| Cas.: 77181-97-6 | Purity: 98% | Rheediaxanthone A | ESD-877447-1MG |
| Cas.: 7716-14-5 | Purity: 98% | delta-Caesalpin | ESD-877448-5MG |
| Cas.: 77156-13-9 | Purity: 95% | Mahanimbilol | ESD-877449-5MG |
| Cas.: 771493-42-6 | Purity: 96% | 6α-Hydroxycleroda-3,13-dien-16,15-olid-18-oic acid | ESD-877450-5MG |
| Cas.: 770721-33-0 | Purity: 96% | 6-Feruloylcatalpol | ESD-877452-5MG |
| Cas.: 770691-21-9 | Purity: ≥99% | Gadobutrol | ESD-877453-5MG |
| Cas.: 770691-21-9 | Purity: ≥99% | Gadobutrol | ESD-877453-10MG |
| Cas.: 769965-95-9 | Purity: 95% | 5′-FLUOROSPIRO[CYCLOPROPANE-1,3′-INDOLIN]-2′-ONE | ESD-877455-250MG |
| Cas.: 769965-95-9 | Purity: 95% | 5′-FLUOROSPIRO[CYCLOPROPANE-1,3′-INDOLIN]-2′-ONE | ESD-877455-1G |
| Cas.: 76996-27-5 | Purity: 97% | Garcinone C | ESD-877456-5MG |
| Cas.: 76994-07-5 | Purity: 97% | Euphroside | ESD-877457-5MG |
| Cas.: 769928-72-5 | Purity: 97% | 15-Methoxypinusolidic acid | ESD-877458-5MG |
| Cas.: 76988-39-1 | Purity: 98% | Ro 22-3245 | ESD-877459-1MG |
| Cas.: 76988-39-1 | Purity: 98% | Ro 22-3245 | ESD-877459-5MG |
| Cas.: 769856-81-7 | Purity: 98% | TPT-260 | ESD-877460-5MG |
| Cas.: 769856-81-7 | Purity: 98% | TPT-260 | ESD-877460-10MG |
| Cas.: 76-98-2 | Purity: 96% | Conopharyengine | ESD-877461-5MG |
| Cas.: 76948-72-6 | Purity: 98% | Cleomiscosin A | ESD-877462-5MG |
| Cas.: 76947-60-9 | Purity: 96% | Onitin 2′-O-glucoside | ESD-877463-5MG |
| Cas.: 769140-74-1 | Purity: 95% | 13-Methylpodocarpa-8,11,13-triene-3β,12-diol | ESD-877464-1MG |
| Cas.: 769106-43-6 | Purity: 95% | tert-Butyl 2′-oxo-2′,4′-dihydro-1’H-spiro-[piperidine-4,3′-quinoline]-1-carboxylate | ESD-877465-1G |
| Cas.: 76844-65-0 | Purity: 98% | 5,6-Dihydroxy-7,8-dimethoxyflavone | ESD-877466-5MG |
| Cas.: 76843-23-7 | Purity: 98% | Przewaquinone A | ESD-877467-5MG |
| Cas.: 76-80-2 | Purity: 97% | Tephrosin | ESD-877468-5MG |
| Cas.: 767-98-6 | Purity: 98% | Mallorepine | ESD-877469-5MG |
| Cas.: 76792-94-4 | Purity: 95% | 5,7,4′-Tri-O-methylaromadendrin | ESD-877470-5MG |
| Cas.: 76-78-8 | Purity: 96% | Quassin | ESD-877472-5MG |
| Cas.: 76778-22-8 | Purity: 98% | GBR 12935 | ESD-877473-10MG |
| Cas.: 76778-22-8 | Purity: 98% | GBR 12935 | ESD-877473-50MG |
| Cas.: 76754-24-0 | Purity: 98% | Lupalbigenin | ESD-877474-5MG |
| Cas.: 76748-86-2 | Purity: ≥98% | Pyronaridine tetraphosphate | ESD-877475-50MG |
| Cas.: 76748-86-2 | Purity: ≥98% | Pyronaridine tetraphosphate | ESD-877475-100MG |
| Cas.: 76689-98-0 | Purity: 95% | 1-Deacetylnimbolinin B | ESD-877476-5MG |
| Cas.: 766480-48-2 | Purity: 98% | 2R,4R-Sacubitril | ESD-877477-1MG |
| Cas.: 766480-48-2 | Purity: 98% | 2R,4R-Sacubitril | ESD-877477-5MG |
| Cas.: 766-34-7 | Purity: 97% | 7-AZASPIRO[3.5]NONANE | ESD-877478-250MG |
| Cas.: 766-34-7 | Purity: 97% | 7-AZASPIRO[3.5]NONANE | ESD-877478-1G |
| Cas.: 76622-26-9 | Purity: 98% | BAM-22P | ESD-877480-500ΜG |
| Cas.: 76622-26-9 | Purity: 98% | BAM-22P | ESD-877480-1MG |
| Cas.: 765962-66-1 | Purity: 95% | 1,4-dioxa-8-azaspiro[4.5]decane-8-sulfonyl chloride | ESD-877481-1G |
| Cas.: 765-64-0 | Purity: 95% | 6-Azaspiro[3.4]octane | ESD-877482-250MG |
| Cas.: 765-64-0 | Purity: 95% | 6-Azaspiro[3.4]octane | ESD-877482-1G |
| Cas.: 765-46-8 | Purity: 95% | Spiro[2.4]hepta-4,6-diene | ESD-877483-1G |
| Cas.: 765-46-8 | Purity: 95% | Spiro[2.4]hepta-4,6-diene | ESD-877483-5G |
| Cas.: 76497-89-7 | Purity: 97% | 8-Acetoxy-15,16-epoxy-8,9-secolabda-13(16),14-diene-7,9-dione | ESD-877484-5MG |
| Cas.: 76497-69-3 | Purity: 97% | 15,16-Dinorlabda-8(17),11-dien-13-one | ESD-877485-5MG |
| Cas.: 76475-32-6 | Purity: 98% | 8-Acetoxy-15,16-epoxy-8,9-secolabda-13(16),14-diene-7,9-dione | ESD-877486-5MG |
| Cas.: 76472-88-3 | Purity: 97% | Morachalcone A | ESD-877487-5MG |
| Cas.: 76461-17-1 | Purity: 98% | Somatostatin-25 | ESD-877488-500ΜG |
| Cas.: 76461-17-1 | Purity: 98% | Somatostatin-25 | ESD-877488-1MG |
| Cas.: 76410-56-5 | Purity: 98% | Dihydroxyaflavinine | ESD-877489-5MG |
| Cas.: 76267-48-6 | Purity: 96% | 7-Deoxy-10-hydroxyloganetin | ESD-877490-5MG |
| Cas.: 76263-13-3 | Purity: 98% | Fluzinamide | ESD-877491-1MG |
| Cas.: 76263-13-3 | Purity: 98% | Fluzinamide | ESD-877491-5MG |
| Cas.: 76252-06-7 | Purity: ≥99% | Nicainoprol | ESD-877492-1MG |
| Cas.: 76252-06-7 | Purity: ≥99% | Nicainoprol | ESD-877492-5MG |
| Cas.: 76248-63-0 | Purity: 95% | Piptocarphin A | ESD-877493-5MG |
| Cas.: 76239-32-2 | Purity: 98% | KP136 | ESD-877494-1MG |
| Cas.: 76239-32-2 | Purity: 98% | KP136 | ESD-877494-5MG |
| Cas.: 7622-53-9 | Purity: 95% | 5-Deoxycajanin | ESD-877495-1MG |
| Cas.: 76215-53-7 | Purity: 95% | Piptocarphin F | ESD-877496-5MG |
| Cas.: 76166-59-1 | Purity: 97% | Derrone | ESD-877497-5MG |
| Cas.: 761438-38-4 | Purity: ≥99% | ALK inhibitor 2 | ESD-877498-5MG |
| Cas.: 761438-38-4 | Purity: ≥99% | ALK inhibitor 2 | ESD-877498-10MG |
| Cas.: 761436-81-1 | Purity: ≥99% | ALK inhibitor 1 | ESD-877499-2MG |
| Cas.: 761436-81-1 | Purity: ≥99% | ALK inhibitor 1 | ESD-877499-5MG |
| Cas.: 761373-05-1 | Purity: ≥98% | 2R,4S-Sacubitril | ESD-877500-1MG |
| Cas.: 761373-05-1 | Purity: ≥98% | 2R,4S-Sacubitril | ESD-877500-5MG |
| Cas.: 76122-57-1 | Purity: 98% | Phaseollidin hydrate | ESD-877501-5MG |
| Cas.: 760937-92-6 | Purity: ≥99% | Teneligliptin | ESD-877502-10MG |
| Cas.: 760937-92-6 | Purity: ≥99% | Teneligliptin | ESD-877502-50MG |
| Cas.: 7608-44-8 | Purity: 95% | Artocarpin | ESD-877503-5MG |
| Cas.: 76060-35-0 | Purity: 97% | [6]-Dehydrogingerdione | ESD-877504-5MG |
| Cas.: 76045-49-3 | Purity: 98% | Broussonin C | ESD-877505-5MG |
| Cas.: 76035-62-6 | Purity: 98% | 3-Epikatonic acid | ESD-877506-5MG |
| Cas.: 759442-73-4 | Purity: 95% | 2-methyl-1,3-diazaspiro[4.4]non-1-en-4-one | ESD-877507-1G |
| Cas.: 758683-21-5 | Purity: 98% | Bay 65-1942 R form | ESD-877508-5MG |
| Cas.: 758683-21-5 | Purity: 98% | Bay 65-1942 R form | ESD-877508-10MG |
| Cas.: 758679-97-9 | Purity: ≥96% | CID-2858522 | ESD-877509-5MG |
| Cas.: 758679-97-9 | Purity: ≥96% | CID-2858522 | ESD-877509-10MG |
| Cas.: 75822-54-7 | Purity: 99% | 5′-Bromospiro[1,3-dioxolane-2,3′-indol]-2′(1’H)-one | ESD-877510-250MG |
| Cas.: 75822-54-7 | Purity: 99% | 5′-Bromospiro[1,3-dioxolane-2,3′-indol]-2′(1’H)-one | ESD-877510-1G |
| Cas.: 75751-72-3 | Purity: 95% | 2-azaspiro[4.4]nonan-3-one | ESD-877511-1G |
| Cas.: 75748-50-4 | Purity: 98% | Ancarolol | ESD-877512-1MG |
| Cas.: 75748-50-4 | Purity: 98% | Ancarolol | ESD-877512-5MG |
| Cas.: 75737-38-1 | Purity: ≥98% | Meta-Topolin | ESD-877513-50MG |
| Cas.: 75737-38-1 | Purity: ≥98% | Meta-Topolin | ESD-877513-100MG |
| Cas.: 757239-76-2 | Purity: 95% | 1-oxa-8-azaspiro[4.5]decan-3-ol | ESD-877514-1G |
| Cas.: 757239-76-2 | Purity: 95% | 1-oxa-8-azaspiro[4.5]decan-3-ol | ESD-877514-5G |
| Cas.: 757192-65-7 | Purity: 95% | 1,8-dimethyl-1,3-diazaspiro[4.5]decane-2,4-dione | ESD-877515-1G |
| Cas.: 75679-58-2 | Purity: 95% | 2′,4′-Dihydroxy-4,6′-dimethoxydihydrochalcone | ESD-877516-1MG |
| Cas.: 75629-20-8 | Purity: 95% | Gomisin K1 | ESD-877517-5MG |
| Cas.: 75626-98-1 | Purity: 98% | Fenclozine | ESD-877518-1MG |
| Cas.: 75626-98-1 | Purity: 98% | Fenclozine | ESD-877518-5MG |
| Cas.: 7560-49-8 | Purity: 95% | Methyl 3,4,5-trimethoxycinnamate | ESD-877519-1G |
| Cas.: 75590-33-9 | Purity: 96% | Kaerophyllin | ESD-877520-5MG |
| Cas.: 75567-38-3 | Purity: 98% | 20-Deoxyingenol 3-angelate | ESD-877521-5MG |
| Cas.: 75541-83-2 | Purity: ≥99% | Exo1 | ESD-877522-10MG |
| Cas.: 75541-83-2 | Purity: ≥99% | Exo1 | ESD-877522-50MG |
| Cas.: 75536-04-8 | Purity: 98% | Moxonidine hydrochloride | ESD-877523-10MG |
| Cas.: 75536-04-8 | Purity: 98% | Moxonidine hydrochloride | ESD-877523-50MG |
| Cas.: 75513-81-4 | Purity: 97% | Cedrin | ESD-877524-5MG |
| Cas.: 755013-59-3 | Purity: ≥98% | Veledimex racemate | ESD-877525-1MG |
| Cas.: 755013-59-3 | Purity: ≥98% | Veledimex racemate | ESD-877525-5MG |
| Cas.: 75451-07-9 | Purity: 98% | AZ-1355 | ESD-877526-1MG |
| Cas.: 75451-07-9 | Purity: 98% | AZ-1355 | ESD-877526-5MG |
| Cas.: 75450-34-9 | Purity: ≥99% | CGP37157 | ESD-877527-5MG |
| Cas.: 75450-34-9 | Purity: ≥99% | CGP37157 | ESD-877527-10MG |
| Cas.: 75443-99-1 | Purity: ≥98% | Aclacinomycin A hydrochloride | ESD-877528-5MG |
| Cas.: 75443-99-1 | Purity: ≥98% | Aclacinomycin A hydrochloride | ESD-877528-10MG |
| Cas.: 753440-87-8 | Purity: 95% | Spiro[piperidine-4,4′-pyrido-[2,3-d][1,3]oxazin]-2′(1’H)-one | ESD-877529-250MG |
| Cas.: 753440-87-8 | Purity: 95% | Spiro[piperidine-4,4′-pyrido-[2,3-d][1,3]oxazin]-2′(1’H)-one | ESD-877529-1G |
| Cas.: 75268-14-3 | Purity: 98% | Bryonamide A | ESD-877530-5MG |
| Cas.: 75239-63-3 | Purity: 96% | Ophiopogonanone A | ESD-877531-5MG |
| Cas.: 75219-46-4 | Purity: 98% | Atrimustine | ESD-877532-1MG |
| Cas.: 75219-46-4 | Purity: 98% | Atrimustine | ESD-877532-5MG |
| Cas.: 752187-80-7 | Purity: ≥99% | Taprenepag | ESD-877533-5MG |
| Cas.: 752187-80-7 | Purity: ≥99% | Taprenepag | ESD-877533-10MG |
| Cas.: 752186-89-3 | Purity: 98% | CP 375 | ESD-877534-1MG |
| Cas.: 752186-89-3 | Purity: 98% | CP 375 | ESD-877534-5MG |
| Cas.: 751-97-3 | Purity: ≥98% | Rolitetracycline | ESD-877535-5MG |
| Cas.: 751-97-3 | Purity: ≥98% | Rolitetracycline | ESD-877535-10MG |
| Cas.: 7507-89-3 | Purity: 98% | 2′,6′-Dihydroxy-4′-methoxyacetophenone | ESD-877536-1MG |
| Cas.: 75078-91-0 | Purity: 98% | Temarotene | ESD-877537-1MG |
| Cas.: 75078-91-0 | Purity: 98% | Temarotene | ESD-877537-5MG |
| Cas.: 75069-59-9 | Purity: 95% | 20,24-Dihydroxydammar-25-en-3-one | ESD-877538-1MG |
| Cas.: 750649-07-1 | Purity: 98% | Daphnilongeranin C | ESD-877539-5MG |
| Cas.: 749234-11-5 | Purity: ≥98% | DMAT | ESD-877540-10MG |
| Cas.: 749234-11-5 | Purity: ≥98% | DMAT | ESD-877540-50MG |
| Cas.: 749227-53-0 | Purity: 98% | Handle region peptide, rat | ESD-877541-1MG |
| Cas.: 749227-53-0 | Purity: 98% | Handle region peptide, rat | ESD-877541-5MG |
| Cas.: 74892-45-8 | Purity: 97% | 5-Acetoxymatairesinol dimethyl ether | ESD-877542-5MG |
| Cas.: 748810-28-8 | Purity: ≥99% | Vernakalant Hydrochloride | ESD-877543-2MG |
| Cas.: 748810-28-8 | Purity: ≥99% | Vernakalant Hydrochloride | ESD-877543-5MG |
| Cas.: 748136-03-0 | Purity: 95% | Methyl ganoderenate D | ESD-877544-5MG |
| Cas.: 74805-92-8 | Purity: 96% | Methylophiopogonanone A | ESD-877545-5MG |
| Cas.: 74805-91-7 | Purity: 95% | Methylophiopogonanone B | ESD-877546-5MG |
| Cas.: 74730-10-2 | Purity: 95% | Pterolactone A | ESD-877547-5MG |
| Cas.: 74713-15-8 | Purity: 98% | Secoxyloganin methyl ester | ESD-877548-5MG |
| Cas.: 74690-89-4 | Purity: 95% | Vibsanin C | ESD-877549-1MG |
| Cas.: 74683-19-5 | Purity: 95% | 3-Methoxy-4,5-methylenedioxycinnamaldehyde | ESD-877550-1MG |
| Cas.: 7464-93-9 | Purity: 98% | 1,3,9-Trimethyluric acid | ESD-877551-5MG |
| Cas.: 74639-14-8 | Purity: 95% | Liquiritin apioside | ESD-877552-5MG |
| Cas.: 74635-87-3 | Purity: 97% | 11-Hydroxydrim-7-en-6-one | ESD-877553-5MG |
| Cas.: 74635-61-3 | Purity: 95% | ent-3β-Angeloyloxykaur-16-en-19-oic acid | ESD-877554-5MG |
| Cas.: 74611-28-2 | Purity: ≥99% | Methiothepin mesylate | ESD-877555-10MG |
| Cas.: 7460-43-7 | Purity: 95% | Rubiadin 1-methyl ether | ESD-877556-5MG |
| Cas.: 74588-78-6 | Purity: ≥99% | D-64131 | ESD-877557-10MG |
| Cas.: 74588-78-6 | Purity: ≥99% | D-64131 | ESD-877557-50MG |
| Cas.: 74560-05-7 | Purity: 99% | Isomedicarpin | ESD-877558-5MG |
| Cas.: 74-55-5 | Purity: 98% | Ethambutol | ESD-877559-500MG |
| Cas.: 74-55-5 | Purity: 98% | Ethambutol | ESD-877559-1G |
| Cas.: 74515-47-2 | Purity: 97% | Cristacarpin | ESD-877560-5MG |
| Cas.: 745056-83-1 | Purity: 97% | 1,6-Dimethyl-5-vinyl-9,10-dihydrophenanthren-2-ol | ESD-877561-5MG |
| Cas.: 745020-66-0 | Purity: ≥98% | NVX-207 | ESD-877562-5MG |
| Cas.: 745020-66-0 | Purity: ≥98% | NVX-207 | ESD-877562-10MG |
| Cas.: 745017-94-1 | Purity: 98% | MMAF | ESD-877563-2MG |
| Cas.: 745017-94-1 | Purity: 98% | MMAF | ESD-877563-5MG |
| Cas.: 74474-76-3 | Purity: 95% | Casegravol | ESD-877564-1MG |
| Cas.: 7437-55-0 | Purity: 98% | 8-Geranyloxypsoralen | ESD-877565-5MG |
| Cas.: 743461-65-6 | Purity: ≥98% | Batefenterol | ESD-877566-5MG |
| Cas.: 743461-65-6 | Purity: ≥98% | Batefenterol | ESD-877566-10MG |
| Cas.: 743441-93-2 | Purity: 95% | (6-methyl-2,4-dioxo-1,3-diazaspiro[4.5]dec-3-yl)acetic acid | ESD-877567-1G |
| Cas.: 74336-91-7 | Purity: 95% | 4′,4”’-Di-O-methylcuppressuflavone | ESD-877568-5MG |
| Cas.: 74284-42-7 | Purity: 98% | 12-Oxograndiflorenic acid | ESD-877569-5MG |
| Cas.: 7423-31-6 | Purity: ≥98% | Stains-All | ESD-877570-200MG |
| Cas.: 74168-08-4 | Purity: 98% | Losmiprofen | ESD-877571-1MG |
| Cas.: 74168-08-4 | Purity: 98% | Losmiprofen | ESD-877571-5MG |
| Cas.: 74161-25-4 | Purity: 98% | 2,3-Dehydrokievitone | ESD-877572-5MG |
| Cas.: 74149-38-5 | Purity: 95% | Bisdethiobis(methylthio)gliotoxin | ESD-877573-5MG |
| Cas.: 74115-01-8 | Purity: ≥99% | SKF-82958 hydrobromide | ESD-877574-5MG |
| Cas.: 74115-01-8 | Purity: ≥99% | SKF-82958 hydrobromide | ESD-877574-10MG |
| Cas.: 740873-06-7 | Purity: 98% | Naluzotan | ESD-877575-1MG |
| Cas.: 740873-06-7 | Purity: 98% | Naluzotan | ESD-877575-5MG |
| Cas.: 740810-42-8 | Purity: 96% | Cudratricusxanthone A | ESD-877576-5MG |
| Cas.: 74058-71-2 | Purity: 95% | N-Benzylhexadecanamide | ESD-877577-5MG |
| Cas.: 74048-71-8 | Purity: 95% | Lancifolin C | ESD-877578-5MG |
| Cas.: 74012-06-9 | Purity: 98% | FMRF | ESD-877579-5MG |
| Cas.: 74012-06-9 | Purity: 98% | FMRF | ESD-877579-10MG |
| Cas.: 739366-20-2 | Purity: ≥97% | Anagliptin | ESD-877580-5MG |
| Cas.: 739366-20-2 | Purity: ≥97% | Anagliptin | ESD-877580-10MG |
| Cas.: 73904-93-5 | Purity: 98% | isolimonexic acid | ESD-877581-5MG |
| Cas.: 73870-35-6 | Purity: ≥98% | Foresaconitine | ESD-877582-5MG |
| Cas.: 73870-35-6 | Purity: ≥98% | Foresaconitine | ESD-877582-10MG |
| Cas.: 73837-24-8 | Purity: ≥99% | Calcitriol Impurities A | ESD-877583-1MG |
| Cas.: 73837-24-8 | Purity: ≥99% | Calcitriol Impurities A | ESD-877583-5MG |
| Cas.: 73815-21-1 | Purity: 97% | 2,6-Dimethyl-7-octene-2,3,6-triol | ESD-877584-5MG |
| Cas.: 7380-40-7 | Purity: ≥99% | Bergamottin | ESD-877585-5MG |
| Cas.: 7380-40-7 | Purity: ≥99% | Bergamottin | ESD-877585-10MG |
| Cas.: 73793-68-7 | Purity: 96% | Kihadanin B | ESD-877586-5MG |
| Cas.: 737-86-0 | Purity: ≥99% | Pyridoxal isonicotinoyl hydrazone | ESD-877587-10MG |
| Cas.: 737-86-0 | Purity: ≥99% | Pyridoxal isonicotinoyl hydrazone | ESD-877587-50MG |
| Cas.: 737789-87-6 | Purity: ≥98% | Relugolix | ESD-877588-1MG |
| Cas.: 737789-87-6 | Purity: ≥98% | Relugolix | ESD-877588-5MG |
| Cas.: 737763-37-0 | Purity: ≥98% | 360A iodide | ESD-877589-2MG |
| Cas.: 737763-37-0 | Purity: ≥98% | 360A iodide | ESD-877589-5MG |
| Cas.: 737727-12-7 | Purity: ≥99% | PNU-282987 Senantiomer free base | ESD-877590-2MG |
| Cas.: 737727-12-7 | Purity: ≥99% | PNU-282987 Senantiomer free base | ESD-877590-5MG |
| Cas.: 73731-86-9 | Purity: 98% | Broussonin B | ESD-877591-5MG |
| Cas.: 73725-85-6 | Purity: ≥98% | Lidanserin | ESD-877592-1MG |
| Cas.: 73725-85-6 | Purity: ≥98% | Lidanserin | ESD-877592-5MG |
| Cas.: 7372-30-7 | Purity: 95% | Acetylursolic acid | ESD-877593-1MG |
| Cas.: 736140-70-8 | Purity: 98% | 1-(4-Methoxycinnamoyl)pyrrole | ESD-877594-5MG |
| Cas.: 736048-65-0 | Purity: ≥99% | PKC-theta inhibitor | ESD-877595-5MG |
| Cas.: 73584-67-5 | Purity: 97% | 27-p-Coumaroyloxyursolic acid | ESD-877596-5MG |
| Cas.: 73483-88-2 | Purity: 98% | Tetrachyrin | ESD-877597-5MG |
| Cas.: 73435-47-9 | Purity: 97% | Dehydrobruceine A | ESD-877598-5MG |
| Cas.: 73384-59-5 | Purity: 98% | Ceftriaxone | ESD-877599-100MG |
| Cas.: 73384-59-5 | Purity: 98% | Ceftriaxone | ESD-877599-500MG |
| Cas.: 733767-34-5 | Purity: 98% | NSC 23766 | ESD-877600-5MG |
| Cas.: 733767-34-5 | Purity: 98% | NSC 23766 | ESD-877600-10MG |
| Cas.: 733750-99-7 | Purity: ≥99% | AR 231453 | ESD-877601-5MG |
| Cas.: 733750-99-7 | Purity: ≥99% | AR 231453 | ESD-877601-10MG |
| Cas.: 73360-56-2 | Purity: 98% | Niclosamide monohydrate | ESD-877602-500MG |
| Cas.: 73360-56-2 | Purity: 98% | Niclosamide monohydrate | ESD-877602-5G |
| Cas.: 73354-15-1 | Purity: 95% | 9-O-Acetyl-4,4′-di-O-methyllariciresinol | ESD-877603-5MG |
| Cas.: 73334-07-3 | Purity: ≥99% | Iopromide | ESD-877604-5MG |
| Cas.: 73334-07-3 | Purity: ≥99% | Iopromide | ESD-877604-10MG |
| Cas.: 732983-37-8 | Purity: ≥98% | BAY 61-3606 | ESD-877605-5MG |
| Cas.: 732983-37-8 | Purity: ≥98% | BAY 61-3606 | ESD-877605-10MG |
| Cas.: 732926-20-4 | Purity: 95% | (8-Benzyl-2,4-dioxo-1,3,8-triaza-spiro[4.5]dec-3-yl)-acetic acid | ESD-877606-1G |
| Cas.: 732926-20-4 | Purity: 95% | (8-Benzyl-2,4-dioxo-1,3,8-triaza-spiro[4.5]dec-3-yl)-acetic acid | ESD-877606-2.5G |
| Cas.: 73281-83-1 | Purity: 98% | 1,2-Dimethylquinolin-4-one-3-carboxylic acid | ESD-877607-5MG |
| Cas.: 73255-40-0 | Purity: 95% | 4-(α-L-Rhamnosyloxy)benzyl isothiocyanate | ESD-877608-5MG |
| Cas.: 73223-83-3 | Purity: 98% | 1,4-Dioxa-spiro[4.5]decan-7-ol | ESD-877609-1G |
| Cas.: 73223-83-3 | Purity: 98% | 1,4-Dioxa-spiro[4.5]decan-7-ol | ESD-877609-5G |
| Cas.: 73215-92-6 | Purity: 96% | Chloranthalactone E | ESD-877610-5MG |
| Cas.: 731858-91-6 | Purity: 95% | 1,4-dioxaspiro[4.5]decan-6-amine | ESD-877611-5MG |
| Cas.: 731858-91-6 | Purity: 95% | 1,4-dioxaspiro[4.5]decan-6-amine | ESD-877611-10MG |
| Cas.: 73166-28-6 | Purity: 97% | Effusol | ESD-877612-5MG |
| Cas.: 730950-07-9 | Purity: 95% | 2-Chloro-N-(8-methyl-2,4-dioxo-1,3-diaza-spiro[4.5]dec-3-yl)-acetamide | ESD-877613-1MG |
| Cas.: 73086-04-1 | Purity: 97% | Procyanidin B2 3”-O-gallate | ESD-877614-5MG |
| Cas.: 73069-28-0 | Purity: ≥99% | Praeruptorin B | ESD-877615-5MG |
| Cas.: 73069-28-0 | Purity: ≥99% | Praeruptorin B | ESD-877615-10MG |
| Cas.: 73046-13-6 | Purity: 95% | 7-Methyl-1,6-dioxaspiro[4.5]decane | ESD-877616-1MG |
| Cas.: 73036-54-1 | Purity: 99% | 7-Ketoisodrimenin | ESD-877617-5MG |
| Cas.: 73002-86-5 | Purity: 95% | 15-Isopimarene-8,18-diol | ESD-877618-1MG |
| Cas.: 72960-21-5 | Purity: 96% | Gomisin E | ESD-877619-5MG |
| Cas.: 72959-46-7 | Purity: 95% | 6,7-Dihydroneridienone A | ESD-877620-5MG |
| Cas.: 72944-06-0 | Purity: 95% | 30-Hydroxylup-20(29)-en-3-one | ESD-877621-5MG |
| Cas.: 72943-88-5 | Purity: 95% | Octadecyl p-coumarate | ESD-877622-5MG |
| Cas.: 72917-31-8 | Purity: 95% | (Z)-Butylidenephthalide | ESD-877623-5MG |
| Cas.: 72896-40-3 | Purity: 96% | Benzoyloxypaeoniflorin | ESD-877624-5MG |
| Cas.: 728865-23-4 | Purity: ≥99% | CHIR-090 | ESD-877625-2MG |
| Cas.: 728865-23-4 | Purity: ≥99% | CHIR-090 | ESD-877625-5MG |
| Cas.: 72882-78-1 | Purity: ≥97% | PF-9366 | ESD-877626-5MG |
| Cas.: 72882-78-1 | Purity: ≥97% | PF-9366 | ESD-877626-10MG |
| Cas.: 72873-74-6 | Purity: ≥99% | SKF-86002 | ESD-877627-2MG |
| Cas.: 72873-74-6 | Purity: ≥99% | SKF-86002 | ESD-877627-5MG |
| Cas.: 72855-79-9 | Purity: 98% | Echitoveniline | ESD-877628-5MG |
| Cas.: 72826-63-2 | Purity: 98% | Deoxyartemisinin | ESD-877629-5MG |
| Cas.: 72795-01-8 | Purity: ≥98% | ICI 118,551 hydrochloride | ESD-877630-10MG |
| Cas.: 72795-01-8 | Purity: ≥98% | ICI 118,551 hydrochloride | ESD-877630-50MG |
| Cas.: 727-81-1 | Purity: ≥99%, 40 mM in Ethanol | Ubiquinone-1 | ESD-877631-100ΜL |
| Cas.: 727664-91-7 | Purity: ≥98% | MLS0315771 | ESD-877632-5MG |
| Cas.: 727664-91-7 | Purity: ≥98% | MLS0315771 | ESD-877632-10MG |
| Cas.: 72755-22-7 | Purity: 96% | Odorinol | ESD-877633-5MG |
| Cas.: 72755-20-5 | Purity: 95% | Odorine | ESD-877634-5MG |
| Cas.: 72752-82-0 | Purity: 95% | 1-Thia-4-azaspiro[4.4]nonan-3-one | ESD-877635-500MG |
| Cas.: 72752-82-0 | Purity: 95% | 1-Thia-4-azaspiro[4.4]nonan-3-one | ESD-877635-1G |
| Cas.: 72734-63-5 | Purity: 98% | D2343 | ESD-877636-1MG |
| Cas.: 72734-63-5 | Purity: 98% | D2343 | ESD-877636-5MG |
| Cas.: 72715-02-7 | Purity: 98% | Ilicol | ESD-877637-5MG |
| Cas.: 72704-04-2 | Purity: 95% | Mollisorin A | ESD-877638-5MG |
| Cas.: 72678-30-9 | Purity: 98% | LS2265 | ESD-877639-1MG |
| Cas.: 72678-30-9 | Purity: 98% | LS2265 | ESD-877639-5MG |
| Cas.: 726174-00-1 | Purity: ≥99% | A-381393 | ESD-877640-5MG |
| Cas.: 726174-00-1 | Purity: ≥99% | A-381393 | ESD-877640-10MG |
| Cas.: 72599-27-0 | Purity: 98% | Miglustat | ESD-877641-5MG |
| Cas.: 72599-27-0 | Purity: 98% | Miglustat | ESD-877641-10MG |
| Cas.: 72561-28-5 | Purity: 95% | Angeloylgomisin Q | ESD-877642-1MG |
| Cas.: 72537-20-3 | Purity: 97% | Polygonal | ESD-877643-5MG |
| Cas.: 725247-18-7 | Purity: ≥99% | XCT790 | ESD-877644-10MG |
| Cas.: 725247-18-7 | Purity: ≥99% | XCT790 | ESD-877644-50MG |
| Cas.: 72514-90-0 | Purity: 98% | Specioside | ESD-877645-5MG |
| Cas.: 72500-11-9 | Purity: 98% | Methyl vanillate glucoside | ESD-877646-5MG |
| Cas.: 724751-56-8 | Purity: 95% | 3′-(4-Phenoxyphenyl)spiro[indoline-3,2′-thiazolidine]-2,4′-dione | ESD-877647-2G |
| Cas.: 724751-56-8 | Purity: 95% | 3′-(4-Phenoxyphenyl)spiro[indoline-3,2′-thiazolidine]-2,4′-dione | ESD-877647-10G |
| Cas.: 72458-85-6 | Purity: 98% | 11-Hydroxytephrosin | ESD-877648-5MG |
| Cas.: 724440-27-1 | Purity: ≥98% | BAY-8002 | ESD-877649-5MG |
| Cas.: 724440-27-1 | Purity: ≥98% | BAY-8002 | ESD-877649-10MG |
| Cas.: 724424-43-5 | Purity: 98% | CE-224535 | ESD-877650-1MG |
| Cas.: 724424-43-5 | Purity: 98% | CE-224535 | ESD-877650-5MG |
| Cas.: 72401-54-8 | Purity: 98% | 6-Methoxydihydrosanguinarine | ESD-877651-5MG |
| Cas.: 723-97-7 | Purity: 98% | Murrayanine | ESD-877652-5MG |
| Cas.: 72396-01-1 | Purity: 98% | Yuheinoside | ESD-877653-5MG |
| Cas.: 7237-81-2 | Purity: 98% | Hepronicate | ESD-877654-1MG |
| Cas.: 7237-81-2 | Purity: 98% | Hepronicate | ESD-877654-5MG |
| Cas.: 723249-01-2 | Purity: 98% | ZLN024 | ESD-877655-5MG |
| Cas.: 723249-01-2 | Purity: 98% | ZLN024 | ESD-877655-10MG |
| Cas.: 722543-31-9 | Purity: ≥99% | AZD1152 | ESD-877656-5MG |
| Cas.: 722543-31-9 | Purity: ≥99% | AZD1152 | ESD-877656-10MG |
| Cas.: 722533-56-4 | Purity: 98% | Elacestrant | ESD-877657-1MG |
| Cas.: 722533-56-4 | Purity: 98% | Elacestrant | ESD-877657-5MG |
| Cas.: 7224-61-5 | Purity: 96% | Laurifoline | ESD-877658-5MG |
| Cas.: 722456-31-7 | Purity: ≥98% | VAS2870 | ESD-877659-5MG |
| Cas.: 722456-31-7 | Purity: ≥98% | VAS2870 | ESD-877659-10MG |
| Cas.: 72229-39-1 | Purity: 95% | 2α-Hydroxyeupatolide 8-O-angelate | ESD-877660-5MG |
| Cas.: 7222-35-7 | Purity: 97% | Echitovenidine | ESD-877661-5MG |
| Cas.: 72203-93-1 | Purity: ≥97% | Calcitetrol | ESD-877662-1MG |
| Cas.: 72203-93-1 | Purity: ≥97% | Calcitetrol | ESD-877662-5MG |
| Cas.: 721958-63-0 | Purity: 97% | 1′-BOC-6-FLUORO-4-OXOSPIRO[CHROMAN-2,4′-PIPERIDINE] | ESD-877663-250MG |
| Cas.: 721958-63-0 | Purity: 97% | 1′-BOC-6-FLUORO-4-OXOSPIRO[CHROMAN-2,4′-PIPERIDINE] | ESD-877663-1G |
| Cas.: 721958-57-2 | Purity: 95% | 6-(TRIFLUOROMETHYL)-2H-SPIRO[BENZOFURAN-3,4′-PIPERIDINE] | ESD-877664-250MG |
| Cas.: 721958-57-2 | Purity: 95% | 6-(TRIFLUOROMETHYL)-2H-SPIRO[BENZOFURAN-3,4′-PIPERIDINE] | ESD-877664-1G |
| Cas.: 72145-19-8 | Purity: 95% | 2-Hydroxyplatyphyllide | ESD-877665-1MG |
| Cas.: 72122-62-4 | Purity: 98% | β-Casomorphin, bovine | ESD-877666-1MG |
| Cas.: 72103-53-8 | Purity: 98% | Tuftsin diacetate | ESD-877667-1MG |
| Cas.: 72103-53-8 | Purity: 98% | Tuftsin diacetate | ESD-877667-5MG |
| Cas.: 72093-21-1 | Purity: ≥98% | Mastoparan | ESD-877668-1MG |
| Cas.: 72093-21-1 | Purity: ≥98% | Mastoparan | ESD-877668-5MG |
| Cas.: 720690-73-3 | Purity: ≥98% | GSK189254A | ESD-877669-1MG |
| Cas.: 720690-73-3 | Purity: ≥98% | GSK189254A | ESD-877669-5MG |
| Cas.: 72061-63-3 | Purity: 97% | Sepinol | ESD-877670-5MG |
| Cas.: 72058-36-7 | Purity: 98% | Lochnericine | ESD-877671-1MG |
| Cas.: 72021-23-9 | Purity: 96% | Henryoside | ESD-877672-5MG |
| Cas.: 72008-03-8 | Purity: 95% | 2-Geranyl-4-isobutyrylphloroglucinol | ESD-877673-5MG |
| Cas.: 71977-09-8 | Purity: 98% | Substance P, Free Acid | ESD-877674-5MG |
| Cas.: 71977-09-8 | Purity: 98% | Substance P, Free Acid | ESD-877674-10MG |
| Cas.: 71933-54-5 | Purity: 97% | Sarmentosin | ESD-877675-5MG |
| Cas.: 719277-26-6 | Purity: ≥98% | TG003 | ESD-877676-10MG |
| Cas.: 719277-26-6 | Purity: ≥98% | TG003 | ESD-877676-50MG |
| Cas.: 71916-97-7 | Purity: 95% | 5-CHLORO-3H-SPIRO[BENZOFURAN-2,4′-PIPERIDINE] HCL | ESD-877677-250MG |
| Cas.: 71916-97-7 | Purity: 95% | 5-CHLORO-3H-SPIRO[BENZOFURAN-2,4′-PIPERIDINE] HCL | ESD-877677-1G |
| Cas.: 71916-73-9 | Purity: 95% | 3H-Spiro[1-benzofuran-2,4′-piperidine] | ESD-877678-1G |
| Cas.: 71916-73-9 | Purity: 95% | 3H-Spiro[1-benzofuran-2,4′-piperidine] | ESD-877678-5G |
| Cas.: 71901-21-8 | Purity: 98% | N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys | ESD-877679-5MG |
| Cas.: 71901-21-8 | Purity: 98% | N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys | ESD-877679-10MG |
| Cas.: 718632-43-0 | Purity: 95% | 4-BOC-6-CYANO-7-OXO-4-AZASPIRO[2.4]HEPTANE | ESD-877680-1G |
| Cas.: 718632-43-0 | Purity: 95% | 4-BOC-6-CYANO-7-OXO-4-AZASPIRO[2.4]HEPTANE | ESD-877680-5G |
| Cas.: 71861-76-2 | Purity: 98% | 1-Acetyl-3-o-toluyl-5-fluorouracil | ESD-877681-1MG |
| Cas.: 71861-76-2 | Purity: 98% | 1-Acetyl-3-o-toluyl-5-fluorouracil | ESD-877681-5MG |
| Cas.: 71850-23-2 | Purity: 95% | 6-Oxa-1-aza-spiro[3.4]octane oxalate | ESD-877682-250MG |
| Cas.: 71850-23-2 | Purity: 95% | 6-Oxa-1-aza-spiro[3.4]octane oxalate | ESD-877682-1G |
| Cas.: 71850-15-2 | Purity: 98% | Camaldulenic acid | ESD-877683-5MG |
| Cas.: 71831-00-0 | Purity: 98% | Sativan | ESD-877684-5MG |
| Cas.: 71827-03-7 | Purity: 98% | Ivermectin B1a | ESD-877685-5MG |
| Cas.: 71822-00-9 | Purity: 97% | 6-(1-Hydroxyethyl)-2,2-dimethylchromene | ESD-877686-5MG |
| Cas.: 7181-73-9 | Purity: 98% | Bephenium | ESD-877687-100MG |
| Cas.: 7181-73-9 | Purity: 98% | Bephenium | ESD-877687-500MG |
| Cas.: 717901-03-6 | Purity: 95% | Verbenacine | ESD-877688-5MG |
| Cas.: 71700-15-7 | Purity: 96% | Chilenine | ESD-877689-5MG |
| Cas.: 716354-86-8 | Purity: 98% | CCR5 antagonist 1 | ESD-877690-1MG |
| Cas.: 716354-86-8 | Purity: 98% | CCR5 antagonist 1 | ESD-877690-5MG |
| Cas.: 7159-86-6 | Purity: 95% | 3α,6β-Ditigloyloxytropan-7β-ol | ESD-877691-5MG |
| Cas.: 7154-01-0 | Purity: 95% | Safrolglycol | ESD-877692-1MG |
| Cas.: 714-72-7 | Purity: 95% | (2,4-dioxo-1,3-diazaspiro[4.4]non-3-yl)acetic acid | ESD-877693-500MG |
| Cas.: 714-72-7 | Purity: 95% | (2,4-dioxo-1,3-diazaspiro[4.4]non-3-yl)acetic acid | ESD-877693-1G |
| Cas.: 714213-80-6 | Purity: 95% | 6′-methyl-5′,6′-dihydrospiro[cyclohexane-1,4′-pyrrolo[3,2,1-ij]quinoline]-1′,2′-dione | ESD-877694-1G |
| Cas.: 71376-34-6 | Purity: ≥99% | Moniliformin sodium salt | ESD-877695-1MG |
| Cas.: 713492-66-1 | Purity: ≥96% | Mcl1-IN-1 | ESD-877696-2MG |
| Cas.: 713492-66-1 | Purity: ≥96% | Mcl1-IN-1 | ESD-877696-5MG |
| Cas.: 71247-78-4 | Purity: 95% | Salaspermic acid | ESD-877697-5MG |
| Cas.: 712272-88-3 | Purity: 95% | Obolactone | ESD-877698-5MG |
| Cas.: 71222-06-5 | Purity: 96% | Schizandriside | ESD-877699-5MG |
| Cas.: 7121-99-5 | Purity: 95% | Erythroxytriol P | ESD-877700-1MG |
| Cas.: 71183-66-9 | Purity: 98% | DL-threo-2-methylisocitrate | ESD-877701-1MG |
| Cas.: 71183-66-9 | Purity: 98% | DL-threo-2-methylisocitrate | ESD-877701-5MG |
| Cas.: 71144-78-0 | Purity: 95% | 3-Acetoxy-5-methoxystilbene | ESD-877702-5MG |
| Cas.: 710952-13-9 | Purity: 98% | 5,8,4′-Trihydroxy-7-methoxyflavone 8-O-glucoside | ESD-877703-5MG |
| Cas.: 710-94-1 | Purity: 95% | 1,3-Diaza-spiro[4.7]dodecane-2,4-dione | ESD-877704-100MG |
| Cas.: 710-94-1 | Purity: 95% | 1,3-Diaza-spiro[4.7]dodecane-2,4-dione | ESD-877704-500MG |
| Cas.: 71079-19-1 | Purity: 98% | Timegadine | ESD-877705-1MG |
| Cas.: 71079-19-1 | Purity: 98% | Timegadine | ESD-877705-5MG |
| Cas.: 71035-06-8 | Purity: 95% | Griselinoside | ESD-877706-1MG |
| Cas.: 710268-50-1 | Purity: 95% | 8-Benzyl-1-thia-4,8-diazaspiro[4.5]decane | ESD-877707-500MG |
| Cas.: 710268-50-1 | Purity: 95% | 8-Benzyl-1-thia-4,8-diazaspiro[4.5]decane | ESD-877707-1G |
| Cas.: 71002-09-0 | Purity: 98% | Pirazolac | ESD-877708-1MG |
| Cas.: 71002-09-0 | Purity: 98% | Pirazolac | ESD-877708-5MG |
| Cas.: 70991-61-6 | Purity: 98% | MTPPA | ESD-877709-1MG |
| Cas.: 70991-61-6 | Purity: 98% | MTPPA | ESD-877709-5MG |
| Cas.: 70987-96-1 | Purity: 98% | 7,3′,4′-Tri-O-methyleriodictyol | ESD-877710-5MG |
| Cas.: 70897-14-2 | Purity: 95% | Dihydrocitflavanone | ESD-877711-1MG |
| Cas.: 70868-78-9 | Purity: 96% | 23-Hydroxytormentic acid | ESD-877712-5MG |
| Cas.: 7083-71-8 | Purity: ≥99% | Emetine dihydrochloride hydrate | ESD-877713-10MG |
| Cas.: 70833-07-7 | Purity: 98% | Prifuroline | ESD-877714-1MG |
| Cas.: 70833-07-7 | Purity: 98% | Prifuroline | ESD-877714-5MG |
| Cas.: 707-15-3 | Purity: 95% | 6-Methyl-1,3-diaza-spiro[4.5]decane-2,4-dione | ESD-877715-1MG |
| Cas.: 70713-45-0 | Purity: 98% | Aligeron | ESD-877716-1MG |
| Cas.: 70713-45-0 | Purity: 98% | Aligeron | ESD-877716-5MG |
| Cas.: 70711-53-4 | Purity: 98% | Phenindione D5 | ESD-877717-5MG |
| Cas.: 70711-53-4 | Purity: 98% | Phenindione D5 | ESD-877717-10MG |
| Cas.: 70704-03-9 | Purity: 98% | Vinconate | ESD-877718-1MG |
| Cas.: 70704-03-9 | Purity: 98% | Vinconate | ESD-877718-5MG |
| Cas.: 705973-69-9 | Purity: 95% | 14β-Benzoyloxy-2-deacetylbaccatin VI | ESD-877720-5MG |
| Cas.: 705946-27-6 | Purity: ≥99% | Tyrosine kinase-IN-1 | ESD-877721-1MG |
| Cas.: 705946-27-6 | Purity: ≥99% | Tyrosine kinase-IN-1 | ESD-877721-5MG |
| Cas.: 70588-12-4 | Purity: 96% | Fern-7-en-19α-ol | ESD-877722-5MG |
| Cas.: 70578-24-4 | Purity: 98% | Yunaconitine | ESD-877723-5MG |
| Cas.: 70578-24-4 | Purity: 98% | Yunaconitine | ESD-877723-10MG |
| Cas.: 70562-63-9 | Purity: 98% | 6-Bromo-1,4-dioxaspiro[4.6]undecane | ESD-877724-1G |
| Cas.: 70562-63-9 | Purity: 98% | 6-Bromo-1,4-dioxaspiro[4.6]undecane | ESD-877724-5G |
| Cas.: 7047-54-3 | Purity: 95% | Corymbol | ESD-877726-5MG |
| Cas.: 70458-92-3 | Purity: 98% | Pefloxacin | ESD-877727-100MG |
| Cas.: 7044-31-7 | Purity: 98% | 17α-Neriifolin | ESD-877728-5MG |
| Cas.: 70389-96-7 | Purity: 95% | 4(15),11-Oppositadien-1-ol | ESD-877730-1MG |
| Cas.: 70389-88-7 | Purity: 97% | Voleneol | ESD-877731-5MG |
| Cas.: 70387-38-1 | Purity: 96% | 6α-Hydroxynidorellol | ESD-877732-5MG |
| Cas.: 70360-12-2 | Purity: 95% | Sideritoflavone | ESD-877733-5MG |
| Cas.: 7029-89-2 | Purity: 98% | DPBQ | ESD-877734-5MG |
| Cas.: 7029-89-2 | Purity: 98% | DPBQ | ESD-877734-10MG |
| Cas.: 702662-50-8 | Purity: ≥99% | STING agonist-1 | ESD-877735-5MG |
| Cas.: 702662-50-8 | Purity: ≥99% | STING agonist-1 | ESD-877735-10MG |
| Cas.: 702-62-5 | Purity: 95% | 1,3-Diazaspiro[4.5]decane-2,4-dione | ESD-877736-5G |
| Cas.: 702-62-5 | Purity: 95% | 1,3-Diazaspiro[4.5]decane-2,4-dione | ESD-877736-25G |
| Cas.: 70206-70-1 | Purity: 95% | 8α-Hydroxy-α-gurjunene | ESD-877737-1MG |
| Cas.: 701977-09-5 | Purity: ≥99% | Taranabant | ESD-877738-2MG |
| Cas.: 701977-09-5 | Purity: ≥99% | Taranabant | ESD-877738-5MG |
| Cas.: 701977-00-6 | Purity: ≥99% | Taranabant racemate | ESD-877739-2MG |
| Cas.: 701977-00-6 | Purity: ≥99% | Taranabant racemate | ESD-877739-5MG |
| Cas.: 70191-83-2 | Purity: 95% | Isotetrandrine N-2′-oxide | ESD-877740-5MG |
| Cas.: 70181-03-2 | Purity: 98% | Dazopride | ESD-877741-1MG |
| Cas.: 70181-03-2 | Purity: 98% | Dazopride | ESD-877741-5MG |
| Cas.: 701232-20-4 | Purity: ≥98% | T863 | ESD-877742-5MG |
| Cas.: 701232-20-4 | Purity: ≥98% | T863 | ESD-877742-10MG |
| Cas.: 70110-59-7 | Purity: 98% | 5-Heneicosylresorcinol | ESD-877745-5MG |
| Cas.: 700878-19-9 | Purity: ≥98% | NMDA-IN-1 | ESD-877746-5MG |
| Cas.: 700878-19-9 | Purity: ≥98% | NMDA-IN-1 | ESD-877746-10MG |
| Cas.: 70052-12-9 | Purity: 98% | Eflornithine | ESD-877747-10MG |
| Cas.: 70052-12-9 | Purity: 98% | Eflornithine | ESD-877747-50MG |
| Cas.: 70051-38-6 | Purity: 99% | Aromadendrane-4β,10α-diol | ESD-877748-5MG |
| Cas.: 69978-82-1 | Purity: 96% | Isocostic acid | ESD-877749-5MG |
| Cas.: 69938-75-6 | Purity: 98% | CP-28888 | ESD-877750-1MG |
| Cas.: 69938-75-6 | Purity: 98% | CP-28888 | ESD-877750-5MG |
| Cas.: 69844-32-2 | Purity: 92% | Thymyl 2-methylbutyrate | ESD-877751-5MG |
| Cas.: 69839-83-4 | Purity: ≥98% | Didox | ESD-877752-5MG |
| Cas.: 69839-83-4 | Purity: ≥98% | Didox | ESD-877752-10MG |
| Cas.: 698394-73-9 | Purity: ≥98% | Vercirnon | ESD-877753-5MG |
| Cas.: 698394-73-9 | Purity: ≥98% | Vercirnon | ESD-877753-10MG |
| Cas.: 69809-22-9 | Purity: ≥99% | Agarotetrol | ESD-877754-5MG |
| Cas.: 69809-22-9 | Purity: ≥99% | Agarotetrol | ESD-877754-10MG |
| Cas.: 69804-59-7 | Purity: 97% | 2,7-Dihydroxy-2H-1,4-benzoxazin-3(4H)-one | ESD-877755-5MG |
| Cas.: 6975-17-3 | Purity: 97% | Ethyl 1-oxaspiro[2.5]octane-2-carboxylate | ESD-877756-1G |
| Cas.: 6975-17-3 | Purity: 97% | Ethyl 1-oxaspiro[2.5]octane-2-carboxylate | ESD-877756-10G |
| Cas.: 697235-39-5 | Purity: ≥99% | Episilvestrol | ESD-877757-1MG |
| Cas.: 69687-87-2 | Purity: 95% | 2,5-Dimethylchroman-4-one | ESD-877758-5MG |
| Cas.: 69651-80-5 | Purity: 95% | Hesperetin 5-O-glucoside | ESD-877759-1MG |
| Cas.: 69636-83-5 | Purity: 95% | α-Cannabispiranol | ESD-877760-1MG |
| Cas.: 69586-96-5 | Purity: 97% | Tupichilignan A | ESD-877761-5MG |
| Cas.: 69573-60-0 | Purity: 98% | Octadecyl caffeate | ESD-877762-5MG |
| Cas.: 69480-06-4 | Purity: 98% | 2′,6′-Dihydroxy-4′-methoxy-3′-methylacetophenone | ESD-877763-5MG |
| Cas.: 69480-03-1 | Purity: 98% | 2-Methyl-4-isobutyrylphloroglucinol | ESD-877764-5MG |
| Cas.: 69470-93-5 | Purity: 97% | 5-Hydroxy-6-methoxy-3-methyl-2-phenylbenzofuran | ESD-877765-5MG |
| Cas.: 694443-03-3 | Purity: ≥98% | BoNT-IN-1 | ESD-877766-2MG |
| Cas.: 694443-03-3 | Purity: ≥98% | BoNT-IN-1 | ESD-877766-5MG |
| Cas.: 693789-34-3 | Purity: 95% | TERT-BUTYL 4,5-DIHYDRO-3H-SPIRO[BENZO[B][1,4]OXAZEPINE-2,4′-PIPERIDINE]-1′-CARBOXYLATE | ESD-877767-1G |
| Cas.: 693288-97-0 | Purity: ≥97% | CPPHA | ESD-877768-5MG |
| Cas.: 693288-97-0 | Purity: ≥97% | CPPHA | ESD-877768-10MG |
| Cas.: 69300-50-1 | Purity: 95% | 6,7-dihydro-2’H,5H,5’H-spiro[1-benzothiophene-4,4′-imidazolidine]-2′,5′-dione | ESD-877769-25MG |
| Cas.: 69300-50-1 | Purity: 95% | 6,7-dihydro-2’H,5H,5’H-spiro[1-benzothiophene-4,4′-imidazolidine]-2′,5′-dione | ESD-877769-50MG |
| Cas.: 692737-80-7 | Purity: ≥99% | dovitinib lactate | ESD-877770-5MG |
| Cas.: 692737-80-7 | Purity: ≥99% | dovitinib lactate | ESD-877770-10MG |
| Cas.: 69251-99-6 | Purity: 95% | 1,2,3-Tri-O-methyl-7,8-O,O-methyleneflavellagic acid | ESD-877771-5MG |
| Cas.: 69219-24-5 | Purity: 95% | Osthol hydrate | ESD-877772-5MG |
| Cas.: 69207-52-9 | Purity: 98% | McN3716 | ESD-877773-1MG |
| Cas.: 69207-52-9 | Purity: 98% | McN3716 | ESD-877773-5MG |
| Cas.: 691852-58-1 | Purity: ≥98% | Nesbuvir | ESD-877774-5MG |
| Cas.: 691852-58-1 | Purity: ≥98% | Nesbuvir | ESD-877774-10MG |
| Cas.: 69176-51-8 | Purity: 98% | Tigloylgomisin P | ESD-877775-5MG |
| Cas.: 69135-41-7 | Purity: 97% | Aromadendrin 7-O-rhamnoside | ESD-877776-5MG |
| Cas.: 69123-90-6 | Purity: ≥98% | Fiacitabine | ESD-877777-5MG |
| Cas.: 69123-90-6 | Purity: ≥98% | Fiacitabine | ESD-877777-10MG |
| Cas.: 69120-07-6 | Purity: 95% | Moracin D | ESD-877778-1MG |
| Cas.: 69120-06-5 | Purity: 97% | Moracin C | ESD-877779-5MG |
| Cas.: 691009-85-5 | Purity: 95% | 16-Hydroxy-8(17),13-labdadien-15,16-olid-19-oic acid | ESD-877780-1MG |
| Cas.: 6909-19-9 | Purity: 95% | 2-Caren-10-ol | ESD-877781-1MG |
| Cas.: 690655-41-5 | Purity: 98% | NCX899 | ESD-877782-1MG |
| Cas.: 690655-41-5 | Purity: 98% | NCX899 | ESD-877782-5MG |
| Cas.: 69065-16-3 | Purity: 95% | 4-Prenyloxyresveratrol | ESD-877783-1MG |
| Cas.: 690632-38-3 | Purity: 95% | tert-Butyl 6-bromo-4-oxospiro[chroman-2,4′-piperidine]-1′-carboxylate | ESD-877784-1G |
| Cas.: 690632-38-3 | Purity: 95% | tert-Butyl 6-bromo-4-oxospiro[chroman-2,4′-piperidine]-1′-carboxylate | ESD-877784-5G |
| Cas.: 690632-05-4 | Purity: 95% | 6-Bromospiro[1,3-benzoxazine-2,4′-piperidine]-4(3H)-one, N-BOC protected | ESD-877785-250MG |
| Cas.: 690632-05-4 | Purity: 95% | 6-Bromospiro[1,3-benzoxazine-2,4′-piperidine]-4(3H)-one, N-BOC protected | ESD-877785-1G |
| Cas.: 69049-73-6 | Purity: ≥95% | Nedocromil | ESD-877786-5MG |
| Cas.: 69049-73-6 | Purity: ≥95% | Nedocromil | ESD-877786-10MG |
| Cas.: 690270-29-2 | Purity: ≥97% | Balapiravir | ESD-877787-2MG |
| Cas.: 690270-29-2 | Purity: ≥97% | Balapiravir | ESD-877787-5MG |
| Cas.: 6899-73-6 | Purity: 97% | Uncarine A | ESD-877789-5MG |
| Cas.: 6890-88-6 | Purity: 95% | Eburicol | ESD-877790-1MG |
| Cas.: 68-88-2 | Purity: 98% | Hydroxyzine | ESD-877791-100MG |
| Cas.: 68-88-2 | Purity: 98% | Hydroxyzine | ESD-877791-500MG |
| Cas.: 688805-40-5 | Purity: 98% | HEX3 | ESD-877792-1MG |
| Cas.: 688805-40-5 | Purity: 98% | HEX3 | ESD-877792-5MG |
| Cas.: 688348-33-6 | Purity: ≥98% | CAY 10465 | ESD-877793-5MG |
| Cas.: 688348-33-6 | Purity: ≥98% | CAY 10465 | ESD-877793-10MG |
| Cas.: 688348-25-6 | Purity: ≥98% | PDM2 | ESD-877794-10MG |
| Cas.: 688348-25-6 | Purity: ≥98% | PDM2 | ESD-877794-50MG |
| Cas.: 68832-39-3 | Purity: 95% | 4-Epi-isoinuviscolide | ESD-877795-1MG |
| Cas.: 6882-99-1 | Purity: 98% | Sempervirine | ESD-877796-5MG |
| Cas.: 6880-91-7 | Purity: ≥99% | Dihydrochelerythrine | ESD-877797-5MG |
| Cas.: 6880-91-7 | Purity: ≥99% | Dihydrochelerythrine | ESD-877797-10MG |
| Cas.: 6880-54-2 | Purity: 95% | Norfluorocurarine | ESD-877798-5MG |
| Cas.: 68799-41-7 | Purity: 98% | 6-Acetyl-2,2-dimethylchroman-4-one | ESD-877799-5MG |
| Cas.: 68799-38-2 | Purity: 95% | 4-Oxobedfordiaic acid | ESD-877800-5MG |
| Cas.: 68776-42-1 | Purity: 98% | 12-Hydroxy-2,3-dihydroeuparin | ESD-877801-5MG |
| Cas.: 6874-98-2 | Purity: 93% | Vellosimine | ESD-877802-5MG |
| Cas.: 6873-15-0 | Purity: 98% | Arborine | ESD-877803-5MG |
| Cas.: 6872-88-4 | Purity: 92% | Xanthoplanine | ESD-877804-5MG |
| Cas.: 6871-44-9 | Purity: 98% | Echitamine | ESD-877805-5MG |
| Cas.: 6871-21-2 | Purity: 98% | Asimilobine | ESD-877806-5MG |
| Cas.: 68710-17-8 | Purity: 97% | Arteanoflavone | ESD-877807-5MG |
| Cas.: 6870-94-6 | Purity: 98% | 11β,17α-Dihydroxy-6α-methylpregna-1,4-diene-3,20-dione | ESD-877808-5MG |
| Cas.: 68635-50-7 | Purity: 98% | Deloxolone | ESD-877809-1MG |
| Cas.: 68635-50-7 | Purity: 98% | Deloxolone | ESD-877809-5MG |
| Cas.: 686344-29-6 | Purity: ≥99% | Otenabant | ESD-877810-5MG |
| Cas.: 686344-29-6 | Purity: ≥99% | Otenabant | ESD-877810-10MG |
| Cas.: 68592-15-4 | Purity: 98% | 4-O-Methyl honokiol | ESD-877811-5MG |
| Cas.: 68592-15-4 | Purity: 98% | 4-O-Methyl honokiol | ESD-877811-10MG |
| Cas.: 6858-85-1 | Purity: 95% | Prometaphanine | ESD-877812-5MG |
| Cas.: 685543-66-2 | Purity: ≥99% | RR-11a analog | ESD-877813-5MG |
| Cas.: 685543-66-2 | Purity: ≥99% | RR-11a analog | ESD-877813-10MG |
| Cas.: 68506-86-5 | Purity: ≥98% | Vigabatrin | ESD-877814-5MG |
| Cas.: 68506-86-5 | Purity: ≥98% | Vigabatrin | ESD-877814-10MG |
| Cas.: 68489-09-8 | Purity: ≥99% | WS-12 | ESD-877815-5MG |
| Cas.: 68489-09-8 | Purity: ≥99% | WS-12 | ESD-877815-10MG |
| Cas.: 68483-33-0 | Purity: ≥99% | Apyramide | ESD-877816-1MG |
| Cas.: 68483-33-0 | Purity: ≥99% | Apyramide | ESD-877816-5MG |
| Cas.: 68436-47-5 | Purity: 96% | Isowighteone | ESD-877817-5MG |
| Cas.: 684217-08-1 | Purity: 98% | 6′,7′-Dihydroxybergamottin acetonide | ESD-877818-5MG |
| Cas.: 68401-05-8 | Purity: 98% | Kuwanon E | ESD-877819-5MG |
| Cas.: 68353-24-2 | Purity: 98% | 1-Methyl-2-nonylquinolin-4(1H)-one | ESD-877820-5MG |
| Cas.: 6832-60-6 | Purity: 96% | Imbricatolic acid | ESD-877821-5MG |
| Cas.: 68318-20-7 | Purity: 98% | Verilopam | ESD-877822-1MG |
| Cas.: 68318-20-7 | Purity: 98% | Verilopam | ESD-877822-5MG |
| Cas.: 68296-27-5 | Purity: 98% | Fargesin | ESD-877823-5MG |
| Cas.: 68291-98-5 | Purity: 98% | Zonisamide sodium | ESD-877824-200MG |
| Cas.: 68291-98-5 | Purity: 98% | Zonisamide sodium | ESD-877824-500MG |
| Cas.: 682741-29-3 | Purity: ≥99% | HTS01037 | ESD-877826-5MG |
| Cas.: 682741-29-3 | Purity: ≥99% | HTS01037 | ESD-877826-10MG |
| Cas.: 68162-52-7 | Purity: 98% | Drobuline hydrochloride | ESD-877827-1MG |
| Cas.: 68162-52-7 | Purity: 98% | Drobuline hydrochloride | ESD-877827-5MG |
| Cas.: 68160-76-9 | Purity: 95% | Nortetraphyllicine | ESD-877828-1MG |
| Cas.: 6812-87-9 | Purity: 95% | Royleanone | ESD-877829-5MG |
| Cas.: 681159-27-3 | Purity: ≥99% | CBR-5884 | ESD-877830-5MG |
| Cas.: 681159-27-3 | Purity: ≥99% | CBR-5884 | ESD-877830-10MG |
| Cas.: 68099-86-5 | Purity: ≥99% | Bepridil hydrochloride | ESD-877831-5MG |
| Cas.: 68099-86-5 | Purity: ≥99% | Bepridil hydrochloride | ESD-877831-10MG |
| Cas.: 68097-13-2 | Purity: 99% | 6-Prenylapigenin | ESD-877832-5MG |
| Cas.: 68077-27-0 | Purity: 98% | Norfloxacin hydrochloride | ESD-877833-500MG |
| Cas.: 68077-27-0 | Purity: 98% | Norfloxacin hydrochloride | ESD-877833-5G |
| Cas.: 680617-50-9 | Purity: 98% | Megastigm-7-ene-3,5,6,9-tetraol | ESD-877834-5MG |
| Cas.: 68030-18-2 | Purity: ≥99% | Berberine chloride hydrate | ESD-877835-500MG |
| Cas.: 68030-18-2 | Purity: ≥99% | Berberine chloride hydrate | ESD-877835-5G |
| Cas.: 67-99-2 | Purity: 95% | Gliotoxin | ESD-877836-5MG |
| Cas.: 6792-07-0 | Purity: 95% | Macusine B | ESD-877837-5MG |
| Cas.: 67920-48-3 | Purity: 95% | 1,6-Dihydro-4,7′-epoxy-1-methoxy- 3′,4′-methylenedioxy-6-oxo-3,8′-lignan | ESD-877838-5MG |
| Cas.: 67884-27-9 | Purity: 98% | n-Butyl-β-D-fructopyranoside | ESD-877839-5MG |
| Cas.: 67884-12-2 | Purity: 98% | Martynoside | ESD-877840-5MG |
| Cas.: 67879-81-6 | Purity: 98% | Glycosolone | ESD-877841-5MG |
| Cas.: 67879-58-7 | Purity: Analysis control, 98% | Caftaric acid | ESD-877842-5MG |
| Cas.: 67879-58-7 | Purity: Analysis control, 98% | Caftaric acid | ESD-877842-10MG |
| Cas.: 6786-16-9 | Purity: 96% | Taraxasterone | ESD-877843-5MG |
| Cas.: 67828-62-0 | Purity: 97% | Ethyl 2,4-dihydroxyphenylacetate | ESD-877844-5MG |
| Cas.: 678138-59-5 | Purity: 97% | 2,3,2″,3″-Tetrahydroochnaflavone | ESD-877845-5MG |
| Cas.: 67812-42-4 | Purity: ≥98% | Norverapamil hydrochloride | ESD-877846-2MG |
| Cas.: 67812-42-4 | Purity: ≥98% | Norverapamil hydrochloride | ESD-877846-5MG |
| Cas.: 6779-87-9 | Purity: ≥98% | 7,8-Dihydro-L-biopterin | ESD-877847-5MG |
| Cas.: 6778-33-2 | Purity: ≥98% | delta-Valerobetaine | ESD-877848-5MG |
| Cas.: 6778-33-2 | Purity: ≥98% | delta-Valerobetaine | ESD-877848-10MG |
| Cas.: 677746-25-7 | Purity: ≥97% | K 01-162 | ESD-877849-1MG |
| Cas.: 677746-25-7 | Purity: ≥97% | K 01-162 | ESD-877849-5MG |
| Cas.: 67765-58-6 | Purity: 98% | Menisdaurin | ESD-877850-5MG |
| Cas.: 677277-98-4 | Purity: 95% | Rediocide C | ESD-877851-5MG |
| Cas.: 67685-22-7 | Purity: 98% | Anhydroglycinol | ESD-877852-5MG |
| Cas.: 67684-64-4 | Purity: ≥98% | trans-ACPD | ESD-877853-2MG |
| Cas.: 67684-64-4 | Purity: ≥98% | trans-ACPD | ESD-877853-5MG |
| Cas.: 67677-81-0 | Purity: 95% | 1-methylspiro[indole-3,4′-piperidin]-2(1H)-one | ESD-877854-1G |
| Cas.: 67667-71-4 | Purity: 95% | 8α-(2-Methylacryloyloxy)hirsutinolide 13-O-acetate | ESD-877855-5MG |
| Cas.: 67667-62-3 | Purity: 95% | De-O-methylacetovanillochromene | ESD-877856-1MG |
| Cas.: 676607-31-1 | Purity: 95% | tert-Butyl spiro[indoline-3,4′-piperidine]-1-carboxylate | ESD-877857-250MG |
| Cas.: 676607-31-1 | Purity: 95% | tert-Butyl spiro[indoline-3,4′-piperidine]-1-carboxylate | ESD-877857-1G |
| Cas.: 67650-47-9 | Purity: 98% | Methyl clerodermate | ESD-877858-5MG |
| Cas.: 676500-67-7 | Purity: 98% | Bevenopran | ESD-877859-1MG |
| Cas.: 676500-67-7 | Purity: 98% | Bevenopran | ESD-877859-5MG |
| Cas.: 676128-63-5 | Purity: ≥99% | RSV604 | ESD-877860-5MG |
| Cas.: 676128-63-5 | Purity: ≥99% | RSV604 | ESD-877860-10MG |
| Cas.: 676128-62-4 | Purity: ≥98% | RSV604 racemate | ESD-877861-5MG |
| Cas.: 676128-62-4 | Purity: ≥98% | RSV604 racemate | ESD-877861-10MG |
| Cas.: 67600-94-6 | Purity: 96% | Hydrangenol 8-O-glucoside | ESD-877862-5MG |
| Cas.: 67567-15-1 | Purity: 97% | Diosbulbin G | ESD-877863-5MG |
| Cas.: 67560-68-3 | Purity: 97% | Lariciresinol dimethyl ether | ESD-877864-5MG |
| Cas.: 675126-05-3 | Purity: 98% | Dasotraline | ESD-877865-1MG |
| Cas.: 675126-05-3 | Purity: 98% | Dasotraline | ESD-877865-5MG |
| Cas.: 675103-36-3 | Purity: ≥98% | BAY-678 | ESD-877866-5MG |
| Cas.: 675103-36-3 | Purity: ≥98% | BAY-678 | ESD-877866-10MG |
| Cas.: 675103-35-2 | Purity: 98% | BAY-678 racemate | ESD-877867-5MG |
| Cas.: 675103-35-2 | Purity: 98% | BAY-678 racemate | ESD-877867-10MG |
| Cas.: 6750-60-3 | Purity: 95% | Spatulenol | ESD-877868-5MG |
| Cas.: 6750-25-0 | Purity: 95% | Eupatolide | ESD-877869-5MG |
| Cas.: 6747-15-5 | Purity: ≥98% | D,L-3-Indolylglycine | ESD-877870-10MG |
| Cas.: 6747-15-5 | Purity: ≥98% | D,L-3-Indolylglycine | ESD-877870-50MG |
| Cas.: 67469-78-7 | Purity: ≥99% | Vanoxerine dihydrochloride | ESD-877871-10MG |
| Cas.: 67469-78-7 | Purity: ≥99% | Vanoxerine dihydrochloride | ESD-877871-50MG |
| Cas.: 67469-69-6 | Purity: 98% | Vanoxerine | ESD-877872-10MG |
| Cas.: 67469-69-6 | Purity: 98% | Vanoxerine | ESD-877872-50MG |
| Cas.: 67467-83-8 | Purity: 98% | Amorolfine | ESD-877873-5MG |
| Cas.: 67451-73-4 | Purity: 98% | Isoasatone A | ESD-877874-5MG |
| Cas.: 6743-62-0 | Purity: 97% | Ethyl β-D-xylopyranoside | ESD-877875-1MG |
| Cas.: 6736-85-2 | Purity: 99% | Catalposide | ESD-877876-5MG |
| Cas.: 67349-43-3 | Purity: 95% | Pterokaurane R | ESD-877877-5MG |
| Cas.: 673-49-4 | Purity: ≥98% | N-Acetylhistamine | ESD-877878-50MG |
| Cas.: 6729-55-1 | Purity: ≥98% | gamma-DGG | ESD-877879-5MG |
| Cas.: 6729-55-1 | Purity: ≥98% | gamma-DGG | ESD-877879-10MG |
| Cas.: 672926-33-9 | Purity: ≥96% | Kif15-IN-2 | ESD-877880-2MG |
| Cas.: 672926-33-9 | Purity: ≥96% | Kif15-IN-2 | ESD-877880-5MG |
| Cas.: 672926-32-8 | Purity: ≥99% | Kif15-IN-1 | ESD-877881-2MG |
| Cas.: 672926-32-8 | Purity: ≥99% | Kif15-IN-1 | ESD-877881-5MG |
| Cas.: 67256-05-7 | Purity: 98% | Dictysine | ESD-877882-5MG |
| Cas.: 67253-01-4 | Purity: 98% | Cabraleadiol | ESD-877883-5MG |
| Cas.: 672336-50-4 | Purity: 95% | 10(14)-Cadinene-4,5-diol | ESD-877884-1MG |
| Cas.: 67224-41-3 | Purity: 98% | ACTH 4-11 | ESD-877885-5MG |
| Cas.: 67224-41-3 | Purity: 98% | ACTH 4-11 | ESD-877885-10MG |
| Cas.: 67214-05-5 | Purity: 97% | 2”-O-Coumaroyljuglanin | ESD-877886-5MG |
| Cas.: 67165-56-4 | Purity: 98% | Diclofensine | ESD-877887-5MG |
| Cas.: 67165-56-4 | Purity: 98% | Diclofensine | ESD-877887-10MG |
| Cas.: 6714-68-7 | Purity: 95% | spiro[1,3-dioxolane-2,3′-indol]-2′(1’H)-one | ESD-877888-1G |
| Cas.: 6714-68-7 | Purity: 95% | spiro[1,3-dioxolane-2,3′-indol]-2′(1’H)-one | ESD-877888-10G |
| Cas.: 6711-69-9 | Purity: 97% | Tubotaiwine | ESD-877889-5MG |
| Cas.: 670270-31-2 | Purity: ≥99% | IU1-47 | ESD-877890-5MG |
| Cas.: 670270-31-2 | Purity: ≥99% | IU1-47 | ESD-877890-10MG |
| Cas.: 670257-89-3 | Purity: 95% | Pepluanin A | ESD-877891-5MG |
| Cas.: 6702-55-2 | Purity: 95% | 3,4-Dihydroxy-2-methoxyxanthone | ESD-877892-5MG |
| Cas.: 67023-81-8 | Purity: 95% | Ohchinin acetate | ESD-877893-1MG |
| Cas.: 67023-80-7 | Purity: 98% | Ohchinin | ESD-877894-5MG |
| Cas.: 66969-81-1 | Purity: 98% | Tiodazosin | ESD-877895-1MG |
| Cas.: 66969-81-1 | Purity: 98% | Tiodazosin | ESD-877895-5MG |
| Cas.: 66952-49-6 | Purity: 98% | Methasulfocarb | ESD-877896-10MG |
| Cas.: 66952-49-6 | Purity: 98% | Methasulfocarb | ESD-877896-50MG |
| Cas.: 66900-93-4 | Purity: 98% | 1,2-O-Isopropylidene-β-D-fructopyranose | ESD-877897-5MG |
| Cas.: 66892-63-5 | Purity: 95% | 6′-fluoro-2′,3′-dihydro-2H,5H-spiro[imidazolidine-4,4′-thiochromene]-2,5-dione 1′,1′-dioxide | ESD-877898-1G |
| Cas.: 66892-54-4 | Purity: 95% | 2,3-dihydro-2’H,5’H-spiro[chromene-4,4′-imidazolidine]-2′,5′-dione | ESD-877899-50MG |
| Cas.: 66892-54-4 | Purity: 95% | 2,3-dihydro-2’H,5’H-spiro[chromene-4,4′-imidazolidine]-2′,5′-dione | ESD-877899-100MG |
| Cas.: 66892-37-3 | Purity: 95% | 6′-methoxy-2′,3′-dihydrospiro[imidazolidine-4,1′-indene]-2,5-dione | ESD-877900-1MG |
| Cas.: 668463-35-2 | Purity: ≥98% | RPR-260243 | ESD-877901-2MG |
| Cas.: 668463-35-2 | Purity: ≥98% | RPR-260243 | ESD-877901-5MG |
| Cas.: 6681-13-6 | Purity: 98% | Hernandezine | ESD-877902-5MG |
| Cas.: 66791-71-7 | Purity: ≥97% | Impurity B of Calcitriol | ESD-877903-1MG |
| Cas.: 66791-71-7 | Purity: ≥97% | Impurity B of Calcitriol | ESD-877903-5MG |
| Cas.: 66777-70-6 | Purity: 97% | 6,8-Diprenylorobol | ESD-877904-5MG |
| Cas.: 66756-57-8 | Purity: 95% | Diosbulbin D | ESD-877905-5MG |
| Cas.: 6674-40-4 | Purity: 97% | 5-Hydroxy-7-acetoxyflavone | ESD-877907-5MG |
| Cas.: 6665-78-7 | Purity: 95% | 5,7-Diacetoxyflavone | ESD-877908-5MG |
| Cas.: 66648-50-8 | Purity: 95% | Ethyl caffeate | ESD-877909-1G |
| Cas.: 66648-45-1 | Purity: 98% | Np-Coumaroyloctopamine | ESD-877910-5MG |
| Cas.: 66648-44-0 | Purity: 97% | N-Feruloyloctopamine | ESD-877911-1MG |
| Cas.: 66648-43-9 | Purity: 97% | N-Ferroyltyramine | ESD-877912-5MG |
| Cas.: 66644-81-3 | Purity: ≥99% | Veralipride | ESD-877913-2MG |
| Cas.: 66644-81-3 | Purity: ≥99% | Veralipride | ESD-877913-5MG |
| Cas.: 666250-52-8 | Purity: 95% | 2′,4′-Dihydroxy-3,7′:4,8′-diepoxylign-7-ene | ESD-877914-5MG |
| Cas.: 666179-96-0 | Purity: 98% | Risperidone mesylate | ESD-877915-10MG |
| Cas.: 666179-96-0 | Purity: 98% | Risperidone mesylate | ESD-877915-50MG |
| Cas.: 666179-74-4 | Purity: 98% | Risperidone hydrochloride | ESD-877916-10MG |
| Cas.: 666179-74-4 | Purity: 98% | Risperidone hydrochloride | ESD-877916-50MG |
| Cas.: 66611-26-5 | Purity: ≥99% | RU 24969 | ESD-877917-5MG |
| Cas.: 66611-26-5 | Purity: ≥99% | RU 24969 | ESD-877917-10MG |
| Cas.: 666-08-0 | Purity: 95% | 2-Azaspiro[3.5]nonane | ESD-877918-250MG |
| Cas.: 66568-97-6 | Purity: 95% | Tsugafolin | ESD-877919-5MG |
| Cas.: 66556-91-0 | Purity: 97% | ent-3β-Hydroxykaur-16-en-19-oic acid | ESD-877920-5MG |
| Cas.: 66504-40-3 | Purity: ≥98% | DOV-216,303 Free Base | ESD-877921-5MG |
| Cas.: 665-04-3 | Purity: 95% | 2-Azaspiro[3.3]heptane | ESD-877922-1G |
| Cas.: 665-04-3 | Purity: 95% | 2-Azaspiro[3.3]heptane | ESD-877922-5G |
| Cas.: 66500-55-8 | Purity: 95% | 1,4-DIOXASPIRO[4.5]DECANE-8-CARBOXYLIC ACID | ESD-877923-1G |
| Cas.: 66500-55-8 | Purity: 95% | 1,4-DIOXASPIRO[4.5]DECANE-8-CARBOXYLIC ACID | ESD-877923-5G |
| Cas.: 66465-24-5 | Purity: 95% | Kaempferol 3-O-(6”-O-acetyl)glucoside-7-O-rhamnoside | ESD-877924-1MG |
| Cas.: 664338-39-0 | Purity: ≥99% | Arterolane | ESD-877925-5MG |
| Cas.: 664338-39-0 | Purity: ≥99% | Arterolane | ESD-877925-10MG |
| Cas.: 66322-34-7 | Purity: 98% | Dihydroguaiaretic acid | ESD-877926-5MG |
| Cas.: 66280-26-0 | Purity: 95% | Pregomisin | ESD-877927-5MG |
| Cas.: 66280-25-9 | Purity: 95% | Gomisin J | ESD-877928-5MG |
| Cas.: 6620-60-6 | Purity: ≥99% | Proglumide | ESD-877929-100MG |
| Cas.: 6619-95-0 | Purity: 98% | Deacetylxylopic acid | ESD-877930-5MG |
| Cas.: 66183-70-8 | Purity: 98% | Cipropride Senantiomer | ESD-877931-1MG |
| Cas.: 66183-70-8 | Purity: 98% | Cipropride Senantiomer | ESD-877931-5MG |
| Cas.: 66178-02-7 | Purity: 95% | Malic acid 4-Me ester | ESD-877932-1MG |
| Cas.: 66148-25-2 | Purity: 95% | Chromolaenide | ESD-877933-5MG |
| Cas.: 661464-94-4 | Purity: 98% | Levalbuterol tartrate | ESD-877934-10MG |
| Cas.: 661464-94-4 | Purity: 98% | Levalbuterol tartrate | ESD-877934-50MG |
| Cas.: 66107-60-6 | Purity: 95% | 14,17-Epidioxy-28-nor-15-taraxerene-2,3-diol | ESD-877935-1MG |
| Cas.: 6610-56-6 | Purity: 97% | Glochidiol | ESD-877936-5MG |
| Cas.: 6610-55-5 | Purity: 95% | Glochidone | ESD-877937-5MG |
| Cas.: 660868-91-7 | Purity: ≥99% | GW843682X | ESD-877938-5MG |
| Cas.: 660868-91-7 | Purity: ≥99% | GW843682X | ESD-877938-10MG |
| Cas.: 66069-55-4 | Purity: 98% | Tigloylgomisin H | ESD-877939-5MG |
| Cas.: 66067-26-3 | Purity: 97% | Licoisoflavanone | ESD-877940-5MG |
| Cas.: 66065-61-0 | Purity: 95% | methyl 1-thia-4-azaspiro[4.5]decane-3-carboxylate hydrochloride | ESD-877941-1G |
| Cas.: 66065-61-0 | Purity: 95% | methyl 1-thia-4-azaspiro[4.5]decane-3-carboxylate hydrochloride | ESD-877941-5G |
| Cas.: 66065-60-9 | Purity: 95% | 1-thia-4-azaspiro[4.5]decane-3-carboxylic acid hydrochloride | ESD-877942-500MG |
| Cas.: 66065-60-9 | Purity: 95% | 1-thia-4-azaspiro[4.5]decane-3-carboxylic acid hydrochloride | ESD-877942-1G |
| Cas.: 66056-30-2 | Purity: 98% | Licoisoflavone B | ESD-877943-5MG |
| Cas.: 66056-23-3 | Purity: 97% | Benzoylgomisin H | ESD-877944-5MG |
| Cas.: 66056-22-2 | Purity: 95% | Angeloylgomisin H | ESD-877945-5MG |
| Cas.: 66056-18-6 | Purity: 98% | Glycyrin | ESD-877946-5MG |
| Cas.: 6601-66-7 | Purity: 96% | 5,7,8,4′-Tetramethoxyflavone | ESD-877947-5MG |
| Cas.: 6601-62-3 | Purity: 98% | Cirsimaritin | ESD-877948-1MG |
| Cas.: 6601-62-3 | Purity: 98% | Cirsimaritin | ESD-877948-5MG |
| Cas.: 659747-28-1 | Purity: 98% | Isogarciniaxanthone E | ESD-877949-5MG |
| Cas.: 65907-75-7 | Purity: 98% | Danshenxinkun A | ESD-877950-5MG |
| Cas.: 65894-41-9 | Purity: 96% | Daturabietatriene | ESD-877951-5MG |
| Cas.: 65891-61-4 | Purity: 98% | Peucedanol 3′-O-glucoside | ESD-877952-5MG |
| Cas.: 6587-37-7 | Purity: 98% | 3-Epiglochidiol diacetate | ESD-877953-5MG |
| Cas.: 65853-04-5 | Purity: 98% | Peucedanol 7-O-glucoside | ESD-877954-5MG |
| Cas.: 65836-72-8 | Purity: ≥98% | DKM 2-93 | ESD-877955-50MG |
| Cas.: 65836-72-8 | Purity: ≥98% | DKM 2-93 | ESD-877955-100MG |
| Cas.: 65807-02-5 | Purity: 98% | Goserelin | ESD-877956-10MG |
| Cas.: 658066-35-4 | Purity: ≥98% | Fluopyram | ESD-877957-10MG |
| Cas.: 658066-35-4 | Purity: ≥98% | Fluopyram | ESD-877957-50MG |
| Cas.: 658062-23-8 | Purity: 95% | 10(14)-Cadinene-4,11-diol | ESD-877958-5MG |
| Cas.: 658062-22-7 | Purity: 95% | 3-Eudesmene-1β,11-diol | ESD-877959-5MG |
| Cas.: 65597-44-6 | Purity: 95% | Cerberic acid | ESD-877960-1MG |
| Cas.: 65597-42-4 | Purity: 99% | Cerbinal | ESD-877961-5MG |
| Cas.: 65582-54-9 | Purity: 97% | 1-Hydroxyacridone | ESD-877962-5MG |
| Cas.: 65513-72-6 | Purity: ≥98% | Glafenine hydrochloride | ESD-877963-100MG |
| Cas.: 654663-85-1 | Purity: 95% | Acantrifoic acid A | ESD-877964-5MG |
| Cas.: 6545-99-9 | Purity: 98% | Phebalosin | ESD-877965-5MG |
| Cas.: 65428-13-9 | Purity: 98% | 1-Methoxyphaseollidin | ESD-877966-5MG |
| Cas.: 65408-91-5 | Purity: 95% | Altholactone | ESD-877967-5MG |
| Cas.: 65388-03-6 | Purity: 98% | α-Isowighteone | ESD-877968-5MG |
| Cas.: 65373-29-7 | Purity: ≥99% | MS21570 | ESD-877969-10MG |
| Cas.: 65373-29-7 | Purity: ≥99% | MS21570 | ESD-877969-50MG |
| Cas.: 653592-04-2 | Purity: ≥98% | MT-DADMe-ImmA | ESD-877970-5MG |
| Cas.: 653592-04-2 | Purity: ≥98% | MT-DADMe-ImmA | ESD-877970-10MG |
| Cas.: 65358-15-8 | Purity: ≥99% | Pseudothymidine | ESD-877971-1MG |
| Cas.: 65358-15-8 | Purity: ≥99% | Pseudothymidine | ESD-877971-5MG |
| Cas.: 653573-60-5 | Purity: 98% | Sodium Channel inhibitor 2 | ESD-877972-1MG |
| Cas.: 653573-60-5 | Purity: 98% | Sodium Channel inhibitor 2 | ESD-877972-5MG |
| Cas.: 65332-45-8 | Purity: 98% | Demethylvestitol | ESD-877973-5MG |
| Cas.: 65307-12-2 | Purity: 98% | Cefetrizole | ESD-877974-1MG |
| Cas.: 65307-12-2 | Purity: 98% | Cefetrizole | ESD-877974-5MG |
| Cas.: 65247-27-0 | Purity: 95% | Arvenin I | ESD-877975-5MG |
| Cas.: 65236-62-6 | Purity: 98% | Dehydrocrenatidine | ESD-877976-5MG |
| Cas.: 6519-27-3 | Purity: 97% | (16R)-E-Isositsirikine | ESD-877977-5MG |
| Cas.: 6519-26-2 | Purity: 95% | (16R)-Dihydrositsirikine | ESD-877978-1MG |
| Cas.: 65184-10-3 | Purity: 98% | Teoprolol | ESD-877979-1MG |
| Cas.: 65184-10-3 | Purity: 98% | Teoprolol | ESD-877979-5MG |
| Cas.: 65092-21-9 | Purity: 95% | 1′-Acetyl-3,5,6,7-tetrahydrospiro[imidazo[4,5-c]-pyridine-4,4′-piperidine] | ESD-877980-500MG |
| Cas.: 65092-20-8 | Purity: 95% | 1′-benzyl-3,5,6,7-tetrahydrospiro[imidazo[4,5-c]pyridine-4,4′-piperidine] | ESD-877981-1G |
| Cas.: 65092-19-5 | Purity: 95% | 1′-methyl-3,5,6,7-tetrahydrospiro[imidazo[4,5-c]pyridine-4,4′-piperidine] | ESD-877982-1G |
| Cas.: 65092-19-5 | Purity: 95% | 1′-methyl-3,5,6,7-tetrahydrospiro[imidazo[4,5-c]pyridine-4,4′-piperidine] | ESD-877982-5G |
| Cas.: 65089-17-0 | Purity: 98% | Pirinixil | ESD-877983-1MG |
| Cas.: 65089-17-0 | Purity: 98% | Pirinixil | ESD-877983-5MG |
| Cas.: 6508-43-6 | Purity: ≥99% | L 152804 | ESD-877984-5MG |
| Cas.: 6508-43-6 | Purity: ≥99% | L 152804 | ESD-877984-10MG |
| Cas.: 65023-16-7 | Purity: 98% | Bometolol Hydrochloride | ESD-877985-1MG |
| Cas.: 65023-16-7 | Purity: 98% | Bometolol Hydrochloride | ESD-877985-5MG |
| Cas.: 65008-17-5 | Purity: 97% | 1,6-Dihydroxy-3,5,7-trimethoxyxanthone | ESD-877986-5MG |
| Cas.: 64998-19-2 | Purity: 95% | 7α-Hydroxystigmasterol | ESD-877987-5MG |
| Cas.: 64996-15-2 | Purity: 95% | (8-Benzyl-1,4-dioxa-8-aza-spiro[4.5]dec-6-yl)-methanol | ESD-877988-1G |
| Cas.: 64996-15-2 | Purity: 95% | (8-Benzyl-1,4-dioxa-8-aza-spiro[4.5]dec-6-yl)-methanol | ESD-877988-5G |
| Cas.: 649749-10-0 | Purity: ≥98% | ATN-224 | ESD-877989-2MG |
| Cas.: 649749-10-0 | Purity: ≥98% | ATN-224 | ESD-877989-5MG |
| Cas.: 64947-43-9 | Purity: 98% | Ditryptophenaline | ESD-877990-5MG |
| Cas.: 64929-59-5 | Purity: 97% | Sendanolactone | ESD-877991-5MG |
| Cas.: 64924-67-0 | Purity: ≥99% | Halofuginone hydrobromide | ESD-877992-5MG |
| Cas.: 64924-67-0 | Purity: ≥99% | Halofuginone hydrobromide | ESD-877992-10MG |
| Cas.: 64917-83-5 | Purity: 98% | Schisantherin E | ESD-877993-5MG |
| Cas.: 64917-83-5 | Purity: 98% | Schisantherin E | ESD-877993-10MG |
| Cas.: 64917-82-4 | Purity: 95% | Schisantherin D | ESD-877994-5MG |
| Cas.: 64890-70-6 | Purity: 95% | trans-Norpterosin C | ESD-877995-5MG |
| Cas.: 64-85-7 | Purity: ≥99% | Deoxycorticosterone | ESD-877996-5MG |
| Cas.: 64790-68-7 | Purity: 95% | Heraclenol acetonide | ESD-877997-1MG |
| Cas.: 647853-82-5 | Purity: 98% | Trilobatin 2”-acetate | ESD-877998-5MG |
| Cas.: 64756-87-2 | Purity: 97% | 6-Hydroxy-1,2,3,7-tetramethoxyxanthone | ESD-878000-5MG |
| Cas.: 64756-86-1 | Purity: 98% | 1,2,3,6,7-Pentamethoxyxanthone | ESD-878001-5MG |
| Cas.: 646995-35-9 | Purity: ≥99% | Cinaciguat hydrochloride | ESD-878002-2MG |
| Cas.: 646995-35-9 | Purity: ≥99% | Cinaciguat hydrochloride | ESD-878002-5MG |
| Cas.: 64681-36-3 | Purity: 98% | Tiglyl carnitine | ESD-878003-1MG |
| Cas.: 64681-36-3 | Purity: 98% | Tiglyl carnitine | ESD-878003-5MG |
| Cas.: 64657-21-2 | Purity: 93% | Coleonol B | ESD-878004-5MG |
| Cas.: 64652-10-4 | Purity: 98% | Demethylluvangetin | ESD-878005-5MG |
| Cas.: 646502-53-6 | Purity: ≥99% | VcMMAE | ESD-878006-1MG |
| Cas.: 646502-53-6 | Purity: ≥99% | VcMMAE | ESD-878006-5MG |
| Cas.: 64622-45-3 | Purity: ≥99% | Ibuprofen piconol | ESD-878007-50MG |
| Cas.: 64622-45-3 | Purity: ≥99% | Ibuprofen piconol | ESD-878007-100MG |
| Cas.: 645419-13-2 | Purity: 95% | 1-(6′-Aminospiro[cyclopropane-1,3′-indolin]-1′-yl)ethanone | ESD-878009-250MG |
| Cas.: 645419-13-2 | Purity: 95% | 1-(6′-Aminospiro[cyclopropane-1,3′-indolin]-1′-yl)ethanone | ESD-878009-1G |
| Cas.: 645414-25-1 | Purity: 95% | Acantrifoside E | ESD-878010-5MG |
| Cas.: 644981-35-1 | Purity: ≥99% | Val-Cit-PAB-MMAE | ESD-878011-1MG |
| Cas.: 644981-35-1 | Purity: ≥99% | Val-Cit-PAB-MMAE | ESD-878011-5MG |
| Cas.: 644967-44-2 | Purity: 98% | Rubianthraquinone | ESD-878012-5MG |
| Cas.: 64490-92-2 | Purity: ≥99% | Tolmetin sodium dihydrate | ESD-878013-100MG |
| Cas.: 64432-04-8 | Purity: 98% | Grifolin monomethyl ether | ESD-878014-5MG |
| Cas.: 64421-27-8 | Purity: 97% | Mussaenoside | ESD-878015-5MG |
| Cas.: 644-06-4 | Purity: 95% | Precocene II | ESD-878016-1G |
| Cas.: 643727-55-3 | Purity: 98% | H100 | ESD-878017-1MG |
| Cas.: 643727-55-3 | Purity: 98% | H100 | ESD-878017-5MG |
| Cas.: 64340-46-1 | Purity: 98% | 6”-O-Acetylsaikosaponin a | ESD-878018-5MG |
| Cas.: 64280-48-4 | Purity: 96% | Kielcorin | ESD-878019-5MG |
| Cas.: 6426-44-4 | Purity: 98% | Glutinol acetate | ESD-878020-5MG |
| Cas.: 6426-43-3 | Purity: Analysis control, 97% | Taraxasterol acetate | ESD-878021-5MG |
| Cas.: 64232-83-3 | Purity: ≥98% | L189 | ESD-878022-10MG |
| Cas.: 64232-83-3 | Purity: ≥98% | L189 | ESD-878022-50MG |
| Cas.: 642-18-2 | Purity: 95% | Alstonine | ESD-878024-5MG |
| Cas.: 642-17-1 | Purity: 96% | Akuammigine | ESD-878025-5MG |
| Cas.: 64215-95-8 | Purity: 97% | Thalirugidine | ESD-878026-5MG |
| Cas.: 64211-46-7 | Purity: ≥98% | Oxiconazole nitrate | ESD-878027-10MG |
| Cas.: 64211-46-7 | Purity: ≥98% | Oxiconazole nitrate | ESD-878027-50MG |
| Cas.: 64199-78-6 | Purity: 98% | Barbinervic acid | ESD-878028-5MG |
| Cas.: 64191-04-4 | Purity: 98% | Pseudocolumbamine | ESD-878029-5MG |
| Cas.: 64190-94-9 | Purity: 95% | Zanthobungeanine | ESD-878030-5MG |
| Cas.: 64185-57-5 | Purity: 95% | trans-2,3-Dihydro-3-hydroxyeuparin | ESD-878031-5MG |
| Cas.: 64181-07-3 | Purity: 95% | 30-Oxolupeol | ESD-878032-5MG |
| Cas.: 64179-41-5 | Purity: 95% | Spiro[benzo[d][1,3]dioxole-2,1′-cyclohexan]-5-amine | ESD-878033-1G |
| Cas.: 64179-40-4 | Purity: 95% | 5-nitrospiro[1,3-benzodioxole-2,1′-cyclohexane] | ESD-878034-1G |
| Cas.: 64165-99-7 | Purity: 99% | 5-Acetyl-2-(1-hydroxy-1-methylethyl)benzofuran | ESD-878035-5MG |
| Cas.: 64165-98-6 | Purity: 98% | Echinoynethiophene A | ESD-878036-5MG |
| Cas.: 641-38-3 | Purity: 98% | Alternariol | ESD-878037-5MG |
| Cas.: 64134-30-1 | Purity: ≥98% | Hexa-His | ESD-878038-5MG |
| Cas.: 64134-30-1 | Purity: ≥98% | Hexa-His | ESD-878038-10MG |
| Cas.: 64125-60-6 | Purity: 98% | Longistylin C | ESD-878039-5MG |
| Cas.: 64121-98-8 | Purity: 98% | Di-O-methylcrenatin | ESD-878040-5MG |
| Cas.: 64097-86-5 | Purity: 95% | 2-Ethyl-2,8-diazaspiro[4.5]decan-1-one hydrochloride | ESD-878041-1G |
| Cas.: 64092-48-4 | Purity: ≥99% | Zomepirac sodium salt | ESD-878042-100MG |
| Cas.: 64092-48-4 | Purity: ≥99% | Zomepirac sodium salt | ESD-878042-500MG |
| Cas.: 64078-09-7 | Purity: 98% | CGP11952 | ESD-878043-1MG |
| Cas.: 64078-09-7 | Purity: 98% | CGP11952 | ESD-878043-5MG |
| Cas.: 64052-90-0 | Purity: 98% | Cannabispirol | ESD-878044-5MG |
| Cas.: 64048-12-0 | Purity: ≥99% | GANT 58 | ESD-878045-5MG |
| Cas.: 64048-12-0 | Purity: ≥99% | GANT 58 | ESD-878045-10MG |
| Cas.: 64032-49-1 | Purity: 98% | Torachrysone 8-O-glucoside | ESD-878046-5MG |
| Cas.: 640290-67-1 | Purity: ≥99% | Neu2000 | ESD-878047-1MG |
| Cas.: 640290-67-1 | Purity: ≥99% | Neu2000 | ESD-878047-5MG |
| Cas.: 640289-58-3 | Purity: 95% | 4(15)-Oppositene-1,7-diol | ESD-878048-1MG |
| Cas.: 63976-69-2 | Purity: 95% | 13-Oxopodocarp-8(14)-en-18-oic acid | ESD-878049-5MG |
| Cas.: 63975-56-4 | Purity: 98% | Hopeyhopin | ESD-878050-5MG |
| Cas.: 63968-82-1 | Purity: 98% | Kassinin | ESD-878051-1MG |
| Cas.: 63968-82-1 | Purity: 98% | Kassinin | ESD-878051-5MG |
| Cas.: 639-36-1 | Purity: 95% | Akuammidine | ESD-878052-5MG |
| Cas.: 63910-76-9 | Purity: 95% | Panaxydiol | ESD-878053-5MG |
| Cas.: 639029-42-8 | Purity: 98% | PRX933 hydrochloride | ESD-878054-1MG |
| Cas.: 639029-42-8 | Purity: 98% | PRX933 hydrochloride | ESD-878054-5MG |
| Cas.: 638-97-1 | Purity: 98% | β-Amyrone | ESD-878055-5MG |
| Cas.: 6386-63-6 | Purity: ≥95% | Cloxyfonac | ESD-878056-10MG |
| Cas.: 6386-63-6 | Purity: ≥95% | Cloxyfonac | ESD-878056-50MG |
| Cas.: 63824-12-4 | Purity: 98% | Aliconazole | ESD-878057-1MG |
| Cas.: 63824-12-4 | Purity: 98% | Aliconazole | ESD-878057-5MG |
| Cas.: 638213-98-6 | Purity: ≥95% | AGL-2263 | ESD-878058-1MG |
| Cas.: 638213-98-6 | Purity: ≥95% | AGL-2263 | ESD-878058-5MG |
| Cas.: 638203-32-4 | Purity: 95% | Phyllostadimer A | ESD-878059-1MG |
| Cas.: 63807-90-9 | Purity: 99% | Dihydroalpinumisoflavone | ESD-878060-5MG |
| Cas.: 63807-85-2 | Purity: 99% | Erythrin C | ESD-878061-5MG |
| Cas.: 6379-72-2 | Purity: 93% | trans-Methylisoeugenol | ESD-878062-5MG |
| Cas.: 63768-17-2 | Purity: 97% | 12α-Hydroxygrandiflorenic acid | ESD-878063-5MG |
| Cas.: 63722-91-8 | Purity: 95% | Paspalinine | ESD-878064-5MG |
| Cas.: 63644-71-3 | Purity: 95% | γ-Methoxyisoeugenol | ESD-878065-5MG |
| Cas.: 63644-68-8 | Purity: 95% | 1,5-Bis(4-hydroxy-3-methoxyphenyl)penta-1,4-diene | ESD-878066-1MG |
| Cas.: 63638-91-5 | Purity: 98% | Brofaromine | ESD-878067-100MG |
| Cas.: 63596-61-2 | Purity: 97% | N-Acetyldelectine | ESD-878068-5MG |
| Cas.: 63590-64-7 | Purity: 98% | Terazosin | ESD-878069-100MG |
| Cas.: 63590-64-7 | Purity: 98% | Terazosin | ESD-878069-500MG |
| Cas.: 63565-07-1 | Purity: 98% | 8-Benzoyl-5,7-dihydroxy-2,2-dimethylchromane | ESD-878070-5MG |
| Cas.: 63555-63-5 | Purity: 98% | C3a 70-77 | ESD-878071-1MG |
| Cas.: 63555-63-5 | Purity: 98% | C3a 70-77 | ESD-878071-5MG |
| Cas.: 63543-52-2 | Purity: 98% | 24,25-Epoxydammar-20(21)-en-3-one | ESD-878072-5MG |
| Cas.: 635323-95-4 | Purity: ≥99% | F-15599 | ESD-878073-1MG |
| Cas.: 635323-95-4 | Purity: ≥99% | F-15599 | ESD-878073-5MG |
| Cas.: 63529-06-6 | Purity: 98% | 4,2′-Dihydroxy-4′-methoxychalcone | ESD-878074-5MG |
| Cas.: 634911-80-1 | Purity: 98% | BOC-D-FMK | ESD-878075-1MG |
| Cas.: 634911-80-1 | Purity: 98% | BOC-D-FMK | ESD-878075-5MG |
| Cas.: 63478-84-2 | Purity: 95% | 1-oxa-4-azaspiro[4.5]decane-3,3-diyldimethanol | ESD-878076-1G |
| Cas.: 63478-84-2 | Purity: 95% | 1-oxa-4-azaspiro[4.5]decane-3,3-diyldimethanol | ESD-878076-5G |
| Cas.: 634616-95-8 | Purity: ≥99% | TBPB | ESD-878077-5MG |
| Cas.: 634616-95-8 | Purity: ≥99% | TBPB | ESD-878077-10MG |
| Cas.: 63461-31-4 | Purity: 95% | Corollin | ESD-878078-5MG |
| Cas.: 63399-38-2 | Purity: 98% | Alepterolic acid | ESD-878079-5MG |
| Cas.: 63399-37-1 | Purity: 98% | 3-Acetoxy-8(17),13E-labdadien-15-oic acid | ESD-878080-5MG |
| Cas.: 63-39-8 | Purity: ≥98% | Uridine triphosphate | ESD-878081-10MG |
| Cas.: 63-39-8 | Purity: ≥98% | Uridine triphosphate | ESD-878081-50MG |
| Cas.: 63388-44-3 | Purity: ≥97% | SJB2-043 | ESD-878082-5MG |
| Cas.: 63388-44-3 | Purity: ≥97% | SJB2-043 | ESD-878082-10MG |
| Cas.: 63358-12-3 | Purity: 97% | (+)-Isolariciresinol 9′-O-glucoside | ESD-878083-5MG |
| Cas.: 63320-67-2 | Purity: 98% | Secoisolariciresinol monoglucoside | ESD-878084-5MG |
| Cas.: 63302-99-8 | Purity: ≥99% | Azaphen dihydrochloride monohydrate | ESD-878085-100MG |
| Cas.: 63302-99-8 | Purity: ≥99% | Azaphen dihydrochloride monohydrate | ESD-878085-500MG |
| Cas.: 632355-68-1 | Purity: 98% | NHE3-IN-1 | ESD-878086-1MG |
| Cas.: 632355-68-1 | Purity: 98% | NHE3-IN-1 | ESD-878086-5MG |
| Cas.: 63233-46-5 | Purity: 98% | KW-6055 | ESD-878087-1MG |
| Cas.: 63233-46-5 | Purity: 98% | KW-6055 | ESD-878087-5MG |
| Cas.: 63213-00-3 | Purity: 97% | Cannabispirenone A | ESD-878088-5MG |
| Cas.: 63208-95-7 | Purity: 95% | 1′-Benzyl-3H-spiro[1,3-benzothiazole-2,4′-piperidine] | ESD-878089-500MG |
| Cas.: 63208-95-7 | Purity: 95% | 1′-Benzyl-3H-spiro[1,3-benzothiazole-2,4′-piperidine] | ESD-878089-1G |
| Cas.: 63139-16-2 | Purity: 98% | Withanolide S | ESD-878090-5MG |
| Cas.: 63119-27-7 | Purity: 98% | Anitrazafen | ESD-878091-5MG |
| Cas.: 63119-27-7 | Purity: 98% | Anitrazafen | ESD-878091-10MG |
| Cas.: 6308-22-1 | Purity: ≥99% | AKOS B018304 | ESD-878092-5MG |
| Cas.: 6308-22-1 | Purity: ≥99% | AKOS B018304 | ESD-878092-10MG |
| Cas.: 63049-05-8 | Purity: 95% | SPIRO[3.3]HEPTAN-1-ONE | ESD-878093-250MG |
| Cas.: 63049-05-8 | Purity: 95% | SPIRO[3.3]HEPTAN-1-ONE | ESD-878093-1G |
| Cas.: 63042-18-2 | Purity: 98% | Estradiol-3-benzoate-17-butyrate | ESD-878094-5MG |
| Cas.: 63038-10-8 | Purity: 80% | Senkyunolide A | ESD-878095-5MG |
| Cas.: 63034-29-7 | Purity: 95% | Hexacosyl (E)-ferulate | ESD-878096-5MG |
| Cas.: 63026-02-8 | Purity: 98% | Crenulatin | ESD-878097-5MG |
| Cas.: 63015-10-1 | Purity: 98% | Androstenone hydrazone | ESD-878098-5MG |
| Cas.: 630124-46-8 | Purity: ≥98% | AST 487 | ESD-878099-5MG |
| Cas.: 630124-46-8 | Purity: ≥98% | AST 487 | ESD-878099-10MG |
| Cas.: 630119-43-6 | Purity: 98% | ABT-670 | ESD-878100-1MG |
| Cas.: 630119-43-6 | Purity: 98% | ABT-670 | ESD-878100-5MG |
| Cas.: 630117-19-0 | Purity: ≥98% | PD-168077 maleate | ESD-878101-5MG |
| Cas.: 630117-19-0 | Purity: ≥98% | PD-168077 maleate | ESD-878101-10MG |
| Cas.: 630057-39-5 | Purity: 98% | Neoprzewaquinone A | ESD-878102-5MG |
| Cas.: 62992-61-4 | Purity: 98% | Etersalate | ESD-878103-1MG |
| Cas.: 62992-61-4 | Purity: 98% | Etersalate | ESD-878103-5MG |
| Cas.: 62987-05-7 | Purity: 98% | Tegadifur | ESD-878104-1MG |
| Cas.: 62987-05-7 | Purity: 98% | Tegadifur | ESD-878104-5MG |
| Cas.: 62956-48-3 | Purity: ≥99% | Gomisin G | ESD-878105-5MG |
| Cas.: 62956-48-3 | Purity: ≥99% | Gomisin G | ESD-878105-10MG |
| Cas.: 62949-93-3 | Purity: 99% | Morusinol | ESD-878106-5MG |
| Cas.: 62949-77-3 | Purity: ≥96% | Kuwanon A | ESD-878107-2MG |
| Cas.: 62949-77-3 | Purity: ≥96% | Kuwanon A | ESD-878107-5MG |
| Cas.: 62874-52-6 | Purity: 95% | Hecubine | ESD-878108-5MG |
| Cas.: 62826-67-9 | Purity: 95% | 1-oxa-6$l^{6}-thiaspiro[2.5]octane-6,6-dione | ESD-878109-1G |
| Cas.: 62820-11-5 | Purity: 95% | Jolkinol A | ESD-878110-5MG |
| Cas.: 627908-92-3 | Purity: ≥95% | SU14813 | ESD-878111-2MG |
| Cas.: 627908-92-3 | Purity: ≥95% | SU14813 | ESD-878111-5MG |
| Cas.: 62756-43-8 | Purity: 97% | 7-hydroxy-3,4-dihydrospiro[1-benzopyran-2,1′-cyclohexane]-4-one | ESD-878112-1G |
| Cas.: 62756-43-8 | Purity: 97% | 7-hydroxy-3,4-dihydrospiro[1-benzopyran-2,1′-cyclohexane]-4-one | ESD-878112-5G |
| Cas.: 62756-24-5 | Purity: 95% | 1′-methyl-3,4-dihydrospiro[1-benzopyran-2,4′-piperidine]-4-one | ESD-878113-1G |
| Cas.: 62756-20-1 | Purity: 95% | 3,4-dihydrospiro[1-benzopyran-2,1′-cyclohexane]-4-one | ESD-878114-1G |
| Cas.: 62756-20-1 | Purity: 95% | 3,4-dihydrospiro[1-benzopyran-2,1′-cyclohexane]-4-one | ESD-878114-2.5G |
| Cas.: 62756-19-8 | Purity: 95% | 3,4-dihydrospiro[1-benzopyran-2,1′-cyclopentane]-4-one | ESD-878115-1G |
| Cas.: 62756-19-8 | Purity: 95% | 3,4-dihydrospiro[1-benzopyran-2,1′-cyclopentane]-4-one | ESD-878115-2.5G |
| Cas.: 627538-65-2 | Purity: 95% | Epitrametol | ESD-878116-1MG |
| Cas.: 627530-84-1 | Purity: ≥98% | BMS-564929 | ESD-878117-5MG |
| Cas.: 627530-84-1 | Purity: ≥98% | BMS-564929 | ESD-878117-10MG |
| Cas.: 6266-66-6 | Purity: ≥98% | PEO-IAA | ESD-878118-10MG |
| Cas.: 6266-66-6 | Purity: ≥98% | PEO-IAA | ESD-878118-50MG |
| Cas.: 62666-20-0 | Purity: 98% | Progabide | ESD-878119-5MG |
| Cas.: 62666-20-0 | Purity: 98% | Progabide | ESD-878119-10MG |
| Cas.: 62623-86-3 | Purity: 95% | 11S,12-Dihydroxyspirovetiv-1(10)-en-2-one | ESD-878120-5MG |
| Cas.: 62623-84-1 | Purity: 95% | (+)-Mellein | ESD-878121-5MG |
| Cas.: 62615-63-8 | Purity: 95% | 4,6,7-Trimethoxy-5-methylcoumarin | ESD-878122-1MG |
| Cas.: 62615-26-3 | Purity: 98% | 2′,4′-Dihydroxy-3′-methoxyacetophenone | ESD-878123-5MG |
| Cas.: 62596-34-3 | Purity: 98% | Cyclomorusin | ESD-878124-5MG |
| Cas.: 62574-30-5 | Purity: 97% | 11R,12-Dihydroxyspirovetiv-1(10)-en-2-one | ESD-878125-5MG |
| Cas.: 62560-95-6 | Purity: 95% | Isodihydrofutoquinol A | ESD-878126-5MG |
| Cas.: 625375-83-9 | Purity: ≥98% | Tariquidar methanesulfonate, hydrate | ESD-878127-10MG |
| Cas.: 625375-83-9 | Purity: ≥98% | Tariquidar methanesulfonate, hydrate | ESD-878127-50MG |
| Cas.: 6252-98-8 | Purity: 95% | 2′,3′-dihydro-2H,5H-spiro[imidazolidine-4,1′-indene]-2,5-dione | ESD-878128-5G |
| Cas.: 62517-34-4 | Purity: 97% | Ethyl p-hydroxyphenyllactate | ESD-878129-5MG |
| Cas.: 625115-52-8 | Purity: ≥99% | Nelociguat | ESD-878130-5MG |
| Cas.: 625115-52-8 | Purity: ≥99% | Nelociguat | ESD-878130-10MG |
| Cas.: 625096-18-6 | Purity: 97% | Viniferol D | ESD-878131-5MG |
| Cas.: 625095-61-6 | Purity: ≥99% | Pradefovir mesylate | ESD-878132-5MG |
| Cas.: 625095-61-6 | Purity: ≥99% | Pradefovir mesylate | ESD-878132-10MG |
| Cas.: 625-04-7 | Purity: 95% | Diacetonamine | ESD-878133-5MG |
| Cas.: 62499-71-2 | Purity: 93% | Isodihydrofutoquinol B | ESD-878134-5MG |
| Cas.: 624733-88-6 | Purity: ≥99% | MK-0812 | ESD-878135-2MG |
| Cas.: 624733-88-6 | Purity: ≥99% | MK-0812 | ESD-878135-5MG |
| Cas.: 62470-46-6 | Purity: 98% | p-Vinylphenol glucoside | ESD-878136-5MG |
| Cas.: 62394-04-1 | Purity: 97% | Cinnzeylanol | ESD-878137-5MG |
| Cas.: 62394-00-7 | Purity: 97% | Alboctalol | ESD-878138-5MG |
| Cas.: 62393-88-8 | Purity: 98% | Kadsuric acid | ESD-878139-5MG |
| Cas.: 62369-72-6 | Purity: 96% | Arjunglucoside II | ESD-878140-5MG |
| Cas.: 623-58-5 | Purity: ≥98% | Acetoacetic acid sodium salt | ESD-878141-5MG |
| Cas.: 623-58-5 | Purity: ≥98% | Acetoacetic acid sodium salt | ESD-878141-10MG |
| Cas.: 62356-47-2 | Purity: 97% | Isotschigin | ESD-878142-5MG |
| Cas.: 62346-14-9 | Purity: 98% | Luteolin 5,3′-dimethyl ether | ESD-878143-5MG |
| Cas.: 6233-83-6 | Purity: ≥99% | Oxytocin acetate | ESD-878144-5MG |
| Cas.: 6233-83-6 | Purity: ≥99% | Oxytocin acetate | ESD-878144-10MG |
| Cas.: 623142-96-1 | Purity: ≥99% | Ki20227 | ESD-878145-2MG |
| Cas.: 623142-96-1 | Purity: ≥99% | Ki20227 | ESD-878145-5MG |
| Cas.: 62312-55-4 | Purity: 98% | 5-Hydroxy-2-pyrrolidinone | ESD-878146-5MG |
| Cas.: 622370-35-8 | Purity: ≥99% | Tradipitant | ESD-878147-1MG |
| Cas.: 622370-35-8 | Purity: ≥99% | Tradipitant | ESD-878147-5MG |
| Cas.: 62218-55-7 | Purity: 96% | 4-Hydroxy-2,6,6-trimethyl-1-cyclohexenecarboxylic acid | ESD-878148-5MG |
| Cas.: 62218-23-9 | Purity: 97% | 3-O-Methylducheside A | ESD-878149-5MG |
| Cas.: 62218-13-7 | Purity: 97% | α-Viniferin | ESD-878150-5MG |
| Cas.: 62218-08-0 | Purity: 96% | ε-Viniferin | ESD-878151-5MG |
| Cas.: 62201-71-2 | Purity: 98% | 12-O-Methylcarnosic acid | ESD-878152-5MG |
| Cas.: 6216-82-6 | Purity: 97% | (-)-Episyringaresinol | ESD-878153-5MG |
| Cas.: 6216-81-5 | Purity: 98% | (-)-Syringaresinol | ESD-878154-5MG |
| Cas.: 62163-24-0 | Purity: 95% | Mirandin B | ESD-878155-5MG |
| Cas.: 62141-26-8 | Purity: 95% | ETHYL 1,4-DIOXASPIRO[4.5]DECANE-8-ACETATE | ESD-878156-1G |
| Cas.: 62141-26-8 | Purity: 95% | ETHYL 1,4-DIOXASPIRO[4.5]DECANE-8-ACETATE | ESD-878156-5G |
| Cas.: 62058-46-2 | Purity: 98% | Nudiposide | ESD-878157-5MG |
| Cas.: 62054-67-5 | Purity: ≥98% | THS-044 | ESD-878158-5MG |
| Cas.: 62054-67-5 | Purity: ≥98% | THS-044 | ESD-878158-10MG |
| Cas.: 62043-53-2 | Purity: 98% | Onitisin 2′-O-glucoside | ESD-878159-5MG |
| Cas.: 62030-88-0 | Purity: 98% | Duoperone | ESD-878160-1MG |
| Cas.: 62030-88-0 | Purity: 98% | Duoperone | ESD-878160-5MG |
| Cas.: 62023-90-9 | Purity: 98% | Juncusol | ESD-878161-5MG |
| Cas.: 620175-39-5 | Purity: ≥98% | AFN-1252 | ESD-878162-2MG |
| Cas.: 620175-39-5 | Purity: ≥98% | AFN-1252 | ESD-878162-5MG |
| Cas.: 62014-87-3 | Purity: 98% | Helichrysetin | ESD-878163-5MG |
| Cas.: 62014-81-7 | Purity: 95% | p-Menthane-1,2,8-triol | ESD-878164-1MG |
| Cas.: 620113-73-7 | Purity: ≥97% | CCG-63808 | ESD-878165-10MG |
| Cas.: 620113-73-7 | Purity: ≥97% | CCG-63808 | ESD-878165-50MG |
| Cas.: 620112-78-9 | Purity: ≥98% | CCG-63802 | ESD-878166-5MG |
| Cas.: 620112-78-9 | Purity: ≥98% | CCG-63802 | ESD-878166-10MG |
| Cas.: 61955-76-8 | Purity: 97% | 9-Hydroxythymol | ESD-878167-5MG |
| Cas.: 619326-75-9 | Purity: 98% | Deoxyisocalyciphylline B | ESD-878168-5MG |
| Cas.: 619326-74-8 | Purity: 98% | Deoxycalyciphylline B | ESD-878169-5MG |
| Cas.: 6190-79-0 | Purity: 97% | 1-Oxaspiro[2.5]octane-2-carboxylic acid | ESD-878170-1MG |
| Cas.: 618913-30-7 | Purity: ≥98% | AZD5904 | ESD-878171-5MG |
| Cas.: 618913-30-7 | Purity: ≥98% | AZD5904 | ESD-878171-10MG |
| Cas.: 61854-37-3 | Purity: 97% | Demethoxy-7-O-methylcapillarisin | ESD-878172-5MG |
| Cas.: 61854-36-2 | Purity: 97% | Demethoxycapillarisin | ESD-878173-5MG |
| Cas.: 61844-62-0 | Purity: 98% | Benzyl p-coumarate | ESD-878174-5MG |
| Cas.: 61837-65-8 | Purity: ≥99% | 4-Hydroxymephenytoin | ESD-878175-1MG |
| Cas.: 61837-65-8 | Purity: ≥99% | 4-Hydroxymephenytoin | ESD-878175-5MG |
| Cas.: 61775-19-7 | Purity: 98% | 5-O-Methylnaringenin | ESD-878176-5MG |
| Cas.: 617722-56-2 | Purity: 97% | Methyl 2-(6-acetyl-5-hydroxy-2,3-dihydrobenzofuran-2-yl)propenoate | ESD-878177-1MG |
| Cas.: 617722-55-1 | Purity: 95% | Methyl 2-(5-acetyl-2,3-dihydrobenzofuran-2-yl)propenoate | ESD-878178-1MG |
| Cas.: 61671-56-5 | Purity: 95% | Neridienone B | ESD-878179-5MG |
| Cas.: 61665-08-5 | Purity: 95% | 11-Methoxyuncarine C | ESD-878180-1MG |
| Cas.: 61658-41-1 | Purity: 98% | Furomollugin | ESD-878181-5MG |
| Cas.: 61617-29-6 | Purity: 98% | Songoroside A | ESD-878182-5MG |
| Cas.: 61597-83-9 | Purity: 97% | 13-Hydroxy-8,11,13-podocarpatrien-18-oic acid | ESD-878183-5MG |
| Cas.: 61597-55-5 | Purity: 97% | 15,16-Epoxy-12-hydroxylabda-8(17),13(16),14-triene | ESD-878184-5MG |
| Cas.: 61596-47-2 | Purity: ≥98% | Prolylleucine | ESD-878185-10MG |
| Cas.: 61596-47-2 | Purity: ≥98% | Prolylleucine | ESD-878185-25MG |
| Cas.: 6159-55-3 | Purity: 98% | Vasicine | ESD-878186-5MG |
| Cas.: 61582-39-6 | Purity: 97% | Acetylatractylodinol | ESD-878187-5MG |
| Cas.: 61570-82-9 | Purity: 96% | 3-Hydroxy-p-menth-1-en-6-one | ESD-878188-5MG |
| Cas.: 615253-61-7 | Purity: ≥99% | SP187 | ESD-878189-1MG |
| Cas.: 615253-61-7 | Purity: ≥99% | SP187 | ESD-878189-5MG |
| Cas.: 61521-74-2 | Purity: 97% | (+)-Nortrachelogenin | ESD-878190-5MG |
| Cas.: 6151-40-2 | Purity: ≥99% | Quinidine hydrochloride monohydrate | ESD-878191-100MG |
| Cas.: 61510-09-6 | Purity: ≥98% | Cholesteryl behenate | ESD-878192-5MG |
| Cas.: 61510-09-6 | Purity: ≥98% | Cholesteryl behenate | ESD-878192-10MG |
| Cas.: 614-82-4 | Purity: 96% | 2,4-Dihydroxyphenylacetic acid | ESD-878193-5MG |
| Cas.: 614749-78-9 | Purity: ≥99% | SM 16 | ESD-878194-5MG |
| Cas.: 614749-78-9 | Purity: ≥99% | SM 16 | ESD-878194-10MG |
| Cas.: 61448-03-1 | Purity: 95% | Lup-20(29)-ene-2α,3β-diol | ESD-878195-5MG |
| Cas.: 61432-71-1 | Purity: 98% | Bisabola-3,10-dien-2-one | ESD-878196-5MG |
| Cas.: 6138-88-1 | Purity: 95% | Naginata ketone | ESD-878197-5MG |
| Cas.: 613684-55-2 | Purity: 92% | erythro-Guaiacylglycerol-β-O-4′-dehydrodisinapyl ether | ESD-878198-5MG |
| Cas.: 613677-28-4 | Purity: ≥99% | Lasmiditan hydrochloride | ESD-878199-1MG |
| Cas.: 613677-28-4 | Purity: ≥99% | Lasmiditan hydrochloride | ESD-878199-5MG |
| Cas.: 613675-34-6 | Purity: 95% | 3-methyl-1-oxa-3,8-diazaspiro[4.5]decan-2-one hydrochloride | ESD-878200-1G |
| Cas.: 613675-34-6 | Purity: 95% | 3-methyl-1-oxa-3,8-diazaspiro[4.5]decan-2-one hydrochloride | ESD-878200-5G |
| Cas.: 61343-15-5 | Purity: 95% | 2-(4-Bromophenyl)-2-azaspiro[4.4]nonane-1,3-dione | ESD-878201-1G |
| Cas.: 6133-30-8 | Purity: ≥98% | Guanidinosuccinic acid | ESD-878202-10MG |
| Cas.: 6133-30-8 | Purity: ≥98% | Guanidinosuccinic acid | ESD-878202-50MG |
| Cas.: 613260-13-2 | Purity: 98% | AVE5688 | ESD-878203-1MG |
| Cas.: 613260-13-2 | Purity: 98% | AVE5688 | ESD-878203-5MG |
| Cas.: 613225-56-2 | Purity: ≥98% | F1063-0967 | ESD-878204-1MG |
| Cas.: 613225-56-2 | Purity: ≥98% | F1063-0967 | ESD-878204-5MG |
| Cas.: 61271-84-9 | Purity: 97% | 1-(4-CHLOROPHENYL)-1,3,8-TRIAZASPIRO[4.5]DECAN-4-ONE | ESD-878205-1G |
| Cas.: 61271-84-9 | Purity: 97% | 1-(4-CHLOROPHENYL)-1,3,8-TRIAZASPIRO[4.5]DECAN-4-ONE | ESD-878205-5G |
| Cas.: 61263-49-8 | Purity: 97% | Vitexilactone | ESD-878206-5MG |
| Cas.: 61262-81-5 | Purity: 96% | Cannabispiran | ESD-878207-5MG |
| Cas.: 612530-44-6 | Purity: ≥99% | PTP1B-IN-1 | ESD-878208-5MG |
| Cas.: 612530-44-6 | Purity: ≥99% | PTP1B-IN-1 | ESD-878208-10MG |
| Cas.: 61240-34-4 | Purity: 95% | Denudadione C | ESD-878209-5MG |
| Cas.: 61235-23-2 | Purity: 98% | 11-Hydroxybisabola-1,3,5-trien-9-one | ESD-878210-5MG |
| Cas.: 61220-69-7 | Purity: ≥99% | Tiopinac | ESD-878211-1MG |
| Cas.: 61218-44-8 | Purity: 95% | 6a-Hydroxymaackiain | ESD-878212-5MG |
| Cas.: 61217-80-9 | Purity: 97% | Uzarigenin digitaloside | ESD-878213-5MG |
| Cas.: 61186-24-1 | Purity: 95% | grandifloroside | ESD-878214-5MG |
| Cas.: 61152-62-3 | Purity: 96% | 4-(3,4-Dihydroxyphenyl)-2-butanone | ESD-878215-5MG |
| Cas.: 61135-92-0 | Purity: 95% | 6a-Hydroxymedicarpin | ESD-878216-5MG |
| Cas.: 61117-89-3 | Purity: 98% | Epipterosin L 2′-O-glucoside | ESD-878217-5MG |
| Cas.: 611168-24-2 | Purity: ≥99% | Glycerol phenylbutyrate | ESD-878218-10MG |
| Cas.: 611168-24-2 | Purity: ≥99% | Glycerol phenylbutyrate | ESD-878218-50MG |
| Cas.: 61093-23-0 | Purity: ≥98% | Cyclic-di-GMP | ESD-878219-1MG |
| Cas.: 610778-85-3 | Purity: 98% | Isobonducellin | ESD-878220-5MG |
| Cas.: 6104-71-8 | Purity: ≥99% | N-Desmethylclozapine | ESD-878221-5MG |
| Cas.: 6104-71-8 | Purity: ≥99% | N-Desmethylclozapine | ESD-878221-10MG |
| Cas.: 610318-54-2 | Purity: ≥99% | RGX-104 free Acid | ESD-878222-2MG |
| Cas.: 610318-54-2 | Purity: ≥99% | RGX-104 free Acid | ESD-878222-5MG |
| Cas.: 61012-31-5 | Purity: 98% | Ferulamide | ESD-878223-5MG |
| Cas.: 6090-95-5 | Purity: ≥98% | Conduritol B epoxide | ESD-878224-5MG |
| Cas.: 6090-95-5 | Purity: ≥98% | Conduritol B epoxide | ESD-878224-10MG |
| Cas.: 60820-94-2 | Purity: 98% | Phytolaccoside B | ESD-878225-5MG |
| Cas.: 60807-25-2 | Purity: 95% | 4-Methoxy-1-methoxycarbonyl-β-carboline | ESD-878226-5MG |
| Cas.: 60796-65-8 | Purity: 98% | 5,7,8-Trimethoxycoumarin | ESD-878227-5MG |
| Cas.: 607737-87-1 | Purity: ≥99% | A 77-01 | ESD-878228-5MG |
| Cas.: 607737-87-1 | Purity: ≥99% | A 77-01 | ESD-878228-10MG |
| Cas.: 607736-84-5 | Purity: 98% | SUN 1334H | ESD-878229-1MG |
| Cas.: 607736-84-5 | Purity: 98% | SUN 1334H | ESD-878229-5MG |
| Cas.: 60761-79-7 | Purity: 99% | ent-kaurane-17,19-dioic acid | ESD-878230-1MG |
| Cas.: 60761-00-4 | Purity: 95% | 2-Hydroxy-1,8-cineole | ESD-878231-1MG |
| Cas.: 606-91-7 | Purity: 98% | Homopterocarpin | ESD-878232-5MG |
| Cas.: 60657-41-2 | Purity: 98% | Lantanilic acid | ESD-878233-5MG |
| Cas.: 606-17-7 | Purity: ≥99% | Iodipamide | ESD-878234-5MG |
| Cas.: 606-17-7 | Purity: ≥99% | Iodipamide | ESD-878234-10MG |
| Cas.: 606125-07-9 | Purity: 95% | Momor-cerebroside I | ESD-878235-5MG |
| Cas.: 606101-58-0 | Purity: ≥99% | MK-0773 | ESD-878236-5MG |
| Cas.: 606101-58-0 | Purity: ≥99% | MK-0773 | ESD-878236-10MG |
| Cas.: 60547-63-9 | Purity: 97% | 1-Acetyltagitin A | ESD-878237-5MG |
| Cas.: 6054-10-0 | Purity: 98% | Braylin | ESD-878238-5MG |
| Cas.: 605-14-1 | Purity: 97% | Serpentinic acid | ESD-878239-5MG |
| Cas.: 604-99-9 | Purity: 98% | Tombozine | ESD-878240-5MG |
| Cas.: 60477-34-1 | Purity: 98% | Pifithrin-β | ESD-878241-5MG |
| Cas.: 60477-34-1 | Purity: 98% | Pifithrin-β | ESD-878241-10MG |
| Cas.: 6040-19-3 | Purity: 98% | Cucurbitacin A | ESD-878242-5MG |
| Cas.: 60374-42-7 | Purity: 98% | 6-Hydroxybentazon | ESD-878243-5MG |
| Cas.: 60374-42-7 | Purity: 98% | 6-Hydroxybentazon | ESD-878243-10MG |
| Cas.: 603-61-2 | Purity: 97% | Tamarixetin | ESD-878244-5MG |
| Cas.: 603-56-5 | Purity: 99% | Chrysosplenetin | ESD-878245-5MG |
| Cas.: 60337-67-9 | Purity: 96% | 9-O-Feruloyllaricriresinol | ESD-878246-5MG |
| Cas.: 603272-51-1 | Purity: ≥99% | GSK-3 inhibitor 1 | ESD-878247-2MG |
| Cas.: 603272-51-1 | Purity: ≥99% | GSK-3 inhibitor 1 | ESD-878247-5MG |
| Cas.: 60317-54-6 | Purity: 98% | Suberylglycine | ESD-878248-10MG |
| Cas.: 60297-37-2 | Purity: 97% | Auriculasin | ESD-878249-5MG |
| Cas.: 60285-94-1 | Purity: ≥99% | H-Arg-4MβNA | ESD-878250-10MG |
| Cas.: 60285-94-1 | Purity: ≥99% | H-Arg-4MβNA | ESD-878250-25MG |
| Cas.: 6027-91-4 | Purity: 98% | Guvacine hydrochloride | ESD-878251-5MG |
| Cas.: 6027-91-4 | Purity: 98% | Guvacine hydrochloride | ESD-878251-10MG |
| Cas.: 60263-07-2 | Purity: 98% | Jacaranone | ESD-878252-5MG |
| Cas.: 60263-06-1 | Purity: 95% | Ethyl (1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetate | ESD-878253-5MG |
| Cas.: 602326-48-7 | Purity: 95% | 8-oxa-5-azaspiro[3.5]nonane | ESD-878254-2.5MG |
| Cas.: 602326-48-7 | Purity: 95% | 8-oxa-5-azaspiro[3.5]nonane | ESD-878254-5MG |
| Cas.: 60211-19-0 | Purity: 95% | SPIRO[3.5]NONAN-1-OL | ESD-878255-1G |
| Cas.: 60211-19-0 | Purity: 95% | SPIRO[3.5]NONAN-1-OL | ESD-878255-5G |
| Cas.: 602-07-3 | Purity: 98% | Taspine | ESD-878256-5MG |
| Cas.: 60197-60-6 | Purity: 98% | Licoflavonol | ESD-878257-5MG |
| Cas.: 60188-95-6 | Purity: 95% | Methyl 15-hydroxy-7-oxodehydroabietate | ESD-878258-1MG |
| Cas.: 6018-40-2 | Purity: 98% | Corypalmine | ESD-878259-5MG |
| Cas.: 60149-07-7 | Purity: 95% | 11,12-Dihydro-7-hydroxyhedychenone | ESD-878260-5MG |
| Cas.: 6014-62-6 | Purity: 97% | Coulteropine | ESD-878261-5MG |
| Cas.: 60132-35-6 | Purity: 98% | Pterodondiol | ESD-878262-5MG |
| Cas.: 60129-65-9 | Purity: 97% | Paniculoside III | ESD-878263-5MG |
| Cas.: 60129-64-8 | Purity: 97% | Paniculoside II | ESD-878264-5MG |
| Cas.: 60125-23-7 | Purity: 95% | o-Hydroxycinnamaldehyde | ESD-878265-1G |
| Cas.: 60094-90-8 | Purity: 98% | Thamnosmonin | ESD-878266-5MG |
| Cas.: 60077-47-6 | Purity: 97% | Vogeloside | ESD-878267-5MG |
| Cas.: 600734-06-3 | Purity: ≥99% | Bay 65-1942 hydrochloride | ESD-878268-2MG |
| Cas.: 600734-06-3 | Purity: ≥99% | Bay 65-1942 hydrochloride | ESD-878268-5MG |
| Cas.: 600734-02-9 | Purity: 98% | Bay 65-1942 free base | ESD-878269-5MG |
| Cas.: 600734-02-9 | Purity: 98% | Bay 65-1942 free base | ESD-878269-10MG |
| Cas.: 60048-88-6 | Purity: 95% | N-Demethylechitamine | ESD-878270-1MG |
| Cas.: 60008-03-9 | Purity: 97% | Glabrene | ESD-878271-5MG |
| Cas.: 60008-01-7 | Purity: 95% | Oblongine | ESD-878272-5MG |
| Cas.: 59979-61-2 | Purity: 98% | Tagitin A | ESD-878273-5MG |
| Cas.: 59979-57-6 | Purity: 98% | Tagitinin F | ESD-878274-5MG |
| Cas.: 59943-31-6 | Purity: 98% | DU717 | ESD-878275-1MG |
| Cas.: 59943-31-6 | Purity: 98% | DU717 | ESD-878275-5MG |
| Cas.: 599179-03-0 | Purity: ≥99% | Vicriviroc maleate | ESD-878276-5MG |
| Cas.: 59914-91-9 | Purity: 98% | Vicenin-3 | ESD-878277-5MG |
| Cas.: 59901-98-3 | Purity: 95% | 3-Hydroxy-8,9-methylenedioxypterocarpene | ESD-878278-5MG |
| Cas.: 59885-89-1 | Purity: 95% | ent-7α,9-Dihydroxy-15-oxokaur-16-en-19,6β-olide | ESD-878279-5MG |
| Cas.: 59780-08-4 | Purity: 98% | 6β-Angeloyloxy-1β, 10β-epoxy-9-oxofuranoeremophilane | ESD-878280-5MG |
| Cas.: 59742-11-9 | Purity: 98% | 1β,10β-Epoxy-6β-isobutyryloxy-9-oxofuranoeremophilane | ESD-878281-5MG |
| Cas.: 59729-37-2 | Purity: ≥99% | Fexinidazole | ESD-878282-5MG |
| Cas.: 59729-37-2 | Purity: ≥99% | Fexinidazole | ESD-878282-10MG |
| Cas.: 59695-59-9 | Purity: 98% | Cephalexin hydrochloride | ESD-878283-500MG |
| Cas.: 59695-59-9 | Purity: 98% | Cephalexin hydrochloride | ESD-878283-1G |
| Cas.: 596814-48-1 | Purity: 98% | 6α-Hydroxyhispanone | ESD-878284-5MG |
| Cas.: 596799-30-3 | Purity: 98% | Calyciphylline A | ESD-878285-5MG |
| Cas.: 59662-49-6 | Purity: ≥99% | AC-55649 | ESD-878286-5MG |
| Cas.: 59662-49-6 | Purity: ≥99% | AC-55649 | ESD-878286-10MG |
| Cas.: 596-55-4 | Purity: 98% | α-Obscurine | ESD-878287-5MG |
| Cas.: 59643-91-3 | Purity: ≥98% | Imexon | ESD-878288-1MG |
| Cas.: 59643-91-3 | Purity: ≥98% | Imexon | ESD-878288-5MG |
| Cas.: 5955-45-3 | Purity: 97% | 3-(3-Methylphenyl)-1,4-diazaspiro[4.5]dec-3-ene-2-thione | ESD-878289-500MG |
| Cas.: 5955-45-3 | Purity: 97% | 3-(3-Methylphenyl)-1,4-diazaspiro[4.5]dec-3-ene-2-thione | ESD-878289-1G |
| Cas.: 5955-39-5 | Purity: 97% | 3-Phenyl-1,4-diazaspiro[4.4]non-3-ene-2-thione | ESD-878290-500MG |
| Cas.: 5955-39-5 | Purity: 97% | 3-Phenyl-1,4-diazaspiro[4.4]non-3-ene-2-thione | ESD-878290-1G |
| Cas.: 595-15-3 | Purity: 98% | Soyasapogenol B | ESD-878291-5MG |
| Cas.: 594839-88-0 | Purity: ≥99% | Tafamidis | ESD-878292-5MG |
| Cas.: 594839-88-0 | Purity: ≥99% | Tafamidis | ESD-878292-10MG |
| Cas.: 59461-30-2 | Purity: ≥98% | Hydroxocobalamin monohydrochloride | ESD-878293-10MG |
| Cas.: 59461-30-2 | Purity: ≥98% | Hydroxocobalamin monohydrochloride | ESD-878293-50MG |
| Cas.: 59443-02-6 | Purity: 98% | 1-Methyl-2-undecylquinolin-4(1H)-one | ESD-878294-5MG |
| Cas.: 59401-28-4 | Purity: 98% | α-Factor Mating Pheromone, yeast | ESD-878295-1MG |
| Cas.: 59401-28-4 | Purity: 98% | α-Factor Mating Pheromone, yeast | ESD-878295-5MG |
| Cas.: 5940-00-1 | Purity: 98% | Darutigenol | ESD-878296-5MG |
| Cas.: 59399-41-6 | Purity: 98% | Y-9738 | ESD-878297-1MG |
| Cas.: 59399-41-6 | Purity: 98% | Y-9738 | ESD-878297-5MG |
| Cas.: 593274-97-6 | Purity: ≥98% | Integrin Antagonists 27 | ESD-878298-2MG |
| Cas.: 593274-97-6 | Purity: ≥98% | Integrin Antagonists 27 | ESD-878298-5MG |
| Cas.: 5928-26-7 | Purity: 98% | Sissotrin | ESD-878299-5MG |
| Cas.: 592542-60-4 | Purity: ≥99% | Rigosertib sodium | ESD-878300-5MG |
| Cas.: 592542-60-4 | Purity: ≥99% | Rigosertib sodium | ESD-878300-10MG |
| Cas.: 592542-59-1 | Purity: ≥98% | Rigosertib | ESD-878301-5MG |
| Cas.: 592542-59-1 | Purity: ≥98% | Rigosertib | ESD-878301-10MG |
| Cas.: 59219-65-7 | Purity: 98% | Darutoside | ESD-878302-5MG |
| Cas.: 59219-64-6 | Purity: 96% | 8(14),15-Isopimaradiene-3β,18-diol | ESD-878303-5MG |
| Cas.: 59204-61-4 | Purity: 97% | β-Dihydroplumericinic acid | ESD-878304-5MG |
| Cas.: 591778-70-0 | Purity: ≥99% | CP-640186 hydrochloride | ESD-878305-2MG |
| Cas.: 591778-70-0 | Purity: ≥99% | CP-640186 hydrochloride | ESD-878305-5MG |
| Cas.: 591230-99-8 | Purity: 98% | Transcrocetinate disodium | ESD-878306-5MG |
| Cas.: 591230-99-8 | Purity: 98% | Transcrocetinate disodium | ESD-878306-10MG |
| Cas.: 59110-35-9 | Purity: 98% | Pamatolol | ESD-878307-1MG |
| Cas.: 59110-35-9 | Purity: 98% | Pamatolol | ESD-878307-5MG |
| Cas.: 59092-94-3 | Purity: 98% | (+)-Rhododendrol | ESD-878308-5MG |
| Cas.: 59086-93-0 | Purity: 98% | Dehydrotoxicarol | ESD-878309-5MG |
| Cas.: 5907-38-0 | Purity: ≥98% | Metamizole sodium hydrate | ESD-878310-500MG |
| Cas.: 590368-25-5 | Purity: ≥98% | Upamostat | ESD-878311-5MG |
| Cas.: 590368-25-5 | Purity: ≥98% | Upamostat | ESD-878311-10MG |
| Cas.: 59014-02-7 | Purity: 95% | 8-Hydroxyhyperforin 8,1-hemiacetal | ESD-878312-1MG |
| Cas.: 59009-93-7 | Purity: 98% | Carburazepam | ESD-878313-1MG |
| Cas.: 59009-93-7 | Purity: 98% | Carburazepam | ESD-878313-5MG |
| Cas.: 58996-10-4 | Purity: 95% | 1′,5′,6′,7′-tetrahydrospiro[cyclohexane-1,2′-cyclopenta[d]pyrimidin]-4′(3’H)-one | ESD-878314-1G |
| Cas.: 58996-10-4 | Purity: 95% | 1′,5′,6′,7′-tetrahydrospiro[cyclohexane-1,2′-cyclopenta[d]pyrimidin]-4′(3’H)-one | ESD-878314-2.5G |
| Cas.: 5890-28-8 | Purity: 96% | Cassythicine | ESD-878315-5MG |
| Cas.: 58872-39-2 | Purity: 98% | H-Val-Pro-Pro-OH | ESD-878316-5MG |
| Cas.: 58872-39-2 | Purity: 98% | H-Val-Pro-Pro-OH | ESD-878316-10MG |
| Cas.: 588706-67-6 | Purity: 95% | Ophiopogonanone F | ESD-878317-5MG |
| Cas.: 58865-88-6 | Purity: 95% | 9-Oxonerolidol | ESD-878319-1MG |
| Cas.: 58816-69-6 | Purity: ≥99% | SB297006 | ESD-878320-5MG |
| Cas.: 58816-69-6 | Purity: ≥99% | SB297006 | ESD-878320-10MG |
| Cas.: 587852-28-6 | Purity: ≥98% | SMI-16a | ESD-878321-5MG |
| Cas.: 587852-28-6 | Purity: ≥98% | SMI-16a | ESD-878321-10MG |
| Cas.: 58762-96-2 | Purity: 98% | pinostilbenoside | ESD-878322-5MG |
| Cas.: 5875-49-0 | Purity: 98% | Meranzin hydrate | ESD-878323-5MG |
| Cas.: 58738-31-1 | Purity: 97% | 16-Oxoprometaphanine | ESD-878324-5MG |
| Cas.: 58698-37-6 | Purity: 98% | 2-C-Methyl-D-erythritol | ESD-878325-5MG |
| Cas.: 586976-24-1 | Purity: 98% | CTPB | ESD-878326-5MG |
| Cas.: 586976-24-1 | Purity: 98% | CTPB | ESD-878326-10MG |
| Cas.: 586960-44-3 | Purity: 98% | Hemslecin D | ESD-878327-5MG |
| Cas.: 58581-89-8 | Purity: 98% | Azelastine | ESD-878328-100MG |
| Cas.: 58581-89-8 | Purity: 98% | Azelastine | ESD-878328-200MG |
| Cas.: 585534-03-8 | Purity: 98% | Confluentin | ESD-878329-5MG |
| Cas.: 585531-74-4 | Purity: 98% | BFCAs-1 | ESD-878330-2MG |
| Cas.: 585531-74-4 | Purity: 98% | BFCAs-1 | ESD-878330-5MG |
| Cas.: 58543-17-2 | Purity: 98% | Rebaudioside B | ESD-878331-5MG |
| Cas.: 58523-30-1 | Purity: 98% | Pseurotin A | ESD-878332-5MG |
| Cas.: 58493-71-3 | Purity: 95% | ent-16β,17-Isopropylidenedioxykaurane | ESD-878333-1MG |
| Cas.: 58473-74-8 | Purity: ≥99% | Cinromide | ESD-878334-100MG |
| Cas.: 58469-06-0 | Purity: 95% | N-(2-Hydroxy-4-methoxyphenyl)acetamide | ESD-878335-1G |
| Cas.: 58456-91-0 | Purity: 98% | MK-447 | ESD-878336-1MG |
| Cas.: 58456-91-0 | Purity: 98% | MK-447 | ESD-878336-5MG |
| Cas.: 58436-28-5 | Purity: 99% | Dihydroresveratrol | ESD-878337-5MG |
| Cas.: 5835-26-7 | Purity: 96% | Isopimaric acid | ESD-878338-5MG |
| Cas.: 58316-42-0 | Purity: 98% | Saikosaponin b3 | ESD-878339-5MG |
| Cas.: 582323-16-8 | Purity: ≥98% | ICA-069673 | ESD-878340-5MG |
| Cas.: 582323-16-8 | Purity: ≥98% | ICA-069673 | ESD-878340-10MG |
| Cas.: 582315-55-7 | Purity: 95% | Betulin palmitate | ESD-878341-1MG |
| Cas.: 581-49-7 | Purity: 97% | Anatabine | ESD-878342-5MG |
| Cas.: 58139-22-3 | Purity: 97% | Loroglossin | ESD-878343-5MG |
| Cas.: 581-31-7 | Purity: 99% | Suberosin | ESD-878344-5MG |
| Cas.: 58124-18-8 | Purity: 98% | 2-Hydroxynaringenin | ESD-878345-5MG |
| Cas.: 58115-31-4 | Purity: 98% | Aurantiamide | ESD-878346-5MG |
| Cas.: 58115-29-0 | Purity: 98% | Luteolin 5-methyl ether | ESD-878347-5MG |
| Cas.: 58113-30-7 | Purity: 98% | 1-(4-(3-Chloropropoxy)-3-methoxyphenyl)ethanone | ESD-878348-5MG |
| Cas.: 58108-99-9 | Purity: 95% | Undulatoside A | ESD-878349-5MG |
| Cas.: 581073-80-5 | Purity: ≥99% | KJ Pyr 9 | ESD-878350-5MG |
| Cas.: 581073-80-5 | Purity: ≥99% | KJ Pyr 9 | ESD-878350-10MG |
| Cas.: 58100-03-1 | Purity: 98% | Tyr-Somatostatin-14 | ESD-878351-1MG |
| Cas.: 58100-03-1 | Purity: 98% | Tyr-Somatostatin-14 | ESD-878351-5MG |
| Cas.: 580-72-3 | Purity: 98% | Matairesinol | ESD-878352-5MG |
| Cas.: 58050-55-8 | Purity: ≥99% | 24, 25-Dihydroxy VD2 | ESD-878353-1MG |
| Cas.: 58050-55-8 | Purity: ≥99% | 24, 25-Dihydroxy VD2 | ESD-878353-10MG |
| Cas.: 58020-43-2 | Purity: 98% | HOKU-81 | ESD-878355-5MG |
| Cas.: 58020-43-2 | Purity: 98% | HOKU-81 | ESD-878355-25MG |
| Cas.: 58012-16-1 | Purity: 97% | 1-(4-Fluorophenyl)-1,3,8-triazaspiro[4.5]decan-4-one | ESD-878356-1G |
| Cas.: 58012-16-1 | Purity: 97% | 1-(4-Fluorophenyl)-1,3,8-triazaspiro[4.5]decan-4-one | ESD-878356-5G |
| Cas.: 58000-48-9 | Purity: 97% | Epicorynoxidine | ESD-878357-5MG |
| Cas.: 57966-42-4 | Purity: 98% | Proctolin | ESD-878358-1MG |
| Cas.: 57966-42-4 | Purity: 98% | Proctolin | ESD-878358-5MG |
| Cas.: 579500-30-4 | Purity: 95% | 8-(4-PIPERIDINYL)-1,4-DIOXA-8-AZASPIRO[4.5]DECANE | ESD-878359-1G |
| Cas.: 579500-30-4 | Purity: 95% | 8-(4-PIPERIDINYL)-1,4-DIOXA-8-AZASPIRO[4.5]DECANE | ESD-878359-5G |
| Cas.: 579500-29-1 | Purity: 95% | 1-N-BOC-4-(1,4-DIOXA-8-AZASPIRO[4.5]DEC-8-YL)PIPERIDINE | ESD-878360-1G |
| Cas.: 579500-29-1 | Purity: 95% | 1-N-BOC-4-(1,4-DIOXA-8-AZASPIRO[4.5]DEC-8-YL)PIPERIDINE | ESD-878360-5G |
| Cas.: 57906-85-1 | Purity: 98% | Corynoxidine | ESD-878361-5MG |
| Cas.: 57906-31-7 | Purity: 95% | 19-Nor-4-hydroxyabieta-8,11,13-trien-7-one | ESD-878362-1MG |
| Cas.: 578710-52-8 | Purity: 98% | Myrianthic acid 3,23-acetonide | ESD-878363-5MG |
| Cas.: 5784-74-7 | Purity: ≥95% | Salsolidine | ESD-878364-25MG |
| Cas.: 5784-74-7 | Purity: ≥95% | Salsolidine | ESD-878364-50MG |
| Cas.: 57808-63-6 | Purity: 98% | Cicloxilic acid | ESD-878365-1MG |
| Cas.: 57808-63-6 | Purity: 98% | Cicloxilic acid | ESD-878365-5MG |
| Cas.: 5778-25-6 | Purity: 95% | 1′,5′,6′,7′-tetrahydrospiro[cyclopentane-1,4′-cyclopenta[d]pyrimidine]-2′-thiol | ESD-878366-1G |
| Cas.: 57719-81-0 | Purity: 97% | ent-11α-Hydroxy-15-oxokaur-16-en-19-oic acid | ESD-878367-5MG |
| Cas.: 57701-86-7 | Purity: 97% | Kansuinine A | ESD-878368-5MG |
| Cas.: 57672-79-4 | Purity: 98% | Baccatin VI | ESD-878369-5MG |
| Cas.: 57672-78-3 | Purity: 95% | 1-Dehydroxybaccatin IV | ESD-878370-5MG |
| Cas.: 57645-91-7 | Purity: ≥99% | Clebopride malate | ESD-878372-5MG |
| Cas.: 57645-91-7 | Purity: ≥99% | Clebopride malate | ESD-878372-10MG |
| Cas.: 57625-31-7 | Purity: 95% | Piperenone | ESD-878373-5MG |
| Cas.: 576-19-2 | Purity: ≥98% | Biocyte | ESD-878374-10MG |
| Cas.: 576-19-2 | Purity: ≥98% | Biocyte | ESD-878374-25MG |
| Cas.: 57586-98-8 | Purity: 95% | Cycloartane-3,24,25-triol | ESD-878375-5MG |
| Cas.: 57576-41-7 | Purity: 97% | Norcepharadione B | ESD-878376-5MG |
| Cas.: 57576-34-8 | Purity: 98% | (2,4-Dihydroxyphenyl)acetonitrile | ESD-878377-5MG |
| Cas.: 57576-31-5 | Purity: 95% | Cycloartane-3,24,25-triol 24,25-acetonide | ESD-878378-1MG |
| Cas.: 57576-29-1 | Purity: 98% | Cycloartane-3β,24,25-triol | ESD-878379-5MG |
| Cas.: 57566-47-9 | Purity: 95% | isofuranodiene | ESD-878380-5MG |
| Cas.: 57498-96-1 | Purity: 95% | Carpachromene | ESD-878381-1MG |
| Cas.: 57498-69-8 | Purity: 95% | Angeflorin | ESD-878382-5MG |
| Cas.: 57475-62-4 | Purity: 95% | 16-Deoxysaikogenin F | ESD-878383-5MG |
| Cas.: 57457-99-5 | Purity: 95% | 2-Epi-3a-epiburchellin | ESD-878384-5MG |
| Cas.: 57457-97-3 | Purity: 93% | p-Menth-8-ene-1,2-diol | ESD-878385-5MG |
| Cas.: 57430-03-2 | Purity: 95% | 1,6-Dihydro-4,7′-epoxy-1-methoxy- 3′,4′-methylenedioxy-6-oxo-3,8′-lignan | ESD-878386-5MG |
| Cas.: 57361-74-7 | Purity: 95% | Dihydroepistephamiersine 6-acetate | ESD-878387-1MG |
| Cas.: 573-44-4 | Purity: 98% | Liriodendrin | ESD-878388-5MG |
| Cas.: 57333-96-7 | Purity: ≥98% | Tacalcitol | ESD-878389-1MG |
| Cas.: 57333-96-7 | Purity: ≥98% | Tacalcitol | ESD-878389-5MG |
| Cas.: 57296-22-7 | Purity: 97% | Boehmenan | ESD-878390-5MG |
| Cas.: 57289-77-7 | Purity: 95% | 9-oxa-2-azaspiro[5.5]undecane | ESD-878391-1G |
| Cas.: 57289-77-7 | Purity: 95% | 9-oxa-2-azaspiro[5.5]undecane | ESD-878391-5G |
| Cas.: 57265-65-3 | Purity: ≥99% | Calmidazolium chloride | ESD-878392-5MG |
| Cas.: 57262-94-9 | Purity: ≥96% | Setiptiline | ESD-878393-2MG |
| Cas.: 57262-94-9 | Purity: ≥96% | Setiptiline | ESD-878393-5MG |
| Cas.: 572-32-7 | Purity: 98% | Ayanin | ESD-878394-5MG |
| Cas.: 571-20-0 | Purity: 98% | 5α-Androstane-3β,17β-diol | ESD-878395-5MG |
| Cas.: 571186-50-0 | Purity: 98% | NCX1022 | ESD-878396-1MG |
| Cas.: 571186-50-0 | Purity: 98% | NCX1022 | ESD-878396-5MG |
| Cas.: 57096-02-3 | Purity: 98% | 4′-Hydroxywogonin | ESD-878397-5MG |
| Cas.: 57079-92-2 | Purity: 98% | Isosativenediol | ESD-878398-5MG |
| Cas.: 570-72-9 | Purity: 95% | Stigmasta-5,8-dien-3-ol | ESD-878399-5MG |
| Cas.: 57046-73-8 | Purity: ≥97% | Paprotrain | ESD-878400-5MG |
| Cas.: 57046-73-8 | Purity: ≥97% | Paprotrain | ESD-878400-10MG |
| Cas.: 570406-98-3 | Purity: ≥97% | Avatrombopag | ESD-878401-10MG |
| Cas.: 56995-20-1 | Purity: 98% | Flupirtine | ESD-878402-10MG |
| Cas.: 56995-20-1 | Purity: 98% | Flupirtine | ESD-878402-50MG |
| Cas.: 569-92-6 | Purity: 97% | Rhamnocitrin | ESD-878403-5MG |
| Cas.: 569-80-2 | Purity: 98% | Penduletin | ESD-878404-5MG |
| Cas.: 56973-66-1 | Purity: 97% | Secoisolariciresinol diferulate | ESD-878405-5MG |
| Cas.: 56973-65-0 | Purity: 92% | Platyphyllenone | ESD-878406-5MG |
| Cas.: 56973-51-4 | Purity: 98% | Alnusdiol | ESD-878407-5MG |
| Cas.: 56-94-0 | Purity: 98% | Demecarium Bromide | ESD-878408-5MG |
| Cas.: 56-94-0 | Purity: 98% | Demecarium Bromide | ESD-878408-10MG |
| Cas.: 5689-38-3 | Purity: 95% | 8-Demethyleucalyptin | ESD-878409-1MG |
| Cas.: 568574-78-7 | Purity: 95% | 2-Chloro-N-(2,4-dioxo-1,3-diaza-spiro[4.5]dec-3-yl)-acetamide | ESD-878410-1MG |
| Cas.: 568544-03-6 | Purity: ≥98% | GSTO1-IN-1 | ESD-878411-10MG |
| Cas.: 568544-03-6 | Purity: ≥98% | GSTO1-IN-1 | ESD-878411-50MG |
| Cas.: 56795-51-8 | Purity: 95% | Scopoletin acetate | ESD-878412-250MG |
| Cas.: 56776-32-0 | Purity: ≥99% | Etifoxine hydrochloride | ESD-878413-5MG |
| Cas.: 56776-32-0 | Purity: ≥99% | Etifoxine hydrochloride | ESD-878413-10MG |
| Cas.: 56755-22-7 | Purity: 98% | Phenylalanine betaine | ESD-878414-5MG |
| Cas.: 56743-52-3 | Purity: 97% | 1-Methoxyallocryptopine | ESD-878415-5MG |
| Cas.: 56701-24-7 | Purity: 95% | (±)-Vestitol | ESD-878416-5MG |
| Cas.: 566939-85-3 | Purity: ≥99% | Orteronel | ESD-878417-5MG |
| Cas.: 566939-85-3 | Purity: ≥99% | Orteronel | ESD-878417-10MG |
| Cas.: 56684-87-8 | Purity: 98% | Batatasin III | ESD-878418-5MG |
| Cas.: 56632-39-4 | Purity: ≥98% | BHPI | ESD-878419-2MG |
| Cas.: 56632-39-4 | Purity: ≥98% | BHPI | ESD-878419-5MG |
| Cas.: 566203-88-1 | Purity: ≥99% | AZD2098 | ESD-878420-1MG |
| Cas.: 566203-88-1 | Purity: ≥99% | AZD2098 | ESD-878420-5MG |
| Cas.: 56605-16-4 | Purity: 98% | NCI172112 | ESD-878421-1MG |
| Cas.: 56605-16-4 | Purity: 98% | NCI172112 | ESD-878421-5MG |
| Cas.: 565460-15-3 | Purity: ≥99% | URB602 | ESD-878422-10MG |
| Cas.: 565460-15-3 | Purity: ≥99% | URB602 | ESD-878422-25MG |
| Cas.: 56496-16-3 | Purity: 95% | 6-Azonia-spiro[5.5]undecane chloride | ESD-878423-250MG |
| Cas.: 56496-16-3 | Purity: 95% | 6-Azonia-spiro[5.5]undecane chloride | ESD-878423-1G |
| Cas.: 56488-59-6 | Purity: 98% | Terbufibrol | ESD-878424-1MG |
| Cas.: 56488-59-6 | Purity: 98% | Terbufibrol | ESD-878424-5MG |
| Cas.: 56486-94-3 | Purity: 95% | Steppogenin | ESD-878425-5MG |
| Cas.: 564-73-8 | Purity: 95% | Hinokiol | ESD-878426-1MG |
| Cas.: 56473-67-7 | Purity: 98% | 4,9-Dihydroxy-α-lapachone | ESD-878427-5MG |
| Cas.: 56421-13-7 | Purity: 98% | Eichlerianic acid | ESD-878428-5MG |
| Cas.: 56421-12-6 | Purity: 95% | Methyl eichlerianate | ESD-878429-1MG |
| Cas.: 56420-45-2 | Purity: 98% | Epirubicin | ESD-878430-5MG |
| Cas.: 56420-45-2 | Purity: 98% | Epirubicin | ESD-878430-10MG |
| Cas.: 564-14-7 | Purity: 98% | Hop-17(21)-en-3β-ol | ESD-878431-5MG |
| Cas.: 56407-87-5 | Purity: 90% | Tetrahydrolachnophyllum lactone | ESD-878432-5MG |
| Cas.: 56391-55-0 | Purity: 98% | Octazamide | ESD-878433-1MG |
| Cas.: 56391-55-0 | Purity: 98% | Octazamide | ESD-878433-5MG |
| Cas.: 56377-67-4 | Purity: 95% | Tirotundin | ESD-878434-5MG |
| Cas.: 5636-92-0 | Purity: 98% | Picloxydine | ESD-878435-1MG |
| Cas.: 5636-92-0 | Purity: 98% | Picloxydine | ESD-878435-5MG |
| Cas.: 5633-14-7 | Purity: ≥99% | Benzetamide hydrochloride | ESD-878436-10MG |
| Cas.: 5633-14-7 | Purity: ≥99% | Benzetamide hydrochloride | ESD-878436-50MG |
| Cas.: 56327-24-3 | Purity: 99% | 8-Phenyl-1,4-dioxaspiro[4.5]decane-8-carbaldehyde | ESD-878437-500MG |
| Cas.: 56327-24-3 | Purity: 99% | 8-Phenyl-1,4-dioxaspiro[4.5]decane-8-carbaldehyde | ESD-878437-1G |
| Cas.: 56324-54-0 | Purity: 98% | Hedychenone | ESD-878438-5MG |
| Cas.: 56319-04-1 | Purity: 95% | Conocarpan acetate | ESD-878439-1MG |
| Cas.: 56317-21-6 | Purity: 97% | Moracin M | ESD-878440-5MG |
| Cas.: 56317-15-8 | Purity: 95% | 5,6,7,8-Tetramethoxycoumarin | ESD-878441-1MG |
| Cas.: 56296-18-5 | Purity: ≥98% | DREADD agonist 21 | ESD-878442-2MG |
| Cas.: 56296-18-5 | Purity: ≥98% | DREADD agonist 21 | ESD-878442-5MG |
| Cas.: 56252-32-5 | Purity: 97% | Anigorufone | ESD-878443-5MG |
| Cas.: 56252-05-2 | Purity: 95% | 2-O-Methylanigorufone | ESD-878444-5MG |
| Cas.: 56252-02-9 | Purity: 96% | Hydroxyanigorufone | ESD-878445-5MG |
| Cas.: 5623-90-5 | Purity: 95% | 2-oxaspiro[4.4]nonane-1,3-dione | ESD-878446-1G |
| Cas.: 5623-90-5 | Purity: 95% | 2-oxaspiro[4.4]nonane-1,3-dione | ESD-878446-5G |
| Cas.: 56222-03-8 | Purity: 98% | Porn | ESD-878447-5MG |
| Cas.: 56218-46-3 | Purity: 96% | Methyl lycernuate A | ESD-878448-5MG |
| Cas.: 561314-57-6 | Purity: 95% | 2,8-Diazaspiro[4.5]decan-3-one | ESD-878449-100MG |
| Cas.: 561314-57-6 | Purity: 95% | 2,8-Diazaspiro[4.5]decan-3-one | ESD-878449-500MG |
| Cas.: 561314-52-1 | Purity: 95% | 1,3,8-Triazaspiro[4.5]decan-2-one | ESD-878450-1G |
| Cas.: 561314-52-1 | Purity: 95% | 1,3,8-Triazaspiro[4.5]decan-2-one | ESD-878450-5G |
| Cas.: 56124-62-0 | Purity: ≥99% | Valrubicin | ESD-878451-10MG |
| Cas.: 56124-62-0 | Purity: ≥99% | Valrubicin | ESD-878451-50MG |
| Cas.: 56121-44-9 | Purity: 95% | 4-O-Methylhelichrysetin | ESD-878452-5MG |
| Cas.: 56121-42-7 | Purity: Analysis control, 98% | Asperglaucide | ESD-878453-5MG |
| Cas.: 5611-51-8 | Purity: ≥98% | Triamcinolone hexacetonide | ESD-878454-5MG |
| Cas.: 56100-42-6 | Purity: ≥98% | l-Atabrine dihydrochloride | ESD-878455-10MG |
| Cas.: 56100-41-5 | Purity: ≥98% | d-Atabrine dihydrochloride | ESD-878456-10MG |
| Cas.: 5608-98-0 | Purity: 95% | 1-oxa-4-thia-8-azaspiro[4.5]decane | ESD-878457-1G |
| Cas.: 5608-98-0 | Purity: 95% | 1-oxa-4-thia-8-azaspiro[4.5]decane | ESD-878457-2.5G |
| Cas.: 56083-03-5 | Purity: 96% | Isobavachromene | ESD-878458-5MG |
| Cas.: 56079-81-3 | Purity: ≥98% | Ropitoin | ESD-878459-1MG |
| Cas.: 56079-81-3 | Purity: ≥98% | Ropitoin | ESD-878459-5MG |
| Cas.: 560-62-3 | Purity: 98% | 9-Hydroxy-4-androstene-3,17-dione | ESD-878460-5MG |
| Cas.: 560083-42-3 | Purity: ≥98% | AC260584 | ESD-878461-1MG |
| Cas.: 560083-42-3 | Purity: ≥98% | AC260584 | ESD-878461-5MG |
| Cas.: 559-74-0 | Purity: 99% | Friedelin | ESD-878462-5MG |
| Cas.: 559-68-2 | Purity: 98% | Morolic acid | ESD-878463-5MG |
| Cas.: 55944-38-2 | Purity: 95% | 8-Benzyl-1-thia-4,8-diazaspiro[4.5]decane-3-carboxylic acid | ESD-878464-500MG |
| Cas.: 5588-20-5 | Purity: 98% | Chlordantoin | ESD-878465-1MG |
| Cas.: 5588-20-5 | Purity: 98% | Chlordantoin | ESD-878465-5MG |
| Cas.: 558640-51-0 | Purity: ≥99% | VER-49009 | ESD-878466-2MG |
| Cas.: 558640-51-0 | Purity: ≥99% | VER-49009 | ESD-878466-5MG |
| Cas.: 55812-91-4 | Purity: 98% | 3′-O-Methyltaxifolin | ESD-878467-5MG |
| Cas.: 5579-89-5 | Purity: 98% | Nifursemizone | ESD-878468-1MG |
| Cas.: 5579-89-5 | Purity: 98% | Nifursemizone | ESD-878468-5MG |
| Cas.: 5579-43-1 | Purity: 97% | 5′,6′,7′,8′-tetrahydro-3’H-spiro[cyclohexane-1,4′-quinazoline]-2′-thiol | ESD-878469-1G |
| Cas.: 5579-43-1 | Purity: 97% | 5′,6′,7′,8′-tetrahydro-3’H-spiro[cyclohexane-1,4′-quinazoline]-2′-thiol | ESD-878469-5G |
| Cas.: 55732-36-0 | Purity: 95% | 3-Deoxo-1β-methoxyjioglutolide | ESD-878470-1MG |
| Cas.: 55727-10-1 | Purity: ≥99% | MESG | ESD-878471-5MG |
| Cas.: 55721-31-8 | Purity: ≥98% | Salinomycin sodium salt | ESD-878472-25MG |
| Cas.: 55721-31-8 | Purity: ≥98% | Salinomycin sodium salt | ESD-878472-50MG |
| Cas.: 55721-11-4 | Purity: ≥98% | Secalciferol | ESD-878473-1MG |
| Cas.: 55696-55-4 | Purity: 98% | 2″-O-Glucosylrutin | ESD-878474-5MG |
| Cas.: 556797-16-1 | Purity: ≥97% | Macitentan (n-butyl analogue) | ESD-878475-2MG |
| Cas.: 556797-16-1 | Purity: ≥97% | Macitentan (n-butyl analogue) | ESD-878475-5MG |
| Cas.: 55610-01-0 | Purity: 98% | Cepharadione A | ESD-878476-5MG |
| Cas.: 55604-88-1 | Purity: 95% | 3a-Hydroxy-3,3a,7,7a-tetrahydrobenzofuran-2,6-dione | ESD-878477-5MG |
| Cas.: 55511-08-5 | Purity: 97% | Biondin C | ESD-878478-5MG |
| Cas.: 55497-79-5 | Purity: 96% | Myriceric acid B | ESD-878479-5MG |
| Cas.: 55486-06-1 | Purity: 95% | Nepetoidin B | ESD-878480-5MG |
| Cas.: 55482-89-8 | Purity: ≥99% | Guacetisal | ESD-878481-5MG |
| Cas.: 55482-89-8 | Purity: ≥99% | Guacetisal | ESD-878481-10MG |
| Cas.: 55481-86-2 | Purity: 97% | Isosaxalin | ESD-878482-5MG |
| Cas.: 55476-47-6 | Purity: ≥98% | PSB-12062 | ESD-878483-5MG |
| Cas.: 55476-47-6 | Purity: ≥98% | PSB-12062 | ESD-878483-10MG |
| Cas.: 554449-27-3 | Purity: 95% | 8β-(4-Hydroxytigloyloxy)ovatifolin | ESD-878484-5MG |
| Cas.: 55395-07-8 | Purity: ≥99% | IKarisoside A | ESD-878485-5MG |
| Cas.: 55381-18-5 | Purity: 98% | OM-189 | ESD-878486-1MG |
| Cas.: 55381-18-5 | Purity: 98% | OM-189 | ESD-878486-5MG |
| Cas.: 553-19-5 | Purity: 98% | Xanthyletin | ESD-878487-5MG |
| Cas.: 553-08-2 | Purity: ≥98% | Thonzonium bromide | ESD-878488-10MG |
| Cas.: 553-08-2 | Purity: ≥98% | Thonzonium bromide | ESD-878488-50MG |
| Cas.: 55306-03-1 | Purity: 98% | Sericic acid | ESD-878489-5MG |
| Cas.: 55303-93-0 | Purity: 97% | Oregonin | ESD-878490-5MG |
| Cas.: 552-59-0 | Purity: 99% | Prunetin | ESD-878491-5MG |
| Cas.: 552-57-8 | Purity: 99% | Isorhoifolin | ESD-878492-5MG |
| Cas.: 552-54-5 | Purity: 98% | Rhamnazin | ESD-878493-5MG |
| Cas.: 55149-05-8 | Purity: 98% | Pirolate | ESD-878494-1MG |
| Cas.: 55149-05-8 | Purity: 98% | Pirolate | ESD-878494-5MG |
| Cas.: 55136-76-0 | Purity: 98% | Kaempferol 3-O-sophoroside-7-O-glucoside | ESD-878495-5MG |
| Cas.: 55102-39-1 | Purity: 98% | 4β-Carboxy-19-nortotarol | ESD-878496-5MG |
| Cas.: 550999-74-1 | Purity: ≥98% | Encenicline hydrochloride | ESD-878497-2MG |
| Cas.: 550999-74-1 | Purity: ≥98% | Encenicline hydrochloride | ESD-878497-5MG |
| Cas.: 550997-55-2 | Purity: 98% | ERB-196 | ESD-878498-1MG |
| Cas.: 550997-55-2 | Purity: 98% | ERB-196 | ESD-878498-5MG |
| Cas.: 550-90-3 | Purity: 96% | Lupanine | ESD-878499-5MG |
| Cas.: 55085-47-7 | Purity: 96% | 5,6,7-Trimethoxycoumarin | ESD-878500-5MG |
| Cas.: 550-83-4 | Purity: ≥99% | Propoxycaine hydrochloride | ESD-878501-50MG |
| Cas.: 55062-36-7 | Purity: 97% | Diversoside | ESD-878502-5MG |
| Cas.: 55051-85-9 | Purity: 98% | 2,6,4′-Trihydroxy-4-methoxybenzophenone | ESD-878503-5MG |
| Cas.: 55050-69-6 | Purity: 98% | Dammar-20(21)-ene-3β,24,25-triol | ESD-878504-5MG |
| Cas.: 550368-41-7 | Purity: 98% | PNRI-299 | ESD-878505-5MG |
| Cas.: 5503-32-2 | Purity: 95% | 2-(Chloromethyl)-1,4-dioxaspiro[4.5]decane | ESD-878506-250MG |
| Cas.: 5503-32-2 | Purity: 95% | 2-(Chloromethyl)-1,4-dioxaspiro[4.5]decane | ESD-878506-1G |
| Cas.: 55028-72-3 | Purity: ≥99% | Cloprostenol sodium salt | ESD-878507-5MG |
| Cas.: 55028-72-3 | Purity: ≥99% | Cloprostenol sodium salt | ESD-878507-10MG |
| Cas.: 549-84-8 | Purity: 98% | β-Yohimbine | ESD-878508-5MG |
| Cas.: 54963-52-9 | Purity: 95% | 2-Oxopomolic acid | ESD-878509-1MG |
| Cas.: 549-32-6 | Purity: ≥97% | Reynoutrin | ESD-878510-5MG |
| Cas.: 549-32-6 | Purity: ≥97% | Reynoutrin | ESD-878510-10MG |
| Cas.: 549-21-3 | Purity: 98% | Oxyberberine | ESD-878511-1MG |
| Cas.: 5489-57-6 | Purity: 98%, naturally derived | Arborinine | ESD-878512-5MG |
| Cas.: 548-89-0 | Purity: 98% | Gyrophoric acid | ESD-878513-5MG |
| Cas.: 548-82-3 | Purity: 99% | Pinobanksin | ESD-878514-5MG |
| Cas.: 548783-71-7 | Purity: ≥98% | Fexofenadine D6 | ESD-878515-1MG |
| Cas.: 54863-37-5 | Purity: ≥98% | Dapansutrile | ESD-878516-10MG |
| Cas.: 54857-86-2 | Purity: ≥98% | TOFA | ESD-878517-5MG |
| Cas.: 54857-86-2 | Purity: ≥98% | TOFA | ESD-878517-10MG |
| Cas.: 54854-91-0 | Purity: 98% | Sanshodiol | ESD-878518-5MG |
| Cas.: 54835-70-0 | Purity: 97% | Roseoside | ESD-878519-5MG |
| Cas.: 548-29-8 | Purity: 97% | Isolariciresinol | ESD-878520-5MG |
| Cas.: 547757-23-3 | Purity: ≥99% | BMS-345541 hydrochloride | ESD-878521-5MG |
| Cas.: 547757-23-3 | Purity: ≥99% | BMS-345541 hydrochloride | ESD-878521-10MG |
| Cas.: 547-44-4 | Purity: ≥98% | Sulfacarbamide | ESD-878522-100MG |
| Cas.: 54695-80-6 | Purity: 98% | Hydroxytyrosol 4-O-glucoside | ESD-878523-5MG |
| Cas.: 54656-47-2 | Purity: 95% | 1-O-Methyljatamanin D | ESD-878524-5MG |
| Cas.: 5463-92-3 | Purity: 98% | Diethyl 2-acetamido-2-phenethylmalonate | ESD-878525-5MG |
| Cas.: 54621-18-0 | Purity: 95% | 8-AMINO-1,4-DIOXASPIRO[4.5]DECANE-8-CARBOXYLIC ACID | ESD-878526-5G |
| Cas.: 54621-17-9 | Purity: 95% | 9,12-dioxa-1,3-diazadispiro[4.2.4^{8}.2^{5}]tetradecane-2,4-dione | ESD-878527-10MG |
| Cas.: 54621-17-9 | Purity: 95% | 9,12-dioxa-1,3-diazadispiro[4.2.4^{8}.2^{5}]tetradecane-2,4-dione | ESD-878527-50MG |
| Cas.: 546114-04-9 | Purity: 95% | 4-AZASPIRO[2.5]OCTAN-5-ONE | ESD-878528-1G |
| Cas.: 546114-04-9 | Purity: 95% | 4-AZASPIRO[2.5]OCTAN-5-ONE | ESD-878528-5G |
| Cas.: 546111-97-1 | Purity: ≥99% | Litronesib Racemate | ESD-878529-2MG |
| Cas.: 546111-97-1 | Purity: ≥99% | Litronesib Racemate | ESD-878529-5MG |
| Cas.: 545882-60-8 | Purity: 95% | 5,8-Dioxaspiro[3.4]octane-2-methanol | ESD-878530-1G |
| Cas.: 545882-60-8 | Purity: 95% | 5,8-Dioxaspiro[3.4]octane-2-methanol | ESD-878530-5G |
| Cas.: 545-48-2 | Purity: 97% | Erythrodiol | ESD-878531-5MG |
| Cas.: 545-46-0 | Purity: 98% | Uvaol | ESD-878532-5MG |
| Cas.: 54542-51-7 | Purity: 98% | 6″-O-Acetylisoquercitrin | ESD-878533-5MG |
| Cas.: 545395-94-6 | Purity: ≥99% | AMG9810 | ESD-878534-5MG |
| Cas.: 545395-94-6 | Purity: ≥99% | AMG9810 | ESD-878534-10MG |
| Cas.: 545-24-4 | Purity: 98% | 5-Glutinen-3β-ol | ESD-878535-5MG |
| Cas.: 5451-67-2 | Purity: 98% | Thymol isobutyrate | ESD-878536-5MG |
| Cas.: 54494-34-7 | Purity: 98% | Jolkinolide E | ESD-878537-5MG |
| Cas.: 54447-84-6 | Purity: ≥99% | c-di-AMP | ESD-878538-500ΜG |
| Cas.: 54447-84-6 | Purity: ≥99% | c-di-AMP | ESD-878538-1MG |
| Cas.: 544467-07-4 | Purity: ≥98% | HIV-1 integration inhibitor | ESD-878539-1MG |
| Cas.: 544467-07-4 | Purity: ≥98% | HIV-1 integration inhibitor | ESD-878539-5MG |
| Cas.: 544417-40-5 | Purity: ≥98% | Capadenoson | ESD-878540-5MG |
| Cas.: 544417-40-5 | Purity: ≥98% | Capadenoson | ESD-878540-10MG |
| Cas.: 54422-49-0 | Purity: 98% | Cadambine | ESD-878541-5MG |
| Cas.: 54405-27-5 | Purity: 98% | Mini Gastrin I, human | ESD-878542-1MG |
| Cas.: 54405-27-5 | Purity: 98% | Mini Gastrin I, human | ESD-878542-5MG |
| Cas.: 543906-09-8 | Purity: ≥99% | Mavoglurant | ESD-878543-5MG |
| Cas.: 543906-09-8 | Purity: ≥99% | Mavoglurant | ESD-878543-10MG |
| Cas.: 54377-24-1 | Purity: 97% | 7-Hydroxy-5,8-dimethoxyflavanone | ESD-878544-5MG |
| Cas.: 54354-62-0 | Purity: 97% | Decarine | ESD-878545-5MG |
| Cas.: 54352-60-2 | Purity: 98% | Eriodictyol 7,3′-dimethyl ether | ESD-878546-5MG |
| Cas.: 54334-04-2 | Purity: 98% | 4β-Hydroxywithanolide E | ESD-878547-5MG |
| Cas.: 543-15-7 | Purity: ≥98% | Heptaminol hydrochloride | ESD-878548-100MG |
| Cas.: 54306-10-4 | Purity: 98% | Kmeriol | ESD-878549-5MG |
| Cas.: 54299-52-4 | Purity: 98% | 2′,4′-Dihydroxy-3′,6′-dimethoxydihydrochalcone | ESD-878550-5MG |
| Cas.: 54232-58-5 | Purity: 95% | 9-Oxooctadeca-10,12-dienoic acid | ESD-878551-5MG |
| Cas.: 54143-56-5 | Purity: ≥99% | Flecainide acetate | ESD-878552-50MG |
| Cas.: 54113-95-0 | Purity: 97% | 15-Hydroxydehydroabietic acid | ESD-878553-5MG |
| Cas.: 54110-25-7 | Purity: ≥98% | Pirozadil | ESD-878554-5MG |
| Cas.: 54110-25-7 | Purity: ≥98% | Pirozadil | ESD-878554-10MG |
| Cas.: 54087-32-0 | Purity: 95% | 5-Methoxy-2′,3′-dehydromarmesin | ESD-878555-5MG |
| Cas.: 54081-48-0 | Purity: 98% | Isoastilbin | ESD-878556-5MG |
| Cas.: 53948-10-0 | Purity: 95% | Aristolactam BIII | ESD-878557-1MG |
| Cas.: 53948-09-7 | Purity: 97% | Aristolactam BII | ESD-878558-5MG |
| Cas.: 53948-07-5 | Purity: 98% | Aristolactam AII | ESD-878559-5MG |
| Cas.: 53947-89-0 | Purity: 95% | Apterin | ESD-878560-5MG |
| Cas.: 53947-86-7 | Purity: 98% | Euparone | ESD-878561-5MG |
| Cas.: 53882-12-5 | Purity: ≥98% | Lodoxamide | ESD-878562-5MG |
| Cas.: 53882-12-5 | Purity: ≥98% | Lodoxamide | ESD-878562-10MG |
| Cas.: 53868-26-1 | Purity: ≥98% | NSC305787 hydrochloride | ESD-878563-5MG |
| Cas.: 53868-26-1 | Purity: ≥98% | NSC305787 hydrochloride | ESD-878563-10MG |
| Cas.: 53859-06-6 | Purity: 98% | Desoxo-narchinol A | ESD-878564-5MG |
| Cas.: 53851-13-1 | Purity: 96% | Caboxine A | ESD-878565-5MG |
| Cas.: 53846-50-7 | Purity: 98% | 8-Prenylnaringenin | ESD-878566-5MG |
| Cas.: 53846-49-4 | Purity: 98% | Flavaprin | ESD-878567-5MG |
| Cas.: 53827-68-2 | Purity: 98% | 3-(β-D-Glucopyranosyloxy)-2-hydroxybenzoic acid methyl ester | ESD-878568-5MG |
| Cas.: 53823-10-2 | Purity: 98% | Trifloroside | ESD-878569-5MG |
| Cas.: 53823-03-3 | Purity: 98% | Onitisin | ESD-878570-5MG |
| Cas.: 53823-02-2 | Purity: 98% | Onitin | ESD-878571-5MG |
| Cas.: 53800-21-8 | Purity: 95% | 16-Oxolycoclavanol | ESD-878572-5MG |
| Cas.: 53783-83-8 | Purity: ≥99% | Tromantadine | ESD-878573-1MG |
| Cas.: 53783-83-8 | Purity: ≥99% | Tromantadine | ESD-878573-5MG |
| Cas.: 53774-63-3 | Purity: ≥99% | L-NIL | ESD-878574-50MG |
| Cas.: 53755-77-4 | Purity: 96% | Lycernuic acid A | ESD-878575-5MG |
| Cas.: 53755-76-3 | Purity: 97% | Lyclaninol | ESD-878576-5MG |
| Cas.: 53734-75-1 | Purity: 95% | Neorauflavene | ESD-878577-5MG |
| Cas.: 53734-74-0 | Purity: 95% | Neorauflavane | ESD-878578-5MG |
| Cas.: 53729-52-5 | Purity: 97% | Bruceantinol | ESD-878579-5MG |
| Cas.: 53662-98-9 | Purity: 98% | Dehydrobruceantin | ESD-878580-5MG |
| Cas.: 53587-37-4 | Purity: 98% | Secolongifolediol | ESD-878581-5MG |
| Cas.: 53583-79-2 | Purity: 98% | Sultopride | ESD-878582-5MG |
| Cas.: 53583-79-2 | Purity: 98% | Sultopride | ESD-878582-10MG |
| Cas.: 5356-56-9 | Purity: 98% | β-Amyrenonol acetate | ESD-878583-5MG |
| Cas.: 53538-13-9 | Purity: 98% | Apigenin 7-O-methylglucuronide | ESD-878584-5MG |
| Cas.: 5353-15-1 | Purity: 98% | γ-Asarone | ESD-878585-5MG |
| Cas.: 53527-42-7 | Purity: 98% | Luteolin-3-O-beta-D-glucuronide | ESD-878586-5MG |
| Cas.: 53527-42-7 | Purity: 98% | Luteolin-3-O-beta-D-glucuronide | ESD-878586-10MG |
| Cas.: 53526-67-3 | Purity: 95% | Durantoside I | ESD-878587-1MG |
| Cas.: 53526-66-2 | Purity: 95% | Durantoside II | ESD-878588-1MG |
| Cas.: 53505-68-3 | Purity: 98% | 4,9,9′-Trihydroxy-3,3′-dimethoxy-8,4′-oxyneolignan | ESD-878589-5MG |
| Cas.: 53484-50-7 | Purity: 98% | 4-Methoxycinnamyl alcohol | ESD-878590-5MG |
| Cas.: 53452-34-9 | Purity: 96% | Creticoside C | ESD-878591-5MG |
| Cas.: 53452-32-7 | Purity: 98% | 2β,6β,15α-Trihydroxy-ent-kaur-16-ene | ESD-878592-5MG |
| Cas.: 53452-12-3 | Purity: 98% | Linaroside | ESD-878593-5MG |
| Cas.: 53377-61-0 | Purity: 98% | 1,3,5-Trihydroxy-4-prenylxanthone | ESD-878594-5MG |
| Cas.: 53370-90-4 | Purity: ≥99% | Exalamide | ESD-878595-10MG |
| Cas.: 53-36-1 | Purity: 98% | Methylprednisolone acetate | ESD-878596-5MG |
| Cas.: 53319-52-1 | Purity: 97% | Isogosferol | ESD-878597-5MG |
| Cas.: 532959-63-0 | Purity: ≥99% | PF-4878691 | ESD-878598-1MG |
| Cas.: 532959-63-0 | Purity: ≥99% | PF-4878691 | ESD-878598-5MG |
| Cas.: 532-65-0 | Purity: 97% | ar-Turmerone | ESD-878599-5MG |
| Cas.: 532-48-9 | Purity: 98% | Euparin | ESD-878600-5MG |
| Cas.: 53188-20-8 | Purity: ≥99% | Etomidate hydrochloride | ESD-878601-10MG |
| Cas.: 53188-20-8 | Purity: ≥99% | Etomidate hydrochloride | ESD-878601-50MG |
| Cas.: 531-29-3 | Purity: 97% | Coniferin | ESD-878602-5MG |
| Cas.: 531-28-2 | Purity: 98% | Androsin | ESD-878603-1MG |
| Cas.: 5309-35-3 | Purity: 98% | 9β,13β-Epidioxyabiet-8(14)-en-18-oic acid | ESD-878604-5MG |
| Cas.: 53066-26-5 | Purity: ≥98% | Lexithromycin | ESD-878605-5MG |
| Cas.: 530-53-0 | Purity: 99% | Deoxyvasicinone | ESD-878606-5MG |
| Cas.: 53016-31-2 | Purity: ≥99% | Norgestimate metabolite Norelgestromin | ESD-878607-5MG |
| Cas.: 53016-31-2 | Purity: ≥99% | Norgestimate metabolite Norelgestromin | ESD-878607-10MG |
| Cas.: 53011-72-6 | Purity: 95% | Murralongin | ESD-878608-1MG |
| Cas.: 52992-82-2 | Purity: 95% | Acetylisocupressic acid | ESD-878609-5MG |
| Cas.: 529488-28-6 | Purity: ≥98% | Genz-644282 | ESD-878610-5MG |
| Cas.: 529488-28-6 | Purity: ≥98% | Genz-644282 | ESD-878610-10MG |
| Cas.: 529-40-8 | Purity: 98% | Ombuin | ESD-878611-5MG |
| Cas.: 52932-74-8 | Purity: 98% | Neosophoramine | ESD-878612-5MG |
| Cas.: 52914-31-5 | Purity: 95% | Dammaradienyl acetate | ESD-878613-5MG |
| Cas.: 528-63-2 | Purity: 98% | Galgravin | ESD-878614-5MG |
| Cas.: 528521-89-3 | Purity: 98% | (S)-7,7′-Bis[di(3,5-dimethylphenyl)phosphino]-1,1′-spirobiindane | ESD-878615-25MG |
| Cas.: 528521-89-3 | Purity: 98% | (S)-7,7′-Bis[di(3,5-dimethylphenyl)phosphino]-1,1′-spirobiindane | ESD-878615-100MG |
| Cas.: 5282-14-4 | Purity: 98% | Olean-12-ene-3β,11α-diol | ESD-878616-5MG |
| Cas.: 52811-37-7 | Purity: 98% | Cearoin | ESD-878617-5MG |
| Cas.: 52811-31-1 | Purity: 80% | (-)-Dalbergiphenol | ESD-878618-5MG |
| Cas.: 52766-70-8 | Purity: 95% | Medicarpin glucoside | ESD-878619-5MG |
| Cas.: 52757-95-6 | Purity: 98% | Sevelamer | ESD-878620-100MG |
| Cas.: 52757-95-6 | Purity: 98% | Sevelamer | ESD-878620-500MG |
| Cas.: 5273-85-8 | Purity: 95% | Isoelemicin | ESD-878621-5MG |
| Cas.: 52706-07-7 | Purity: 98% | Scillascillin | ESD-878622-5MG |
| Cas.: 52645-97-3 | Purity: 98% | Siegeskaurolic acid | ESD-878623-5MG |
| Cas.: 52628-62-3 | Purity: 97% | Dehydroadynerigenin digitaloside | ESD-878624-5MG |
| Cas.: 526214-79-9 | Purity: 98% | Gnetofuran B | ESD-878625-5MG |
| Cas.: 52617-37-5 | Purity: 98% | Ponicidin | ESD-878626-5MG |
| Cas.: 52611-75-3 | Purity: 98% | Epipterosin L | ESD-878627-5MG |
| Cas.: 526-06-7 | Purity: 98% | Eudesmin | ESD-878628-5MG |
| Cas.: 52591-10-3 | Purity: 99% | Iriflophenone | ESD-878629-5MG |
| Cas.: 52589-11-4 | Purity: 96% | Phellamurin | ESD-878630-5MG |
| Cas.: 52557-26-3 | Purity: 95% | Ingenol 3-palmitate | ESD-878631-5MG |
| Cas.: 52546-93-7 | Purity: 97% | 3-(4-Methoxyphenyl)-1,4-diazaspiro-[4.5]dec-3-ene-2-thione | ESD-878632-500MG |
| Cas.: 52546-93-7 | Purity: 97% | 3-(4-Methoxyphenyl)-1,4-diazaspiro-[4.5]dec-3-ene-2-thione | ESD-878632-1G |
| Cas.: 52528-26-4 | Purity: 95% | (7-METHYL-1,4-DITHIA-SPIRO(4.5)DEC-6-EN-8-YL)-METHANOL | ESD-878633-10MG |
| Cas.: 52525-35-6 | Purity: 93% | Quercetin 3-O-robinobioside | ESD-878634-5MG |
| Cas.: 525-21-3 | Purity: 98% | Fraxidin | ESD-878635-5MG |
| Cas.: 52506-21-5 | Purity: 95% | Methyl 8-oxo-1,4-dioxaspiro[4.5]decane-7-carboxylate | ESD-878636-100MG |
| Cas.: 52506-21-5 | Purity: 95% | Methyl 8-oxo-1,4-dioxaspiro[4.5]decane-7-carboxylate | ESD-878636-1G |
| Cas.: 524924-76-3 | Purity: ≥98% | Methoxy-PEPy | ESD-878637-2MG |
| Cas.: 524924-76-3 | Purity: ≥98% | Methoxy-PEPy | ESD-878637-5MG |
| Cas.: 52483-19-9 | Purity: 95% | 5-(Z-Heptadec-8-enyl)resorcinol | ESD-878638-5MG |
| Cas.: 524-81-2 | Purity: ≥99% | Mebhydrolin | ESD-878639-100MG |
| Cas.: 524722-52-9 | Purity: 98% | Vandetanib hydrochloride | ESD-878640-25MG |
| Cas.: 524722-52-9 | Purity: 98% | Vandetanib hydrochloride | ESD-878640-100MG |
| Cas.: 524684-52-4 | Purity: ≥98% | Prinaberel | ESD-878641-10MG |
| Cas.: 524684-52-4 | Purity: ≥98% | Prinaberel | ESD-878641-50MG |
| Cas.: 52452-60-5 | Purity: ≥98% | Terphenyllin | ESD-878642-1MG |
| Cas.: 52452-60-5 | Purity: ≥98% | Terphenyllin | ESD-878642-5MG |
| Cas.: 52438-21-8 | Purity: 98% | 1-Cinnamoylpyrrolidine | ESD-878643-5MG |
| Cas.: 524-15-2 | Purity: 99% | γ-Fagarine | ESD-878644-5MG |
| Cas.: 52389-15-8 | Purity: 95% | Epistephamiersine | ESD-878645-5MG |
| Cas.: 523-73-9 | Purity: 98% | Flavoglaucin | ESD-878646-5MG |
| Cas.: 52358-58-4 | Purity: 95% | Erysotramidine | ESD-878647-1MG |
| Cas.: 52330-12-8 | Purity: 98% | Alnusonol | ESD-878648-5MG |
| Cas.: 52330-11-7 | Purity: 97% | Alnusone | ESD-878649-5MG |
| Cas.: 52328-96-8 | Purity: 98% | Bisdemethoxycurcumin | ESD-878650-5MG |
| Cas.: 5231-60-7 | Purity: 97% | Vindorosine | ESD-878651-5MG |
| Cas.: 52275-04-4 | Purity: 98% | 3,5-Diprenyl-4-hydroxybenzaldehyde | ESD-878652-5MG |
| Cas.: 522606-67-3 | Purity: ≥98% | SID 3712249 | ESD-878653-5MG |
| Cas.: 522606-67-3 | Purity: ≥98% | SID 3712249 | ESD-878653-10MG |
| Cas.: 52250-38-1 | Purity: 98% | Violanone | ESD-878654-5MG |
| Cas.: 522-47-4 | Purity: 98% | Lochnerine | ESD-878655-5MG |
| Cas.: 522-30-5 | Purity: 98% | Norsanguinarine | ESD-878656-5MG |
| Cas.: 52225-20-4 | Purity: ≥98% | DL-α-Tocopherol acetate | ESD-878657-100MG |
| Cas.: 52213-27-1 | Purity: 96% | 3-Epicorosolic acid | ESD-878658-5MG |
| Cas.: 522-11-2 | Purity: 99% | Evoxine | ESD-878659-5MG |
| Cas.: 52205-73-9 | Purity: ≥99% | Estramustine phosphate sodium | ESD-878660-50MG |
| Cas.: 521-78-8 | Purity: ≥99% | Trimipramine maleate | ESD-878661-100MG |
| Cas.: 52151-92-5 | Purity: 97% | Piperitol | ESD-878662-5MG |
| Cas.: 521-51-7 | Purity: 95% | Pedicin | ESD-878663-1MG |
| Cas.: 521-34-6 | Purity: Analysis control, 98% | Sciadopitysin | ESD-878664-5MG |
| Cas.: 521-32-4 | Purity: 98% | Bilobetin | ESD-878665-5MG |
| Cas.: 52128-35-5 | Purity: ≥98% | Trimetrexate | ESD-878666-5MG |
| Cas.: 52128-35-5 | Purity: ≥98% | Trimetrexate | ESD-878666-10MG |
| Cas.: 52117-69-8 | Purity: 98% | 3-O-Acetylpinobanksin | ESD-878667-5MG |
| Cas.: 521-17-5 | Purity: 98% | Androstenediol | ESD-878668-5MG |
| Cas.: 52094-69-6 | Purity: 95% | 8-methyl-1,3,8-triazaspiro[4.5]decane-2,4-dione | ESD-878669-1G |
| Cas.: 520-42-3 | Purity: 98% | Asebogenin | ESD-878670-5MG |
| Cas.: 520-32-1 | Purity: 98% | Tricin | ESD-878671-5MG |
| Cas.: 520-28-5 | Purity: 99% | Tectochrysin | ESD-878672-5MG |
| Cas.: 520-11-6 | Purity: 98% | Nepetin | ESD-878673-1MG |
| Cas.: 51995-99-4 | Purity: 98% | Dehydroespeletone | ESD-878674-5MG |
| Cas.: 519-57-3 | Purity: 98% | Sulochrin | ESD-878675-5MG |
| Cas.: 519-34-6 | Purity: 99% | Maclurin | ESD-878676-1MG |
| Cas.: 519-23-3 | Purity: 98% | Ellipticine | ESD-878677-5MG |
| Cas.: 519-23-3 | Purity: 98% | Ellipticine | ESD-878677-10MG |
| Cas.: 519187-97-4 | Purity: ≥99% | Edonerpic maleate | ESD-878678-1MG |
| Cas.: 519187-97-4 | Purity: ≥99% | Edonerpic maleate | ESD-878678-5MG |
| Cas.: 51905-84-1 | Purity: 97% | Dehydrohautriwaic acid | ESD-878679-5MG |
| Cas.: 518-96-7 | Purity: 98% | Isomaculosidine | ESD-878680-5MG |
| Cas.: 5188-73-8 | Purity: 98% | Axillarin | ESD-878681-5MG |
| Cas.: 518-83-2 | Purity: 97% | Xanthopurpurin | ESD-878682-5MG |
| Cas.: 51876-97-2 | Purity: 98% | Alrestatin sodium | ESD-878683-5MG |
| Cas.: 51876-97-2 | Purity: 98% | Alrestatin sodium | ESD-878683-10MG |
| Cas.: 51857-11-5 | Purity: 98% | 7-O-Methyleriodictyol | ESD-878684-5MG |
| Cas.: 51847-92-8 | Purity: 98% | Licoricone | ESD-878685-5MG |
| Cas.: 51828-10-5 | Purity: 98% | 2′-O-Methylisoliquiritigenin | ESD-878687-5MG |
| Cas.: 51804-69-4 | Purity: 96% | Dihydrooxoepistephamiersine | ESD-878688-5MG |
| Cas.: 51804-68-3 | Purity: 95% | Oxoepistephamiersine | ESD-878689-1MG |
| Cas.: 51803-68-0 | Purity: 98% | 3,8-Di-O-methylellagic acid 2-O-glucoside | ESD-878690-5MG |
| Cas.: 517885-72-2 | Purity: 95% | Dehydroglyasperin D | ESD-878691-5MG |
| Cas.: 517883-38-4 | Purity: 98% | Rengynic acid | ESD-878692-5MG |
| Cas.: 517-63-5 | Purity: 98% | Stephanine | ESD-878693-5MG |
| Cas.: 51-71-8 | Purity: 98% | Phenelzine | ESD-878694-100MG |
| Cas.: 51-71-8 | Purity: 98% | Phenelzine | ESD-878694-500MG |
| Cas.: 51666-26-3 | Purity: 97% | Erythrartine | ESD-878695-5MG |
| Cas.: 51656-91-8 | Purity: 95% | ethyl 2-{1,4-dioxaspiro[4.5]decan-8-ylidene}acetate | ESD-878696-1G |
| Cas.: 51656-91-8 | Purity: 95% | ethyl 2-{1,4-dioxaspiro[4.5]decan-8-ylidene}acetate | ESD-878696-5G |
| Cas.: 516-54-1 | Purity: ≥98% | allopregnanolone | ESD-878697-2MG |
| Cas.: 516-54-1 | Purity: ≥98% | allopregnanolone | ESD-878697-5MG |
| Cas.: 51652-39-2 | Purity: 95% | 2-Methoxyphenalen-1-one | ESD-878698-5MG |
| Cas.: 51650-59-0 | Purity: 97% | Murrangatin diacetate | ESD-878699-5MG |
| Cas.: 516-37-0 | Purity: 96% | Cerevisterol | ESD-878700-5MG |
| Cas.: 51593-96-5 | Purity: 95% | Cuspidiol | ESD-878701-1MG |
| Cas.: 515814-01-4 | Purity: ≥99% | Voclosporin | ESD-878702-5MG |
| Cas.: 515814-01-4 | Purity: ≥99% | Voclosporin | ESD-878702-10MG |
| Cas.: 51551-29-2 | Purity: 98% | Neoechinulin A | ESD-878703-5MG |
| Cas.: 51543-40-9 | Purity: 98% | 2-Flurbiprofen | ESD-878704-5MG |
| Cas.: 51511-05-8 | Purity: 95% | Adiantulupanone | ESD-878705-5MG |
| Cas.: 514814-49-4 | Purity: 98% | PMX 205 | ESD-878706-500ΜG |
| Cas.: 514814-49-4 | Purity: 98% | PMX 205 | ESD-878706-1MG |
| Cas.: 514-65-8 | Purity: 98% | Biperiden | ESD-878707-100MG |
| Cas.: 514-65-8 | Purity: 98% | Biperiden | ESD-878707-500MG |
| Cas.: 514-62-5 | Purity: 98% | Ferruginol | ESD-878708-5MG |
| Cas.: 514-47-6 | Purity: 98% | Euphol | ESD-878709-5MG |
| Cas.: 514-46-5 | Purity: 98% | Tirucallol | ESD-878710-5MG |
| Cas.: 51419-51-3 | Purity: 98% | Odonicin | ESD-878711-5MG |
| Cas.: 514-07-8 | Purity: 98% | Taraxerone | ESD-878712-5MG |
| Cas.: 5140-42-1 | Purity: 95% | brown iine | ESD-878713-5MG |
| Cas.: 51392-72-4 | Purity: 95% | 1-Azaspiro[3.3]heptane oxalate | ESD-878714-250MG |
| Cas.: 51361-60-5 | Purity: 95% | δ-Amyrin acetate | ESD-878715-1MG |
| Cas.: 5132-66-1 | Purity: 98% | 27-Hydroxymangiferonic acid | ESD-878716-5MG |
| Cas.: 5128-43-8 | Purity: 97% | 5,7-Diacetoxy-3,8,4′-trimethoxyflavone | ESD-878717-5MG |
| Cas.: 512781-45-2 | Purity: 98% | Afzelechin 3-O-xyloside | ESD-878718-5MG |
| Cas.: 5127-64-0 | Purity: 99% | Gallocatechin gallate | ESD-878719-1MG |
| Cas.: 51264-14-3 | Purity: ≥99% | Amsacrine | ESD-878720-10MG |
| Cas.: 51264-14-3 | Purity: ≥99% | Amsacrine | ESD-878720-50MG |
| Cas.: 51225-30-0 | Purity: 99% | Wighteone | ESD-878721-5MG |
| Cas.: 51225-28-6 | Purity: 97% | 6,8-Diprenylgenistein | ESD-878722-5MG |
| Cas.: 511-89-7 | Purity: 98% | Plumieride | ESD-878723-5MG |
| Cas.: 51165-05-0 | Purity: 98% | Substance P (7-11) | ESD-878724-5MG |
| Cas.: 51165-05-0 | Purity: 98% | Substance P (7-11) | ESD-878724-10MG |
| Cas.: 51154-48-4 | Purity: 98% | Fibracillin | ESD-878725-1MG |
| Cas.: 51154-48-4 | Purity: 98% | Fibracillin | ESD-878725-5MG |
| Cas.: 51152-20-6 | Purity: 96% | Episyringaresinol | ESD-878726-5MG |
| Cas.: 51145-74-5 | Purity: 95% | 1,3-diazaspiro[4.5]decane-2,4,8-trione | ESD-878727-1G |
| Cas.: 51130-61-1 | Purity: 95% | 9-oxa-6-azaspiro[4.5]decane | ESD-878728-1G |
| Cas.: 511-28-4 | Purity: ≥98% | Vitamin D4 | ESD-878729-1MG |
| Cas.: 511-15-9 | Purity: 97% | Totarol | ESD-878730-5MG |
| Cas.: 51110-01-1 | Purity: ≥99% | Somatostatin | ESD-878731-1MG |
| Cas.: 51110-01-1 | Purity: ≥99% | Somatostatin | ESD-878731-5MG |
| Cas.: 51095-86-4 | Purity: 95% | Nicotine 1′-N-oxide | ESD-878732-1MG |
| Cas.: 51095-85-3 | Purity: 97% | 2,7-Dihydrohomoerysotrine | ESD-878733-5MG |
| Cas.: 51095-47-7 | Purity: 98% | Methyl p-hydroxyphenyllactate | ESD-878734-5MG |
| Cas.: 510-77-0 | Purity: ≥99% | Galanthaminone | ESD-878735-5MG |
| Cas.: 510-77-0 | Purity: ≥99% | Galanthaminone | ESD-878735-10MG |
| Cas.: 51020-86-1 | Purity: 95% | Licarin A | ESD-878736-5MG |
| Cas.: 51020-45-2 | Purity: 97% | Demethylcephalotaxinone | ESD-878737-5MG |
| Cas.: 51005-44-8 | Purity: 97% | Minecoside | ESD-878738-5MG |
| Cas.: 50972-17-3 | Purity: 98% | Bacampicillin | ESD-878739-10MG |
| Cas.: 50972-17-3 | Purity: 98% | Bacampicillin | ESD-878739-50MG |
| Cas.: 5096-70-8 | Purity: 95% | N-Methylcoclaurine | ESD-878740-5MG |
| Cas.: 5096-57-1 | Purity: 98% | Canadine | ESD-878741-5MG |
| Cas.: 509-17-1 | Purity: 95% | Ajacine | ESD-878743-5MG |
| Cas.: 509102-00-5 | Purity: ≥98% | MIM1 | ESD-878744-1MG |
| Cas.: 509102-00-5 | Purity: ≥98% | MIM1 | ESD-878744-5MG |
| Cas.: 509093-47-4 | Purity: ≥99% | IRAK-1-4 Inhibitor I | ESD-878745-5MG |
| Cas.: 509093-47-4 | Purity: ≥99% | IRAK-1-4 Inhibitor I | ESD-878745-10MG |
| Cas.: 509078-16-4 | Purity: 97% | 1β-Hydroxytorilin | ESD-878746-5MG |
| Cas.: 509077-91-2 | Purity: 95% | Taiwanhomoflavone B | ESD-878747-5MG |
| Cas.: 50906-56-4 | Purity: 98% | Arteannuin B | ESD-878748-5MG |
| Cas.: 508-99-6 | Purity: ≥99% | Hydrocortisone cypionate | ESD-878749-1MG |
| Cas.: 508-99-6 | Purity: ≥99% | Hydrocortisone cypionate | ESD-878749-5MG |
| Cas.: 508-71-4 | Purity: 95% | Rosenolactone | ESD-878750-1MG |
| Cas.: 50868-52-5 | Purity: 98% | 1,5,6-Trihydroxy-3-methoxyxanthone | ESD-878751-5MG |
| Cas.: 5085-72-3 | Purity: 99% | Friedelanol | ESD-878752-5MG |
| Cas.: 50838-11-4 | Purity: 95% | 14,15-Didehydroisoeburnamine | ESD-878754-1MG |
| Cas.: 5081-51-6 | Purity: 99% | Vasicinol | ESD-878755-5MG |
| Cas.: 5081-48-1 | Purity: ≥99% | Ellipticine hydrochloride | ESD-878756-5MG |
| Cas.: 5081-48-1 | Purity: ≥99% | Ellipticine hydrochloride | ESD-878756-10MG |
| Cas.: 508-09-8 | Purity: 98% | Glutinone | ESD-878757-5MG |
| Cas.: 508-04-3 | Purity: 96% | 13(18)-Oleanen-3-ol | ESD-878758-5MG |
| Cas.: 50656-77-4 | Purity: 96% | Niranthin | ESD-878759-5MG |
| Cas.: 50597-93-8 | Purity: 97% | Isojacareubin | ESD-878760-5MG |
| Cas.: 50-56-6 | Purity: ≥98% | Oxytocin | ESD-878761-5MG |
| Cas.: 50-56-6 | Purity: ≥98% | Oxytocin | ESD-878761-10MG |
| Cas.: 5054-59-1 | Purity: ≥99% | Thalidomide-OH | ESD-878762-100MG |
| Cas.: 5054-59-1 | Purity: ≥99% | Thalidomide-OH | ESD-878762-500MG |
| Cas.: 505-44-2 | Purity: ≥98% | Iberin | ESD-878763-2MG |
| Cas.: 5052-96-0 | Purity: 95% | 1-oxa-3,8-diazaspiro[4.5]decan-2-one hydrochloride | ESD-878764-1G |
| Cas.: 5052-96-0 | Purity: 95% | 1-oxa-3,8-diazaspiro[4.5]decan-2-one hydrochloride | ESD-878764-5G |
| Cas.: 5052-95-9 | Purity: 95% | 1-Oxa-3,8-diazaspiro[4.5]decan-2-one hydrochloride | ESD-878765-1G |
| Cas.: 5052-95-9 | Purity: 95% | 1-Oxa-3,8-diazaspiro[4.5]decan-2-one hydrochloride | ESD-878765-5G |
| Cas.: 50461-86-4 | Purity: 95% | Araneosol | ESD-878766-1MG |
| Cas.: 50428-93-8 | Purity: 95% | Methyl 2α-hydroxyhardwickiate | ESD-878767-5MG |
| Cas.: 5041-67-8 | Purity: ≥98% | Juglanin | ESD-878768-1MG |
| Cas.: 5041-67-8 | Purity: ≥98% | Juglanin | ESD-878768-5MG |
| Cas.: 503837-98-7 | Purity: ≥98% | Sortin1 | ESD-878769-2MG |
| Cas.: 503837-98-7 | Purity: ≥98% | Sortin1 | ESD-878769-5MG |
| Cas.: 50370-12-2 | Purity: ≥98% | Cefadroxil | ESD-878770-100MG |
| Cas.: 50357-45-4 | Purity: 98% | Pentamidine dihydrochloride | ESD-878771-10MG |
| Cas.: 50357-45-4 | Purity: 98% | Pentamidine dihydrochloride | ESD-878771-50MG |
| Cas.: 503559-84-0 | Purity: 98% | Glucagon receptor antagonists-1 | ESD-878772-5MG |
| Cas.: 503559-84-0 | Purity: 98% | Glucagon receptor antagonists-1 | ESD-878772-10MG |
| Cas.: 503551-94-8 | Purity: 95% | 9-benzyl-1-oxa-9-azaspiro[5.5]undecan-4-yl methanesulfonate | ESD-878773-1G |
| Cas.: 503551-93-7 | Purity: 95% | 2-benzyl-6-oxa-2-azaspiro[4.5]decan-9-yl methanesulfonate | ESD-878774-1G |
| Cas.: 503551-92-6 | Purity: 95% | 1-oxa-9-thiaspiro[5.5]undecan-4-yl methanesulfonate | ESD-878775-1G |
| Cas.: 503551-90-4 | Purity: 95% | 1-oxaspiro[5.5]undecan-4-yl methanesulfonate | ESD-878776-1G |
| Cas.: 503551-89-1 | Purity: 95% | 6-oxaspiro[4.5]decan-9-yl methanesulfonate | ESD-878777-1G |
| Cas.: 503551-88-0 | Purity: 95% | 2,6-dioxaspiro[4.5]decan-9-yl methanesulfonate | ESD-878778-1MG |
| Cas.: 503551-84-6 | Purity: 95% | 1,9-dioxaspiro[5.5]undecan-4-yl methanesulfonate | ESD-878779-1G |
| Cas.: 50333-13-6 | Purity: 98% | N-Methylflindersine | ESD-878780-5MG |
| Cas.: 5027-76-9 | Purity: 98% | Oleuropeic acid | ESD-878781-5MG |
| Cas.: 50276-98-7 | Purity: 97% | Erythrocentaurin | ESD-878782-5MG |
| Cas.: 50276-96-5 | Purity: 98% | Ochnaflavone | ESD-878783-5MG |
| Cas.: 5027-30-5 | Purity: 95% | Phloracetophenone 4′-O-glucoside | ESD-878784-5MG |
| Cas.: 5025-82-1 | Purity: ≥99% | Folcisteine | ESD-878786-100MG |
| Cas.: 5025-82-1 | Purity: ≥99% | Folcisteine | ESD-878786-500MG |
| Cas.: 502487-67-4 | Purity: ≥98% | SQ109 | ESD-878787-5MG |
| Cas.: 502487-67-4 | Purity: ≥98% | SQ109 | ESD-878787-10MG |
| Cas.: 501-96-2 | Purity: 98% | (-)-Rhododendrol | ESD-878788-5MG |
| Cas.: 501948-05-6 | Purity: 98% | Rosabulin | ESD-878789-1MG |
| Cas.: 501948-05-6 | Purity: 98% | Rosabulin | ESD-878789-5MG |
| Cas.: 501935-96-2 | Purity: ≥96% | CTX1 | ESD-878790-5MG |
| Cas.: 501935-96-2 | Purity: ≥96% | CTX1 | ESD-878790-10MG |
| Cas.: 501921-61-5 | Purity: ≥98% | Entasobulin | ESD-878791-1MG |
| Cas.: 501921-61-5 | Purity: ≥98% | Entasobulin | ESD-878791-5MG |
| Cas.: 50-19-1 | Purity: 98% | Oxyfenamate | ESD-878792-1MG |
| Cas.: 50-19-1 | Purity: 98% | Oxyfenamate | ESD-878792-5MG |
| Cas.: 501698-03-9 | Purity: ≥99% | GDP366 | ESD-878793-5MG |
| Cas.: 501698-03-9 | Purity: ≥99% | GDP366 | ESD-878793-10MG |
| Cas.: 501-68-8 | Purity: ≥98% | Beclamide | ESD-878794-100MG |
| Cas.: 501684-93-1 | Purity: ≥99% | NS 1738 | ESD-878795-5MG |
| Cas.: 501684-93-1 | Purity: ≥99% | NS 1738 | ESD-878795-10MG |
| Cas.: 501666-85-9 | Purity: ≥98% | DC1SMe | ESD-878796-5MG |
| Cas.: 501666-85-9 | Purity: ≥98% | DC1SMe | ESD-878796-10MG |
| Cas.: 501086-15-3 | Purity: 95% | Pilosol A | ESD-878797-5MG |
| Cas.: 501010-06-6 | Purity: ≥99% | GGTI-2418 | ESD-878798-5MG |
| Cas.: 501010-06-6 | Purity: ≥99% | GGTI-2418 | ESD-878798-10MG |
| Cas.: 500-92-5 | Purity: ≥99% | Proguanil | ESD-878799-10MG |
| Cas.: 500-92-5 | Purity: ≥99% | Proguanil | ESD-878799-25MG |
| Cas.: 5008-48-0 | Purity: 97% | Securinol A | ESD-878800-5MG |
| Cas.: 500574-38-9 | Purity: 95% | Simulanol | ESD-878801-5MG |
| Cas.: 500-42-5 | Purity: 98% | Chlorazanil | ESD-878802-50MG |
| Cas.: 500363-63-3 | Purity: ≥98% | NSC117079 | ESD-878803-5MG |
| Cas.: 500363-63-3 | Purity: ≥98% | NSC117079 | ESD-878803-10MG |
| Cas.: 500360-86-1 | Purity: 95% | 9-Benzyl-3,9-diazaspiro[5.5]undecan-2-one | ESD-878804-1G |
| Cas.: 500017-70-9 | Purity: ≥99% | DC_517 | ESD-878805-2MG |
| Cas.: 500017-70-9 | Purity: ≥99% | DC_517 | ESD-878805-5MG |
| Cas.: 500006-77-9 | Purity: 95% | Spiro[cyclohexane-1,3′-(3′,4′-dihydro-isoquinolin)]-1′-yl-aminoacetic acid | ESD-878806-1G |
| Cas.: 497836-10-9 | Purity: 98% | D77 | ESD-878808-2MG |
| Cas.: 497836-10-9 | Purity: 98% | D77 | ESD-878808-5MG |
| Cas.: 497833-27-9 | Purity: 98% | Givinostat | ESD-878809-2MG |
| Cas.: 497833-27-9 | Purity: 98% | Givinostat | ESD-878809-5MG |
| Cas.: 49776-92-3 | Purity: 98% | 11β-Hydroxylupeol | ESD-878810-5MG |
| Cas.: 497259-23-1 | Purity: ≥99% | TPPB | ESD-878811-1MG |
| Cas.: 497223-28-6 | Purity: ≥98% | Cenicriviroc Mesylate | ESD-878812-1MG |
| Cas.: 497223-28-6 | Purity: ≥98% | Cenicriviroc Mesylate | ESD-878812-5MG |
| Cas.: 497223-25-3 | Purity: ≥98% | Cenicriviroc | ESD-878813-1MG |
| Cas.: 497223-25-3 | Purity: ≥98% | Cenicriviroc | ESD-878813-5MG |
| Cas.: 497142-88-8 | Purity: 98% | Tupichinol A | ESD-878814-5MG |
| Cas.: 4970-26-7 | Purity: 95% | (-)-Praeruptorin B | ESD-878815-5MG |
| Cas.: 496921-73-4 | Purity: 98% | NEO 376 | ESD-878816-1MG |
| Cas.: 496921-73-4 | Purity: 98% | NEO 376 | ESD-878816-5MG |
| Cas.: 496807-64-8 | Purity: ≥98% | EN460 | ESD-878818-1MG |
| Cas.: 496807-64-8 | Purity: ≥98% | EN460 | ESD-878818-5MG |
| Cas.: 496794-70-8 | Purity: ≥99% | HhAntag | ESD-878819-5MG |
| Cas.: 496794-70-8 | Purity: ≥99% | HhAntag | ESD-878819-10MG |
| Cas.: 49679-20-1 | Purity: 97% | Nandazurine | ESD-878820-5MG |
| Cas.: 496791-37-8 | Purity: 98% | AR-C155858 | ESD-878821-1MG |
| Cas.: 496791-37-8 | Purity: 98% | AR-C155858 | ESD-878821-5MG |
| Cas.: 49672-69-7 | Purity: 95% | 1,4-Dioxa-spiro[4.5]dec-7-ylamine | ESD-878822-1G |
| Cas.: 49672-69-7 | Purity: 95% | 1,4-Dioxa-spiro[4.5]dec-7-ylamine | ESD-878822-5G |
| Cas.: 4965-99-5 | Purity: 95% | Simiarenol acetate | ESD-878823-1MG |
| Cas.: 49624-66-0 | Purity: 98% | Angelicain | ESD-878824-5MG |
| Cas.: 496054-87-6 | Purity: ≥99% | Radiprodil | ESD-878825-5MG |
| Cas.: 496054-87-6 | Purity: ≥99% | Radiprodil | ESD-878825-10MG |
| Cas.: 495-83-0 | Purity: 98% | Tigloidin | ESD-878826-1MG |
| Cas.: 495-83-0 | Purity: 98% | Tigloidin | ESD-878826-5MG |
| Cas.: 495399-09-2 | Purity: ≥98% | Saroglitazar | ESD-878827-1MG |
| Cas.: 495399-09-2 | Purity: ≥98% | Saroglitazar | ESD-878827-5MG |
| Cas.: 495389-95-2 | Purity: 95% | 11α,12α-Oxidotaraxerol palmitate | ESD-878828-5MG |
| Cas.: 495-32-9 | Purity: 99% | Nodakenetin | ESD-878829-5MG |
| Cas.: 495-30-7 | Purity: 96% | Ammajin | ESD-878830-5MG |
| Cas.: 493-95-8 | Purity: 97% | Savinin | ESD-878831-5MG |
| Cas.: 492-14-8 | Purity: 97% | Butin | ESD-878832-5MG |
| Cas.: 492-12-6 | Purity: 98% | Plathymenin | ESD-878833-5MG |
| Cas.: 491871-58-0 | Purity: ≥97% | TCS PIM-1 1 | ESD-878834-10MG |
| Cas.: 491871-58-0 | Purity: ≥97% | TCS PIM-1 1 | ESD-878834-50MG |
| Cas.: 491833-30-8 | Purity: ≥99% | Genz-123346 free base | ESD-878835-5MG |
| Cas.: 491833-30-8 | Purity: ≥99% | Genz-123346 free base | ESD-878835-10MG |
| Cas.: 491613-65-1 | Purity: 98% | Dicliripariside A | ESD-878836-5MG |
| Cas.: 491577-61-8 | Purity: 98% | DW-1350 | ESD-878837-1MG |
| Cas.: 491577-61-8 | Purity: 98% | DW-1350 | ESD-878837-5MG |
| Cas.: 490-31-3 | Purity: 96% | Robinetin | ESD-878838-5MG |
| Cas.: 489-86-1 | Purity: 97% | Guaiol | ESD-878839-1MG |
| Cas.: 489-41-8 | Purity: 98% | Globuol | ESD-878840-1MG |
| Cas.: 489416-12-8 | Purity: ≥99% | ST-193 | ESD-878841-1MG |
| Cas.: 489416-12-8 | Purity: ≥99% | ST-193 | ESD-878841-5MG |
| Cas.: 489402-47-3 | Purity: ≥99% | ML213 | ESD-878842-5MG |
| Cas.: 489402-47-3 | Purity: ≥99% | ML213 | ESD-878842-10MG |
| Cas.: 488847-28-5 | Purity: 98% | ORM-10103 | ESD-878843-5MG |
| Cas.: 488847-28-5 | Purity: 98% | ORM-10103 | ESD-878843-10MG |
| Cas.: 488793-85-7 | Purity: ≥99% | ARN272 | ESD-878844-5MG |
| Cas.: 488793-85-7 | Purity: ≥99% | ARN272 | ESD-878844-10MG |
| Cas.: 488-76-6 | Purity: 98% | vibo-Quercitol | ESD-878845-1MG |
| Cas.: 4884-68-8 | Purity: 98% | Hydrastinine hydrochloride | ESD-878846-10MG |
| Cas.: 4884-68-8 | Purity: 98% | Hydrastinine hydrochloride | ESD-878846-50MG |
| Cas.: 488138-32-5 | Purity: 95% | 5-O-Ethylcleroindicin D | ESD-878847-5MG |
| Cas.: 4880-87-9 | Purity: 97% | N-Acetylstepharine | ESD-878848-5MG |
| Cas.: 487-79-6 | Purity: ≥99% | Kainic acid | ESD-878849-1MG |
| Cas.: 487-79-6 | Purity: ≥99% | Kainic acid | ESD-878849-5MG |
| Cas.: 487-36-5 | Purity: 98% | (+)-Pinoresinol | ESD-878850-5MG |
| Cas.: 487020-03-1 | Purity: ≥99% | HI-TOPK-032 | ESD-878851-5MG |
| Cas.: 487020-03-1 | Purity: ≥99% | HI-TOPK-032 | ESD-878851-10MG |
| Cas.: 486-86-2 | Purity: 98% | N-Methylcytisine | ESD-878852-1MG |
| Cas.: 486-84-0 | Purity: 98% | Harman | ESD-878853-1MG |
| Cas.: 486-79-3 | Purity: ≥98% | Dipyrocetyl | ESD-878854-10MG |
| Cas.: 486-64-6 | Purity: 99% | Vasicinone | ESD-878855-5MG |
| Cas.: 486430-94-8 | Purity: 95% | Cyclocalopin A | ESD-878856-1MG |
| Cas.: 486430-93-7 | Purity: 97% | O-Acetylcyclocalopin A | ESD-878857-5MG |
| Cas.: 486427-17-2 | Purity: ≥99% | CIQ | ESD-878858-5MG |
| Cas.: 486427-17-2 | Purity: ≥99% | CIQ | ESD-878858-10MG |
| Cas.: 486-39-5 | Purity: 98% | Coclaurine | ESD-878859-5MG |
| Cas.: 486-28-2 | Purity: 98% | Fraxinol | ESD-878860-5MG |
| Cas.: 485-90-5 | Purity: 98% | Hydrangetin | ESD-878861-5MG |
| Cas.: 485811-84-5 | Purity: 97% | Mirabijalone D | ESD-878862-5MG |
| Cas.: 485-19-8 | Purity: 97% | Reticuline | ESD-878863-5MG |
| Cas.: 4849-90-5 | Purity: 99% | Aristolochic acid C | ESD-878864-5MG |
| Cas.: 484-74-2 | Purity: 98% | Isodictamnine | ESD-878865-5MG |
| Cas.: 4846-19-9 | Purity: ≥99% | N-Nornuciferine | ESD-878866-5MG |
| Cas.: 4846-19-9 | Purity: ≥99% | N-Nornuciferine | ESD-878866-10MG |
| Cas.: 484049-04-9 | Purity: ≥98% | DPH | ESD-878867-10MG |
| Cas.: 483-92-1 | Purity: 99% | Luvangetin | ESD-878868-5MG |
| Cas.: 483-91-0 | Purity: 98% | Calycanthoside | ESD-878869-5MG |
| Cas.: 483-66-9 | Purity: 97% | Sphondin | ESD-878870-5MG |
| Cas.: 483-34-1 | Purity: 98% | Tetrahydrocolumbamine | ESD-878871-1MG |
| Cas.: 483313-22-0 | Purity: ≥99% | SB-674042 | ESD-878872-5MG |
| Cas.: 483313-22-0 | Purity: ≥99% | SB-674042 | ESD-878872-10MG |
| Cas.: 483-09-0 | Purity: 98% | Isorauhimbine | ESD-878873-5MG |
| Cas.: 4829-56-5 | Purity: 98% | 14-Dehydrobrowniine | ESD-878874-5MG |
| Cas.: 482-91-7 | Purity: 95% | Aricine | ESD-878875-1MG |
| Cas.: 482-83-7 | Purity: 98% | Dalbergin | ESD-878876-1MG |
| Cas.: 482-70-2 | Purity: 98% | Chimaphilin | ESD-878877-5MG |
| Cas.: 482-68-8 | Purity: 97% | Sarpagine | ESD-878878-5MG |
| Cas.: 482-53-1 | Purity: 97% | Osajin | ESD-878879-5MG |
| Cas.: 482-39-3 | Purity: 95% | Afzelin | ESD-878880-5MG |
| Cas.: 48236-96-0 | Purity: 98% | Tetrahydroamentoflavone | ESD-878881-5MG |
| Cas.: 482-25-7 | Purity: 95% | Byakangelicin | ESD-878882-5MG |
| Cas.: 481-73-2 | Purity: 97% | Citreorosein | ESD-878883-5MG |
| Cas.: 481-45-8 | Purity: 97% | Kayaflavone | ESD-878884-5MG |
| Cas.: 481-18-5 | Purity: 95% | α-Spinasterol | ESD-878885-5MG |
| Cas.: 480998-12-7 | Purity: 98% | MC-DOXHZN hydrochloride | ESD-878886-2MG |
| Cas.: 480998-12-7 | Purity: 98% | MC-DOXHZN hydrochloride | ESD-878886-5MG |
| Cas.: 480-81-9 | Purity: 98% | Seneciphylline | ESD-878887-5MG |
| Cas.: 480-64-8 | Purity: 99% | Orsellinic acid | ESD-878888-1MG |
| Cas.: 480-56-8 | Purity: 97% | Lecanoric acid | ESD-878889-5MG |
| Cas.: 480-47-7 | Purity: 98% | Hydrangenol | ESD-878890-5MG |
| Cas.: 480449-71-6 | Purity: 98% | Edoxaban tosylate | ESD-878891-5MG |
| Cas.: 480449-71-6 | Purity: 98% | Edoxaban tosylate | ESD-878891-10MG |
| Cas.: 480-37-5 | Purity: 98% | Pinostrobin | ESD-878892-5MG |
| Cas.: 480-33-1 | Purity: 98% | Mellein | ESD-878893-5MG |
| Cas.: 480-23-9 | Purity: 98% | Orobol | ESD-878894-5MG |
| Cas.: 479-90-3 | Purity: 95% | Artemetin | ESD-878895-5MG |
| Cas.: 479683-64-2 | Purity: 98% | CP-809101 | ESD-878896-10MG |
| Cas.: 479683-64-2 | Purity: 98% | CP-809101 | ESD-878896-50MG |
| Cas.: 479636-66-3 | Purity: 95% | 8-(tert-Butoxycarbonyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-ene-3-carboxylic acid | ESD-878897-1G |
| Cas.: 479636-66-3 | Purity: 95% | 8-(tert-Butoxycarbonyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-ene-3-carboxylic acid | ESD-878897-5G |
| Cas.: 479636-65-2 | Purity: 95% | 3-ETHYL 8-BOC-1-OXA-2,8-DIAZASPIRO[4.5]DEC-2-ENE-3-CARBOXYLATE | ESD-878898-250MG |
| Cas.: 479636-65-2 | Purity: 95% | 3-ETHYL 8-BOC-1-OXA-2,8-DIAZASPIRO[4.5]DEC-2-ENE-3-CARBOXYLATE | ESD-878898-1G |
| Cas.: 479-50-5 | Purity: ≥98% | Lucanthone | ESD-878899-1MG |
| Cas.: 479-50-5 | Purity: ≥98% | Lucanthone | ESD-878899-5MG |
| Cas.: 479-43-6 | Purity: 98% | Canthin-6-one | ESD-878900-5MG |
| Cas.: 479-21-0 | Purity: 95% | Cotoin | ESD-878901-1MG |
| Cas.: 479-20-9 | Purity: 98% | Atranorin | ESD-878902-5MG |
| Cas.: 478963-79-0 | Purity: ≥99% | Calcium-Sensing Receptor Antagonists I | ESD-878903-10MG |
| Cas.: 478963-79-0 | Purity: ≥99% | Calcium-Sensing Receptor Antagonists I | ESD-878903-100MG |
| Cas.: 478-61-5 | Purity: 98% | Berbamine | ESD-878904-5MG |
| Cas.: 478314-67-9 | Purity: 98% | 4-Hydroxymethylphenol 1-O-rhamnoside | ESD-878905-5MG |
| Cas.: 478296-72-9 | Purity: ≥98% | Gabapentin enacarbil | ESD-878906-5MG |
| Cas.: 478296-72-9 | Purity: ≥98% | Gabapentin enacarbil | ESD-878906-10MG |
| Cas.: 478158-77-9 | Purity: 95% | Isoerysenegalensein E | ESD-878907-5MG |
| Cas.: 477953-07-4 | Purity: 97% | Neostenine | ESD-878908-5MG |
| Cas.: 477873-63-5 | Purity: 97% | 3-(2-Glucosyloxy-4-methoxyphenyl)propanoic acid | ESD-878909-5MG |
| Cas.: 477-84-9 | Purity: 98% | Damnacanthal | ESD-878910-5MG |
| Cas.: 477-57-6 | Purity: 97% | isotetrandrine | ESD-878911-5MG |
| Cas.: 477565-36-9 | Purity: 98% | Musellarin A | ESD-878912-5MG |
| Cas.: 477529-70-7 | Purity: 95% | Sculponeatin K | ESD-878913-1MG |
| Cas.: 477-33-8 | Purity: 98% | Samidin | ESD-878914-5MG |
| Cas.: 477336-75-7 | Purity: 96% | Ophiopogonanone C | ESD-878915-5MG |
| Cas.: 476682-97-0 | Purity: 96% | 6,9,10-Trihydroxy-7-megastigmen-3-one | ESD-878916-5MG |
| Cas.: 476630-49-6 | Purity: 95% | Eupaglehnin C | ESD-878917-5MG |
| Cas.: 476617-51-3 | Purity: 98% | Bay 41-4109 less active enantiomer | ESD-878918-1MG |
| Cas.: 476617-51-3 | Purity: 98% | Bay 41-4109 less active enantiomer | ESD-878918-5MG |
| Cas.: 476322-70-0 | Purity: 98% | NGD-4715 | ESD-878919-1MG |
| Cas.: 476322-70-0 | Purity: 98% | NGD-4715 | ESD-878919-5MG |
| Cas.: 476159-98-5 | Purity: ≥99% | AZM475271 | ESD-878920-5MG |
| Cas.: 476159-98-5 | Purity: ≥99% | AZM475271 | ESD-878920-10MG |
| Cas.: 475-81-0 | Purity: 98% | Glaucine | ESD-878921-5MG |
| Cas.: 4757-55-5 | Purity: 98% | Dimetacrine | ESD-878922-1MG |
| Cas.: 4757-55-5 | Purity: 98% | Dimetacrine | ESD-878922-5MG |
| Cas.: 475-75-2 | Purity: 96% | Liriodenine | ESD-878923-5MG |
| Cas.: 475650-36-3 | Purity: ≥99% | Inarigivir | ESD-878924-5MG |
| Cas.: 475650-36-3 | Purity: ≥99% | Inarigivir | ESD-878924-10MG |
| Cas.: 475479-34-6 | Purity: ≥99% | Aleglitazar | ESD-878925-5MG |
| Cas.: 475085-57-5 | Purity: ≥99% | MRE-269 | ESD-878926-2MG |
| Cas.: 475085-57-5 | Purity: ≥99% | MRE-269 | ESD-878926-5MG |
| Cas.: 4745-17-9 | Purity: 95% | 1,4-dioxaspiro[4.4]nonan-2-ylmethanamine | ESD-878927-10MG |
| Cas.: 4745-17-9 | Purity: 95% | 1,4-dioxaspiro[4.4]nonan-2-ylmethanamine | ESD-878927-50MG |
| Cas.: 47439-36-1 | Purity: 98% | Nitroxazepine | ESD-878929-1MG |
| Cas.: 47439-36-1 | Purity: 98% | Nitroxazepine | ESD-878929-5MG |
| Cas.: 474012-90-3 | Purity: 98% | CAL-130 Racemate | ESD-878930-2MG |
| Cas.: 474012-90-3 | Purity: 98% | CAL-130 Racemate | ESD-878930-5MG |
| Cas.: 473981-11-2 | Purity: 98% | Forskolin G | ESD-878931-5MG |
| Cas.: 473921-12-9 | Purity: ≥98% | Lersivirine | ESD-878932-5MG |
| Cas.: 473921-12-9 | Purity: ≥98% | Lersivirine | ESD-878932-10MG |
| Cas.: 473728-58-4 | Purity: ≥95% | SCH 563705 | ESD-878933-2MG |
| Cas.: 473728-58-4 | Purity: ≥95% | SCH 563705 | ESD-878933-5MG |
| Cas.: 473727-83-2 | Purity: ≥98% | Navarixin | ESD-878934-5MG |
| Cas.: 473727-83-2 | Purity: ≥98% | Navarixin | ESD-878934-10MG |
| Cas.: 473720-30-8 | Purity: ≥98% | AMG 487 S-enantiomer | ESD-878935-2MG |
| Cas.: 473720-30-8 | Purity: ≥98% | AMG 487 S-enantiomer | ESD-878935-5MG |
| Cas.: 473719-41-4 | Purity: ≥99% | AMG 487 | ESD-878936-2MG |
| Cas.: 473719-41-4 | Purity: ≥99% | AMG 487 | ESD-878936-5MG |
| Cas.: 473451-73-9 | Purity: 98% | Carpinontriol B | ESD-878937-5MG |
| Cas.: 473451-72-8 | Purity: 97% | Carpinontriol A | ESD-878938-5MG |
| Cas.: 473268-46-1 | Purity: ≥99% | ADDA 5 hydrochloride | ESD-878939-5MG |
| Cas.: 473268-46-1 | Purity: ≥99% | ADDA 5 hydrochloride | ESD-878939-10MG |
| Cas.: 47326-53-4 | Purity: 98% | Spegatrine | ESD-878940-5MG |
| Cas.: 4730-93-2 | Purity: 95% | 3a’,4′,7′,7a’-tetrahydrospiro[cyclopropane-1,8′-[2]oxa[4,7]methano[2]benzofuran]-1′,3′-dione | ESD-878941-1G |
| Cas.: 4728-30-7 | Purity: 97% | Isopimara-8(14),15-dien-3β-ol | ESD-878942-5MG |
| Cas.: 472-30-0 | Purity: 98% | Masticadienolic acid | ESD-878943-5MG |
| Cas.: 471-69-2 | Purity: 98% | Dipterocarpol | ESD-878944-5MG |
| Cas.: 471271-55-3 | Purity: 97% | (E)-Aldosecoganin | ESD-878945-5MG |
| Cas.: 4707-33-9 | Purity: 98% | α-Lapachone | ESD-878946-5MG |
| Cas.: 469-39-6 | Purity: 97% | Cycloeucalenol | ESD-878948-5MG |
| Cas.: 468747-17-3 | Purity: ≥99% | mTOR inhibitor-1 | ESD-878949-5MG |
| Cas.: 468747-17-3 | Purity: ≥99% | mTOR inhibitor-1 | ESD-878949-10MG |
| Cas.: 468-68-8 | Purity: 95% | Drimenol | ESD-878950-5MG |
| Cas.: 4684-32-6 | Purity: 98% | Picrinine | ESD-878951-5MG |
| Cas.: 4684-28-0 | Purity: 95% | Norscopolamine | ESD-878952-1MG |
| Cas.: 468103-76-6 | Purity: 97% | 2,7-Dihydroxy-1,6-dimethylpyrene | ESD-878953-5MG |
| Cas.: 467-81-2 | Purity: 96% | Rehmannic acid | ESD-878954-5MG |
| Cas.: 467459-31-0 | Purity: 98% | Idalopirdine | ESD-878955-2MG |
| Cas.: 467459-31-0 | Purity: 98% | Idalopirdine | ESD-878955-5MG |
| Cas.: 4666-84-6 | Purity: 98% | Cryptomeridiol | ESD-878956-5MG |
| Cas.: 466-09-1 | Purity: 97% | Uzarigenin | ESD-878957-5MG |
| Cas.: 466-02-4 | Purity: 97% | Hedragonic acid | ESD-878958-5MG |
| Cas.: 466-01-3 | Purity: 97% | Hederagonic acid | ESD-878959-5MG |
| Cas.: 4657-58-3 | Purity: 98% | Cycloartanol | ESD-878960-5MG |
| Cas.: 465-74-7 | Purity: 96% | quinovic acid | ESD-878961-5MG |
| Cas.: 465-16-7 | Purity: ≥99% | Oleandrin | ESD-878962-2MG |
| Cas.: 465-16-7 | Purity: ≥99% | Oleandrin | ESD-878962-5MG |
| Cas.: 4651-46-1 | Purity: 96% | α-Spinasterol acetate | ESD-878963-5MG |
| Cas.: 465-13-4 | Purity: 97% | Neritaloside | ESD-878964-5MG |
| Cas.: 465-02-1 | Purity: 97% | Germanicol | ESD-878965-5MG |
| Cas.: 465-00-9 | Purity: 98% | Arjunolic acid | ESD-878966-5MG |
| Cas.: 464930-42-5 | Purity: ≥99% | SSR240612 | ESD-878967-5MG |
| Cas.: 464930-42-5 | Purity: ≥99% | SSR240612 | ESD-878967-10MG |
| Cas.: 464924-27-4 | Purity: 98% | SLLK, Control Peptide for TSP1 Inhibitor | ESD-878968-1MG |
| Cas.: 464924-27-4 | Purity: 98% | SLLK, Control Peptide for TSP1 Inhibitor | ESD-878968-5MG |
| Cas.: 464-86-8 | Purity: 98% | Conquinamine | ESD-878969-5MG |
| Cas.: 464-85-7 | Purity: 97% | Quinamine | ESD-878970-5MG |
| Cas.: 4646-86-0 | Purity: 98% | (R)-4-Methoxydalbergione | ESD-878971-5MG |
| Cas.: 460746-46-7 | Purity: ≥99% | ABT-239 | ESD-878972-1MG |
| Cas.: 460746-46-7 | Purity: ≥99% | ABT-239 | ESD-878972-5MG |
| Cas.: 460330-27-2 | Purity: 98% | GT 949 | ESD-878973-5MG |
| Cas.: 460330-27-2 | Purity: 98% | GT 949 | ESD-878973-10MG |
| Cas.: 4602-36-2 | Purity: 97% | 3-Phenyl-1,4-diazaspiro[4.5]dec-3-ene-2-thione | ESD-878974-500MG |
| Cas.: 4602-36-2 | Purity: 97% | 3-Phenyl-1,4-diazaspiro[4.5]dec-3-ene-2-thione | ESD-878974-1G |
| Cas.: 459856-18-9 | Purity: 98% | Pexacerfont | ESD-878975-1MG |
| Cas.: 459856-18-9 | Purity: 98% | Pexacerfont | ESD-878975-5MG |
| Cas.: 459836-30-7 | Purity: 98% | PEAQX | ESD-878976-5MG |
| Cas.: 459836-30-7 | Purity: 98% | PEAQX | ESD-878976-10MG |
| Cas.: 45982-66-9 | Purity: 95% | 1,4-dioxaspiro[4.5]decan-2-ylmethanamine | ESD-878977-1G |
| Cas.: 45982-66-9 | Purity: 95% | 1,4-dioxaspiro[4.5]decan-2-ylmethanamine | ESD-878977-2.5G |
| Cas.: 4586-68-9 | Purity: 97% | Ilicic acid | ESD-878978-5MG |
| Cas.: 4580-63-6 | Purity: 95% | 1-Thia-4-azaspiro[4.5]decan-3-one | ESD-878979-500MG |
| Cas.: 4580-63-6 | Purity: 95% | 1-Thia-4-azaspiro[4.5]decan-3-one | ESD-878979-1G |
| Cas.: 457081-03-7 | Purity: ≥98% | Pyridone 6 | ESD-878980-1MG |
| Cas.: 457081-03-7 | Purity: ≥98% | Pyridone 6 | ESD-878980-2MG |
| Cas.: 457048-34-9 | Purity: 98% | 1alpha, 24, 25-Trihydroxy VD2 | ESD-878981-1MG |
| Cas.: 457048-34-9 | Purity: 98% | 1alpha, 24, 25-Trihydroxy VD2 | ESD-878981-5MG |
| Cas.: 4569-98-6 | Purity: 98% | 5-O-Methylgenistein | ESD-878982-5MG |
| Cas.: 455325-51-6 | Purity: ≥97% | ATB107 | ESD-878983-5MG |
| Cas.: 455325-51-6 | Purity: ≥97% | ATB107 | ESD-878983-10MG |
| Cas.: 455264-31-0 | Purity: ≥98% | Zaurategrast | ESD-878984-5MG |
| Cas.: 455264-31-0 | Purity: ≥98% | Zaurategrast | ESD-878984-10MG |
| Cas.: 455264-30-9 | Purity: ≥99% | Zaurategrast ethyl ester | ESD-878985-5MG |
| Cas.: 455264-30-9 | Purity: ≥99% | Zaurategrast ethyl ester | ESD-878985-10MG |
| Cas.: 455255-15-9 | Purity: 95% | Isovouacapenol C | ESD-878986-5MG |
| Cas.: 454212-54-5 | Purity: 98% | Nudifloside D | ESD-878987-5MG |
| Cas.: 453518-30-4 | Purity: 95% | Saprirearine | ESD-878988-1MG |
| Cas.: 4533-39-5 | Purity: 98% | Nitracrine | ESD-878989-1MG |
| Cas.: 4533-39-5 | Purity: 98% | Nitracrine | ESD-878989-5MG |
| Cas.: 452-35-7 | Purity: ≥98% | Ethoxzolamide | ESD-878990-100MG |
| Cas.: 451-71-8 | Purity: 98% | Glyhexamide | ESD-878991-1MG |
| Cas.: 451-71-8 | Purity: 98% | Glyhexamide | ESD-878991-5MG |
| Cas.: 451493-31-5 | Purity: ≥99% | AV-412 | ESD-878992-2MG |
| Cas.: 451493-31-5 | Purity: ≥99% | AV-412 | ESD-878992-5MG |
| Cas.: 451492-95-8 | Purity: ≥98% | AV-412 free base | ESD-878993-2MG |
| Cas.: 451492-95-8 | Purity: ≥98% | AV-412 free base | ESD-878993-5MG |
| Cas.: 451478-47-0 | Purity: 98% | 10-Hydroxydihydroperaksine | ESD-878994-5MG |
| Cas.: 451462-58-1 | Purity: 98% | H-1152 | ESD-878995-2MG |
| Cas.: 451462-58-1 | Purity: 98% | H-1152 | ESD-878995-5MG |
| Cas.: 450348-85-3 | Purity: ≥99% | AVE-3085 | ESD-878996-1MG |
| Cas.: 450348-85-3 | Purity: ≥99% | AVE-3085 | ESD-878996-5MG |
| Cas.: 449808-64-4 | Purity: ≥98% | R1487 Hydrochloride | ESD-878997-5MG |
| Cas.: 449808-64-4 | Purity: ≥98% | R1487 Hydrochloride | ESD-878997-10MG |
| Cas.: 449729-89-9 | Purity: 98% | (+)-S-Myricanol glucoside | ESD-878998-5MG |
| Cas.: 4491-19-4 | Purity: 98% | Indaconitine | ESD-878999-5MG |
| Cas.: 4491-19-4 | Purity: 98% | Indaconitine | ESD-878999-10MG |
| Cas.: 448949-11-9 | Purity: 95% | 4′,4”-Dihydroxyanigorootin | ESD-879000-5MG |
| Cas.: 448906-42-1 | Purity: ≥99% | ITE | ESD-879001-5MG |
| Cas.: 448906-42-1 | Purity: ≥99% | ITE | ESD-879001-10MG |
| Cas.: 4478-33-5 | Purity: 97% | 8-Hydroxythymol | ESD-879002-5MG |
| Cas.: 447454-49-1 | Purity: 95% | Ruixianglangdusu B | ESD-879003-1MG |
| Cas.: 446-71-9 | Purity: 98% | Homoeriodictyol | ESD-879004-5MG |
| Cas.: 446292-10-0 | Purity: 98% | 4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one | ESD-879005-5MG |
| Cas.: 445295-04-5 | Purity: ≥99% | CP671305 | ESD-879006-1MG |
| Cas.: 445295-04-5 | Purity: ≥99% | CP671305 | ESD-879006-5MG |
| Cas.: 4449-55-2 | Purity: 98% | Warangalone | ESD-879008-5MG |
| Cas.: 444932-31-4 | Purity: 98% | TC-O 9311 | ESD-879009-5MG |
| Cas.: 444932-31-4 | Purity: 98% | TC-O 9311 | ESD-879009-10MG |
| Cas.: 444890-41-9 | Purity: 98% | Mitoquinone | ESD-879010-5MG |
| Cas.: 444890-41-9 | Purity: 98% | Mitoquinone | ESD-879010-10MG |
| Cas.: 444-27-9 | Purity: ≥98% | Timonacic | ESD-879011-100MG |
| Cas.: 4439-68-3 | Purity: 97% | Norkhellol | ESD-879012-5MG |
| Cas.: 443913-15-3 | Purity: ≥99% | p38-α MAPK-IN-1 | ESD-879013-1MG |
| Cas.: 443913-15-3 | Purity: ≥99% | p38-α MAPK-IN-1 | ESD-879013-5MG |
| Cas.: 443639-96-1 | Purity: ≥99% | S119-8 | ESD-879014-5MG |
| Cas.: 443639-96-1 | Purity: ≥99% | S119-8 | ESD-879014-10MG |
| Cas.: 4431-42-9 | Purity: 98% | Isopedicin | ESD-879015-5MG |
| Cas.: 443104-02-7 | Purity: ≥98% | CDDO-Im | ESD-879016-2MG |
| Cas.: 443104-02-7 | Purity: ≥98% | CDDO-Im | ESD-879016-5MG |
| Cas.: 4430-35-7 | Purity: ≥98% | Hesperin | ESD-879017-5MG |
| Cas.: 4430-35-7 | Purity: ≥98% | Hesperin | ESD-879017-10MG |
| Cas.: 442908-10-3 | Purity: ≥98% | Vipadenant | ESD-879018-2MG |
| Cas.: 442908-10-3 | Purity: ≥98% | Vipadenant | ESD-879018-5MG |
| Cas.: 442851-27-6 | Purity: 97% | Methyl isodrimeninol | ESD-879019-5MG |
| Cas.: 442666-98-0 | Purity: ≥99% | Anguizole | ESD-879020-5MG |
| Cas.: 442666-98-0 | Purity: ≥99% | Anguizole | ESD-879020-10MG |
| Cas.: 441764-20-1 | Purity: 98% | Rubanthrone A | ESD-879021-5MG |
| Cas.: 440122-66-7 | Purity: ≥98% | WAY-200070 | ESD-879022-5MG |
| Cas.: 440122-66-7 | Purity: ≥98% | WAY-200070 | ESD-879022-10MG |
| Cas.: 440087-73-0 | Purity: 95% | Spiro[cyclopentane-1,3′-(3′,4′-dihydro-isoquinolin)]-1′-yl-aminoacetic acid | ESD-879023-1G |
| Cas.: 439923-16-7 | Purity: 96% | Isoscabertopin | ESD-879024-5MG |
| Cas.: 439-89-4 | Purity: 98% | Gentianine | ESD-879025-5MG |
| Cas.: 439575-02-7 | Purity: ≥97% | BMS-509744 | ESD-879027-2MG |
| Cas.: 439575-02-7 | Purity: ≥97% | BMS-509744 | ESD-879027-5MG |
| Cas.: 439288-66-1 | Purity: ≥99% | GW627368 | ESD-879028-1MG |
| Cas.: 439288-66-1 | Purity: ≥99% | GW627368 | ESD-879028-5MG |
| Cas.: 439239-90-4 | Purity: 98% | Lasmiditan | ESD-879029-2MG |
| Cas.: 439239-90-4 | Purity: 98% | Lasmiditan | ESD-879029-5MG |
| Cas.: 439153-64-7 | Purity: 98% | LNK754 | ESD-879030-1MG |
| Cas.: 439153-64-7 | Purity: 98% | LNK754 | ESD-879030-5MG |
| Cas.: 439144-66-8 | Purity: ≥98% | IMD-0560 | ESD-879031-1MG |
| Cas.: 439144-66-8 | Purity: ≥98% | IMD-0560 | ESD-879031-5MG |
| Cas.: 439083-90-6 | Purity: ≥98% | Bay 60-7550 | ESD-879032-5MG |
| Cas.: 439083-90-6 | Purity: ≥98% | Bay 60-7550 | ESD-879032-10MG |
| Cas.: 438621-58-0 | Purity: 95% | 8-BENZYL-1,3,8-TRIAZASPIRO[4.5]DECAN-2-ONE | ESD-879033-250MG |
| Cas.: 438621-58-0 | Purity: 95% | 8-BENZYL-1,3,8-TRIAZASPIRO[4.5]DECAN-2-ONE | ESD-879033-1G |
| Cas.: 438536-34-6 | Purity: 95% | 3(20)-Phytene-1,2-diol | ESD-879034-5MG |
| Cas.: 4382-56-3 | Purity: 98% | Perakine | ESD-879035-5MG |
| Cas.: 4382-34-7 | Purity: 97% | Robtin | ESD-879036-5MG |
| Cas.: 4382-33-6 | Purity: 98% | Dihydrorobinetin | ESD-879037-5MG |
| Cas.: 4382-17-6 | Purity: 97% | Quercetin 3,3′-dimethyl ether | ESD-879038-5MG |
| Cas.: 437615-43-5 | Purity: 97% | 3”,4”-Di-Op-coumaroylquercitrin | ESD-879039-5MG |
| Cas.: 437-50-3 | Purity: 98% | Gentisin | ESD-879040-5MG |
| Cas.: 436088-64-1 | Purity: 95% | 2-Amino-8-phenyl-7,9-dioxa-1-thia-3-aza-spiro[4.5]dec-2-en-4-one | ESD-879042-1G |
| Cas.: 435-97-2 | Purity: ≥98% | Phenprocoumon | ESD-879043-10MG |
| Cas.: 435-97-2 | Purity: ≥98% | Phenprocoumon | ESD-879043-50MG |
| Cas.: 4339-72-4 | Purity: 95% | 3-O-Acetyloleanolic acid | ESD-879044-5MG |
| Cas.: 4338-47-0 | Purity: ≥99% | Kinetin riboside | ESD-879045-100MG |
| Cas.: 432529-82-3 | Purity: ≥97% | BCI-121 | ESD-879046-5MG |
| Cas.: 432529-82-3 | Purity: ≥97% | BCI-121 | ESD-879046-10MG |
| Cas.: 432499-63-3 | Purity: ≥98% | 4E2RCat | ESD-879047-1MG |
| Cas.: 432499-63-3 | Purity: ≥98% | 4E2RCat | ESD-879047-5MG |
| Cas.: 4320-13-2 | Purity: ≥97% | Thiazinamium chloride | ESD-879048-1MG |
| Cas.: 4320-13-2 | Purity: ≥97% | Thiazinamium chloride | ESD-879048-5MG |
| Cas.: 43200-81-3 | Purity: 98% | 6-(5-Chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one | ESD-879049-5MG |
| Cas.: 431980-38-0 | Purity: ≥99% | RN-18 | ESD-879051-5MG |
| Cas.: 431980-38-0 | Purity: ≥99% | RN-18 | ESD-879051-10MG |
| Cas.: 431979-47-4 | Purity: ≥98% | SJ-172550 | ESD-879052-5MG |
| Cas.: 431979-47-4 | Purity: ≥98% | SJ-172550 | ESD-879052-10MG |
| Cas.: 4312-32-7 | Purity: 98% | Tetrahydrocoptisine | ESD-879053-5MG |
| Cas.: 4312-32-7 | Purity: 98% | Tetrahydrocoptisine | ESD-879053-10MG |
| Cas.: 431040-19-6 | Purity: 98% | Adenosine antagonist-1 | ESD-879054-1MG |
| Cas.: 431040-19-6 | Purity: 98% | Adenosine antagonist-1 | ESD-879054-5MG |
| Cas.: 430462-93-4 | Purity: 98% | HQ-415 | ESD-879055-2MG |
| Cas.: 430462-93-4 | Purity: 98% | HQ-415 | ESD-879055-5MG |
| Cas.: 429658-95-7 | Purity: ≥99% | Dabigatran ethyl ester | ESD-879056-5MG |
| Cas.: 429658-95-7 | Purity: ≥99% | Dabigatran ethyl ester | ESD-879056-10MG |
| Cas.: 42940-56-7 | Purity: 95% | 7,9-Dioxo-8-azaspiro[4.5]decane-6,10-dicarbonitrile | ESD-879057-500MG |
| Cas.: 4290-13-5 | Purity: 95% | Santamarine | ESD-879058-5MG |
| Cas.: 428861-91-0 | Purity: 98% | PNU-176798 | ESD-879059-1MG |
| Cas.: 428861-91-0 | Purity: 98% | PNU-176798 | ESD-879059-5MG |
| Cas.: 428-38-6 | Purity: 95% | 2,3-dihydrospiro[indene-1,4′-piperidine] | ESD-879060-1G |
| Cas.: 42835-68-7 | Purity: 98% | Flumequine sodium | ESD-879061-5MG |
| Cas.: 42833-49-8 | Purity: 98% | 2,3-Dimethoxyxanthone | ESD-879062-5MG |
| Cas.: 42830-48-8 | Purity: 98% | Catechin 7-O-xyloside | ESD-879063-5MG |
| Cas.: 426821-85-4 | Purity: 95% | 4-Hydroxy-3-methoxyphenol 1-O-(6-O-syringoyl)glucoside | ESD-879064-1MG |
| Cas.: 4267-80-5 | Purity: 98% | Hemapolin | ESD-879065-5MG |
| Cas.: 4263-87-0 | Purity: 96% | Dehydrodiconiferyl alcohol | ESD-879067-5MG |
| Cas.: 426266-88-8 | Purity: 95% | 21,23-Dihydro-23-hydroxy-21-oxozapoterin | ESD-879068-5MG |
| Cas.: 425680-98-4 | Purity: 95% | 8-Hydroxybergaptol 5-O-glucoside | ESD-879069-5MG |
| Cas.: 425613-09-8 | Purity: ≥99% | SJ000291942 | ESD-879070-5MG |
| Cas.: 425613-09-8 | Purity: ≥99% | SJ000291942 | ESD-879070-10MG |
| Cas.: 425408-42-0 | Purity: 96% | Ethyl chlorogenate | ESD-879071-5MG |
| Cas.: 424792-50-7 | Purity: 95% | 4′-METHOXYSPIRO[CYCLOPROPANE-1,3′-INDOLIN]-2′-ONE | ESD-879072-1G |
| Cas.: 42438-78-8 | Purity: 98% | Pashanone | ESD-879073-5MG |
| Cas.: 4237-93-8 | Purity: 98% | ACTH 11-24 | ESD-879074-1MG |
| Cas.: 4237-93-8 | Purity: 98% | ACTH 11-24 | ESD-879074-5MG |
| Cas.: 423170-79-0 | Purity: 98% | (-)-Phaselic acid | ESD-879075-5MG |
| Cas.: 423148-78-1 | Purity: ≥98% | PYZD-4409 | ESD-879076-5MG |
| Cas.: 423148-78-1 | Purity: ≥98% | PYZD-4409 | ESD-879076-10MG |
| Cas.: 42191-83-3 | Purity: 97% | Ethyl 3H-spiro[isobenzofuran-1,4′-piperidine]-1′-carboxylate | ESD-879077-5G |
| Cas.: 421583-14-4 | Purity: 98% | Cephalocyclidin A | ESD-879078-5MG |
| Cas.: 421558-76-1 | Purity: 98% | Artemyriantholide D | ESD-879079-5MG |
| Cas.: 420831-40-9 | Purity: ≥99% | AK-7 | ESD-879080-10MG |
| Cas.: 420831-40-9 | Purity: ≥99% | AK-7 | ESD-879080-50MG |
| Cas.: 4206-58-0 | Purity: 95% | Sinapaldehyde | ESD-879081-5G |
| Cas.: 420126-30-3 | Purity: ≥99% | Antitumor agent-3 | ESD-879082-2MG |
| Cas.: 420126-30-3 | Purity: ≥99% | Antitumor agent-3 | ESD-879082-5MG |
| Cas.: 41997-41-5 | Purity: 95% | Dihydropashanone | ESD-879083-1MG |
| Cas.: 41983-91-9 | Purity: 99% | Glabranin | ESD-879084-5MG |
| Cas.: 4197-97-1 | Purity: 98% | Pinocembrin chalcone | ESD-879085-5MG |
| Cas.: 419547-11-8 | Purity: ≥98% | NAV-2729 | ESD-879086-5MG |
| Cas.: 419547-11-8 | Purity: ≥98% | NAV-2729 | ESD-879086-10MG |
| Cas.: 41945-48-6 | Purity: ≥98% | Sodium tauroglycocholate | ESD-879087-100MG |
| Cas.: 4184-34-3 | Purity: 98% | Mangiferolic acid | ESD-879088-5MG |
| Cas.: 41787-69-3 | Purity: 95% | Junicedric acid | ESD-879089-1MG |
| Cas.: 4177-58-6 | Purity: 98% | Clothixamide | ESD-879090-1MG |
| Cas.: 4177-58-6 | Purity: 98% | Clothixamide | ESD-879090-5MG |
| Cas.: 41756-77-8 | Purity: 95% | Dihydrophaseic acid | ESD-879091-1MG |
| Cas.: 41744-39-2 | Purity: 95% | Acuminatin | ESD-879092-1MG |
| Cas.: 41743-86-6 | Purity: 98% | (-)-Sativan | ESD-879093-5MG |
| Cas.: 41743-57-1 | Purity: 98% | Sugeroside | ESD-879094-5MG |
| Cas.: 41743-56-0 | Purity: 98% | Luteone | ESD-879095-5MG |
| Cas.: 41743-41-3 | Purity: 98% | Procyanidin A2 | ESD-879096-5MG |
| Cas.: 41733-55-5 | Purity: ≥99% | Furosemide sodium | ESD-879097-500MG |
| Cas.: 41733-55-5 | Purity: ≥99% | Furosemide sodium | ESD-879097-1G |
| Cas.: 41703-38-2 | Purity: 96% | Grasshopper ketone | ESD-879098-5MG |
| Cas.: 41689-50-3 | Purity: 98% | Epiaschantin | ESD-879099-5MG |
| Cas.: 41682-30-8 | Purity: 95% | 8-Acetoxypentadeca-1,9Z-diene-4,6-diyn-3-ol | ESD-879100-1MG |
| Cas.: 41682-21-7 | Purity: 95% | 8-Methyleugenitol | ESD-879101-5MG |
| Cas.: 41653-73-0 | Purity: 97% | Koaburaside | ESD-879102-5MG |
| Cas.: 41653-72-9 | Purity: 95% | Lacinilene C | ESD-879103-5MG |
| Cas.: 41610-69-9 | Purity: 95% | Ylangenol | ESD-879104-5MG |
| Cas.: 41607-20-9 | Purity: 98% | (-)-Pinoresinol 4-O-glucoside | ESD-879105-5MG |
| Cas.: 415903-37-6 | Purity: ≥99% | Grapiprant | ESD-879106-5MG |
| Cas.: 415903-37-6 | Purity: ≥99% | Grapiprant | ESD-879106-10MG |
| Cas.: 41590-29-8 | Purity: 95% | 4,R-ajmalicine N-oxide | ESD-879107-1MG |
| Cas.: 41552-95-8 | Purity: ≥99% | A2AR-agonist-1 | ESD-879108-5MG |
| Cas.: 41552-95-8 | Purity: ≥99% | A2AR-agonist-1 | ESD-879108-10MG |
| Cas.: 41552-82-3 | Purity: 98% | N6-Cyclopentyladenosine | ESD-879109-1MG |
| Cas.: 41530-90-9 | Purity: 98% | ent-Kaurane-2α,6α,16β-triol | ESD-879110-5MG |
| Cas.: 41514-64-1 | Purity: 98% | Koaburaside monomethyl ether | ESD-879111-5MG |
| Cas.: 41447-16-9 | Purity: 95% | (+)-N-Methylallosedridine | ESD-879112-1MG |
| Cas.: 41447-15-8 | Purity: 95% | (-)-N-Methylsedridine | ESD-879113-1MG |
| Cas.: 41442-57-3 | Purity: 98% | 5-Heptadecylresorcinol | ESD-879114-5MG |
| Cas.: 413599-62-9 | Purity: ≥99% | ZD-4190 | ESD-879115-5MG |
| Cas.: 413599-62-9 | Purity: ≥99% | ZD-4190 | ESD-879115-10MG |
| Cas.: 41347-49-3 | Purity: 96% | Anhydrotuberosin | ESD-879116-5MG |
| Cas.: 41332-24-5 | Purity: ≥98% | NP118809 | ESD-879117-100MG |
| Cas.: 41332-24-5 | Purity: ≥98% | NP118809 | ESD-879117-200MG |
| Cas.: 412950-08-4 | Purity: ≥99% | Rilapladib | ESD-879118-5MG |
| Cas.: 412950-08-4 | Purity: ≥99% | Rilapladib | ESD-879118-10MG |
| Cas.: 412029-03-9 | Purity: 98% | erythro-Guaiacylglycerol β-sinapyl ether 7-O-glucoside | ESD-879119-5MG |
| Cas.: 41177-35-9 | Purity: 98% | CS476 | ESD-879120-1MG |
| Cas.: 41177-35-9 | Purity: 98% | CS476 | ESD-879120-5MG |
| Cas.: 41137-87-5 | Purity: 96% | Hirsutenone | ESD-879121-5MG |
| Cas.: 41137-86-4 | Purity: 98% | Hirsutanonol | ESD-879122-5MG |
| Cas.: 41137-85-3 | Purity: 99% | Platyphyllonol | ESD-879123-5MG |
| Cas.: 41060-16-6 | Purity: 97% | Skullcapflavone I | ESD-879124-5MG |
| Cas.: 410528-02-8 | Purity: ≥99% | Palovarotene | ESD-879125-5MG |
| Cas.: 410528-02-8 | Purity: ≥99% | Palovarotene | ESD-879125-10MG |
| Cas.: 410074-74-7 | Purity: ≥99% | Amitifadine hydrochloride | ESD-879126-5MG |
| Cas.: 410074-74-7 | Purity: ≥99% | Amitifadine hydrochloride | ESD-879126-10MG |
| Cas.: 410074-60-1 | Purity: ≥99% | CCG 203769 | ESD-879127-5MG |
| Cas.: 410074-60-1 | Purity: ≥99% | CCG 203769 | ESD-879127-10MG |
| Cas.: 4099-30-3 | Purity: ≥99% | Desacetylcinobufotalin | ESD-879128-5MG |
| Cas.: 4099-30-3 | Purity: ≥99% | Desacetylcinobufotalin | ESD-879128-10MG |
| Cas.: 40951-69-7 | Purity: 97% | Taxiresinol | ESD-879130-5MG |
| Cas.: 409351-28-6 | Purity: ≥99% | VU0152100 | ESD-879131-10MG |
| Cas.: 409351-28-6 | Purity: ≥99% | VU0152100 | ESD-879131-50MG |
| Cas.: 409345-29-5 | Purity: ≥98% | JNJ16259685 | ESD-879132-5MG |
| Cas.: 409345-29-5 | Purity: ≥98% | JNJ16259685 | ESD-879132-10MG |
| Cas.: 4093-35-0 | Purity: 98% | Bromopride | ESD-879133-5MG |
| Cas.: 4093-35-0 | Purity: 98% | Bromopride | ESD-879133-10MG |
| Cas.: 40918-90-9 | Purity: 97% | 3,4-Dimethoxycinnamyl alcohol | ESD-879134-5MG |
| Cas.: 4083-56-1 | Purity: 95% | 1-thia-4-azaspiro[5.5]undecane | ESD-879135-10MG |
| Cas.: 4083-56-1 | Purity: 95% | 1-thia-4-azaspiro[5.5]undecane | ESD-879135-50MG |
| Cas.: 408324-76-5 | Purity: 98% | Hannokinol | ESD-879136-5MG |
| Cas.: 408324-01-6 | Purity: 96% | 3,5-Dihydroxy-1,7-bis(3,4-dihydroxyphenyl)heptane | ESD-879137-5MG |
| Cas.: 408324-00-5 | Purity: 97% | 3,5-Dihydroxy-1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)heptane | ESD-879138-5MG |
| Cas.: 408303-43-5 | Purity: ≥99% | GW 766994 | ESD-879139-5MG |
| Cas.: 408303-43-5 | Purity: ≥99% | GW 766994 | ESD-879139-10MG |
| Cas.: 40768-81-8 | Purity: 95% | 1,7-Diepi-8,15-cedranediol | ESD-879140-5MG |
| Cas.: 40716-66-3 | Purity: 95% | Nerolidol | ESD-879141-1MG |
| Cas.: 406-76-8 | Purity: 98% | DL-Carnitine | ESD-879142-500MG |
| Cas.: 406-76-8 | Purity: 98% | DL-Carnitine | ESD-879142-5G |
| Cas.: 40672-47-7 | Purity: 97% | Taxifolin 3-O-xyloside | ESD-879143-5MG |
| Cas.: 40661-45-8 | Purity: 96% | Cornoside | ESD-879144-5MG |
| Cas.: 406228-55-5 | Purity: ≥99% | A-385358 | ESD-879145-5MG |
| Cas.: 406228-55-5 | Purity: ≥99% | A-385358 | ESD-879145-10MG |
| Cas.: 406211-06-1 | Purity: ≥95% | IKK-IN-1 | ESD-879146-1MG |
| Cas.: 406211-06-1 | Purity: ≥95% | IKK-IN-1 | ESD-879146-5MG |
| Cas.: 406205-74-1 | Purity: ≥98% | Bay 59-3074 | ESD-879147-5MG |
| Cas.: 406205-74-1 | Purity: ≥98% | Bay 59-3074 | ESD-879147-10MG |
| Cas.: 405911-09-3 | Purity: 98% | GW3965 | ESD-879148-5MG |
| Cas.: 405911-09-3 | Purity: 98% | GW3965 | ESD-879148-10MG |
| Cas.: 405281-76-7 | Purity: 96% | Dadahol A | ESD-879149-5MG |
| Cas.: 405157-88-2 | Purity: 95% | Drechslerine D | ESD-879150-5MG |
| Cas.: 405157-84-8 | Purity: 97% | Drechslerine A | ESD-879151-5MG |
| Cas.: 405098-33-1 | Purity: ≥98% | W-54011 | ESD-879152-1MG |
| Cas.: 405098-33-1 | Purity: ≥98% | W-54011 | ESD-879152-5MG |
| Cas.: 40433-82-7 | Purity: 98% | Pinusolidic acid | ESD-879154-5MG |
| Cas.: 40421-52-1 | Purity: 95% | erythro-1-Phenylpropane-1,2-diol | ESD-879155-1MG |
| Cas.: 40391-99-9 | Purity: ≥98% | Pamidronic acid | ESD-879156-50MG |
| Cas.: 403857-21-6 | Purity: 98% | Benzyl 2-hydroxy-6-(β-glucosyloxy)benzoate | ESD-879157-5MG |
| Cas.: 40357-59-3 | Purity: 97% | Obtusafuran methyl ether | ESD-879158-5MG |
| Cas.: 4031-55-4 | Purity: 95% | p-Menth-1-ene-3,6-diol | ESD-879159-5MG |
| Cas.: 4030-51-7 | Purity: 98% | Cassyfiline | ESD-879160-5MG |
| Cas.: 402938-74-3 | Purity: 95% | 1,9-dioxa-4-azaspiro[5.5]undecane | ESD-879161-10MG |
| Cas.: 402938-74-3 | Purity: 95% | 1,9-dioxa-4-azaspiro[5.5]undecane | ESD-879161-50MG |
| Cas.: 4027-35-4 | Purity: 95% | spiro[4.5]decan-8-one | ESD-879162-1G |
| Cas.: 4027-35-4 | Purity: 95% | spiro[4.5]decan-8-one | ESD-879162-2.5G |
| Cas.: 402713-81-9 | Purity: ≥98% | SB-399885 hydrochloride | ESD-879163-5MG |
| Cas.: 402713-81-9 | Purity: ≥98% | SB-399885 hydrochloride | ESD-879163-10MG |
| Cas.: 402567-16-2 | Purity: ≥99% | Firategrast | ESD-879164-5MG |
| Cas.: 402567-16-2 | Purity: ≥99% | Firategrast | ESD-879164-10MG |
| Cas.: 402473-54-5 | Purity: ≥98% | ONO-AE3-208 | ESD-879165-2MG |
| Cas.: 402473-54-5 | Purity: ≥98% | ONO-AE3-208 | ESD-879165-5MG |
| Cas.: 40172-65-4 | Purity: ≥99% | SKA-31 | ESD-879166-5MG |
| Cas.: 40172-65-4 | Purity: ≥99% | SKA-31 | ESD-879166-10MG |
| Cas.: 401648-35-9 | Purity: 95% | 2-benzyl-2,8-diazaspiro[5.5]undecane | ESD-879167-1G |
| Cas.: 401519-96-8 | Purity: ≥98% | NCX 1000 | ESD-879168-1MG |
| Cas.: 401519-96-8 | Purity: ≥98% | NCX 1000 | ESD-879168-5MG |
| Cas.: 400827-46-5 | Purity: ≥99% | Ceftaroline fosamil | ESD-879169-5MG |
| Cas.: 400827-46-5 | Purity: ≥99% | Ceftaroline fosamil | ESD-879169-10MG |
| Cas.: 400729-14-8 | Purity: 95% | 3,4-dihydrospiro[chromene-2,4′-piperidine] hydrochloride | ESD-879170-1G |
| Cas.: 400729-14-8 | Purity: 95% | 3,4-dihydrospiro[chromene-2,4′-piperidine] hydrochloride | ESD-879170-2.5G |
| Cas.: 40013-87-4 | Purity: ≥98% | 24, 25-Dihydroxy VD3 | ESD-879171-1MG |
| Cas.: 39986-86-2 | Purity: 98% | 4′-Hydroxy-5,6-dehydrokawain | ESD-879172-5MG |
| Cas.: 39967-60-7 | Purity: ≥98% | Deoxypseudouridine | ESD-879173-1MG |
| Cas.: 39967-60-7 | Purity: ≥98% | Deoxypseudouridine | ESD-879173-5MG |
| Cas.: 39965-06-5 | Purity: 95% | Victoxinine | ESD-879174-5MG |
| Cas.: 39946-41-3 | Purity: 98% | Periplocoside N | ESD-879175-5MG |
| Cas.: 39945-41-0 | Purity: 95% | Norglaucine hydrochloride | ESD-879176-5MG |
| Cas.: 39903-21-4 | Purity: 98% | 29-Hydroxyfriedelan-3-one | ESD-879177-5MG |
| Cas.: 3984-73-4 | Purity: 99% | Methyllinderone | ESD-879178-5MG |
| Cas.: 398473-34-2 | Purity: ≥98% | JNJ-5207852 | ESD-879179-5MG |
| Cas.: 398473-34-2 | Purity: ≥98% | JNJ-5207852 | ESD-879179-10MG |
| Cas.: 39815-40-2 | Purity: 98% | Epitulipinolide diepoxide | ESD-879180-5MG |
| Cas.: 39763-33-2 | Purity: 96% | Dehydrovomifoliol | ESD-879181-5MG |
| Cas.: 39729-21-0 | Purity: 97% | Daphmacropodine | ESD-879182-5MG |
| Cas.: 39723-40-5 | Purity: 98% | Catharticin | ESD-879183-5MG |
| Cas.: 39686-51-6 | Purity: 95% | 1,5-Diphenylpentan-1-one | ESD-879184-5MG |
| Cas.: 39674-97-0 | Purity: ≥99% | BVT948 | ESD-879185-5MG |
| Cas.: 3964-81-6 | Purity: 98% | Azatadine | ESD-879186-10MG |
| Cas.: 3964-81-6 | Purity: 98% | Azatadine | ESD-879186-50MG |
| Cas.: 396091-77-3 | Purity: ≥99% | Pasireotide L-aspartate salt | ESD-879187-1MG |
| Cas.: 396091-77-3 | Purity: ≥99% | Pasireotide L-aspartate salt | ESD-879187-5MG |
| Cas.: 396091-73-9 | Purity: 98% | Pasireotide | ESD-879188-1MG |
| Cas.: 396091-73-9 | Purity: 98% | Pasireotide | ESD-879188-5MG |
| Cas.: 396073-89-5 | Purity: ≥99% | BN82002 | ESD-879189-5MG |
| Cas.: 396073-89-5 | Purity: ≥99% | BN82002 | ESD-879189-10MG |
| Cas.: 395679-53-5 | Purity: 98% | SB-568849 | ESD-879190-1MG |
| Cas.: 395679-53-5 | Purity: 98% | SB-568849 | ESD-879190-5MG |
| Cas.: 39537-99-0 | Purity: 98% | Nicotinoyl cyclandelate | ESD-879191-1MG |
| Cas.: 39537-99-0 | Purity: 98% | Nicotinoyl cyclandelate | ESD-879191-5MG |
| Cas.: 395104-30-0 | Purity: 98% | CC-401 | ESD-879192-2MG |
| Cas.: 395104-30-0 | Purity: 98% | CC-401 | ESD-879192-5MG |
| Cas.: 395069-92-8 | Purity: 98% | MPG, HIV related | ESD-879193-1MG |
| Cas.: 395069-92-8 | Purity: 98% | MPG, HIV related | ESD-879193-5MG |
| Cas.: 39388-57-3 | Purity: 98% | Kamebanin | ESD-879194-5MG |
| Cas.: 393862-19-6 | Purity: 97% | Plucheoside B aglycone | ESD-879195-5MG |
| Cas.: 393514-24-4 | Purity: ≥97% | BCTC | ESD-879196-5MG |
| Cas.: 393514-24-4 | Purity: ≥97% | BCTC | ESD-879196-10MG |
| Cas.: 39263-81-5 | Purity: 95% | 2-Phenyl-1,2,4-triaza-spiro[4.5]decane-3-thione | ESD-879197-1G |
| Cas.: 39263-81-5 | Purity: 95% | 2-Phenyl-1,2,4-triaza-spiro[4.5]decane-3-thione | ESD-879197-2G |
| Cas.: 3924-70-7 | Purity: 98% | Amcinafal | ESD-879198-1MG |
| Cas.: 3924-70-7 | Purity: 98% | Amcinafal | ESD-879198-5MG |
| Cas.: 392331-78-1 | Purity: 95% | 7-Boc-2-oxo-1,7-diaza-spiro[3.5]nonane | ESD-879199-1G |
| Cas.: 392331-35-0 | Purity: 95% | tert-Butyl 3-oxo-1-thia-4,8-diazaspiro[4.5]decane-8-carboxylate | ESD-879200-500MG |
| Cas.: 392331-35-0 | Purity: 95% | tert-Butyl 3-oxo-1-thia-4,8-diazaspiro[4.5]decane-8-carboxylate | ESD-879200-1G |
| Cas.: 3922-90-5 | Purity: 98% | Oleandomycin | ESD-879201-5MG |
| Cas.: 3922-90-5 | Purity: 98% | Oleandomycin | ESD-879201-10MG |
| Cas.: 3918-92-1 | Purity: ≥99% | L-Valyl-L-phenylalanine | ESD-879202-50MG |
| Cas.: 3918-92-1 | Purity: ≥99% | L-Valyl-L-phenylalanine | ESD-879202-100MG |
| Cas.: 391682-51-2 | Purity: 97% | (E)-Cinnamyl-(Z)-p-coumarate | ESD-879203-5MG |
| Cas.: 39124-19-1 | Purity: 95% | 8-OXA-1,3-DIAZASPIRO[4.5]DECANE-2,4-DIONE | ESD-879204-1G |
| Cas.: 39122-38-8 | Purity: ≥99% | NSC 185058 | ESD-879205-5MG |
| Cas.: 39122-38-8 | Purity: ≥99% | NSC 185058 | ESD-879205-10MG |
| Cas.: 390808-64-7 | Purity: 98% | MSI-1701 | ESD-879206-1MG |
| Cas.: 390808-64-7 | Purity: 98% | MSI-1701 | ESD-879206-5MG |
| Cas.: 39071-33-5 | Purity: 97% | Ingenol 20-palmitate | ESD-879207-5MG |
| Cas.: 390362-53-5 | Purity: 95% | Buxbodine D | ESD-879208-1MG |
| Cas.: 39024-15-2 | Purity: 98% | 3-Epiwilsonine | ESD-879209-5MG |
| Cas.: 39024-12-9 | Purity: 98% | Wilsonine | ESD-879210-5MG |
| Cas.: 39016-05-2 | Purity: 98% | C-Peptide, dog | ESD-879211-500ΜG |
| Cas.: 39016-05-2 | Purity: 98% | C-Peptide, dog | ESD-879211-1MG |
| Cas.: 39012-04-9 | Purity: 95% | Epimedoside A | ESD-879212-5MG |
| Cas.: 38968-07-9 | Purity: 95% | 2′-O-Methylperlatolic acid | ESD-879213-5MG |
| Cas.: 389574-20-3 | Purity: 98% | Prasugrel (Maleic acid) | ESD-879214-100MG |
| Cas.: 389574-20-3 | Purity: 98% | Prasugrel (Maleic acid) | ESD-879214-500MG |
| Cas.: 389572-87-6 | Purity: 98% | 2: PN: US20040072744 SEQID: 2 claimed protein | ESD-879215-1MG |
| Cas.: 389572-87-6 | Purity: 98% | 2: PN: US20040072744 SEQID: 2 claimed protein | ESD-879215-5MG |
| Cas.: 389572-70-7 | Purity: 95% | Piperlotine A | ESD-879216-5MG |
| Cas.: 38954-02-8 | Purity: 98% | Icariside D2 | ESD-879217-5MG |
| Cas.: 38927-54-7 | Purity: 98% | Isodeoxyelephantopin | ESD-879218-5MG |
| Cas.: 38916-91-5 | Purity: 95% | erythro-Guaiacylglycerol | ESD-879219-5MG |
| Cas.: 389139-89-3 | Purity: 98% | Omadacycline | ESD-879220-2MG |
| Cas.: 389139-89-3 | Purity: 98% | Omadacycline | ESD-879220-5MG |
| Cas.: 3887-13-6 | Purity: 98% | Gly6 | ESD-879221-1MG |
| Cas.: 3887-13-6 | Purity: 98% | Gly6 | ESD-879221-5MG |
| Cas.: 3886-39-3 | Purity: 98% | RD3-0028 | ESD-879222-1MG |
| Cas.: 3886-39-3 | Purity: 98% | RD3-0028 | ESD-879222-5MG |
| Cas.: 388592-44-7 | Purity: ≥99% | CK-869 | ESD-879223-5MG |
| Cas.: 388592-44-7 | Purity: ≥99% | CK-869 | ESD-879223-10MG |
| Cas.: 388-51-2 | Purity: 98% | Metofenazate | ESD-879224-1MG |
| Cas.: 388-51-2 | Purity: 98% | Metofenazate | ESD-879224-5MG |
| Cas.: 387877-45-4 | Purity: 98% | MBC-11 trisodium | ESD-879225-5MG |
| Cas.: 38710-26-8 | Purity: 98% | Seneciphylline N-oxide | ESD-879226-5MG |
| Cas.: 38695-41-9 | Purity: 99% | Preskimmianine | ESD-879227-5MG |
| Cas.: 3868-31-3 | Purity: 98% | 8-Hydroxyguanosine | ESD-879228-1MG |
| Cas.: 3868-31-3 | Purity: 98% | 8-Hydroxyguanosine | ESD-879228-5MG |
| Cas.: 38674-21-4 | Purity: 95% | 1-Oxa-7-azaspiro[3.5]nonane hydrochloride | ESD-879229-1G |
| Cas.: 38674-21-4 | Purity: 95% | 1-Oxa-7-azaspiro[3.5]nonane hydrochloride | ESD-879229-5G |
| Cas.: 3863-59-0 | Purity: 98% | Hydrocortisone phosphate | ESD-879230-50MG |
| Cas.: 38602-52-7 | Purity: 97% | Lasiodonin | ESD-879231-5MG |
| Cas.: 385800-16-8 | Purity: 98% | Naproxen etemesil | ESD-879232-5MG |
| Cas.: 385800-16-8 | Purity: 98% | Naproxen etemesil | ESD-879232-10MG |
| Cas.: 38579-27-0 | Purity: ≥99% | H-Lys-Trp-Lys-OH | ESD-879233-10MG |
| Cas.: 38579-27-0 | Purity: ≥99% | H-Lys-Trp-Lys-OH | ESD-879233-50MG |
| Cas.: 385384-29-2 | Purity: 95% | Daphnicyclidin H | ESD-879234-5MG |
| Cas.: 385384-26-9 | Purity: 95% | Daphnicyclidin F | ESD-879235-5MG |
| Cas.: 385384-24-7 | Purity: 95% | Daphnicyclidin D | ESD-879236-5MG |
| Cas.: 385367-47-5 | Purity: 98% | Tarafenacin | ESD-879237-10MG |
| Cas.: 385367-47-5 | Purity: 98% | Tarafenacin | ESD-879237-50MG |
| Cas.: 384860-61-1 | Purity: 95% | 4-imino-2-mercapto-5-(4-phenyl-1,3-thiazol-2-yl)-3-azaspiro[5.5]undec-1-ene-1-carbonitrile | ESD-879238-1G |
| Cas.: 38458-58-1 | Purity: 95% | Hiyodorilactone A | ESD-879239-5MG |
| Cas.: 38456-39-2 | Purity: 95% | Deacetyleupaserrin | ESD-879240-5MG |
| Cas.: 38451-63-7 | Purity: 98% | Asatone | ESD-879241-5MG |
| Cas.: 38412-82-7 | Purity: 95% | 3,4,4′,7-Tetrahydroxyflavan | ESD-879242-5MG |
| Cas.: 38412-47-4 | Purity: 98% | Altechromone A | ESD-879243-5MG |
| Cas.: 383907-43-5 | Purity: ≥98% | NSC 663284 | ESD-879244-2MG |
| Cas.: 383907-43-5 | Purity: ≥98% | NSC 663284 | ESD-879244-5MG |
| Cas.: 3835-52-7 | Purity: 97% | Taxinine | ESD-879245-5MG |
| Cas.: 383432-38-0 | Purity: ≥99% | CP-724714 | ESD-879246-5MG |
| Cas.: 383432-38-0 | Purity: ≥99% | CP-724714 | ESD-879246-10MG |
| Cas.: 383392-66-3 | Purity: 98% | UC-112 | ESD-879247-10MG |
| Cas.: 383392-66-3 | Purity: 98% | UC-112 | ESD-879247-50MG |
| Cas.: 383199-88-0 | Purity: 98% | PNU288034 | ESD-879248-1MG |
| Cas.: 383199-88-0 | Purity: 98% | PNU288034 | ESD-879248-5MG |
| Cas.: 38309-60-3 | Purity: 95% | 3H-Spiro[2-benzofuran-1,4′-piperidine] | ESD-879249-1G |
| Cas.: 38309-60-3 | Purity: 95% | 3H-Spiro[2-benzofuran-1,4′-piperidine] | ESD-879249-5G |
| Cas.: 38302-15-7 | Purity: 95% | Naringenin trimethyl ether | ESD-879250-5MG |
| Cas.: 38276-59-4 | Purity: 95% | Burchellin | ESD-879251-5MG |
| Cas.: 382607-78-5 | Purity: 98% | O6BTG-octylglucoside | ESD-879252-5MG |
| Cas.: 382607-78-5 | Purity: 98% | O6BTG-octylglucoside | ESD-879252-10MG |
| Cas.: 38242-02-3 | Purity: 98% | β-Amyrenonol | ESD-879253-5MG |
| Cas.: 38230-99-8 | Purity: 98% | Chloroenhydrin | ESD-879254-5MG |
| Cas.: 38216-54-5 | Purity: 96% | Aureusidin | ESD-879255-5MG |
| Cas.: 3819-00-9 | Purity: ≥98% | Piperacetazine | ESD-879256-5MG |
| Cas.: 3819-00-9 | Purity: ≥98% | Piperacetazine | ESD-879256-10MG |
| Cas.: 3818-50-6 | Purity: ≥99% | Bephenium hydroxynaphthoate | ESD-879257-100MG |
| Cas.: 3818-50-6 | Purity: ≥99% | Bephenium hydroxynaphthoate | ESD-879257-500MG |
| Cas.: 381691-22-1 | Purity: 97% | 28-Hydroxy-3-oxoolean-12-en-29-oic acid | ESD-879258-5MG |
| Cas.: 381683-92-7 | Purity: 98% | Ecopladib | ESD-879259-1MG |
| Cas.: 381683-92-7 | Purity: 98% | Ecopladib | ESD-879259-5MG |
| Cas.: 38146-79-1 | Purity: 98% | 8,9-Dehydrothymol isobutyrate | ESD-879260-5MG |
| Cas.: 381168-77-0 | Purity: ≥99% | ML367 | ESD-879261-5MG |
| Cas.: 381168-77-0 | Purity: ≥99% | ML367 | ESD-879261-10MG |
| Cas.: 38101-59-6 | Purity: ≥99% | Oglufanide | ESD-879262-2MG |
| Cas.: 38101-59-6 | Purity: ≥99% | Oglufanide | ESD-879262-5MG |
| Cas.: 380899-24-1 | Purity: ≥99% | SB-649868 | ESD-879263-1MG |
| Cas.: 380899-24-1 | Purity: ≥99% | SB-649868 | ESD-879263-5MG |
| Cas.: 38072-88-7 | Purity: 95% | Pterolactam | ESD-879264-5MG |
| Cas.: 380607-77-2 | Purity: ≥98% | CMPDA | ESD-879265-5MG |
| Cas.: 380607-77-2 | Purity: ≥98% | CMPDA | ESD-879265-10MG |
| Cas.: 380487-65-0 | Purity: 98% | α-Epoxydihydroartemisinic acid | ESD-879266-5MG |
| Cas.: 38030-57-8 | Purity: 98% | all-trans-4-Oxoretinoic acid | ESD-879267-2MG |
| Cas.: 38030-57-8 | Purity: 98% | all-trans-4-Oxoretinoic acid | ESD-879267-5MG |
| Cas.: 38006-08-5 | Purity: 98% | Sulfamonomethoxine sodium | ESD-879268-5MG |
| Cas.: 37988-18-4 | Purity: ≥98% | LM22A-4 | ESD-879269-5MG |
| Cas.: 37988-18-4 | Purity: ≥98% | LM22A-4 | ESD-879269-10MG |
| Cas.: 379270-38-9 | Purity: ≥99% | Tenofovir alafenamide fumarate | ESD-879270-5MG |
| Cas.: 379270-38-9 | Purity: ≥99% | Tenofovir alafenamide fumarate | ESD-879270-10MG |
| Cas.: 37905-07-0 | Purity: 97% | Jolkinolide A | ESD-879271-5MG |
| Cas.: 3785-24-8 | Purity: Analysis control, 98% | Nepodin | ESD-879272-5MG |
| Cas.: 37836-90-1 | Purity: ≥98% | MPO-IN-28 | ESD-879273-5MG |
| Cas.: 37836-90-1 | Purity: ≥98% | MPO-IN-28 | ESD-879273-10MG |
| Cas.: 37831-70-2 | Purity: 99% | Phaseollidin | ESD-879274-5MG |
| Cas.: 37795-69-0 | Purity: 98% | W-2429 | ESD-879275-1MG |
| Cas.: 37795-69-0 | Purity: 98% | W-2429 | ESD-879275-5MG |
| Cas.: 3778-25-4 | Purity: 97% | 7”-O-Methylsciadopitysin | ESD-879276-5MG |
| Cas.: 377727-26-9 | Purity: 98% | Sch412348 | ESD-879277-1MG |
| Cas.: 377727-26-9 | Purity: 98% | Sch412348 | ESD-879277-5MG |
| Cas.: 3776-39-4 | Purity: 98% | Enmein | ESD-879278-5MG |
| Cas.: 3774-64-9 | Purity: 97% | Questin | ESD-879279-5MG |
| Cas.: 3772-56-3 | Purity: 97% | Totaradiol | ESD-879280-5MG |
| Cas.: 3772-55-2 | Purity: 95% | Dehydroabietinol | ESD-879281-1MG |
| Cas.: 37693-01-9 | Purity: ≥99% | Clofoctol | ESD-879282-100MG |
| Cas.: 37687-34-6 | Purity: 98% | 6-Acetonyldihydrosanguinarine | ESD-879283-5MG |
| Cas.: 37661-08-8 | Purity: ≥99% | Bacampicillin hydrochloride | ESD-879284-10MG |
| Cas.: 37661-08-8 | Purity: ≥99% | Bacampicillin hydrochloride | ESD-879284-50MG |
| Cas.: 376594-67-1 | Purity: ≥99% | LY450108 | ESD-879285-5MG |
| Cas.: 376594-67-1 | Purity: ≥99% | LY450108 | ESD-879285-10MG |
| Cas.: 376362-03-7 | Purity: 95% | 2′-O-Methylbroussonin C | ESD-879286-5MG |
| Cas.: 376361-97-6 | Purity: 96% | 4′-O-Demethylbroussonin A | ESD-879287-5MG |
| Cas.: 376361-96-5 | Purity: 97% | 7,4′-Dihydroxy-3′-prenylflavan | ESD-879288-5MG |
| Cas.: 37609-31-7 | Purity: 95% | SPIRO[3.4]OCTAN-1-ONE | ESD-879289-250MG |
| Cas.: 37609-31-7 | Purity: 95% | SPIRO[3.4]OCTAN-1-ONE | ESD-879289-1G |
| Cas.: 375822-19-8 | Purity: 98% | D-Ala-Lys-AMCA | ESD-879290-1MG |
| Cas.: 375822-19-8 | Purity: 98% | D-Ala-Lys-AMCA | ESD-879290-5MG |
| Cas.: 37548-29-1 | Purity: 98% | ACTH 22-39 | ESD-879291-1MG |
| Cas.: 37548-29-1 | Purity: 98% | ACTH 22-39 | ESD-879291-5MG |
| Cas.: 375345-95-2 | Purity: ≥99% | Mibampator | ESD-879292-5MG |
| Cas.: 375345-95-2 | Purity: ≥99% | Mibampator | ESD-879292-10MG |
| Cas.: 37526-80-0 | Purity: 98% | Melarsonyl | ESD-879293-1MG |
| Cas.: 37526-80-0 | Purity: 98% | Melarsonyl | ESD-879293-5MG |
| Cas.: 37519-14-5 | Purity: ≥99% | Acetaminophen metabolite 3-hydroxy-acetaminophen | ESD-879294-1MG |
| Cas.: 37519-14-5 | Purity: ≥99% | Acetaminophen metabolite 3-hydroxy-acetaminophen | ESD-879294-5MG |
| Cas.: 374913-63-0 | Purity: ≥99% | Madrasin | ESD-879295-5MG |
| Cas.: 374913-63-0 | Purity: ≥99% | Madrasin | ESD-879295-10MG |
| Cas.: 374796-29-9 | Purity: 95% | tert-butyl 4-hydroxy-1-oxa-9-azaspiro[5.5]undecane-9-carboxylate | ESD-879296-1G |
| Cas.: 374796-29-9 | Purity: 95% | tert-butyl 4-hydroxy-1-oxa-9-azaspiro[5.5]undecane-9-carboxylate | ESD-879296-5G |
| Cas.: 374795-48-9 | Purity: 95% | 2-OXA-9-AZASPIRO[5.5]UNDECANE HCL | ESD-879297-1G |
| Cas.: 374795-48-9 | Purity: 95% | 2-OXA-9-AZASPIRO[5.5]UNDECANE HCL | ESD-879297-5G |
| Cas.: 374795-47-8 | Purity: 95% | 2-Oxa-9-azaspiro[5.5]undecane-9-carboxylicacid tert-butyl ester | ESD-879298-250MG |
| Cas.: 374795-47-8 | Purity: 95% | 2-Oxa-9-azaspiro[5.5]undecane-9-carboxylicacid tert-butyl ester | ESD-879298-500MG |
| Cas.: 374795-01-4 | Purity: 95% | 3,3-dimethyl-2-oxa-8-azaspiro[4.5]decane | ESD-879299-1G |
| Cas.: 374795-01-4 | Purity: 95% | 3,3-dimethyl-2-oxa-8-azaspiro[4.5]decane | ESD-879299-5G |
| Cas.: 374794-92-0 | Purity: 95% | 1-Oxa-8-azaspiro[4.5]decan-2-one hydrochloride | ESD-879300-1G |
| Cas.: 374703-78-3 | Purity: ≥99% | PKG drug G1 | ESD-879301-5MG |
| Cas.: 374703-78-3 | Purity: ≥99% | PKG drug G1 | ESD-879301-10MG |
| Cas.: 37468-32-9 | Purity: 98% | ALLO-1 | ESD-879302-1MG |
| Cas.: 374675-21-5 | Purity: 98% | Kisspeptin-10, human | ESD-879303-1MG |
| Cas.: 374675-21-5 | Purity: 98% | Kisspeptin-10, human | ESD-879303-5MG |
| Cas.: 374559-48-5 | Purity: ≥99% | Istaroxime hydrochloride | ESD-879304-2MG |
| Cas.: 374559-48-5 | Purity: ≥99% | Istaroxime hydrochloride | ESD-879304-5MG |
| Cas.: 3736-81-0 | Purity: ≥99% | Diloxanide furoate | ESD-879305-50MG |
| Cas.: 373641-87-3 | Purity: 98% | KAT681 | ESD-879306-1MG |
| Cas.: 373641-87-3 | Purity: 98% | KAT681 | ESD-879306-5MG |
| Cas.: 3733-63-9 | Purity: 98% | Decloxizine | ESD-879307-50MG |
| Cas.: 3733-63-9 | Purity: 98% | Decloxizine | ESD-879307-100MG |
| Cas.: 372523-75-6 | Purity: ≥99% | TCS-OX2-29 | ESD-879309-5MG |
| Cas.: 372523-75-6 | Purity: ≥99% | TCS-OX2-29 | ESD-879309-10MG |
| Cas.: 372105-27-6 | Purity: 98% | Namitecan | ESD-879310-1MG |
| Cas.: 372105-27-6 | Purity: 98% | Namitecan | ESD-879310-5MG |
| Cas.: 37209-30-6 | Purity: 95% | Citromycin | ESD-879311-5MG |
| Cas.: 371935-79-4 | Purity: ≥99% | PI-103 Hydrochloride | ESD-879312-5MG |
| Cas.: 371935-79-4 | Purity: ≥99% | PI-103 Hydrochloride | ESD-879312-10MG |
| Cas.: 37134-40-0 | Purity: ≥99% | Bicyclomycin benzoate | ESD-879313-5MG |
| Cas.: 37134-40-0 | Purity: ≥99% | Bicyclomycin benzoate | ESD-879313-10MG |
| Cas.: 37126-91-3 | Purity: 99% | Murrangatin | ESD-879314-5MG |
| Cas.: 37064-30-5 | Purity: 97% | Procyanidin C1 | ESD-879315-5MG |
| Cas.: 3705-27-9 | Purity: 95% | Cyclo(Gly-L-Pro) | ESD-879316-1MG |
| Cas.: 3705-26-8 | Purity: 95% | Cyclo(L-Phe-L-Pro) | ESD-879317-1MG |
| Cas.: 37025-55-1 | Purity: ≥98% | Carbetocin | ESD-879318-5MG |
| Cas.: 37025-55-1 | Purity: ≥98% | Carbetocin | ESD-879318-10MG |
| Cas.: 370102-93-5 | Purity: 97% | (-)-Variabilin | ESD-879319-5MG |
| Cas.: 369391-55-9 | Purity: 97% | Hydramicromelin B | ESD-879320-5MG |
| Cas.: 3687-28-3 | Purity: 98% | Aucuparin | ESD-879321-5MG |
| Cas.: 3686-58-6 | Purity: ≥98% | Tolycaine | ESD-879322-10MG |
| Cas.: 3686-58-6 | Purity: ≥98% | Tolycaine | ESD-879322-50MG |
| Cas.: 3684-46-6 | Purity: ≥98% | Broxaldine | ESD-879323-10MG |
| Cas.: 3682-04-0 | Purity: 95% | Naringenin triacetate | ESD-879324-5MG |
| Cas.: 367928-68-5 | Purity: 95% | 8-Phenyl-1-thia-4-azaspiro[4.5]decane-3-carboxylic acid | ESD-879325-1G |
| Cas.: 367928-68-5 | Purity: 95% | 8-Phenyl-1-thia-4-azaspiro[4.5]decane-3-carboxylic acid | ESD-879325-5G |
| Cas.: 367273-07-2 | Purity: ≥98% | AGN 195183 | ESD-879326-2MG |
| Cas.: 367273-07-2 | Purity: ≥98% | AGN 195183 | ESD-879326-5MG |
| Cas.: 366450-46-6 | Purity: 95% | Semialactone | ESD-879327-5MG |
| Cas.: 36592-77-5 | Purity: ≥99% | Metipranolol hydrochloride | ESD-879328-5MG |
| Cas.: 36592-77-5 | Purity: ≥99% | Metipranolol hydrochloride | ESD-879328-10MG |
| Cas.: 3659-21-0 | Purity: 95% | 5-Azaspiro[2.4]heptane hydrochloride | ESD-879329-250MG |
| Cas.: 3659-21-0 | Purity: 95% | 5-Azaspiro[2.4]heptane hydrochloride | ESD-879329-1G |
| Cas.: 36545-53-6 | Purity: 96% | Cycloheterophyllin | ESD-879330-5MG |
| Cas.: 36519-42-3 | Purity: 97% | Serpentinine | ESD-879331-5MG |
| Cas.: 3650-43-9 | Purity: 85% | β-Costic acid | ESD-879332-5MG |
| Cas.: 3650-31-5 | Purity: 95% | Agatholal | ESD-879333-5MG |
| Cas.: 364779-15-7 | Purity: 98% | Ginsenoside Rk3 | ESD-879334-5MG |
| Cas.: 364779-15-7 | Purity: 98% | Ginsenoside Rk3 | ESD-879334-10MG |
| Cas.: 364606-20-2 | Purity: 97% | 2-Mercapto-3-propyl-1,3-diaza-spiro[4.5]dec-1-en-4-one | ESD-879335-1G |
| Cas.: 364606-20-2 | Purity: 97% | 2-Mercapto-3-propyl-1,3-diaza-spiro[4.5]dec-1-en-4-one | ESD-879335-5G |
| Cas.: 36450-02-9 | Purity: 95% | 6β-Hydroxystigmast-4-en-3-one | ESD-879336-5MG |
| Cas.: 36450-01-8 | Purity: 95% | 6-Hydroxystigmasta-4,22-dien-3-one | ESD-879337-1MG |
| Cas.: 36420-64-1 | Purity: 95% | 1-Oxa-4,9-diazaspiro[5.5]undecane | ESD-879338-1MG |
| Cas.: 36417-86-4 | Purity: 98% | Np-Coumaroyltyramine | ESD-879339-5MG |
| Cas.: 364071-17-0 | Purity: ≥98% | OT-R antagonist 1 | ESD-879340-1MG |
| Cas.: 364071-17-0 | Purity: ≥98% | OT-R antagonist 1 | ESD-879340-5MG |
| Cas.: 364071-16-9 | Purity: ≥99% | OT-R antagonist 2 | ESD-879341-1MG |
| Cas.: 364071-16-9 | Purity: ≥99% | OT-R antagonist 2 | ESD-879341-5MG |
| Cas.: 364042-47-7 | Purity: 98% | A 419259 | ESD-879342-5MG |
| Cas.: 364042-47-7 | Purity: 98% | A 419259 | ESD-879342-10MG |
| Cas.: 36396-99-3 | Purity: ≥99% | N6-Cyclohexyladenosine | ESD-879343-10MG |
| Cas.: 36396-99-3 | Purity: ≥99% | N6-Cyclohexyladenosine | ESD-879343-50MG |
| Cas.: 36379-74-5 | Purity: 96% | Dehydroherbarin | ESD-879344-5MG |
| Cas.: 363600-92-4 | Purity: ≥98% | C29 | ESD-879345-1MG |
| Cas.: 363600-92-4 | Purity: ≥98% | C29 | ESD-879345-5MG |
| Cas.: 36357-32-1 | Purity: 96% | Cyclo(L-Ala-L-Pro) | ESD-879346-5MG |
| Cas.: 363571-83-9 | Purity: ≥98% | Kinesore | ESD-879347-1MG |
| Cas.: 363571-83-9 | Purity: ≥98% | Kinesore | ESD-879347-5MG |
| Cas.: 362665-57-4 | Purity: 98% | Pitolisant oxalate | ESD-879348-10MG |
| Cas.: 362665-57-4 | Purity: 98% | Pitolisant oxalate | ESD-879348-50MG |
| Cas.: 36238-67-2 | Purity: 96% | Cyclo(D-Leu-L-Pro) | ESD-879349-5MG |
| Cas.: 362-08-3 | Purity: 98% | 2-Methoxyestrone | ESD-879350-5MG |
| Cas.: 362-08-3 | Purity: 98% | 2-Methoxyestrone | ESD-879350-10MG |
| Cas.: 36190-95-1 | Purity: 98% | 3′-O-Methylorobol | ESD-879351-5MG |
| Cas.: 36167-63-2 | Purity: ≥98% | Halofantrine hydrochloride | ESD-879352-5MG |
| Cas.: 36167-63-2 | Purity: ≥98% | Halofantrine hydrochloride | ESD-879352-10MG |
| Cas.: 3615-24-5 | Purity: 98% | Ramifenazone | ESD-879353-10MG |
| Cas.: 3615-24-5 | Purity: 98% | Ramifenazone | ESD-879353-50MG |
| Cas.: 36150-23-9 | Purity: 98% | Kobusin | ESD-879354-5MG |
| Cas.: 36150-07-9 | Purity: 97% | Dehydroleucodine | ESD-879355-5MG |
| Cas.: 36150-04-6 | Purity: 98% | Mullilam diol | ESD-879356-5MG |
| Cas.: 361444-66-8 | Purity: 98% | JDTic | ESD-879357-5MG |
| Cas.: 36138-41-7 | Purity: 95% | 3,4-Secolupa-4(23),20(29)-diene-3,28-dioic acid | ESD-879358-5MG |
| Cas.: 36098-33-6 | Purity: ≥98% | F16 | ESD-879359-10MG |
| Cas.: 36098-33-6 | Purity: ≥98% | F16 | ESD-879359-25MG |
| Cas.: 3606-45-9 | Purity: ≥99% | Dihydrosanguinarine | ESD-879360-5MG |
| Cas.: 3606-45-9 | Purity: ≥99% | Dihydrosanguinarine | ESD-879360-10MG |
| Cas.: 3604-92-0 | Purity: 98% | Diepiserratenediol | ESD-879361-1MG |
| Cas.: 3602-54-8 | Purity: 95% | 2,4-Dihydroxy-6-methoxyacetophenone | ESD-879362-250MG |
| Cas.: 359600-10-5 | Purity: 98% | RNPA1000 | ESD-879363-2MG |
| Cas.: 359600-10-5 | Purity: 98% | RNPA1000 | ESD-879363-5MG |
| Cas.: 35959-08-1 | Purity: 98% | 3β-Acetoxyurs-11-en-28,13β-olide | ESD-879364-5MG |
| Cas.: 35959-05-8 | Purity: 98% | 3β-Hydroxyurs-11-en-28,13β-olide | ESD-879365-5MG |
| Cas.: 35943-38-5 | Purity: 98% | Pteroside D | ESD-879366-5MG |
| Cas.: 35938-43-3 | Purity: 95% | Pterosin C | ESD-879367-5MG |
| Cas.: 3591-19-3 | Purity: 98% | 3,3-Dimethoxy-5α-androstan-17-one | ESD-879368-5MG |
| Cas.: 35899-54-8 | Purity: ≥99% | SIBA | ESD-879369-5MG |
| Cas.: 35899-54-8 | Purity: ≥99% | SIBA | ESD-879369-10MG |
| Cas.: 35897-94-0 | Purity: 97% | 10-Hydroxyligstroside | ESD-879370-5MG |
| Cas.: 35897-92-8 | Purity: 98% | Ligustroside | ESD-879371-5MG |
| Cas.: 35878-41-2 | Purity: 98% | Vestitol | ESD-879372-5MG |
| Cas.: 358721-70-7 | Purity: ≥98% | UBCS039 | ESD-879373-5MG |
| Cas.: 358721-70-7 | Purity: ≥98% | UBCS039 | ESD-879373-10MG |
| Cas.: 358721-33-2 | Purity: 95% | Apocynol A | ESD-879374-1MG |
| Cas.: 35833-72-8 | Purity: 95% | 3-Epicabraleahydroxylactone | ESD-879375-1MG |
| Cas.: 35833-70-6 | Purity: 98% | Cabraleahydroxylactone acetate | ESD-879376-5MG |
| Cas.: 35833-69-3 | Purity: 98% | Cabraleahydroxylactone | ESD-879377-5MG |
| Cas.: 35833-62-6 | Purity: 95% | Cabraleadiol 3-acetate | ESD-879378-1MG |
| Cas.: 35790-95-5 | Purity: 97% | β-Hederin | ESD-879379-1MG |
| Cas.: 357645-16-0 | Purity: 97% | 7,8,9,9-Tetradehydroisolariciresinol | ESD-879380-5MG |
| Cas.: 35761-54-7 | Purity: 98% | Cabraleone | ESD-879381-5MG |
| Cas.: 35748-51-7 | Purity: 98% | Pressinoic Acid | ESD-879383-1MG |
| Cas.: 35748-51-7 | Purity: 98% | Pressinoic Acid | ESD-879383-5MG |
| Cas.: 357400-13-6 | Purity: ≥98% | NNC 55-0396 | ESD-879384-1MG |
| Cas.: 357400-13-6 | Purity: ≥98% | NNC 55-0396 | ESD-879384-5MG |
| Cas.: 35738-25-1 | Purity: 95% | 3β-Acetoxy-11α, 12α-epoxyoleanan-28, 13β-olide | ESD-879385-5MG |
| Cas.: 35730-78-0 | Purity: ≥97% | Cynaropicrin | ESD-879386-5MG |
| Cas.: 35730-78-0 | Purity: ≥97% | Cynaropicrin | ESD-879386-10MG |
| Cas.: 3570-62-5 | Purity: 97% | Moslosooflavone | ESD-879387-5MG |
| Cas.: 3570-40-9 | Purity: 95% | Albaspidin AA | ESD-879388-5MG |
| Cas.: 35688-09-6 | Purity: 98% | Questinol | ESD-879389-5MG |
| Cas.: 3567-76-8 | Purity: 98% | Aminochlorthenoxazin | ESD-879390-1MG |
| Cas.: 3567-76-8 | Purity: 98% | Aminochlorthenoxazin | ESD-879390-5MG |
| Cas.: 3565-72-8 | Purity: 98% | Embramine | ESD-879391-1MG |
| Cas.: 3565-72-8 | Purity: 98% | Embramine | ESD-879391-5MG |
| Cas.: 356559-13-2 | Purity: 98% | SB-505124 hydrochloride | ESD-879392-10MG |
| Cas.: 356559-13-2 | Purity: 98% | SB-505124 hydrochloride | ESD-879392-50MG |
| Cas.: 3563-92-6 | Purity: ≥99% | Zylofuramine | ESD-879393-5MG |
| Cas.: 3563-92-6 | Purity: ≥99% | Zylofuramine | ESD-879393-10MG |
| Cas.: 3561-81-7 | Purity: 98% | Mesuaxanthone A | ESD-879394-5MG |
| Cas.: 3561-24-8 | Purity: 95% | 2′,4′,5′,7′-Tetrabromo-3′,6′-dihydroxy-3-oxo-3H-spiro-[isobenzofuran-1,9′-xanthene]-6-carboxylic acid | ESD-879395-250MG |
| Cas.: 3561-24-8 | Purity: 95% | 2′,4′,5′,7′-Tetrabromo-3′,6′-dihydroxy-3-oxo-3H-spiro-[isobenzofuran-1,9′-xanthene]-6-carboxylic acid | ESD-879395-1G |
| Cas.: 35552-76-2 | Purity: 98% | N,N-dimethyl-2-Quinoxalinamine | ESD-879396-5MG |
| Cas.: 355406-09-6 | Purity: 98% | YM-155 hydrochloride | ESD-879397-5MG |
| Cas.: 355406-09-6 | Purity: 98% | YM-155 hydrochloride | ESD-879397-10MG |
| Cas.: 355143-38-3 | Purity: 92% | 6′-Op-Hydroxybenzoylcatalposide | ESD-879398-5MG |
| Cas.: 355129-15-6 | Purity: ≥99% | Eprotirome | ESD-879399-1MG |
| Cas.: 35467-43-7 | Purity: 98% | Hirsuteine | ESD-879400-5MG |
| Cas.: 3546-41-6 | Purity: ≥98% | Pyrvinium pamoate | ESD-879401-10MG |
| Cas.: 3546-41-6 | Purity: ≥98% | Pyrvinium pamoate | ESD-879401-50MG |
| Cas.: 354553-35-8 | Purity: 97% | Caraphenol A | ESD-879402-5MG |
| Cas.: 35450-86-3 | Purity: 98% | Lutonarin | ESD-879403-5MG |
| Cas.: 3543-74-6 | Purity: 98% | 5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester | ESD-879404-5MG |
| Cas.: 3542-72-1 | Purity: 98% | Norathyriol | ESD-879405-5MG |
| Cas.: 353519-63-8 | Purity: ≥99% | HLM006474 | ESD-879406-5MG |
| Cas.: 353519-63-8 | Purity: ≥99% | HLM006474 | ESD-879406-10MG |
| Cas.: 35349-68-9 | Purity: 97% | 9-Hydroxycalabaxanthone | ESD-879407-5MG |
| Cas.: 35340-49-9 | Purity: ≥99% | Dihydrofluorescein diacetate | ESD-879408-50MG |
| Cas.: 353262-04-1 | Purity: ≥99% | NS6180 | ESD-879409-5MG |
| Cas.: 353262-04-1 | Purity: ≥99% | NS6180 | ESD-879409-10MG |
| Cas.: 35302-70-6 | Purity: 98% | Pinosylvin monomethyl ether | ESD-879410-5MG |
| Cas.: 352658-23-2 | Purity: 95% | Caesalmin B | ESD-879411-5MG |
| Cas.: 352458-37-8 | Purity: ≥99% | Delafloxacin meglumine | ESD-879412-10MG |
| Cas.: 352458-37-8 | Purity: ≥99% | Delafloxacin meglumine | ESD-879412-50MG |
| Cas.: 352452-38-1 | Purity: 95% | 4-[(Furan-2-ylmethyl)-carbamoyl]-1,2,2-trimethyl-spiro[2.3]hexane-1-carboxylic acid | ESD-879413-1G |
| Cas.: 35241-80-6 | Purity: 95% | 9-Methoxy-α-lapachone | ESD-879414-1MG |
| Cas.: 35214-82-5 | Purity: 97% | Neobyakangelicol | ESD-879415-5MG |
| Cas.: 352017-71-1 | Purity: 98% | PAR-4 Agonist Peptide, amide | ESD-879416-1MG |
| Cas.: 352017-71-1 | Purity: 98% | PAR-4 Agonist Peptide, amide | ESD-879416-5MG |
| Cas.: 351994-94-0 | Purity: ≥99% | Emeramide | ESD-879417-100MG |
| Cas.: 351994-94-0 | Purity: ≥99% | Emeramide | ESD-879417-500MG |
| Cas.: 35176-46-6 | Purity: 98% | 5-Nonadecylresorcinol | ESD-879418-5MG |
| Cas.: 351531-39-0 | Purity: 97% | Thalibaline | ESD-879419-5MG |
| Cas.: 351528-73-9 | Purity: 95% | 5′-chloro-2′,3′-dihydrospiro[imidazolidine-4,1′-indene]-2,5-dione | ESD-879420-1G |
| Cas.: 351490-27-2 | Purity: ≥99% | SB-423562 | ESD-879421-1MG |
| Cas.: 351490-27-2 | Purity: ≥99% | SB-423562 | ESD-879421-5MG |
| Cas.: 351346-10-6 | Purity: 95% | (7R,8R)-Dihydrodehydrodiconiferyl alcohol 9-O-β-D-glucoside | ESD-879422-5MG |
| Cas.: 351344-10-0 | Purity: ≥98% | Methyllycaconitine citrate | ESD-879423-5MG |
| Cas.: 351344-10-0 | Purity: ≥98% | Methyllycaconitine citrate | ESD-879423-10MG |
| Cas.: 35118-14-0 | Purity: 95% | 6′,7′-dimethoxy-3′,4′-dihydro-2’H-spiro[indole-3,1′-isoquinolin]-2(1H)-one | ESD-879424-1G |
| Cas.: 35118-14-0 | Purity: 95% | 6′,7′-dimethoxy-3′,4′-dihydro-2’H-spiro[indole-3,1′-isoquinolin]-2(1H)-one | ESD-879424-2.5G |
| Cas.: 35109-93-4 | Purity: 98% | Adynerin | ESD-879425-5MG |
| Cas.: 350986-74-2 | Purity: 97% | Dendocarbin A | ESD-879426-5MG |
| Cas.: 35040-32-5 | Purity: 97% | 2,5-Dihydroxyxanthone | ESD-879427-5MG |
| Cas.: 35030-38-7 | Purity: 98% | ent-17-Hydroxykaur-15-en-19-oic acid | ESD-879428-5MG |
| Cas.: 350-12-9 | Purity: ≥98% | Sulbentine | ESD-879429-50MG |
| Cas.: 350-12-9 | Purity: ≥98% | Sulbentine | ESD-879429-100MG |
| Cas.: 35001-23-1 | Purity: 90% | 10β-Hydroxycadina-4,11(13)-dien-12,8β-olide | ESD-879430-5MG |
| Cas.: 35001-19-5 | Purity: 97% | 4α,6α-Dihydroxyeudesm-11(13)-en-12,8β-olide | ESD-879431-5MG |
| Cas.: 34981-26-5 | Purity: 97% | Kurarinone | ESD-879432-5MG |
| Cas.: 349554-02-5 | Purity: 98% | Enalapril D5 maleate | ESD-879433-1MG |
| Cas.: 349554-02-5 | Purity: 98% | Enalapril D5 maleate | ESD-879433-5MG |
| Cas.: 349545-02-4 | Purity: 95% | 3″,4″-Di-O-acetyl-2″,6″-di-Op-coumaroylastragalin | ESD-879434-5MG |
| Cas.: 349534-73-2 | Purity: 97% | dodonolide | ESD-879435-5MG |
| Cas.: 349534-70-9 | Purity: 95% | Methyl dodonate A | ESD-879436-5MG |
| Cas.: 349487-98-5 | Purity: 98% | Methyl dodonate A acetate | ESD-879437-5MG |
| Cas.: 349112-30-7 | Purity: 98% | Cryptomeridiol 11-rhamnoside | ESD-879438-5MG |
| Cas.: 34839-70-8 | Purity: ≥97% | Metiamide | ESD-879439-2MG |
| Cas.: 34839-70-8 | Purity: ≥97% | Metiamide | ESD-879439-5MG |
| Cas.: 34818-83-2 | Purity: 98% | 4′-Demethyleucomin | ESD-879440-5MG |
| Cas.: 34818-17-2 | Purity: 95% | Marilactone | ESD-879441-5MG |
| Cas.: 347379-29-7 | Purity: ≥98% | LTV-1 | ESD-879442-2MG |
| Cas.: 347379-29-7 | Purity: ≥98% | LTV-1 | ESD-879442-5MG |
| Cas.: 347323-96-0 | Purity: 98% | ITX3 | ESD-879443-5MG |
| Cas.: 347323-96-0 | Purity: 98% | ITX3 | ESD-879443-10MG |
| Cas.: 34670-43-4 | Purity: ≥99% | 4-Azido-L-phenylalanine hydrochloride | ESD-879444-100MG |
| Cas.: 346688-38-8 | Purity: ≥99% | Pridopidine | ESD-879445-2MG |
| Cas.: 346688-38-8 | Purity: ≥99% | Pridopidine | ESD-879445-5MG |
| Cas.: 3466-23-7 | Purity: 97% | Dehydrodeguelin | ESD-879446-5MG |
| Cas.: 3464-66-2 | Purity: 98% | 1-Methoxycarbonyl-β-carboline | ESD-879447-5MG |
| Cas.: 346458-41-1 | Purity: 97% | 1’H-Spiro[cyclopentane-1,2′-quinazoline]-4′-thiol | ESD-879448-500MG |
| Cas.: 346458-41-1 | Purity: 97% | 1’H-Spiro[cyclopentane-1,2′-quinazoline]-4′-thiol | ESD-879448-1G |
| Cas.: 345987-15-7 | Purity: ≥98% | AS601245 | ESD-879449-1MG |
| Cas.: 345987-15-7 | Purity: ≥98% | AS601245 | ESD-879449-5MG |
| Cas.: 345641-00-1 | Purity: 98% | Dauricumine | ESD-879450-5MG |
| Cas.: 345303-91-5 | Purity: ≥98% | AZD9056 hydrochloride | ESD-879451-1MG |
| Cas.: 345303-91-5 | Purity: ≥98% | AZD9056 hydrochloride | ESD-879451-5MG |
| Cas.: 345287-92-5 | Purity: 95% | 1,3,6-Trihydroxy-2,5-dimethoxyxanthone | ESD-879452-1MG |
| Cas.: 34509-52-9 | Purity: 95% | Myricanol triacetate | ESD-879453-5MG |
| Cas.: 344940-63-2 | Purity: ≥96% | Diphenylterazine | ESD-879454-5MG |
| Cas.: 344940-63-2 | Purity: ≥96% | Diphenylterazine | ESD-879454-10MG |
| Cas.: 34446-06-5 | Purity: 97% | Matairesinol monoglucoside | ESD-879455-5MG |
| Cas.: 344458-19-1 | Purity: ≥98% | PJ34 | ESD-879456-10MG |
| Cas.: 344458-19-1 | Purity: ≥98% | PJ34 | ESD-879456-50MG |
| Cas.: 34444-37-6 | Purity: 97% | nortrachelogenin | ESD-879457-5MG |
| Cas.: 34444-01-4 | Purity: 98% | Cefamandole | ESD-879458-10MG |
| Cas.: 34434-99-6 | Purity: 95% | α-Onocerin diacetate | ESD-879459-5MG |
| Cas.: 3443-28-5 | Purity: 97% | Prudomestin | ESD-879460-5MG |
| Cas.: 34425-25-7 | Purity: 98% | Lyoniside | ESD-879462-5MG |
| Cas.: 34421-19-7 | Purity: 96% | 2,3-Dihydrosciadopitysin | ESD-879463-5MG |
| Cas.: 34399-44-5 | Purity: 98% | N-Demethyl-α-obscurine | ESD-879464-5MG |
| Cas.: 34366-34-2 | Purity: 95% | isoapetalic acid | ESD-879465-1MG |
| Cas.: 343569-15-3 | Purity: 98% | Delicaflavone | ESD-879466-5MG |
| Cas.: 34346-01-5 | Purity: ≥99% | PLGA | ESD-879467-500MG |
| Cas.: 34346-01-5 | Purity: ≥99% | PLGA | ESD-879467-1G |
| Cas.: 34340-51-7 | Purity: 97% | 2,3-Dihydroamentoflavone | ESD-879468-5MG |
| Cas.: 34334-69-5 | Purity: 98% | Cirsiliol | ESD-879469-5MG |
| Cas.: 343306-79-6 | Purity: ≥98% | Sugammadex sodium | ESD-879470-10MG |
| Cas.: 343306-79-6 | Purity: ≥98% | Sugammadex sodium | ESD-879470-25MG |
| Cas.: 34302-37-9 | Purity: 96% | ent-Kaurane-2α,16β-diol | ESD-879471-5MG |
| Cas.: 34293-09-9 | Purity: 98% | 5,6-Dimethoxy-2-isopropenylbenzofuran | ESD-879472-5MG |
| Cas.: 342777-54-2 | Purity: ≥98% | LM22B-10 | ESD-879473-2MG |
| Cas.: 342777-54-2 | Purity: ≥98% | LM22B-10 | ESD-879473-5MG |
| Cas.: 34274-91-4 | Purity: 95% | Gardneramine | ESD-879474-5MG |
| Cas.: 342652-67-9 | Purity: ≥98% | MRK-016 | ESD-879475-5MG |
| Cas.: 342652-67-9 | Purity: ≥98% | MRK-016 | ESD-879475-10MG |
| Cas.: 342577-38-2 | Purity: ≥99% | Velneperit | ESD-879476-5MG |
| Cas.: 342577-38-2 | Purity: ≥99% | Velneperit | ESD-879476-10MG |
| Cas.: 34233-69-7 | Purity: ≥99% | Clozapine (N-oxide) | ESD-879477-5MG |
| Cas.: 34233-69-7 | Purity: ≥99% | Clozapine (N-oxide) | ESD-879477-10MG |
| Cas.: 34211-53-5 | Purity: 98% | Tovopyrifolin C | ESD-879478-5MG |
| Cas.: 3420-57-3 | Purity: 99% | 3-Methoxyfuran | ESD-879479-1MG |
| Cas.: 341971-45-7 | Purity: 97% | Actinidic acid | ESD-879480-1MG |
| Cas.: 34175-96-7 | Purity: 97% | Pterosin B | ESD-879481-5MG |
| Cas.: 34169-70-5 | Purity: 98% | Pterosin D | ESD-879482-5MG |
| Cas.: 34169-69-2 | Purity: 98% | Pterosin Z | ESD-879483-5MG |
| Cas.: 34168-56-4 | Purity: 98% | Catalponol | ESD-879484-5MG |
| Cas.: 34161-24-5 | Purity: ≥99% | Fipexide | ESD-879485-100MG |
| Cas.: 341503-22-8 | Purity: 97% | 2α,3α,24-Trihydroxyursa-12,20(30)-dien-28-oic acid | ESD-879486-5MG |
| Cas.: 341498-89-3 | Purity: 98% | PNU-248686A | ESD-879487-1MG |
| Cas.: 341498-89-3 | Purity: 98% | PNU-248686A | ESD-879487-5MG |
| Cas.: 341001-38-5 | Purity: ≥99% | Nucleozin | ESD-879488-5MG |
| Cas.: 341001-38-5 | Purity: ≥99% | Nucleozin | ESD-879488-10MG |
| Cas.: 340997-02-6 | Purity: 98% | 2”,3”-Dihydroochnaflavone | ESD-879489-5MG |
| Cas.: 34086-50-5 | Purity: 98% | Alpinumisoflavone | ESD-879490-5MG |
| Cas.: 340702-68-3 | Purity: 96% | 2-(2′-Hydroxytetracosanoylamino)-octadecane-1,3,4-triol tetraacetate | ESD-879491-1MG |
| Cas.: 34041-84-4 | Purity: ≥96% | Diclofensine hydrochloride | ESD-879492-5MG |
| Cas.: 34041-84-4 | Purity: ≥96% | Diclofensine hydrochloride | ESD-879492-10MG |
| Cas.: 34031-32-8 | Purity: ≥98% | Auranofin | ESD-879493-10MG |
| Cas.: 34031-32-8 | Purity: ≥98% | Auranofin | ESD-879493-50MG |
| Cas.: 33996-58-6 | Purity: ≥99% | Etiracetam | ESD-879494-50MG |
| Cas.: 33985-68-1 | Purity: ≥99% | DIM-C-pPhOCH3 | ESD-879495-5MG |
| Cas.: 33985-68-1 | Purity: ≥99% | DIM-C-pPhOCH3 | ESD-879495-10MG |
| Cas.: 33980-71-1 | Purity: 95% | 7-Oxodehydroabietinol | ESD-879496-1MG |
| Cas.: 33954-34-6 | Purity: 98% | Thalrugosidine | ESD-879497-5MG |
| Cas.: 339539-92-3 | Purity: 98% | Anamorelin Fumarate | ESD-879498-5MG |
| Cas.: 339539-92-3 | Purity: 98% | Anamorelin Fumarate | ESD-879498-10MG |
| Cas.: 339163-65-4 | Purity: ≥99% | RCM-1 | ESD-879499-5MG |
| Cas.: 339163-65-4 | Purity: ≥99% | RCM-1 | ESD-879499-10MG |
| Cas.: 33900-74-2 | Purity: 96% | 2,3,4′-Trihydroxy-3′,5′-dimethoxypropiophenone | ESD-879500-5MG |
| Cas.: 338992-53-3 | Purity: 98% | Vandetanib trifluoroacetate | ESD-879501-25MG |
| Cas.: 338992-53-3 | Purity: 98% | Vandetanib trifluoroacetate | ESD-879501-100MG |
| Cas.: 338747-41-4 | Purity: ≥98% | BQCA | ESD-879502-5MG |
| Cas.: 338747-41-4 | Purity: ≥98% | BQCA | ESD-879502-10MG |
| Cas.: 33815-57-5 | Purity: 98% | Di-O-methylbergenin | ESD-879504-5MG |
| Cas.: 33788-39-5 | Purity: 95% | Deodarin | ESD-879505-1MG |
| Cas.: 33776-88-4 | Purity: 98% | Androstanolone heptanoate | ESD-879506-5MG |
| Cas.: 337527-10-3 | Purity: 95% | Abieta-8,11,13-triene-7,15,18-triol | ESD-879507-5MG |
| Cas.: 3374-88-7 | Purity: ≥99% | ICA | ESD-879508-1MG |
| Cas.: 3374-88-7 | Purity: ≥99% | ICA | ESD-879508-5MG |
| Cas.: 33745-21-0 | Purity: 97% | Cannabivarin | ESD-879509-5MG |
| Cas.: 33708-72-4 | Purity: 98% | Pachypodol | ESD-879510-5MG |
| Cas.: 3368-87-4 | Purity: 96% | 19,20-(E)-Vallesamine | ESD-879511-5MG |
| Cas.: 33676-00-5 | Purity: 95% | Hypophyllanthin | ESD-879512-5MG |
| Cas.: 33627-41-7 | Purity: 98% | 1-O-Acetylbritannilactone | ESD-879513-5MG |
| Cas.: 33627-28-0 | Purity: 98% | Britanin | ESD-879514-5MG |
| Cas.: 33620-72-3 | Purity: 98% | Britannilactone | ESD-879515-5MG |
| Cas.: 336191-16-3 | Purity: 95% | tert-Butyl 8-benzyl-2,8-diazaspiro[4.5]decane-2-carboxylate | ESD-879516-500MG |
| Cas.: 336191-16-3 | Purity: 95% | tert-Butyl 8-benzyl-2,8-diazaspiro[4.5]decane-2-carboxylate | ESD-879516-1G |
| Cas.: 336191-15-2 | Purity: 95% | 8-Benzyl-2,8-diazaspiro[4.5]decane | ESD-879517-100MG |
| Cas.: 336191-15-2 | Purity: 95% | 8-Benzyl-2,8-diazaspiro[4.5]decane | ESD-879517-500MG |
| Cas.: 33606-81-4 | Purity: 98% | Myricanol | ESD-879518-5MG |
| Cas.: 33600-93-0 | Purity: 95% | Polpunonic acid | ESD-879519-5MG |
| Cas.: 335299-59-7 | Purity: 98% | Tentoprazole sodium | ESD-879520-1MG |
| Cas.: 335299-59-7 | Purity: 98% | Tentoprazole sodium | ESD-879520-5MG |
| Cas.: 335165-68-9 | Purity: ≥99% | BAI1 | ESD-879521-5MG |
| Cas.: 335165-68-9 | Purity: ≥99% | BAI1 | ESD-879521-10MG |
| Cas.: 334969-03-8 | Purity: ≥98% | Recilisib | ESD-879522-5MG |
| Cas.: 334969-03-8 | Purity: ≥98% | Recilisib | ESD-879522-10MG |
| Cas.: 334951-92-7 | Purity: ≥98% | MEK inhibitor | ESD-879523-5MG |
| Cas.: 334951-92-7 | Purity: ≥98% | MEK inhibitor | ESD-879523-10MG |
| Cas.: 334951-90-5 | Purity: ≥99% | BIBF0775 | ESD-879524-5MG |
| Cas.: 334951-90-5 | Purity: ≥99% | BIBF0775 | ESD-879524-10MG |
| Cas.: 334949-59-6 | Purity: ≥99% | BIX02188 | ESD-879525-5MG |
| Cas.: 334949-59-6 | Purity: ≥99% | BIX02188 | ESD-879525-10MG |
| Cas.: 33458-93-4 | Purity: ≥99% | AH 6809 | ESD-879526-5MG |
| Cas.: 33458-93-4 | Purity: ≥99% | AH 6809 | ESD-879526-10MG |
| Cas.: 33458-82-1 | Purity: 97% | Euonymine | ESD-879527-5MG |
| Cas.: 33429-83-3 | Purity: 98% | Quercetin 3,4′-dimethyl ether | ESD-879528-5MG |
| Cas.: 33417-17-3 | Purity: 95% | 3-Hydroxy-3-acetonyloxindole | ESD-879529-5MG |
| Cas.: 33401-94-4 | Purity: ≥99% | Pyrantel tartrate | ESD-879530-100MG |
| Cas.: 33401-94-4 | Purity: ≥99% | Pyrantel tartrate | ESD-879530-500MG |
| Cas.: 333994-00-6 | Purity: ≥99% | TAK-220 | ESD-879531-1MG |
| Cas.: 333994-00-6 | Purity: ≥99% | TAK-220 | ESD-879531-5MG |
| Cas.: 33390-42-0 | Purity: 97% | Gartanin | ESD-879532-5MG |
| Cas.: 33390-41-9 | Purity: 98% | 8-Deoxygartanin | ESD-879533-5MG |
| Cas.: 333798-10-0 | Purity: 97% | 9-O-Methyl-4-hydroxyboeravinone B | ESD-879534-5MG |
| Cas.: 333745-53-2 | Purity: ≥99% | LX2343 | ESD-879535-5MG |
| Cas.: 333745-53-2 | Purity: ≥99% | LX2343 | ESD-879535-10MG |
| Cas.: 333361-85-6 | Purity: 97% | Trianthenol | ESD-879536-5MG |
| Cas.: 33253-99-5 | Purity: 98% | 3-Hydroxychimaphilin | ESD-879537-5MG |
| Cas.: 332420-90-3 | Purity: ≥98% | C 87 | ESD-879538-5MG |
| Cas.: 332420-90-3 | Purity: ≥98% | C 87 | ESD-879538-10MG |
| Cas.: 33237-37-5 | Purity: 97% | Rutaevin | ESD-879539-5MG |
| Cas.: 332371-82-1 | Purity: 95% | 1,7-Bis(4-hydroxyphenyl)hepta-4,6-dien-3-one | ESD-879540-5MG |
| Cas.: 33231-14-0 | Purity: ≥99% | DZ2002 | ESD-879541-2MG |
| Cas.: 33231-14-0 | Purity: ≥99% | DZ2002 | ESD-879541-5MG |
| Cas.: 33228-65-8 | Purity: 97% | Glucosyringic acid | ESD-879542-5MG |
| Cas.: 332117-28-9 | Purity: ≥97% | Chembridge-5861528 | ESD-879543-5MG |
| Cas.: 332117-28-9 | Purity: ≥97% | Chembridge-5861528 | ESD-879543-10MG |
| Cas.: 331963-29-2 | Purity: 98% | I2906 | ESD-879544-100MG |
| Cas.: 331963-29-2 | Purity: 98% | I2906 | ESD-879544-500MG |
| Cas.: 331954-16-6 | Purity: 95% | 2′,4′-Dihydroxy-7-methoxy-8-prenylflavan | ESD-879545-5MG |
| Cas.: 331761-20-7 | Purity: 95% | Tetramethyl 5′,5′,8′,9′-tetramethyl-5′,6′-dihydrospiro[1,3-dithiole-2,1′-thiopyrano[2,3-c]quinoline]-2′,3′ ,4,5-tetracarboxylate | ESD-879546-1G |
| Cas.: 331761-20-7 | Purity: 95% | Tetramethyl 5′,5′,8′,9′-tetramethyl-5′,6′-dihydrospiro[1,3-dithiole-2,1′-thiopyrano[2,3-c]quinoline]-2′,3′ ,4,5-tetracarboxylate | ESD-879546-5G |
| Cas.: 33173-53-4 | Purity: ≥99% | 4-Azido-L-phenylalanine | ESD-879547-100MG |
| Cas.: 33173-53-4 | Purity: ≥99% | 4-Azido-L-phenylalanine | ESD-879547-500MG |
| Cas.: 33116-33-5 | Purity: 95% | Stephavanine | ESD-879548-5MG |
| Cas.: 330786-25-9 | Purity: ≥99% | PCI 29732 | ESD-879549-2MG |
| Cas.: 330786-25-9 | Purity: ≥99% | PCI 29732 | ESD-879549-5MG |
| Cas.: 330676-02-3 | Purity: ≥99% | KH7 | ESD-879550-5MG |
| Cas.: 330676-02-3 | Purity: ≥99% | KH7 | ESD-879550-10MG |
| Cas.: 330600-85-6 | Purity: 95% | Peramivir | ESD-879551-10MG |
| Cas.: 330600-85-6 | Purity: 95% | Peramivir | ESD-879551-50MG |
| Cas.: 330461-64-8 | Purity: ≥99% | AK-1 | ESD-879552-5MG |
| Cas.: 330461-64-8 | Purity: ≥99% | AK-1 | ESD-879552-10MG |
| Cas.: 330203-01-5 | Purity: 98% | TC HSD 21 | ESD-879553-5MG |
| Cas.: 330203-01-5 | Purity: 98% | TC HSD 21 | ESD-879553-10MG |
| Cas.: 3301-61-9 | Purity: 98% | ent-16β,17-Dihydroxykauran-19-oic acid | ESD-879554-5MG |
| Cas.: 3301-49-3 | Purity: 99% | Kumatakenin | ESD-879555-5MG |
| Cas.: 329975-47-5 | Purity: 98% | 3,4-Secocucurbita-4,24-diene-3,26,29-trioic acid | ESD-879556-5MG |
| Cas.: 329773-35-5 | Purity: ≥99% | Cinaciguat | ESD-879557-2MG |
| Cas.: 329773-35-5 | Purity: ≥99% | Cinaciguat | ESD-879557-5MG |
| Cas.: 32971-25-8 | Purity: 98% | (+)-Pinoresinol diacetate | ESD-879558-5MG |
| Cas.: 329221-38-7 | Purity: ≥99% | AX20017 | ESD-879560-5MG |
| Cas.: 329221-38-7 | Purity: ≥99% | AX20017 | ESD-879560-10MG |
| Cas.: 329218-11-3 | Purity: ≥98% | Quetiapine sulfoxide dihydrochloride | ESD-879561-5MG |
| Cas.: 329218-11-3 | Purity: ≥98% | Quetiapine sulfoxide dihydrochloride | ESD-879561-10MG |
| Cas.: 329216-63-9 | Purity: 98% | Quetiapine sulfoxide | ESD-879562-5MG |
| Cas.: 329216-63-9 | Purity: 98% | Quetiapine sulfoxide | ESD-879562-10MG |
| Cas.: 329059-55-4 | Purity: ≥99% | BRD7116 | ESD-879563-5MG |
| Cas.: 329059-55-4 | Purity: ≥99% | BRD7116 | ESD-879563-10MG |
| Cas.: 328998-53-4 | Purity: ≥98% | inS3-54A18 | ESD-879564-2MG |
| Cas.: 328998-53-4 | Purity: ≥98% | inS3-54A18 | ESD-879564-5MG |
| Cas.: 328898-40-4 | Purity: ≥99% | Tildipirosin | ESD-879565-2MG |
| Cas.: 328898-40-4 | Purity: ≥99% | Tildipirosin | ESD-879565-5MG |
| Cas.: 32886-97-8 | Purity: 98% | Pivmecillinam | ESD-879566-10MG |
| Cas.: 32886-97-8 | Purity: 98% | Pivmecillinam | ESD-879566-50MG |
| Cas.: 32885-82-8 | Purity: 95% | De-O-methyllasiodiplodin | ESD-879567-5MG |
| Cas.: 32885-81-7 | Purity: 95% | Lasiodiplodin | ESD-879568-5MG |
| Cas.: 32884-36-9 | Purity: 98% | Cajanin | ESD-879569-5MG |
| Cas.: 328232-95-7 | Purity: ≥99% | MK-0557 | ESD-879570-5MG |
| Cas.: 328232-95-7 | Purity: ≥99% | MK-0557 | ESD-879570-10MG |
| Cas.: 32808-51-8 | Purity: 98% | Bucloxic acid | ESD-879572-1MG |
| Cas.: 32808-51-8 | Purity: 98% | Bucloxic acid | ESD-879572-5MG |
| Cas.: 32795-47-4 | Purity: ≥98% | Nomifensine maleate | ESD-879573-50MG |
| Cas.: 32795-47-4 | Purity: ≥98% | Nomifensine maleate | ESD-879573-100MG |
| Cas.: 32795-44-1 | Purity: ≥98% | N-Acetylprocainamide | ESD-879574-100MG |
| Cas.: 32769-01-0 | Purity: 92% | Tricin 7-O-glucoside | ESD-879575-5MG |
| Cas.: 327622-65-1 | Purity: 95% | Macrocarpal O | ESD-879576-5MG |
| Cas.: 327610-87-7 | Purity: ≥99% | NO-prednisolone | ESD-879577-1MG |
| Cas.: 327610-87-7 | Purity: ≥99% | NO-prednisolone | ESD-879577-5MG |
| Cas.: 327601-97-8 | Purity: 98% | Macrocarpal L | ESD-879578-5MG |
| Cas.: 32727-29-0 | Purity: 97% | Isorhapontin | ESD-879579-5MG |
| Cas.: 327092-81-9 | Purity: ≥98% | AKR1C3-IN-1 | ESD-879580-10MG |
| Cas.: 327092-81-9 | Purity: ≥98% | AKR1C3-IN-1 | ESD-879580-50MG |
| Cas.: 327056-26-8 | Purity: 98% | AZD 9272 | ESD-879581-5MG |
| Cas.: 327056-26-8 | Purity: 98% | AZD 9272 | ESD-879581-10MG |
| Cas.: 327033-36-3 | Purity: ≥99% | TCS-PIM-1-4a | ESD-879582-5MG |
| Cas.: 327033-36-3 | Purity: ≥99% | TCS-PIM-1-4a | ESD-879582-10MG |
| Cas.: 326866-17-5 | Purity: 98% | FAAH inhibitor 1 | ESD-879583-5MG |
| Cas.: 326866-17-5 | Purity: 98% | FAAH inhibitor 1 | ESD-879583-10MG |
| Cas.: 326594-34-7 | Purity: 95% | Fraxamoside | ESD-879584-1MG |
| Cas.: 32602-81-6 | Purity: 96% | Kaempferol 3-neohesperidoside | ESD-879585-5MG |
| Cas.: 325970-71-6 | Purity: ≥98% | L67 | ESD-879586-5MG |
| Cas.: 325970-71-6 | Purity: ≥98% | L67 | ESD-879586-10MG |
| Cas.: 325686-49-5 | Purity: 98% | Ascleposide E | ESD-879587-5MG |
| Cas.: 32533-11-2 | Purity: 95% | 8-Benzyl-1-thia-4,8-diazaspiro[4.5]decan-3-one | ESD-879588-500MG |
| Cas.: 32533-11-2 | Purity: 95% | 8-Benzyl-1-thia-4,8-diazaspiro[4.5]decan-3-one | ESD-879588-1G |
| Cas.: 32507-77-0 | Purity: 95% | Ergosta-7,22-dien-3-one | ESD-879589-5MG |
| Cas.: 32492-74-3 | Purity: 96% | Myricanone | ESD-879590-5MG |
| Cas.: 324759-76-4 | Purity: ≥98% | CCT020312 | ESD-879591-5MG |
| Cas.: 324759-76-4 | Purity: ≥98% | CCT020312 | ESD-879591-10MG |
| Cas.: 324523-20-8 | Purity: ≥99% | NPS-2143 hydrochloride | ESD-879592-5MG |
| Cas.: 324523-20-8 | Purity: ≥99% | NPS-2143 hydrochloride | ESD-879592-10MG |
| Cas.: 32451-85-7 | Purity: 98% | Lup-20(29)-ene-3α,23-diol | ESD-879593-5MG |
| Cas.: 32421-46-8 | Purity: 98% | Bunaftide | ESD-879594-1MG |
| Cas.: 32421-46-8 | Purity: 98% | Bunaftide | ESD-879594-5MG |
| Cas.: 324077-62-5 | Purity: 98% | ZSET-845 | ESD-879595-1MG |
| Cas.: 324077-62-5 | Purity: 98% | ZSET-845 | ESD-879595-5MG |
| Cas.: 32383-76-9 | Purity: 99% | Medicarpin | ESD-879596-5MG |
| Cas.: 32262-18-3 | Purity: 98% | 4-Methoxy-1-methylquinolin-2-one | ESD-879597-5MG |
| Cas.: 322471-42-1 | Purity: 95% | 2α,7β,13α-Triacetoxy-5α-cinnamoyloxy-9β-hydroxy-2(3→20)abeotaxa-4(20),11-dien-10-one | ESD-879598-5MG |
| Cas.: 32214-80-5 | Purity: 98% | Lupeol palmitate | ESD-879599-5MG |
| Cas.: 32207-10-6 | Purity: 95% | Heraclenol 3′-O-glucoside | ESD-879600-5MG |
| Cas.: 321995-62-4 | Purity: 98% | AGN 194078 | ESD-879601-1MG |
| Cas.: 321995-62-4 | Purity: 98% | AGN 194078 | ESD-879601-5MG |
| Cas.: 32179-18-3 | Purity: 95% | 1,10:4,5-Diepoxy-7(11)-germacren-8-one | ESD-879602-5MG |
| Cas.: 32174-62-2 | Purity: 95% | Pilloin | ESD-879603-5MG |
| Cas.: 321688-88-4 | Purity: ≥96% | Poloxin | ESD-879604-10MG |
| Cas.: 321688-88-4 | Purity: ≥96% | Poloxin | ESD-879604-50MG |
| Cas.: 321661-62-5 | Purity: ≥98% | Cytosporone B | ESD-879605-2MG |
| Cas.: 321661-62-5 | Purity: ≥98% | Cytosporone B | ESD-879605-5MG |
| Cas.: 321-55-1 | Purity: ≥98% | Haloxon | ESD-879606-5MG |
| Cas.: 321-55-1 | Purity: ≥98% | Haloxon | ESD-879606-10MG |
| Cas.: 320772-89-2 | Purity: 95% | spiro[indole-3,3′-pipidin]-2(1H)-one hydrochloride | ESD-879607-250MG |
| Cas.: 320772-89-2 | Purity: 95% | spiro[indole-3,3′-pipidin]-2(1H)-one hydrochloride | ESD-879607-1G |
| Cas.: 320624-68-8 | Purity: 98% | Marmin acetonide | ESD-879608-5MG |
| Cas.: 320419-82-7 | Purity: 95% | 3-Phenyl-1-oxa-3,8-diazaspiro[4.5]decan-2-onehydrochloride | ESD-879609-500MG |
| Cas.: 3198-49-0 | Purity: 97% | Ethyl glucoside | ESD-879610-1MG |
| Cas.: 3187-58-4 | Purity: 98% | Methyl orsellinate | ESD-879612-50MG |
| Cas.: 31842-01-0 | Purity: ≥99% | Indoprofen | ESD-879613-5MG |
| Cas.: 31842-01-0 | Purity: ≥99% | Indoprofen | ESD-879613-10MG |
| Cas.: 31828-68-9 | Purity: ≥98% | L-Homocysteine thiolactone hydrochloride | ESD-879614-5MG |
| Cas.: 31828-68-9 | Purity: ≥98% | L-Homocysteine thiolactone hydrochloride | ESD-879614-10MG |
| Cas.: 317374-08-6 | Purity: 98% | 2-Methyl-4-(2-methylbenzoylamino)benzoic acid | ESD-879615-5MG |
| Cas.: 31721-95-6 | Purity: 98% | 3,5,7-Trihydroxychromone | ESD-879616-5MG |
| Cas.: 31721-94-5 | Purity: 98% | 5,7-Dihydroxychromone | ESD-879617-5MG |
| Cas.: 31712-49-9 | Purity: 95% | Hesperetin 7-O-glucoside | ESD-879618-1MG |
| Cas.: 31690-09-2 | Purity: ≥98% | Levomefolic acid | ESD-879619-2MG |
| Cas.: 31685-80-0 | Purity: 98% | Pinusolide | ESD-879620-5MG |
| Cas.: 316354-15-1 | Purity: 95% | Methyl 3-methoxy-2,8-dioxo-1-oxaspiro[4.5]deca-3,6,9-triene-4-carboxylate | ESD-879623-500MG |
| Cas.: 316354-15-1 | Purity: 95% | Methyl 3-methoxy-2,8-dioxo-1-oxaspiro[4.5]deca-3,6,9-triene-4-carboxylate | ESD-879623-1G |
| Cas.: 3162-45-6 | Purity: 98% | 5,7-Dihydroxy-6,8-dimethoxyflavone | ESD-879624-5MG |
| Cas.: 31575-93-6 | Purity: 98% | Heraclenol | ESD-879625-5MG |
| Cas.: 315703-52-7 | Purity: ≥99% | JK184 | ESD-879626-5MG |
| Cas.: 315698-17-0 | Purity: ≥98% | ML311 | ESD-879627-5MG |
| Cas.: 315698-17-0 | Purity: ≥98% | ML311 | ESD-879627-10MG |
| Cas.: 315698-07-8 | Purity: 98% | BRD 4354 | ESD-879628-5MG |
| Cas.: 315698-07-8 | Purity: 98% | BRD 4354 | ESD-879628-10MG |
| Cas.: 315694-89-4 | Purity: 98% | TC-DAPK 6 | ESD-879629-10MG |
| Cas.: 315694-89-4 | Purity: 98% | TC-DAPK 6 | ESD-879629-50MG |
| Cas.: 3155-43-9 | Purity: 90% | 1,18-Octadecanediol | ESD-879630-5MG |
| Cas.: 3153-73-9 | Purity: 98% | Matsukaze-lactone | ESD-879631-5MG |
| Cas.: 3153-55-7 | Purity: 98% | O-Nornuciferine | ESD-879632-5MG |
| Cas.: 315236-68-1 | Purity: 98% | Sutherlandin trans-p-coumarate | ESD-879633-5MG |
| Cas.: 31520-95-3 | Purity: 97% | Ifflaiamine | ESD-879634-5MG |
| Cas.: 314728-85-3 | Purity: ≥99% | Sunifiram | ESD-879635-5MG |
| Cas.: 314728-85-3 | Purity: ≥99% | Sunifiram | ESD-879635-10MG |
| Cas.: 31427-08-4 | Purity: 95% | Isotachioside | ESD-879636-5MG |
| Cas.: 314054-00-7 | Purity: ≥98% | C-176 | ESD-879637-5MG |
| Cas.: 314054-00-7 | Purity: ≥98% | C-176 | ESD-879637-10MG |
| Cas.: 314042-01-8 | Purity: ≥98% | CID-1067700 | ESD-879638-5MG |
| Cas.: 314042-01-8 | Purity: ≥98% | CID-1067700 | ESD-879638-10MG |
| Cas.: 31404-03-2 | Purity: 95% | 8-Methyl-1-thia-4-azaspiro[4.5]decane | ESD-879639-500MG |
| Cas.: 31404-03-2 | Purity: 95% | 8-Methyl-1-thia-4-azaspiro[4.5]decane | ESD-879639-1G |
| Cas.: 314-03-4 | Purity: 98% | Pimethixene | ESD-879640-10MG |
| Cas.: 313526-24-8 | Purity: ≥98% | IBR2 | ESD-879641-5MG |
| Cas.: 313526-24-8 | Purity: ≥98% | IBR2 | ESD-879641-10MG |
| Cas.: 313493-80-0 | Purity: ≥99% | CID 1375606 | ESD-879642-5MG |
| Cas.: 313493-80-0 | Purity: ≥99% | CID 1375606 | ESD-879642-10MG |
| Cas.: 313397-13-6 | Purity: 98% | Reversan | ESD-879643-2MG |
| Cas.: 313397-13-6 | Purity: 98% | Reversan | ESD-879643-5MG |
| Cas.: 313380-27-7 | Purity: ≥99% | FDI-6 | ESD-879644-5MG |
| Cas.: 313380-27-7 | Purity: ≥99% | FDI-6 | ESD-879644-10MG |
| Cas.: 3133-16-2 | Purity: ≥99% | 4-Octyl Itaconate | ESD-879645-50MG |
| Cas.: 3133-16-2 | Purity: ≥99% | 4-Octyl Itaconate | ESD-879645-100MG |
| Cas.: 313254-51-2 | Purity: ≥98% | ICA-121431 | ESD-879646-10MG |
| Cas.: 313254-51-2 | Purity: ≥98% | ICA-121431 | ESD-879646-50MG |
| Cas.: 31298-06-3 | Purity: 95% | Arjunic acid | ESD-879647-5MG |
| Cas.: 312951-85-2 | Purity: ≥98% | PROTO-1 | ESD-879648-2MG |
| Cas.: 312951-85-2 | Purity: ≥98% | PROTO-1 | ESD-879648-5MG |
| Cas.: 312946-37-5 | Purity: ≥98% | LDN-27219 | ESD-879649-10MG |
| Cas.: 312946-37-5 | Purity: ≥98% | LDN-27219 | ESD-879649-50MG |
| Cas.: 31282-07-2 | Purity: 95% | Raucaffricine | ESD-879650-5MG |
| Cas.: 312752-85-5 | Purity: 98% | YM758 | ESD-879651-1MG |
| Cas.: 312752-85-5 | Purity: 98% | YM758 | ESD-879651-5MG |
| Cas.: 312-63-0 | Purity: ≥99% | ELN484228 | ESD-879652-5MG |
| Cas.: 312-63-0 | Purity: ≥99% | ELN484228 | ESD-879652-10MG |
| Cas.: 31262-37-0 | Purity: 97% | Tetrahydrocannabivarin | ESD-879653-5MG |
| Cas.: 312608-26-7 | Purity: 95% | 2-Amino-8-pyridin-3-yl-7,9-dioxa-1-thia-3-aza-spiro[4.5]dec-2-en-4-one | ESD-879654-1G |
| Cas.: 312600-59-2 | Purity: 95% | 3,4-DIHYDRO-1H-SPIRO[NAPHTHALENE-2,4′-PIPERIDIN]-1-ONE HCL | ESD-879655-1G |
| Cas.: 312600-59-2 | Purity: 95% | 3,4-DIHYDRO-1H-SPIRO[NAPHTHALENE-2,4′-PIPERIDIN]-1-ONE HCL | ESD-879655-5G |
| Cas.: 3122-88-1 | Purity: 99% | Eucalyptin | ESD-879656-5MG |
| Cas.: 3122-87-0 | Purity: 97% | Sideroxylin | ESD-879657-5MG |
| Cas.: 312271-03-7 | Purity: 98% | M2I-1 | ESD-879658-2MG |
| Cas.: 312271-03-7 | Purity: 98% | M2I-1 | ESD-879658-5MG |
| Cas.: 31222-32-9 | Purity: 98% | Cimigenol-3-one | ESD-879659-5MG |
| Cas.: 31197-54-3 | Purity: 95% | Methylionene | ESD-879660-5MG |
| Cas.: 311795-38-7 | Purity: ≥99% | Glutaminase C-IN-1 | ESD-879661-5MG |
| Cas.: 311795-38-7 | Purity: ≥99% | Glutaminase C-IN-1 | ESD-879661-10MG |
| Cas.: 31127-85-2 | Purity: ≥98% | Bis-PEG4-acid | ESD-879662-100MG |
| Cas.: 311-21-7 | Purity: 95% | 3-oxa-9-azaspiro[5.5]undecane | ESD-879663-1G |
| Cas.: 31106-05-5 | Purity: 98% | Taxifolin 3′-O-glucoside | ESD-879664-5MG |
| Cas.: 310-93-0 | Purity: 95% | 8-Oxa-2-azaspiro[4.5]decane | ESD-879665-5G |
| Cas.: 310888-07-4 | Purity: 98% | 5,7,3′-Trihydroxy-6,4′,5′-trimethoxyflavanone | ESD-879666-5MG |
| Cas.: 31076-39-8 | Purity: 96% | Cededarin | ESD-879667-5MG |
| Cas.: 3106-85-2 | Purity: 98% | Spaglumic Acid | ESD-879668-10MG |
| Cas.: 3106-85-2 | Purity: 98% | Spaglumic Acid | ESD-879668-50MG |
| Cas.: 3105-97-3 | Purity: ≥98% | Hycanthone | ESD-879669-10MG |
| Cas.: 31058-02-3 | Purity: 95% | Spiro[3.5]nonan-7-one | ESD-879670-250MG |
| Cas.: 31058-02-3 | Purity: 95% | Spiro[3.5]nonan-7-one | ESD-879670-1G |
| Cas.: 310433-44-4 | Purity: 95% | Echinophyllin C | ESD-879671-5MG |
| Cas.: 310427-95-3 | Purity: 98% | M-2420 | ESD-879672-1MG |
| Cas.: 310427-95-3 | Purity: 98% | M-2420 | ESD-879672-5MG |
| Cas.: 310392-94-0 | Purity: 98% | Wf-516 | ESD-879673-1MG |
| Cas.: 310392-94-0 | Purity: 98% | Wf-516 | ESD-879673-5MG |
| Cas.: 309247-84-5 | Purity: ≥98% | Crustacean Cardioactive Peptide CCAP | ESD-879674-1MG |
| Cas.: 309247-84-5 | Purity: ≥98% | Crustacean Cardioactive Peptide CCAP | ESD-879674-5MG |
| Cas.: 3090-70-8 | Purity: 98% | 3β-Acetoxy-5α-androstan-17β-ol | ESD-879675-5MG |
| Cas.: 30890-35-8 | Purity: 95% | 8-Epixanthatin | ESD-879676-5MG |
| Cas.: 308362-25-6 | Purity: ≥99% | Ridinilazole | ESD-879677-1MG |
| Cas.: 308362-25-6 | Purity: ≥99% | Ridinilazole | ESD-879677-5MG |
| Cas.: 30828-09-2 | Purity: 95% | 4-Oxododecanedioic acid | ESD-879678-5MG |
| Cas.: 308246-57-3 | Purity: ≥99% | LMP744 hydrochloride | ESD-879679-1MG |
| Cas.: 308246-57-3 | Purity: ≥99% | LMP744 hydrochloride | ESD-879679-5MG |
| Cas.: 308246-52-8 | Purity: 98% | LMP744 | ESD-879680-1MG |
| Cas.: 308246-52-8 | Purity: 98% | LMP744 | ESD-879680-5MG |
| Cas.: 3080-20-4 | Purity: 97% | β-Anhydrouzarigenin | ESD-879681-5MG |
| Cas.: 307983-31-9 | Purity: ≥99% | GRA Ex-25 | ESD-879682-2MG |
| Cas.: 307983-31-9 | Purity: ≥99% | GRA Ex-25 | ESD-879682-5MG |
| Cas.: 307519-88-6 | Purity: ≥98% | NMDI14 | ESD-879683-5MG |
| Cas.: 307519-88-6 | Purity: ≥98% | NMDI14 | ESD-879683-10MG |
| Cas.: 307329-27-7 | Purity: 95% | Tetramethyl 8′-methoxy-5′,5′-dimethyl-5′,6′-dihydrospiro[1,3-dithiole-2,1′-thiopyrano[2,3-c]quinoline]-2′,3′, 4,5-tetracarboxylate | ESD-879684-500MG |
| Cas.: 307329-27-7 | Purity: 95% | Tetramethyl 8′-methoxy-5′,5′-dimethyl-5′,6′-dihydrospiro[1,3-dithiole-2,1′-thiopyrano[2,3-c]quinoline]-2′,3′, 4,5-tetracarboxylate | ESD-879684-1G |
| Cas.: 307002-71-7 | Purity: ≥98% | CL-82198 | ESD-879685-5MG |
| Cas.: 307002-71-7 | Purity: ≥98% | CL-82198 | ESD-879685-10MG |
| Cas.: 306288-04-0 | Purity: ≥99% | AVE 0991 sodium salt | ESD-879686-2MG |
| Cas.: 306288-04-0 | Purity: ≥99% | AVE 0991 sodium salt | ESD-879686-5MG |
| Cas.: 3057-91-8 | Purity: 97% | Spiro[3.3]heptane-2,6-dicarboxylic acid | ESD-879687-1G |
| Cas.: 30536-48-2 | Purity: 98% | Caulilexin C | ESD-879688-5MG |
| Cas.: 305343-76-4 | Purity: 95% | Tetramethyl 5′,5′,8′-trimethyl-5′,6′-dihydrospiro[1,3-dithiole-2,1′-thiopyrano[2,3-c]quinoline]-2′,3′,4, 5-tetracarboxylate | ESD-879689-500MG |
| Cas.: 305343-76-4 | Purity: 95% | Tetramethyl 5′,5′,8′-trimethyl-5′,6′-dihydrospiro[1,3-dithiole-2,1′-thiopyrano[2,3-c]quinoline]-2′,3′,4, 5-tetracarboxylate | ESD-879689-1G |
| Cas.: 305-33-9 | Purity: ≥99% | iproniazid phosphate | ESD-879690-100MG |
| Cas.: 30489-27-1 | Purity: 98% | Alisol C | ESD-879692-5MG |
| Cas.: 304853-42-7 | Purity: ≥98% | Tanaproget | ESD-879693-2MG |
| Cas.: 304853-42-7 | Purity: ≥98% | Tanaproget | ESD-879693-5MG |
| Cas.: 30484-88-9 | Purity: 98% | Mearnsitrin | ESD-879694-5MG |
| Cas.: 304-84-7 | Purity: ≥99% | Etamivan | ESD-879695-100MG |
| Cas.: 30482-25-8 | Purity: 95% | 1,4-Dioxaspiro[4.5]decan-8-ylmethanamine | ESD-879696-1G |
| Cas.: 30482-25-8 | Purity: 95% | 1,4-Dioxaspiro[4.5]decan-8-ylmethanamine | ESD-879696-5G |
| Cas.: 304642-94-2 | Purity: 98% | Xerophilusin G | ESD-879697-5MG |
| Cas.: 304642-91-9 | Purity: 98% | Flagelin 22 | ESD-879698-1MG |
| Cas.: 304642-91-9 | Purity: 98% | Flagelin 22 | ESD-879698-5MG |
| Cas.: 30452-60-9 | Purity: 95% | Cyclomosalenone | ESD-879699-5MG |
| Cas.: 304468-42-6 | Purity: 97% | 5′-BROMOSPIRO[CYCLOHEXANE-1,3′-INDOLIN]-2′-ONE | ESD-879700-250MG |
| Cas.: 304468-42-6 | Purity: 97% | 5′-BROMOSPIRO[CYCLOHEXANE-1,3′-INDOLIN]-2′-ONE | ESD-879700-1G |
| Cas.: 304462-19-9 | Purity: ≥99% | AVE 0991 | ESD-879701-2MG |
| Cas.: 304462-19-9 | Purity: ≥99% | AVE 0991 | ESD-879701-5MG |
| Cas.: 3044-60-8 | Purity: 95% | Toxicarolisoflavone | ESD-879702-5MG |
| Cas.: 30413-84-4 | Purity: 95% | Corydalmine | ESD-879703-5MG |
| Cas.: 304025-09-0 | Purity: 98% | AVE-8134 | ESD-879704-1MG |
| Cas.: 304025-09-0 | Purity: 98% | AVE-8134 | ESD-879704-5MG |
| Cas.: 3039-71-2 | Purity: 98% | U18666A | ESD-879705-5MG |
| Cas.: 3039-71-2 | Purity: 98% | U18666A | ESD-879705-10MG |
| Cas.: 30368-42-4 | Purity: 97% | Dalbergioidin | ESD-879706-5MG |
| Cas.: 30359-01-4 | Purity: 97% | Centrolobol | ESD-879707-5MG |
| Cas.: 30315-04-9 | Purity: 96% | Picrasin B acetate | ESD-879708-5MG |
| Cas.: 303149-14-6 | Purity: ≥98% | HT-2157 | ESD-879709-1MG |
| Cas.: 303149-14-6 | Purity: ≥98% | HT-2157 | ESD-879709-5MG |
| Cas.: 303126-97-8 | Purity: ≥99% | SR0987 | ESD-879710-5MG |
| Cas.: 303126-97-8 | Purity: ≥99% | SR0987 | ESD-879710-10MG |
| Cas.: 303008-81-3 | Purity: 95% | Pandamarilactonine B | ESD-879711-1MG |
| Cas.: 303008-80-2 | Purity: 95% | Pandamarilactonine A | ESD-879712-1MG |
| Cas.: 30279-49-3 | Purity: 98% | Suclofenide | ESD-879713-1MG |
| Cas.: 30279-49-3 | Purity: 98% | Suclofenide | ESD-879713-5MG |
| Cas.: 30273-62-2 | Purity: 95% | 3,4,5-Trimethoxycinnamyl alcohol | ESD-879714-5MG |
| Cas.: 30271-38-6 | Purity: ≥98% | 24-Hydroxycholesterol | ESD-879715-2MG |
| Cas.: 30271-38-6 | Purity: ≥98% | 24-Hydroxycholesterol | ESD-879715-5MG |
| Cas.: 30265-10-2 | Purity: 95% | 6′-methoxy-3′,4′-dihydro-2H,2’H,5H-spiro[imidazolidine-4,1′-naphthalene]-2,5-dione | ESD-879716-1G |
| Cas.: 3025-96-5 | Purity: ≥98% | 4-Acetamidobutanoic acid | ESD-879717-200MG |
| Cas.: 30244-37-2 | Purity: 96% | 1-Hydroxybaccatin I | ESD-879718-5MG |
| Cas.: 30233-64-8 | Purity: 98% | Monobehenin | ESD-879719-100MG |
| Cas.: 30233-64-8 | Purity: 98% | Monobehenin | ESD-879719-500MG |
| Cas.: 30220-43-0 | Purity: 98% | Effusanin A | ESD-879720-5MG |
| Cas.: 3019-51-0 | Purity: 98% | Isoboldine | ESD-879721-5MG |
| Cas.: 30189-85-6 | Purity: ≥97% | PPA-904 | ESD-879722-1MG |
| Cas.: 30189-85-6 | Purity: ≥97% | PPA-904 | ESD-879722-5MG |
| Cas.: 301847-37-0 | Purity: 98% | Org41841 | ESD-879723-1MG |
| Cas.: 301847-37-0 | Purity: 98% | Org41841 | ESD-879723-5MG |
| Cas.: 301655-50-5 | Purity: 95% | Tetramethyl 9′-ethoxy-5′,5′-dimethyl-5′,6′-dihydrospiro[1,3-dithiole-2,1′-thiopyrano[2,3-c]quinoline]-2′,3′, 4,5-tetracarboxylate | ESD-879724-500MG |
| Cas.: 301655-50-5 | Purity: 95% | Tetramethyl 9′-ethoxy-5′,5′-dimethyl-5′,6′-dihydrospiro[1,3-dithiole-2,1′-thiopyrano[2,3-c]quinoline]-2′,3′, 4,5-tetracarboxylate | ESD-879724-1G |
| Cas.: 30164-93-3 | Purity: 98% | Jasminin | ESD-879725-5MG |
| Cas.: 301530-12-1 | Purity: 95% | Seneganolide | ESD-879726-1MG |
| Cas.: 30152-60-4 | Purity: 95% | 5′,6′,7′,8′-tetrahydro-1’H-spiro[cyclohexane-1,2′-quinazolin]-4′(3’H)-one | ESD-879727-1G |
| Cas.: 30152-57-9 | Purity: 95% | spiro[3.3]heptan-2-one | ESD-879728-1G |
| Cas.: 301351-95-1 | Purity: ≥99% | Arg-AMS | ESD-879729-5MG |
| Cas.: 301351-95-1 | Purity: ≥99% | Arg-AMS | ESD-879729-10MG |
| Cas.: 301226-27-7 | Purity: 95% | tert-Butyl 2-oxo-1-oxa-8-azaspiro[4.5]decane-8-carboxylate | ESD-879730-500MG |
| Cas.: 301226-27-7 | Purity: 95% | tert-Butyl 2-oxo-1-oxa-8-azaspiro[4.5]decane-8-carboxylate | ESD-879730-1G |
| Cas.: 301226-25-5 | Purity: 96% | 1-Oxa-5-azaspiro[2.4]heptane-5-carboxylic acid tert-butyl ester | ESD-879731-500MG |
| Cas.: 301226-25-5 | Purity: 96% | 1-Oxa-5-azaspiro[2.4]heptane-5-carboxylic acid tert-butyl ester | ESD-879731-1G |
| Cas.: 301-19-9 | Purity: 98% | Robinin | ESD-879732-5MG |
| Cas.: 300-84-5 | Purity: ≥98% | Hypotaurine | ESD-879733-50MG |
| Cas.: 300842-64-2 | Purity: ≥99% | NVP-ACC789 | ESD-879734-5MG |
| Cas.: 300842-64-2 | Purity: ≥99% | NVP-ACC789 | ESD-879734-10MG |
| Cas.: 300816-15-3 | Purity: ≥99% | RS 504393 | ESD-879735-5MG |
| Cas.: 300816-15-3 | Purity: ≥99% | RS 504393 | ESD-879735-10MG |
| Cas.: 300815-41-2 | Purity: 98% | RS102895 | ESD-879736-10MG |
| Cas.: 300815-41-2 | Purity: 98% | RS102895 | ESD-879736-50MG |
| Cas.: 300697-12-5 | Purity: 95% | N~2~-phenyl-1,3,5-triazaspiro[5.5]undeca-1,3-diene-2,4-diamine | ESD-879737-1G |
| Cas.: 300552-38-9 | Purity: 95% | 6-Chlorospiro[chroman-2,4′-piperidin]-4-one hydrochloride | ESD-879738-250MG |
| Cas.: 300552-38-9 | Purity: 95% | 6-Chlorospiro[chroman-2,4′-piperidin]-4-one hydrochloride | ESD-879738-1G |
| Cas.: 300353-13-3 | Purity: ≥99% | Ro 28-1675 | ESD-879739-5MG |
| Cas.: 300353-13-3 | Purity: ≥99% | Ro 28-1675 | ESD-879739-10MG |
| Cas.: 30034-03-8 | Purity: ≥98% | Cefamandole sodium | ESD-879740-10MG |
| Cas.: 299-75-2 | Purity: ≥98% | Treosulfan | ESD-879741-5MG |
| Cas.: 299-75-2 | Purity: ≥98% | Treosulfan | ESD-879741-10MG |
| Cas.: 2990-43-4 | Purity: 98% | Eledoisin Related Peptide | ESD-879742-1MG |
| Cas.: 2990-43-4 | Purity: 98% | Eledoisin Related Peptide | ESD-879742-5MG |
| Cas.: 298708-81-3 | Purity: ≥98% | Bay 41-4109 | ESD-879743-1MG |
| Cas.: 298708-81-3 | Purity: ≥98% | Bay 41-4109 | ESD-879743-5MG |
| Cas.: 298708-79-9 | Purity: ≥98% | Bay 41-4109 racemate | ESD-879744-1MG |
| Cas.: 298708-79-9 | Purity: ≥98% | Bay 41-4109 racemate | ESD-879744-5MG |
| Cas.: 298690-60-5 | Purity: ≥99% | Ro 67-7476 | ESD-879745-2MG |
| Cas.: 298690-60-5 | Purity: ≥99% | Ro 67-7476 | ESD-879745-5MG |
| Cas.: 298684-44-3 | Purity: ≥99% | ML402 | ESD-879746-1MG |
| Cas.: 298684-44-3 | Purity: ≥99% | ML402 | ESD-879746-5MG |
| Cas.: 29836-27-9 | Purity: 98% | Shanzhiside | ESD-879747-5MG |
| Cas.: 29800-45-1 | Purity: 95% | SPIRO[3.5]NONAN-1-ONE | ESD-879748-250MG |
| Cas.: 29800-45-1 | Purity: 95% | SPIRO[3.5]NONAN-1-ONE | ESD-879748-1G |
| Cas.: 297740-99-9 | Purity: 98% | Nudifloside C | ESD-879749-5MG |
| Cas.: 297740-98-8 | Purity: 97% | Nudifloside B | ESD-879750-5MG |
| Cas.: 297730-17-7 | Purity: ≥99% | AVN-944 | ESD-879751-2MG |
| Cas.: 297730-17-7 | Purity: ≥99% | AVN-944 | ESD-879751-5MG |
| Cas.: 29752-43-0 | Purity: 98% | Altenuene | ESD-879752-5MG |
| Cas.: 2975-00-0 | Purity: 98% | Altretamine hydrochloride | ESD-879753-100MG |
| Cas.: 2975-00-0 | Purity: 98% | Altretamine hydrochloride | ESD-879753-500MG |
| Cas.: 29748-10-5 | Purity: 98% | Loganetin | ESD-879754-5MG |
| Cas.: 29748-10-5 | Purity: 98% | Loganetin | ESD-879754-10MG |
| Cas.: 29741-10-4 | Purity: ≥99% | Luteolin 7-O-glucuronide | ESD-879755-5MG |
| Cas.: 29741-10-4 | Purity: ≥99% | Luteolin 7-O-glucuronide | ESD-879755-10MG |
| Cas.: 297180-15-5 | Purity: ≥99% | Lipofermata | ESD-879756-5MG |
| Cas.: 29708-87-0 | Purity: 98% | Methyl chlorogenate | ESD-879757-1MG |
| Cas.: 296272-61-2 | Purity: 95% | Tetraethyl 5′,5′,9′-trimethyl-5′,6′-dihydrospiro[1,3-dithiole-2,1′-thiopyrano[2,3-c]quinoline]-2′,3′,4, 5-tetracarboxylate | ESD-879758-500MG |
| Cas.: 296272-61-2 | Purity: 95% | Tetraethyl 5′,5′,9′-trimethyl-5′,6′-dihydrospiro[1,3-dithiole-2,1′-thiopyrano[2,3-c]quinoline]-2′,3′,4, 5-tetracarboxylate | ESD-879758-1G |
| Cas.: 29621-75-8 | Purity: 95% | Friedelin 3,4-lactone | ESD-879759-5MG |
| Cas.: 295803-03-1 | Purity: 97% | Gynuramide II | ESD-879760-5MG |
| Cas.: 2957-21-3 | Purity: ≥98% | Sakuranetin | ESD-879761-5MG |
| Cas.: 2957-21-3 | Purity: ≥98% | Sakuranetin | ESD-879761-10MG |
| Cas.: 2955-27-3 | Purity: 98% | Ursocholic acid | ESD-879762-5MG |
| Cas.: 2955-27-3 | Purity: 98% | Ursocholic acid | ESD-879762-10MG |
| Cas.: 295347-16-9 | Purity: 95% | Tetramethyl 5′,5′,7′-trimethyl-5′,6′-dihydrospiro[1,3-dithiole-2,1′-thiopyrano[2,3-c]quinoline]-2′,3′,4, 5-tetracarboxylate | ESD-879763-500MG |
| Cas.: 295347-16-9 | Purity: 95% | Tetramethyl 5′,5′,7′-trimethyl-5′,6′-dihydrospiro[1,3-dithiole-2,1′-thiopyrano[2,3-c]quinoline]-2′,3′,4, 5-tetracarboxylate | ESD-879763-1G |
| Cas.: 29505-31-5 | Purity: 95% | Valerosidate | ESD-879764-5MG |
| Cas.: 294856-66-9 | Purity: 98% | Cypellocarpin C | ESD-879765-5MG |
| Cas.: 29424-96-2 | Purity: 98% | 7,4′-Di-O-methylnaringenin | ESD-879766-5MG |
| Cas.: 29388-59-8 | Purity: 98% | Secoisolariciresinol | ESD-879767-5MG |
| Cas.: 29388-33-8 | Purity: 98% | Anhydrosecoisolariciresinol | ESD-879768-5MG |
| Cas.: 29376-68-9 | Purity: 99% | Thevetiaflavone | ESD-879769-5MG |
| Cas.: 2935-32-2 | Purity: 93% | Olean-12-ene-3,11-dione | ESD-879770-5MG |
| Cas.: 29307-03-7 | Purity: 97% | Deoxyelephantopin | ESD-879771-5MG |
| Cas.: 29261-12-9 | Purity: ≥98% | 25,26-Dihydroxyvitamin D3 | ESD-879772-1MG |
| Cas.: 29261-12-9 | Purity: ≥98% | 25,26-Dihydroxyvitamin D3 | ESD-879772-5MG |
| Cas.: 29218-27-7 | Purity: ≥99% | Toloxatone | ESD-879773-5MG |
| Cas.: 29218-27-7 | Purity: ≥99% | Toloxatone | ESD-879773-10MG |
| Cas.: 292168-79-7 | Purity: ≥98% | KY1220 | ESD-879774-2MG |
| Cas.: 292168-79-7 | Purity: ≥98% | KY1220 | ESD-879774-5MG |
| Cas.: 2921-57-5 | Purity: ≥99% | Methylprednisolone succinate | ESD-879775-10MG |
| Cas.: 2921-57-5 | Purity: ≥99% | Methylprednisolone succinate | ESD-879775-50MG |
| Cas.: 2920-86-7 | Purity: 98% | Prednisolone hemisuccinate | ESD-879776-100MG |
| Cas.: 292057-76-2 | Purity: 98% | Mcl1-IN-2 | ESD-879777-2MG |
| Cas.: 292057-76-2 | Purity: 98% | Mcl1-IN-2 | ESD-879777-5MG |
| Cas.: 291535-65-4 | Purity: 97% | Shegansu B | ESD-879778-5MG |
| Cas.: 29133-52-6 | Purity: 95% | 1-Methoxyberberine | ESD-879779-5MG |
| Cas.: 29110-47-2 | Purity: 98% | Guanfacine | ESD-879780-10MG |
| Cas.: 29110-47-2 | Purity: 98% | Guanfacine | ESD-879780-50MG |
| Cas.: 290815-26-8 | Purity: ≥98% | Avosentan | ESD-879781-5MG |
| Cas.: 290815-26-8 | Purity: ≥98% | Avosentan | ESD-879781-10MG |
| Cas.: 290814-68-5 | Purity: ≥98% | PBOX 6 | ESD-879782-5MG |
| Cas.: 290814-68-5 | Purity: ≥98% | PBOX 6 | ESD-879782-10MG |
| Cas.: 29080-58-8 | Purity: 98% | 7,3′,4′-Tri-O-methylluteolin | ESD-879783-5MG |
| Cas.: 290315-45-6 | Purity: ≥98% | BMS 299897 | ESD-879784-5MG |
| Cas.: 290315-45-6 | Purity: ≥98% | BMS 299897 | ESD-879784-10MG |
| Cas.: 290304-24-4 | Purity: ≥98% | Daun02 | ESD-879785-2MG |
| Cas.: 290304-24-4 | Purity: ≥98% | Daun02 | ESD-879785-5MG |
| Cas.: 290296-72-9 | Purity: 98% | Netupitant metabolite N-desmethyl Netupitant | ESD-879786-1MG |
| Cas.: 290296-72-9 | Purity: 98% | Netupitant metabolite N-desmethyl Netupitant | ESD-879786-5MG |
| Cas.: 290296-68-3 | Purity: 98% | Befetupitant | ESD-879787-1MG |
| Cas.: 290296-68-3 | Purity: 98% | Befetupitant | ESD-879787-5MG |
| Cas.: 29028-10-2 | Purity: 95% | 3-Epiglochidiol | ESD-879788-5MG |
| Cas.: 289893-26-1 | Purity: ≥99% | Arimoclomol maleate | ESD-879789-5MG |
| Cas.: 289893-26-1 | Purity: ≥99% | Arimoclomol maleate | ESD-879789-10MG |
| Cas.: 28978-03-2 | Purity: 98% | Persicoside | ESD-879790-5MG |
| Cas.: 289715-28-2 | Purity: ≥98% | CB 300919 | ESD-879791-5MG |
| Cas.: 289715-28-2 | Purity: ≥98% | CB 300919 | ESD-879791-10MG |
| Cas.: 28957-08-6 | Purity: 98% | Lasiokaurin | ESD-879792-5MG |
| Cas.: 28955-30-8 | Purity: 98% | Cassiachromone | ESD-879793-5MG |
| Cas.: 289483-69-8 | Purity: ≥99% | E7820 | ESD-879794-5MG |
| Cas.: 289483-69-8 | Purity: ≥99% | E7820 | ESD-879794-10MG |
| Cas.: 289480-64-4 | Purity: ≥98% | Treprostinil sodium | ESD-879795-1MG |
| Cas.: 289480-64-4 | Purity: ≥98% | Treprostinil sodium | ESD-879795-5MG |
| Cas.: 289479-94-3 | Purity: ≥95% | TN1 | ESD-879796-1MG |
| Cas.: 289479-94-3 | Purity: ≥95% | TN1 | ESD-879796-5MG |
| Cas.: 28936-91-6 | Purity: 95% | 8-Acetyl-1,3,8-triazaspiro[4.5]decane-2,4-dione | ESD-879797-1G |
| Cas.: 28936-91-6 | Purity: 95% | 8-Acetyl-1,3,8-triazaspiro[4.5]decane-2,4-dione | ESD-879797-2.5G |
| Cas.: 289056-24-2 | Purity: 93% | Stigmast-5-ene-3β,7α,16β-triol | ESD-879798-5MG |
| Cas.: 289054-34-8 | Purity: 97% | Ergosta-5,24(28)-diene-3β,7α,16β-triol | ESD-879799-5MG |
| Cas.: 288628-05-7 | Purity: ≥99% | Irosustat | ESD-879800-5MG |
| Cas.: 288628-05-7 | Purity: ≥99% | Irosustat | ESD-879800-10MG |
| Cas.: 288591-93-5 | Purity: ≥99% | Leu-AMS | ESD-879801-1MG |
| Cas.: 288591-93-5 | Purity: ≥99% | Leu-AMS | ESD-879801-5MG |
| Cas.: 28845-86-5 | Purity: ≥98%, 149 mM in Ethanol | Docosatrienoic Acid | ESD-879802-100ΜL |
| Cas.: 288262-96-4 | Purity: ≥98% | BX471 hydrochloride | ESD-879803-10MG |
| Cas.: 288262-96-4 | Purity: ≥98% | BX471 hydrochloride | ESD-879803-50MG |
| Cas.: 288259-72-3 | Purity: 97% | Denudanolide A | ESD-879804-5MG |
| Cas.: 288248-46-4 | Purity: 95% | Phlorigidoside B | ESD-879805-1MG |
| Cas.: 28822-73-3 | Purity: 95% | 3,4-Dihydroxyphenylglycol | ESD-879806-1MG |
| Cas.: 288141-04-8 | Purity: 98% | Platyphyllonol 5-O-β-D-xylopyranoside | ESD-879807-5MG |
| Cas.: 2880-49-1 | Purity: 98% | Heraclenin | ESD-879808-5MG |
| Cas.: 28757-27-9 | Purity: 98% | Apigenin 5-O-glucoside | ESD-879809-5MG |
| Cas.: 28755-03-5 | Purity: ≥99% | 3CAI | ESD-879810-5MG |
| Cas.: 28755-03-5 | Purity: ≥99% | 3CAI | ESD-879810-10MG |
| Cas.: 287194-38-1 | Purity: 98% | DHMEQ racemate | ESD-879811-1MG |
| Cas.: 2870-71-5 | Purity: 98% | Atropine methyl bromide | ESD-879812-10MG |
| Cas.: 2870-71-5 | Purity: 98% | Atropine methyl bromide | ESD-879812-50MG |
| Cas.: 286942-97-0 | Purity: 98% | Ezatiostat hydrochloride | ESD-879813-5MG |
| Cas.: 286942-97-0 | Purity: 98% | Ezatiostat hydrochloride | ESD-879813-10MG |
| Cas.: 286936-40-1 | Purity: ≥99% | OTX008 | ESD-879814-5MG |
| Cas.: 286936-40-1 | Purity: ≥99% | OTX008 | ESD-879814-10MG |
| Cas.: 286852-20-8 | Purity: ≥99% | Cyclosporin A-Derivative 1 Free base | ESD-879815-1MG |
| Cas.: 286852-20-8 | Purity: ≥99% | Cyclosporin A-Derivative 1 Free base | ESD-879815-5MG |
| Cas.: 28645-27-4 | Purity: 97% | Meloscandonine | ESD-879816-5MG |
| Cas.: 28619-41-2 | Purity: 97% | Erythristemine | ESD-879817-5MG |
| Cas.: 28610-31-3 | Purity: 97% | 8-Prenylkaempferol | ESD-879818-5MG |
| Cas.: 285986-31-4 | Purity: ≥98% | STAT5-IN-1 | ESD-879819-5MG |
| Cas.: 285986-31-4 | Purity: ≥98% | STAT5-IN-1 | ESD-879819-10MG |
| Cas.: 28598-08-5 | Purity: ≥99% | Cinoctramide | ESD-879820-10MG |
| Cas.: 28594-00-5 | Purity: 93% | 22-Dehydroclerosteryl acetate | ESD-879821-5MG |
| Cas.: 28593-92-2 | Purity: 98% | Docosyl caffeate | ESD-879822-5MG |
| Cas.: 28593-90-0 | Purity: 97% | Eicosanyl caffeate | ESD-879823-5MG |
| Cas.: 28590-40-1 | Purity: 98% | Persicogenin | ESD-879824-5MG |
| Cas.: 28587-43-1 | Purity: 95% | 7-Geranyloxy-6-methoxycoumarin | ESD-879825-1MG |
| Cas.: 2856-75-9 | Purity: ≥98% | Modaline sulfate | ESD-879826-100MG |
| Cas.: 28562-58-5 | Purity: 98% | 4-Benzoyloxy-2-azetidinone | ESD-879827-5MG |
| Cas.: 28546-58-9 | Purity: 98% | Uldazepam | ESD-879828-1MG |
| Cas.: 28546-58-9 | Purity: 98% | Uldazepam | ESD-879828-5MG |
| Cas.: 284672-78-2 | Purity: 95% | 9-Deacetyltaxinine E | ESD-879829-5MG |
| Cas.: 284672-76-0 | Purity: 95% | 20-Deacetyltaxuspine X | ESD-879830-5MG |
| Cas.: 284661-68-3 | Purity: ≥99% | DPC-681 | ESD-879831-1MG |
| Cas.: 284661-68-3 | Purity: ≥99% | DPC-681 | ESD-879831-5MG |
| Cas.: 28449-62-9 | Purity: 98% | Tomentin | ESD-879832-5MG |
| Cas.: 284490-13-7 | Purity: ≥99% | Forodesine hydrochloride | ESD-879833-1MG |
| Cas.: 284490-13-7 | Purity: ≥99% | Forodesine hydrochloride | ESD-879833-2500ΜG |
| Cas.: 28420-25-9 | Purity: 96% | 6-Hydroxy-2,6-dimethyl-2,7-octadienoic acid | ESD-879834-5MG |
| Cas.: 28399-31-7 | Purity: ≥98% | DCP-LA | ESD-879835-1MG |
| Cas.: 28399-31-7 | Purity: ≥98% | DCP-LA | ESD-879835-5MG |
| Cas.: 28398-06-3 | Purity: 80% | 1(10)-Aristolen-2-one | ESD-879836-5MG |
| Cas.: 28342-33-8 | Purity: 95% | Oxychelerythrine | ESD-879837-1MG |
| Cas.: 28342-31-6 | Purity: 98% | 6-Ethoxydihydrosanguinarine | ESD-879838-5MG |
| Cas.: 28325-56-6 | Purity: 98% | IVHD-valtrate | ESD-879839-5MG |
| Cas.: 283174-18-5 | Purity: 96% | 11β-Hydroxycedrelone | ESD-879840-5MG |
| Cas.: 283173-50-2 | Purity: 98% | Rucaparib | ESD-879841-5MG |
| Cas.: 283173-50-2 | Purity: 98% | Rucaparib | ESD-879841-10MG |
| Cas.: 283172-68-9 | Purity: 98% | WD2000-012547 | ESD-879842-1MG |
| Cas.: 283172-68-9 | Purity: 98% | WD2000-012547 | ESD-879842-5MG |
| Cas.: 283159-90-0 | Purity: ≥98% | Valifenalate | ESD-879843-10MG |
| Cas.: 283159-90-0 | Purity: ≥98% | Valifenalate | ESD-879843-25MG |
| Cas.: 282546-99-0 | Purity: 95% | 5-Bromo-3-(1,4-dioxaspiro[4.5]dec-7-en-8-yl)-1H-indole | ESD-879844-1G |
| Cas.: 282546-99-0 | Purity: 95% | 5-Bromo-3-(1,4-dioxaspiro[4.5]dec-7-en-8-yl)-1H-indole | ESD-879844-5G |
| Cas.: 28254-53-7 | Purity: 95% | Reynosin | ESD-879845-1MG |
| Cas.: 28217-60-9 | Purity: 98% | Phlorin | ESD-879846-5MG |
| Cas.: 28200-65-9 | Purity: 95% | Lauterine | ESD-879847-5MG |
| Cas.: 2819-56-9 | Purity: 95% | 2-oxo-1-oxaspiro[4.5]decane-4-carboxylic acid | ESD-879848-1G |
| Cas.: 2819-56-9 | Purity: 95% | 2-oxo-1-oxaspiro[4.5]decane-4-carboxylic acid | ESD-879848-5G |
| Cas.: 28189-90-4 | Purity: 97% | Sinensin | ESD-879849-5MG |
| Cas.: 28178-92-9 | Purity: 97% | Futoquinol | ESD-879850-5MG |
| Cas.: 28114-87-6 | Purity: 97% | SPIRO[3.3]HEPTANE-2-CARBOXYLIC ACID | ESD-879851-1G |
| Cas.: 28094-15-7 | Purity: ≥98% | Oxidopamine hydrochloride | ESD-879852-5MG |
| Cas.: 280565-85-7 | Purity: 97% | Rediocide A | ESD-879853-5MG |
| Cas.: 2798-20-1 | Purity: 98% | Gardenin B | ESD-879854-5MG |
| Cas.: 27979-58-4 | Purity: 99% | 5,7-Dihydroxyphthalide | ESD-879855-5MG |
| Cas.: 279683-46-4 | Purity: 95% | 14-Deoxy-ε-caesalpin | ESD-879856-5MG |
| Cas.: 27912-14-7 | Purity: ≥99% | Levobunolol hydrochloride | ESD-879857-10MG |
| Cas.: 27912-14-7 | Purity: ≥99% | Levobunolol hydrochloride | ESD-879857-50MG |
| Cas.: 27856-54-8 | Purity: 97% | Lamiide | ESD-879858-5MG |
| Cas.: 27832-84-4 | Purity: 95% | Serratenediol diacetate | ESD-879859-1MG |
| Cas.: 27784-33-4 | Purity: 95% | 5-Oxa-7-azaspiro[3.4]octan-6-one | ESD-879860-1G |
| Cas.: 277751-61-8 | Purity: 98% | Uncarinic acid E | ESD-879861-5MG |
| Cas.: 27773-39-3 | Purity: 96% | Ervamycine | ESD-879862-5MG |
| Cas.: 27770-13-4 | Purity: 98% | 5-Hydroxy-1-methoxyxanthone | ESD-879863-5MG |
| Cas.: 27740-43-8 | Purity: 92% | Erysotrine | ESD-879864-5MG |
| Cas.: 276856-55-4 | Purity: 95% | Cryptomoscatone D2 | ESD-879865-5MG |
| Cas.: 27661-51-4 | Purity: 95% | Leucoside | ESD-879866-1MG |
| Cas.: 2761-77-5 | Purity: 93% | Communic acid | ESD-879867-5MG |
| Cas.: 27542-39-8 | Purity: 98% | Tamarixin | ESD-879868-5MG |
| Cas.: 275371-94-3 | Purity: ≥97% | Taspoglutide | ESD-879869-1MG |
| Cas.: 275371-94-3 | Purity: ≥97% | Taspoglutide | ESD-879869-5MG |
| Cas.: 27530-67-2 | Purity: 95% | Feretoside | ESD-879870-5MG |
| Cas.: 27510-33-4 | Purity: 95% | O-Methylpallidine | ESD-879871-5MG |
| Cas.: 27483-18-7 | Purity: 95% | Cyclo(D-Val-L-Pro) | ESD-879873-1MG |
| Cas.: 27470-51-5 | Purity: ≥99% | Suxibuzone | ESD-879874-10MG |
| Cas.: 27468-20-8 | Purity: 97% | Deoxyneocryptotanshinone | ESD-879875-5MG |
| Cas.: 274675-25-1 | Purity: 98% | Xanthohumol D | ESD-879876-5MG |
| Cas.: 27460-33-9 | Purity: 98% | Chol-5-en-24-al-3β-ol | ESD-879877-5MG |
| Cas.: 27460-33-9 | Purity: 98% | Chol-5-en-24-al-3β-ol | ESD-879877-10MG |
| Cas.: 27391-16-8 | Purity: 97% | threo-Guaiacylglycerol | ESD-879878-5MG |
| Cas.: 273727-89-2 | Purity: 98% | ZM39923 | ESD-879879-10MG |
| Cas.: 273727-89-2 | Purity: 98% | ZM39923 | ESD-879879-50MG |
| Cas.: 27270-89-9 | Purity: 98% | Phyllostine | ESD-879880-5MG |
| Cas.: 27259-79-6 | Purity: 95% | DIMETHYL SPIRO[3.3]HEPTANE-2,6-DICARBOXYLATE | ESD-879881-1G |
| Cas.: 27259-79-6 | Purity: 95% | DIMETHYL SPIRO[3.3]HEPTANE-2,6-DICARBOXYLATE | ESD-879881-5G |
| Cas.: 272122-56-2 | Purity: 95% | Decursidate | ESD-879882-5MG |
| Cas.: 27127-79-3 | Purity: 97% | Thevetin B | ESD-879883-5MG |
| Cas.: 27076-46-6 | Purity: 98% | Alpertine | ESD-879884-1MG |
| Cas.: 27076-46-6 | Purity: 98% | Alpertine | ESD-879884-5MG |
| Cas.: 270249-38-2 | Purity: 95% | 2′-O-Methylkurarinone | ESD-879885-5MG |
| Cas.: 2701-50-0 | Purity: 98% | 17-Hydroxy-1a,2a-methylenepregna-4,6-diene-3,20-dione acetate | ESD-879886-5MG |
| Cas.: 27003-73-2 | Purity: 98% | (+)-Lariciresinol | ESD-879887-5MG |
| Cas.: 269742-39-4 | Purity: 98% | 16-Acetoxy-7-O-acetylhorminone | ESD-879888-5MG |
| Cas.: 269739-78-8 | Purity: 95% | Aglaxiflorin D | ESD-879889-5MG |
| Cas.: 269718-84-5 | Purity: 98% | Pardoprunox | ESD-879890-2MG |
| Cas.: 269718-84-5 | Purity: 98% | Pardoprunox | ESD-879890-5MG |
| Cas.: 269718-83-4 | Purity: ≥98% | Pardoprunox hydrochloride | ESD-879891-2MG |
| Cas.: 269718-83-4 | Purity: ≥98% | Pardoprunox hydrochloride | ESD-879891-5MG |
| Cas.: 26905-70-4 | Purity: 98% | 2-(4-Chloro-3-hydroxy-1-butynyl)-5-(1,3-pentadiynyl)thiophene | ESD-879892-5MG |
| Cas.: 2688-49-5 | Purity: 95% | 6-Hydroxybenzofuran-2(3H)-one | ESD-879893-1MG |
| Cas.: 268541-26-0 | Purity: 98% | Triptohypol F | ESD-879894-5MG |
| Cas.: 268214-52-4 | Purity: 95% | Coronalolic acid | ESD-879895-1MG |
| Cas.: 268214-51-3 | Purity: 95% | Coronalolide | ESD-879896-5MG |
| Cas.: 268214-50-2 | Purity: 98% | Coronalolide methyl ester | ESD-879897-5MG |
| Cas.: 268203-93-6 | Purity: ≥99% | Udenafil | ESD-879898-5MG |
| Cas.: 268203-93-6 | Purity: ≥99% | Udenafil | ESD-879898-10MG |
| Cas.: 2679-65-4 | Purity: 95% | Robtein | ESD-879899-1MG |
| Cas.: 26791-73-1 | Purity: 98% | Xanthatin | ESD-879900-5MG |
| Cas.: 2671-32-1 | Purity: 96% | Picraline | ESD-879901-5MG |
| Cas.: 2668-66-8 | Purity: ≥99% | Medrysone | ESD-879902-100MG |
| Cas.: 2665-57-8 | Purity: 97% | Conodurine | ESD-879903-5MG |
| Cas.: 26652-12-0 | Purity: 95% | Salirepin | ESD-879904-5MG |
| Cas.: 26647-82-5 | Purity: 98% | Succinyl phosphonate | ESD-879905-2MG |
| Cas.: 26647-82-5 | Purity: 98% | Succinyl phosphonate | ESD-879905-5MG |
| Cas.: 266359-93-7 | Purity: ≥99% | Reparixin L-lysine salt | ESD-879906-2MG |
| Cas.: 266359-93-7 | Purity: ≥99% | Reparixin L-lysine salt | ESD-879906-5MG |
| Cas.: 26614-48-2 | Purity: 93% | 3-Ethoxyandrosta-3,5-dien-17β-ol | ESD-879907-5MG |
| Cas.: 26585-14-8 | Purity: 95% | Crenatine | ESD-879908-5MG |
| Cas.: 26585-13-7 | Purity: 98% | Dehydrocrenatine | ESD-879909-5MG |
| Cas.: 26575-93-9 | Purity: Analysis control, 98% | Alisol C 23-acetate | ESD-879910-5MG |
| Cas.: 26575-93-9 | Purity: Analysis control, 98% | Alisol C 23-acetate | ESD-879910-10MG |
| Cas.: 265669-37-2 | Purity: 98% | β-catenin peptide | ESD-879911-1MG |
| Cas.: 265669-37-2 | Purity: 98% | β-catenin peptide | ESD-879911-5MG |
| Cas.: 265646-85-3 | Purity: ≥99% | Endovion | ESD-879912-5MG |
| Cas.: 265646-85-3 | Purity: ≥99% | Endovion | ESD-879912-10MG |
| Cas.: 265644-24-4 | Purity: 97% | 3-Hydroxycatalponol | ESD-879913-5MG |
| Cas.: 26563-68-8 | Purity: 95% | 3-Epimaslinic acid | ESD-879914-5MG |
| Cas.: 26560-38-3 | Purity: 98% | Calcium N5-methyltetrahydrofolate | ESD-879915-5MG |
| Cas.: 26560-38-3 | Purity: 98% | Calcium N5-methyltetrahydrofolate | ESD-879915-10MG |
| Cas.: 26531-85-1 | Purity: 98% | Primeverose | ESD-879916-5MG |
| Cas.: 265129-71-3 | Purity: ≥98% | GW7647 | ESD-879917-5MG |
| Cas.: 265129-71-3 | Purity: ≥98% | GW7647 | ESD-879917-10MG |
| Cas.: 265120-00-1 | Purity: 95% | Taiwanhomoflavone A | ESD-879918-5MG |
| Cas.: 26509-45-5 | Purity: 95% | Methyleugenolglycol | ESD-879919-5MG |
| Cas.: 2649-68-5 | Purity: 98% | Clovanediol diacetate | ESD-879920-5MG |
| Cas.: 2649-64-1 | Purity: 98% | Clovanediol | ESD-879921-5MG |
| Cas.: 26490-31-3 | Purity: 98% | Nandrolone laurate | ESD-879922-5MG |
| Cas.: 26488-24-4 | Purity: 98% | Cyclo(D-Phe-L-Pro) | ESD-879923-5MG |
| Cas.: 26486-92-0 | Purity: 97% | 6-Deoxyisojacareubin | ESD-879924-5MG |
| Cas.: 264622-58-4 | Purity: ≥98% | MRS 1754 | ESD-879925-5MG |
| Cas.: 264622-58-4 | Purity: ≥98% | MRS 1754 | ESD-879925-10MG |
| Cas.: 264622-53-9 | Purity: ≥98% | MRS-1706 | ESD-879926-5MG |
| Cas.: 264622-53-9 | Purity: ≥98% | MRS-1706 | ESD-879926-10MG |
| Cas.: 2642-98-0 | Purity: 98% | 6-Aminochrysene | ESD-879927-25MG |
| Cas.: 264234-05-1 | Purity: 95% | 6′,7′-Dihydroxybergamottin | ESD-879928-1MG |
| Cas.: 263890-70-6 | Purity: ≥98% | GR148672X | ESD-879929-1MG |
| Cas.: 263890-70-6 | Purity: ≥98% | GR148672X | ESD-879929-5MG |
| Cas.: 263844-80-0 | Purity: 95% | 3-Acetoxy-27-hydroxy-20(29)-lupen-28-oic acid methyl ester | ESD-879930-5MG |
| Cas.: 263844-79-7 | Purity: 95% | 3,27-Dihydroxy-20(29)-lupen-28-oic acid methyl ester | ESD-879931-5MG |
| Cas.: 263764-83-6 | Purity: 95% | Buergerin G | ESD-879932-5MG |
| Cas.: 263368-92-9 | Purity: 95% | 4-(cis)-Acetyl-3,6,8-trihydroxy-3-methyldihydronaphthalenone | ESD-879933-1MG |
| Cas.: 263368-91-8 | Purity: 97% | 4-(trans)-Acetyl-3,6,8-trihydroxy-3-methyldihydronaphthalenone | ESD-879934-5MG |
| Cas.: 263251-78-1 | Purity: ≥98% | Tavilermide | ESD-879935-1MG |
| Cas.: 263251-78-1 | Purity: ≥98% | Tavilermide | ESD-879935-5MG |
| Cas.: 263249-77-0 | Purity: 97% | Perilloxin | ESD-879936-5MG |
| Cas.: 263241-09-4 | Purity: 95% | Dehydroperilloxin | ESD-879937-5MG |
| Cas.: 26315-07-1 | Purity: 94% | 22-Dehydroclerosterol | ESD-879938-5MG |
| Cas.: 26296-50-4 | Purity: 95% | Ficaprenol 11 | ESD-879939-1MG |
| Cas.: 26271-33-0 | Purity: 95% | 2,3′,4,6-Tetrahydroxybenzophenone | ESD-879940-1MG |
| Cas.: 262355-96-4 | Purity: 95% | 13-Oxopodocarp-8(14)-ene-7α,18-diol | ESD-879941-1MG |
| Cas.: 262350-52-7 | Purity: 95% | Mudanpioside J | ESD-879942-5MG |
| Cas.: 262350-51-6 | Purity: 97% | Debenzoylgalloylpaeoniflorin | ESD-879943-5MG |
| Cas.: 262292-34-2 | Purity: 98% | 3,6-Dihydroxy-1,7-dimethoxyxanthone | ESD-879944-5MG |
| Cas.: 262272-76-4 | Purity: 95% | 3α-Acetoxy-20-oxo-29-norlupane-23,28-dioic acid | ESD-879945-5MG |
| Cas.: 2620-62-4 | Purity: ≥99% | N6,N6-Dimethyladenosine | ESD-879946-50MG |
| Cas.: 26194-57-0 | Purity: 98% | Isotaxiresinol | ESD-879947-5MG |
| Cas.: 261944-46-1 | Purity: ≥99% | Soraprazan | ESD-879948-1MG |
| Cas.: 261944-46-1 | Purity: ≥99% | Soraprazan | ESD-879948-5MG |
| Cas.: 261776-60-7 | Purity: 98% | 6-Methyl-8-prenylnaringenin | ESD-879949-5MG |
| Cas.: 261768-88-1 | Purity: 95% | 3,19-Dihydroxy-6,23-dioxo-12-ursen-28-oic acid | ESD-879950-5MG |
| Cas.: 261766-73-8 | Purity: 98% | 5-HT4 antagonist 1 | ESD-879951-1MG |
| Cas.: 261766-73-8 | Purity: 98% | 5-HT4 antagonist 1 | ESD-879951-5MG |
| Cas.: 261365-11-1 | Purity: ≥99% | MB05032 | ESD-879952-2MG |
| Cas.: 261365-11-1 | Purity: ≥99% | MB05032 | ESD-879952-5MG |
| Cas.: 261351-23-9 | Purity: 97% | Antiarol rutinoside | ESD-879953-5MG |
| Cas.: 26130-02-9 | Purity: ≥99% | Frentizole | ESD-879954-5MG |
| Cas.: 26130-02-9 | Purity: ≥99% | Frentizole | ESD-879954-10MG |
| Cas.: 260980-89-0 | Purity: ≥98% | Topilutamide | ESD-879955-1MG |
| Cas.: 260980-89-0 | Purity: ≥98% | Topilutamide | ESD-879955-5MG |
| Cas.: 260968-11-4 | Purity: 95% | Reneilmol | ESD-879956-1MG |
| Cas.: 2608-21-1 | Purity: 98% | Sotetsuflavone | ESD-879958-1MG |
| Cas.: 2608-21-1 | Purity: 98% | Sotetsuflavone | ESD-879958-5MG |
| Cas.: 26063-96-7 | Purity: 97% | 3-Isomangostin hydrate | ESD-879959-5MG |
| Cas.: 26063-95-6 | Purity: 98% | 1-Isomangostin hydrate | ESD-879960-5MG |
| Cas.: 260553-97-7 | Purity: ≥99% | TM-25659 | ESD-879961-5MG |
| Cas.: 260553-97-7 | Purity: ≥99% | TM-25659 | ESD-879961-10MG |
| Cas.: 260397-58-8 | Purity: 98% | Dihydroisotanshinone II | ESD-879962-1MG |
| Cas.: 260393-05-3 | Purity: 95% | Zamanic acid | ESD-879963-1MG |
| Cas.: 259753-12-3 | Purity: 97% | 10-Hydroxymajoroside | ESD-879964-5MG |
| Cas.: 259678-73-4 | Purity: 95% | 2-Deacetyltaxuspine X | ESD-879965-5MG |
| Cas.: 259653-54-8 | Purity: 95% | 5-Hydroxy-7-methoxy-3-(4-hydroxybenzylidene)chroman-4-one | ESD-879966-1MG |
| Cas.: 25953-17-7 | Purity: ≥99% | Minaprine dihydrochloride | ESD-879967-100MG |
| Cas.: 259525-01-4 | Purity: 98% | Enecadin | ESD-879968-1MG |
| Cas.: 259525-01-4 | Purity: 98% | Enecadin | ESD-879968-5MG |
| Cas.: 259143-58-3 | Purity: 96% | 3′-Hydroxydehydroaglaiastatin | ESD-879969-5MG |
| Cas.: 25913-34-2 | Purity: ≥98% | Tinoridine hydrochloride | ESD-879970-5MG |
| Cas.: 25913-34-2 | Purity: ≥98% | Tinoridine hydrochloride | ESD-879970-10MG |
| Cas.: 259099-25-7 | Purity: 96% | Yunaconitoline | ESD-879971-5MG |
| Cas.: 258267-23-1 | Purity: 95% | Tetramethyl 5′,5′,9′-trimethyl-5′,6′-dihydrospiro[1,3-dithiole-2,1′-thiopyrano[2,3-c]quinoline]-2′,3′,4, 5-tetracarboxylate | ESD-879972-500MG |
| Cas.: 258267-23-1 | Purity: 95% | Tetramethyl 5′,5′,9′-trimethyl-5′,6′-dihydrospiro[1,3-dithiole-2,1′-thiopyrano[2,3-c]quinoline]-2′,3′,4, 5-tetracarboxylate | ESD-879972-1G |
| Cas.: 258267-22-0 | Purity: 95% | Tetramethyl 5′,5′-dimethyl-5′,6′-dihydrospiro[1,3-dithiole-2,1′-thiopyrano[2,3-c]quinoline]-2′,3′,4,5-tetracarboxylate | ESD-879973-500MG |
| Cas.: 258267-22-0 | Purity: 95% | Tetramethyl 5′,5′-dimethyl-5′,6′-dihydrospiro[1,3-dithiole-2,1′-thiopyrano[2,3-c]quinoline]-2′,3′,4,5-tetracarboxylate | ESD-879973-1G |
| Cas.: 257930-74-8 | Purity: ≥99% | Secoisolariciresinol diglucoside | ESD-879974-5MG |
| Cas.: 257930-74-8 | Purity: ≥99% | Secoisolariciresinol diglucoside | ESD-879974-10MG |
| Cas.: 25739-41-7 | Purity: 98% | Velutin | ESD-879975-5MG |
| Cas.: 25696-21-3 | Purity: 98% | ACTH 1-14 | ESD-879977-1MG |
| Cas.: 25696-21-3 | Purity: 98% | ACTH 1-14 | ESD-879977-5MG |
| Cas.: 256925-92-5 | Purity: 95% | Cimiracemoside C | ESD-879978-1MG |
| Cas.: 256925-03-8 | Purity: ≥98% | AL 082D06 | ESD-879979-2MG |
| Cas.: 256925-03-8 | Purity: ≥98% | AL 082D06 | ESD-879979-5MG |
| Cas.: 2567-65-9 | Purity: 96% | 3,2′-Dihydroxy-4,4′-dimethoxychalcone | ESD-879980-5MG |
| Cas.: 25654-31-3 | Purity: 96% | Cannabigerol | ESD-879981-5MG |
| Cas.: 256477-09-5 | Purity: ≥98% | UK-371804 | ESD-879982-5MG |
| Cas.: 256477-09-5 | Purity: ≥98% | UK-371804 | ESD-879982-10MG |
| Cas.: 25645-19-6 | Purity: 95% | Preisocalamendiol | ESD-879983-1MG |
| Cas.: 256445-68-8 | Purity: 95% | Schleicheol 2 | ESD-879984-1MG |
| Cas.: 256445-66-6 | Purity: 95% | Schleicheol 1 | ESD-879985-1MG |
| Cas.: 256347-91-8 | Purity: 95% | 7β-Acetoxytaxuspine C | ESD-879986-5MG |
| Cas.: 25597-09-5 | Purity: 98% | Stearoylcarnitine | ESD-879987-5MG |
| Cas.: 25597-09-5 | Purity: 98% | Stearoylcarnitine | ESD-879987-10MG |
| Cas.: 25577-04-2 | Purity: 98% | 1,6,7-Trihydroxyxanthone | ESD-879988-5MG |
| Cas.: 255730-18-8 | Purity: ≥98% | Artemisone | ESD-879989-5MG |
| Cas.: 255730-18-8 | Purity: ≥98% | Artemisone | ESD-879989-10MG |
| Cas.: 25545-07-7 | Purity: 98% | 1-(4-Hydroxybenzoyl)glucose | ESD-879990-5MG |
| Cas.: 25532-45-0 | Purity: 96% | Mayumbine | ESD-879991-5MG |
| Cas.: 2552-55-8 | Purity: ≥98% | Ibotenic acid | ESD-879992-5MG |
| Cas.: 2552-55-8 | Purity: ≥98% | Ibotenic acid | ESD-879992-10MG |
| Cas.: 25518-54-1 | Purity: ≥99% | Dodecanoylcarnitine | ESD-879993-5MG |
| Cas.: 255064-79-0 | Purity: 98% | CDK2 | ESD-879994-1MG |
| Cas.: 255064-79-0 | Purity: 98% | CDK2 | ESD-879994-5MG |
| Cas.: 254886-77-6 | Purity: 98% | Kushenol X | ESD-879995-5MG |
| Cas.: 25488-59-9 | Purity: 98% | Dimethylmatairesinol | ESD-879996-5MG |
| Cas.: 254750-02-2 | Purity: ≥99% | Emricasan | ESD-879997-5MG |
| Cas.: 254750-02-2 | Purity: ≥99% | Emricasan | ESD-879997-10MG |
| Cas.: 254740-64-2 | Purity: ≥99% | Sparsentan | ESD-879998-1MG |
| Cas.: 254740-64-2 | Purity: ≥99% | Sparsentan | ESD-879998-5MG |
| Cas.: 2545-00-8 | Purity: 98% | Afzelechin | ESD-879999-5MG |
| Cas.: 254452-91-0 | Purity: 98% | Dehydropitavastatin ethyl ester | ESD-880000-5MG |
| Cas.: 254435-95-5 | Purity: ≥98% | Alisporivir | ESD-880001-1MG |
| Cas.: 254435-95-5 | Purity: ≥98% | Alisporivir | ESD-880001-5MG |
| Cas.: 2543-95-5 | Purity: 98% | (S)-4-Methoxydalbergione | ESD-880002-5MG |
| Cas.: 2543-94-4 | Purity: 97% | Phellopterin | ESD-880003-5MG |
| Cas.: 25422-31-5 | Purity: 98% | Fibrinopeptide A, human | ESD-880004-1MG |
| Cas.: 25422-31-5 | Purity: 98% | Fibrinopeptide A, human | ESD-880004-5MG |
| Cas.: 2540-56-9 | Purity: ≥99%, 356 mM in Ethanol | Bovinic acid | ESD-880005-50ΜL |
| Cas.: 253863-19-3 | Purity: ≥99% | 5Z-7-Oxozeaenol | ESD-880006-1MG |
| Cas.: 253863-19-3 | Purity: ≥99% | 5Z-7-Oxozeaenol | ESD-880006-5MG |
| Cas.: 253863-00-2 | Purity: ≥99% | L-778123 hydrochloride | ESD-880007-5MG |
| Cas.: 253863-00-2 | Purity: ≥99% | L-778123 hydrochloride | ESD-880007-10MG |
| Cas.: 25368-01-8 | Purity: 97% | Litseglutine B | ESD-880008-5MG |
| Cas.: 2535-06-0 | Purity: 95% | 16-O-Acetylpolyporenic acid C | ESD-880009-1MG |
| Cas.: 253426-24-3 | Purity: ≥99% | Ombrabulin hydrochloride | ESD-880010-1MG |
| Cas.: 253426-24-3 | Purity: ≥99% | Ombrabulin hydrochloride | ESD-880010-5MG |
| Cas.: 25330-21-6 | Purity: 98% | Isocalamendiol | ESD-880011-5MG |
| Cas.: 25314-87-8 | Purity: 98% | Elucaine | ESD-880012-1MG |
| Cas.: 25314-87-8 | Purity: 98% | Elucaine | ESD-880012-5MG |
| Cas.: 253141-50-3 | Purity: 98% | TAT 48-57 | ESD-880013-1MG |
| Cas.: 253141-50-3 | Purity: 98% | TAT 48-57 | ESD-880013-5MG |
| Cas.: 253128-41-5 | Purity: 98% | Eribulin | ESD-880014-1MG |
| Cas.: 252979-56-9 | Purity: ≥98% | Banoxantrone dihydrochloride | ESD-880015-5MG |
| Cas.: 252979-56-9 | Purity: ≥98% | Banoxantrone dihydrochloride | ESD-880015-10MG |
| Cas.: 252977-51-8 | Purity: ≥99% | TPA 023 | ESD-880016-1MG |
| Cas.: 252977-51-8 | Purity: ≥99% | TPA 023 | ESD-880016-5MG |
| Cas.: 252920-94-8 | Purity: 98% | Solabegron | ESD-880017-5MG |
| Cas.: 252920-94-8 | Purity: 98% | Solabegron | ESD-880017-10MG |
| Cas.: 252882-61-4 | Purity: 95% | spiro[indole-3,4′-pipidin]-2(1H)-one | ESD-880018-1G |
| Cas.: 25279-15-6 | Purity: 98% | 20S,24R-Epoxydamara-12β,25-diol-3-one | ESD-880019-5MG |
| Cas.: 252351-96-5 | Purity: 98% | Lucialdehyde C | ESD-880020-5MG |
| Cas.: 252351-95-4 | Purity: 95% | Lucidadiol | ESD-880021-5MG |
| Cas.: 252336-82-6 | Purity: 95% | 8-(2-Fluoro-4-nitrophenyl)-1,4-dioxa-8-azaspiro[4.5]decane | ESD-880022-1G |
| Cas.: 252333-72-5 | Purity: 96% | Isotaxiresinol 9,9′-acetonide | ESD-880023-5MG |
| Cas.: 252333-71-4 | Purity: 95% | Isolariciresinol 9,9′-acetonide | ESD-880024-5MG |
| Cas.: 252264-92-9 | Purity: 98% | T82 | ESD-880025-1MG |
| Cas.: 252264-92-9 | Purity: 98% | T82 | ESD-880025-5MG |
| Cas.: 252248-89-8 | Purity: 96% | 1-Cinnamoylpyrrole | ESD-880026-5MG |
| Cas.: 252025-52-8 | Purity: ≥98% | Adjudin | ESD-880027-5MG |
| Cas.: 252025-52-8 | Purity: ≥98% | Adjudin | ESD-880027-10MG |
| Cas.: 25162-30-5 | Purity: 99% | Isohomoarbutin | ESD-880028-5MG |
| Cas.: 251349-54-9 | Purity: ≥99% | Antibiotic-5d | ESD-880029-5MG |
| Cas.: 251349-54-9 | Purity: ≥99% | Antibiotic-5d | ESD-880029-10MG |
| Cas.: 2513-33-9 | Purity: 98% | 2-(2,4-Dihydroxybenzoyl)benzoic acid | ESD-880030-5MG |
| Cas.: 250691-57-7 | Purity: 95% | Salvisyrianone | ESD-880031-5MG |
| Cas.: 250601-04-8 | Purity: 98% | Imiglitazar | ESD-880032-1MG |
| Cas.: 250601-04-8 | Purity: 98% | Imiglitazar | ESD-880032-5MG |
| Cas.: 250293-31-3 | Purity: 95% | Excavatin M | ESD-880033-1MG |
| Cas.: 250217-73-3 | Purity: 95% | Otophylloside F | ESD-880034-5MG |
| Cas.: 25018-67-1 | Purity: 95% | 1,2:4,5-Di-O-isopropylidene-β-D-fructopyranose | ESD-880035-1MG |
| Cas.: 250159-48-9 | Purity: 98% | Miriplatin (hydrate) | ESD-880036-5MG |
| Cas.: 250159-48-9 | Purity: 98% | Miriplatin (hydrate) | ESD-880036-10MG |
| Cas.: 249916-07-2 | Purity: 95% | Borreriagenin | ESD-880037-1MG |
| Cas.: 249889-64-3 | Purity: 98% | SB-334867 | ESD-880038-5MG |
| Cas.: 249889-64-3 | Purity: 98% | SB-334867 | ESD-880038-10MG |
| Cas.: 249503-25-1 | Purity: ≥99% | Galidesivir | ESD-880039-1MG |
| Cas.: 249503-25-1 | Purity: ≥99% | Galidesivir | ESD-880039-5MG |
| Cas.: 249296-44-4 | Purity: ≥99% | Varenicline | ESD-880040-5MG |
| Cas.: 249296-44-4 | Purity: ≥99% | Varenicline | ESD-880040-10MG |
| Cas.: 24910-11-0 | Purity: 95% | 3,9-Diazaspiro[5.5]undecane-2,4-dione | ESD-880041-1G |
| Cas.: 24909-95-3 | Purity: 98% | Bakkenolide III | ESD-880042-5MG |
| Cas.: 248922-46-5 | Purity: 98% | PD0176078 | ESD-880043-1MG |
| Cas.: 248922-46-5 | Purity: 98% | PD0176078 | ESD-880043-5MG |
| Cas.: 248594-19-6 | Purity: 98% | Erlotinib mesylate | ESD-880044-100MG |
| Cas.: 248594-19-6 | Purity: 98% | Erlotinib mesylate | ESD-880044-500MG |
| Cas.: 24853-80-3 | Purity: 98% | Azaphen | ESD-880045-100MG |
| Cas.: 24853-80-3 | Purity: 98% | Azaphen | ESD-880045-500MG |
| Cas.: 248282-01-1 | Purity: ≥98% | Paquinimod | ESD-880046-5MG |
| Cas.: 248282-01-1 | Purity: ≥98% | Paquinimod | ESD-880046-10MG |
| Cas.: 248260-75-5 | Purity: 98% | KRN2 | ESD-880047-5MG |
| Cas.: 248260-75-5 | Purity: 98% | KRN2 | ESD-880047-10MG |
| Cas.: 24808-04-6 | Purity: 98% | (-)-Epiafzelechin | ESD-880048-5MG |
| Cas.: 2479-49-4 | Purity: ≥98% | Benzophenonetetracarboxylic acid | ESD-880049-10MG |
| Cas.: 2479-49-4 | Purity: ≥98% | Benzophenonetetracarboxylic acid | ESD-880049-50MG |
| Cas.: 24778-48-1 | Purity: 98% | β-Peltoboykinolic acid | ESD-880050-5MG |
| Cas.: 24759-97-5 | Purity: 95% | spiro[oxirane-2,2′-tricyclo[3.3.1.1~3,7~]decane] | ESD-880051-1G |
| Cas.: 24759-97-5 | Purity: 95% | spiro[oxirane-2,2′-tricyclo[3.3.1.1~3,7~]decane] | ESD-880051-5G |
| Cas.: 247171-44-4 | Purity: 98% | Tyrosine Protein Kinase JAK 2 Phospho-Tyr8, 9 | ESD-880052-1MG |
| Cas.: 247171-44-4 | Purity: 98% | Tyrosine Protein Kinase JAK 2 Phospho-Tyr8, 9 | ESD-880052-5MG |
| Cas.: 247109-17-7 | Purity: 95% | N-*1*-(1,4-Dioxa-spiro[4.4]non-2-ylmethyl)-ethane-1,2-diamine | ESD-880053-500MG |
| Cas.: 247109-17-7 | Purity: 95% | N-*1*-(1,4-Dioxa-spiro[4.4]non-2-ylmethyl)-ethane-1,2-diamine | ESD-880053-1G |
| Cas.: 247078-43-9 | Purity: 95% | Daphnezomine B | ESD-880054-1MG |
| Cas.: 2470-73-7 | Purity: ≥99% | Dixyrazine | ESD-880055-1MG |
| Cas.: 2470-73-7 | Purity: ≥99% | Dixyrazine | ESD-880055-5MG |
| Cas.: 247036-52-8 | Purity: 95% | 6-Deoxy-9α-hydroxycedrodorin | ESD-880056-1MG |
| Cas.: 24694-80-2 | Purity: 95% | Chlorouvedalin | ESD-880057-1MG |
| Cas.: 24694-79-9 | Purity: 95% | Uvedalin | ESD-880058-1MG |
| Cas.: 246870-75-7 | Purity: 95% | Derrisisoflavone B | ESD-880059-5MG |
| Cas.: 246868-97-3 | Purity: 97% | Aglin A | ESD-880060-5MG |
| Cas.: 2466-42-4 | Purity: 97% | Neolitsine | ESD-880061-5MG |
| Cas.: 246266-38-6 | Purity: 98% | 3-Geranyl-4-methoxybenzoic acid | ESD-880062-5MG |
| Cas.: 246020-68-8 | Purity: ≥98% | TRi-1 | ESD-880063-5MG |
| Cas.: 246020-68-8 | Purity: ≥98% | TRi-1 | ESD-880063-10MG |
| Cas.: 2457-80-9 | Purity: 95% | 5′-S-Methyl-5′-thioadenosine | ESD-880064-1G |
| Cas.: 245765-41-7 | Purity: ≥99% | Ozenoxacin | ESD-880065-1MG |
| Cas.: 245765-41-7 | Purity: ≥99% | Ozenoxacin | ESD-880065-5MG |
| Cas.: 245747-08-4 | Purity: ≥99% | Pyr6 | ESD-880066-5MG |
| Cas.: 245747-08-4 | Purity: ≥99% | Pyr6 | ESD-880066-10MG |
| Cas.: 245443-52-1 | Purity: ≥98% | Protease-Activated Receptor-4 | ESD-880067-5MG |
| Cas.: 245443-52-1 | Purity: ≥98% | Protease-Activated Receptor-4 | ESD-880067-10MG |
| Cas.: 245342-14-7 | Purity: ≥98% | LED209 | ESD-880068-5MG |
| Cas.: 245342-14-7 | Purity: ≥98% | LED209 | ESD-880068-10MG |
| Cas.: 245323-24-4 | Purity: 95% | Makisterone A 20,22-monoacetonide | ESD-880069-5MG |
| Cas.: 24526-64-5 | Purity: ≥99% | Nomifensine | ESD-880070-50MG |
| Cas.: 24526-64-5 | Purity: ≥99% | Nomifensine | ESD-880070-100MG |
| Cas.: 24514-86-1 | Purity: 95% | n-Tritriacontan-16,18-dione | ESD-880071-5MG |
| Cas.: 24513-57-3 | Purity: 95% | 21-Episerratriol | ESD-880072-1MG |
| Cas.: 24513-51-7 | Purity: 97% | 3α,21β-Dihydroxyserrat-14-en-16-one | ESD-880073-5MG |
| Cas.: 24513-41-5 | Purity: 98% | Monomethyl kolavate | ESD-880074-5MG |
| Cas.: 245124-69-0 | Purity: ≥98% | Pipendoxifene hydrochloride | ESD-880075-1MG |
| Cas.: 245124-69-0 | Purity: ≥98% | Pipendoxifene hydrochloride | ESD-880075-5MG |
| Cas.: 245075-84-7 | Purity: ≥99% | LR-90 | ESD-880076-5MG |
| Cas.: 245075-84-7 | Purity: ≥99% | LR-90 | ESD-880076-10MG |
| Cas.: 24480-45-3 | Purity: 98% | Bryonolic acid | ESD-880077-5MG |
| Cas.: 2447-70-3 | Purity: 95% | Pseudoakuammigine | ESD-880078-1MG |
| Cas.: 244277-75-6 | Purity: 97% | 3,5,7,15-Tetraacetoxy-9-nicotinoyloxy-6(17),11-jatrophadien-14-one | ESD-880079-5MG |
| Cas.: 244204-40-8 | Purity: 95% | Celaphanol A | ESD-880080-5MG |
| Cas.: 244167-04-2 | Purity: 95% | Taxumairol R | ESD-880081-5MG |
| Cas.: 24405-57-0 | Purity: 95% | β-Rotunol | ESD-880082-5MG |
| Cas.: 24404-50-0 | Purity: 98% | (+)-Epipinoresinol | ESD-880083-5MG |
| Cas.: 243984-11-4 | Purity: ≥99% | Resatorvid | ESD-880084-5MG |
| Cas.: 243984-11-4 | Purity: ≥99% | Resatorvid | ESD-880084-10MG |
| Cas.: 243966-09-8 | Purity: ≥98% | TCS 401 | ESD-880085-5MG |
| Cas.: 243966-09-8 | Purity: ≥98% | TCS 401 | ESD-880085-10MG |
| Cas.: 2438-32-6 | Purity: ≥98% | Dexchlorpheniramine maleate | ESD-880086-200MG |
| Cas.: 24352-51-0 | Purity: 95% | 3,5-Cycloergosta-6,8(14),22-triene | ESD-880087-1G |
| Cas.: 24338-53-2 | Purity: 98% | Nagilactone C | ESD-880088-5MG |
| Cas.: 24314-59-8 | Purity: 97% | Scandine | ESD-880089-5MG |
| Cas.: 24274-60-0 | Purity: 95% | Acetylcephalotaxine | ESD-880090-5MG |
| Cas.: 24240-04-8 | Purity: 98% | Allocryptopine | ESD-880091-5MG |
| Cas.: 24224-30-4 | Purity: 95% | 3-Methyl-9H-carbazol-2-ol | ESD-880092-1MG |
| Cas.: 24219-97-4 | Purity: 98% | Mianserin | ESD-880093-100MG |
| Cas.: 24219-97-4 | Purity: 98% | Mianserin | ESD-880093-200MG |
| Cas.: 24192-64-1 | Purity: 98% | Epiyangambin | ESD-880094-5MG |
| Cas.: 241820-91-7 | Purity: 95% | 2-Oxa-7-azaspiro[3.5]nonane oxalate | ESD-880095-250MG |
| Cas.: 241820-91-7 | Purity: 95% | 2-Oxa-7-azaspiro[3.5]nonane oxalate | ESD-880095-1G |
| Cas.: 24164-13-4 | Purity: 95% | Epitulipinolide | ESD-880096-1MG |
| Cas.: 241499-17-2 | Purity: 98% | N-type calcium channel blocker-1 | ESD-880097-1MG |
| Cas.: 241499-17-2 | Purity: 98% | N-type calcium channel blocker-1 | ESD-880097-5MG |
| Cas.: 24144-92-1 | Purity: ≥99% | TMS | ESD-880098-5MG |
| Cas.: 24144-92-1 | Purity: ≥99% | TMS | ESD-880098-10MG |
| Cas.: 24144-61-4 | Purity: 99% | Khellactone | ESD-880099-5MG |
| Cas.: 2413-38-9 | Purity: ≥99% | Flupentixol dihydrochloride | ESD-880100-5MG |
| Cas.: 2413-38-9 | Purity: ≥99% | Flupentixol dihydrochloride | ESD-880100-10MG |
| Cas.: 24047-25-4 | Purity: 98% | Guanoxabenz | ESD-880101-1MG |
| Cas.: 24047-25-4 | Purity: 98% | Guanoxabenz | ESD-880101-5MG |
| Cas.: 240401-28-9 | Purity: 95% | tert-Butyl 2-hydroxy-7-azaspiro[3.5]nonane-7-carboxylate | ESD-880102-1G |
| Cas.: 240401-28-9 | Purity: 95% | tert-Butyl 2-hydroxy-7-azaspiro[3.5]nonane-7-carboxylate | ESD-880102-5G |
| Cas.: 240401-27-8 | Purity: 95% | tert-Butyl 2-oxa-7-azaspiro[3.5]nonane-7-carboxylate | ESD-880103-1G |
| Cas.: 240401-09-6 | Purity: 97% | 3-Hydroxy-1-oxa-8-azaspiro[4.5]decane-8-carboxylic acid tert-butyl ester | ESD-880104-100MG |
| Cas.: 240401-09-6 | Purity: 97% | 3-Hydroxy-1-oxa-8-azaspiro[4.5]decane-8-carboxylic acid tert-butyl ester | ESD-880104-500MG |
| Cas.: 24022-13-7 | Purity: 95% | Agathadiol diacetate | ESD-880105-5MG |
| Cas.: 240122-32-1 | Purity: 95% | Griffithinam | ESD-880106-1MG |
| Cas.: 240122-30-9 | Purity: 96% | Griffithhazanone A | ESD-880107-5MG |
| Cas.: 2400-71-7 | Purity: 98% | Pyrocatechol monoglucoside | ESD-880108-5MG |
| Cas.: 2398-63-2 | Purity: 95% | 17-Ethylendioxyandrosta-1,4-dien-3-one | ESD-880109-5MG |
| Cas.: 23980-14-5 | Purity: 98% | Ethyl dirazepate | ESD-880110-1MG |
| Cas.: 23980-14-5 | Purity: 98% | Ethyl dirazepate | ESD-880110-5MG |
| Cas.: 239800-99-8 | Purity: 97% | 13-Deacetyltaxachitriene A | ESD-880111-5MG |
| Cas.: 23971-42-8 | Purity: 99% | Meranzin | ESD-880112-5MG |
| Cas.: 23963-54-4 | Purity: 95% | Glochidonol | ESD-880113-1MG |
| Cas.: 239463-72-0 | Purity: 98% | 5-(2-Aminopropyl)-7-cyanoindolin-1-yl)propyl benzoate | ESD-880114-5MG |
| Cas.: 239440-20-1 | Purity: 98% | FR183998 free base | ESD-880115-1MG |
| Cas.: 239440-20-1 | Purity: 98% | FR183998 free base | ESD-880115-5MG |
| Cas.: 23887-46-9 | Purity: 98% | Cinepazide | ESD-880116-50MG |
| Cas.: 23887-46-9 | Purity: 98% | Cinepazide | ESD-880116-100MG |
| Cas.: 23885-43-0 | Purity: 95% | Zapoterin | ESD-880117-5MG |
| Cas.: 23815-91-0 | Purity: 98% | Bradykinin (1-3) | ESD-880118-5MG |
| Cas.: 23815-91-0 | Purity: 98% | Bradykinin (1-3) | ESD-880118-10MG |
| Cas.: 23815-88-5 | Purity: 98% | Bradykinin (1-6) | ESD-880119-5MG |
| Cas.: 23815-88-5 | Purity: 98% | Bradykinin (1-6) | ESD-880119-10MG |
| Cas.: 23811-50-9 | Purity: 97% | Trichokaurin | ESD-880120-5MG |
| Cas.: 237407-59-9 | Purity: 95% | Rivulobirin E | ESD-880122-5MG |
| Cas.: 23733-95-1 | Purity: 95% | trans-3′-O-Benzoyl-4′-O-methylkhallactone | ESD-880123-5MG |
| Cas.: 23733-92-8 | Purity: 95% | trans-Methylkhallactone | ESD-880124-5MG |
| Cas.: 23694-17-9 | Purity: ≥99% | Sultopride hydrochloride | ESD-880125-5MG |
| Cas.: 23694-17-9 | Purity: ≥99% | Sultopride hydrochloride | ESD-880125-10MG |
| Cas.: 23670-94-2 | Purity: 96% | Stigmast-4-ene-3,6-dione | ESD-880126-5MG |
| Cas.: 23665-96-5 | Purity: 98% | Neogrifolin | ESD-880127-5MG |
| Cas.: 23642-66-2 | Purity: ≥99% | Benfluorex hydrochloride | ESD-880128-100MG |
| Cas.: 236406-61-4 | Purity: 96% | 2,7-Diazaspiro[4.5]decane-7-carboxylic acid tert-butyl ester | ESD-880129-250MG |
| Cas.: 236406-61-4 | Purity: 96% | 2,7-Diazaspiro[4.5]decane-7-carboxylic acid tert-butyl ester | ESD-880129-1G |
| Cas.: 236406-39-6 | Purity: 95% | tert-butyl 2,8-diazaspiro[4.5]decane-8-carboxylate | ESD-880130-250MG |
| Cas.: 236406-39-6 | Purity: 95% | tert-butyl 2,8-diazaspiro[4.5]decane-8-carboxylate | ESD-880130-1G |
| Cas.: 23627-87-4 | Purity: 98% | Trifolin | ESD-880131-5MG |
| Cas.: 23624-21-7 | Purity: 98% | Putraflavone | ESD-880132-5MG |
| Cas.: 23599-47-5 | Purity: 98% | Cinnamolide | ESD-880133-5MG |
| Cas.: 23555-00-2 | Purity: ≥99% | Hoechst 34580 | ESD-880134-5MG |
| Cas.: 23555-00-2 | Purity: ≥99% | Hoechst 34580 | ESD-880134-10MG |
| Cas.: 23532-11-8 | Purity: 95% | 8-Debenzoylpaeoniflorin | ESD-880135-5MG |
| Cas.: 23526-45-6 | Purity: 97% | Vomifoliol | ESD-880136-5MG |
| Cas.: 23513-53-3 | Purity: 98% | (+)-Maackiain | ESD-880137-5MG |
| Cas.: 23476-83-7 | Purity: 95% | 3,12-Bis(3-chloro-2-hydroxypropyl)-3,12-diaza-6,9-diazoniadispiro[5.2.5.2]hexadecane dichloride | ESD-880139-500MG |
| Cas.: 23458-04-0 | Purity: 95% | trans-Khellactone | ESD-880140-5MG |
| Cas.: 23455-44-9 | Purity: 95% | α-Spinasterone | ESD-880141-1MG |
| Cas.: 23452-05-3 | Purity: 98% | Alternariol monomethyl ether | ESD-880142-5MG |
| Cas.: 23417-92-7 | Purity: 98% | 7-Prenyloxy-γ-Fagarine | ESD-880143-5MG |
| Cas.: 23413-80-1 | Purity: ≥99% | Aspirin Aluminum | ESD-880144-100MG |
| Cas.: 23413-80-1 | Purity: ≥99% | Aspirin Aluminum | ESD-880144-1G |
| Cas.: 23407-76-3 | Purity: 98% | Theviridoside | ESD-880145-5MG |
| Cas.: 233279-39-5 | Purity: 96% | Glycoborinine | ESD-880146-5MG |
| Cas.: 233254-24-5 | Purity: ≥98% | Tomegalovir | ESD-880147-5MG |
| Cas.: 233254-24-5 | Purity: ≥98% | Tomegalovir | ESD-880147-10MG |
| Cas.: 232931-57-6 | Purity: ≥98% | SJG-136 | ESD-880148-2MG |
| Cas.: 232931-57-6 | Purity: ≥98% | SJG-136 | ESD-880148-5MG |
| Cas.: 23261-20-3 | Purity: ≥98% | VAL-083 | ESD-880149-5MG |
| Cas.: 23261-20-3 | Purity: ≥98% | VAL-083 | ESD-880149-10MG |
| Cas.: 23256-30-6 | Purity: ≥99% | Nifurtimox | ESD-880150-5MG |
| Cas.: 23256-30-6 | Purity: ≥99% | Nifurtimox | ESD-880150-10MG |
| Cas.: 23249-97-0 | Purity: ≥98% | Procodazole | ESD-880151-500MG |
| Cas.: 23246-80-2 | Purity: 95% | 5,7-Diacetoxy-8-methoxyflavone | ESD-880152-5MG |
| Cas.: 232271-19-1 | Purity: ≥95% | TR-14035 | ESD-880153-2MG |
| Cas.: 232271-19-1 | Purity: ≥95% | TR-14035 | ESD-880153-5MG |
| Cas.: 232266-08-9 | Purity: 95% | 23-Hydroxymangiferonic acid | ESD-880154-1MG |
| Cas.: 23202-85-9 | Purity: 97% | matairesinoside | ESD-880155-5MG |
| Cas.: 2318-78-7 | Purity: 95% | Simiarenone | ESD-880156-1MG |
| Cas.: 23179-78-4 | Purity: 97% | Songoramine | ESD-880157-5MG |
| Cas.: 23146-22-7 | Purity: ≥98% | IQ-1S free acid | ESD-880158-5MG |
| Cas.: 23146-22-7 | Purity: ≥98% | IQ-1S free acid | ESD-880158-10MG |
| Cas.: 23141-27-7 | Purity: 98% | Vincosamide | ESD-880159-5MG |
| Cas.: 23141-25-5 | Purity: 98% | Strictosamide | ESD-880160-5MG |
| Cas.: 23132-13-0 | Purity: 97% | Heveaflavone | ESD-880161-5MG |
| Cas.: 231280-71-0 | Purity: 95% | Mudanpioside H | ESD-880162-5MG |
| Cas.: 2310135-18-1 | Purity: ≥98% | N-deacetylated BMS-202 | ESD-880164-5MG |
| Cas.: 2310135-18-1 | Purity: ≥98% | N-deacetylated BMS-202 | ESD-880164-10MG |
| Cas.: 23095-44-5 | Purity: 98% | Girinimbine | ESD-880165-5MG |
| Cas.: 2308-85-2 | Purity: 95% | Sitosteryl palmitate | ESD-880166-5MG |
| Cas.: 2307249-33-6 | Purity: ≥99% | BAY885 | ESD-880167-5MG |
| Cas.: 2307249-33-6 | Purity: ≥99% | BAY885 | ESD-880167-10MG |
| Cas.: 2306178-56-1 | Purity: ≥99% | DMX-5804 | ESD-880168-5MG |
| Cas.: 2306178-56-1 | Purity: ≥99% | DMX-5804 | ESD-880168-10MG |
| Cas.: 230615-23-3 | Purity: ≥98% | Varenicline Hydrochloride | ESD-880169-5MG |
| Cas.: 230615-23-3 | Purity: ≥98% | Varenicline Hydrochloride | ESD-880169-10MG |
| Cas.: 23052-81-5 | Purity: ≥99% | L-APB | ESD-880170-1MG |
| Cas.: 23052-81-5 | Purity: ≥99% | L-APB | ESD-880170-5MG |
| Cas.: 2300982-44-7 | Purity: ≥98% | RIPK1-IN-7 | ESD-880171-5MG |
| Cas.: 2300982-44-7 | Purity: ≥98% | RIPK1-IN-7 | ESD-880171-10MG |
| Cas.: 229971-81-7 | Purity: ≥99% | ADH-1 | ESD-880173-5MG |
| Cas.: 229971-81-7 | Purity: ≥99% | ADH-1 | ESD-880173-10MG |
| Cas.: 229961-45-9 | Purity: ≥98% | AGN 194310 | ESD-880174-1MG |
| Cas.: 229961-45-9 | Purity: ≥98% | AGN 194310 | ESD-880174-5MG |
| Cas.: 22934-99-2 | Purity: 98% | Desmethoxycentaureidin | ESD-880175-5MG |
| Cas.: 229005-80-5 | Purity: ≥99% | TAK-779 | ESD-880176-5MG |
| Cas.: 229005-80-5 | Purity: ≥99% | TAK-779 | ESD-880176-10MG |
| Cas.: 22864-92-2 | Purity: 97% | 6-Acetonyldihydrochelerythrine | ESD-880177-5MG |
| Cas.: 22841-42-5 | Purity: 97% | 9-Epiblumenol B | ESD-880179-5MG |
| Cas.: 228266-41-9 | Purity: ≥99% | Taltobulin trifluoroacetate | ESD-880180-5MG |
| Cas.: 228266-41-9 | Purity: ≥99% | Taltobulin trifluoroacetate | ESD-880180-10MG |
| Cas.: 228266-40-8 | Purity: ≥99% | Taltobulin | ESD-880181-5MG |
| Cas.: 228266-40-8 | Purity: ≥99% | Taltobulin | ESD-880181-10MG |
| Cas.: 22805-15-8 | Purity: 99% | 3-(4-Hydroxy-3,5-dimethoxyphenyl)-1,2-propanediol | ESD-880182-5MG |
| Cas.: 22804-52-0 | Purity: 98% | 1,2,3,7-Tetramethoxyxanthone | ESD-880183-5MG |
| Cas.: 22804-49-5 | Purity: 95% | 1-Hydroxy-2,3,5-trimethoxyxanthone | ESD-880184-5MG |
| Cas.: 22798-98-7 | Purity: 97% | Ecdysterone 2,3:20,22-diacetonide | ESD-880185-5MG |
| Cas.: 22798-96-5 | Purity: 98% | Ecdysterone 20,22-monoacetonide | ESD-880186-5MG |
| Cas.: 2277-28-3 | Purity: ≥99% | 1-Linoleoyl Glycerol | ESD-880187-100MG |
| Cas.: 2276-90-6 | Purity: ≥98% | iotalamic acid | ESD-880188-5MG |
| Cas.: 2276-90-6 | Purity: ≥98% | iotalamic acid | ESD-880188-10MG |
| Cas.: 22767-72-2 | Purity: 98% | Ethyl 3-(4-methoxyphenyl)propanoate | ESD-880189-1G |
| Cas.: 2274819-46-2 | Purity: ≥97% | LUT014 | ESD-880190-5MG |
| Cas.: 2274819-46-2 | Purity: ≥97% | LUT014 | ESD-880190-10MG |
| Cas.: 227471-20-7 | Purity: 95% | Mucrolidin | ESD-880191-5MG |
| Cas.: 22736-85-2 | Purity: 98% | Diflumidone | ESD-880192-1MG |
| Cas.: 22736-85-2 | Purity: 98% | Diflumidone | ESD-880192-5MG |
| Cas.: 227318-75-4 | Purity: 98% | Sotirimod | ESD-880193-1MG |
| Cas.: 227318-75-4 | Purity: 98% | Sotirimod | ESD-880193-5MG |
| Cas.: 227289-51-2 | Purity: 95% | (3S,7S)-5,6-Dehydro-4”-de-O-methylcentrolobine | ESD-880194-1MG |
| Cas.: 2271358-65-5 | Purity: ≥98% | UAMC-3203 hydrochloride | ESD-880195-5MG |
| Cas.: 2271358-65-5 | Purity: ≥98% | UAMC-3203 hydrochloride | ESD-880195-10MG |
| Cas.: 2271122-53-1 | Purity: 98% | ZK824859 | ESD-880196-5MG |
| Cas.: 2271122-53-1 | Purity: 98% | ZK824859 | ESD-880196-10MG |
| Cas.: 227011-48-5 | Purity: 95% | 9-Deacetyl-9-benzoyl-10-debenzoyl-4β,20-epoxytaxchinin A | ESD-880197-5MG |
| Cas.: 22697-65-0 | Purity: 95% | 3,6-Dimethoxyapigenin | ESD-880198-5MG |
| Cas.: 226954-04-7 | Purity: ≥99% | Emapunil | ESD-880199-5MG |
| Cas.: 226954-04-7 | Purity: ≥99% | Emapunil | ESD-880199-10MG |
| Cas.: 226916-19-4 | Purity: 95% | (2E)-3-{1,4-Dioxaspiro[4.5]dec-7-en-7-yl}prop-2-enoic acid | ESD-880200-1G |
| Cas.: 226904-40-1 | Purity: 96% | 4-Hydroxy-1,10-secocadin-5-ene-1,10-dione | ESD-880201-5MG |
| Cas.: 226904-00-3 | Purity: 98% | Lansoprazole sodium | ESD-880202-500MG |
| Cas.: 226904-00-3 | Purity: 98% | Lansoprazole sodium | ESD-880202-1G |
| Cas.: 22671-29-0 | Purity: 98% | L-Hexanoylcarnitine | ESD-880203-5MG |
| Cas.: 22671-29-0 | Purity: 98% | L-Hexanoylcarnitine | ESD-880203-10MG |
| Cas.: 226711-23-5 | Purity: 95% | Bakkenolide Db | ESD-880204-5MG |
| Cas.: 226700-81-8 | Purity: ≥99% | Fosamprenavir Calcium Salt | ESD-880205-1MG |
| Cas.: 226700-81-8 | Purity: ≥99% | Fosamprenavir Calcium Salt | ESD-880205-5MG |
| Cas.: 226700-79-4 | Purity: ≥99% | Fosamprenavir | ESD-880206-1MG |
| Cas.: 226700-79-4 | Purity: ≥99% | Fosamprenavir | ESD-880206-5MG |
| Cas.: 226566-43-4 | Purity: 98% | RWJ-445167 | ESD-880207-1MG |
| Cas.: 226566-43-4 | Purity: 98% | RWJ-445167 | ESD-880207-5MG |
| Cas.: 226562-47-6 | Purity: 96% | 3-Hydroxy-12-oleanene-23,28-dioic acid | ESD-880208-5MG |
| Cas.: 226561-02-0 | Purity: 98% | Amaronol B | ESD-880209-5MG |
| Cas.: 226560-96-9 | Purity: 98% | Amaronol A | ESD-880210-5MG |
| Cas.: 22649-04-3 | Purity: 97% | Torachrysone | ESD-880211-5MG |
| Cas.: 226256-56-0 | Purity: ≥99% | Cinacalcet | ESD-880212-10MG |
| Cas.: 226256-56-0 | Purity: ≥99% | Cinacalcet | ESD-880212-50MG |
| Cas.: 226226-39-7 | Purity: ≥99% | Teijin compound 1 | ESD-880213-5MG |
| Cas.: 22594-91-8 | Purity: 98% | Lucidioline | ESD-880214-5MG |
| Cas.: 22570-53-2 | Purity: 98% | Zeorin | ESD-880215-5MG |
| Cas.: 2255-50-7 | Purity: 95% | Robustine | ESD-880216-5MG |
| Cas.: 2255338-25-9 | Purity: 98% | SGC-iMLLT | ESD-880217-1MG |
| Cas.: 2255338-25-9 | Purity: 98% | SGC-iMLLT | ESD-880217-5MG |
| Cas.: 2255-14-3 | Purity: 98% | Galactose 1-phosphate | ESD-880218-10MG |
| Cas.: 22549-21-9 | Purity: 99% | Ocotillone | ESD-880219-5MG |
| Cas.: 2253744-53-3 | Purity: ≥99% | DJ-V-159 | ESD-880220-5MG |
| Cas.: 2253744-53-3 | Purity: ≥99% | DJ-V-159 | ESD-880220-10MG |
| Cas.: 22518-08-7 | Purity: 97% | 8-Hydroxy-9,10-diisobutyryloxythymol | ESD-880221-5MG |
| Cas.: 22518-03-2 | Purity: 95% | 8,9-Dehydro-7,9-diisobutyryloxythymol | ESD-880222-5MG |
| Cas.: 22518-00-9 | Purity: 98% | 1-[2-Hydroxy-4-(hydroxymethyl)phenyl]ethanone | ESD-880223-5MG |
| Cas.: 225110-25-8 | Purity: 95% | Falcarindiol | ESD-880224-5MG |
| Cas.: 2250288-69-6 | Purity: ≥99% | TD-106 | ESD-880225-5MG |
| Cas.: 2250288-69-6 | Purity: ≥99% | TD-106 | ESD-880225-10MG |
| Cas.: 22494-47-9 | Purity: 98% | Clozic | ESD-880226-1MG |
| Cas.: 22494-47-9 | Purity: 98% | Clozic | ESD-880226-5MG |
| Cas.: 2248666-66-0 | Purity: ≥98% | PF429242 dihydrochloride | ESD-880227-5MG |
| Cas.: 2248666-66-0 | Purity: ≥98% | PF429242 dihydrochloride | ESD-880227-10MG |
| Cas.: 224824-74-2 | Purity: 97% | Erigeside I | ESD-880228-5MG |
| Cas.: 2248003-71-4 | Purity: ≥98% | AZD3229 Tosylate | ESD-880229-2MG |
| Cas.: 2248003-71-4 | Purity: ≥98% | AZD3229 Tosylate | ESD-880229-5MG |
| Cas.: 2248003-60-1 | Purity: ≥99% | AZD3229 | ESD-880230-2MG |
| Cas.: 2248003-60-1 | Purity: ≥99% | AZD3229 | ESD-880230-5MG |
| Cas.: 22478-65-5 | Purity: 95% | 18-Norabieta-8,11,13-trien-4-ol | ESD-880231-1MG |
| Cas.: 2247372-59-2 | Purity: ≥99% | TUG-1375 | ESD-880232-5MG |
| Cas.: 2247127-79-1 | Purity: ≥98% | Glutaminase-IN-1 | ESD-880233-5MG |
| Cas.: 2247127-79-1 | Purity: ≥98% | Glutaminase-IN-1 | ESD-880233-10MG |
| Cas.: 224624-80-0 | Purity: ≥98% | Miridesap | ESD-880234-5MG |
| Cas.: 2245892-85-5 | Purity: ≥99% | NVP-BHG712 isomer | ESD-880235-5MG |
| Cas.: 2245892-85-5 | Purity: ≥99% | NVP-BHG712 isomer | ESD-880235-10MG |
| Cas.: 2245255-66-5 | Purity: ≥95% | GSK2807 Trifluoroacetate | ESD-880236-5MG |
| Cas.: 2245255-66-5 | Purity: ≥95% | GSK2807 Trifluoroacetate | ESD-880236-10MG |
| Cas.: 2244684-49-7 | Purity: ≥99% | Homo-PROTAC pVHL30 degrader 1 | ESD-880237-5MG |
| Cas.: 2244684-49-7 | Purity: ≥99% | Homo-PROTAC pVHL30 degrader 1 | ESD-880237-10MG |
| Cas.: 2244520-98-5 | Purity: ≥99% | Homo-PROTAC cereblon degrader 1 | ESD-880238-5MG |
| Cas.: 2244520-98-5 | Purity: ≥99% | Homo-PROTAC cereblon degrader 1 | ESD-880238-10MG |
| Cas.: 22428-86-0 | Purity: 95% | 8-Hydroxy-1,4-dithiaspiro[4.5]decane | ESD-880239-1G |
| Cas.: 224186-05-4 | Purity: 97% | Integracin B | ESD-880240-5MG |
| Cas.: 224186-03-2 | Purity: 97% | Integracin A | ESD-880241-5MG |
| Cas.: 224157-99-7 | Purity: 98% | Sch59498 | ESD-880242-1MG |
| Cas.: 224157-99-7 | Purity: 98% | Sch59498 | ESD-880242-5MG |
| Cas.: 22415-24-3 | Purity: 95% | 3- Epiturraeanthin | ESD-880243-1MG |
| Cas.: 2241135-31-7 | Purity: 98% | (3,4-Dihydroxy-5-methoxybenzoyl)taraxerol | ESD-880244-5MG |
| Cas.: 2241025-68-1 | Purity: ≥98% | MF-094 | ESD-880245-5MG |
| Cas.: 2241025-68-1 | Purity: ≥98% | MF-094 | ESD-880245-10MG |
| Cas.: 2239299-08-0 | Purity: 98% | Aspergillon A | ESD-880246-5MG |
| Cas.: 22391-34-0 | Purity: 97% | Aristola-1(10),8-dien-2-one | ESD-880247-5MG |
| Cas.: 22384-63-0 | Purity: 98% | Pedalitin | ESD-880248-5MG |
| Cas.: 223763-80-2 | Purity: 98% | Bestatin trifluoroacetate | ESD-880249-10MG |
| Cas.: 223763-80-2 | Purity: 98% | Bestatin trifluoroacetate | ESD-880249-50MG |
| Cas.: 223666-07-7 | Purity: ≥95% | Collagen proline hydroxylase inhibitor | ESD-880250-5MG |
| Cas.: 223663-32-9 | Purity: 98% | Collagen proline hydroxylase inhibitor-1 | ESD-880251-5MG |
| Cas.: 223652-90-2 | Purity: ≥99% | Garenoxacin Mesylate hydrate | ESD-880252-5MG |
| Cas.: 223652-90-2 | Purity: ≥99% | Garenoxacin Mesylate hydrate | ESD-880252-10MG |
| Cas.: 223645-67-8 | Purity: 98% | Ripasudil free base | ESD-880253-2MG |
| Cas.: 223645-67-8 | Purity: 98% | Ripasudil free base | ESD-880253-5MG |
| Cas.: 223580-51-6 | Purity: 98% | Tiadinil | ESD-880254-10MG |
| Cas.: 223580-51-6 | Purity: 98% | Tiadinil | ESD-880254-50MG |
| Cas.: 223568-55-6 | Purity: ≥97% | EP1013 | ESD-880255-1MG |
| Cas.: 223568-55-6 | Purity: ≥97% | EP1013 | ESD-880255-5MG |
| Cas.: 223559-44-2 | Purity: 95% | 6-Acetylamino-4-oxo-2-spiro(N-Boc-piperidine-4-yl)-benzopyran | ESD-880256-250MG |
| Cas.: 223559-44-2 | Purity: 95% | 6-Acetylamino-4-oxo-2-spiro(N-Boc-piperidine-4-yl)-benzopyran | ESD-880256-1G |
| Cas.: 2235358-74-2 | Purity: ≥99% | Deltasonamide 2 (TFA) | ESD-880257-5MG |
| Cas.: 2235358-74-2 | Purity: ≥99% | Deltasonamide 2 (TFA) | ESD-880257-10MG |
| Cas.: 223532-02-3 | Purity: ≥99% | CPA inhibitor | ESD-880258-5MG |
| Cas.: 223532-02-3 | Purity: ≥99% | CPA inhibitor | ESD-880258-10MG |
| Cas.: 223488-57-1 | Purity: ≥99% | Evatanepag | ESD-880259-1MG |
| Cas.: 223488-57-1 | Purity: ≥99% | Evatanepag | ESD-880259-5MG |
| Cas.: 2234281-75-3 | Purity: ≥98% | JI051 | ESD-880260-5MG |
| Cas.: 2234281-75-3 | Purity: ≥98% | JI051 | ESD-880260-10MG |
| Cas.: 22338-69-8 | Purity: 98% | Grandifloric acid | ESD-880261-5MG |
| Cas.: 22338-67-6 | Purity: 96% | Grandiflorenic acid | ESD-880262-5MG |
| Cas.: 22333-58-0 | Purity: 96% | 9-Hydroxy-α-lapachone | ESD-880263-5MG |
| Cas.: 22329-76-6 | Purity: 95% | Methyl ferulate | ESD-880264-5G |
| Cas.: 22318-10-1 | Purity: 95% | Evodol | ESD-880265-5MG |
| Cas.: 2231761-98-9 | Purity: 93% | Bistachybotrysin E | ESD-880266-5MG |
| Cas.: 2231323-99-0 | Purity: 98% | 3,4-Dihydroxybenzoyllupeol | ESD-880267-5MG |
| Cas.: 223132-38-5 | Purity: ≥99% | Inolitazone dihydrochloride | ESD-880268-2MG |
| Cas.: 223132-38-5 | Purity: ≥99% | Inolitazone dihydrochloride | ESD-880268-5MG |
| Cas.: 223132-37-4 | Purity: 98% | Inolitazone | ESD-880269-2MG |
| Cas.: 223132-37-4 | Purity: 98% | Inolitazone | ESD-880269-5MG |
| Cas.: 2230850-47-0 | Purity: ≥99% | EHMT2-IN-2 | ESD-880270-5MG |
| Cas.: 2230850-47-0 | Purity: ≥99% | EHMT2-IN-2 | ESD-880270-10MG |
| Cas.: 2230849-55-3 | Purity: ≥99% | EHMT2-IN-1 | ESD-880271-5MG |
| Cas.: 2230849-55-3 | Purity: ≥99% | EHMT2-IN-1 | ESD-880271-10MG |
| Cas.: 2230821-27-7 | Purity: ≥99% | Gefitinib-based PROTAC 3 | ESD-880272-5MG |
| Cas.: 2230821-27-7 | Purity: ≥99% | Gefitinib-based PROTAC 3 | ESD-880272-10MG |
| Cas.: 2230496-80-5 | Purity: ≥98% | ZL0420 | ESD-880273-5MG |
| Cas.: 2230496-80-5 | Purity: ≥98% | ZL0420 | ESD-880273-10MG |
| Cas.: 222989-99-3 | Purity: 98% | Finasteride acetate | ESD-880274-100MG |
| Cas.: 222989-99-3 | Purity: 98% | Finasteride acetate | ESD-880274-200MG |
| Cas.: 2227549-00-8 | Purity: ≥99% | BI 01383298 | ESD-880275-5MG |
| Cas.: 2227549-00-8 | Purity: ≥99% | BI 01383298 | ESD-880275-10MG |
| Cas.: 2227425-05-8 | Purity: 98% | PF-06869206 | ESD-880276-1MG |
| Cas.: 2227425-05-8 | Purity: 98% | PF-06869206 | ESD-880276-5MG |
| Cas.: 222716-34-9 | Purity: ≥99% | SZL P1-41 | ESD-880277-5MG |
| Cas.: 222716-34-9 | Purity: ≥99% | SZL P1-41 | ESD-880277-10MG |
| Cas.: 2226534-49-0 | Purity: ≥99% | Y06137 | ESD-880278-5MG |
| Cas.: 2226534-49-0 | Purity: ≥99% | Y06137 | ESD-880278-10MG |
| Cas.: 2226521-65-7 | Purity: ≥98% | FM381 | ESD-880279-2MG |
| Cas.: 2226521-65-7 | Purity: ≥98% | FM381 | ESD-880279-5MG |
| Cas.: 2226517-76-4 | Purity: ≥99% | SGC-GAK-1 | ESD-880280-5MG |
| Cas.: 2226517-76-4 | Purity: ≥99% | SGC-GAK-1 | ESD-880280-10MG |
| Cas.: 222631-44-9 | Purity: ≥99% | Galidesivir hydrochloride | ESD-880281-1MG |
| Cas.: 222631-44-9 | Purity: ≥99% | Galidesivir hydrochloride | ESD-880281-5MG |
| Cas.: 222629-77-8 | Purity: 95% | Antidesmone | ESD-880282-5MG |
| Cas.: 2225940-52-1 | Purity: ≥95% | Pomalidomide-PEG4-C2-NH2 | ESD-880283-100MG |
| Cas.: 2225940-52-1 | Purity: ≥95% | Pomalidomide-PEG4-C2-NH2 | ESD-880283-500MG |
| Cas.: 2225819-06-5 | Purity: ≥98% | BAY-2402234 | ESD-880284-5MG |
| Cas.: 2225819-06-5 | Purity: ≥98% | BAY-2402234 | ESD-880284-10MG |
| Cas.: 222551-17-9 | Purity: ≥98% | Adoprazine | ESD-880285-5MG |
| Cas.: 222551-17-9 | Purity: ≥98% | Adoprazine | ESD-880285-10MG |
| Cas.: 22255-10-3 | Purity: 97% | α-Amyrin palmitate | ESD-880286-5MG |
| Cas.: 22255-07-8 | Purity: 98% | Methyl 6-hydroxyangolensate | ESD-880287-5MG |
| Cas.: 2222365-76-4 | Purity: 98% | 7α-Galloyloxysweroside | ESD-880288-5MG |
| Cas.: 2222365-75-3 | Purity: 97% | 7β-Galloyloxysweroside | ESD-880289-5MG |
| Cas.: 2222365-74-2 | Purity: 98% | Viburnumoside | ESD-880290-5MG |
| Cas.: 2222285-85-8 | Purity: 96% | Epimedonin K | ESD-880291-5MG |
| Cas.: 2222285-84-7 | Purity: 97% | Epimedonin J | ESD-880292-5MG |
| Cas.: 2222285-83-6 | Purity: 97% | Epimedonin I | ESD-880293-5MG |
| Cas.: 2222285-82-5 | Purity: 95% | Epimedonin H | ESD-880294-5MG |
| Cas.: 2220243-41-2 | Purity: 95% | 3″-O-Desmethylspinorhamnoside | ESD-880295-5MG |
| Cas.: 221899-21-4 | Purity: 97% | Macrocarpal N | ESD-880296-5MG |
| Cas.: 22181-94-8 | Purity: 98% | Benin | ESD-880297-1MG |
| Cas.: 22181-94-8 | Purity: 98% | Benin | ESD-880297-5MG |
| Cas.: 221666-27-9 | Purity: 95% | (+)-Conocarpan | ESD-880298-1MG |
| Cas.: 2215-96-5 | Purity: 95% | 2,6-Dimethoxy-1-acetonylquinol | ESD-880299-5MG |
| Cas.: 221529-58-4 | Purity: ≥98% | RO1138452 | ESD-880300-5MG |
| Cas.: 221529-58-4 | Purity: ≥98% | RO1138452 | ESD-880300-10MG |
| Cas.: 2215102-38-6 | Purity: 96% | Epimedonin L | ESD-880301-5MG |
| Cas.: 22149-69-5 | Purity: 95% | Stigmastane-3,6-dione | ESD-880302-5MG |
| Cas.: 22149-65-1 | Purity: 98% | Hopane-3β,22-diol | ESD-880303-5MG |
| Cas.: 22149-28-6 | Purity: 95% | 11-Hydroxytabersonine | ESD-880304-5MG |
| Cas.: 221466-42-8 | Purity: 95% | 2β-Hydroxykolaveool | ESD-880305-1MG |
| Cas.: 221466-41-7 | Purity: 98% | 2-Oxokolavelool | ESD-880306-5MG |
| Cas.: 221456-63-9 | Purity: 95% | Fischeria A | ESD-880307-5MG |
| Cas.: 22139-77-1 | Purity: Analysis control, 98% | Pinosylvin | ESD-880308-100MG |
| Cas.: 22136-74-9 | Purity: 98% | Podocarpusflavone A | ESD-880309-5MG |
| Cas.: 22136-74-9 | Purity: 98% | Podocarpusflavone A | ESD-880309-10MG |
| Cas.: 221342-48-9 | Purity: 95% | Spiro[3.5]nonane-6,8-dione | ESD-880310-250MG |
| Cas.: 221342-48-9 | Purity: 95% | Spiro[3.5]nonane-6,8-dione | ESD-880310-1G |
| Cas.: 221289-31-2 | Purity: 98% | Lethedioside A | ESD-880311-5MG |
| Cas.: 221289-20-9 | Purity: 95% | Lethedoside A | ESD-880312-5MG |
| Cas.: 221257-06-3 | Purity: 98% | 7,4′-Di-O-methylapigenin 5-O-xylosylglucoside | ESD-880313-5MG |
| Cas.: 221244-14-0 | Purity: ≥99% | 1-NM-PP1 | ESD-880314-5MG |
| Cas.: 221244-14-0 | Purity: ≥99% | 1-NM-PP1 | ESD-880314-10MG |
| Cas.: 221243-82-9 | Purity: ≥98% | 1-Naphthyl PP1 | ESD-880315-5MG |
| Cas.: 221243-82-9 | Purity: ≥98% | 1-Naphthyl PP1 | ESD-880315-10MG |
| Cas.: 22122-96-9 | Purity: 95% | 2′,3’a,4′,5′,6′,7′-Hexahydro-spiro[cyclohexane-1,3′-indazole] | ESD-880316-50MG |
| Cas.: 22122-96-9 | Purity: 95% | 2′,3’a,4′,5′,6′,7′-Hexahydro-spiro[cyclohexane-1,3′-indazole] | ESD-880316-100MG |
| Cas.: 2212020-52-3 | Purity: ≥99% | GLP-1 receptor agonist 1 | ESD-880317-5MG |
| Cas.: 2212020-52-3 | Purity: ≥99% | GLP-1 receptor agonist 1 | ESD-880317-10MG |
| Cas.: 221174-33-0 | Purity: ≥95% | Glyoxalase I inhibitor | ESD-880318-5MG |
| Cas.: 221150-19-2 | Purity: 99% | Erysubin B | ESD-880319-5MG |
| Cas.: 221150-18-1 | Purity: 97% | Erysubin A | ESD-880320-5MG |
| Cas.: 221148-94-3 | Purity: 96% | 1α,4β,10β-Trihydroxyguaia-2,11(13)-dien-12,6α-olide | ESD-880321-5MG |
| Cas.: 221002-11-5 | Purity: 95% | 1″-Methoxyerythrinin C | ESD-880322-5MG |
| Cas.: 220932-65-0 | Purity: 95% | 13-O-Cinnamoylbaccatin III | ESD-880323-5MG |
| Cas.: 2209109-64-6 | Purity: 95% | Stachartone A | ESD-880324-5MG |
| Cas.: 220880-90-0 | Purity: 98% | 2,3-O-Isopropylidenyl euscaphic acid | ESD-880325-5MG |
| Cas.: 220862-05-5 | Purity: 98% | Thunalbene | ESD-880326-5MG |
| Cas.: 220736-54-9 | Purity: 95% | Curlignan | ESD-880327-1MG |
| Cas.: 220662-95-3 | Purity: 98% | Rivanicline oxalate | ESD-880328-10MG |
| Cas.: 220662-95-3 | Purity: 98% | Rivanicline oxalate | ESD-880328-50MG |
| Cas.: 220641-11-2 | Purity: ≥98% | Naminidil | ESD-880329-1MG |
| Cas.: 220641-11-2 | Purity: ≥98% | Naminidil | ESD-880329-5MG |
| Cas.: 2206-20-4 | Purity: ≥98% | 3α-Aminocholestane | ESD-880330-1MG |
| Cas.: 2206-20-4 | Purity: ≥98% | 3α-Aminocholestane | ESD-880330-5MG |
| Cas.: 220611-41-6 | Purity: 95% | (-)-GB-1a | ESD-880331-5MG |
| Cas.: 220551-92-8 | Purity: ≥99% | DAA-1106 | ESD-880332-2MG |
| Cas.: 220551-92-8 | Purity: ≥99% | DAA-1106 | ESD-880332-5MG |
| Cas.: 22049-24-7 | Purity: 95% | 9-methyl-6,9-diazaspiro[4.5]decane-7,10-dione | ESD-880333-1G |
| Cas.: 22049-24-7 | Purity: 95% | 9-methyl-6,9-diazaspiro[4.5]decane-7,10-dione | ESD-880333-2.5G |
| Cas.: 22048-98-2 | Purity: 98% | 1-Methyl-2-pentyl-4(1H)-quinolinone | ESD-880334-5MG |
| Cas.: 220460-92-4 | Purity: 98% | WAY-151932 | ESD-880335-1MG |
| Cas.: 220460-92-4 | Purity: 98% | WAY-151932 | ESD-880335-5MG |
| Cas.: 220384-17-8 | Purity: 95% | 5-Epicanadensene | ESD-880336-5MG |
| Cas.: 220355-63-5 | Purity: ≥97% | UKI-1 | ESD-880337-1MG |
| Cas.: 220355-63-5 | Purity: ≥97% | UKI-1 | ESD-880337-5MG |
| Cas.: 22033-87-0 | Purity: ≥98% | Olesoxime | ESD-880338-5MG |
| Cas.: 22033-87-0 | Purity: ≥98% | Olesoxime | ESD-880338-10MG |
| Cas.: 220328-03-0 | Purity: 95% | 3,11,12-Trihydroxyspirovetiv-1(10)-en-2-one | ESD-880339-5MG |
| Cas.: 220291-94-1 | Purity: 95% | 1-oxa-4-azaspiro[5.6]dodecane | ESD-880340-1G |
| Cas.: 220291-93-0 | Purity: 95% | 5-oxa-8-azaspiro[3.5]nonane | ESD-880341-1G |
| Cas.: 220291-92-9 | Purity: 95% | 4-OXA-7-AZASPIRO[2.5]OCTANE HCL | ESD-880342-250MG |
| Cas.: 220291-92-9 | Purity: 95% | 4-OXA-7-AZASPIRO[2.5]OCTANE HCL | ESD-880342-1G |
| Cas.: 220290-68-6 | Purity: 95% | 2-Oxa-6-azaspiro[3.4]octane | ESD-880343-1G |
| Cas.: 220290-68-6 | Purity: 95% | 2-Oxa-6-azaspiro[3.4]octane | ESD-880343-5G |
| Cas.: 220201-34-3 | Purity: ≥98% | Talaporfin sodium | ESD-880344-5MG |
| Cas.: 220201-34-3 | Purity: ≥98% | Talaporfin sodium | ESD-880344-10MG |
| Cas.: 22012-98-2 | Purity: 98% | Cryptomerin B | ESD-880345-5MG |
| Cas.: 2201066-53-5 | Purity: ≥99% | AGI-24512 | ESD-880346-5MG |
| Cas.: 2201066-53-5 | Purity: ≥99% | AGI-24512 | ESD-880346-10MG |
| Cas.: 22006-64-0 | Purity: 98% | ACTH 1-13 | ESD-880347-1MG |
| Cas.: 22006-64-0 | Purity: 98% | ACTH 1-13 | ESD-880347-5MG |
| Cas.: 219984-49-3 | Purity: 98% | Revexepride | ESD-880348-1MG |
| Cas.: 219984-49-3 | Purity: 98% | Revexepride | ESD-880348-5MG |
| Cas.: 219931-45-0 | Purity: ≥99% | Aminoacyl tRNA synthetase-IN-1 | ESD-880349-1MG |
| Cas.: 219931-45-0 | Purity: ≥99% | Aminoacyl tRNA synthetase-IN-1 | ESD-880349-5MG |
| Cas.: 219916-77-5 | Purity: 95% | 5,8,9,14-Tetraacetoxy-3-benzoyloxy-10,15-dihydroxypepluane | ESD-880350-5MG |
| Cas.: 219861-73-1 | Purity: 97% | 2,2′,3′-Trihydroxy-4,6-dimethoxybenzophenone | ESD-880351-5MG |
| Cas.: 219832-49-2 | Purity: ≥98% | MP-A08 | ESD-880352-1MG |
| Cas.: 219832-49-2 | Purity: ≥98% | MP-A08 | ESD-880352-5MG |
| Cas.: 21978-49-4 | Purity: 95% | Bombiprenone | ESD-880353-5MG |
| Cas.: 219757-90-1 | Purity: 98% | Sulamserod | ESD-880354-1MG |
| Cas.: 219757-90-1 | Purity: 98% | Sulamserod | ESD-880354-5MG |
| Cas.: 219749-76-5 | Purity: 95% | 19-Acetoxytaxagifine | ESD-880355-5MG |
| Cas.: 219721-33-2 | Purity: 95% | 14-Deoxy-12-hydroxyandrographolide | ESD-880356-5MG |
| Cas.: 219649-95-3 | Purity: 98% | Griffipavixanthone | ESD-880357-5MG |
| Cas.: 2196204-23-4 | Purity: ≥99% | AZ1495 | ESD-880358-5MG |
| Cas.: 2196204-23-4 | Purity: ≥99% | AZ1495 | ESD-880358-10MG |
| Cas.: 2196203-96-8 | Purity: ≥99% | TH34 | ESD-880359-5MG |
| Cas.: 2196203-96-8 | Purity: ≥99% | TH34 | ESD-880359-10MG |
| Cas.: 2196-18-1 | Purity: 97% | β-Hydroxypropiovanillone | ESD-880360-5MG |
| Cas.: 2196-14-7 | Purity: 95% | 7,4′-Dihydroxyflavone | ESD-880361-5MG |
| Cas.: 219552-69-9 | Purity: 98% | Parasin I | ESD-880362-500ΜG |
| Cas.: 219552-69-9 | Purity: 98% | Parasin I | ESD-880362-1MG |
| Cas.: 219298-74-5 | Purity: 98% | 2-Hydroxy-3,4,5,6-tetramethoxychalcone | ESD-880363-5MG |
| Cas.: 21913-98-4 | Purity: 98% | 3′-Methoxydaidzein | ESD-880364-5MG |
| Cas.: 2189-80-2 | Purity: 98% | Taraxeryl acetate | ESD-880365-5MG |
| Cas.: 218901-26-9 | Purity: 97% | Ciwujiatone | ESD-880366-5MG |
| Cas.: 21887-01-4 | Purity: 97% | Horminone | ESD-880367-5MG |
| Cas.: 2188162-97-0 | Purity: 98% | 6-Hydroxycoumurrayin | ESD-880368-5MG |
| Cas.: 2188162-96-9 | Purity: 98% | 6-(3-Methyl-2-oxobutyroyl)-7-methoxycoumarin | ESD-880369-5MG |
| Cas.: 2188162-95-8 | Purity: 98% | 4′-O-Isobutyroylpeguangxienin | ESD-880370-5MG |
| Cas.: 2188162-94-7 | Purity: 96% | 6′′-O-β-D-Apiofuranosylapterin | ESD-880371-5MG |
| Cas.: 218780-16-6 | Purity: 97% | 12-Hydroxyisodrimenin | ESD-880372-5MG |
| Cas.: 2186648-60-0 | Purity: 97% | 3α-Cinnamoyloxy-9β,17-dihydroxy-ent-kaur-15-en-19-oic acid | ESD-880373-5MG |
| Cas.: 2185857-97-8 | Purity: ≥99% | PF-06873600 | ESD-880374-5MG |
| Cas.: 2185857-97-8 | Purity: ≥99% | PF-06873600 | ESD-880374-10MG |
| Cas.: 21853-11-2 | Purity: ≥98% | 5α-Pregnane-3β, 6α-diol-20-one | ESD-880375-5MG |
| Cas.: 21853-11-2 | Purity: ≥98% | 5α-Pregnane-3β, 6α-diol-20-one | ESD-880375-10MG |
| Cas.: 21852-80-2 | Purity: 95% | Falcarinol | ESD-880376-1MG |
| Cas.: 2183470-12-2 | Purity: ≥99% | GCN2iB | ESD-880377-5MG |
| Cas.: 2183470-12-2 | Purity: ≥99% | GCN2iB | ESD-880377-10MG |
| Cas.: 218290-59-6 | Purity: 97% | Macrocarpal K | ESD-880378-5MG |
| Cas.: 2181-84-2 | Purity: 98% | Isopteleine | ESD-880379-5MG |
| Cas.: 218137-86-1 | Purity: ≥99% | C75 | ESD-880380-2MG |
| Cas.: 218137-86-1 | Purity: ≥99% | C75 | ESD-880380-5MG |
| Cas.: 21802-37-9 | Purity: ≥98% | Caerulomycin A | ESD-880381-1MG |
| Cas.: 21802-37-9 | Purity: ≥98% | Caerulomycin A | ESD-880381-5MG |
| Cas.: 217963-18-3 | Purity: ≥98% | SCH00013 | ESD-880382-1MG |
| Cas.: 217963-18-3 | Purity: ≥98% | SCH00013 | ESD-880382-5MG |
| Cas.: 21796-15-6 | Purity: 97% | Thalifoline | ESD-880383-5MG |
| Cas.: 2179-37-5 | Purity: ≥99% | Benzcyclane | ESD-880384-1MG |
| Cas.: 2179-37-5 | Purity: ≥99% | Benzcyclane | ESD-880384-5MG |
| Cas.: 217810-46-3 | Purity: 95% | 9,16-Dioxo-10,12,14-octadecatrienoic acid | ESD-880385-1MG |
| Cas.: 217799-03-6 | Purity: 98% | KP496 | ESD-880386-1MG |
| Cas.: 217799-03-6 | Purity: 98% | KP496 | ESD-880386-5MG |
| Cas.: 217650-27-6 | Purity: 95% | 4-Cadinen-7-ol | ESD-880387-1MG |
| Cas.: 217645-70-0 | Purity: ≥95% | BX471 | ESD-880388-10MG |
| Cas.: 217645-70-0 | Purity: ≥95% | BX471 | ESD-880388-50MG |
| Cas.: 217466-37-0 | Purity: 98% | 1β-Hydroxy-2-oxopomolic acid | ESD-880389-5MG |
| Cas.: 2173232-79-4 | Purity: ≥98% | LOM612 | ESD-880390-5MG |
| Cas.: 2173232-79-4 | Purity: ≥98% | LOM612 | ESD-880390-10MG |
| Cas.: 2172879-52-4 | Purity: ≥99% | LIT-927 | ESD-880391-5MG |
| Cas.: 2172879-52-4 | Purity: ≥99% | LIT-927 | ESD-880391-10MG |
| Cas.: 2172651-73-7 | Purity: ≥99% | RMC-4550 | ESD-880392-5MG |
| Cas.: 2172651-73-7 | Purity: ≥99% | RMC-4550 | ESD-880392-10MG |
| Cas.: 2172624-69-8 | Purity: 97% | 6-Hydroxyisosativan | ESD-880393-5MG |
| Cas.: 2172624-68-7 | Purity: 98% | Derrisisoflavone K | ESD-880394-5MG |
| Cas.: 2172624-67-6 | Purity: 97% | Derrisisoflavone J | ESD-880395-5MG |
| Cas.: 2172624-66-5 | Purity: 95% | Derrisisoflavone I | ESD-880396-5MG |
| Cas.: 2172624-65-4 | Purity: 93% | Derrisisoflavone H | ESD-880397-5MG |
| Cas.: 217171-01-2 | Purity: ≥95% | PD173212 | ESD-880398-2MG |
| Cas.: 217171-01-2 | Purity: ≥95% | PD173212 | ESD-880398-5MG |
| Cas.: 21715-46-8 | Purity: ≥99% | Etifoxine | ESD-880399-5MG |
| Cas.: 21715-46-8 | Purity: ≥99% | Etifoxine | ESD-880399-10MG |
| Cas.: 217099-44-0 | Purity: ≥99% | BCX 1470 methanesulfonate | ESD-880400-5MG |
| Cas.: 217099-44-0 | Purity: ≥99% | BCX 1470 methanesulfonate | ESD-880400-10MG |
| Cas.: 217099-43-9 | Purity: 98% | BCX 1470 | ESD-880401-5MG |
| Cas.: 217099-43-9 | Purity: 98% | BCX 1470 | ESD-880401-10MG |
| Cas.: 217094-32-1 | Purity: ≥99% | K-604 dihydrochloride | ESD-880402-5MG |
| Cas.: 217094-32-1 | Purity: ≥99% | K-604 dihydrochloride | ESD-880402-10MG |
| Cas.: 2170695-14-2 | Purity: ≥98% | dTRIM24 | ESD-880403-5MG |
| Cas.: 2170695-14-2 | Purity: ≥98% | dTRIM24 | ESD-880403-10MG |
| Cas.: 2170608-82-7 | Purity: ≥99% | PZ-2891 | ESD-880404-5MG |
| Cas.: 2170608-82-7 | Purity: ≥99% | PZ-2891 | ESD-880404-10MG |
| Cas.: 2170388-84-6 | Purity: 98% | Glabralide B | ESD-880405-5MG |
| Cas.: 21698-44-2 | Purity: 93% | Shyobunone | ESD-880406-5MG |
| Cas.: 21671-00-1 | Purity: 98% | Shoreic acid | ESD-880407-5MG |
| Cas.: 216691-95-1 | Purity: ≥99% | Bz 423 | ESD-880408-1MG |
| Cas.: 2166387-65-9 | Purity: ≥99% | BI-3802 | ESD-880409-5MG |
| Cas.: 2166387-65-9 | Purity: ≥99% | BI-3802 | ESD-880409-10MG |
| Cas.: 2166387-64-8 | Purity: ≥99% | BI-3812 | ESD-880410-5MG |
| Cas.: 2166387-64-8 | Purity: ≥99% | BI-3812 | ESD-880410-10MG |
| Cas.: 2165340-32-7 | Purity: ≥99% | CU-CPT-9a | ESD-880411-5MG |
| Cas.: 2165340-32-7 | Purity: ≥99% | CU-CPT-9a | ESD-880411-10MG |
| Cas.: 216450-65-6 | Purity: ≥98% | Sophoflavescenol | ESD-880412-1MG |
| Cas.: 216450-65-6 | Purity: ≥98% | Sophoflavescenol | ESD-880412-5MG |
| Cas.: 21634-52-6 | Purity: 98% | 3,5,7,8,3′,4′,5′-Heptamethoxyflavone | ESD-880413-5MG |
| Cas.: 2163056-91-3 | Purity: ≥99% | BI-1347 | ESD-880414-5MG |
| Cas.: 2163056-91-3 | Purity: ≥99% | BI-1347 | ESD-880414-10MG |
| Cas.: 2162962-69-6 | Purity: ≥99% | CU-CPT9b | ESD-880415-5MG |
| Cas.: 2162962-69-6 | Purity: ≥99% | CU-CPT9b | ESD-880415-10MG |
| Cas.: 216244-04-1 | Purity: 98% | 1alpha, 25-Dihydroxy VD2-D6 | ESD-880416-1MG |
| Cas.: 216244-04-1 | Purity: 98% | 1alpha, 25-Dihydroxy VD2-D6 | ESD-880416-5MG |
| Cas.: 216167-92-9 | Purity: ≥99% | Camobucol | ESD-880417-1MG |
| Cas.: 216167-92-9 | Purity: ≥99% | Camobucol | ESD-880417-5MG |
| Cas.: 216011-55-1 | Purity: 95% | 15,16-Epoxy-12-hydroxylabda-8(17),13(16),14-triene | ESD-880418-1MG |
| Cas.: 215923-54-9 | Purity: ≥99% | CX546 | ESD-880419-10MG |
| Cas.: 215923-54-9 | Purity: ≥99% | CX546 | ESD-880419-50MG |
| Cas.: 21586-90-3 | Purity: 98% | Bruceine E | ESD-880420-5MG |
| Cas.: 2158322-33-7 | Purity: ≥98% | PAC | ESD-880421-1MG |
| Cas.: 2158322-29-1 | Purity: 98% | PROTAC ER Degrader-3 | ESD-880422-5MG |
| Cas.: 2158322-29-1 | Purity: 98% | PROTAC ER Degrader-3 | ESD-880422-10MG |
| Cas.: 2158197-70-5 | Purity: ≥98% | HS-1371 | ESD-880423-5MG |
| Cas.: 2158197-70-5 | Purity: ≥98% | HS-1371 | ESD-880423-10MG |
| Cas.: 215803-78-4 | Purity: 98% | SB-277011 | ESD-880424-10MG |
| Cas.: 215803-78-4 | Purity: 98% | SB-277011 | ESD-880424-50MG |
| Cas.: 215802-15-6 | Purity: 98% | SB269652 | ESD-880425-2MG |
| Cas.: 215802-15-6 | Purity: 98% | SB269652 | ESD-880425-5MG |
| Cas.: 215609-93-1 | Purity: 95% | 23-Deoxojessic acid | ESD-880426-5MG |
| Cas.: 215529-47-8 | Purity: 98% | Bamirastine | ESD-880427-1MG |
| Cas.: 215529-47-8 | Purity: 98% | Bamirastine | ESD-880427-5MG |
| Cas.: 215258-13-2 | Purity: 98% | FR167344 free base | ESD-880428-1MG |
| Cas.: 215258-13-2 | Purity: 98% | FR167344 free base | ESD-880428-5MG |
| Cas.: 215190-27-5 | Purity: 98% | Fmoc-3-carboxymethyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one | ESD-880429-1G |
| Cas.: 215174-50-8 | Purity: ≥98% | Rimacalib | ESD-880430-5MG |
| Cas.: 215174-50-8 | Purity: ≥98% | Rimacalib | ESD-880430-10MG |
| Cas.: 215160-96-6 | Purity: 98% | 3α,30-Diacetyloxy-12α-hydroxy-23-oxoeupha-7,24-dien-21,16β-olid-28-oic acid 28-O-β-D-glucopyranosyl ester | ESD-880431-5MG |
| Cas.: 2150-11-0 | Purity: 95% | 7,3′,4′-Trihydroxyflavone | ESD-880432-1MG |
| Cas.: 21499-24-1 | Purity: 98% | Agrimonolide | ESD-880433-5MG |
| Cas.: 2148339-28-8 | Purity: ≥98% | AS2717638 | ESD-880434-5MG |
| Cas.: 2148339-28-8 | Purity: ≥98% | AS2717638 | ESD-880434-10MG |
| Cas.: 214769-96-7 | Purity: 95% | 2-Deacetyltaxachitriene A | ESD-880435-5MG |
| Cas.: 214766-78-6 | Purity: ≥99% | Degarelix | ESD-880436-2MG |
| Cas.: 214766-78-6 | Purity: ≥99% | Degarelix | ESD-880436-5MG |
| Cas.: 2146095-85-2 | Purity: ≥98% | SHIN1 | ESD-880437-1MG |
| Cas.: 2146095-85-2 | Purity: ≥98% | SHIN1 | ESD-880437-5MG |
| Cas.: 2146095-13-6 | Purity: 98% | Macropa-NH2 | ESD-880438-5MG |
| Cas.: 2146095-13-6 | Purity: 98% | Macropa-NH2 | ESD-880438-10MG |
| Cas.: 214558-72-2 | Purity: 98% | YM-58790 | ESD-880439-1MG |
| Cas.: 214558-72-2 | Purity: 98% | YM-58790 | ESD-880439-5MG |
| Cas.: 214548-46-6 | Purity: ≥97% | Lusaperidone | ESD-880440-1MG |
| Cas.: 214548-46-6 | Purity: ≥97% | Lusaperidone | ESD-880440-5MG |
| Cas.: 21453-69-0 | Purity: 98% | (+)-Syringaresinol | ESD-880441-5MG |
| Cas.: 214487-46-4 | Purity: 98% | MEN11467 | ESD-880442-1MG |
| Cas.: 214487-46-4 | Purity: 98% | MEN11467 | ESD-880442-5MG |
| Cas.: 214351-30-1 | Purity: 98% | 16α-Hydroxybauerenol | ESD-880443-5MG |
| Cas.: 2143475-98-1 | Purity: ≥99% | GeA-69 | ESD-880444-5MG |
| Cas.: 2143475-98-1 | Purity: ≥99% | GeA-69 | ESD-880444-10MG |
| Cas.: 2143061-81-6 | Purity: ≥99% | AZD-5991 | ESD-880445-5MG |
| Cas.: 2143061-81-6 | Purity: ≥99% | AZD-5991 | ESD-880445-10MG |
| Cas.: 214150-74-0 | Purity: 98% | 1-Norbetulonic acid | ESD-880446-5MG |
| Cas.: 21414-41-5 | Purity: ≥99% | Glucoraphanin | ESD-880447-5MG |
| Cas.: 21414-41-5 | Purity: ≥99% | Glucoraphanin | ESD-880447-10MG |
| Cas.: 2140-73-0 | Purity: ≥99% | 1-Methylinosine | ESD-880448-10MG |
| Cas.: 2140-73-0 | Purity: ≥99% | 1-Methylinosine | ESD-880448-50MG |
| Cas.: 2140-69-4 | Purity: ≥99% | 3-Methyluridine | ESD-880449-5MG |
| Cas.: 2140-67-2 | Purity: ≥99% | N2,N2-Dimethylguanosine | ESD-880450-5MG |
| Cas.: 2140-65-0 | Purity: ≥98% | 1-Methylguanosine | ESD-880451-5MG |
| Cas.: 2140-46-7 | Purity: ≥98% | 25-Hydroxycholesterol | ESD-880452-5MG |
| Cas.: 2140-46-7 | Purity: ≥98% | 25-Hydroxycholesterol | ESD-880452-10MG |
| Cas.: 2140301-96-6 | Purity: ≥99% | PF-06700841 P-Tosylate | ESD-880453-5MG |
| Cas.: 2140301-96-6 | Purity: ≥99% | PF-06700841 P-Tosylate | ESD-880453-10MG |
| Cas.: 2140289-17-2 | Purity: ≥98% | BETd-246 | ESD-880454-5MG |
| Cas.: 2140289-17-2 | Purity: ≥98% | BETd-246 | ESD-880454-10MG |
| Cas.: 21401-21-8 | Purity: 98% | Taxiphyllin | ESD-880455-5MG |
| Cas.: 213997-73-0 | Purity: ≥95% | Norvancomycin hydrochloride | ESD-880456-5MG |
| Cas.: 2139-47-1 | Purity: ≥99% | Nifenazone | ESD-880457-100MG |
| Cas.: 213912-46-0 | Purity: 98% | Barbacarpan | ESD-880458-5MG |
| Cas.: 213905-35-2 | Purity: 95% | 1-Acetoxy-9,17-octadecadiene-12,14-diyne-11,16-diol | ESD-880459-1MG |
| Cas.: 213819-48-8 | Purity: ≥98% | Belotecan hydrochloride | ESD-880460-5MG |
| Cas.: 213819-48-8 | Purity: ≥98% | Belotecan hydrochloride | ESD-880460-10MG |
| Cas.: 213769-80-3 | Purity: 95% | 6,8-Cyclo-1,4-eudesmanediol | ESD-880461-5MG |
| Cas.: 213769-33-6 | Purity: ≥99% | CYT-1010 | ESD-880462-5MG |
| Cas.: 213769-33-6 | Purity: ≥99% | CYT-1010 | ESD-880462-10MG |
| Cas.: 213743-31-8 | Purity: ≥99% | RK-24466 | ESD-880463-1MG |
| Cas.: 213743-31-8 | Purity: ≥99% | RK-24466 | ESD-880463-5MG |
| Cas.: 2137047-43-7 | Purity: ≥98% | VU6005649 | ESD-880464-1MG |
| Cas.: 2137047-43-7 | Purity: ≥98% | VU6005649 | ESD-880464-5MG |
| Cas.: 2135696-72-7 | Purity: ≥99% | Kinase inhibitor-1 | ESD-880465-5MG |
| Cas.: 2135600-76-7 | Purity: ≥99% | LSZ-102 | ESD-880466-5MG |
| Cas.: 2135600-76-7 | Purity: ≥99% | LSZ-102 | ESD-880466-10MG |
| Cas.: 213552-47-7 | Purity: 98% | Drim-7-ene-11,12-diol acetonide | ESD-880467-5MG |
| Cas.: 213546-53-3 | Purity: ≥97% | SN50 | ESD-880468-1MG |
| Cas.: 213546-53-3 | Purity: ≥97% | SN50 | ESD-880468-5MG |
| Cas.: 2134602-45-0 | Purity: ≥98% | SR17018 | ESD-880469-5MG |
| Cas.: 2134602-45-0 | Purity: ≥98% | SR17018 | ESD-880469-10MG |
| Cas.: 213411-84-8 | Purity: 98% | BM152054 | ESD-880470-1MG |
| Cas.: 213411-84-8 | Purity: 98% | BM152054 | ESD-880470-5MG |
| Cas.: 2134096-03-8 | Purity: ≥98% | HS-10296 hydrochloride | ESD-880471-5MG |
| Cas.: 2134096-03-8 | Purity: ≥98% | HS-10296 hydrochloride | ESD-880471-10MG |
| Cas.: 213400-34-1 | Purity: ≥99% | UPF-648 | ESD-880472-2MG |
| Cas.: 2133364-01-7 | Purity: 98% | Vildagliptin dihydrate | ESD-880473-10MG |
| Cas.: 2133364-01-7 | Purity: 98% | Vildagliptin dihydrate | ESD-880473-50MG |
| Cas.: 2133294-96-7 | Purity: ≥98% | Foliglurax monohydrochloride | ESD-880474-5MG |
| Cas.: 2133294-96-7 | Purity: ≥98% | Foliglurax monohydrochloride | ESD-880474-10MG |
| Cas.: 213329-46-5 | Purity: 96% | 18-Nor-4,15-dihydroxyabieta-8,11,13-trien-7-one | ESD-880475-5MG |
| Cas.: 213329-45-4 | Purity: 93% | 15,18-Dihydroxyabieta-8,11,13-trien-7-one | ESD-880476-5MG |
| Cas.: 2132396-40-6 | Purity: ≥98% | CD73-IN-1 | ESD-880477-1MG |
| Cas.: 2132396-40-6 | Purity: ≥98% | CD73-IN-1 | ESD-880477-5MG |
| Cas.: 2131803-90-0 | Purity: ≥99% | WYC-209 | ESD-880478-5MG |
| Cas.: 2131803-90-0 | Purity: ≥99% | WYC-209 | ESD-880478-10MG |
| Cas.: 2131798-13-3 | Purity: ≥96% | GSK656 | ESD-880479-5MG |
| Cas.: 2131798-13-3 | Purity: ≥96% | GSK656 | ESD-880479-10MG |
| Cas.: 2131184-57-9 | Purity: ≥98% | VU0661013 | ESD-880480-5MG |
| Cas.: 2131184-57-9 | Purity: ≥98% | VU0661013 | ESD-880480-10MG |
| Cas.: 2130958-55-1 | Purity: ≥99% | AST2818 mesylate | ESD-880481-5MG |
| Cas.: 2130958-55-1 | Purity: ≥99% | AST2818 mesylate | ESD-880481-10MG |
| Cas.: 21302-79-4 | Purity: 98% | Ceanothic acid | ESD-880482-5MG |
| Cas.: 2130-22-5 | Purity: 98% | Tetrahymanol acetate | ESD-880483-5MG |
| Cas.: 2130-17-8 | Purity: 98% | Tetrahymanol | ESD-880484-5MG |
| Cas.: 212844-54-7 | Purity: ≥97% | Purvalanol B | ESD-880485-2MG |
| Cas.: 212844-54-7 | Purity: ≥97% | Purvalanol B | ESD-880485-5MG |
| Cas.: 212710-51-5 | Purity: 95% | 7-thia-1,3-diazaspiro[4.4]nonane-2,4-dione | ESD-880486-50MG |
| Cas.: 212710-51-5 | Purity: 95% | 7-thia-1,3-diazaspiro[4.4]nonane-2,4-dione | ESD-880486-100MG |
| Cas.: 2126744-35-0 | Purity: ≥99% | SW-100 | ESD-880487-5MG |
| Cas.: 2126744-35-0 | Purity: ≥99% | SW-100 | ESD-880487-10MG |
| Cas.: 212391-58-7 | Purity: ≥98% | PP58 | ESD-880488-1MG |
| Cas.: 212391-58-7 | Purity: ≥98% | PP58 | ESD-880488-5MG |
| Cas.: 2123491-32-5 | Purity: ≥99% | CLK1-IN-1 | ESD-880489-5MG |
| Cas.: 2123491-32-5 | Purity: ≥99% | CLK1-IN-1 | ESD-880489-10MG |
| Cas.: 212321-78-3 | Purity: ≥96% | BIBR 1087 SE | ESD-880490-5MG |
| Cas.: 212321-78-3 | Purity: ≥96% | BIBR 1087 SE | ESD-880490-10MG |
| Cas.: 2122-36-3 | Purity: 95% | Apparicine | ESD-880491-1MG |
| Cas.: 212201-70-2 | Purity: ≥99% | Ipfencarbazone | ESD-880492-10MG |
| Cas.: 212201-70-2 | Purity: ≥99% | Ipfencarbazone | ESD-880492-50MG |
| Cas.: 212201-12-2 | Purity: 95% | 5,7-Dihydroxy-3-(4-hydroxy-3,5-dimethoxybenzyl)-6,8-dimethylchroman-4-one | ESD-880493-5MG |
| Cas.: 2121989-91-9 | Purity: ≥98% | GSK2850163 | ESD-880494-5MG |
| Cas.: 2121989-91-9 | Purity: ≥98% | GSK2850163 | ESD-880494-10MG |
| Cas.: 2119605-13-7 | Purity: 98% | Changweikang aldehyde | ESD-880495-5MG |
| Cas.: 211948-69-5 | Purity: 98% | 1,3,7-Trihydroxy-2-methoxyxanthone | ESD-880496-5MG |
| Cas.: 211914-50-0 | Purity: ≥99% | Dabigatran ethyl ester hydrochloride | ESD-880497-5MG |
| Cas.: 211914-50-0 | Purity: ≥99% | Dabigatran ethyl ester hydrochloride | ESD-880497-10MG |
| Cas.: 2118944-88-8 | Purity: ≥98% | FL-411 | ESD-880498-5MG |
| Cas.: 2118944-88-8 | Purity: ≥98% | FL-411 | ESD-880498-10MG |
| Cas.: 211813-86-4 | Purity: ≥99% | Eniporide hydrochloride | ESD-880499-5MG |
| Cas.: 211813-86-4 | Purity: ≥99% | Eniporide hydrochloride | ESD-880499-10MG |
| Cas.: 211799-56-3 | Purity: 98% | 2′,4′,5′-Trimethoxy-2”,2”-dimethylpyrano[5”,6”:6,7]isoflavone | ESD-880500-5MG |
| Cas.: 2117404-84-7 | Purity: ≥97% | BAY-677 | ESD-880501-5MG |
| Cas.: 2117404-84-7 | Purity: ≥97% | BAY-677 | ESD-880501-10MG |
| Cas.: 211735-76-1 | Purity: ≥99% | Farampator | ESD-880502-5MG |
| Cas.: 211735-76-1 | Purity: ≥99% | Farampator | ESD-880502-10MG |
| Cas.: 211555-30-5 | Purity: 98% | 6-Amino-5-nitropyridin-2-one | ESD-880503-50MG |
| Cas.: 211516-63-1 | Purity: 98% | Oleanolic acid derivative 2 | ESD-880504-1MG |
| Cas.: 211516-63-1 | Purity: 98% | Oleanolic acid derivative 2 | ESD-880504-5MG |
| Cas.: 211238-60-7 | Purity: 95% | 9,17-Octadecadiene-12,14-diyne-1,11,16-triol | ESD-880505-1MG |
| Cas.: 2111-46-8 | Purity: 95% | Marsformoxide B | ESD-880506-5MG |
| Cas.: 211126-61-3 | Purity: 98% | Rubranol | ESD-880507-5MG |
| Cas.: 211110-63-3 | Purity: ≥99% | Sobetirome | ESD-880508-5MG |
| Cas.: 211110-63-3 | Purity: ≥99% | Sobetirome | ESD-880508-10MG |
| Cas.: 2110449-60-8 | Purity: ≥99% | Glutaminyl Cyclase Inhibitor 1 | ESD-880509-5MG |
| Cas.: 2110449-60-8 | Purity: ≥99% | Glutaminyl Cyclase Inhibitor 1 | ESD-880509-10MG |
| Cas.: 21104-28-9 | Purity: 97% | Mahanimbine | ESD-880510-5MG |
| Cas.: 2109805-75-4 | Purity: ≥98% | CU-CPT17e | ESD-880511-5MG |
| Cas.: 2109805-75-4 | Purity: ≥98% | CU-CPT17e | ESD-880511-10MG |
| Cas.: 210829-30-4 | Purity: ≥99% | Gemcitabine (elaidate) | ESD-880512-5MG |
| Cas.: 210829-30-4 | Purity: ≥99% | Gemcitabine (elaidate) | ESD-880512-10MG |
| Cas.: 210826-40-7 | Purity: ≥99% | MCC950 | ESD-880513-2MG |
| Cas.: 210826-40-7 | Purity: ≥99% | MCC950 | ESD-880513-5MG |
| Cas.: 21061-92-7 | Purity: 95% | 6α-Hydroxylycopodine | ESD-880514-5MG |
| Cas.: 21056-52-0 | Purity: 97% | Periplanetin | ESD-880515-5MG |
| Cas.: 210537-05-6 | Purity: 95% | 1,11b-Dihydro-11b-hydroxymaackiain | ESD-880516-5MG |
| Cas.: 21040-64-2 | Purity: 95% | Spiradine F | ESD-880517-5MG |
| Cas.: 21040-45-9 | Purity: 95% | Cinnamyl acetate | ESD-880518-1MG |
| Cas.: 210354-22-6 | Purity: ≥99% | GW274150 | ESD-880519-1MG |
| Cas.: 210354-22-6 | Purity: ≥99% | GW274150 | ESD-880519-5MG |
| Cas.: 210353-53-0 | Purity: ≥99% | Gemifloxacin mesylate | ESD-880520-10MG |
| Cas.: 210353-53-0 | Purity: ≥99% | Gemifloxacin mesylate | ESD-880520-50MG |
| Cas.: 210302-17-3 | Purity: ≥99% | BAM 15 | ESD-880521-5MG |
| Cas.: 210302-17-3 | Purity: ≥99% | BAM 15 | ESD-880521-10MG |
| Cas.: 2102933-95-7 | Purity: ≥98% | GSK-LSD1 Dihydrochloride | ESD-880522-5MG |
| Cas.: 2102933-95-7 | Purity: ≥98% | GSK-LSD1 Dihydrochloride | ESD-880522-10MG |
| Cas.: 2102-75-2 | Purity: 98% | 7-Hydroxycadalene | ESD-880523-5MG |
| Cas.: 2102196-57-4 | Purity: ≥98% | GPR40 agonist 4 | ESD-880524-1MG |
| Cas.: 2102196-57-4 | Purity: ≥98% | GPR40 agonist 4 | ESD-880524-5MG |
| Cas.: 2101836-45-5 | Purity: 98% | 6-Formyl-1,2,9,10-tetramethoxy-6a,7-dehydroaporphine | ESD-880525-5MG |
| Cas.: 2101315-36-8 | Purity: ≥99% | Gboxin | ESD-880526-5MG |
| Cas.: 2101315-36-8 | Purity: ≥99% | Gboxin | ESD-880526-10MG |
| Cas.: 2101291-07-8 | Purity: ≥99% | AZD-0284 | ESD-880527-5MG |
| Cas.: 2101291-07-8 | Purity: ≥99% | AZD-0284 | ESD-880527-10MG |
| Cas.: 2101200-09-1 | Purity: ≥98% | (S,R,S)-AHPC-PEG1-N3 | ESD-880528-100MG |
| Cas.: 2101200-09-1 | Purity: ≥98% | (S,R,S)-AHPC-PEG1-N3 | ESD-880528-500MG |
| Cas.: 210110-90-0 | Purity: ≥98% | Miglustat hydrochloride | ESD-880529-5MG |
| Cas.: 210110-90-0 | Purity: ≥98% | Miglustat hydrochloride | ESD-880529-10MG |
| Cas.: 210108-91-1 | Purity: 95% | 5,8,9,10,14-Pentaacetoxy-3-benzoyloxy-15-hydroxypepluane | ESD-880530-5MG |
| Cas.: 210108-90-0 | Purity: 95% | Jatrophane 6 | ESD-880531-5MG |
| Cas.: 210108-89-7 | Purity: 96% | Jatrophane 5 | ESD-880532-5MG |
| Cas.: 210108-88-6 | Purity: 95% | Jatrophane 4 | ESD-880533-5MG |
| Cas.: 210108-87-5 | Purity: 96% | Jatrophane 3 | ESD-880534-5MG |
| Cas.: 210108-86-4 | Purity: 97% | Jatrophane 2 | ESD-880535-5MG |
| Cas.: 210108-85-3 | Purity: 95% | Jatrophane 1 | ESD-880536-5MG |
| Cas.: 210050-83-2 | Purity: 95% | Erythbidin A | ESD-880537-5MG |
| Cas.: 2100284-59-9 | Purity: ≥99% | AZ3451 | ESD-880538-5MG |
| Cas.: 2100284-59-9 | Purity: ≥99% | AZ3451 | ESD-880538-10MG |
| Cas.: 209986-17-4 | Purity: ≥99% | Compound E | ESD-880539-1MG |
| Cas.: 209986-17-4 | Purity: ≥99% | Compound E | ESD-880539-5MG |
| Cas.: 209984-58-7 | Purity: 98% | LY-411575 isomer 1 | ESD-880540-1MG |
| Cas.: 2099-26-5 | Purity: 98% | Androst-5-ene-3β,17β-diol 3,17-diacetate | ESD-880541-5MG |
| Cas.: 2098969-71-0 | Purity: ≥98% | DO34 analog | ESD-880542-5MG |
| Cas.: 2098969-71-0 | Purity: ≥98% | DO34 analog | ESD-880542-10MG |
| Cas.: 2098884-53-6 | Purity: 98% | PAT-1251 Hydrochloride | ESD-880543-5MG |
| Cas.: 2098884-53-6 | Purity: 98% | PAT-1251 Hydrochloride | ESD-880543-10MG |
| Cas.: 2098836-50-9 | Purity: 98% | AT6 | ESD-880544-1MG |
| Cas.: 2098836-45-2 | Purity: ≥98% | BRD4 degrader AT1 | ESD-880545-5MG |
| Cas.: 2098836-45-2 | Purity: ≥98% | BRD4 degrader AT1 | ESD-880545-10MG |
| Cas.: 2098546-05-3 | Purity: ≥99% | EBI-2511 | ESD-880546-5MG |
| Cas.: 2098546-05-3 | Purity: ≥99% | EBI-2511 | ESD-880546-10MG |
| Cas.: 2098488-36-7 | Purity: ≥95% | Thalidomide-O-amido-C4-N3 | ESD-880547-100MG |
| Cas.: 2098487-75-1 | Purity: ≥98% | PROTAC Sirt2 Degrader-1 | ESD-880548-5MG |
| Cas.: 2098487-75-1 | Purity: ≥98% | PROTAC Sirt2 Degrader-1 | ESD-880548-10MG |
| Cas.: 2098466-94-3 | Purity: ≥99% | TyK2-IN-2 | ESD-880549-1MG |
| Cas.: 2098466-94-3 | Purity: ≥99% | TyK2-IN-2 | ESD-880549-5MG |
| Cas.: 209808-47-9 | Purity: ≥99% | AR-M 1000390 hydrochloride | ESD-880550-5MG |
| Cas.: 209808-47-9 | Purity: ≥99% | AR-M 1000390 hydrochloride | ESD-880550-10MG |
| Cas.: 2097973-72-1 | Purity: ≥96% | (S,R,S)-AHPC-PEG2-NH2 hydrochloride | ESD-880552-10MG |
| Cas.: 2097973-72-1 | Purity: ≥96% | (S,R,S)-AHPC-PEG2-NH2 hydrochloride | ESD-880552-25MG |
| Cas.: 2097971-11-2 | Purity: ≥99% | (S,R,S)-AHPC-PEG3-NH2 hydrochloride | ESD-880553-10MG |
| Cas.: 2097971-11-2 | Purity: ≥99% | (S,R,S)-AHPC-PEG3-NH2 hydrochloride | ESD-880553-25MG |
| Cas.: 2097971-01-0 | Purity: ≥99% | PROTAC BRD9 Degrader-1 | ESD-880554-5MG |
| Cas.: 2097971-01-0 | Purity: ≥99% | PROTAC BRD9 Degrader-1 | ESD-880554-10MG |
| Cas.: 2097381-85-4 | Purity: ≥99% | VH-298 | ESD-880555-2MG |
| Cas.: 2097381-85-4 | Purity: ≥99% | VH-298 | ESD-880555-5MG |
| Cas.: 2096992-20-8 | Purity: ≥98% | MELK-8a hydrochloride | ESD-880556-1MG |
| Cas.: 2096992-20-8 | Purity: ≥98% | MELK-8a hydrochloride | ESD-880556-5MG |
| Cas.: 2096455-90-0 | Purity: ≥98% | Adriforant hydrochloride | ESD-880557-1MG |
| Cas.: 2096455-90-0 | Purity: ≥98% | Adriforant hydrochloride | ESD-880557-5MG |
| Cas.: 2095732-06-0 | Purity: 98% | CB-1158 | ESD-880558-5MG |
| Cas.: 2095732-06-0 | Purity: 98% | CB-1158 | ESD-880558-10MG |
| Cas.: 2095704-43-9 | Purity: ≥98% | SLV-2436 | ESD-880559-5MG |
| Cas.: 2095704-43-9 | Purity: ≥98% | SLV-2436 | ESD-880559-10MG |
| Cas.: 2095677-20-4 | Purity: ≥99% | eIF4A3-IN-2 | ESD-880560-5MG |
| Cas.: 2095677-20-4 | Purity: ≥99% | eIF4A3-IN-2 | ESD-880560-10MG |
| Cas.: 2095616-82-1 | Purity: ≥98% | CH7057288 | ESD-880561-5MG |
| Cas.: 2095616-82-1 | Purity: ≥98% | CH7057288 | ESD-880561-10MG |
| Cas.: 2095551-10-1 | Purity: ≥99% | Sofosbuvir impurity M | ESD-880562-1MG |
| Cas.: 2095551-10-1 | Purity: ≥99% | Sofosbuvir impurity M | ESD-880562-5MG |
| Cas.: 209543-57-7 | Purity: 98% | Gln-AMS | ESD-880563-5MG |
| Cas.: 209543-57-7 | Purity: 98% | Gln-AMS | ESD-880563-10MG |
| Cas.: 2095432-58-7 | Purity: ≥99% | SAG hydrochloride | ESD-880564-1MG |
| Cas.: 2095432-58-7 | Purity: ≥99% | SAG hydrochloride | ESD-880564-5MG |
| Cas.: 2095128-17-7 | Purity: 98% | MA-0204 | ESD-880565-5MG |
| Cas.: 2095128-17-7 | Purity: 98% | MA-0204 | ESD-880565-10MG |
| Cas.: 209414-27-7 | Purity: 98% | 1-(2-Amino-5-chlorophenyl)-1-(trifluoromethyl)-3-cyclopropyl-2-propyn-1-ol | ESD-880566-5MG |
| Cas.: 209348-85-6 | Purity: 95% | Benzyl 5-fluorospiro[indoline-3,4′-piperidine]-1′-carboxylate | ESD-880567-250MG |
| Cas.: 209348-85-6 | Purity: 95% | Benzyl 5-fluorospiro[indoline-3,4′-piperidine]-1′-carboxylate | ESD-880567-1G |
| Cas.: 209342-40-5 | Purity: ≥99% | Finafloxacin | ESD-880568-1MG |
| Cas.: 209342-40-5 | Purity: ≥99% | Finafloxacin | ESD-880568-5MG |
| Cas.: 2093393-05-4 | Purity: ≥99% | TC13172 | ESD-880569-5MG |
| Cas.: 2093393-05-4 | Purity: ≥99% | TC13172 | ESD-880569-10MG |
| Cas.: 2093391-24-1 | Purity: ≥98% | HJB97 | ESD-880570-5MG |
| Cas.: 2093391-24-1 | Purity: ≥98% | HJB97 | ESD-880570-10MG |
| Cas.: 2093388-62-4 | Purity: ≥99% | BETd-260 | ESD-880571-5MG |
| Cas.: 2093388-62-4 | Purity: ≥99% | BETd-260 | ESD-880571-10MG |
| Cas.: 2093388-45-3 | Purity: ≥98% | Lenalidomide-C5-NH2 | ESD-880572-100MG |
| Cas.: 2093388-45-3 | Purity: ≥98% | Lenalidomide-C5-NH2 | ESD-880572-500MG |
| Cas.: 2093388-33-9 | Purity: ≥98% | PROTAC BET degrader-2 | ESD-880573-5MG |
| Cas.: 2093388-33-9 | Purity: ≥98% | PROTAC BET degrader-2 | ESD-880573-10MG |
| Cas.: 2093387-77-8 | Purity: 98% | PROTAC BET-binding moiety 1 | ESD-880574-5MG |
| Cas.: 2093387-77-8 | Purity: 98% | PROTAC BET-binding moiety 1 | ESD-880574-10MG |
| Cas.: 209248-71-5 | Purity: ≥98% | Diprotin A TFA | ESD-880575-5MG |
| Cas.: 209248-71-5 | Purity: ≥98% | Diprotin A TFA | ESD-880575-10MG |
| Cas.: 209219-38-5 | Purity: ≥99% | Nastorazepide | ESD-880576-5MG |
| Cas.: 209219-38-5 | Purity: ≥99% | Nastorazepide | ESD-880576-10MG |
| Cas.: 20913-18-2 | Purity: 98% | Obtucarbamate B | ESD-880577-5MG |
| Cas.: 209115-67-3 | Purity: 95% | Mangochinine | ESD-880578-1MG |
| Cas.: 2089647-47-0 | Purity: ≥99% | SGN-2FF | ESD-880579-5MG |
| Cas.: 2089647-47-0 | Purity: ≥99% | SGN-2FF | ESD-880579-10MG |
| Cas.: 2089148-72-9 | Purity: ≥99% | A-395 | ESD-880580-5MG |
| Cas.: 2089148-72-9 | Purity: ≥99% | A-395 | ESD-880580-10MG |
| Cas.: 2088-71-3 | Purity: 98% | Testosterone benzoate | ESD-880581-5MG |
| Cas.: 2088485-34-9 | Purity: ≥99% | Deltasonamide 2 | ESD-880582-5MG |
| Cas.: 2088485-34-9 | Purity: ≥99% | Deltasonamide 2 | ESD-880582-10MG |
| Cas.: 20869-95-8 | Purity: 99% | Ermanin | ESD-880583-5MG |
| Cas.: 2084868-04-0 | Purity: ≥99% | Capzimin | ESD-880584-5MG |
| Cas.: 2084868-04-0 | Purity: ≥99% | Capzimin | ESD-880584-10MG |
| Cas.: 20835-91-0 | Purity: 96% | Stigmastane-3β,5α,6β-triol | ESD-880585-5MG |
| Cas.: 208346-80-9 | Purity: 97% | Ethyl 4-(rhamnosyloxy)benzylcarbamate | ESD-880586-5MG |
| Cas.: 20830-81-3 | Purity: 98% | Daunorubicin | ESD-880587-10MG |
| Cas.: 20830-81-3 | Purity: 98% | Daunorubicin | ESD-880587-50MG |
| Cas.: 2081098-85-1 | Purity: 98% | 16-Desoxycucurbitacin V | ESD-880589-5MG |
| Cas.: 208106-53-0 | Purity: 98% | Shanciol B | ESD-880590-5MG |
| Cas.: 2080306-23-4 | Purity: ≥99% | BAY-299 | ESD-880591-5MG |
| Cas.: 2080306-23-4 | Purity: ≥99% | BAY-299 | ESD-880591-10MG |
| Cas.: 2079896-25-4 | Purity: ≥98% | GSK 4027 | ESD-880592-5MG |
| Cas.: 2079896-25-4 | Purity: ≥98% | GSK 4027 | ESD-880592-10MG |
| Cas.: 2079886-19-2 | Purity: ≥98% | GSK4028 | ESD-880593-5MG |
| Cas.: 2079886-19-2 | Purity: ≥98% | GSK4028 | ESD-880593-10MG |
| Cas.: 2079885-05-3 | Purity: 98% | L-45 | ESD-880594-5MG |
| Cas.: 2079885-05-3 | Purity: 98% | L-45 | ESD-880594-10MG |
| Cas.: 207987-59-5 | Purity: 98% | RS-601 | ESD-880595-1MG |
| Cas.: 207987-59-5 | Purity: 98% | RS-601 | ESD-880595-5MG |
| Cas.: 20784-60-5 | Purity: 97% | 4′-O-Methylbroussochalcone B | ESD-880597-5MG |
| Cas.: 207792-17-4 | Purity: 95% | 1,7-Bis(4-hydroxyphenyl)-3-hydroxy-1,3-heptadien-5-one | ESD-880598-5MG |
| Cas.: 207557-30-5 | Purity: 98% | 1-(2-Chloroacetyl)pyrrolidine-2-carbonitrile | ESD-880599-5MG |
| Cas.: 207446-92-2 | Purity: 95% | Arteannuin N | ESD-880600-5MG |
| Cas.: 207446-90-0 | Purity: 95% | Arteannuin M | ESD-880601-1MG |
| Cas.: 207446-89-7 | Purity: 95% | Arteannuin L | ESD-880602-1MG |
| Cas.: 20733-94-2 | Purity: 98% | Methyl sinapate | ESD-880603-1G |
| Cas.: 207277-66-5 | Purity: 98% | NNC45-0781 | ESD-880604-1MG |
| Cas.: 207277-66-5 | Purity: 98% | NNC45-0781 | ESD-880604-5MG |
| Cas.: 20725-03-5 | Purity: 98% | Fustin | ESD-880605-5MG |
| Cas.: 20724-73-6 | Purity: ≥99% | NM107 | ESD-880606-5MG |
| Cas.: 20724-73-6 | Purity: ≥99% | NM107 | ESD-880606-10MG |
| Cas.: 2072057-17-9 | Purity: ≥99% | RG7834 | ESD-880607-5MG |
| Cas.: 2072057-17-9 | Purity: ≥99% | RG7834 | ESD-880607-10MG |
| Cas.: 20716-98-7 | Purity: 98% | Norlichexanthone | ESD-880608-5MG |
| Cas.: 2070864-35-4 | Purity: 98% | GENZ-882706 | ESD-880609-5MG |
| Cas.: 2070864-35-4 | Purity: 98% | GENZ-882706 | ESD-880609-10MG |
| Cas.: 2070018-30-1 | Purity: ≥99% | IDO-IN-3 | ESD-880610-2MG |
| Cas.: 2070018-30-1 | Purity: ≥99% | IDO-IN-3 | ESD-880610-5MG |
| Cas.: 2070015-25-5 | Purity: ≥97% | EPZ020411 hydrochloride | ESD-880611-2MG |
| Cas.: 2070015-25-5 | Purity: ≥97% | EPZ020411 hydrochloride | ESD-880611-5MG |
| Cas.: 2070015-09-5 | Purity: ≥97% | NU6300 | ESD-880612-5MG |
| Cas.: 2070015-09-5 | Purity: ≥97% | NU6300 | ESD-880612-10MG |
| Cas.: 2070015-04-0 | Purity: 98% | Cetirizine D8 dihydrochloride | ESD-880613-1MG |
| Cas.: 2070015-04-0 | Purity: 98% | Cetirizine D8 dihydrochloride | ESD-880613-5MG |
| Cas.: 2070015-00-6 | Purity: ≥98% | GNE-7915 tosylate | ESD-880614-5MG |
| Cas.: 2070015-00-6 | Purity: ≥98% | GNE-7915 tosylate | ESD-880614-10MG |
| Cas.: 2070014-98-9 | Purity: ≥99% | IFN alpha-IFNAR-IN-1 hydrochloride | ESD-880615-5MG |
| Cas.: 2070014-98-9 | Purity: ≥99% | IFN alpha-IFNAR-IN-1 hydrochloride | ESD-880615-10MG |
| Cas.: 2070009-72-0 | Purity: ≥99% | D8-MMAE | ESD-880616-1MG |
| Cas.: 2070009-72-0 | Purity: ≥99% | D8-MMAE | ESD-880616-5MG |
| Cas.: 2070009-64-0 | Purity: ≥99% | GSK2110183 analog 1 hydrochloride | ESD-880617-2MG |
| Cas.: 2070009-64-0 | Purity: ≥99% | GSK2110183 analog 1 hydrochloride | ESD-880617-5MG |
| Cas.: 2070009-61-7 | Purity: ≥99% | Z-Gly-Gly-Arg-AMC acetate | ESD-880618-5MG |
| Cas.: 2070009-61-7 | Purity: ≥99% | Z-Gly-Gly-Arg-AMC acetate | ESD-880618-10MG |
| Cas.: 2070009-46-8 | Purity: 98% | Tos-Gly-Pro-Arg-ANBA-IPA acetate | ESD-880619-5MG |
| Cas.: 2070009-46-8 | Purity: 98% | Tos-Gly-Pro-Arg-ANBA-IPA acetate | ESD-880619-10MG |
| Cas.: 2070009-26-4 | Purity: 98% | pGlu-Pro-Arg-MNA monoacetate | ESD-880620-5MG |
| Cas.: 2070009-26-4 | Purity: 98% | pGlu-Pro-Arg-MNA monoacetate | ESD-880620-10MG |
| Cas.: 20697-20-5 | Purity: 98% | Methysticin | ESD-880621-5MG |
| Cas.: 20697-20-5 | Purity: 98% | Methysticin | ESD-880621-10MG |
| Cas.: 2066-89-9 | Purity: ≥98% | Pasiniazid | ESD-880622-500MG |
| Cas.: 2066-89-9 | Purity: ≥98% | Pasiniazid | ESD-880622-1G |
| Cas.: 206560-99-8 | Purity: 98% | 7-O-Methylporiol | ESD-880623-5MG |
| Cas.: 2065228-63-7 | Purity: 97% | Carmichaenine E | ESD-880624-5MG |
| Cas.: 2065228-62-6 | Purity: 98% | Carmichaenine D | ESD-880625-5MG |
| Cas.: 2065228-61-5 | Purity: 97% | Carmichaenine C | ESD-880626-5MG |
| Cas.: 2065228-60-4 | Purity: 98% | Carmichaenine B | ESD-880627-5MG |
| Cas.: 2065228-59-1 | Purity: 96% | Carmichaenine A | ESD-880628-5MG |
| Cas.: 20649-42-7 | Purity: 97% | Coniferaldehyde | ESD-880629-5MG |
| Cas.: 2064292-52-8 | Purity: ≥98% | (S,R,S)-AHPC-PEG4-NH2 hydrochloride | ESD-880630-10MG |
| Cas.: 2064292-52-8 | Purity: ≥98% | (S,R,S)-AHPC-PEG4-NH2 hydrochloride | ESD-880630-25MG |
| Cas.: 2064292-12-0 | Purity: ≥98% | A1874 | ESD-880631-5MG |
| Cas.: 2064292-12-0 | Purity: ≥98% | A1874 | ESD-880631-10MG |
| Cas.: 20633-72-1 | Purity: 98% | Monomelittoside | ESD-880632-5MG |
| Cas.: 20633-72-1 | Purity: 98% | Monomelittoside | ESD-880632-10MG |
| Cas.: 20628-09-5 | Purity: 97% | Encecalin | ESD-880633-5MG |
| Cas.: 2062-78-4 | Purity: ≥99% | Pimozide | ESD-880634-50MG |
| Cas.: 206275-15-2 | Purity: ≥98% | CB30865 | ESD-880635-5MG |
| Cas.: 206275-15-2 | Purity: ≥98% | CB30865 | ESD-880635-10MG |
| Cas.: 2062685-10-1 | Purity: 95% | 16,25-Di-O-acetylcucurbitacin F | ESD-880636-5MG |
| Cas.: 206184-49-8 | Purity: ≥98% | Tenofovir hydrate | ESD-880637-5MG |
| Cas.: 206184-49-8 | Purity: ≥98% | Tenofovir hydrate | ESD-880637-10MG |
| Cas.: 2061-64-5 | Purity: 96% | Ergosterol peroxide | ESD-880638-5MG |
| Cas.: 2057509-72-3 | Purity: ≥99% | AZD4573 | ESD-880640-5MG |
| Cas.: 2057509-72-3 | Purity: ≥99% | AZD4573 | ESD-880640-10MG |
| Cas.: 205701-85-5 | Purity: 98% | RWJ-51204 | ESD-880641-1MG |
| Cas.: 205701-85-5 | Purity: 98% | RWJ-51204 | ESD-880641-5MG |
| Cas.: 2056-98-6 | Purity: ≥98% | Deoxycytidine triphosphate | ESD-880642-10MG |
| Cas.: 205654-37-1 | Purity: 98% | CMI-392 | ESD-880643-1MG |
| Cas.: 205654-37-1 | Purity: 98% | CMI-392 | ESD-880643-5MG |
| Cas.: 2055882-23-8 | Purity: 97% | Pterocarpadiol D | ESD-880644-5MG |
| Cas.: 2055882-22-7 | Purity: 97% | Pterocarpadiol C | ESD-880645-5MG |
| Cas.: 2055882-21-6 | Purity: 98% | Pterocarpadiol A | ESD-880646-5MG |
| Cas.: 2055882-20-5 | Purity: 96% | Pterocarpadiol B | ESD-880647-5MG |
| Cas.: 205534-17-4 | Purity: 96% | 2″,4″-Di-O-(Zp-coumaroyl)afzelin | ESD-880648-5MG |
| Cas.: 2055155-78-5 | Purity: 97% | Jinflexin D | ESD-880649-5MG |
| Cas.: 2055155-75-2 | Purity: 96% | Jinflexin A | ESD-880650-5MG |
| Cas.: 2055073-74-8 | Purity: 95% | Rauvovertine C | ESD-880651-5MG |
| Cas.: 2055073-72-6 | Purity: 97% | 10-Hydroxyperaksine | ESD-880652-5MG |
| Cas.: 205440-22-8 | Purity: 95% | Taxezopidine G | ESD-880653-5MG |
| Cas.: 205391-02-2 | Purity: 98% | DAF 2DA | ESD-880654-1MG |
| Cas.: 20537-88-6 | Purity: ≥98% | Amifostine | ESD-880655-10MG |
| Cas.: 20537-88-6 | Purity: ≥98% | Amifostine | ESD-880655-50MG |
| Cas.: 205304-86-5 | Purity: 98% | Tubulysin A | ESD-880656-1MG |
| Cas.: 205248-65-3 | Purity: 98% | Isonardoperoxide | ESD-880657-5MG |
| Cas.: 205187-53-7 | Purity: 98% | CX-157 | ESD-880658-1MG |
| Cas.: 205187-53-7 | Purity: 98% | CX-157 | ESD-880658-5MG |
| Cas.: 205187-35-5 | Purity: 98% | 2614W94 | ESD-880659-1MG |
| Cas.: 205187-35-5 | Purity: 98% | 2614W94 | ESD-880659-5MG |
| Cas.: 20516-23-8 | Purity: 98% | Peucedanol | ESD-880660-5MG |
| Cas.: 205115-75-9 | Purity: 97% | Lansiumarin C | ESD-880661-1MG |
| Cas.: 20493-56-5 | Purity: 98% | Curzerenone | ESD-880662-5MG |
| Cas.: 20489-11-6 | Purity: 97% | Nardosinonediol | ESD-880663-5MG |
| Cas.: 20486-27-5 | Purity: 96% | Procumbide | ESD-880664-5MG |
| Cas.: 20482-21-7 | Purity: 97% | 8-O-Acetyltorilolone | ESD-880665-5MG |
| Cas.: 204718-47-8 | Purity: 98% | NRA-0160 | ESD-880666-1MG |
| Cas.: 204718-47-8 | Purity: 98% | NRA-0160 | ESD-880666-5MG |
| Cas.: 204697-65-4 | Purity: ≥99% | Olcegepant | ESD-880667-2MG |
| Cas.: 204697-65-4 | Purity: ≥99% | Olcegepant | ESD-880667-5MG |
| Cas.: 20460-33-7 | Purity: 98% | Epitaraxerol | ESD-880668-5MG |
| Cas.: 204519-66-4 | Purity: 98% | Talnetant hydrochloride | ESD-880669-10MG |
| Cas.: 204519-66-4 | Purity: 98% | Talnetant hydrochloride | ESD-880669-50MG |
| Cas.: 204512-90-3 | Purity: ≥99% | Tecadenoson | ESD-880670-5MG |
| Cas.: 204512-90-3 | Purity: ≥99% | Tecadenoson | ESD-880670-10MG |
| Cas.: 204388-70-5 | Purity: 95% | 1-Oxa-6-azaspiro[3.5]nonane | ESD-880671-1G |
| Cas.: 204388-70-5 | Purity: 95% | 1-Oxa-6-azaspiro[3.5]nonane | ESD-880671-5G |
| Cas.: 204185-91-1 | Purity: 95% | Caesalmin E | ESD-880672-5MG |
| Cas.: 204134-70-3 | Purity: 95% | 4′-Hydroxy-2-O-methylanigorufone | ESD-880673-5MG |
| Cas.: 204067-52-7 | Purity: ≥99% | FR194738 | ESD-880674-1MG |
| Cas.: 204067-52-7 | Purity: ≥99% | FR194738 | ESD-880674-5MG |
| Cas.: 204067-45-8 | Purity: 98% | FR194738 free base | ESD-880675-1MG |
| Cas.: 204067-45-8 | Purity: 98% | FR194738 free base | ESD-880675-5MG |
| Cas.: 204067-01-6 | Purity: ≥99% | PD176252 | ESD-880676-2MG |
| Cas.: 204067-01-6 | Purity: ≥99% | PD176252 | ESD-880676-5MG |
| Cas.: 2040295-03-0 | Purity: ≥99% | Pexidartinib hydrochloride | ESD-880677-5MG |
| Cas.: 2040295-03-0 | Purity: ≥99% | Pexidartinib hydrochloride | ESD-880677-10MG |
| Cas.: 203935-39-1 | Purity: ≥99% | Helioxanthin derivative 5-4-2 | ESD-880678-2MG |
| Cas.: 203935-39-1 | Purity: ≥99% | Helioxanthin derivative 5-4-2 | ESD-880678-5MG |
| Cas.: 203934-60-5 | Purity: 95% | 8-tert-Butyl 3-ethyl 2,8-diazaspiro[4.5]decane-3,8-dicarboxylate | ESD-880679-250MG |
| Cas.: 203934-60-5 | Purity: 95% | 8-tert-Butyl 3-ethyl 2,8-diazaspiro[4.5]decane-3,8-dicarboxylate | ESD-880679-1G |
| Cas.: 203849-91-6 | Purity: ≥99% | MMAD | ESD-880680-5MG |
| Cas.: 203849-91-6 | Purity: ≥99% | MMAD | ESD-880680-10MG |
| Cas.: 20380-11-4 | Purity: ≥99% | 27-Hydroxycholesterol | ESD-880681-1MG |
| Cas.: 20380-11-4 | Purity: ≥99% | 27-Hydroxycholesterol | ESD-880681-5MG |
| Cas.: 203737-93-3 | Purity: 98% | Istaroxime | ESD-880682-2MG |
| Cas.: 203737-93-3 | Purity: 98% | Istaroxime | ESD-880682-5MG |
| Cas.: 203662-53-7 | Purity: 95% | tert-Butyl 2-(hydroxymethyl)-1-oxa-7-azaspiro[3.5]nonane-7-carboxylate | ESD-880683-1G |
| Cas.: 203640-27-1 | Purity: ≥98% | S 3304 | ESD-880684-1MG |
| Cas.: 203640-27-1 | Purity: ≥98% | S 3304 | ESD-880684-5MG |
| Cas.: 2035814-50-5 | Purity: ≥99% | JNJ-61432059 | ESD-880685-5MG |
| Cas.: 2035814-50-5 | Purity: ≥99% | JNJ-61432059 | ESD-880685-10MG |
| Cas.: 2035509-96-5 | Purity: ≥98% | AX-15836 | ESD-880686-2MG |
| Cas.: 2035509-96-5 | Purity: ≥98% | AX-15836 | ESD-880686-5MG |
| Cas.: 203524-64-5 | Purity: 95% | 2,4,6,6-Tetramethyl-3(6H)-pyridinone | ESD-880687-5MG |
| Cas.: 2035-15-6 | Purity: 98% | Maackiain | ESD-880688-5MG |
| Cas.: 2034-74-4 | Purity: 98% | 7-Oxo-β-sitosterol | ESD-880689-5MG |
| Cas.: 203455-81-6 | Purity: 95% | 18-Norabieta-8,11,13-triene-4,15-diol | ESD-880690-1MG |
| Cas.: 2031177-48-5 | Purity: 98% | ZM223 | ESD-880691-5MG |
| Cas.: 2031177-48-5 | Purity: 98% | ZM223 | ESD-880691-10MG |
| Cas.: 2031161-35-8 | Purity: ≥99% | UT-155 | ESD-880692-5MG |
| Cas.: 2031161-35-8 | Purity: ≥99% | UT-155 | ESD-880692-10MG |
| Cas.: 20310-89-8 | Purity: 98% | Saponarin | ESD-880693-5MG |
| Cas.: 2030-53-7 | Purity: 95% | Aporheine | ESD-880694-1MG |
| Cas.: 20300-44-1 | Purity: 98% | Desglucohellebrin | ESD-880695-5MG |
| Cas.: 202917-18-8 | Purity: ≥97% | Glucagon receptor antagonists-2 | ESD-880696-5MG |
| Cas.: 202917-18-8 | Purity: ≥97% | Glucagon receptor antagonists-2 | ESD-880696-10MG |
| Cas.: 202917-17-7 | Purity: 98% | Glucagon receptor antagonists-3 | ESD-880697-5MG |
| Cas.: 202917-17-7 | Purity: 98% | Glucagon receptor antagonists-3 | ESD-880697-10MG |
| Cas.: 202846-95-5 | Purity: 98% | 8-Hydroxy-3,5,7,3′,4′,5′-hexamethoxyflavone | ESD-880698-5MG |
| Cas.: 202821-81-6 | Purity: ≥98% | BMS-191011 | ESD-880699-5MG |
| Cas.: 202821-81-6 | Purity: ≥98% | BMS-191011 | ESD-880699-10MG |
| Cas.: 202808-11-5 | Purity: 98% | MRZ 2-514 | ESD-880700-1MG |
| Cas.: 202808-11-5 | Purity: 98% | MRZ 2-514 | ESD-880700-5MG |
| Cas.: 202721-09-3 | Purity: 95% | Forsythenside A | ESD-880701-5MG |
| Cas.: 202596-22-3 | Purity: 95% | Calyxin H | ESD-880702-1MG |
| Cas.: 202592-23-2 | Purity: ≥99% | JQ-1 carboxylic acid | ESD-880703-5MG |
| Cas.: 202592-23-2 | Purity: ≥99% | JQ-1 carboxylic acid | ESD-880703-10MG |
| Cas.: 202578-52-7 | Purity: 98% | DMP 696 | ESD-880704-1MG |
| Cas.: 202578-52-7 | Purity: 98% | DMP 696 | ESD-880704-5MG |
| Cas.: 202522-40-5 | Purity: 95% | 13-O-Ethylpiptocarphol | ESD-880705-5MG |
| Cas.: 20248-08-2 | Purity: 98% | δ-Amyrone | ESD-880706-5MG |
| Cas.: 202464-88-8 | Purity: 98% | (S)-Rasagiline mesylate | ESD-880707-5MG |
| Cas.: 202464-88-8 | Purity: 98% | (S)-Rasagiline mesylate | ESD-880707-10MG |
| Cas.: 202463-52-3 | Purity: 98% | 2,5,2′-Trihydroxy-4-methoxybenzophenone | ESD-880708-5MG |
| Cas.: 20245-39-0 | Purity: 98% | 1,3,7-Trihydroxy-2-prenylxanthone | ESD-880709-5MG |
| Cas.: 2023822-41-3 | Purity: 97% | Scillascilloside B-1 | ESD-880710-5MG |
| Cas.: 2023822-40-2 | Purity: 98% | Scillascillone | ESD-880711-5MG |
| Cas.: 2023788-19-2 | Purity: 98% | Tirzepatide | ESD-880712-1MG |
| Cas.: 2023788-19-2 | Purity: 98% | Tirzepatide | ESD-880712-5MG |
| Cas.: 202350-68-3 | Purity: ≥96% | PNU-159682 | ESD-880713-1MG |
| Cas.: 202350-68-3 | Purity: ≥96% | PNU-159682 | ESD-880713-5MG |
| Cas.: 202343-57-5 | Purity: 95% | Dasycarpol | ESD-880714-5MG |
| Cas.: 202337-44-8 | Purity: 98% | 6-O-(p-Hydroxybenzoyl)glucose | ESD-880715-5MG |
| Cas.: 20230-41-5 | Purity: 97% | Dregeoside Aa1 | ESD-880716-5MG |
| Cas.: 202057-76-9 | Purity: ≥97% | Manitimus | ESD-880717-1MG |
| Cas.: 202057-76-9 | Purity: ≥97% | Manitimus | ESD-880717-5MG |
| Cas.: 20196-89-8 | Purity: 98% | Kaempferol 7-O-rhamnoside | ESD-880718-5MG |
| Cas.: 20194-41-6 | Purity: 95% | Epicatechin pentaacetate | ESD-880719-1MG |
| Cas.: 201943-63-7 | Purity: ≥99% | LY341495 | ESD-880720-2MG |
| Cas.: 201943-63-7 | Purity: ≥99% | LY341495 | ESD-880720-5MG |
| Cas.: 2019-25-2 | Purity: 98% | Chlorazanil hydrochloride | ESD-880721-50MG |
| Cas.: 20188-85-6 | Purity: 99% | Ombuoside | ESD-880722-5MG |
| Cas.: 20186-22-5 | Purity: 98% | Pisatin | ESD-880723-5MG |
| Cas.: 2018300-62-2 | Purity: ≥99% | TPOP146 | ESD-880724-1MG |
| Cas.: 2018300-62-2 | Purity: ≥99% | TPOP146 | ESD-880724-5MG |
| Cas.: 2018282-44-3 | Purity: ≥98% | BMT-145027 | ESD-880725-1MG |
| Cas.: 2018282-44-3 | Purity: ≥98% | BMT-145027 | ESD-880725-5MG |
| Cas.: 20175-84-2 | Purity: 97% | Isodiospyrin | ESD-880726-5MG |
| Cas.: 2016795-77-8 | Purity: ≥99% | EC330 | ESD-880727-1MG |
| Cas.: 2016795-77-8 | Purity: ≥99% | EC330 | ESD-880727-5MG |
| Cas.: 201653-76-1 | Purity: 98% | NAMI-A | ESD-880728-1MG |
| Cas.: 201653-76-1 | Purity: 98% | NAMI-A | ESD-880728-5MG |
| Cas.: 201534-10-3 | Purity: 95% | Triptocalline A | ESD-880729-5MG |
| Cas.: 201534-09-0 | Purity: 95% | Triptocallic acid D | ESD-880730-1MG |
| Cas.: 201467-81-4 | Purity: ≥96% | N33-TEG-COOH | ESD-880731-100MG |
| Cas.: 201410-53-9 | Purity: ≥99% | Talarozole | ESD-880732-2MG |
| Cas.: 201410-53-9 | Purity: ≥99% | Talarozole | ESD-880732-5MG |
| Cas.: 20133-19-1 | Purity: 95% | 1-(3,4-Dimethoxyphenyl)propane-1,2-diol | ESD-880733-5MG |
| Cas.: 20107-13-5 | Purity: 95% | cis-Methylkhallactone | ESD-880734-5MG |
| Cas.: 20105-22-0 | Purity: 95% | Ravenine | ESD-880735-5MG |
| Cas.: 201038-74-6 | Purity: 98% | SB-269970 | ESD-880736-10MG |
| Cas.: 201038-74-6 | Purity: 98% | SB-269970 | ESD-880736-50MG |
| Cas.: 2010216-41-6 | Purity: 97% | Garcimultiflorone J | ESD-880737-5MG |
| Cas.: 2010159-60-9 | Purity: 98% | (S,R,S)-AHPC-PEG2-NH2 | ESD-880738-100MG |
| Cas.: 2010159-60-9 | Purity: 98% | (S,R,S)-AHPC-PEG2-NH2 | ESD-880738-500MG |
| Cas.: 2010159-57-4 | Purity: ≥98% | (S,R,S)-AHPC-PEG4-NH2 | ESD-880739-100MG |
| Cas.: 2010159-57-4 | Purity: ≥98% | (S,R,S)-AHPC-PEG4-NH2 | ESD-880739-500MG |
| Cas.: 2010159-56-3 | Purity: 98% | (S,R,S)-AHPC-PEG3-NH2 | ESD-880740-100MG |
| Cas.: 2010159-56-3 | Purity: 98% | (S,R,S)-AHPC-PEG3-NH2 | ESD-880740-500MG |
| Cas.: 2010159-48-3 | Purity: ≥99% | MZP-55 | ESD-880741-5MG |
| Cas.: 2010159-48-3 | Purity: ≥99% | MZP-55 | ESD-880741-10MG |
| Cas.: 2010159-47-2 | Purity: ≥98% | MZP-54 | ESD-880742-5MG |
| Cas.: 2010159-47-2 | Purity: ≥98% | MZP-54 | ESD-880742-10MG |
| Cas.: 2010159-45-0 | Purity: ≥97% | (S,R,S)-AHPC-PEG2-N3 | ESD-880743-100MG |
| Cas.: 2010159-45-0 | Purity: ≥97% | (S,R,S)-AHPC-PEG2-N3 | ESD-880743-500MG |
| Cas.: 20086-07-1 | Purity: 98% | Diosbulbin C | ESD-880744-5MG |
| Cas.: 200813-31-6 | Purity: 95% | 16-Nor-15-oxodehydroabietic acid | ESD-880745-5MG |
| Cas.: 200803-37-8 | Purity: 98% | OSIP-486823 | ESD-880746-1MG |
| Cas.: 200803-37-8 | Purity: 98% | OSIP-486823 | ESD-880746-5MG |
| Cas.: 2007885-39-2 | Purity: ≥98% | PAT-1251 | ESD-880747-5MG |
| Cas.: 2007885-39-2 | Purity: ≥98% | PAT-1251 | ESD-880747-10MG |
| Cas.: 20073-24-9 | Purity: 98% | 3-CPs | ESD-880748-1MG |
| Cas.: 20073-24-9 | Purity: 98% | 3-CPs | ESD-880748-5MG |
| Cas.: 20065-99-0 | Purity: 95% | Hennadiol | ESD-880749-5MG |
| Cas.: 20045-06-1 | Purity: 97% | Picralinal | ESD-880750-5MG |
| Cas.: 200435-92-3 | Purity: ≥99% | 2′-O,4′-C-Methyleneuridine | ESD-880751-10MG |
| Cas.: 200435-92-3 | Purity: ≥99% | 2′-O,4′-C-Methyleneuridine | ESD-880751-50MG |
| Cas.: 2003260-55-5 | Purity: ≥98% | NCGC00244536 | ESD-880752-1MG |
| Cas.: 2003260-55-5 | Purity: ≥98% | NCGC00244536 | ESD-880752-5MG |
| Cas.: 2002381-25-9 | Purity: ≥99% | APS-2-79 | ESD-880753-5MG |
| Cas.: 2002381-25-9 | Purity: ≥99% | APS-2-79 | ESD-880753-10MG |
| Cas.: 20013-76-7 | Purity: 95% | Dehydrochromolaenin | ESD-880754-5MG |
| Cas.: 20013-75-6 | Purity: 95% | Pyrocurzerenone | ESD-880755-5MG |
| Cas.: 200134-22-1 | Purity: ≥98% | INH14 | ESD-880756-5MG |
| Cas.: 200134-22-1 | Purity: ≥98% | INH14 | ESD-880756-10MG |
| Cas.: 200132-83-8 | Purity: ≥97% | Kasugamycin hydrochloride hydrate | ESD-880757-500MG |
| Cas.: 200132-83-8 | Purity: ≥97% | Kasugamycin hydrochloride hydrate | ESD-880757-1G |
| Cas.: 200127-80-6 | Purity: 97% | 3′-Methoxydaidzin | ESD-880758-5MG |
| Cas.: 200125-11-7 | Purity: 95% | N-trans-Sinapoyltyramine | ESD-880759-5MG |
| Cas.: 200050-59-5 | Purity: 98% | L-771688 | ESD-880760-1MG |
| Cas.: 200050-59-5 | Purity: 98% | L-771688 | ESD-880760-5MG |
| Cas.: 19992-50-8 | Purity: ≥98% | ML329 | ESD-880761-5MG |
| Cas.: 19992-50-8 | Purity: ≥98% | ML329 | ESD-880761-10MG |
| Cas.: 199864-86-3 | Purity: ≥99% | RS 127445 | ESD-880762-5MG |
| Cas.: 199864-86-3 | Purity: ≥99% | RS 127445 | ESD-880762-10MG |
| Cas.: 199851-52-0 | Purity: 95% | Isocudraniaxanthone B | ESD-880763-5MG |
| Cas.: 1997387-43-5 | Purity: ≥99% | PZM21 | ESD-880764-1MG |
| Cas.: 1997387-43-5 | Purity: ≥99% | PZM21 | ESD-880764-5MG |
| Cas.: 199727-68-9 | Purity: 98% | CEF4 | ESD-880765-1MG |
| Cas.: 199727-68-9 | Purity: 98% | CEF4 | ESD-880765-5MG |
| Cas.: 199727-62-3 | Purity: 98% | CEF3 | ESD-880766-1MG |
| Cas.: 199727-62-3 | Purity: 98% | CEF3 | ESD-880766-5MG |
| Cas.: 19970-45-7 | Purity: ≥98% | SJ572403 | ESD-880767-5MG |
| Cas.: 19970-45-7 | Purity: ≥98% | SJ572403 | ESD-880767-10MG |
| Cas.: 199657-29-9 | Purity: 98% | Givinostat hydrochloride | ESD-880768-2MG |
| Cas.: 199657-29-9 | Purity: 98% | Givinostat hydrochloride | ESD-880768-5MG |
| Cas.: 19956-54-8 | Purity: 98% | Methyllucidone | ESD-880769-5MG |
| Cas.: 19956-53-7 | Purity: 98% | Lucidone | ESD-880770-5MG |
| Cas.: 199433-58-4 | Purity: ≥98% | Y-33075 | ESD-880771-10MG |
| Cas.: 199433-58-4 | Purity: ≥98% | Y-33075 | ESD-880771-50MG |
| Cas.: 19942-04-2 | Purity: 97% | 3-Epicabraleadiol | ESD-880772-5MG |
| Cas.: 19941-83-4 | Purity: 96% | Kolavenol | ESD-880773-5MG |
| Cas.: 199331-36-7 | Purity: 97% | Glyurallin A | ESD-880774-5MG |
| Cas.: 199331-35-6 | Purity: 97% | Dehydroglyasperin C | ESD-880775-5MG |
| Cas.: 1993086-20-6 | Purity: 95% | tert-Butyl 7-methoxy-2-oxo-1H-spiro[indole-3,4′-piperidine]-1′-carboxylate | ESD-880776-1MG |
| Cas.: 1992047-64-9 | Purity: ≥99% | MS023 dihydrochloride | ESD-880777-2MG |
| Cas.: 1992047-64-9 | Purity: ≥99% | MS023 dihydrochloride | ESD-880777-5MG |
| Cas.: 19914-20-6 | Purity: 97% | Enniatin B1 | ESD-880778-5MG |
| Cas.: 1990-77-8 | Purity: 98% | Syringaresinol diacetate | ESD-880779-5MG |
| Cas.: 19902-91-1 | Purity: 98% | Dihydromethysticin | ESD-880780-5MG |
| Cas.: 19902-91-1 | Purity: 98% | Dihydromethysticin | ESD-880780-10MG |
| Cas.: 19895-95-5 | Purity: 98% | Kaempferol 3-O-sophoroside | ESD-880781-5MG |
| Cas.: 19891-85-1 | Purity: 95% | 29-Nor-20-oxolupeol | ESD-880782-5MG |
| Cas.: 19891-51-1 | Purity: ≥98% | Nagilactone B | ESD-880783-1MG |
| Cas.: 19891-51-1 | Purity: ≥98% | Nagilactone B | ESD-880783-5MG |
| Cas.: 19888-34-7 | Purity: 97% | Humulene epoxide II | ESD-880784-5MG |
| Cas.: 198827-23-5 | Purity: 98% | (7R)-Methoxy-8-epi-matairesinol | ESD-880785-5MG |
| Cas.: 198821-22-6 | Purity: ≥98% | Merimepodib | ESD-880786-2MG |
| Cas.: 198821-22-6 | Purity: ≥98% | Merimepodib | ESD-880786-5MG |
| Cas.: 19865-87-3 | Purity: 98% | Cabralealactone | ESD-880787-5MG |
| Cas.: 1985606-14-1 | Purity: ≥99% | Baloxavir marboxil | ESD-880788-1MG |
| Cas.: 1985606-14-1 | Purity: ≥99% | Baloxavir marboxil | ESD-880788-5MG |
| Cas.: 1984-94-7 | Purity: 98% | Sulfasymazine | ESD-880790-1MG |
| Cas.: 1984-94-7 | Purity: 98% | Sulfasymazine | ESD-880790-5MG |
| Cas.: 1984862-48-7 | Purity: ≥97% | OABK hydrochloride | ESD-880791-1MG |
| Cas.: 1984862-48-7 | Purity: ≥97% | OABK hydrochloride | ESD-880791-5MG |
| Cas.: 198481-32-2 | Purity: 98% | Bazedoxifene | ESD-880792-5MG |
| Cas.: 198481-32-2 | Purity: 98% | Bazedoxifene | ESD-880792-10MG |
| Cas.: 19833-15-9 | Purity: 98% | Betulinic acid palmitate | ESD-880793-5MG |
| Cas.: 19833-13-7 | Purity: 93% | Erythrodiol 3-palmitate | ESD-880794-5MG |
| Cas.: 198142-65-3 | Purity: 95% | 2,7-Bibromospiro[fluorene-9,9′-xanthene] | ESD-880795-1G |
| Cas.: 198142-65-3 | Purity: 95% | 2,7-Bibromospiro[fluorene-9,9′-xanthene] | ESD-880795-5G |
| Cas.: 198062-54-3 | Purity: ≥99% | GW311616 | ESD-880796-2MG |
| Cas.: 198062-54-3 | Purity: ≥99% | GW311616 | ESD-880796-5MG |
| Cas.: 198013-53-5 | Purity: 98% | BO3482 | ESD-880797-1MG |
| Cas.: 198013-53-5 | Purity: 98% | BO3482 | ESD-880797-5MG |
| Cas.: 1980054-87-2 | Purity: 95% | 1-(Trifluoromethyl)-2-thia-6-azaspiro[3 3]heptane hemioxalate | ESD-880798-250MG |
| Cas.: 1980053-02-8 | Purity: 95% | 8-Oxa-5-azaspiro[3·5]nonane oxalate | ESD-880799-250MG |
| Cas.: 1980048-81-4 | Purity: 95% | 4-azaspiro[2·3]hexane hemioxalate | ESD-880800-100MG |
| Cas.: 1980048-81-4 | Purity: 95% | 4-azaspiro[2·3]hexane hemioxalate | ESD-880800-250MG |
| Cas.: 197913-15-8 | Purity: 98% | CDD3506 | ESD-880801-5MG |
| Cas.: 197913-15-8 | Purity: 98% | CDD3506 | ESD-880801-10MG |
| Cas.: 197894-84-1 | Purity: ≥98% | CI-1044 | ESD-880802-1MG |
| Cas.: 197894-84-1 | Purity: ≥98% | CI-1044 | ESD-880802-5MG |
| Cas.: 197890-44-1 | Purity: ≥98% | GW311616 hydrochloride | ESD-880803-2MG |
| Cas.: 1978388-58-7 | Purity: 98% | Stachartin E | ESD-880804-5MG |
| Cas.: 1978388-57-6 | Purity: 97% | Stachartin D | ESD-880805-5MG |
| Cas.: 1978388-56-5 | Purity: 98% | Stachartin C | ESD-880806-5MG |
| Cas.: 1978388-55-4 | Purity: 97% | Stachartin B | ESD-880807-5MG |
| Cas.: 1978388-54-3 | Purity: 98% | Stachartin A | ESD-880808-5MG |
| Cas.: 197781-86-5 | Purity: 95% | 7-O-Acetylbonducellpin C | ESD-880809-5MG |
| Cas.: 197781-85-4 | Purity: 95% | Bonducellpin D | ESD-880810-5MG |
| Cas.: 197781-84-3 | Purity: 95% | Bonducellpin C | ESD-880811-5MG |
| Cas.: 19775-48-5 | Purity: 95% | Daphmacrine | ESD-880812-1MG |
| Cas.: 1977495-97-8 | Purity: ≥99% | Trilaciclib hydrochloride | ESD-880813-1MG |
| Cas.: 1977495-97-8 | Purity: ≥99% | Trilaciclib hydrochloride | ESD-880813-5MG |
| Cas.: 197723-00-5 | Purity: ≥95% | NKP-1339 | ESD-880814-5MG |
| Cas.: 197723-00-5 | Purity: ≥95% | NKP-1339 | ESD-880814-10MG |
| Cas.: 197654-04-9 | Purity: 98% | Tigecycline hydrochloride | ESD-880815-10MG |
| Cas.: 197654-04-9 | Purity: 98% | Tigecycline hydrochloride | ESD-880815-50MG |
| Cas.: 19764-35-3 | Purity: 98% | Triandrin | ESD-880816-5MG |
| Cas.: 197576-78-6 | Purity: 98% | RPR107393 free base | ESD-880817-1MG |
| Cas.: 197576-78-6 | Purity: 98% | RPR107393 free base | ESD-880817-5MG |
| Cas.: 197506-02-8 | Purity: 98% | LM-1484 | ESD-880818-1MG |
| Cas.: 197506-02-8 | Purity: 98% | LM-1484 | ESD-880818-5MG |
| Cas.: 197447-32-8 | Purity: 95% | Latisxanthone C | ESD-880819-5MG |
| Cas.: 197307-49-6 | Purity: 97% | 11-Dehydroxygrevilloside B | ESD-880820-5MG |
| Cas.: 197250-15-0 | Purity: ≥99% | Gap 26 | ESD-880821-1MG |
| Cas.: 197250-15-0 | Purity: ≥99% | Gap 26 | ESD-880821-5MG |
| Cas.: 19718-88-8 | Purity: 95% | 1,4-Diazaspiro[4.5]decan-2-one | ESD-880822-500MG |
| Cas.: 19716-66-6 | Purity: 98% | Pseudopalmatine | ESD-880823-5MG |
| Cas.: 197018-71-6 | Purity: 97% | 7,4′-Di-O-methylapigenin 5-O-glucoside | ESD-880824-5MG |
| Cas.: 1969289-10-8 | Purity: 97% | Glabralide A | ESD-880825-5MG |
| Cas.: 19691-80-6 | Purity: 98% | Athidathion | ESD-880826-10MG |
| Cas.: 19691-80-6 | Purity: 98% | Athidathion | ESD-880826-50MG |
| Cas.: 196808-24-9 | Purity: ≥99% | GW1929 | ESD-880827-5MG |
| Cas.: 196808-24-9 | Purity: ≥99% | GW1929 | ESD-880827-10MG |
| Cas.: 1966183-72-1 | Purity: 97% | Giffonin R | ESD-880828-5MG |
| Cas.: 1964515-43-2 | Purity: ≥99% | LDH-IN-1 | ESD-880829-5MG |
| Cas.: 1964515-43-2 | Purity: ≥99% | LDH-IN-1 | ESD-880829-10MG |
| Cas.: 19626-92-7 | Purity: 95% | Indole-3-acrylic acid methyl ester | ESD-880830-1G |
| Cas.: 195987-41-8 | Purity: ≥99% | BMS-214662 | ESD-880831-1MG |
| Cas.: 195987-41-8 | Purity: ≥99% | BMS-214662 | ESD-880831-5MG |
| Cas.: 1959537-86-0 | Purity: ≥98% | FT827 | ESD-880832-5MG |
| Cas.: 1959537-86-0 | Purity: ≥98% | FT827 | ESD-880832-10MG |
| Cas.: 195883-06-8 | Purity: ≥98% | Omtriptolide | ESD-880833-1MG |
| Cas.: 195883-06-8 | Purity: ≥98% | Omtriptolide | ESD-880833-5MG |
| Cas.: 195735-16-1 | Purity: 95% | 2,6,16-Kauranetriol 2-O-β-D-allopyranoside | ESD-880834-10MG |
| Cas.: 195733-43-8 | Purity: ≥99% | Atrasentan hydrochloride | ESD-880835-2MG |
| Cas.: 195733-43-8 | Purity: ≥99% | Atrasentan hydrochloride | ESD-880835-5MG |
| Cas.: 1957236-21-3 | Purity: ≥99% | Thalidomide-O-amido-PEG3-C2-NH2 (TFA) | ESD-880836-100MG |
| Cas.: 1957236-21-3 | Purity: ≥99% | Thalidomide-O-amido-PEG3-C2-NH2 (TFA) | ESD-880836-500MG |
| Cas.: 1957235-75-4 | Purity: ≥99% | Thalidomide-O-amido-PEG2-C2-NH2 (TFA) | ESD-880837-100MG |
| Cas.: 1957235-75-4 | Purity: ≥99% | Thalidomide-O-amido-PEG2-C2-NH2 (TFA) | ESD-880837-500MG |
| Cas.: 195723-38-7 | Purity: 97% | 2,16,19-Kauranetriol 2-O-β-D-allopyranoside | ESD-880838-5MG |
| Cas.: 195723-10-5 | Purity: 95% | Methyl 4-O-feruloylquinate | ESD-880839-5MG |
| Cas.: 1956426-56-4 | Purity: ≥99% | KN-93 hydrochloride | ESD-880840-1MG |
| Cas.: 1956426-56-4 | Purity: ≥99% | KN-93 hydrochloride | ESD-880840-5MG |
| Cas.: 1956389-84-6 | Purity: 95% | 1,8-diazaspiro[4.5]decan-2-one dihydrochloride | ESD-880841-1G |
| Cas.: 1956389-84-6 | Purity: 95% | 1,8-diazaspiro[4.5]decan-2-one dihydrochloride | ESD-880841-5G |
| Cas.: 1956370-21-0 | Purity: ≥99% | RIPA-56 | ESD-880842-10MG |
| Cas.: 1956370-21-0 | Purity: ≥99% | RIPA-56 | ESD-880842-50MG |
| Cas.: 1956366-10-1 | Purity: ≥99% | Ulixertinib hydrochloride | ESD-880843-5MG |
| Cas.: 1956366-10-1 | Purity: ≥99% | Ulixertinib hydrochloride | ESD-880843-10MG |
| Cas.: 1956331-86-4 | Purity: 95% | 1-OXA-4,9-DIAZASPIRO[5.5]UNDECANE 2HCL | ESD-880844-1G |
| Cas.: 1956331-86-4 | Purity: 95% | 1-OXA-4,9-DIAZASPIRO[5.5]UNDECANE 2HCL | ESD-880844-5G |
| Cas.: 19562-30-2 | Purity: ≥98% | Piromidic acid | ESD-880845-10MG |
| Cas.: 19562-30-2 | Purity: ≥98% | Piromidic acid | ESD-880845-50MG |
| Cas.: 1955550-51-2 | Purity: 98% | FMK 9a | ESD-880846-1MG |
| Cas.: 1955550-51-2 | Purity: 98% | FMK 9a | ESD-880846-5MG |
| Cas.: 195514-80-8 | Purity: ≥99% | AP20187 | ESD-880847-1MG |
| Cas.: 195514-80-8 | Purity: ≥99% | AP20187 | ESD-880847-5MG |
| Cas.: 195514-63-7 | Purity: ≥99% | Rimiducid | ESD-880848-2MG |
| Cas.: 195514-63-7 | Purity: ≥99% | Rimiducid | ESD-880848-5MG |
| Cas.: 19533-92-7 | Purity: 97% | Alphitolic acid | ESD-880849-5MG |
| Cas.: 1953130-87-4 | Purity: ≥99% | PTI-428 | ESD-880850-5MG |
| Cas.: 1953130-87-4 | Purity: ≥99% | PTI-428 | ESD-880850-10MG |
| Cas.: 195199-95-2 | Purity: ≥99% | SB 258719 | ESD-880851-5MG |
| Cas.: 195199-95-2 | Purity: ≥99% | SB 258719 | ESD-880851-10MG |
| Cas.: 195199-04-3 | Purity: 98% | Dye 937 | ESD-880852-5MG |
| Cas.: 195199-04-3 | Purity: 98% | Dye 937 | ESD-880852-10MG |
| Cas.: 195142-72-4 | Purity: 98% | Dihydrosenkyunolide C | ESD-880853-5MG |
| Cas.: 1951408-58-4 | Purity: ≥98% | EED inhibitor-1 | ESD-880854-1MG |
| Cas.: 1951408-58-4 | Purity: ≥98% | EED inhibitor-1 | ESD-880854-5MG |
| Cas.: 1950634-92-0 | Purity: ≥99% | dBET6 | ESD-880856-5MG |
| Cas.: 1950634-92-0 | Purity: ≥99% | dBET6 | ESD-880856-10MG |
| Cas.: 195055-03-9 | Purity: ≥99% | R121919 | ESD-880857-1MG |
| Cas.: 195055-03-9 | Purity: ≥99% | R121919 | ESD-880857-5MG |
| Cas.: 1949837-12-0 | Purity: ≥99% | ARV-771 | ESD-880858-1MG |
| Cas.: 1949837-12-0 | Purity: ≥99% | ARV-771 | ESD-880858-5MG |
| Cas.: 194940-15-3 | Purity: 95% | 4-Hydroxycinnamamide | ESD-880859-1G |
| Cas.: 1949-20-8 | Purity: ≥98% | Oxolamine citrate | ESD-880860-500MG |
| Cas.: 1949-20-8 | Purity: ≥98% | Oxolamine citrate | ESD-880860-1G |
| Cas.: 194862-84-5 | Purity: 95% | 8-Oxa-2-azaspiro[4.5]decan-3-one | ESD-880861-1G |
| Cas.: 1948273-03-7 | Purity: ≥98% | (S,R,S)-AHPC-Me hydrochloride | ESD-880862-100MG |
| Cas.: 1948273-03-7 | Purity: ≥98% | (S,R,S)-AHPC-Me hydrochloride | ESD-880862-500MG |
| Cas.: 1948273-02-6 | Purity: 98% | (S,R,S)-AHPC-Me | ESD-880863-100MG |
| Cas.: 1948273-02-6 | Purity: 98% | (S,R,S)-AHPC-Me | ESD-880863-500MG |
| Cas.: 194798-83-9 | Purity: ≥99% | Fosfluconazole | ESD-880864-10MG |
| Cas.: 194798-83-9 | Purity: ≥99% | Fosfluconazole | ESD-880864-25MG |
| Cas.: 194782-02-0 | Purity: 95% | Taxuspine X | ESD-880865-5MG |
| Cas.: 19467-03-9 | Purity: 98% | Melittoside | ESD-880866-1MG |
| Cas.: 19467-03-9 | Purity: 98% | Melittoside | ESD-880866-5MG |
| Cas.: 194613-74-6 | Purity: 95% | 21αH-24-Norhopa-4(23),22(29)-diene-3β,6β-diol | ESD-880867-1MG |
| Cas.: 1946010-79-2 | Purity: ≥99% | SAR405 R enantiomer | ESD-880868-2MG |
| Cas.: 1946010-79-2 | Purity: ≥99% | SAR405 R enantiomer | ESD-880868-5MG |
| Cas.: 1945950-21-9 | Purity: ≥99% | PDD 00017273 | ESD-880869-5MG |
| Cas.: 1945950-21-9 | Purity: ≥99% | PDD 00017273 | ESD-880869-10MG |
| Cas.: 19452-84-7 | Purity: 95% | Taberpsychine | ESD-880870-1MG |
| Cas.: 1942919-79-0 | Purity: ≥99% | NVP-BSK805 dihydrochloride | ESD-880871-2MG |
| Cas.: 1942919-79-0 | Purity: ≥99% | NVP-BSK805 dihydrochloride | ESD-880871-5MG |
| Cas.: 19427-82-8 | Purity: 97% | Selinidin | ESD-880872-5MG |
| Cas.: 19417-00-6 | Purity: 96% | Isohyenanchin | ESD-880873-5MG |
| Cas.: 194157-10-3 | Purity: 95% | 7-Oxa-2-azaspiro[3.5]nonane | ESD-880874-1G |
| Cas.: 194145-29-4 | Purity: 97% | Rivulobirin B | ESD-880875-5MG |
| Cas.: 194093-42-0 | Purity: ≥99% | Pumosetrag Hydrochloride | ESD-880876-5MG |
| Cas.: 194093-42-0 | Purity: ≥99% | Pumosetrag Hydrochloride | ESD-880876-10MG |
| Cas.: 194027-11-7 | Purity: 98% | 6β,19-Dihydroxy-3-oxours-12-en-28-oic acid | ESD-880877-5MG |
| Cas.: 1940176-03-3 | Purity: ≥99% | Abiraterone metabolite 1 | ESD-880878-5MG |
| Cas.: 1940176-03-3 | Purity: ≥99% | Abiraterone metabolite 1 | ESD-880878-10MG |
| Cas.: 19397-28-5 | Purity: 95% | Cedrelopsin | ESD-880879-5MG |
| Cas.: 193969-08-3 | Purity: 95% | 10-O-Vanilloylaucubin | ESD-880880-1MG |
| Cas.: 193892-33-0 | Purity: 95% | 3-Phenyl-1,2-dihydroacenaphthylene-1,2-diol | ESD-880881-5MG |
| Cas.: 193746-75-7 | Purity: ≥98% | SB 242235 | ESD-880882-2MG |
| Cas.: 193746-75-7 | Purity: ≥98% | SB 242235 | ESD-880882-5MG |
| Cas.: 193694-24-5 | Purity: 98% | 8β-Methoxyatractylenolide I | ESD-880883-5MG |
| Cas.: 19368-18-4 | Purity: ≥98% | Ftaxilide | ESD-880884-10MG |
| Cas.: 1936529-65-5 | Purity: ≥99% | YKL-05-099 | ESD-880885-1MG |
| Cas.: 1936529-65-5 | Purity: ≥99% | YKL-05-099 | ESD-880885-5MG |
| Cas.: 1936428-93-1 | Purity: ≥98% | GNE-272 | ESD-880886-2MG |
| Cas.: 1936428-93-1 | Purity: ≥98% | GNE-272 | ESD-880886-5MG |
| Cas.: 1936422-33-1 | Purity: ≥98% | GNE-781 | ESD-880887-5MG |
| Cas.: 1936422-33-1 | Purity: ≥98% | GNE-781 | ESD-880887-10MG |
| Cas.: 1936421-41-8 | Purity: ≥99% | GNE-049 | ESD-880888-5MG |
| Cas.: 1936421-41-8 | Purity: ≥99% | GNE-049 | ESD-880888-10MG |
| Cas.: 193620-69-8 | Purity: ≥99% | TAS-301 | ESD-880889-5MG |
| Cas.: 193620-69-8 | Purity: ≥99% | TAS-301 | ESD-880889-10MG |
| Cas.: 19360-72-6 | Purity: 98% | 3,8”-Binaringenin | ESD-880890-5MG |
| Cas.: 193273-69-7 | Purity: ≥98% | Capromorelin Tartrate | ESD-880891-2MG |
| Cas.: 193273-69-7 | Purity: ≥98% | Capromorelin Tartrate | ESD-880891-5MG |
| Cas.: 1932687-71-2 | Purity: 97% | 1-O-Acetyl-6α-O-(2-methylbutyryl)britannilactone | ESD-880892-5MG |
| Cas.: 1932405-61-2 | Purity: 98% | Ethyl β-D-apiofuranoside | ESD-880893-5MG |
| Cas.: 1932348-11-2 | Purity: 98% | 3-Hydroxyperillaldehyde | ESD-880894-5MG |
| Cas.: 193153-04-7 | Purity: ≥97% | Otamixaban | ESD-880895-10MG |
| Cas.: 193153-04-7 | Purity: ≥97% | Otamixaban | ESD-880895-100MG |
| Cas.: 193022-04-7 | Purity: ≥98% | CTS-1027 | ESD-880896-5MG |
| Cas.: 193022-04-7 | Purity: ≥98% | CTS-1027 | ESD-880896-10MG |
| Cas.: 193001-14-8 | Purity: 98% | ZM323881 | ESD-880897-10MG |
| Cas.: 193001-14-8 | Purity: 98% | ZM323881 | ESD-880897-50MG |
| Cas.: 192870-65-8 | Purity: 95% | 8-(2-PROPENYLOXY)-1,4-DIOXASPIRO[4.5]DECANE | ESD-880898-250MG |
| Cas.: 192870-65-8 | Purity: 95% | 8-(2-PROPENYLOXY)-1,4-DIOXASPIRO[4.5]DECANE | ESD-880898-1G |
| Cas.: 192819-27-5 | Purity: 98% | CDC801 | ESD-880899-1MG |
| Cas.: 192819-27-5 | Purity: 98% | CDC801 | ESD-880899-5MG |
| Cas.: 1927857-56-4 | Purity: ≥98% | PQR620 | ESD-880900-1MG |
| Cas.: 1927857-56-4 | Purity: ≥98% | PQR620 | ESD-880900-5MG |
| Cas.: 192767-01-4 | Purity: 98% | L791943 | ESD-880901-1MG |
| Cas.: 192767-01-4 | Purity: 98% | L791943 | ESD-880901-5MG |
| Cas.: 192718-06-2 | Purity: ≥98% | C527 | ESD-880902-5MG |
| Cas.: 192718-06-2 | Purity: ≥98% | C527 | ESD-880902-10MG |
| Cas.: 192703-06-3 | Purity: ≥99% | SR144528 | ESD-880903-5MG |
| Cas.: 192703-06-3 | Purity: ≥99% | SR144528 | ESD-880903-10MG |
| Cas.: 192569-17-8 | Purity: 98% | 11α-Hydroxycanrenone | ESD-880904-5MG |
| Cas.: 192566-65-7 | Purity: 95% | 9α,11,12-Trihydroxydrim-7-en-6-one | ESD-880905-5MG |
| Cas.: 192564-14-0 | Purity: ≥99% | Oritavancin diphosphate | ESD-880906-2MG |
| Cas.: 192564-14-0 | Purity: ≥99% | Oritavancin diphosphate | ESD-880906-5MG |
| Cas.: 19254-69-4 | Purity: 96% | Ergosta-4,6,8(14),22-tetraen-3-one | ESD-880907-5MG |
| Cas.: 192322-50-2 | Purity: ≥99% | CGP71683 hydrochloride | ESD-880908-5MG |
| Cas.: 192322-50-2 | Purity: ≥99% | CGP71683 hydrochloride | ESD-880908-10MG |
| Cas.: 192314-93-5 | Purity: ≥98% | Iclaprim | ESD-880909-1MG |
| Cas.: 192314-93-5 | Purity: ≥98% | Iclaprim | ESD-880909-5MG |
| Cas.: 1922702-07-5 | Purity: 95% | 8-ethyl-1-thia-4,8-diazaspiro[4.5]decane-3-carboxylic acid dihydrochloride | ESD-880910-1G |
| Cas.: 1922702-07-5 | Purity: 95% | 8-ethyl-1-thia-4,8-diazaspiro[4.5]decane-3-carboxylic acid dihydrochloride | ESD-880910-5G |
| Cas.: 1922702-03-1 | Purity: 95% | methyl 8-ethyl-1-thia-4,8-diazaspiro[4.5]decane-3-carboxylate dihydrochloride | ESD-880911-1G |
| Cas.: 1922702-03-1 | Purity: 95% | methyl 8-ethyl-1-thia-4,8-diazaspiro[4.5]decane-3-carboxylate dihydrochloride | ESD-880911-5G |
| Cas.: 1922701-97-0 | Purity: 95% | 8-methyl-1-thia-4,8-diazaspiro[4.5]decane-3-carboxylic acid dihydrochloride | ESD-880912-1G |
| Cas.: 1922701-97-0 | Purity: 95% | 8-methyl-1-thia-4,8-diazaspiro[4.5]decane-3-carboxylic acid dihydrochloride | ESD-880912-5G |
| Cas.: 1922701-96-9 | Purity: 95% | methyl 1-thia-4-azaspiro[4.4]nonane-3-carboxylate hydrochloride | ESD-880913-1G |
| Cas.: 1922701-96-9 | Purity: 95% | methyl 1-thia-4-azaspiro[4.4]nonane-3-carboxylate hydrochloride | ESD-880913-5G |
| Cas.: 1922129-46-1 | Purity: 98% | Galanganone C | ESD-880914-5MG |
| Cas.: 1922129-43-8 | Purity: 97% | Galanganone B | ESD-880915-5MG |
| Cas.: 1922129-42-7 | Purity: 98% | Galanganone A | ESD-880916-5MG |
| Cas.: 192185-71-0 | Purity: ≥99% | Tipifarnib S enantiomer | ESD-880917-2MG |
| Cas.: 192185-71-0 | Purity: ≥99% | Tipifarnib S enantiomer | ESD-880917-5MG |
| Cas.: 19202-36-9 | Purity: 97% | Hinokiflavone | ESD-880918-5MG |
| Cas.: 1919888-06-4 | Purity: ≥99% | LY3295668 | ESD-880919-5MG |
| Cas.: 1919888-06-4 | Purity: ≥99% | LY3295668 | ESD-880919-10MG |
| Cas.: 1919853-46-5 | Purity: ≥99% | PTP1B-IN-2 | ESD-880920-1MG |
| Cas.: 1919853-46-5 | Purity: ≥99% | PTP1B-IN-2 | ESD-880920-5MG |
| Cas.: 1919820-28-2 | Purity: ≥98% | LTI-291 | ESD-880921-5MG |
| Cas.: 1919820-28-2 | Purity: ≥98% | LTI-291 | ESD-880921-10MG |
| Cas.: 19186-35-7 | Purity: 96% | Deoxypodophyllotoxin | ESD-880922-5MG |
| Cas.: 191673-07-1 | Purity: 95% | 4-Spiro-[1-thiophthalane] piperidine hydrochloride | ESD-880923-1G |
| Cas.: 191673-07-1 | Purity: 95% | 4-Spiro-[1-thiophthalane] piperidine hydrochloride | ESD-880923-5G |
| Cas.: 1915-98-6 | Purity: 98% | 2-Hydroxyxanthone | ESD-880924-5MG |
| Cas.: 191547-12-3 | Purity: 95% | 2-Deacetoxytaxinine B | ESD-880925-5MG |
| Cas.: 191545-24-1 | Purity: 97% | Epieriocalyxin A | ESD-880926-5MG |
| Cas.: 1914963-20-4 | Purity: 97% | Isoficusin A | ESD-880927-5MG |
| Cas.: 1914078-41-3 | Purity: ≥98% | eCF506 | ESD-880928-5MG |
| Cas.: 1914078-41-3 | Purity: ≥98% | eCF506 | ESD-880928-10MG |
| Cas.: 19132-81-1 | Purity: 95% | Ursolic aldehyde | ESD-880929-5MG |
| Cas.: 1913269-12-1 | Purity: ≥99% | KN-93 phosphate | ESD-880930-1MG |
| Cas.: 1913269-12-1 | Purity: ≥99% | KN-93 phosphate | ESD-880930-5MG |
| Cas.: 19131-13-6 | Purity: 98% | 6-Deoxy-3-O-methyl-β-allopyranosyl(1→4)-β-cymaronic acid δ-lactone | ESD-880931-5MG |
| Cas.: 191282-48-1 | Purity: ≥99% | trans-C75 | ESD-880932-2MG |
| Cas.: 191282-48-1 | Purity: ≥99% | trans-C75 | ESD-880932-5MG |
| Cas.: 1912445-55-6 | Purity: ≥99% | Branebrutinib | ESD-880933-5MG |
| Cas.: 1912445-55-6 | Purity: ≥99% | Branebrutinib | ESD-880933-10MG |
| Cas.: 1911-78-0 | Purity: 96% | Oplopanone | ESD-880934-5MG |
| Cas.: 191114-48-4 | Purity: ≥99% | Telithromycin | ESD-880935-1MG |
| Cas.: 191114-48-4 | Purity: ≥99% | Telithromycin | ESD-880935-5MG |
| Cas.: 191089-60-8 | Purity: ≥98% | K-7174 dihydrochloride | ESD-880936-5MG |
| Cas.: 191089-60-8 | Purity: ≥98% | K-7174 dihydrochloride | ESD-880936-10MG |
| Cas.: 191089-59-5 | Purity: 98% | K-7174 | ESD-880937-5MG |
| Cas.: 191089-59-5 | Purity: 98% | K-7174 | ESD-880937-10MG |
| Cas.: 1910755-56-4 | Purity: 95% | methyl 8-methyl-1-thia-4,8-diazaspiro[4.5]decane-3-carboxylate dihydrochloride | ESD-880938-1G |
| Cas.: 1910755-56-4 | Purity: 95% | methyl 8-methyl-1-thia-4,8-diazaspiro[4.5]decane-3-carboxylate dihydrochloride | ESD-880938-5G |
| Cas.: 19103-54-9 | Purity: 98% | Salvigenin | ESD-880939-5MG |
| Cas.: 190967-35-2 | Purity: 98% | RWJ 63556 | ESD-880940-1MG |
| Cas.: 190967-35-2 | Purity: 98% | RWJ 63556 | ESD-880940-5MG |
| Cas.: 190906-61-7 | Purity: 98% | Triptocallic acid A | ESD-880941-5MG |
| Cas.: 19057-67-1 | Purity: 95% | Prosapogenin A | ESD-880942-1MG |
| Cas.: 1905481-36-8 | Purity: ≥98% | KDM5A-IN-1 | ESD-880943-1MG |
| Cas.: 1905481-36-8 | Purity: ≥98% | KDM5A-IN-1 | ESD-880943-5MG |
| Cas.: 1905453-18-0 | Purity: ≥98% | NSC232003 | ESD-880944-1MG |
| Cas.: 1905453-18-0 | Purity: ≥98% | NSC232003 | ESD-880944-5MG |
| Cas.: 1904611-63-7 | Purity: ≥98% | PDE1-IN-2 | ESD-880946-1MG |
| Cas.: 1904611-63-7 | Purity: ≥98% | PDE1-IN-2 | ESD-880946-5MG |
| Cas.: 190436-05-6 | Purity: 98% | β-amyloid 1-11 | ESD-880947-1MG |
| Cas.: 190436-05-6 | Purity: 98% | β-amyloid 1-11 | ESD-880947-5MG |
| Cas.: 19041-66-8 | Purity: 98% | 17β-Benzoyloxy-androsta-1,4-dien-3-one | ESD-880948-5MG |
| Cas.: 190381-82-9 | Purity: 95% | Orientanol A | ESD-880949-5MG |
| Cas.: 1903800-11-2 | Purity: ≥99% | KIN1408 | ESD-880950-1MG |
| Cas.: 1903800-11-2 | Purity: ≥99% | KIN1408 | ESD-880950-5MG |
| Cas.: 1902173-22-1 | Purity: 96% | Spiratisanin C | ESD-880951-5MG |
| Cas.: 1902173-19-6 | Purity: 97% | Spiratisanin B | ESD-880952-5MG |
| Cas.: 1902173-16-3 | Purity: 96% | Spiratisanin A | ESD-880953-5MG |
| Cas.: 19013-07-1 | Purity: 95% | Demethoxyencecalin | ESD-880954-1MG |
| Cas.: 19013-03-7 | Purity: 99% | Eupatoriochromene | ESD-880955-5MG |
| Cas.: 19012-97-6 | Purity: 95% | 7-Hydroxy-2,2-dimethylchromene | ESD-880956-5MG |
| Cas.: 1900703-81-2 | Purity: 97% | Leptabiside C | ESD-880957-5MG |
| Cas.: 1900703-79-8 | Purity: 97% | Leptabiside A | ESD-880958-5MG |
| Cas.: 189954-96-9 | Purity: ≥99% | Firocoxib | ESD-880959-2MG |
| Cas.: 189954-96-9 | Purity: ≥99% | Firocoxib | ESD-880959-5MG |
| Cas.: 189744-94-3 | Purity: ≥98% | Ro 10-5824 dihydrochloride | ESD-880960-5MG |
| Cas.: 189744-94-3 | Purity: ≥98% | Ro 10-5824 dihydrochloride | ESD-880960-10MG |
| Cas.: 1897-26-3 | Purity: 95% | Akuammiline | ESD-880961-5MG |
| Cas.: 189699-82-9 | Purity: ≥99% | FR-188582 | ESD-880962-1MG |
| Cas.: 189699-82-9 | Purity: ≥99% | FR-188582 | ESD-880962-5MG |
| Cas.: 189689-32-5 | Purity: 98% | 6,4′-Dihydroxy-7-methoxyflavanone | ESD-880963-5MG |
| Cas.: 189689-31-4 | Purity: 98% | 6,7,4′-Trihydroxyflavanone | ESD-880964-5MG |
| Cas.: 1895895-38-1 | Purity: ≥98% | CHZ868 | ESD-880965-2MG |
| Cas.: 1895895-38-1 | Purity: ≥98% | CHZ868 | ESD-880965-5MG |
| Cas.: 189564-33-8 | Purity: 98% | CGP 65015 | ESD-880966-1MG |
| Cas.: 189564-33-8 | Purity: 98% | CGP 65015 | ESD-880966-5MG |
| Cas.: 18956-15-5 | Purity: 98% | Pinostrobin chalcone | ESD-880967-5MG |
| Cas.: 1895049-20-3 | Purity: ≥98% | Molibresib besylate | ESD-880968-2MG |
| Cas.: 1895049-20-3 | Purity: ≥98% | Molibresib besylate | ESD-880968-5MG |
| Cas.: 18942-26-2 | Purity: ≥98% | Chebulinic acid | ESD-880969-5MG |
| Cas.: 18942-26-2 | Purity: ≥98% | Chebulinic acid | ESD-880969-10MG |
| Cas.: 189362-06-9 | Purity: 98% | K134 | ESD-880971-1MG |
| Cas.: 189351-15-3 | Purity: 97% | Corchoionol C | ESD-880972-5MG |
| Cas.: 1893415-00-3 | Purity: ≥99% | AZD9567 | ESD-880973-5MG |
| Cas.: 1893415-00-3 | Purity: ≥99% | AZD9567 | ESD-880973-10MG |
| Cas.: 189333-49-1 | Purity: 95% | 3-Benzyl-3,9-diazaspiro[5.5]undecane | ESD-880974-1G |
| Cas.: 189333-48-0 | Purity: 95% | 9-Benzyl-3,9-diazaspiro[5.5]undecane-2,4-dione | ESD-880975-1G |
| Cas.: 189333-48-0 | Purity: 95% | 9-Benzyl-3,9-diazaspiro[5.5]undecane-2,4-dione | ESD-880975-5G |
| Cas.: 189333-03-7 | Purity: 95% | 2,9-Diazaspiro[5.5]undecane-2-carboxylicacid tert-butyl ester | ESD-880976-100MG |
| Cas.: 189333-03-7 | Purity: 95% | 2,9-Diazaspiro[5.5]undecane-2-carboxylicacid tert-butyl ester | ESD-880976-250MG |
| Cas.: 189322-69-8 | Purity: 98% | 3′-Methoxyrocaglamide | ESD-880977-5MG |
| Cas.: 189322-67-6 | Purity: 98% | 3′-Hydroxyrocaglamide | ESD-880978-5MG |
| Cas.: 189264-47-9 | Purity: 97% | Cleroindicin F | ESD-880979-5MG |
| Cas.: 189264-45-7 | Purity: 97% | Cleroindicin D | ESD-880980-5MG |
| Cas.: 189224-48-4 | Purity: 98% | KU14R | ESD-880981-5MG |
| Cas.: 189224-48-4 | Purity: 98% | KU14R | ESD-880981-10MG |
| Cas.: 189197-69-1 | Purity: ≥99% | Ro 48-8071 fumarate | ESD-880982-5MG |
| Cas.: 189197-69-1 | Purity: ≥99% | Ro 48-8071 fumarate | ESD-880982-10MG |
| Cas.: 1891097-17-8 | Purity: 98% | 3′-O-Methylmurraol | ESD-880983-5MG |
| Cas.: 189109-45-3 | Purity: 95% | Byzantionoside B | ESD-880984-5MG |
| Cas.: 1891087-61-8 | Purity: ≥98% | BAY-1816032 | ESD-880985-5MG |
| Cas.: 1891087-61-8 | Purity: ≥98% | BAY-1816032 | ESD-880985-10MG |
| Cas.: 1890153-71-5 | Purity: 98% | 1-(4-Hydroxy-2,2-dimethylchroman-6-yl)ethanone | ESD-880986-5MG |
| Cas.: 188970-21-0 | Purity: 98% | Melilotigenin C | ESD-880987-5MG |
| Cas.: 188894-19-1 | Purity: 95% | Junipediol B 8-O-glucoside | ESD-880988-5MG |
| Cas.: 188860-26-6 | Purity: ≥99% | DMA | ESD-880989-5MG |
| Cas.: 188860-26-6 | Purity: ≥99% | DMA | ESD-880989-10MG |
| Cas.: 188842-14-0 | Purity: 98% | Antennapedia Peptide | ESD-880990-1MG |
| Cas.: 188842-14-0 | Purity: 98% | Antennapedia Peptide | ESD-880990-5MG |
| Cas.: 1888378-32-2 | Purity: 98% | IDO-IN-11 | ESD-880991-1MG |
| Cas.: 1888378-12-8 | Purity: 98% | IDO-IN-9 | ESD-880992-1MG |
| Cas.: 1888341-29-4 | Purity: ≥99% | IDO-IN-12 | ESD-880993-1MG |
| Cas.: 1888341-29-4 | Purity: ≥99% | IDO-IN-12 | ESD-880993-5MG |
| Cas.: 188818-27-1 | Purity: 97% | 8-Glucosyl-5,7-dihydroxy-2-(1-methylpropyl)chromone | ESD-880994-5MG |
| Cas.: 188785-44-6 | Purity: 97% | 8-Glucosyl-5,7-dihydroxy-2-isopropylchromone | ESD-880995-5MG |
| Cas.: 188742-80-5 | Purity: 97% | 4,5-Di-O-caffeoylquinic acid methyl ester | ESD-880996-5MG |
| Cas.: 188404-10-6 | Purity: ≥98%, 27 mM in Methyl acetate | MAFP | ESD-880997-100ΜL |
| Cas.: 188396-77-2 | Purity: 98% | Paliroden | ESD-880998-1MG |
| Cas.: 188396-77-2 | Purity: 98% | Paliroden | ESD-880998-5MG |
| Cas.: 1883737-63-0 | Purity: 98% | FHZ | ESD-880999-5MG |
| Cas.: 1883737-63-0 | Purity: 98% | FHZ | ESD-880999-10MG |
| Cas.: 1883727-34-1 | Purity: ≥98% | AMG-176 | ESD-881000-1MG |
| Cas.: 1883711-97-4 | Purity: ≥99% | AM-0902 | ESD-881001-5MG |
| Cas.: 1883711-97-4 | Purity: ≥99% | AM-0902 | ESD-881001-10MG |
| Cas.: 18836-52-7 | Purity: 95% | Pellitorine | ESD-881002-5MG |
| Cas.: 1883602-21-8 | Purity: ≥98% | TES-1025 | ESD-881003-5MG |
| Cas.: 1883602-21-8 | Purity: ≥98% | TES-1025 | ESD-881003-10MG |
| Cas.: 1883602-20-7 | Purity: ≥99% | TES-991 | ESD-881004-5MG |
| Cas.: 1883602-20-7 | Purity: ≥99% | TES-991 | ESD-881004-10MG |
| Cas.: 1883548-89-7 | Purity: ≥99% | NI-57 | ESD-881005-5MG |
| Cas.: 1883548-89-7 | Purity: ≥99% | NI-57 | ESD-881005-10MG |
| Cas.: 1883510-31-3 | Purity: ≥98% | ML327 | ESD-881006-1MG |
| Cas.: 1883510-31-3 | Purity: ≥98% | ML327 | ESD-881006-5MG |
| Cas.: 188343-77-3 | Purity: ≥99% | MBP146-78 | ESD-881007-1MG |
| Cas.: 188343-77-3 | Purity: ≥99% | MBP146-78 | ESD-881007-5MG |
| Cas.: 1883299-62-4 | Purity: 98% | PF-06700841 | ESD-881008-5MG |
| Cas.: 1883299-62-4 | Purity: 98% | PF-06700841 | ESD-881008-10MG |
| Cas.: 188300-82-5 | Purity: 97% | Jaslanceoside B | ESD-881009-5MG |
| Cas.: 188293-70-1 | Purity: 95% | 8α-(2-Methylacryloyloxy)hirsutinolide | ESD-881011-5MG |
| Cas.: 188260-50-6 | Purity: 98% | BCR-ABL-IN-1 | ESD-881012-1MG |
| Cas.: 188260-50-6 | Purity: 98% | BCR-ABL-IN-1 | ESD-881012-5MG |
| Cas.: 1881233-39-1 | Purity: ≥98% | PI4KIIIbeta-IN-10 | ESD-881013-1MG |
| Cas.: 1881233-39-1 | Purity: ≥98% | PI4KIIIbeta-IN-10 | ESD-881013-5MG |
| Cas.: 18810-25-8 | Purity: 98% | Odoroside H | ESD-881014-5MG |
| Cas.: 187988-48-3 | Purity: 98% | 5-Acetyltaxachitriene A | ESD-881015-5MG |
| Cas.: 187870-78-6 | Purity: ≥98% | Rimeporide | ESD-881016-1MG |
| Cas.: 187870-78-6 | Purity: ≥98% | Rimeporide | ESD-881016-5MG |
| Cas.: 1876450-21-3 | Purity: ≥95% | MM 07 | ESD-881018-1MG |
| Cas.: 1876450-21-3 | Purity: ≥95% | MM 07 | ESD-881018-5MG |
| Cas.: 187539-57-7 | Purity: 98% | Ethyl rutinoside | ESD-881019-5MG |
| Cas.: 18749-71-8 | Purity: 95% | Sitoindoside I | ESD-881020-5MG |
| Cas.: 18747-42-7 | Purity: 95% | Methylisopelletierine | ESD-881021-5MG |
| Cas.: 1874276-76-2 | Purity: ≥99% | LXS196 | ESD-881022-2MG |
| Cas.: 1874276-76-2 | Purity: ≥99% | LXS196 | ESD-881022-5MG |
| Cas.: 1873376-49-8 | Purity: ≥98% | CXCR2-IN-1 | ESD-881023-1MG |
| Cas.: 1873376-49-8 | Purity: ≥98% | CXCR2-IN-1 | ESD-881023-5MG |
| Cas.: 1872403-23-0 | Purity: 98% | Kimcuongin | ESD-881024-5MG |
| Cas.: 1872387-43-3 | Purity: 98% | DC661 | ESD-881025-2MG |
| Cas.: 1872387-43-3 | Purity: 98% | DC661 | ESD-881025-5MG |
| Cas.: 187227-45-8 | Purity: ≥99% | Oseltamivir (acid) | ESD-881026-5MG |
| Cas.: 187227-45-8 | Purity: ≥99% | Oseltamivir (acid) | ESD-881026-10MG |
| Cas.: 18711-16-5 | Purity: ≥99% | NS309 | ESD-881027-5MG |
| Cas.: 18711-16-5 | Purity: ≥99% | NS309 | ESD-881027-10MG |
| Cas.: 187110-72-1 | Purity: 97% | Clauszoline M | ESD-881028-5MG |
| Cas.: 187034-31-7 | Purity: 98% | TAPI-2 | ESD-881029-1MG |
| Cas.: 187034-31-7 | Purity: 98% | TAPI-2 | ESD-881029-5MG |
| Cas.: 186971-69-7 | Purity: 98% | TAK-024 | ESD-881030-1MG |
| Cas.: 186971-69-7 | Purity: 98% | TAK-024 | ESD-881030-5MG |
| Cas.: 186953-56-0 | Purity: ≥98% | Pafuramidine | ESD-881031-5MG |
| Cas.: 186953-56-0 | Purity: ≥98% | Pafuramidine | ESD-881031-10MG |
| Cas.: 1869082-58-5 | Purity: 98% | Effususol A | ESD-881032-5MG |
| Cas.: 1869082-57-4 | Purity: 98% | 9,10-Didehydroeffususol A | ESD-881033-5MG |
| Cas.: 186689-07-6 | Purity: ≥98% | 2-NBDG | ESD-881034-5MG |
| Cas.: 186689-07-6 | Purity: ≥98% | 2-NBDG | ESD-881034-10MG |
| Cas.: 186544-27-4 | Purity: ≥99% | LY 344864 S-enantiomer | ESD-881035-2MG |
| Cas.: 186544-27-4 | Purity: ≥99% | LY 344864 S-enantiomer | ESD-881035-5MG |
| Cas.: 186544-26-3 | Purity: ≥99% | LY 344864 | ESD-881036-5MG |
| Cas.: 186544-26-3 | Purity: ≥99% | LY 344864 | ESD-881036-10MG |
| Cas.: 186543-64-6 | Purity: ≥98% | LY 344864 racemate | ESD-881037-2MG |
| Cas.: 186543-64-6 | Purity: ≥98% | LY 344864 racemate | ESD-881037-5MG |
| Cas.: 186497-38-1 | Purity: 98% | ZD-1611 | ESD-881038-1MG |
| Cas.: 186497-38-1 | Purity: 98% | ZD-1611 | ESD-881038-5MG |
| Cas.: 18642-44-9 | Purity: 98% | Actein | ESD-881039-5MG |
| Cas.: 186392-65-4 | Purity: ≥99% | Ingliforib | ESD-881040-5MG |
| Cas.: 186392-65-4 | Purity: ≥99% | Ingliforib | ESD-881040-10MG |
| Cas.: 186374-63-0 | Purity: 93% | enantio-7(11)-Eudesmen-4-ol | ESD-881041-5MG |
| Cas.: 1863117-91-2 | Purity: 98% | Photo-lysine | ESD-881042-5MG |
| Cas.: 1863117-91-2 | Purity: 98% | Photo-lysine | ESD-881042-10MG |
| Cas.: 1862238-00-3 | Purity: ≥98% | Sirt2-IN-1 | ESD-881043-5MG |
| Cas.: 1862238-00-3 | Purity: ≥98% | Sirt2-IN-1 | ESD-881043-10MG |
| Cas.: 1862237-99-7 | Purity: 98% | SirReal1-O-propargyl | ESD-881044-5MG |
| Cas.: 1862237-99-7 | Purity: 98% | SirReal1-O-propargyl | ESD-881044-10MG |
| Cas.: 186204-33-1 | Purity: 98% | Lurasidone metabolite 14326 | ESD-881045-1MG |
| Cas.: 186204-33-1 | Purity: 98% | Lurasidone metabolite 14326 | ESD-881045-5MG |
| Cas.: 186204-32-0 | Purity: ≥99% | Lurasidone Metabolite 14283 hydrochloride | ESD-881046-5MG |
| Cas.: 186202-97-1 | Purity: 95% | 6-Hydroxy-2-benzyl-2-azaspiro[4.4]nonane | ESD-881047-100MG |
| Cas.: 186202-97-1 | Purity: 95% | 6-Hydroxy-2-benzyl-2-azaspiro[4.4]nonane | ESD-881047-500MG |
| Cas.: 186140-36-3 | Purity: 95% | 11α,12α-Epoxy-3β,23-dihydroxy-30-norolean-20(29)-en-28,13β-olide | ESD-881048-1MG |
| Cas.: 186139-09-3 | Purity: 98% | MSI-1436 | ESD-881049-1MG |
| Cas.: 186139-09-3 | Purity: 98% | MSI-1436 | ESD-881049-5MG |
| Cas.: 18609-17-1 | Purity: 98% | Quercetin 3-O-sophoroside | ESD-881050-1MG |
| Cas.: 18609-16-0 | Purity: 95% | Deacetylnimbin | ESD-881051-5MG |
| Cas.: 185991-24-6 | Purity: 98% | AMD 3465 | ESD-881052-5MG |
| Cas.: 185991-24-6 | Purity: 98% | AMD 3465 | ESD-881052-10MG |
| Cas.: 1859-87-6 | Purity: 96% | Echinulin | ESD-881053-5MG |
| Cas.: 1859141-26-6 | Purity: ≥98% | ROC-325 | ESD-881054-5MG |
| Cas.: 1859141-26-6 | Purity: ≥98% | ROC-325 | ESD-881054-10MG |
| Cas.: 1859053-21-6 | Purity: ≥99% | Rucaparib Camsylate | ESD-881055-5MG |
| Cas.: 1859053-21-6 | Purity: ≥99% | Rucaparib Camsylate | ESD-881055-10MG |
| Cas.: 185845-89-0 | Purity: 97% | Pterodontic acid | ESD-881056-5MG |
| Cas.: 185821-32-3 | Purity: 97% | 2α,3β-Dihydroxypterodontic acid | ESD-881057-5MG |
| Cas.: 1857417-10-7 | Purity: ≥98% | MI-538 | ESD-881058-1MG |
| Cas.: 1857417-10-7 | Purity: ≥98% | MI-538 | ESD-881058-5MG |
| Cas.: 1857-30-3 | Purity: 97% | Viroallosecurinine | ESD-881059-5MG |
| Cas.: 185-70-6 | Purity: 95% | 1-Oxaspiro[2.5]octane | ESD-881060-250MG |
| Cas.: 185-70-6 | Purity: 95% | 1-Oxaspiro[2.5]octane | ESD-881060-1G |
| Cas.: 1855871-76-9 | Purity: ≥98% | V-9302 | ESD-881061-5MG |
| Cas.: 1855871-76-9 | Purity: ≥98% | V-9302 | ESD-881061-10MG |
| Cas.: 185526-32-3 | Purity: 97% | 1′-(tert-Butoxycarbonyl)-2,3-dihydrospiro-[indene-1,4′-piperidine]-3-carboxylic acid | ESD-881062-250MG |
| Cas.: 185526-32-3 | Purity: 97% | 1′-(tert-Butoxycarbonyl)-2,3-dihydrospiro-[indene-1,4′-piperidine]-3-carboxylic acid | ESD-881062-500MG |
| Cas.: 185525-52-4 | Purity: 97% | 1,3-DIHYDROSPIRO[INDENE-2,4′-PIPERIDINE] HCL | ESD-881063-1G |
| Cas.: 185525-52-4 | Purity: 97% | 1,3-DIHYDROSPIRO[INDENE-2,4′-PIPERIDINE] HCL | ESD-881063-5G |
| Cas.: 185525-49-9 | Purity: 95% | Spiro[indene-2,4′-pipidin]-1(3H)-one hydrochloride | ESD-881064-1G |
| Cas.: 185525-49-9 | Purity: 95% | Spiro[indene-2,4′-pipidin]-1(3H)-one hydrochloride | ESD-881064-5G |
| Cas.: 185517-74-2 | Purity: ≥99% | (S)-Rasagiline | ESD-881065-5MG |
| Cas.: 185517-74-2 | Purity: ≥99% | (S)-Rasagiline | ESD-881065-10MG |
| Cas.: 185414-25-9 | Purity: 98% | Corchoionoside C | ESD-881066-5MG |
| Cas.: 185383-63-5 | Purity: 95% | 3-(1,4-Dioxaspiro[4,5]dec-7-en-8-yl)-5-methoxy-1H-indole | ESD-881067-1G |
| Cas.: 185383-63-5 | Purity: 95% | 3-(1,4-Dioxaspiro[4,5]dec-7-en-8-yl)-5-methoxy-1H-indole | ESD-881067-5G |
| Cas.: 18525-14-9 | Purity: 98% | 5-O-Methyllatifolin | ESD-881068-5MG |
| Cas.: 1851373-36-8 | Purity: ≥98% | QC6352 | ESD-881069-1MG |
| Cas.: 1851373-36-8 | Purity: ≥98% | QC6352 | ESD-881069-5MG |
| Cas.: 185055-67-8 | Purity: ≥98% | Ferroquine | ESD-881070-2MG |
| Cas.: 185055-67-8 | Purity: ≥98% | Ferroquine | ESD-881070-5MG |
| Cas.: 185020-38-6 | Purity: 98% | (+)-Nyasol | ESD-881071-5MG |
| Cas.: 184865-04-1 | Purity: 98% | β-Amyloid 29-40 | ESD-881072-1MG |
| Cas.: 184865-04-1 | Purity: 98% | β-Amyloid 29-40 | ESD-881072-5MG |
| Cas.: 1848233-58-8 | Purity: ≥98% | DO34 | ESD-881073-5MG |
| Cas.: 1848233-58-8 | Purity: ≥98% | DO34 | ESD-881073-10MG |
| Cas.: 1847485-97-5 | Purity: ≥98% | ATP-Red 1 | ESD-881074-5MG |
| Cas.: 1847485-97-5 | Purity: ≥98% | ATP-Red 1 | ESD-881074-10MG |
| Cas.: 18465-71-9 | Purity: 98% | 2-C-Methyl-D-erythrono-1,4-lactone | ESD-881075-5MG |
| Cas.: 1846570-40-8 | Purity: 98% | CM-579 | ESD-881076-5MG |
| Cas.: 1846570-40-8 | Purity: 98% | CM-579 | ESD-881076-10MG |
| Cas.: 184653-84-7 | Purity: 98% | Carabersat | ESD-881077-1MG |
| Cas.: 184653-84-7 | Purity: 98% | Carabersat | ESD-881077-5MG |
| Cas.: 184587-72-2 | Purity: 96% | Mangostanol | ESD-881079-5MG |
| Cas.: 18457-46-0 | Purity: 95% | Taxinine J | ESD-881080-5MG |
| Cas.: 18457-45-9 | Purity: 95% | 7-Deacetoxytaxinine J | ESD-881081-5MG |
| Cas.: 18457-44-8 | Purity: 95% | Taxinine B | ESD-881082-5MG |
| Cas.: 18456-03-6 | Purity: 98% | Bakkenolide D | ESD-881083-5MG |
| Cas.: 18456-02-5 | Purity: 97% | 1-Oxobakkenolide S | ESD-881084-5MG |
| Cas.: 184-14-5 | Purity: 95% | 2-azaspiro[4.6]undecane | ESD-881085-1G |
| Cas.: 184-14-5 | Purity: 95% | 2-azaspiro[4.6]undecane | ESD-881085-5G |
| Cas.: 18412-96-9 | Purity: 95% | GB-2a | ESD-881086-5MG |
| Cas.: 18411-75-1 | Purity: 97% | Hautriwaic acid | ESD-881087-5MG |
| Cas.: 1841078-87-2 | Purity: ≥99% | MK-6240 | ESD-881088-5MG |
| Cas.: 1841078-87-2 | Purity: ≥99% | MK-6240 | ESD-881088-10MG |
| Cas.: 1840966-49-5 | Purity: 96% | Isoleojaponin | ESD-881089-5MG |
| Cas.: 184046-40-0 | Purity: 95% | Dimeric coniferyl acetate | ESD-881090-1MG |
| Cas.: 184036-34-8 | Purity: 98% | Sitaxsentan | ESD-881091-10MG |
| Cas.: 184036-34-8 | Purity: 98% | Sitaxsentan | ESD-881091-50MG |
| Cas.: 18386-63-5 | Purity: 95% | spiro[3.4]octane-2-carboxylic acid | ESD-881092-2.5MG |
| Cas.: 18386-63-5 | Purity: 95% | spiro[3.4]octane-2-carboxylic acid | ESD-881092-5MG |
| Cas.: 1838651-58-3 | Purity: ≥99% | ACT-709478 | ESD-881093-5MG |
| Cas.: 1838651-58-3 | Purity: ≥99% | ACT-709478 | ESD-881093-10MG |
| Cas.: 183849-43-6 | Purity: 98% | Abaperidone | ESD-881094-1MG |
| Cas.: 183849-43-6 | Purity: 98% | Abaperidone | ESD-881094-5MG |
| Cas.: 183745-81-5 | Purity: 98% | β-Amyloid 1-15 | ESD-881095-1MG |
| Cas.: 183745-81-5 | Purity: 98% | β-Amyloid 1-15 | ESD-881095-5MG |
| Cas.: 18363-10-5 | Purity: 95% | 2-oxo-1-oxaspiro[4.4]nonane-4-carboxylic acid | ESD-881096-1G |
| Cas.: 18363-10-5 | Purity: 95% | 2-oxo-1-oxaspiro[4.4]nonane-4-carboxylic acid | ESD-881096-5G |
| Cas.: 183626-28-0 | Purity: 95% | Cleroindicin C | ESD-881097-5MG |
| Cas.: 1835705-61-7 | Purity: ≥96% | (S,R,S)-AHPC-(C3-PEG)2-C6-Cl | ESD-881098-100MG |
| Cas.: 1835705-61-7 | Purity: ≥96% | (S,R,S)-AHPC-(C3-PEG)2-C6-Cl | ESD-881098-500MG |
| Cas.: 1835705-59-3 | Purity: ≥96% | (S,R,S)-AHPC-PEG6-C4-Cl | ESD-881099-100MG |
| Cas.: 1835705-59-3 | Purity: ≥96% | (S,R,S)-AHPC-PEG6-C4-Cl | ESD-881099-500MG |
| Cas.: 1835705-53-7 | Purity: ≥98% | Boc-C1-PEG2-C4-Cl | ESD-881100-100MG |
| Cas.: 18356-28-0 | Purity: ≥99% | Rolziracetam | ESD-881101-5MG |
| Cas.: 18356-28-0 | Purity: ≥99% | Rolziracetam | ESD-881101-10MG |
| Cas.: 1835283-94-7 | Purity: ≥98% | Pan-RAS-IN-1 | ESD-881102-1MG |
| Cas.: 1835283-94-7 | Purity: ≥98% | Pan-RAS-IN-1 | ESD-881102-5MG |
| Cas.: 1834571-04-8 | Purity: ≥98% | Tat-NR2B9c TFA | ESD-881103-1MG |
| Cas.: 1834571-04-8 | Purity: ≥98% | Tat-NR2B9c TFA | ESD-881103-5MG |
| Cas.: 18331-34-5 | Purity: ≥99% | BTR-1 | ESD-881104-5MG |
| Cas.: 18331-34-5 | Purity: ≥99% | BTR-1 | ESD-881104-10MG |
| Cas.: 183-31-3 | Purity: 95% | 2,3-dihydrospiro([1,3]benzothiazole-2,1′-cyclopentane) | ESD-881105-500MG |
| Cas.: 183-31-3 | Purity: 95% | 2,3-dihydrospiro([1,3]benzothiazole-2,1′-cyclopentane) | ESD-881105-1G |
| Cas.: 183293-82-5 | Purity: ≥98% | Gemcabene | ESD-881106-5MG |
| Cas.: 183293-82-5 | Purity: ≥98% | Gemcabene | ESD-881106-10MG |
| Cas.: 1832686-44-8 | Purity: ≥99% | SRI 31215 TFA | ESD-881107-5MG |
| Cas.: 1832686-44-8 | Purity: ≥99% | SRI 31215 TFA | ESD-881107-10MG |
| Cas.: 1832671-96-1 | Purity: 98% | Y06036 | ESD-881108-5MG |
| Cas.: 1832671-96-1 | Purity: 98% | Y06036 | ESD-881108-10MG |
| Cas.: 18326-06-2 | Purity: 95% | 2-Acetoxy-3-deacetoxycaesaldekarin E | ESD-881109-5MG |
| Cas.: 183210-63-1 | Purity: 96% | 1,7-Dihydroxy-2,3-methylenedioxyxanthone | ESD-881110-5MG |
| Cas.: 183204-74-2 | Purity: ≥97% | Tipiracil | ESD-881111-5MG |
| Cas.: 183204-74-2 | Purity: ≥97% | Tipiracil | ESD-881111-10MG |
| Cas.: 183-20-0 | Purity: 95% | 1,3-dihydrospiro[indene-2,3′-pyrrolidine] | ESD-881112-1G |
| Cas.: 1831167-98-6 | Purity: 98% | DDP-38003 dihydrochloride | ESD-881113-1MG |
| Cas.: 1831167-98-6 | Purity: 98% | DDP-38003 dihydrochloride | ESD-881113-5MG |
| Cas.: 183075-03-8 | Purity: 98% | 3,4-O-Isopropylidene shikimic acid | ESD-881114-5MG |
| Cas.: 1830306-93-8 | Purity: 98% | Giffonin P | ESD-881115-5MG |
| Cas.: 18296-45-2 | Purity: 97% | Didrovaltrate | ESD-881116-5MG |
| Cas.: 182959-28-0 | Purity: 98% | YM-53601 free base | ESD-881117-1MG |
| Cas.: 182959-28-0 | Purity: 98% | YM-53601 free base | ESD-881117-5MG |
| Cas.: 1829580-18-8 | Purity: 97% | Dibritannilactone B | ESD-881118-5MG |
| Cas.: 18286-71-0 | Purity: 98% | N-Benzyllinoleamide | ESD-881119-5MG |
| Cas.: 182760-06-1 | Purity: ≥99% | Ravuconazole | ESD-881120-2MG |
| Cas.: 182760-06-1 | Purity: ≥99% | Ravuconazole | ESD-881120-5MG |
| Cas.: 182563-08-2 | Purity: ≥99% | LY334370 | ESD-881121-5MG |
| Cas.: 182563-08-2 | Purity: ≥99% | LY334370 | ESD-881121-10MG |
| Cas.: 182-53-6 | Purity: 95% | 3H-Spiro[1,3-benzothiazole-2,1′-cyclohexane] | ESD-881122-500MG |
| Cas.: 182-53-6 | Purity: 95% | 3H-Spiro[1,3-benzothiazole-2,1′-cyclohexane] | ESD-881122-1G |
| Cas.: 1825355-56-3 | Purity: ≥98% | Ribocil-C | ESD-881123-5MG |
| Cas.: 1825355-56-3 | Purity: ≥98% | Ribocil-C | ESD-881123-10MG |
| Cas.: 1825355-55-2 | Purity: 98% | Ribocil B | ESD-881124-2MG |
| Cas.: 1825355-55-2 | Purity: 98% | Ribocil B | ESD-881124-5MG |
| Cas.: 1825352-65-5 | Purity: ≥99% | Risdiplam | ESD-881125-5MG |
| Cas.: 1825352-65-5 | Purity: ≥99% | Risdiplam | ESD-881125-10MG |
| Cas.: 18251-36-0 | Purity: 97% | Thalidezine | ESD-881126-5MG |
| Cas.: 1824053-12-4 | Purity: 95% | 4-Methyl-2H-spiro[1-benzofuran-3,4′-piperidine] hydrochloride | ESD-881127-1MG |
| Cas.: 1823960-41-3 | Purity: 95% | Spiro[3.3]heptan-1-ol | ESD-881128-50MG |
| Cas.: 1823960-41-3 | Purity: 95% | Spiro[3.3]heptan-1-ol | ESD-881128-250MG |
| Cas.: 1823958-83-3 | Purity: 95% | SPIRO[CYCLOPROPANE-1,3′-PYRROLO[3,2-B]PYRIDIN]-2′(1’H)-ONE | ESD-881129-1G |
| Cas.: 1823957-29-4 | Purity: 95% | 6-METHYL-4-AZASPIRO[2.4]HEPTANE HCL | ESD-881130-50MG |
| Cas.: 1823957-29-4 | Purity: 95% | 6-METHYL-4-AZASPIRO[2.4]HEPTANE HCL | ESD-881130-250MG |
| Cas.: 1823952-27-7 | Purity: 95% | 1′,2′-DIHYDROSPIRO[CYCLOPROPANE-1,3′-PYRROLO[3,2-B]PYRIDINE] | ESD-881131-1G |
| Cas.: 1823903-80-5 | Purity: 95% | 6′-(TRIFLUOROMETHYL)SPIRO[CYCLOPROPANE-1,3′-INDOLINE] | ESD-881132-1G |
| Cas.: 1823898-56-1 | Purity: 95% | 1-AZASPIRO[4.5]DECAN-8-AMINE HCL | ESD-881133-250MG |
| Cas.: 1823898-56-1 | Purity: 95% | 1-AZASPIRO[4.5]DECAN-8-AMINE HCL | ESD-881133-1G |
| Cas.: 1823881-89-5 | Purity: 95% | 4′-(TRIFLUOROMETHYL)SPIRO[CYCLOPROPANE-1,3′-INDOLINE] | ESD-881134-1G |
| Cas.: 1823868-84-3 | Purity: 95% | 4′-METHOXYSPIRO[CYCLOPROPANE-1,3′-INDOLINE] | ESD-881135-250MG |
| Cas.: 1823868-84-3 | Purity: 95% | 4′-METHOXYSPIRO[CYCLOPROPANE-1,3′-INDOLINE] | ESD-881135-1G |
| Cas.: 1823863-23-5 | Purity: 95% | tert-Butyl 5-benzyl-2,5,8-triazaspiro[3.5]nonane-2-carboxylate | ESD-881136-250MG |
| Cas.: 1823549-10-5 | Purity: 95% | 7-Chloro-1H-spiro[indole-3,4′-piperidine]-2-one hydrochloride | ESD-881137-1MG |
| Cas.: 1823524-06-6 | Purity: 95% | 5-Methyl-2,5,8-triazaspiro[3.5]nonane, N-BOC-protected | ESD-881138-250MG |
| Cas.: 1823515-64-5 | Purity: 95% | 6-((TERT-BUTOXYCARBONYL)AMINO)-2-OXASPIRO[3.3]HEPTANE-6-CARBOXYLIC ACID | ESD-881139-250MG |
| Cas.: 1823515-64-5 | Purity: 95% | 6-((TERT-BUTOXYCARBONYL)AMINO)-2-OXASPIRO[3.3]HEPTANE-6-CARBOXYLIC ACID | ESD-881139-1G |
| Cas.: 1823500-42-0 | Purity: 95% | BENZYL 8-AMINO-5-AZASPIRO[2.5]OCTANE-5-CARBOXYLATE HCL | ESD-881140-250MG |
| Cas.: 1823500-42-0 | Purity: 95% | BENZYL 8-AMINO-5-AZASPIRO[2.5]OCTANE-5-CARBOXYLATE HCL | ESD-881140-1G |
| Cas.: 1823381-46-9 | Purity: 95% | 7-METHYL-5-AZASPIRO[3.4]OCTANE HCL | ESD-881141-1G |
| Cas.: 1823381-46-9 | Purity: 95% | 7-METHYL-5-AZASPIRO[3.4]OCTANE HCL | ESD-881141-5G |
| Cas.: 1823371-47-6 | Purity: 95% | 2-OXASPIRO[3.3]HEPTAN-5-OL | ESD-881142-250MG |
| Cas.: 1823371-47-6 | Purity: 95% | 2-OXASPIRO[3.3]HEPTAN-5-OL | ESD-881142-1G |
| Cas.: 18233-70-0 | Purity: ≥99% | N-Acetylputrescine hydrochloride | ESD-881143-5MG |
| Cas.: 18233-70-0 | Purity: ≥99% | N-Acetylputrescine hydrochloride | ESD-881143-10MG |
| Cas.: 1823366-67-1 | Purity: 95% | 6′-METHOXYSPIRO[CYCLOPROPANE-1,3′-INDOLIN]-2′-ONE | ESD-881144-1G |
| Cas.: 1823338-03-9 | Purity: 95% | 4′-METHYLSPIRO[CYCLOPROPANE-1,3′-INDOLIN]-2′-ONE | ESD-881145-1G |
| Cas.: 1823268-79-6 | Purity: 95% | 2-Benzyl-2,8-diazadispiro[3.1.3.1]decane | ESD-881146-250MG |
| Cas.: 1823264-83-0 | Purity: 95% | 5-TERT-BUTYL 1-ETHYL 5-AZASPIRO[2.3]HEXANE-1,5-DICARBOXYLATE | ESD-881147-1G |
| Cas.: 1823264-51-2 | Purity: 95% | 2-tert-Butyl 8-methyl 5-thia-2-azaspiro[3.4]octane-2,8-dicarboxylate | ESD-881148-100MG |
| Cas.: 182296-65-7 | Purity: 97% | 1,1′-bislusianthridin | ESD-881149-5MG |
| Cas.: 1822816-46-5 | Purity: 95% | 4′-(TRIFLUOROMETHYL)SPIRO[CYCLOPROPANE-1,3′-INDOLIN]-2′-ONE | ESD-881150-1G |
| Cas.: 182261-94-5 | Purity: 95% | Clausine I | ESD-881151-1MG |
| Cas.: 182249-69-0 | Purity: 95% | 3,4-seco-Olean-12-en-4-ol-3,28-dioic acid | ESD-881152-5MG |
| Cas.: 182234-25-9 | Purity: 98% | Spirotryprostatin A | ESD-881153-5MG |
| Cas.: 182138-70-1 | Purity: 95% | Nyssoside | ESD-881154-1MG |
| Cas.: 1821370-70-0 | Purity: ≥99% | Diethyl-pythiDC | ESD-881155-5MG |
| Cas.: 1821370-70-0 | Purity: ≥99% | Diethyl-pythiDC | ESD-881155-10MG |
| Cas.: 182132-59-8 | Purity: 95% | Quinovic acid 3β-O-(3′,4′-O-isopropylidene)-β-D-fucopyranoside | ESD-881156-5MG |
| Cas.: 1821143-80-9 | Purity: ≥98% | DMU2139 | ESD-881157-5MG |
| Cas.: 1821143-80-9 | Purity: ≥98% | DMU2139 | ESD-881157-10MG |
| Cas.: 1821143-79-6 | Purity: ≥98% | DMU2105 | ESD-881158-5MG |
| Cas.: 1821143-79-6 | Purity: ≥98% | DMU2105 | ESD-881158-10MG |
| Cas.: 1820889-23-3 | Purity: ≥98% | INCB-057643 | ESD-881159-2MG |
| Cas.: 1820889-23-3 | Purity: ≥98% | INCB-057643 | ESD-881159-5MG |
| Cas.: 1820-84-4 | Purity: 97% | Ethyl β-D-fructofuranoside | ESD-881160-1MG |
| Cas.: 1820812-16-5 | Purity: ≥98% | TAK-071 | ESD-881161-5MG |
| Cas.: 1820812-16-5 | Purity: ≥98% | TAK-071 | ESD-881161-10MG |
| Cas.: 182073-77-4 | Purity: 98% | ZD8321 | ESD-881162-1MG |
| Cas.: 182073-77-4 | Purity: 98% | ZD8321 | ESD-881162-5MG |
| Cas.: 1820708-73-3 | Purity: ≥99% | SKA-121 | ESD-881163-1MG |
| Cas.: 1820708-73-3 | Purity: ≥99% | SKA-121 | ESD-881163-5MG |
| Cas.: 1820684-31-8 | Purity: ≥98% | M443 | ESD-881164-5MG |
| Cas.: 1820684-31-8 | Purity: ≥98% | M443 | ESD-881164-10MG |
| Cas.: 1820619-57-5 | Purity: 95% | 5-((BENZYLOXY)CARBONYL)-5-AZASPIRO[2.3]HEXANE-1-CARBOXYLIC ACID | ESD-881165-250MG |
| Cas.: 1820619-57-5 | Purity: 95% | 5-((BENZYLOXY)CARBONYL)-5-AZASPIRO[2.3]HEXANE-1-CARBOXYLIC ACID | ESD-881165-1G |
| Cas.: 1820598-88-6 | Purity: 95% | 1-[(1R,2S,4S)-spiro[bicyclo[2.2.1]heptane-7,1′-cyclopropane]-5-en-2-yl]methanamine | ESD-881166-250MG |
| Cas.: 1820598-88-6 | Purity: 95% | 1-[(1R,2S,4S)-spiro[bicyclo[2.2.1]heptane-7,1′-cyclopropane]-5-en-2-yl]methanamine | ESD-881166-1G |
| Cas.: 1820574-86-4 | Purity: 95% | tert-butyl rac-(1R,3r,5S)-8H-spiro[8-azabicyclo[3.2.1]octane-3,2′-[1,4]oxazinane]-8-carboxylate | ESD-881167-1G |
| Cas.: 1820574-86-4 | Purity: 95% | tert-butyl rac-(1R,3r,5S)-8H-spiro[8-azabicyclo[3.2.1]octane-3,2′-[1,4]oxazinane]-8-carboxylate | ESD-881167-5G |
| Cas.: 1820565-69-2 | Purity: ≥99% | PIM-447 dihydrochloride | ESD-881168-1MG |
| Cas.: 1820565-69-2 | Purity: ≥99% | PIM-447 dihydrochloride | ESD-881168-5MG |
| Cas.: 1820034-05-6 | Purity: 96% | Meliasendanin D | ESD-881169-5MG |
| Cas.: 1819986-22-5 | Purity: ≥99% | amyloid P-IN-1 | ESD-881170-1MG |
| Cas.: 1819986-22-5 | Purity: ≥99% | amyloid P-IN-1 | ESD-881170-5MG |
| Cas.: 18196-13-9 | Purity: 96% | Naringenin 7,4′-diacetate | ESD-881171-5MG |
| Cas.: 18194-29-1 | Purity: 97% | Sequirin C | ESD-881172-5MG |
| Cas.: 1818885-28-7 | Purity: ≥98% | ARV-825 | ESD-881173-5MG |
| Cas.: 1818885-28-7 | Purity: ≥98% | ARV-825 | ESD-881173-10MG |
| Cas.: 1818389-84-2 | Purity: ≥99% | SPHINX31 | ESD-881174-5MG |
| Cas.: 1818389-84-2 | Purity: ≥99% | SPHINX31 | ESD-881174-10MG |
| Cas.: 1818339-66-0 | Purity: ≥99% | PF-06751979 | ESD-881175-5MG |
| Cas.: 1818339-66-0 | Purity: ≥99% | PF-06751979 | ESD-881175-10MG |
| Cas.: 1818314-88-3 | Purity: ≥99% | BMS-1166 | ESD-881176-5MG |
| Cas.: 1818314-88-3 | Purity: ≥99% | BMS-1166 | ESD-881176-10MG |
| Cas.: 181816-48-8 | Purity: 98% | Ombrabulin | ESD-881177-1MG |
| Cas.: 181816-48-8 | Purity: 98% | Ombrabulin | ESD-881177-5MG |
| Cas.: 1817698-21-7 | Purity: ≥98% | BDP5290 | ESD-881178-2MG |
| Cas.: 1817698-21-7 | Purity: ≥98% | BDP5290 | ESD-881178-5MG |
| Cas.: 1817626-54-2 | Purity: ≥99% | PF06650833 | ESD-881179-5MG |
| Cas.: 1817626-54-2 | Purity: ≥99% | PF06650833 | ESD-881179-10MG |
| Cas.: 1816331-66-4 | Purity: ≥99% | GSK864 | ESD-881180-1MG |
| Cas.: 1816331-66-4 | Purity: ≥99% | GSK864 | ESD-881180-2MG |
| Cas.: 181632-25-7 | Purity: ≥99% | SB 242084 | ESD-881181-5MG |
| Cas.: 181632-25-7 | Purity: ≥99% | SB 242084 | ESD-881181-10MG |
| Cas.: 1816294-67-3 | Purity: ≥98% | SR-4370 | ESD-881182-5MG |
| Cas.: 1816294-67-3 | Purity: ≥98% | SR-4370 | ESD-881182-10MG |
| Cas.: 1815580-06-3 | Purity: ≥98% | SKLB-23bb | ESD-881183-1MG |
| Cas.: 1815580-06-3 | Purity: ≥98% | SKLB-23bb | ESD-881183-5MG |
| Cas.: 1813527-81-9 | Purity: ≥98% | CCG215022 | ESD-881184-1MG |
| Cas.: 1813527-81-9 | Purity: ≥98% | CCG215022 | ESD-881184-5MG |
| Cas.: 181309-92-2 | Purity: 95% | Taxuspine W | ESD-881185-5MG |
| Cas.: 1811510-56-1 | Purity: ≥99% | PF-06260933 | ESD-881186-5MG |
| Cas.: 1811510-56-1 | Purity: ≥99% | PF-06260933 | ESD-881186-10MG |
| Cas.: 18110-86-6 | Purity: 98% | 5-Hydroxy-4-methoxycanthin-6-one | ESD-881187-5MG |
| Cas.: 18103-42-9 | Purity: 98% | 5,7-Dihydroxy-3′,4′,5′-trimethoxyflavone | ESD-881188-5MG |
| Cas.: 18103-41-8 | Purity: 98% | Corymbosin | ESD-881189-5MG |
| Cas.: 1810034-40-2 | Purity: 96% | Curcumaromin C | ESD-881190-5MG |
| Cas.: 1810034-39-9 | Purity: 96% | Curcumaromin B | ESD-881191-5MG |
| Cas.: 1810034-38-8 | Purity: 95% | Curcumaromin A | ESD-881192-5MG |
| Cas.: 180995-40-8 | Purity: 97% | 1-(3,4,5-Trihydroxypentanoyl)-β-carboline | ESD-881193-5MG |
| Cas.: 180977-44-0 | Purity: ≥96% | GGTI298 | ESD-881194-1MG |
| Cas.: 180977-44-0 | Purity: ≥96% | GGTI298 | ESD-881194-5MG |
| Cas.: 18096-45-2 | Purity: 95% | 3′,5′,6′,7′-Tetrahydrospiro[cyclohexane-1,4′-imidazo[4,5-c]pyridine] | ESD-881195-1G |
| Cas.: 180964-26-5 | Purity: 98% | Neuchromenin | ESD-881196-5MG |
| Cas.: 180961-65-3 | Purity: 97% | Spiramilactone B | ESD-881197-5MG |
| Cas.: 180-94-9 | Purity: 95% | 1,5-Dioxa-9-azaspiro[5.5]undecane, tech | ESD-881198-1G |
| Cas.: 180-94-9 | Purity: 95% | 1,5-Dioxa-9-azaspiro[5.5]undecane, tech | ESD-881198-5G |
| Cas.: 1809427-19-7 | Purity: ≥99% | DT-061 | ESD-881199-1MG |
| Cas.: 1809427-19-7 | Purity: ≥99% | DT-061 | ESD-881199-5MG |
| Cas.: 1809249-37-3 | Purity: ≥99% | Remdesivir | ESD-881200-5MG |
| Cas.: 1809085-30-0 | Purity: ≥99% | VU0650786 | ESD-881201-5MG |
| Cas.: 1809085-30-0 | Purity: ≥99% | VU0650786 | ESD-881201-10MG |
| Cas.: 18085-97-7 | Purity: ≥99% | Jaceosidin | ESD-881202-1MG |
| Cas.: 18085-97-7 | Purity: ≥99% | Jaceosidin | ESD-881202-5MG |
| Cas.: 180-84-7 | Purity: 97% | 1,7-Dioxaspiro[5.5]undecane | ESD-881203-5G |
| Cas.: 180-84-7 | Purity: 97% | 1,7-Dioxaspiro[5.5]undecane | ESD-881203-25G |
| Cas.: 1808260-84-5 | Purity: ≥99% | FASN-IN-1 | ESD-881204-5MG |
| Cas.: 1808260-84-5 | Purity: ≥99% | FASN-IN-1 | ESD-881204-10MG |
| Cas.: 1808160-52-2 | Purity: ≥98% | CF53 | ESD-881205-5MG |
| Cas.: 1808160-52-2 | Purity: ≥98% | CF53 | ESD-881205-10MG |
| Cas.: 1808159-02-5 | Purity: 92% | Qingyangshengenin 3-O-α-L-cymaropyranosyl-(1→4)-β-D-oleandropyranosyl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranoside | ESD-881206-5MG |
| Cas.: 1808113-09-8 | Purity: ≥98% | Corin | ESD-881207-5MG |
| Cas.: 1808113-09-8 | Purity: ≥98% | Corin | ESD-881207-10MG |
| Cas.: 1808094-07-6 | Purity: ≥98% | PF-06471553 | ESD-881208-5MG |
| Cas.: 1808094-07-6 | Purity: ≥98% | PF-06471553 | ESD-881208-10MG |
| Cas.: 1808011-22-4 | Purity: ≥99% | EPZ031686 | ESD-881209-1MG |
| Cas.: 1808011-22-4 | Purity: ≥99% | EPZ031686 | ESD-881209-5MG |
| Cas.: 1807988-47-1 | Purity: ≥99% | IITZ-01 | ESD-881210-5MG |
| Cas.: 1807988-47-1 | Purity: ≥99% | IITZ-01 | ESD-881210-10MG |
| Cas.: 1807900-80-6 | Purity: 98% | Fulvestrant R enantiomer | ESD-881211-5MG |
| Cas.: 1807900-80-6 | Purity: 98% | Fulvestrant R enantiomer | ESD-881211-10MG |
| Cas.: 1807523-99-4 | Purity: ≥98% | IACS-10759 Hydrochloride | ESD-881212-5MG |
| Cas.: 1807523-99-4 | Purity: ≥98% | IACS-10759 Hydrochloride | ESD-881212-10MG |
| Cas.: 18069-14-2 | Purity: 97% | Polypodine B | ESD-881213-5MG |
| Cas.: 1805789-54-1 | Purity: ≥98% | CT7001 hydrochloride | ESD-881214-1MG |
| Cas.: 1805789-54-1 | Purity: ≥98% | CT7001 hydrochloride | ESD-881214-5MG |
| Cas.: 1805787-93-2 | Purity: ≥99% | JAK3-IN-1 | ESD-881215-5MG |
| Cas.: 1805787-93-2 | Purity: ≥99% | JAK3-IN-1 | ESD-881215-10MG |
| Cas.: 180-48-3 | Purity: 95% | 2-azaspiro[5.5]undecane | ESD-881216-1G |
| Cas.: 180-48-3 | Purity: 95% | 2-azaspiro[5.5]undecane | ESD-881216-5G |
| Cas.: 180468-39-7 | Purity: ≥99% | Solifenacin hydrochloride | ESD-881217-5MG |
| Cas.: 180468-39-7 | Purity: ≥99% | Solifenacin hydrochloride | ESD-881217-10MG |
| Cas.: 180465-84-3 | Purity: 95% | tert-Butyl spiro[indoline-3,4′-piperidine]-1′-carboxylate | ESD-881218-1G |
| Cas.: 180465-84-3 | Purity: 95% | tert-Butyl spiro[indoline-3,4′-piperidine]-1′-carboxylate | ESD-881218-5G |
| Cas.: 180386-35-0 | Purity: 95% | 2-(8-(tert-Butoxycarbonyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl)acetic acid | ESD-881219-1G |
| Cas.: 180386-35-0 | Purity: 95% | 2-(8-(tert-Butoxycarbonyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl)acetic acid | ESD-881219-5G |
| Cas.: 1803611-33-7 | Purity: 95% | SPIRO[3.5]NONAN-1-AMINE HCL | ESD-881220-250MG |
| Cas.: 1803611-33-7 | Purity: 95% | SPIRO[3.5]NONAN-1-AMINE HCL | ESD-881220-1G |
| Cas.: 1803274-65-8 | Purity: ≥98% | BAY-1436032 | ESD-881221-5MG |
| Cas.: 1803274-65-8 | Purity: ≥98% | BAY-1436032 | ESD-881221-10MG |
| Cas.: 180300-43-0 | Purity: ≥99% | Ethynylcytidine | ESD-881222-5MG |
| Cas.: 180300-43-0 | Purity: ≥99% | Ethynylcytidine | ESD-881222-10MG |
| Cas.: 1802977-61-2 | Purity: ≥99% | GNE-140 racemate | ESD-881223-1MG |
| Cas.: 1802977-61-2 | Purity: ≥99% | GNE-140 racemate | ESD-881223-5MG |
| Cas.: 1802661-73-9 | Purity: ≥99% | ONO-8590580 | ESD-881224-5MG |
| Cas.: 1802661-73-9 | Purity: ≥99% | ONO-8590580 | ESD-881224-10MG |
| Cas.: 1802637-39-3 | Purity: 98% | BB-Cl-Amidine | ESD-881225-1MG |
| Cas.: 1802637-39-3 | Purity: 98% | BB-Cl-Amidine | ESD-881225-5MG |
| Cas.: 1802525-61-6 | Purity: ≥99% | LRRK2 inhibitor 1 | ESD-881226-5MG |
| Cas.: 1802525-61-6 | Purity: ≥99% | LRRK2 inhibitor 1 | ESD-881226-10MG |
| Cas.: 1802326-66-4 | Purity: ≥99% | JNJ-63533054 | ESD-881227-5MG |
| Cas.: 1802326-66-4 | Purity: ≥99% | JNJ-63533054 | ESD-881227-10MG |
| Cas.: 1802251-00-8 | Purity: ≥98% | GSK1379725A | ESD-881228-5MG |
| Cas.: 1802251-00-8 | Purity: ≥98% | GSK1379725A | ESD-881228-10MG |
| Cas.: 1802226-78-3 | Purity: ≥99% | PSB-12379 | ESD-881229-5MG |
| Cas.: 1802226-78-3 | Purity: ≥99% | PSB-12379 | ESD-881229-10MG |
| Cas.: 1802175-07-0 | Purity: ≥96% | CPI-169 | ESD-881230-2MG |
| Cas.: 1802175-07-0 | Purity: ≥96% | CPI-169 | ESD-881230-5MG |
| Cas.: 1802148-05-5 | Purity: ≥99% | AZD7986 | ESD-881231-1MG |
| Cas.: 1802148-05-5 | Purity: ≥99% | AZD7986 | ESD-881231-5MG |
| Cas.: 1801873-49-3 | Purity: ≥99% | OICR-0547 | ESD-881232-5MG |
| Cas.: 1801873-49-3 | Purity: ≥99% | OICR-0547 | ESD-881232-10MG |
| Cas.: 180185-61-9 | Purity: 98% | TAK-778 | ESD-881233-1MG |
| Cas.: 180185-61-9 | Purity: 98% | TAK-778 | ESD-881233-5MG |
| Cas.: 1801767-45-2 | Purity: 95% | TERT-BUTYL 2-AZASPIRO[3.3]HEPTAN-5-YLCARBAMATE HYDROCHLORIDE | ESD-881234-250MG |
| Cas.: 1801767-45-2 | Purity: 95% | TERT-BUTYL 2-AZASPIRO[3.3]HEPTAN-5-YLCARBAMATE HYDROCHLORIDE | ESD-881234-1G |
| Cas.: 1801750-22-0 | Purity: 96% | (-)-Anthracophyllone | ESD-881235-5MG |
| Cas.: 1801747-11-4 | Purity: ≥99% | SHP099 hydrochloride | ESD-881236-1MG |
| Cas.: 1801747-11-4 | Purity: ≥99% | SHP099 hydrochloride | ESD-881236-5MG |
| Cas.: 180164-14-1 | Purity: 98% | Megastigm-7-ene-3,4,6,9-tetrol | ESD-881237-5MG |
| Cas.: 180160-47-8 | Purity: 97% | 5-CHLORO-3H-SPIRO[ISOBENZOFURAN-1,4′-PIPERIDIN]-3-ONE HCL | ESD-881238-1G |
| Cas.: 180160-47-8 | Purity: 97% | 5-CHLORO-3H-SPIRO[ISOBENZOFURAN-1,4′-PIPERIDIN]-3-ONE HCL | ESD-881238-5G |
| Cas.: 1801530-11-9 | Purity: ≥99% | Imidazole ketone erastin | ESD-881239-5MG |
| Cas.: 1801530-11-9 | Purity: ≥99% | Imidazole ketone erastin | ESD-881239-10MG |
| Cas.: 180144-61-0 | Purity: 98% | SR121566A | ESD-881240-1MG |
| Cas.: 180144-61-0 | Purity: 98% | SR121566A | ESD-881240-5MG |
| Cas.: 180084-26-8 | Purity: ≥98% | SB-224289 hydrochloride | ESD-881241-5MG |
| Cas.: 180084-26-8 | Purity: ≥98% | SB-224289 hydrochloride | ESD-881241-10MG |
| Cas.: 180083-23-2 | Purity: 95% | (2′-Methyl-4′-(5-methyl-1,2,4-oxadiazol-3-yl)-[1,1′-biphenyl]-4-yl)(1′-methyl-6,7- dihydrospiro[furo[2,3-f]indole-3,4′-piperidin]-5(2H)-yl)methanone | ESD-881242-1G |
| Cas.: 180059-77-2 | Purity: 97% | Voafinidine | ESD-881243-5MG |
| Cas.: 1800477-30-8 | Purity: 98% | IACS-9571 | ESD-881244-1MG |
| Cas.: 1800477-30-8 | Purity: 98% | IACS-9571 | ESD-881244-5MG |
| Cas.: 1800465-47-7 | Purity: ≥98% | KRN5 | ESD-881245-5MG |
| Cas.: 1800465-47-7 | Purity: ≥98% | KRN5 | ESD-881245-10MG |
| Cas.: 18004-20-1 | Purity: 99% | Ketohakonanol | ESD-881246-5MG |
| Cas.: 1800340-40-2 | Purity: ≥98% | BMS-986158 | ESD-881247-1MG |
| Cas.: 1800340-40-2 | Purity: ≥98% | BMS-986158 | ESD-881247-5MG |
| Cas.: 1800029-50-8 | Purity: 98% | Cynanoside F | ESD-881248-5MG |
| Cas.: 1800025-30-2 | Purity: ≥98% | MGAT2-IN-1 | ESD-881249-1MG |
| Cas.: 1800025-30-2 | Purity: ≥98% | MGAT2-IN-1 | ESD-881249-5MG |
| Cas.: 1799974-70-1 | Purity: ≥99% | KI696 | ESD-881250-1MG |
| Cas.: 1799974-70-1 | Purity: ≥99% | KI696 | ESD-881250-5MG |
| Cas.: 1799974-69-8 | Purity: ≥99% | KI696 isomer | ESD-881251-1MG |
| Cas.: 1799974-69-8 | Purity: ≥99% | KI696 isomer | ESD-881251-5MG |
| Cas.: 1799948-06-3 | Purity: ≥99% | HIF-2α-IN-1 | ESD-881252-1MG |
| Cas.: 1799948-06-3 | Purity: ≥99% | HIF-2α-IN-1 | ESD-881252-5MG |
| Cas.: 179986-89-1 | Purity: 98% | Pancreatic Polypeptide, bovine | ESD-881253-500ΜG |
| Cas.: 179986-89-1 | Purity: 98% | Pancreatic Polypeptide, bovine | ESD-881253-1MG |
| Cas.: 1799824-08-0 | Purity: ≥99% | E-7386 | ESD-881254-1MG |
| Cas.: 1799824-08-0 | Purity: ≥99% | E-7386 | ESD-881254-5MG |
| Cas.: 1799711-21-9 | Purity: ≥99% | dBET1 | ESD-881255-2MG |
| Cas.: 1799711-21-9 | Purity: ≥99% | dBET1 | ESD-881255-5MG |
| Cas.: 1799631-75-6 | Purity: ≥98% | MIK665 | ESD-881256-5MG |
| Cas.: 1799631-75-6 | Purity: ≥98% | MIK665 | ESD-881256-10MG |
| Cas.: 1799506-30-1 | Purity: ≥98% | Cl-C6-PEG4-O-CH2COOH | ESD-881257-100MG |
| Cas.: 1799328-86-1 | Purity: ≥98% | ASTX660 | ESD-881258-1MG |
| Cas.: 1799328-86-1 | Purity: ≥98% | ASTX660 | ESD-881258-5MG |
| Cas.: 17989-41-2 | Purity: ≥98% | Glycerol 3-phosphate | ESD-881259-1MG |
| Cas.: 17989-41-2 | Purity: ≥98% | Glycerol 3-phosphate | ESD-881259-5MG |
| Cas.: 1798871-31-4 | Purity: ≥98% | Centrinone-B | ESD-881260-2MG |
| Cas.: 1798871-31-4 | Purity: ≥98% | Centrinone-B | ESD-881260-5MG |
| Cas.: 1798871-30-3 | Purity: ≥98% | Centrinone | ESD-881261-2MG |
| Cas.: 1798871-30-3 | Purity: ≥98% | Centrinone | ESD-881261-5MG |
| Cas.: 17983-82-3 | Purity: 98% | 27-Hydroxymangiferolic acid | ESD-881262-5MG |
| Cas.: 1798331-92-6 | Purity: ≥99% | QX77 | ESD-881263-5MG |
| Cas.: 1798331-92-6 | Purity: ≥99% | QX77 | ESD-881263-10MG |
| Cas.: 17974-57-1 | Purity: ≥97% | β-Apo-13-carotenone | ESD-881264-1MG |
| Cas.: 17974-57-1 | Purity: ≥97% | β-Apo-13-carotenone | ESD-881264-5MG |
| Cas.: 1797406-81-5 | Purity: ≥98% | (S,R,S)-AHPC-PEG4-N3 | ESD-881265-100MG |
| Cas.: 1797406-81-5 | Purity: ≥98% | (S,R,S)-AHPC-PEG4-N3 | ESD-881265-500MG |
| Cas.: 1797406-69-9 | Purity: ≥98% | MZ 1 | ESD-881266-1MG |
| Cas.: 1797406-69-9 | Purity: ≥98% | MZ 1 | ESD-881266-5MG |
| Cas.: 1796596-46-7 | Purity: ≥99% | NSC23005 sodium | ESD-881267-5MG |
| Cas.: 1796596-46-7 | Purity: ≥99% | NSC23005 sodium | ESD-881267-10MG |
| Cas.: 1796565-52-0 | Purity: ≥99% | Orexin 2 Receptor Agonist | ESD-881268-2MG |
| Cas.: 1796565-52-0 | Purity: ≥99% | Orexin 2 Receptor Agonist | ESD-881268-5MG |
| Cas.: 179603-47-5 | Purity: 97% | Macrocarpal J | ESD-881269-5MG |
| Cas.: 179528-45-1 | Purity: ≥98% | PD150606 | ESD-881270-5MG |
| Cas.: 179528-45-1 | Purity: ≥98% | PD150606 | ESD-881270-10MG |
| Cas.: 17948-42-4 | Purity: 98% | Venoterpine | ESD-881271-5MG |
| Cas.: 17948-33-3 | Purity: 97% | Rutacridone | ESD-881272-5MG |
| Cas.: 1794789-93-7 | Purity: 98% | Vilazodone D8 | ESD-881273-1MG |
| Cas.: 1794789-93-7 | Purity: 98% | Vilazodone D8 | ESD-881273-5MG |
| Cas.: 17946-87-1 | Purity: 97% | Leucodin | ESD-881274-5MG |
| Cas.: 179457-70-6 | Purity: 98% | 2-Methoxyanofinic acid | ESD-881275-5MG |
| Cas.: 179411-94-0 | Purity: 98% | SDZ 220-581 Ammonium salt | ESD-881276-10MG |
| Cas.: 179411-94-0 | Purity: 98% | SDZ 220-581 Ammonium salt | ESD-881276-50MG |
| Cas.: 179411-93-9 | Purity: ≥99% | SDZ 220-581 hydrochloride | ESD-881277-10MG |
| Cas.: 179411-93-9 | Purity: ≥99% | SDZ 220-581 hydrochloride | ESD-881277-50MG |
| Cas.: 179388-54-6 | Purity: 97% | Macrocarpal I | ESD-881278-5MG |
| Cas.: 179388-53-5 | Purity: 93% | Macrocarpal H | ESD-881279-5MG |
| Cas.: 17934-59-7 | Purity: 97% | Convallagenin B | ESD-881280-5MG |
| Cas.: 17934-15-5 | Purity: 95% | 7-O-Methyleucomol | ESD-881281-5MG |
| Cas.: 17934-12-2 | Purity: 95% | Eucomol | ESD-881282-5MG |
| Cas.: 17928-63-1 | Purity: 95% | Sugetriol 6,9-diacetate | ESD-881283-1MG |
| Cas.: 179068-02-1 | Purity: ≥99% | PHCCC | ESD-881284-2MG |
| Cas.: 179068-02-1 | Purity: ≥99% | PHCCC | ESD-881284-5MG |
| Cas.: 178908-09-3 | Purity: 98% | UK-240455 | ESD-881285-1MG |
| Cas.: 178908-09-3 | Purity: 98% | UK-240455 | ESD-881285-5MG |
| Cas.: 17884-88-7 | Purity: 98% | Myricadiol | ESD-881286-5MG |
| Cas.: 1788090-69-6 | Purity: 98% | Vitexolide D | ESD-881287-5MG |
| Cas.: 1788054-91-0 | Purity: 95% | TERT-BUTYL 5-AMINO-2-AZASPIRO[3.3]HEPTANE-2-CARBOXYLATE HYDROCHLORIDE | ESD-881288-250MG |
| Cas.: 1788054-91-0 | Purity: 95% | TERT-BUTYL 5-AMINO-2-AZASPIRO[3.3]HEPTANE-2-CARBOXYLATE HYDROCHLORIDE | ESD-881288-1G |
| Cas.: 178765-54-3 | Purity: 95% | 3-Hydroxybakuchiol | ESD-881289-5MG |
| Cas.: 178764-92-6 | Purity: 98% | Agrocybenine | ESD-881290-5MG |
| Cas.: 178616-26-7 | Purity: ≥98% | CFM-2 | ESD-881291-10MG |
| Cas.: 178616-26-7 | Purity: ≥98% | CFM-2 | ESD-881291-50MG |
| Cas.: 178600-68-5 | Purity: 98% | Oleoside | ESD-881292-5MG |
| Cas.: 1785764-72-8 | Purity: 95% | ethyl 4-hydroxy-1-oxa-9-azaspiro[5.5]undecane-9-carboxylate | ESD-881293-1G |
| Cas.: 1785764-72-8 | Purity: 95% | ethyl 4-hydroxy-1-oxa-9-azaspiro[5.5]undecane-9-carboxylate | ESD-881293-5G |
| Cas.: 1785764-61-5 | Purity: 95% | di-tert-butyl 6,7-dihydro-1’H-spiro[imidazo[4,5-c]pyridine-4,4′-piperidine]-1,1′(5H)-dicarboxylate | ESD-881294-1G |
| Cas.: 1785764-61-5 | Purity: 95% | di-tert-butyl 6,7-dihydro-1’H-spiro[imidazo[4,5-c]pyridine-4,4′-piperidine]-1,1′(5H)-dicarboxylate | ESD-881294-5G |
| Cas.: 1785761-76-3 | Purity: 95% | 9-benzyl-1-oxa-9-azaspiro[5.5]undecan-4-ol | ESD-881295-1G |
| Cas.: 1785761-67-2 | Purity: 95% | ethyl 4-hydroxy-4-methyl-1-oxa-9-azaspiro[5.5]undecane-9-carboxylate | ESD-881296-500MG |
| Cas.: 17854-59-0 | Purity: 98% | Mepixanox | ESD-881297-1MG |
| Cas.: 17854-59-0 | Purity: 98% | Mepixanox | ESD-881297-5MG |
| Cas.: 178481-68-0 | Purity: 98% | Hoechst 33342 analog | ESD-881298-5MG |
| Cas.: 178481-68-0 | Purity: 98% | Hoechst 33342 analog | ESD-881298-10MG |
| Cas.: 178456-58-1 | Purity: 95% | 6-epi-Albrassitriol | ESD-881299-5MG |
| Cas.: 1784282-12-7 | Purity: ≥99% | KHS101 hydrochloride | ESD-881300-5MG |
| Cas.: 1784282-12-7 | Purity: ≥99% | KHS101 hydrochloride | ESD-881300-10MG |
| Cas.: 1783637-53-5 | Purity: 95% | 5-AZASPIRO[2.4]HEPTAN-6-ONE | ESD-881301-250MG |
| Cas.: 1783637-53-5 | Purity: 95% | 5-AZASPIRO[2.4]HEPTAN-6-ONE | ESD-881301-1G |
| Cas.: 178330-78-4 | Purity: 98% | 12-Hydroxy-6-epi-albrassitriol | ESD-881302-5MG |
| Cas.: 1782-79-2 | Purity: 98% | Linderone | ESD-881303-5MG |
| Cas.: 178273-87-5 | Purity: 98% | Piboserod hydrochloride | ESD-881304-10MG |
| Cas.: 178273-87-5 | Purity: 98% | Piboserod hydrochloride | ESD-881304-50MG |
| Cas.: 1782-65-6 | Purity: 97% | Hardwickiic acid | ESD-881305-5MG |
| Cas.: 1782235-14-6 | Purity: ≥97% | CHIR-99021 trihydrochloride | ESD-881306-2MG |
| Cas.: 1782235-14-6 | Purity: ≥97% | CHIR-99021 trihydrochloride | ESD-881306-5MG |
| Cas.: 17822-06-9 | Purity: 95% | Tetrahymanone | ESD-881307-5MG |
| Cas.: 1781882-65-2 | Purity: ≥98% | Pyridostatin hydrochloride | ESD-881308-5MG |
| Cas.: 1781882-65-2 | Purity: ≥98% | Pyridostatin hydrochloride | ESD-881308-10MG |
| Cas.: 17811-32-4 | Purity: 95% | 3-Deoxyzinnolide | ESD-881309-1MG |
| Cas.: 1779796-27-8 | Purity: ≥99% | LY2365109 hydrochloride | ESD-881310-2MG |
| Cas.: 1779796-27-8 | Purity: ≥99% | LY2365109 hydrochloride | ESD-881310-5MG |
| Cas.: 1779133-34-4 | Purity: 95% | 2-Isopropyl-3-methyl-1,3,8-triazaspiro[4.5]dec-1-en-4-one hydrochloride | ESD-881311-1G |
| Cas.: 1779133-27-5 | Purity: 95% | 2-(4-Methoxyphenyl)-1,3,8-triazaspiro[4.5]dec-1-en-4-one hydrochloride | ESD-881312-1G |
| Cas.: 1779133-13-9 | Purity: 95% | 6-Oxaspiro[2.5]octan-1-amine hydrochloride | ESD-881313-1G |
| Cas.: 1779133-13-9 | Purity: 95% | 6-Oxaspiro[2.5]octan-1-amine hydrochloride | ESD-881313-5G |
| Cas.: 1779129-96-2 | Purity: 95% | 4-Fluoro-3H-spiro[2-benzofuran-1,4′-piperidine] hydrochloride | ESD-881314-1G |
| Cas.: 1779129-70-2 | Purity: 95% | 5′,7′-Dihydrospiro[cyclopropane-1,6′-pyrazolo[3,2-b][1,3]oxazine]-3′-amine | ESD-881315-1G |
| Cas.: 1779128-13-0 | Purity: 95% | 2-(3-Fluorophenyl)-1,3,8-triazaspiro[4.5]dec-1-en-4-one dihydrochloride | ESD-881316-1G |
| Cas.: 1779126-43-0 | Purity: 95% | tert-Butyl 2-cyclopropyl-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate | ESD-881317-1G |
| Cas.: 1779126-36-1 | Purity: 95% | 2-(2-Methoxyphenyl)-1,3,8-triazaspiro[4.5]dec-1-en-4-one hydrochloride | ESD-881318-1G |
| Cas.: 1779125-98-2 | Purity: 95% | 2-Cyclopropyl-3-methyl-1,3,8-triazaspiro[4.5]dec-1-en-4-one hydrochloride | ESD-881319-1G |
| Cas.: 1779125-91-5 | Purity: 95% | tert-Butyl 7-bromo-2-oxo-1,2-dihydrospiro[indole-3,4′-piperidine]-1′-carboxylate | ESD-881320-1G |
| Cas.: 1779125-38-0 | Purity: 95% | 5-Methoxy-1,2-dihydrospiro[indole-3,4′-piperidine]-2-one hydrochloride | ESD-881321-1G |
| Cas.: 1779125-33-5 | Purity: 95% | 5-Chloro-1,2-dihydrospiro[indole-3,4′-piperidine]-2-one hydrochloride | ESD-881322-1G |
| Cas.: 177904-00-6 | Purity: 98% | PD-159020 | ESD-881323-1MG |
| Cas.: 177904-00-6 | Purity: 98% | PD-159020 | ESD-881323-5MG |
| Cas.: 1777807-64-3 | Purity: 98% | ZINC03129319 | ESD-881324-25MG |
| Cas.: 177707-12-9 | Purity: ≥99% | NKP608 | ESD-881325-5MG |
| Cas.: 177707-12-9 | Purity: ≥99% | NKP608 | ESD-881325-10MG |
| Cas.: 1776055-05-0 | Purity: 98% | ML230 | ESD-881326-2MG |
| Cas.: 1776055-05-0 | Purity: 98% | ML230 | ESD-881326-5MG |
| Cas.: 177602-14-1 | Purity: 95% | Glycerol 1-(26-hydroxyhexacosanoate) | ESD-881327-1MG |
| Cas.: 1774905-24-6 | Purity: 95% | 4-Chloro-3H-spiro[2-benzofuran-1,4′-piperidine] hydrochloride | ESD-881328-1G |
| Cas.: 1774904-83-4 | Purity: 95% | 6-Fluoro-1,2-dihydrospiro[indole-3,4′-piperidine]-2-one hydrochloride | ESD-881329-1G |
| Cas.: 1774899-05-6 | Purity: 95% | 2,3-Dimethyl-1,3,8-triazaspiro[4.5]dec-1-en-4-one hydrochloride | ESD-881330-1G |
| Cas.: 1774897-61-8 | Purity: 95% | 4-Methyl-3H-spiro[2-benzofuran-1,4′-piperidine] hydrochloride | ESD-881331-1G |
| Cas.: 1774897-50-5 | Purity: 97% | Benzyl N-?k6-azaspiro[2.5]octan-1-yl?lcarbamate hydrochloride | ESD-881332-1G |
| Cas.: 1774897-34-5 | Purity: 95% | tert-Butyl2-(4-methoxyphenyl)-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate | ESD-881333-1G |
| Cas.: 1774897-11-8 | Purity: 95% | tert-Butyl 2-ethyl-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate | ESD-881334-1G |
| Cas.: 1774896-53-5 | Purity: 95% | tert-Butyl N-{spiro[2.4]heptan-1-yl}carbamate | ESD-881335-1G |
| Cas.: 1774896-08-0 | Purity: 95% | tert-Butyl2-(2-fluorophenyl)-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate | ESD-881336-1G |
| Cas.: 1774895-85-0 | Purity: 95% | 2-Cyclopropyl-1,3,8-triazaspiro[4.5]dec-1-en-4-one hydrochloride | ESD-881337-1G |
| Cas.: 177469-96-4 | Purity: 98% | Implitapide | ESD-881338-5MG |
| Cas.: 177469-96-4 | Purity: 98% | Implitapide | ESD-881338-10MG |
| Cas.: 177468-85-8 | Purity: 96% | Aglain C | ESD-881339-5MG |
| Cas.: 1773489-72-7 | Purity: ≥99% | Nidufexor | ESD-881340-5MG |
| Cas.: 1773489-72-7 | Purity: ≥99% | Nidufexor | ESD-881340-10MG |
| Cas.: 177262-32-7 | Purity: 96% | Aglain B | ESD-881341-5MG |
| Cas.: 1772614-25-1 | Purity: 97% | Rubuminatus B | ESD-881342-5MG |
| Cas.: 1772588-99-4 | Purity: 93% | 26-O-Acetylsootepin A | ESD-881343-5MG |
| Cas.: 177-19-5 | Purity: 95% | 6,9-diazaspiro[4.5]decane | ESD-881344-1G |
| Cas.: 177-19-5 | Purity: 95% | 6,9-diazaspiro[4.5]decane | ESD-881344-2.5G |
| Cas.: 176983-21-4 | Purity: 98% | 2α,19α-Dihydroxy-3-oxo-urs-12-en-28-oic acid | ESD-881345-5MG |
| Cas.: 17692-71-6 | Purity: 98% | Vanitiolide | ESD-881346-100MG |
| Cas.: 17692-51-2 | Purity: ≥99% | Metergoline | ESD-881347-50MG |
| Cas.: 17692-51-2 | Purity: ≥99% | Metergoline | ESD-881347-100MG |
| Cas.: 176-92-1 | Purity: 95% | 1-oxa-8-azaspiro[4.5]decane | ESD-881348-1G |
| Cas.: 17676-24-3 | Purity: 97% | trans-Hinokiresinol | ESD-881349-5MG |
| Cas.: 176-73-8 | Purity: 95% | 7-azaspiro[4.5]decane | ESD-881350-250MG |
| Cas.: 176-73-8 | Purity: 95% | 7-azaspiro[4.5]decane | ESD-881350-1G |
| Cas.: 176-67-0 | Purity: 95% | 2,8-Diazaspiro[4.5]decane | ESD-881351-250MG |
| Cas.: 176-67-0 | Purity: 95% | 2,8-Diazaspiro[4.5]decane | ESD-881351-1G |
| Cas.: 176-66-9 | Purity: 95% | 2-Azaspiro[4.5]decane | ESD-881352-500MG |
| Cas.: 176665-78-4 | Purity: 98% | Ducheside A | ESD-881353-5MG |
| Cas.: 176655-55-3 | Purity: 98% | Ritonavir metabolite | ESD-881354-5MG |
| Cas.: 176655-55-3 | Purity: 98% | Ritonavir metabolite | ESD-881354-10MG |
| Cas.: 176-64-7 | Purity: 95% | 8-Aza-spiro[4.5]decane | ESD-881355-1G |
| Cas.: 176-64-7 | Purity: 95% | 8-Aza-spiro[4.5]decane | ESD-881355-5G |
| Cas.: 176520-13-1 | Purity: 96% | Scutebarbatine A | ESD-881356-5MG |
| Cas.: 176519-75-8 | Purity: 96% | 8-Hydroxyodoroside A | ESD-881357-5MG |
| Cas.: 17635-59-5 | Purity: 98% | Dihydropinosylvin monomethyl ether | ESD-881358-5MG |
| Cas.: 176-35-2 | Purity: 97% | 1,4-Dioxa-7-thiaspiro[4.4]nonane | ESD-881359-1G |
| Cas.: 176-33-0 | Purity: 95% | 1,4-dioxa-7-azaspiro[4.4]nonane | ESD-881360-1G |
| Cas.: 176-33-0 | Purity: 95% | 1,4-dioxa-7-azaspiro[4.4]nonane | ESD-881360-5G |
| Cas.: 176-32-9 | Purity: 95% | 1,4-DIOXASPIRO(4.4)NONANE | ESD-881361-1EA |
| Cas.: 176251-49-3 | Purity: 95% | 8,8-Difluoro-1,4-dioxaspiro[4.5]decane | ESD-881362-1G |
| Cas.: 176251-49-3 | Purity: 95% | 8,8-Difluoro-1,4-dioxaspiro[4.5]decane | ESD-881362-5G |
| Cas.: 17622-86-5 | Purity: 95% | Nervogenic acid | ESD-881363-1MG |
| Cas.: 176161-24-3 | Purity: ≥98% | Maribavir | ESD-881364-5MG |
| Cas.: 176161-24-3 | Purity: ≥98% | Maribavir | ESD-881364-10MG |
| Cas.: 175-96-2 | Purity: 95% | 2,7-DIAZA-SPIRO[4.4]NONANE 2HCL | ESD-881365-1G |
| Cas.: 175-94-0 | Purity: 95% | 2-azaspiro[4.4]nonane | ESD-881366-1G |
| Cas.: 175-94-0 | Purity: 95% | 2-azaspiro[4.4]nonane | ESD-881366-5G |
| Cas.: 175862-40-5 | Purity: 97% | Wedelialactone A | ESD-881367-5MG |
| Cas.: 175556-08-8 | Purity: 95% | Longifloroside A | ESD-881368-1MG |
| Cas.: 175448-05-2 | Purity: 98% | Jaspolyanthoside | ESD-881369-5MG |
| Cas.: 175414-77-4 | Purity: 98% | Voreloxin | ESD-881370-5MG |
| Cas.: 175414-77-4 | Purity: 98% | Voreloxin | ESD-881370-10MG |
| Cas.: 17528-72-2 | Purity: ≥98% | Tetrahydrobiopterin | ESD-881371-5MG |
| Cas.: 17528-72-2 | Purity: ≥98% | Tetrahydrobiopterin | ESD-881371-10MG |
| Cas.: 17526-15-7 | Purity: 95% | Xanthorin | ESD-881372-1MG |
| Cas.: 175212-04-1 | Purity: 98% | CMI977 | ESD-881373-1MG |
| Cas.: 175212-04-1 | Purity: 98% | CMI977 | ESD-881373-5MG |
| Cas.: 175140-00-8 | Purity: ≥99% | CP 376395 | ESD-881374-5MG |
| Cas.: 175140-00-8 | Purity: ≥99% | CP 376395 | ESD-881374-10MG |
| Cas.: 175139-41-0 | Purity: 98% | CP 316311 | ESD-881375-1MG |
| Cas.: 175139-41-0 | Purity: 98% | CP 316311 | ESD-881375-5MG |
| Cas.: 175094-15-2 | Purity: 97% | Juncusol 7-O-glucoside | ESD-881376-5MG |
| Cas.: 175094-14-1 | Purity: 96% | Juncusol 2-O-glucoside | ESD-881377-5MG |
| Cas.: 175013-84-0 | Purity: ≥99% | Tonabersat | ESD-881378-5MG |
| Cas.: 175013-84-0 | Purity: ≥99% | Tonabersat | ESD-881378-10MG |
| Cas.: 174-79-8 | Purity: 95% | 2,6-Dioxaspiro[3.3]heptane | ESD-881379-250MG |
| Cas.: 174672-06-1 | Purity: 98% | AN2718 | ESD-881380-5MG |
| Cas.: 174672-06-1 | Purity: 98% | AN2718 | ESD-881380-10MG |
| Cas.: 174-66-3 | Purity: 95% | Spiro[cyclopropane-1,3′-indoline] hydrochloride | ESD-881381-1G |
| Cas.: 174-66-3 | Purity: 95% | Spiro[cyclopropane-1,3′-indoline] hydrochloride | ESD-881381-5G |
| Cas.: 174636-32-9 | Purity: ≥99% | Talnetant | ESD-881382-10MG |
| Cas.: 174636-32-9 | Purity: ≥99% | Talnetant | ESD-881382-50MG |
| Cas.: 174635-69-9 | Purity: ≥99% | SB-222200 | ESD-881383-10MG |
| Cas.: 174635-69-9 | Purity: ≥99% | SB-222200 | ESD-881383-50MG |
| Cas.: 174634-09-4 | Purity: ≥99% | TAS-103 dihydrochloride | ESD-881384-5MG |
| Cas.: 174634-09-4 | Purity: ≥99% | TAS-103 dihydrochloride | ESD-881384-10MG |
| Cas.: 174634-08-3 | Purity: 98% | TAS-103 | ESD-881385-5MG |
| Cas.: 174634-08-3 | Purity: 98% | TAS-103 | ESD-881385-10MG |
| Cas.: 174575-17-8 | Purity: ≥98% | SDZ 220-581 | ESD-881386-10MG |
| Cas.: 174575-17-8 | Purity: ≥98% | SDZ 220-581 | ESD-881386-50MG |
| Cas.: 174568-92-4 | Purity: ≥98% | Glyoxalase I inhibitor free base | ESD-881387-5MG |
| Cas.: 174568-92-4 | Purity: ≥98% | Glyoxalase I inhibitor free base | ESD-881387-10MG |
| Cas.: 1745-36-4 | Purity: 97% | α-Spinasterol glucoside | ESD-881388-5MG |
| Cas.: 174484-41-4 | Purity: ≥99% | Tipranavir | ESD-881389-1MG |
| Cas.: 174423-30-4 | Purity: 97% | Sanggenol A | ESD-881390-5MG |
| Cas.: 174402-32-5 | Purity: ≥98% | Edotecarin | ESD-881391-1MG |
| Cas.: 174402-32-5 | Purity: ≥98% | Edotecarin | ESD-881391-5MG |
| Cas.: 174232-30-5 | Purity: 95% | Pancixanthone A | ESD-881392-5MG |
| Cas.: 17422-90-1 | Purity: 95% | Methyl 3-(2,4-dihydroxyphenyl)propionate | ESD-881393-250MG |
| Cas.: 174204-83-2 | Purity: 95% | 3-Chloro-4-hydroxypiperidin-2-one | ESD-881394-5MG |
| Cas.: 173997-05-2 | Purity: 98% | Nepicastat | ESD-881395-5MG |
| Cas.: 173997-05-2 | Purity: 98% | Nepicastat | ESD-881395-10MG |
| Cas.: 173992-05-7 | Purity: 98% | 5-Acetyl-6-hydroxy-2-(1-hydroxy-1-methylethyl)benzofuran | ESD-881396-5MG |
| Cas.: 173991-81-6 | Purity: 97% | 22α-Hydroxy-3-oxo-12-ursen-30-oic acid | ESD-881397-5MG |
| Cas.: 17397-93-2 | Purity: 97% | Tanshinone IIB | ESD-881398-5MG |
| Cas.: 173952-44-8 | Purity: ≥99% | SYM2206 | ESD-881399-5MG |
| Cas.: 173952-44-8 | Purity: ≥99% | SYM2206 | ESD-881399-10MG |
| Cas.: 173937-91-2 | Purity: 98% | Atrasentan | ESD-881400-2MG |
| Cas.: 173937-91-2 | Purity: 98% | Atrasentan | ESD-881400-5MG |
| Cas.: 17391-09-2 | Purity: 98% | Isocarapanaubine | ESD-881401-5MG |
| Cas.: 173865-33-3 | Purity: ≥98% | CDD3505 | ESD-881402-5MG |
| Cas.: 173865-33-3 | Purity: ≥98% | CDD3505 | ESD-881402-10MG |
| Cas.: 173531-58-3 | Purity: ≥99% | Naphthoquine phosphate | ESD-881403-10MG |
| Cas.: 173531-58-3 | Purity: ≥99% | Naphthoquine phosphate | ESD-881403-50MG |
| Cas.: 173529-10-7 | Purity: ≥98% | HMN-176 | ESD-881404-2MG |
| Cas.: 173529-10-7 | Purity: ≥98% | HMN-176 | ESD-881404-5MG |
| Cas.: 173528-92-2 | Purity: ≥97% | HMN-154 | ESD-881405-1MG |
| Cas.: 173528-92-2 | Purity: ≥97% | HMN-154 | ESD-881405-5MG |
| Cas.: 173429-83-9 | Purity: 98% | Ficusin A | ESD-881406-5MG |
| Cas.: 173326-37-9 | Purity: 98% | BQ-788 | ESD-881407-1MG |
| Cas.: 173326-37-9 | Purity: 98% | BQ-788 | ESD-881407-5MG |
| Cas.: 173294-74-1 | Purity: 97% | Garciniaxanthone E | ESD-881408-5MG |
| Cas.: 173220-32-1 | Purity: 97% | 2,5-Dihydroxy-1-methoxyxanthone | ESD-881409-5MG |
| Cas.: 173075-45-1 | Purity: 97% | Ganoderic acid DM | ESD-881410-5MG |
| Cas.: 173039-10-6 | Purity: ≥98% | 2-PMPA | ESD-881411-5MG |
| Cas.: 173039-10-6 | Purity: ≥98% | 2-PMPA | ESD-881411-10MG |
| Cas.: 17303-67-2 | Purity: 98% | Goniothalamin | ESD-881412-5MG |
| Cas.: 17302-61-3 | Purity: 98% | Poloxime | ESD-881413-5MG |
| Cas.: 17302-61-3 | Purity: 98% | Poloxime | ESD-881413-10MG |
| Cas.: 17298-37-2 | Purity: 98% | Propionylcarnitine | ESD-881414-5MG |
| Cas.: 17298-37-2 | Purity: 98% | Propionylcarnitine | ESD-881414-10MG |
| Cas.: 17297-56-2 | Purity: 98% | Biorobin | ESD-881415-5MG |
| Cas.: 17290-70-9 | Purity: 99% | Isosinensetin | ESD-881416-5MG |
| Cas.: 1728-15-0 | Purity: 95% | 6-Bromo-1,4-dioxaspiro[4.5]decane | ESD-881417-1G |
| Cas.: 1728-15-0 | Purity: 95% | 6-Bromo-1,4-dioxaspiro[4.5]decane | ESD-881417-5G |
| Cas.: 17278-28-3 | Purity: 98% | Isocucurbitacin B | ESD-881418-5MG |
| Cas.: 172760-03-1 | Purity: 95% | Mudanpioside C | ESD-881419-5MG |
| Cas.: 172733-79-8 | Purity: 95% | 4-Spiro-[3-phthalide]piperidine hydrochloride | ESD-881420-500MG |
| Cas.: 172733-79-8 | Purity: 95% | 4-Spiro-[3-phthalide]piperidine hydrochloride | ESD-881420-1G |
| Cas.: 172723-28-3 | Purity: 95% | Senkyunolide S | ESD-881421-5MG |
| Cas.: 172673-20-0 | Purity: 98% | Fosaprepitant | ESD-881422-5MG |
| Cas.: 172673-20-0 | Purity: 98% | Fosaprepitant | ESD-881422-10MG |
| Cas.: 172617-99-1 | Purity: 95% | Eucalyptone | ESD-881423-5MG |
| Cas.: 172549-37-0 | Purity: 95% | Senkyunolide R | ESD-881424-5MG |
| Cas.: 17249-61-5 | Purity: 95% | Eupatarone | ESD-881425-5MG |
| Cas.: 172486-22-5 | Purity: 97% | 9-Deacetyl-9-benzoyl-10-debenzoyltaxchinin A | ESD-881426-5MG |
| Cas.: 17245-30-6 | Purity: 98% | 3,5,6,7,3′,4′,5′-Heptamethoxyflavone | ESD-881427-5MG |
| Cas.: 17245-25-9 | Purity: 97% | Coumurrayin | ESD-881428-5MG |
| Cas.: 1724-18-1 | Purity: 98% | Oleanolic acid derivative 1 | ESD-881429-1MG |
| Cas.: 1724-18-1 | Purity: 98% | Oleanolic acid derivative 1 | ESD-881429-5MG |
| Cas.: 172377-87-6 | Purity: 98% | 2-Hydroxy-3-methoxybenzoic acid glucose ester | ESD-881431-5MG |
| Cas.: 172377-52-5 | Purity: ≥99% | Estradiol 3-sulfamate | ESD-881432-1MG |
| Cas.: 172377-52-5 | Purity: ≥99% | Estradiol 3-sulfamate | ESD-881432-5MG |
| Cas.: 17202-91-4 | Purity: 95% | spiro[2.5]octan-1-amine hydrochloride | ESD-881434-1G |
| Cas.: 17202-91-4 | Purity: 95% | spiro[2.5]octan-1-amine hydrochloride | ESD-881434-5G |
| Cas.: 17202-86-7 | Purity: 95% | spiro[2.5]octane-1-carboxylic acid | ESD-881435-1G |
| Cas.: 17202-86-7 | Purity: 95% | spiro[2.5]octane-1-carboxylic acid | ESD-881435-5G |
| Cas.: 17202-64-1 | Purity: 95% | Spiro[2.2]pentane-1-carboxylic acid | ESD-881436-1G |
| Cas.: 17202-64-1 | Purity: 95% | Spiro[2.2]pentane-1-carboxylic acid | ESD-881436-5G |
| Cas.: 17202-56-1 | Purity: 95% | spiro[2.3]hexane-1-carboxylic acid | ESD-881437-25MG |
| Cas.: 17202-56-1 | Purity: 95% | spiro[2.3]hexane-1-carboxylic acid | ESD-881437-50MG |
| Cas.: 17202-53-8 | Purity: 95% | Spiro[2.4]heptan-1-amine hydrochloride | ESD-881438-1G |
| Cas.: 171864-80-5 | Purity: 98% | Tryprostatin A | ESD-881439-5MG |
| Cas.: 171864-20-3 | Purity: 97% | 3-O-Coumaroylarjunolic acid | ESD-881440-5MG |
| Cas.: 17184-21-3 | Purity: 97% | Cauloside A | ESD-881441-5MG |
| Cas.: 17183-98-1 | Purity: 98% | 17-Acetyloxy-6-chloro-1α-chloromethylpregna-4,6-diene-3,20-dione | ESD-881442-5MG |
| Cas.: 171817-95-1 | Purity: 98% | 2-(1H-Indole-3-carboxamido)benzoic acid | ESD-881443-5MG |
| Cas.: 171783-05-4 | Purity: ≥98% | Crosstide | ESD-881444-1MG |
| Cas.: 171783-05-4 | Purity: ≥98% | Crosstide | ESD-881444-5MG |
| Cas.: 171-75-5 | Purity: 95% | Spiro[indoline-3,4′-piperidine] | ESD-881445-1G |
| Cas.: 171-75-5 | Purity: 95% | Spiro[indoline-3,4′-piperidine] | ESD-881445-5G |
| Cas.: 171746-21-7 | Purity: ≥99% | AGN 193109 | ESD-881446-5MG |
| Cas.: 171746-21-7 | Purity: ≥99% | AGN 193109 | ESD-881446-10MG |
| Cas.: 171722-81-9 | Purity: 98% | YM-46303 | ESD-881447-1MG |
| Cas.: 171722-81-9 | Purity: 98% | YM-46303 | ESD-881447-5MG |
| Cas.: 171674-89-8 | Purity: 93% | Nitidanin | ESD-881448-1MG |
| Cas.: 171598-74-6 | Purity: 98% | Trans (2,3)-Dihydrotetrabenazine | ESD-881449-2MG |
| Cas.: 171598-74-6 | Purity: 98% | Trans (2,3)-Dihydrotetrabenazine | ESD-881449-5MG |
| Cas.: 17159-82-9 | Purity: 95% | 1,4-Dioxaspiro[4.5]decan-8-ylmethanol | ESD-881450-5G |
| Cas.: 171569-81-6 | Purity: 98% | 10,11-Dihydro-24-hydroxyaflavinine | ESD-881451-5MG |
| Cas.: 17144-64-8 | Purity: 95% | (3-methyl-1,5-dioxaspiro[5.5]undec-3-yl)amine | ESD-881452-1G |
| Cas.: 17144-64-8 | Purity: 95% | (3-methyl-1,5-dioxaspiro[5.5]undec-3-yl)amine | ESD-881452-5G |
| Cas.: 171438-55-4 | Purity: 95% | Dammarenediol II 3-O-caffeate | ESD-881453-5MG |
| Cas.: 171436-38-7 | Purity: 98% | Protease-Activated Receptor-2 Activating Peptide | ESD-881454-1MG |
| Cas.: 171436-38-7 | Purity: 98% | Protease-Activated Receptor-2 Activating Peptide | ESD-881454-5MG |
| Cas.: 171422-85-8 | Purity: 98% | Otophylloside B 4”’-O-β-D-cymaropyranoside | ESD-881455-5MG |
| Cas.: 171422-82-5 | Purity: 97% | Otophylloside B 4”’-O-α-L-cymaropyranoside | ESD-881456-5MG |
| Cas.: 171361-65-2 | Purity: 92% | Ethyl 1-oxaspiro[2.5]octane-6-carboxylate | ESD-881457-1G |
| Cas.: 171361-65-2 | Purity: 92% | Ethyl 1-oxaspiro[2.5]octane-6-carboxylate | ESD-881457-5G |
| Cas.: 1713240-67-5 | Purity: ≥99% | CM-4620 | ESD-881459-5MG |
| Cas.: 1713240-67-5 | Purity: ≥99% | CM-4620 | ESD-881459-10MG |
| Cas.: 1713164-01-2 | Purity: 97% | 4-Bromo-1,2-dihydrospiro[indole-3,4′-piperidine]-2-one | ESD-881460-1G |
| Cas.: 1713163-98-4 | Purity: 95% | 2-(2-Fluorophenyl)-1,3,8-triazaspiro[4.5]dec-1-en-4-one hydrochloride | ESD-881461-1G |
| Cas.: 1713163-91-7 | Purity: 95% | 2-Ethyl-1,3,8-triazaspiro[4.5]dec-1-en-4-one hydrochloride | ESD-881462-1G |
| Cas.: 1713163-31-5 | Purity: 95% | 4-Chloro-1,2-dihydrospiro[indole-3,4′-piperidine]-2-one hydrochloride | ESD-881463-1G |
| Cas.: 1713163-29-1 | Purity: 97% | tert-Butyl 1-{[(benzyloxy)carbonyl]amino}-5-azaspiro[2.4]heptane-5-carboxylate | ESD-881464-1G |
| Cas.: 1713162-99-2 | Purity: 95% | 2-Cyclobutyl-3-methyl-1,3,8-triazaspiro[4.5]dec-1-en-4-one hydrochloride | ESD-881465-1G |
| Cas.: 1713162-87-8 | Purity: 95% | tert-Butyl 2-isopropyl-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate | ESD-881466-1G |
| Cas.: 171102-29-7 | Purity: 98% | AGN 192836 | ESD-881467-1MG |
| Cas.: 171102-29-7 | Purity: 98% | AGN 192836 | ESD-881467-5MG |
| Cas.: 1710630-11-7 | Purity: 98% | MGAT2-IN-2 | ESD-881468-5MG |
| Cas.: 1710630-11-7 | Purity: 98% | MGAT2-IN-2 | ESD-881468-10MG |
| Cas.: 170921-48-9 | Purity: 95% | 8-Benzyl-1,3,8-triazaspiro[4.5]decan-4-one | ESD-881469-1G |
| Cas.: 170921-48-9 | Purity: 95% | 8-Benzyl-1,3,8-triazaspiro[4.5]decan-4-one | ESD-881469-5G |
| Cas.: 1708971-72-5 | Purity: ≥99% | FGFR4-IN-1 | ESD-881470-1MG |
| Cas.: 1708971-72-5 | Purity: ≥99% | FGFR4-IN-1 | ESD-881470-5MG |
| Cas.: 170894-20-9 | Purity: 95% | Persianone | ESD-881471-5MG |
| Cas.: 17088-50-5 | Purity: 98% | Acutumine | ESD-881472-5MG |
| Cas.: 170846-89-6 | Purity: ≥98% | E4CPG | ESD-881473-5MG |
| Cas.: 170846-89-6 | Purity: ≥98% | E4CPG | ESD-881473-10MG |
| Cas.: 170842-46-3 | Purity: 98% | Substituted piperidines-1 | ESD-881474-1MG |
| Cas.: 170842-46-3 | Purity: 98% | Substituted piperidines-1 | ESD-881474-5MG |
| Cas.: 1708113-43-2 | Purity: ≥99% | ACY-1083 | ESD-881475-5MG |
| Cas.: 1708113-43-2 | Purity: ≥99% | ACY-1083 | ESD-881475-10MG |
| Cas.: 170809-51-5 | Purity: ≥96% | Astressin | ESD-881476-500ΜG |
| Cas.: 170809-51-5 | Purity: ≥96% | Astressin | ESD-881476-1MG |
| Cas.: 170791-09-0 | Purity: 98% | Trityl candesartan cilexetil | ESD-881477-5MG |
| Cas.: 1707714-56-4 | Purity: 95% | 5-Methoxy-3H-spiro[2-benzofuran-1,4′-piperidine] hydrochloride | ESD-881478-1G |
| Cas.: 1707714-45-1 | Purity: 95% | tert-Butyl2-(3-methoxyphenyl)-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate | ESD-881479-1G |
| Cas.: 1707713-85-6 | Purity: 95% | tert-Butyl2-(4-fluorophenyl)-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate | ESD-881480-1G |
| Cas.: 1707713-79-8 | Purity: 95% | 5-Bromo-1,2-dihydrospiro[indole-3,4′-piperidine]-2-one hydrochloride | ESD-881481-1G |
| Cas.: 1707602-66-1 | Purity: 95% | Benzyl N-?k5-azaspiro[2.4]heptan-1-yl?lcarbamate hydrochloride | ESD-881482-1G |
| Cas.: 1707602-59-2 | Purity: 95% | 2-(3-Methoxyphenyl)-1,3,8-triazaspiro[4.5]dec-1-en-4-one hydrochloride | ESD-881483-1G |
| Cas.: 1707602-35-4 | Purity: 95% | tert-Butyl 4-chloro-2-oxo-1,2-dihydrospiro[indole-3,4′-piperidine]-1′-carboxylat | ESD-881484-1G |
| Cas.: 1707602-32-1 | Purity: 95% | 2-Ethyl-3-methyl-1,3,8-triazaspiro[4.5]dec-1-en-4-one hydrochloride | ESD-881485-1G |
| Cas.: 1707602-26-3 | Purity: 95% | 7-Bromo-1,2-dihydrospiro[indole-3,4′-piperidine]-2-one hydrochloride | ESD-881486-1G |
| Cas.: 1707580-82-2 | Purity: 97% | tert-Butyl 4-bromo-2-oxo-1,2-dihydrospiro[indole-3,4′-piperidine]-1′-carboxylate | ESD-881487-1G |
| Cas.: 1707580-81-1 | Purity: 95% | tert-Butyl 2-cyclobutyl-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate | ESD-881488-1G |
| Cas.: 1707580-74-2 | Purity: 95% | 2-(4-Fluorophenyl)-1,3,8-triazaspiro[4.5]dec-1-en-4-one | ESD-881489-1G |
| Cas.: 1707575-98-1 | Purity: 95% | 6-Methoxy-3H-spiro[2-benzofuran-1,4′-piperidine]hydrochloride | ESD-881490-1G |
| Cas.: 1707575-96-9 | Purity: 95% | 4-Methoxy-3H-spiro[2-benzofuran-1,4′-piperidine] hydrochloride | ESD-881491-1G |
| Cas.: 1707575-94-7 | Purity: 95% | 2-Cyclobutyl-1,3,8-triazaspiro[4.5]dec-1-en-4-one hydrochloride | ESD-881492-1G |
| Cas.: 1707369-78-5 | Purity: 95% | tert-Butyl2-(2-methoxyphenyl)-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylat | ESD-881493-1G |
| Cas.: 1707369-75-2 | Purity: 95% | tert-Butyl 6-bromo-1,2-dihydrospiro[indole-3,4′-piperidine]-1′-carboxylate | ESD-881494-1G |
| Cas.: 1707367-86-9 | Purity: 95% | 2-Isopropyl-1,3,8-triazaspiro[4.5]dec-1-en-4-one hydrochloride | ESD-881495-1G |
| Cas.: 1707367-60-9 | Purity: 95% | 6,6-Difluorospiro[2.5]octan-1-amine hydrochloride | ESD-881496-1G |
| Cas.: 1707365-33-0 | Purity: 95% | 1′,3′-Dihydrospiro?kcyclobutane-1,2′-pyrazolo[3,2-b][1,3]oxazine?l-6′-carboxylic | ESD-881497-1G |
| Cas.: 1707365-30-7 | Purity: 95% | tert-Butyl 2-methyl-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate | ESD-881498-1G |
| Cas.: 1707361-82-7 | Purity: 97% | 7-Fluoro-1,2-dihydrospiro[indole-3,4′-piperidine]-2-one | ESD-881499-1G |
| Cas.: 1707361-64-5 | Purity: 95% | tert-Butyl2-(3-fluorophenyl)-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate | ESD-881500-1G |
| Cas.: 1707361-59-8 | Purity: 95% | 5-Fluoro-1,2-dihydrospiro[indole-3,4′-piperidine]-2-one hydrochloride | ESD-881501-1G |
| Cas.: 1707358-72-2 | Purity: 95% | 1′,3′-Dihydrospiro?kcyclopropane-1,2′-pyrazolo[3,2-b][1,3]oxazine?l-6′-amine | ESD-881502-1G |
| Cas.: 1707358-66-4 | Purity: 95% | 2-Methyl-1,3,8-triazaspiro[4.5]dec-1-en-4-one hydrochloride | ESD-881503-1G |
| Cas.: 1707358-49-3 | Purity: 95% | tert-Butyl N-{5-oxaspiro[2.5]octan-1-yl}carbamate | ESD-881504-1G |
| Cas.: 1706777-46-9 | Purity: 98% | Zidebactam sodium salt | ESD-881505-5MG |
| Cas.: 1706777-46-9 | Purity: 98% | Zidebactam sodium salt | ESD-881505-10MG |
| Cas.: 1706436-59-0 | Purity: 95% | 2-Boc-2,7-diazaspiro[4.5]decane oxalate | ESD-881506-1MG |
| Cas.: 1706435-18-8 | Purity: 95% | 3,3-dimethyl-2-oxa-7-azaspiro[4.4]nonane | ESD-881507-1G |
| Cas.: 1706435-18-8 | Purity: 95% | 3,3-dimethyl-2-oxa-7-azaspiro[4.4]nonane | ESD-881507-5G |
| Cas.: 170568-47-5 | Purity: 98% | U-101017 | ESD-881508-1MG |
| Cas.: 170568-47-5 | Purity: 98% | U-101017 | ESD-881508-5MG |
| Cas.: 170508-14-2 | Purity: 95% | 6-[(tert-Butoxycarbonyl)amino]spiro[3.3]-heptane-2-carboxylic acid methyl ester | ESD-881509-500MG |
| Cas.: 170508-14-2 | Purity: 95% | 6-[(tert-Butoxycarbonyl)amino]spiro[3.3]-heptane-2-carboxylic acid methyl ester | ESD-881509-1G |
| Cas.: 1704801-24-0 | Purity: ≥99% | AX-024 hydrochloride | ESD-881510-2MG |
| Cas.: 1704801-24-0 | Purity: ≥99% | AX-024 hydrochloride | ESD-881510-5MG |
| Cas.: 1704740-52-2 | Purity: 98% | AZ PFKFB3 26 | ESD-881511-5MG |
| Cas.: 1704740-52-2 | Purity: 98% | AZ PFKFB3 26 | ESD-881511-10MG |
| Cas.: 170380-69-5 | Purity: 95% | 1,4-Epidioxybisabola-2,10-dien-9-one | ESD-881512-5MG |
| Cas.: 170380-68-4 | Purity: 97% | 4-(6-Methyl-4-oxohept-5-en-2-yl)cyclohex-2-en-1-one | ESD-881513-5MG |
| Cas.: 17034-34-3 | Purity: 98% | Secretin, porcine | ESD-881514-1MG |
| Cas.: 17034-34-3 | Purity: 98% | Secretin, porcine | ESD-881514-5MG |
| Cas.: 1702864-11-6 | Purity: 98% | FF-10101 succinate | ESD-881515-5MG |
| Cas.: 1702864-11-6 | Purity: 98% | FF-10101 succinate | ESD-881515-10MG |
| Cas.: 1702809-17-3 | Purity: ≥99% | THZ531 | ESD-881516-5MG |
| Cas.: 1702809-17-3 | Purity: ≥99% | THZ531 | ESD-881516-10MG |
| Cas.: 170228-81-6 | Purity: 97% | 3-BOC–3-Azaspiro[5.5]undecane-9-carboxylic acid | ESD-881517-250MG |
| Cas.: 170228-81-6 | Purity: 97% | 3-BOC–3-Azaspiro[5.5]undecane-9-carboxylic acid | ESD-881517-1G |
| Cas.: 1702259-66-2 | Purity: ≥98% | H3B-6527 | ESD-881518-1MG |
| Cas.: 1702259-66-2 | Purity: ≥98% | H3B-6527 | ESD-881518-5MG |
| Cas.: 17020-27-8 | Purity: 95% | 24-Methylenecycloartane-3β,26-diol | ESD-881519-1MG |
| Cas.: 17020-04-1 | Purity: 95% | Bauerenol acetate | ESD-881520-5MG |
| Cas.: 170105-16-5 | Purity: ≥98% | imidafenacin | ESD-881521-10MG |
| Cas.: 170105-16-5 | Purity: ≥98% | imidafenacin | ESD-881521-25MG |
| Cas.: 17008-69-4 | Purity: 98% | Pseudobufarenogin | ESD-881522-5MG |
| Cas.: 1700693-08-8 | Purity: ≥98% | JH-II-127 | ESD-881523-2MG |
| Cas.: 1700693-08-8 | Purity: ≥98% | JH-II-127 | ESD-881523-5MG |
| Cas.: 170011-47-9 | Purity: 95% | 1,4-Dioxaspiro[4.5]dec-7-en-8-yl trifluoromethanesulfonate | ESD-881524-250MG |
| Cas.: 170011-47-9 | Purity: 95% | 1,4-Dioxaspiro[4.5]dec-7-en-8-yl trifluoromethanesulfonate | ESD-881524-1G |
| Cas.: 170006-73-2 | Purity: 98% | FTI-277 | ESD-881525-2MG |
| Cas.: 170006-73-2 | Purity: 98% | FTI-277 | ESD-881525-5MG |
| Cas.: 170006-72-1 | Purity: 98% | FTI 276 | ESD-881526-5MG |
| Cas.: 170006-72-1 | Purity: 98% | FTI 276 | ESD-881526-10MG |
| Cas.: 1699750-95-2 | Purity: ≥99% | EOAI3402143 | ESD-881527-5MG |
| Cas.: 1699750-95-2 | Purity: ≥99% | EOAI3402143 | ESD-881527-10MG |
| Cas.: 1699720-85-8 | Purity: ≥98% | (S)-ML753286 | ESD-881528-5MG |
| Cas.: 1699720-85-8 | Purity: ≥98% | (S)-ML753286 | ESD-881528-10MG |
| Cas.: 1699717-32-2 | Purity: ≥97% | BAY-545 | ESD-881529-5MG |
| Cas.: 1699717-32-2 | Purity: ≥97% | BAY-545 | ESD-881529-10MG |
| Cas.: 16994-56-2 | Purity: ≥99% | Reserpine hydrochloride | ESD-881530-100MG |
| Cas.: 169901-27-3 | Purity: 98% | DC1 | ESD-881531-1MG |
| Cas.: 1698878-14-6 | Purity: ≥99% | Nampt-IN-1 | ESD-881532-5MG |
| Cas.: 1698878-14-6 | Purity: ≥99% | Nampt-IN-1 | ESD-881532-10MG |
| Cas.: 169869-90-3 | Purity: ≥99% | Exatecan Mesylate | ESD-881533-1MG |
| Cas.: 169869-90-3 | Purity: ≥99% | Exatecan Mesylate | ESD-881533-5MG |
| Cas.: 16982-01-7 | Purity: 95% | Iso-cuparenal | ESD-881534-5MG |
| Cas.: 169815-40-1 | Purity: ≥98% | AQ-13 dihydrochloride | ESD-881535-5MG |
| Cas.: 169815-40-1 | Purity: ≥98% | AQ-13 dihydrochloride | ESD-881535-10MG |
| Cas.: 16981-20-7 | Purity: 95% | Mesuol | ESD-881536-5MG |
| Cas.: 1698055-86-5 | Purity: ≥98% | ARS-1630 | ESD-881537-5MG |
| Cas.: 1698055-86-5 | Purity: ≥98% | ARS-1630 | ESD-881537-10MG |
| Cas.: 1698024-73-5 | Purity: ≥98% | ARS-1323 | ESD-881538-5MG |
| Cas.: 1698024-73-5 | Purity: ≥98% | ARS-1323 | ESD-881538-10MG |
| Cas.: 16976-98-0 | Purity: 95% | 2,3-dihydrospiro[indene-1,3′-pyrrolidine] | ESD-881539-1G |
| Cas.: 16976-98-0 | Purity: 95% | 2,3-dihydrospiro[indene-1,3′-pyrrolidine] | ESD-881539-2.5G |
| Cas.: 16962-90-6 | Purity: 95% | Odoratone | ESD-881540-1MG |
| Cas.: 1695533-89-1 | Purity: ≥98% | KO-947 | ESD-881541-5MG |
| Cas.: 1695533-89-1 | Purity: ≥98% | KO-947 | ESD-881541-10MG |
| Cas.: 1693731-40-6 | Purity: ≥99% | CCT251236 | ESD-881542-1MG |
| Cas.: 1693731-40-6 | Purity: ≥99% | CCT251236 | ESD-881542-5MG |
| Cas.: 169332-61-0 | Purity: ≥99% | Ac-DEVD-AMC | ESD-881543-1MG |
| Cas.: 169332-61-0 | Purity: ≥99% | Ac-DEVD-AMC | ESD-881543-5MG |
| Cas.: 169326-06-1 | Purity: 98% | 16,23-Oxidoalisol B | ESD-881544-5MG |
| Cas.: 169293-50-9 | Purity: 98% | Nebivolol hydrochloride | ESD-881545-5MG |
| Cas.: 169281-53-2 | Purity: 98% | L162389 | ESD-881546-1MG |
| Cas.: 169281-53-2 | Purity: 98% | L162389 | ESD-881546-5MG |
| Cas.: 169274-78-6 | Purity: 98% | Ro 25-6981 | ESD-881547-5MG |
| Cas.: 169274-78-6 | Purity: 98% | Ro 25-6981 | ESD-881547-10MG |
| Cas.: 169234-89-3 | Purity: 95% | Dihydropedicin | ESD-881548-1MG |
| Cas.: 169217-47-4 | Purity: 95% | Trametol | ESD-881549-1MG |
| Cas.: 169206-67-1 | Purity: 95% | tert-Butyl 3-oxo-2,8-diazaspiro[4.5]decane-8-carboxylate | ESD-881550-1G |
| Cas.: 169206-67-1 | Purity: 95% | tert-Butyl 3-oxo-2,8-diazaspiro[4.5]decane-8-carboxylate | ESD-881550-5G |
| Cas.: 169206-62-6 | Purity: 95% | 3-Benzyl-1,3,8-triaza-spiro[4.5]decane-2,4-dione | ESD-881551-500MG |
| Cas.: 169206-62-6 | Purity: 95% | 3-Benzyl-1,3,8-triaza-spiro[4.5]decane-2,4-dione | ESD-881551-1G |
| Cas.: 16915-70-1 | Purity: 98% | Nifursol | ESD-881552-100MG |
| Cas.: 16915-70-1 | Purity: 98% | Nifursol | ESD-881552-500MG |
| Cas.: 1691249-45-2 | Purity: ≥99% | Zanubrutinib | ESD-881553-1MG |
| Cas.: 1691249-45-2 | Purity: ≥99% | Zanubrutinib | ESD-881553-5MG |
| Cas.: 1691201-82-7 | Purity: 96% | 4-Demethyltraxillaside | ESD-881554-5MG |
| Cas.: 1690-62-6 | Purity: 95% | 4′-O-Methylcoumestrol | ESD-881555-5MG |
| Cas.: 1688673-09-7 | Purity: ≥99% | TAS-115 mesylate | ESD-881556-5MG |
| Cas.: 1688673-09-7 | Purity: ≥99% | TAS-115 mesylate | ESD-881556-10MG |
| Cas.: 168828-58-8 | Purity: ≥99% | Sutezolid | ESD-881557-5MG |
| Cas.: 168828-58-8 | Purity: ≥99% | Sutezolid | ESD-881557-10MG |
| Cas.: 16851-21-1 | Purity: 98% | Morelloflavone | ESD-881558-5MG |
| Cas.: 16850-91-2 | Purity: 98% | Dehydrogeijerin | ESD-881559-5MG |
| Cas.: 168482-23-3 | Purity: ≥98% | SHU 9119 | ESD-881560-1MG |
| Cas.: 168482-23-3 | Purity: ≥98% | SHU 9119 | ESD-881560-5MG |
| Cas.: 1684386-71-7 | Purity: ≥99% | VER-246608 | ESD-881561-1MG |
| Cas.: 1684386-71-7 | Purity: ≥99% | VER-246608 | ESD-881561-5MG |
| Cas.: 168433-84-9 | Purity: 98% | SC58451 | ESD-881562-1MG |
| Cas.: 168433-84-9 | Purity: 98% | SC58451 | ESD-881562-5MG |
| Cas.: 168393-18-8 | Purity: 97% | threo-Guaiacylglycerol β-coniferyl ether | ESD-881563-5MG |
| Cas.: 168293-10-5 | Purity: 98% | C-Veratroylglycol | ESD-881564-5MG |
| Cas.: 168281-05-8 | Purity: 97% | 3,5-Dimethoxy-3′-hydroxybibenzyl | ESD-881565-5MG |
| Cas.: 168254-96-4 | Purity: 96% | Evofolin B | ESD-881566-5MG |
| Cas.: 168254-95-3 | Purity: 95% | Wilforol C | ESD-881567-1MG |
| Cas.: 168109-52-2 | Purity: 98% | Taxin B | ESD-881568-5MG |
| Cas.: 168037-22-7 | Purity: 95% | cis-Miyabenol C | ESD-881569-5MG |
| Cas.: 16803-07-9 | Purity: 95% | 1,4-dioxa-8-azaspiro[4.6]undecane | ESD-881570-1G |
| Cas.: 16803-07-9 | Purity: 95% | 1,4-dioxa-8-azaspiro[4.6]undecane | ESD-881570-5G |
| Cas.: 168001-54-5 | Purity: 97% | Otophylloside B 4”’-O-β-D-oleandropyranoside | ESD-881571-5MG |
| Cas.: 167958-89-6 | Purity: 97% | Stigmasta-4,22-diene-3β,6β-diol | ESD-881572-5MG |
| Cas.: 16790-93-5 | Purity: 98% | 19(S)-Hydroxyconopharyengine | ESD-881573-5MG |
| Cas.: 16790-92-4 | Purity: 98% | Crassanine | ESD-881574-5MG |
| Cas.: 167906-75-4 | Purity: 98% | Taxachitriene B | ESD-881575-5MG |
| Cas.: 167906-74-3 | Purity: 95% | Taxachitriene A | ESD-881576-5MG |
| Cas.: 167898-32-0 | Purity: 95% | ent-Kaurane-16β,19,20-triol | ESD-881577-5MG |
| Cas.: 167875-39-0 | Purity: 90% | Rubelloside B | ESD-881578-5MG |
| Cas.: 1676893-24-5 | Purity: ≥99% | NSC781406 | ESD-881579-1MG |
| Cas.: 1676893-24-5 | Purity: ≥99% | NSC781406 | ESD-881579-5MG |
| Cas.: 16759-59-4 | Purity: 98% | Benoxafos | ESD-881580-5MG |
| Cas.: 16759-59-4 | Purity: 98% | Benoxafos | ESD-881580-10MG |
| Cas.: 1675821-32-5 | Purity: 98% | EML 425 | ESD-881581-5MG |
| Cas.: 1675821-32-5 | Purity: 98% | EML 425 | ESD-881581-10MG |
| Cas.: 1675-66-7 | Purity: ≥98% | Adelmidrol | ESD-881582-100MG |
| Cas.: 167484-65-3 | Purity: 95% | 5-Fluoro-2H-spiro[1-benzofuran-3,4′-piperidine]hydrochloride | ESD-881583-1G |
| Cas.: 1674359-84-2 | Purity: 97% | Sophoracarpan B | ESD-881584-5MG |
| Cas.: 1674359-82-0 | Purity: 98% | Sophoracarpan A | ESD-881585-5MG |
| Cas.: 1673560-66-1 | Purity: 98% | PD-1-IN-17 | ESD-881586-5MG |
| Cas.: 1673560-66-1 | Purity: 98% | PD-1-IN-17 | ESD-881586-10MG |
| Cas.: 167305-00-2 | Purity: ≥97% | Omapatrilat | ESD-881587-5MG |
| Cas.: 167305-00-2 | Purity: ≥97% | Omapatrilat | ESD-881587-10MG |
| Cas.: 167276-19-9 | Purity: 98% | Quercetin dimer | ESD-881588-5MG |
| Cas.: 1672665-49-4 | Purity: ≥99% | PT-2385 | ESD-881589-2MG |
| Cas.: 1672665-49-4 | Purity: ≥99% | PT-2385 | ESD-881589-5MG |
| Cas.: 1672662-14-4 | Purity: ≥99% | PT2399 | ESD-881590-5MG |
| Cas.: 1672662-14-4 | Purity: ≥99% | PT2399 | ESD-881590-10MG |
| Cas.: 1672-46-4 | Purity: ≥99% | Digoxigenin | ESD-881591-10MG |
| Cas.: 1672-46-4 | Purity: ≥99% | Digoxigenin | ESD-881591-50MG |
| Cas.: 167074-97-7 | Purity: 98% | 10-Oxo Docetaxel | ESD-881592-1MG |
| Cas.: 167074-97-7 | Purity: 98% | 10-Oxo Docetaxel | ESD-881592-5MG |
| Cas.: 167073-19-0 | Purity: 98% | Pitavastatin ethyl ester | ESD-881593-5MG |
| Cas.: 166990-10-9 | Purity: 98% | Murrayamine O | ESD-881594-5MG |
| Cas.: 166974-23-8 | Purity: 98% | GV-196771A | ESD-881595-1MG |
| Cas.: 166974-23-8 | Purity: 98% | GV-196771A | ESD-881595-5MG |
| Cas.: 166882-70-8 | Purity: 98% | AZD 4407 | ESD-881596-1MG |
| Cas.: 166882-70-8 | Purity: 98% | AZD 4407 | ESD-881596-5MG |
| Cas.: 1667718-89-9 | Purity: 95% | Prerubialatin | ESD-881597-5MG |
| Cas.: 166734-83-4 | Purity: ≥99% | Ornidazole Levo- | ESD-881598-50MG |
| Cas.: 166547-20-2 | Purity: 97% | Eurycarpin A | ESD-881599-5MG |
| Cas.: 1664-33-1 | Purity: 95% | 6,9-diazaspiro[4.5]decan-10-one | ESD-881600-1G |
| Cas.: 1664-33-1 | Purity: 95% | 6,9-diazaspiro[4.5]decan-10-one | ESD-881600-2.5G |
| Cas.: 166410-37-3 | Purity: ≥99% | Fmoc-1,6-diaminohexane | ESD-881601-200MG |
| Cas.: 166398-41-0 | Purity: 95% | (1,4-Dioxa-spiro[4.5]dec-8-yl)-methyl-amine | ESD-881602-1G |
| Cas.: 166398-41-0 | Purity: 95% | (1,4-Dioxa-spiro[4.5]dec-8-yl)-methyl-amine | ESD-881602-5G |
| Cas.: 166335-18-8 | Purity: 98% | PNU-103017 | ESD-881603-1MG |
| Cas.: 166335-18-8 | Purity: 98% | PNU-103017 | ESD-881603-5MG |
| Cas.: 166322-14-1 | Purity: 97% | 9-O-Feruloyl-5,5′-dimethoxylariciresinol | ESD-881604-5MG |
| Cas.: 1662688-34-7 | Purity: 97% | Taberdivarine H | ESD-881605-5MG |
| Cas.: 16625-57-3 | Purity: 95% | Argentinine | ESD-881606-1MG |
| Cas.: 1661914-46-0 | Purity: 97% | Taxilluside A | ESD-881607-5MG |
| Cas.: 1661854-97-2 | Purity: ≥99% | TAS6417 | ESD-881608-5MG |
| Cas.: 1661854-97-2 | Purity: ≥99% | TAS6417 | ESD-881608-10MG |
| Cas.: 1661839-45-7 | Purity: ≥99% | CCT251545 | ESD-881609-2MG |
| Cas.: 1661839-45-7 | Purity: ≥99% | CCT251545 | ESD-881609-5MG |
| Cas.: 1661020-92-3 | Purity: 98% | MW-150 dihydrochloride dihydrate | ESD-881610-5MG |
| Cas.: 1661020-92-3 | Purity: 98% | MW-150 dihydrochloride dihydrate | ESD-881610-10MG |
| Cas.: 1660963-42-7 | Purity: ≥99% | EGFR-IN-3 | ESD-881611-5MG |
| Cas.: 1660963-42-7 | Purity: ≥99% | EGFR-IN-3 | ESD-881611-10MG |
| Cas.: 166095-21-2 | Purity: ≥98% | BMS-191095 | ESD-881612-1MG |
| Cas.: 166095-21-2 | Purity: ≥98% | BMS-191095 | ESD-881612-5MG |
| Cas.: 1660156-04-6 | Purity: 98% | Cyclogrifolin | ESD-881613-5MG |
| Cas.: 16584-54-6 | Purity: 98% | 1-Hydroxy-N-methylacridone | ESD-881614-5MG |
| Cas.: 165800-04-4 | Purity: ≥96% | Eperezolid | ESD-881615-5MG |
| Cas.: 165800-04-4 | Purity: ≥96% | Eperezolid | ESD-881615-10MG |
| Cas.: 1657033-33-4 | Purity: 90% | 2-methyl-2,6-diazaspiro[3.3]heptane bis(trifluoroacetate) | ESD-881616-250MG |
| Cas.: 1657033-33-4 | Purity: 90% | 2-methyl-2,6-diazaspiro[3.3]heptane bis(trifluoroacetate) | ESD-881616-1G |
| Cas.: 1657014-42-0 | Purity: ≥99% | GDC-0575 dihydrochloride | ESD-881617-5MG |
| Cas.: 1657014-42-0 | Purity: ≥99% | GDC-0575 dihydrochloride | ESD-881617-10MG |
| Cas.: 165689-32-7 | Purity: 95% | Torososide A | ESD-881618-1MG |
| Cas.: 16566-88-4 | Purity: 95% | Methyl 6-acetoxyangolensate | ESD-881619-1MG |
| Cas.: 165668-41-7 | Purity: ≥99% | Indisulam | ESD-881620-5MG |
| Cas.: 165668-41-7 | Purity: ≥99% | Indisulam | ESD-881620-10MG |
| Cas.: 165538-40-9 | Purity: ≥99% | Terutroban | ESD-881621-10MG |
| Cas.: 165538-40-9 | Purity: ≥99% | Terutroban | ESD-881621-50MG |
| Cas.: 165459-53-0 | Purity: 95% | 16-Hydroxy-2-oxocleroda-3,13-dien-15,16-olide | ESD-881622-1MG |
| Cas.: 165377-43-5 | Purity: 98% | Cutamesine | ESD-881623-10MG |
| Cas.: 165377-43-5 | Purity: 98% | Cutamesine | ESD-881623-50MG |
| Cas.: 165338-28-3 | Purity: 96% | Hemiphroside B | ESD-881624-5MG |
| Cas.: 165338-27-2 | Purity: 93% | Hemiphroside A | ESD-881625-5MG |
| Cas.: 1652591-81-5 | Purity: ≥98% | GSK484 hydrochloride | ESD-881626-5MG |
| Cas.: 1652591-81-5 | Purity: ≥98% | GSK484 hydrochloride | ESD-881626-10MG |
| Cas.: 165197-71-7 | Purity: 98% | Cleroindicin E | ESD-881627-5MG |
| Cas.: 1651890-44-6 | Purity: ≥99% | Pyridoclax | ESD-881628-2MG |
| Cas.: 1651890-44-6 | Purity: ≥99% | Pyridoclax | ESD-881628-5MG |
| Cas.: 1651839-34-7 | Purity: 97% | Lycojaponicuminol C | ESD-881629-5MG |
| Cas.: 165074-00-0 | Purity: 97% | 6-Epidemethylesquirolin D | ESD-881630-5MG |
| Cas.: 1650550-25-6 | Purity: ≥99% | Enasidenib mesylate | ESD-881631-5MG |
| Cas.: 1650550-25-6 | Purity: ≥99% | Enasidenib mesylate | ESD-881631-10MG |
| Cas.: 1650548-73-4 | Purity: 95% | 6-Bromo-1,2-dihydrospiro[indole-3,4′-piperidine]-2-one hydrochloride | ESD-881632-1G |
| Cas.: 16503-32-5 | Purity: 91% | Brevilin A | ESD-881633-5MG |
| Cas.: 164991-53-1 | Purity: 95% | Calyxin B | ESD-881634-1MG |
| Cas.: 1648863-90-4 | Purity: ≥99% | G-5555 | ESD-881635-1MG |
| Cas.: 1648863-90-4 | Purity: ≥99% | G-5555 | ESD-881635-5MG |
| Cas.: 164661-12-5 | Purity: 95% | 4-(3,4-Dimethoxyphenyl)-3-butene-1,2-diol | ESD-881636-5MG |
| Cas.: 164658-13-3 | Purity: ≥99% | CGP60474 | ESD-881637-5MG |
| Cas.: 164658-13-3 | Purity: ≥99% | CGP60474 | ESD-881637-10MG |
| Cas.: 1644069-80-6 | Purity: ≥97% | DDR Inhibitor | ESD-881638-5MG |
| Cas.: 1644069-80-6 | Purity: ≥97% | DDR Inhibitor | ESD-881638-10MG |
| Cas.: 1644060-37-6 | Purity: ≥99% | Fumarate hydratase-IN-1 | ESD-881639-2MG |
| Cas.: 1644060-37-6 | Purity: ≥99% | Fumarate hydratase-IN-1 | ESD-881639-5MG |
| Cas.: 1643368-58-4 | Purity: ≥99% | BMS-986142 | ESD-881640-5MG |
| Cas.: 1643368-58-4 | Purity: ≥99% | BMS-986142 | ESD-881640-10MG |
| Cas.: 1643125-33-0 | Purity: ≥98% | SAFit2 | ESD-881641-5MG |
| Cas.: 1643125-32-9 | Purity: ≥99% | SAFit1 | ESD-881642-5MG |
| Cas.: 1643125-32-9 | Purity: ≥99% | SAFit1 | ESD-881642-10MG |
| Cas.: 1642306-14-6 | Purity: 98% | Otophylloside T | ESD-881643-5MG |
| Cas.: 1642303-38-5 | Purity: ≥99% | ITI214 | ESD-881644-2MG |
| Cas.: 1642303-38-5 | Purity: ≥99% | ITI214 | ESD-881644-5MG |
| Cas.: 1642297-01-5 | Purity: ≥99% | GDC-0927 | ESD-881645-5MG |
| Cas.: 1642297-01-5 | Purity: ≥99% | GDC-0927 | ESD-881645-10MG |
| Cas.: 1642288-47-8 | Purity: ≥99% | Mavacamten | ESD-881646-1MG |
| Cas.: 1642288-47-8 | Purity: ≥99% | Mavacamten | ESD-881646-5MG |
| Cas.: 1641940-94-4 | Purity: ≥98% | Alfacalcidol-D6 | ESD-881647-1MG |
| Cas.: 1641940-94-4 | Purity: ≥98% | Alfacalcidol-D6 | ESD-881647-5MG |
| Cas.: 16408-75-6 | Purity: 95% | Cassamedine | ESD-881648-5MG |
| Cas.: 164078-72-2 | Purity: 95% | 6-Fluoro-3H-spiro[2-benzofuran-1,4′-piperidine] hydrochloride | ESD-881649-1G |
| Cas.: 1640282-30-9 | Purity: 98% | TH588 hydrochloride | ESD-881650-5MG |
| Cas.: 1640282-30-9 | Purity: 98% | TH588 hydrochloride | ESD-881650-25MG |
| Cas.: 164022-75-7 | Purity: 97% | Clerodenoside A | ESD-881651-5MG |
| Cas.: 1639895-85-4 | Purity: ≥98% | tBID | ESD-881652-1MG |
| Cas.: 1639895-85-4 | Purity: ≥98% | tBID | ESD-881652-5MG |
| Cas.: 1639810-67-5 | Purity: 97% | Dauca-8,11-dien-7-one | ESD-881653-5MG |
| Cas.: 1639792-20-3 | Purity: ≥98% | Saroglitazar Magnesium | ESD-881654-1MG |
| Cas.: 1639792-20-3 | Purity: ≥98% | Saroglitazar Magnesium | ESD-881654-5MG |
| Cas.: 163956-16-9 | Purity: 97% | cis-Tiliroside | ESD-881655-5MG |
| Cas.: 1639-43-6 | Purity: 98% | Androstenediol-3-acetate | ESD-881656-5MG |
| Cas.: 1639422-97-1 | Purity: ≥98% | JH-VIII-157-02 | ESD-881657-5MG |
| Cas.: 1639422-97-1 | Purity: ≥98% | JH-VIII-157-02 | ESD-881657-10MG |
| Cas.: 1639417-54-1 | Purity: ≥98% | Tenalisib R Enantiomer | ESD-881658-1MG |
| Cas.: 1639417-54-1 | Purity: ≥98% | Tenalisib R Enantiomer | ESD-881658-5MG |
| Cas.: 1639411-87-2 | Purity: 98% | 9-Azido-Neu5DAz | ESD-881659-5MG |
| Cas.: 1639411-87-2 | Purity: 98% | 9-Azido-Neu5DAz | ESD-881659-10MG |
| Cas.: 1639257-37-6 | Purity: 97% | 12E,14-Labdadien-20,8β-olide | ESD-881660-5MG |
| Cas.: 1639257-36-5 | Purity: 96% | 8(17),12E,14-Labdatrien-20-oic acid | ESD-881661-5MG |
| Cas.: 1639042-28-6 | Purity: 98% | AZD9496 maleate | ESD-881662-2MG |
| Cas.: 1639042-28-6 | Purity: 98% | AZD9496 maleate | ESD-881662-5MG |
| Cas.: 1638767-88-0 | Purity: 95% | 5-Azaspiro[2.3]hexane hemioxalate | ESD-881663-250MG |
| Cas.: 1638765-27-1 | Purity: 95% | 5-Benzyl-2-oxa-5,8-diazaspiro[3.5]nonane | ESD-881664-250MG |
| Cas.: 1638526-21-2 | Purity: ≥98% | EMT inhibitor-1 | ESD-881665-5MG |
| Cas.: 1638526-21-2 | Purity: ≥98% | EMT inhibitor-1 | ESD-881665-10MG |
| Cas.: 1638504-66-1 | Purity: 98% | HIV-1 integration inhibitor 4 | ESD-881666-1MG |
| Cas.: 1638504-66-1 | Purity: 98% | HIV-1 integration inhibitor 4 | ESD-881666-5MG |
| Cas.: 1638504-56-9 | Purity: 98% | HIV-1 integration inhibitor 3 | ESD-881667-1MG |
| Cas.: 1638504-56-9 | Purity: 98% | HIV-1 integration inhibitor 3 | ESD-881667-5MG |
| Cas.: 163838-04-8 | Purity: 98% | UP202-56 | ESD-881668-1MG |
| Cas.: 163838-04-8 | Purity: 98% | UP202-56 | ESD-881668-5MG |
| Cas.: 1638250-96-0 | Purity: ≥98% | ETC-159 | ESD-881669-1MG |
| Cas.: 1638250-96-0 | Purity: ≥98% | ETC-159 | ESD-881669-5MG |
| Cas.: 1638221-35-8 | Purity: 95% | 1,4,9-triazaspiro[5.5]undecan-5-one dihydrochloride | ESD-881670-250MG |
| Cas.: 1638221-35-8 | Purity: 95% | 1,4,9-triazaspiro[5.5]undecan-5-one dihydrochloride | ESD-881670-1G |
| Cas.: 1638211-05-8 | Purity: 98% | TH287 hydrochloride | ESD-881671-5MG |
| Cas.: 1638211-05-8 | Purity: 98% | TH287 hydrochloride | ESD-881671-10MG |
| Cas.: 1637-75-8 | Purity: ≥99% | 3-Hydroxyhippuric acid | ESD-881673-50MG |
| Cas.: 1637752-37-4 | Purity: 95% | 4′-BROMOSPIRO[CYCLOPROPANE-1,3′-INDOLIN]-2′-ONE | ESD-881674-1G |
| Cas.: 1637752-37-4 | Purity: 95% | 4′-BROMOSPIRO[CYCLOPROPANE-1,3′-INDOLIN]-2′-ONE | ESD-881674-5G |
| Cas.: 1637752-36-3 | Purity: 95% | 4′-CHLOROSPIRO[CYCLOPROPANE-1,3′-INDOLIN]-2′-ONE | ESD-881675-1G |
| Cas.: 1637752-28-3 | Purity: 95% | SPIRO[CYCLOPROPANE-1,3′-PYRROLO[2,3-C]PYRIDIN]-2′(1’H)-ONE | ESD-881676-1G |
| Cas.: 1637735-84-2 | Purity: ≥98% | FIIN-3 | ESD-881677-1MG |
| Cas.: 1637735-84-2 | Purity: ≥98% | FIIN-3 | ESD-881677-5MG |
| Cas.: 163768-50-1 | Purity: ≥97% | Auristatin F | ESD-881678-1MG |
| Cas.: 163768-50-1 | Purity: ≥97% | Auristatin F | ESD-881678-5MG |
| Cas.: 1637542-34-7 | Purity: 98% | (Rac)-Nedisertib | ESD-881679-5MG |
| Cas.: 1637542-34-7 | Purity: 98% | (Rac)-Nedisertib | ESD-881679-10MG |
| Cas.: 1637300-25-4 | Purity: ≥98% | AF64394 | ESD-881680-5MG |
| Cas.: 1637300-25-4 | Purity: ≥98% | AF64394 | ESD-881680-10MG |
| Cas.: 1636881-61-2 | Purity: ≥98% | Mavoglurant racemate | ESD-881681-2MG |
| Cas.: 1636881-61-2 | Purity: ≥98% | Mavoglurant racemate | ESD-881681-5MG |
| Cas.: 163634-05-7 | Purity: 95% | Evofolin C | ESD-881682-1MG |
| Cas.: 1636180-98-7 | Purity: ≥98% | Tarloxotinib bromide | ESD-881683-5MG |
| Cas.: 1636180-98-7 | Purity: ≥98% | Tarloxotinib bromide | ESD-881683-10MG |
| Cas.: 163560-19-8 | Purity: 98% | AMARA peptide | ESD-881684-1MG |
| Cas.: 163560-19-8 | Purity: 98% | AMARA peptide | ESD-881684-5MG |
| Cas.: 163513-81-3 | Purity: 96% | Triptoquinonide | ESD-881685-5MG |
| Cas.: 163434-73-9 | Purity: 96% | 2″,4″-Di-O-(Ep-coumaroyl)afzelin | ESD-881686-5MG |
| Cas.: 163391-76-2 | Purity: 98% | Stachybotrylactam | ESD-881687-5MG |
| Cas.: 1633009-87-6 | Purity: ≥99% | BI 689648 | ESD-881688-1MG |
| Cas.: 1633009-87-6 | Purity: ≥99% | BI 689648 | ESD-881688-5MG |
| Cas.: 163269-30-5 | Purity: 98% | Bethoxazin | ESD-881689-10MG |
| Cas.: 163269-30-5 | Purity: 98% | Bethoxazin | ESD-881689-50MG |
| Cas.: 1632032-53-1 | Purity: ≥98% | LB-100 | ESD-881690-2MG |
| Cas.: 1632032-53-1 | Purity: ≥98% | LB-100 | ESD-881690-5MG |
| Cas.: 1632006-28-0 | Purity: ≥99% | Esaxerenone | ESD-881691-1MG |
| Cas.: 1632006-28-0 | Purity: ≥99% | Esaxerenone | ESD-881691-5MG |
| Cas.: 16320-04-0 | Purity: ≥99% | Gestrinone | ESD-881692-5MG |
| Cas.: 16320-04-0 | Purity: ≥99% | Gestrinone | ESD-881692-10MG |
| Cas.: 163136-19-4 | Purity: 96% | Cannabisin F | ESD-881693-5MG |
| Cas.: 1630970-05-6 | Purity: 98% | Albatrelin G | ESD-881694-5MG |
| Cas.: 1630936-42-3 | Purity: 96% | 17-Hydroxy-18-dehydroneogrifolin | ESD-881695-5MG |
| Cas.: 163060-07-9 | Purity: 95% | Lup-20(29)-ene-3β,23-diol | ESD-881696-5MG |
| Cas.: 1630086-20-2 | Purity: ≥99% | Kira8 | ESD-881697-5MG |
| Cas.: 1629869-44-8 | Purity: ≥99% | Pimodivir | ESD-881698-2MG |
| Cas.: 1629869-44-8 | Purity: ≥99% | Pimodivir | ESD-881698-5MG |
| Cas.: 162929-64-8 | Purity: 98% | C-telopeptide | ESD-881699-1MG |
| Cas.: 162929-64-8 | Purity: 98% | C-telopeptide | ESD-881699-5MG |
| Cas.: 1629268-19-4 | Purity: ≥99% | K-Ras G12C-IN-3 | ESD-881700-1MG |
| Cas.: 1629268-19-4 | Purity: ≥99% | K-Ras G12C-IN-3 | ESD-881700-5MG |
| Cas.: 1629267-75-9 | Purity: 98% | K-Ras G12C-IN-2 | ESD-881701-1MG |
| Cas.: 1629267-75-9 | Purity: 98% | K-Ras G12C-IN-2 | ESD-881701-5MG |
| Cas.: 1629265-17-3 | Purity: ≥98% | K-Ras G12C-IN-1 | ESD-881702-1MG |
| Cas.: 1629265-17-3 | Purity: ≥98% | K-Ras G12C-IN-1 | ESD-881702-5MG |
| Cas.: 1629229-37-3 | Purity: ≥98% | Fezolinetant | ESD-881703-1MG |
| Cas.: 1629229-37-3 | Purity: ≥98% | Fezolinetant | ESD-881703-5MG |
| Cas.: 1629166-02-4 | Purity: ≥99% | SBC-110736 | ESD-881704-5MG |
| Cas.: 1629166-02-4 | Purity: ≥99% | SBC-110736 | ESD-881704-10MG |
| Cas.: 1629125-65-0 | Purity: ≥99% | IDO-IN-4 | ESD-881705-2MG |
| Cas.: 1629125-65-0 | Purity: ≥99% | IDO-IN-4 | ESD-881705-5MG |
| Cas.: 1629063-81-5 | Purity: ≥98% | GNE-131 | ESD-881706-5MG |
| Cas.: 1629063-81-5 | Purity: ≥98% | GNE-131 | ESD-881706-10MG |
| Cas.: 1628830-21-6 | Purity: ≥99% | EZM 2302 | ESD-881707-5MG |
| Cas.: 1628830-21-6 | Purity: ≥99% | EZM 2302 | ESD-881707-10MG |
| Cas.: 1628805-46-8 | Purity: ≥98% | IDH-305 | ESD-881708-1MG |
| Cas.: 1628805-46-8 | Purity: ≥98% | IDH-305 | ESD-881708-5MG |
| Cas.: 1628607-64-6 | Purity: ≥98% | INCB054329 | ESD-881709-5MG |
| Cas.: 1628607-64-6 | Purity: ≥98% | INCB054329 | ESD-881709-10MG |
| Cas.: 1628607-62-4 | Purity: 98% | INCB054329 Racemate | ESD-881710-5MG |
| Cas.: 1628607-62-4 | Purity: 98% | INCB054329 Racemate | ESD-881710-10MG |
| Cas.: 1628428-01-2 | Purity: ≥99% | PKR-IN-2 | ESD-881711-5MG |
| Cas.: 1628428-01-2 | Purity: ≥99% | PKR-IN-2 | ESD-881711-10MG |
| Cas.: 1628416-28-3 | Purity: ≥99% | CFTR corrector 2 | ESD-881712-5MG |
| Cas.: 1628416-28-3 | Purity: ≥99% | CFTR corrector 2 | ESD-881712-10MG |
| Cas.: 1628332-52-4 | Purity: ≥99% | GSK467 | ESD-881713-5MG |
| Cas.: 1628332-52-4 | Purity: ≥99% | GSK467 | ESD-881713-10MG |
| Cas.: 1628291-95-1 | Purity: ≥98% | HC-070 | ESD-881714-5MG |
| Cas.: 1628291-95-1 | Purity: ≥98% | HC-070 | ESD-881714-10MG |
| Cas.: 1628287-16-0 | Purity: ≥99% | Pico145 | ESD-881715-5MG |
| Cas.: 1628287-16-0 | Purity: ≥99% | Pico145 | ESD-881715-10MG |
| Cas.: 1628210-26-3 | Purity: ≥98% | KDM5-IN-1 | ESD-881716-1MG |
| Cas.: 1628210-26-3 | Purity: ≥98% | KDM5-IN-1 | ESD-881716-5MG |
| Cas.: 1627856-64-7 | Purity: ≥99% | GSK3179106 | ESD-881717-1MG |
| Cas.: 1627856-64-7 | Purity: ≥99% | GSK3179106 | ESD-881717-5MG |
| Cas.: 162784-72-7 | Purity: 98% | 7-Epi-10-oxo-docetaxel | ESD-881718-1MG |
| Cas.: 162784-72-7 | Purity: 98% | 7-Epi-10-oxo-docetaxel | ESD-881718-5MG |
| Cas.: 1627696-51-8 | Purity: ≥99% | LY3177833 | ESD-881719-5MG |
| Cas.: 1627696-51-8 | Purity: ≥99% | LY3177833 | ESD-881719-10MG |
| Cas.: 1627676-59-8 | Purity: 98% | PFI-2 | ESD-881720-10MG |
| Cas.: 1627676-59-8 | Purity: 98% | PFI-2 | ESD-881720-50MG |
| Cas.: 162762-93-8 | Purity: 95% | Yunnancoronarin A | ESD-881721-1MG |
| Cas.: 1627521-95-2 | Purity: 96% | Anemarrhena B | ESD-881722-5MG |
| Cas.: 1627516-10-2 | Purity: 97% | Sonnerphenolic B | ESD-881723-5MG |
| Cas.: 16274-34-3 | Purity: 97% | 1-Hydroxy-2-prenylnaphthalene | ESD-881724-5MG |
| Cas.: 16274-33-2 | Purity: 95% | 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran | ESD-881725-1MG |
| Cas.: 16274-11-6 | Purity: 95% | Kaempferol tetraacetate | ESD-881726-5MG |
| Cas.: 1627091-47-7 | Purity: ≥99% | MLi-2 | ESD-881727-2MG |
| Cas.: 1627091-47-7 | Purity: ≥99% | MLi-2 | ESD-881727-5MG |
| Cas.: 162704-20-3 | Purity: 98% | UK-157147 | ESD-881728-1MG |
| Cas.: 162704-20-3 | Purity: 98% | UK-157147 | ESD-881728-5MG |
| Cas.: 16265-56-8 | Purity: 98% | 6-Deoxyjacareubin | ESD-881729-5MG |
| Cas.: 1626359-62-3 | Purity: ≥95% | SPDB-DM4 | ESD-881730-1MG |
| Cas.: 1626359-62-3 | Purity: ≥95% | SPDB-DM4 | ESD-881730-5MG |
| Cas.: 1626359-59-8 | Purity: 98% | sulfo-SPDB-DM4 | ESD-881731-1MG |
| Cas.: 1626359-59-8 | Purity: 98% | sulfo-SPDB-DM4 | ESD-881731-5MG |
| Cas.: 162616-73-1 | Purity: 98% | Sorokinianin | ESD-881732-5MG |
| Cas.: 162616-70-8 | Purity: 97% | Isolupalbigenin | ESD-881733-5MG |
| Cas.: 162602-04-2 | Purity: 95% | 3-Hydroxy-5,7-dimethoxy-3′,4′-methylenedioxyflavan | ESD-881734-5MG |
| Cas.: 16252-93-0 | Purity: 95% | 3-amino-8-methyl-1,3-diazaspiro[4.5]decane-2,4-dione | ESD-881735-1G |
| Cas.: 16252-63-4 | Purity: 95% | 3-Amino-1,3-diaza-spiro[4.5]decane-2,4-dione | ESD-881736-1G |
| Cas.: 162473-22-5 | Purity: 97% | Subelliptenone G | ESD-881737-5MG |
| Cas.: 1624117-53-8 | Purity: ≥99% | XY1 | ESD-881738-5MG |
| Cas.: 1624117-53-8 | Purity: ≥99% | XY1 | ESD-881738-10MG |
| Cas.: 162411-67-8 | Purity: 95% | Stilbostemin B | ESD-881739-1MG |
| Cas.: 1623786-67-3 | Purity: 95% | Vibralactone L | ESD-881740-1MG |
| Cas.: 1623786-66-2 | Purity: 95% | Vibralactone K | ESD-881741-1MG |
| Cas.: 162358-09-0 | Purity: 98% | Tricetyl fingolimod | ESD-881742-5MG |
| Cas.: 162358-08-9 | Purity: 98% | Diethyl 2-acetamido-2-(4-octylphenethyl)malonate | ESD-881743-5MG |
| Cas.: 1623437-86-4 | Purity: 98% | Hydramicromelin D | ESD-881744-5MG |
| Cas.: 1623410-12-7 | Purity: 95% | Baccatin IX | ESD-881745-5MG |
| Cas.: 1623410-10-5 | Purity: 97% | Baccatin VIII | ESD-881746-5MG |
| Cas.: 1623069-76-0 | Purity: 95% | Baccatin X | ESD-881747-1MG |
| Cas.: 1622902-68-4 | Purity: ≥99% | abrocitinib | ESD-881748-5MG |
| Cas.: 1622902-68-4 | Purity: ≥99% | abrocitinib | ESD-881748-10MG |
| Cas.: 162290-05-3 | Purity: 97% | 7,3′-Dihydroxy-4′-methoxyflavan | ESD-881749-5MG |
| Cas.: 1622863-21-1 | Purity: ≥98% | Neoseptin 3 | ESD-881750-5MG |
| Cas.: 1622337-40-9 | Purity: 98% | Jasnervoside G | ESD-881751-5MG |
| Cas.: 1622337-36-3 | Purity: 96% | Jasnervoside C | ESD-881752-5MG |
| Cas.: 162229-27-8 | Purity: 98% | Dorsmanin A | ESD-881753-5MG |
| Cas.: 1622069-56-0 | Purity: 95% | 3-Benzyl-1-oxa-3,8-diazaspiro-[4.6]undecan-2-one hydrochloride | ESD-881754-500MG |
| Cas.: 1622006-09-0 | Purity: ≥99% | Radioprotectin-1 | ESD-881755-5MG |
| Cas.: 1622006-09-0 | Purity: ≥99% | Radioprotectin-1 | ESD-881755-10MG |
| Cas.: 1621884-22-7 | Purity: ≥96% | PSI-7409 tetrasodium | ESD-881756-1MG |
| Cas.: 1621884-22-7 | Purity: ≥96% | PSI-7409 tetrasodium | ESD-881756-5MG |
| Cas.: 1621866-96-3 | Purity: 98% | AZD1208 hydrochloride | ESD-881757-5MG |
| Cas.: 1621866-96-3 | Purity: 98% | AZD1208 hydrochloride | ESD-881757-10MG |
| Cas.: 1621-56-3 | Purity: ≥99% | 7-Methoxyisoflavone | ESD-881758-100MG |
| Cas.: 1621523-07-6 | Purity: ≥97% | THZ1-R | ESD-881759-1MG |
| Cas.: 1621523-07-6 | Purity: ≥97% | THZ1-R | ESD-881759-5MG |
| Cas.: 1621397-55-4 | Purity: 90% | 3′-Bromospiro[fluorene-9,9′-xanthene] | ESD-881760-250MG |
| Cas.: 1621397-55-4 | Purity: 90% | 3′-Bromospiro[fluorene-9,9′-xanthene] | ESD-881760-1G |
| Cas.: 1621175-65-2 | Purity: ≥99% | TC-G-1008 | ESD-881761-5MG |
| Cas.: 1621175-65-2 | Purity: ≥99% | TC-G-1008 | ESD-881761-10MG |
| Cas.: 1620921-68-7 | Purity: 95% | 4′,4”’-Di-O-methylisochamaejasmin | ESD-881762-5MG |
| Cas.: 162059-94-1 | Purity: 95% | Myriceric acid C | ESD-881763-1MG |
| Cas.: 1620574-24-4 | Purity: ≥99% | DLK-IN-1 | ESD-881764-5MG |
| Cas.: 1620574-24-4 | Purity: ≥99% | DLK-IN-1 | ESD-881764-10MG |
| Cas.: 1620458-09-4 | Purity: ≥98% | Zoliflodacin | ESD-881765-5MG |
| Cas.: 1620458-09-4 | Purity: ≥98% | Zoliflodacin | ESD-881765-10MG |
| Cas.: 1620401-83-3 | Purity: 98% | UNC0379 TFA | ESD-881766-5MG |
| Cas.: 1620401-83-3 | Purity: 98% | UNC0379 TFA | ESD-881766-10MG |
| Cas.: 1620401-82-2 | Purity: ≥99% | UNC0379 | ESD-881767-5MG |
| Cas.: 1620401-82-2 | Purity: ≥99% | UNC0379 | ESD-881767-10MG |
| Cas.: 16198-01-9 | Purity: 97% | Catechin pentaacetate | ESD-881768-5MG |
| Cas.: 1619-13-2 | Purity: 97% | Prehelminthosporol | ESD-881769-5MG |
| Cas.: 1618658-88-0 | Purity: ≥98% | CC-671 | ESD-881770-1MG |
| Cas.: 1618658-88-0 | Purity: ≥98% | CC-671 | ESD-881770-5MG |
| Cas.: 161832-65-1 | Purity: ≥98% | Talampanel | ESD-881771-5MG |
| Cas.: 161832-65-1 | Purity: ≥98% | Talampanel | ESD-881771-10MG |
| Cas.: 161804-20-2 | Purity: ≥99% | Benzamil hydrochloride | ESD-881772-5MG |
| Cas.: 161804-20-2 | Purity: ≥99% | Benzamil hydrochloride | ESD-881772-10MG |
| Cas.: 161796-84-5 | Purity: 98% | Esomeprazole potassium salt | ESD-881774-50MG |
| Cas.: 161796-84-5 | Purity: 98% | Esomeprazole potassium salt | ESD-881774-100MG |
| Cas.: 1617-70-5 | Purity: 95% | Lupenone | ESD-881775-5MG |
| Cas.: 1617-68-1 | Purity: 98% | Lupeol acetate | ESD-881776-1MG |
| Cas.: 161753-49-7 | Purity: 95% | 12-Oxocalanolide A | ESD-881777-1MG |
| Cas.: 1617-49-8 | Purity: 98% | 2,3,8-Tri-O-methylellagic acid | ESD-881778-5MG |
| Cas.: 1617495-03-0 | Purity: ≥99% | RA190 | ESD-881779-5MG |
| Cas.: 1617495-03-0 | Purity: ≥99% | RA190 | ESD-881779-10MG |
| Cas.: 161715-21-5 | Purity: ≥98% | Tebipenem | ESD-881780-5MG |
| Cas.: 161715-21-5 | Purity: ≥98% | Tebipenem | ESD-881780-10MG |
| Cas.: 161710-10-7 | Purity: ≥98% | Z-Ile-Leu-aldehyde | ESD-881781-2MG |
| Cas.: 161710-10-7 | Purity: ≥98% | Z-Ile-Leu-aldehyde | ESD-881781-5MG |
| Cas.: 1616-93-9 | Purity: 95% | β-Amyrin acetate | ESD-881782-5MG |
| Cas.: 1616757-59-5 | Purity: 95% | Caesalpine A | ESD-881783-5MG |
| Cas.: 1616690-16-4 | Purity: ≥98% | Desidustat | ESD-881784-1MG |
| Cas.: 1616690-16-4 | Purity: ≥98% | Desidustat | ESD-881784-5MG |
| Cas.: 1616683-55-6 | Purity: 95% | Dodovislactone B | ESD-881785-5MG |
| Cas.: 1616683-54-5 | Purity: 95% | Dodovislactone A | ESD-881786-1MG |
| Cas.: 1616683-53-4 | Purity: 95% | Dodovisone D | ESD-881787-1MG |
| Cas.: 1616683-52-3 | Purity: 95% | Dodovisone C | ESD-881788-1MG |
| Cas.: 1616683-51-2 | Purity: 95% | Dodovisone B | ESD-881789-5MG |
| Cas.: 1616683-50-1 | Purity: 95% | Dodovisone A | ESD-881790-5MG |
| Cas.: 1616592-62-1 | Purity: 95% | Erythrinin H | ESD-881791-1MG |
| Cas.: 1616592-61-0 | Purity: 95% | Erythrin G | ESD-881792-5MG |
| Cas.: 1616592-60-9 | Purity: 98% | Erythrinin F | ESD-881793-5MG |
| Cas.: 1616592-59-6 | Purity: 95% | Erythrin D | ESD-881794-5MG |
| Cas.: 1616413-96-7 | Purity: ≥99% | UCB9608 | ESD-881795-5MG |
| Cas.: 1616413-96-7 | Purity: ≥99% | UCB9608 | ESD-881795-10MG |
| Cas.: 1616080-84-2 | Purity: 95% | Hispidanin B | ESD-881796-5MG |
| Cas.: 161605-73-8 | Purity: ≥99% | Fanapanel | ESD-881797-10MG |
| Cas.: 161605-73-8 | Purity: ≥99% | Fanapanel | ESD-881797-50MG |
| Cas.: 1615-94-7 | Purity: 98% | Simiarenol | ESD-881798-5MG |
| Cas.: 161582-11-2 | Purity: 98% | Ro 48-8071 | ESD-881799-5MG |
| Cas.: 161582-11-2 | Purity: 98% | Ro 48-8071 | ESD-881799-10MG |
| Cas.: 1615713-87-5 | Purity: ≥99% | DprE1-IN-2 | ESD-881800-2MG |
| Cas.: 1615713-87-5 | Purity: ≥99% | DprE1-IN-2 | ESD-881800-5MG |
| Cas.: 1613710-01-2 | Purity: ≥98% | ARN-3236 | ESD-881801-2MG |
| Cas.: 1613710-01-2 | Purity: ≥98% | ARN-3236 | ESD-881801-5MG |
| Cas.: 1613617-05-2 | Purity: ≥98% | SAHA chloroalkane T1 | ESD-881802-5MG |
| Cas.: 1613617-05-2 | Purity: ≥98% | SAHA chloroalkane T1 | ESD-881802-10MG |
| Cas.: 1613404-76-4 | Purity: ≥99% | Deltarasin hydrochloride | ESD-881803-2MG |
| Cas.: 1613404-76-4 | Purity: ≥99% | Deltarasin hydrochloride | ESD-881803-5MG |
| Cas.: 1613152-34-3 | Purity: 97% | 1-O-Acetyl-6-O-isobutyrylbritannilactone | ESD-881804-5MG |
| Cas.: 161230-88-2 | Purity: ≥97% | MDL 105519 | ESD-881806-5MG |
| Cas.: 161230-88-2 | Purity: ≥97% | MDL 105519 | ESD-881806-10MG |
| Cas.: 1612239-23-2 | Purity: 97% | Myricadenin A | ESD-881807-5MG |
| Cas.: 1611493-60-7 | Purity: ≥98% | Bictegravir | ESD-881808-1MG |
| Cas.: 1611493-60-7 | Purity: ≥98% | Bictegravir | ESD-881808-5MG |
| Cas.: 161115-59-9 | Purity: ≥99% | Desisobutyryl-ciclesonide | ESD-881809-5MG |
| Cas.: 161115-59-9 | Purity: ≥99% | Desisobutyryl-ciclesonide | ESD-881809-10MG |
| Cas.: 161099-42-9 | Purity: 97% | Bidwillol A | ESD-881810-5MG |
| Cas.: 1610800-25-3 | Purity: 98% | Diacylglycerol acyltransferase inhibitor-1 | ESD-881811-5MG |
| Cas.: 1610800-25-3 | Purity: 98% | Diacylglycerol acyltransferase inhibitor-1 | ESD-881811-10MG |
| Cas.: 1610536-69-0 | Purity: ≥99% | JNJ-47117096 hydrochloride | ESD-881812-5MG |
| Cas.: 1610536-69-0 | Purity: ≥99% | JNJ-47117096 hydrochloride | ESD-881812-10MG |
| Cas.: 16100-84-8 | Purity: 96% | Dihydroperaksine | ESD-881813-5MG |
| Cas.: 1610056-01-3 | Purity: 98% | Peptide T TFA | ESD-881814-1MG |
| Cas.: 1610056-01-3 | Purity: 98% | Peptide T TFA | ESD-881814-5MG |
| Cas.: 1609584-72-6 | Purity: ≥98% | Mps1-IN-3 | ESD-881815-2MG |
| Cas.: 1609584-72-6 | Purity: ≥98% | Mps1-IN-3 | ESD-881815-5MG |
| Cas.: 1609452-30-3 | Purity: ≥99% | SEL120-34A HCl | ESD-881816-5MG |
| Cas.: 1609452-30-3 | Purity: ≥99% | SEL120-34A HCl | ESD-881816-10MG |
| Cas.: 1609409-16-6 | Purity: 95% | 2-methyl-2,9-diazaspiro[5.5]undecan-3-one dihydrochloride | ESD-881817-1G |
| Cas.: 1609409-16-6 | Purity: 95% | 2-methyl-2,9-diazaspiro[5.5]undecan-3-one dihydrochloride | ESD-881817-5G |
| Cas.: 1609409-15-5 | Purity: 95% | 2,8-diazaspiro[5.5]undecan-3-one dihydrochloride | ESD-881818-1G |
| Cas.: 1609409-15-5 | Purity: 95% | 2,8-diazaspiro[5.5]undecan-3-one dihydrochloride | ESD-881818-5G |
| Cas.: 1609409-14-4 | Purity: 95% | tert-butyl (5r,8r)-2-azaspiro[4.5]dec-8-ylcarbamate | ESD-881819-1G |
| Cas.: 1609407-83-1 | Purity: 95% | 2-cyclopropyl-2,6-diazaspiro[3.3]heptane bis(trifluoroacetate) | ESD-881820-250MG |
| Cas.: 1609407-83-1 | Purity: 95% | 2-cyclopropyl-2,6-diazaspiro[3.3]heptane bis(trifluoroacetate) | ESD-881820-1G |
| Cas.: 1609407-80-8 | Purity: 95% | tert-butyl 3-(hydroxymethyl)-2,8-diazaspiro[4.5]decane-2-carboxylate hydrochloride | ESD-881821-250MG |
| Cas.: 1609407-80-8 | Purity: 95% | tert-butyl 3-(hydroxymethyl)-2,8-diazaspiro[4.5]decane-2-carboxylate hydrochloride | ESD-881821-1G |
| Cas.: 1609407-15-9 | Purity: 95% | 3,4-dihydrospiro[chromene-2,1′-cyclohexan]-4-amine hydrochloride | ESD-881822-1G |
| Cas.: 1609407-15-9 | Purity: 95% | 3,4-dihydrospiro[chromene-2,1′-cyclohexan]-4-amine hydrochloride | ESD-881822-5G |
| Cas.: 1609407-01-3 | Purity: 95% | 1-methyl-1,8-diazaspiro[4.5]decan-2-one dihydrochloride | ESD-881823-1G |
| Cas.: 1609407-01-3 | Purity: 95% | 1-methyl-1,8-diazaspiro[4.5]decan-2-one dihydrochloride | ESD-881823-5G |
| Cas.: 1609406-92-9 | Purity: 95% | 2,5,7-triazaspiro[3.4]octan-6-one hydrochloride | ESD-881824-1G |
| Cas.: 1609406-92-9 | Purity: 95% | 2,5,7-triazaspiro[3.4]octan-6-one hydrochloride | ESD-881824-5G |
| Cas.: 1609403-99-7 | Purity: 95% | 1′,4′-dihydro-3’H-spiro[piperidine-4,2′-quinoxalin]-3′-one hydrochloride | ESD-881825-1G |
| Cas.: 1609403-99-7 | Purity: 95% | 1′,4′-dihydro-3’H-spiro[piperidine-4,2′-quinoxalin]-3′-one hydrochloride | ESD-881825-5G |
| Cas.: 1609403-58-8 | Purity: 95% | 4-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one hydrochloride | ESD-881826-1G |
| Cas.: 1609403-58-8 | Purity: 95% | 4-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one hydrochloride | ESD-881826-5G |
| Cas.: 1609403-56-6 | Purity: 95% | 3,9-diazaspiro[5.6]dodecan-10-one dihydrochloride | ESD-881827-1G |
| Cas.: 1609403-56-6 | Purity: 95% | 3,9-diazaspiro[5.6]dodecan-10-one dihydrochloride | ESD-881827-5G |
| Cas.: 1609403-10-2 | Purity: 95% | 5-methyl-2,5,7-triazaspiro[3.4]octan-6-one hydrochloride | ESD-881828-250MG |
| Cas.: 1609403-10-2 | Purity: 95% | 5-methyl-2,5,7-triazaspiro[3.4]octan-6-one hydrochloride | ESD-881828-1G |
| Cas.: 1609403-01-1 | Purity: 95% | 9-methyl-6-oxa-2,9-diazaspiro[4.5]decane dihydrochloride | ESD-881829-1G |
| Cas.: 1609403-01-1 | Purity: 95% | 9-methyl-6-oxa-2,9-diazaspiro[4.5]decane dihydrochloride | ESD-881829-5G |
| Cas.: 1609402-96-1 | Purity: 95% | 3,9-diazaspiro[5.5]undecane-2,4-dione dihydrochloride | ESD-881830-1G |
| Cas.: 1609402-96-1 | Purity: 95% | 3,9-diazaspiro[5.5]undecane-2,4-dione dihydrochloride | ESD-881830-5G |
| Cas.: 1609402-65-4 | Purity: 95% | 2-methyl-2,9-diazaspiro[5.5]undecane dihydrochloride | ESD-881831-1G |
| Cas.: 1609402-65-4 | Purity: 95% | 2-methyl-2,9-diazaspiro[5.5]undecane dihydrochloride | ESD-881831-5G |
| Cas.: 1609401-18-4 | Purity: 95% | 9-methyl-1-oxa-9-azaspiro[5.5]undecan-4-amine dihydrochloride | ESD-881832-250MG |
| Cas.: 1609400-93-2 | Purity: 95% | tert-butyl (5s,8s)-2-azaspiro[4.5]dec-8-ylcarbamate | ESD-881833-1G |
| Cas.: 1609400-64-7 | Purity: 95% | 1,3-dioxa-8-azaspiro[4.5]decan-2-one hydrochloride | ESD-881834-1G |
| Cas.: 1609400-64-7 | Purity: 95% | 1,3-dioxa-8-azaspiro[4.5]decan-2-one hydrochloride | ESD-881834-5G |
| Cas.: 1609400-09-0 | Purity: 95% | 1,4-dimethyl-1,4,9-triazaspiro[5.5]undecane trihydrochloride | ESD-881835-1G |
| Cas.: 1609400-09-0 | Purity: 95% | 1,4-dimethyl-1,4,9-triazaspiro[5.5]undecane trihydrochloride | ESD-881835-5G |
| Cas.: 1609399-87-2 | Purity: 95% | 2,7-diazaspiro[4.4]nonane-1,3-dione hydrochloride | ESD-881836-1G |
| Cas.: 1609399-87-2 | Purity: 95% | 2,7-diazaspiro[4.4]nonane-1,3-dione hydrochloride | ESD-881836-5G |
| Cas.: 1609395-85-8 | Purity: 95% | 9-methyl-6-oxa-2,9-diazaspiro[4.5]decan-8-one hydrochloride | ESD-881837-1G |
| Cas.: 1609395-85-8 | Purity: 95% | 9-methyl-6-oxa-2,9-diazaspiro[4.5]decan-8-one hydrochloride | ESD-881837-5G |
| Cas.: 1609395-61-0 | Purity: 95% | 1-oxa-3,7-diazaspiro[4.5]decan-2-one hydrochloride | ESD-881838-1G |
| Cas.: 1609395-61-0 | Purity: 95% | 1-oxa-3,7-diazaspiro[4.5]decan-2-one hydrochloride | ESD-881838-5G |
| Cas.: 1609395-35-8 | Purity: 95% | 3,4-dihydrospiro[chromene-2,1′-cyclopentan]-4-amine hydrochloride | ESD-881839-1G |
| Cas.: 1609395-35-8 | Purity: 95% | 3,4-dihydrospiro[chromene-2,1′-cyclopentan]-4-amine hydrochloride | ESD-881839-5G |
| Cas.: 1609395-33-6 | Purity: 95% | 1-methyl-1,4,9-triazaspiro[5.5]undecan-5-one dihydrochloride | ESD-881840-1G |
| Cas.: 1609395-33-6 | Purity: 95% | 1-methyl-1,4,9-triazaspiro[5.5]undecan-5-one dihydrochloride | ESD-881840-5G |
| Cas.: 1609389-52-7 | Purity: ≥99% | ACY-957 | ESD-881841-5MG |
| Cas.: 1609389-52-7 | Purity: ≥99% | ACY-957 | ESD-881841-10MG |
| Cas.: 160927-81-1 | Purity: 95% | Villosin C | ESD-881842-1MG |
| Cas.: 160800-57-7 | Purity: ≥99% | Auristatin E | ESD-881843-1MG |
| Cas.: 160800-57-7 | Purity: ≥99% | Auristatin E | ESD-881843-5MG |
| Cas.: 1607837-31-9 | Purity: ≥98% | CCT-251921 | ESD-881844-1MG |
| Cas.: 1607837-31-9 | Purity: ≥98% | CCT-251921 | ESD-881844-5MG |
| Cas.: 1607828-35-2 | Purity: 95% | 2,3-Dihydro-3α-methoxynimbolide | ESD-881845-5MG |
| Cas.: 1607799-13-2 | Purity: ≥99% | Bremelanotide Acetate | ESD-881846-10MG |
| Cas.: 1607799-13-2 | Purity: ≥99% | Bremelanotide Acetate | ESD-881846-50MG |
| Cas.: 160746-93-0 | Purity: 95% | 2-Benzyl-2-azaspiro[4.4]nonan-6-one | ESD-881847-100MG |
| Cas.: 160746-93-0 | Purity: 95% | 2-Benzyl-2-azaspiro[4.4]nonan-6-one | ESD-881847-500MG |
| Cas.: 1606994-55-1 | Purity: ≥99% | Elamipretide TFA | ESD-881848-1MG |
| Cas.: 1606994-55-1 | Purity: ≥99% | Elamipretide TFA | ESD-881848-5MG |
| Cas.: 160623-47-2 | Purity: 97% | 1,4,6-Trihydroxy-5-methoxy-7-prenylxanthone | ESD-881849-5MG |
| Cas.: 160598-92-5 | Purity: 98% | Villosin | ESD-881850-5MG |
| Cas.: 160568-14-9 | Purity: 98% | Zarzissine | ESD-881851-5MG |
| Cas.: 1605304-56-0 | Purity: 95% | 5,7,3′,4′-Tetrahydroxy-3-methoxy-8-geranylflavone | ESD-881852-5MG |
| Cas.: 160507-18-6 | Purity: 97% | Dihydroxyalnusone | ESD-881853-5MG |
| Cas.: 160499-09-2 | Purity: 95% | 5-Azaspiro[3.5]nonane | ESD-881854-250MG |
| Cas.: 160498-02-2 | Purity: 90% | Bisandrographolide C | ESD-881855-5MG |
| Cas.: 16049-28-8 | Purity: 97% | Antirhine | ESD-881856-5MG |
| Cas.: 160481-71-0 | Purity: 95% | 30-Oxopseudotaraxasterol | ESD-881857-5MG |
| Cas.: 1604810-84-5 | Purity: ≥99% | THZ2 | ESD-881858-5MG |
| Cas.: 1604810-84-5 | Purity: ≥99% | THZ2 | ESD-881858-10MG |
| Cas.: 160436-10-2 | Purity: 95% | 5,7,3′,5′-Tetrahydroxyflavanone | ESD-881859-5MG |
| Cas.: 1603845-32-4 | Purity: ≥98% | TX1-85-1 | ESD-881860-1MG |
| Cas.: 1603845-32-4 | Purity: ≥98% | TX1-85-1 | ESD-881860-5MG |
| Cas.: 16037-91-5 | Purity: ≥98% | Stibogluconate sodium | ESD-881861-500MG |
| Cas.: 16037-91-5 | Purity: ≥98% | Stibogluconate sodium | ESD-881861-1G |
| Cas.: 160333-27-7 | Purity: 95% | Bisdehydroneotuberostemonine | ESD-881862-5MG |
| Cas.: 160312-62-9 | Purity: ≥98% | L-368,899 hydrochloride | ESD-881863-1MG |
| Cas.: 160312-62-9 | Purity: ≥98% | L-368,899 hydrochloride | ESD-881863-5MG |
| Cas.: 160242-09-1 | Purity: 93% | 14-Deoxy-11-hydroxyandrographolide | ESD-881864-5MG |
| Cas.: 160098-78-2 | Purity: 95% | Cryptofolione | ESD-881865-5MG |
| Cas.: 160047-56-3 | Purity: 98% | Sambutoxin | ESD-881866-5MG |
| Cas.: 159997-94-1 | Purity: 98% | Biricodar | ESD-881867-1MG |
| Cas.: 159997-94-1 | Purity: 98% | Biricodar | ESD-881867-5MG |
| Cas.: 159989-64-7 | Purity: ≥98% | Nelfinavir | ESD-881868-2MG |
| Cas.: 159989-64-7 | Purity: ≥98% | Nelfinavir | ESD-881868-5MG |
| Cas.: 1599477-75-4 | Purity: ≥98% | GPR120-IN-1 | ESD-881869-2MG |
| Cas.: 1599477-75-4 | Purity: ≥98% | GPR120-IN-1 | ESD-881869-5MG |
| Cas.: 1599440-33-1 | Purity: ≥98% | Dxd | ESD-881870-1MG |
| Cas.: 1599432-18-4 | Purity: ≥99% | ibrutinib-biotin | ESD-881871-5MG |
| Cas.: 1599432-18-4 | Purity: ≥99% | ibrutinib-biotin | ESD-881871-10MG |
| Cas.: 1599432-08-2 | Purity: ≥99% | NIBR189 | ESD-881872-2MG |
| Cas.: 1599432-08-2 | Purity: ≥99% | NIBR189 | ESD-881872-5MG |
| Cas.: 159934-13-1 | Purity: 97% | Macranthoin G | ESD-881873-5MG |
| Cas.: 159858-85-2 | Purity: 97% | Polypodine B 20,22-acetonide | ESD-881874-5MG |
| Cas.: 159857-80-4 | Purity: ≥99% | MC-Val-Cit-PAB | ESD-881875-100MG |
| Cas.: 159857-80-4 | Purity: ≥99% | MC-Val-Cit-PAB | ESD-881875-500MG |
| Cas.: 159853-36-8 | Purity: 95% | 4′-O-Methylirenolone | ESD-881876-5MG |
| Cas.: 1598383-41-5 | Purity: 98% | EPZ011989 trifluoroacetate | ESD-881877-5MG |
| Cas.: 1598383-41-5 | Purity: 98% | EPZ011989 trifluoroacetate | ESD-881877-10MG |
| Cas.: 159813-69-1 | Purity: 97% | Sikokianin C | ESD-881878-5MG |
| Cas.: 159813-37-3 | Purity: 98% | (6R,9S)-3-Oxo-α-ionol glucoside | ESD-881879-5MG |
| Cas.: 159748-08-0 | Purity: 98% | LY285434 | ESD-881880-1MG |
| Cas.: 159748-08-0 | Purity: 98% | LY285434 | ESD-881880-5MG |
| Cas.: 1597402-27-1 | Purity: ≥98% | JPH203 Dihydrochloride | ESD-881881-5MG |
| Cas.: 1597402-27-1 | Purity: ≥98% | JPH203 Dihydrochloride | ESD-881881-10MG |
| Cas.: 15966-93-5 | Purity: ≥98% | SU5408 | ESD-881882-1MG |
| Cas.: 15966-93-5 | Purity: ≥98% | SU5408 | ESD-881882-5MG |
| Cas.: 159650-12-1 | Purity: 97% | Saropyrone | ESD-881883-5MG |
| Cas.: 159646-83-0 | Purity: ≥98% | QL9 | ESD-881884-1MG |
| Cas.: 159646-83-0 | Purity: ≥98% | QL9 | ESD-881884-5MG |
| Cas.: 159635-39-9 | Purity: 95% | Spiro[Chromene-2,4′-pipidin]-4(3H)-one hydrochloride | ESD-881885-1G |
| Cas.: 159634-86-3 | Purity: 95% | 1-(Methylsulfonyl)spiro[indoline-3,4′-piperidine]hydrochloride | ESD-881886-500MG |
| Cas.: 159634-86-3 | Purity: 95% | 1-(Methylsulfonyl)spiro[indoline-3,4′-piperidine]hydrochloride | ESD-881886-1G |
| Cas.: 159634-63-6 | Purity: 95% | 1’H-SPIRO[PIPERIDINE-4,4′-QUINOLIN]-2′(3’H)-ONE | ESD-881887-250MG |
| Cas.: 159634-63-6 | Purity: 95% | 1’H-SPIRO[PIPERIDINE-4,4′-QUINOLIN]-2′(3’H)-ONE | ESD-881887-1G |
| Cas.: 159634-59-0 | Purity: 99% | tert-Butyl 3-oxo-2,3-dihydrospiro[indene-1,4′-piperidine]-1′-carboxylate | ESD-881888-250MG |
| Cas.: 159-62-6 | Purity: 95% | Spiro[fluorene-9,9′-xanthene] | ESD-881889-1G |
| Cas.: 159-62-6 | Purity: 95% | Spiro[fluorene-9,9′-xanthene] | ESD-881889-5G |
| Cas.: 159623-48-0 | Purity: 95% | 3,4-Secotirucalla-4(28),7,24-triene-3,26-dioic acid | ESD-881890-1MG |
| Cas.: 159532-41-9 | Purity: 98% | Fluconazole mesylate | ESD-881891-100MG |
| Cas.: 159532-41-9 | Purity: 98% | Fluconazole mesylate | ESD-881891-500MG |
| Cas.: 159325-23-2 | Purity: 98% | SZ1676 | ESD-881892-1MG |
| Cas.: 159325-23-2 | Purity: 98% | SZ1676 | ESD-881892-5MG |
| Cas.: 1592-70-7 | Purity: 98% | Isokaempferide | ESD-881893-5MG |
| Cas.: 159190-44-0 | Purity: 98% | L-NIO dihydrochloride | ESD-881894-5MG |
| Cas.: 159190-44-0 | Purity: 98% | L-NIO dihydrochloride | ESD-881894-10MG |
| Cas.: 159138-80-4 | Purity: ≥98% | Cariporide | ESD-881895-5MG |
| Cas.: 159138-80-4 | Purity: ≥98% | Cariporide | ESD-881895-10MG |
| Cas.: 159096-49-8 | Purity: 95% | F1839-I | ESD-881896-5MG |
| Cas.: 158959-32-1 | Purity: ≥98% | SC57666 | ESD-881897-1MG |
| Cas.: 158959-32-1 | Purity: ≥98% | SC57666 | ESD-881897-5MG |
| Cas.: 1589488-34-5 | Purity: 95% | Wedelobatin A | ESD-881898-1MG |
| Cas.: 1589-04-4 | Purity: 95% | 3,12-diaza-6,9-diazoniadispiro[5.2.5.2]hexadecane dichloride | ESD-881899-500MG |
| Cas.: 1589-04-4 | Purity: 95% | 3,12-diaza-6,9-diazoniadispiro[5.2.5.2]hexadecane dichloride | ESD-881899-1G |
| Cas.: 158890-29-0 | Purity: 95% | 2-chloro-1-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}ethan-1-one | ESD-881900-1G |
| Cas.: 158890-29-0 | Purity: 95% | 2-chloro-1-{1,4-dioxa-8-azaspiro[4.5]decan-8-yl}ethan-1-one | ESD-881900-2.5G |
| Cas.: 158876-82-5 | Purity: 98% | Rupatadine | ESD-881901-100MG |
| Cas.: 158876-82-5 | Purity: 98% | Rupatadine | ESD-881901-500MG |
| Cas.: 1588521-78-1 | Purity: ≥99% | BET-BAY 002 | ESD-881902-2MG |
| Cas.: 1588521-78-1 | Purity: ≥99% | BET-BAY 002 | ESD-881902-5MG |
| Cas.: 1588516-88-4 | Purity: 97% | ent-17-Hydroxykaura-9(11),15-dien-19-oic acid | ESD-881903-5MG |
| Cas.: 1588516-87-3 | Purity: 97% | 3α-Tigloyloxypterokaurene L3 | ESD-881904-5MG |
| Cas.: 1588441-26-2 | Purity: 95% | 7-Methyl-2,7-diazaspiro[3.5]nonane dihydrochloride | ESD-881905-1G |
| Cas.: 1588441-26-2 | Purity: 95% | 7-Methyl-2,7-diazaspiro[3.5]nonane dihydrochloride | ESD-881905-5G |
| Cas.: 1588441-25-1 | Purity: 95% | 2,3-Dihydro-1H-spiro[isoquinoline-4,4′-piperidine] dihydrochloride | ESD-881906-250MG |
| Cas.: 1588441-25-1 | Purity: 95% | 2,3-Dihydro-1H-spiro[isoquinoline-4,4′-piperidine] dihydrochloride | ESD-881906-1G |
| Cas.: 158836-71-6 | Purity: ≥99% | Nitroflurbiprofen | ESD-881907-1MG |
| Cas.: 158836-71-6 | Purity: ≥99% | Nitroflurbiprofen | ESD-881907-5MG |
| Cas.: 1587705-63-2 | Purity: ≥99% | INH154 | ESD-881908-5MG |
| Cas.: 1587705-63-2 | Purity: ≥99% | INH154 | ESD-881908-10MG |
| Cas.: 158681-13-1 | Purity: ≥99% | Rimonabant Hydrochloride | ESD-881909-10MG |
| Cas.: 158681-13-1 | Purity: ≥99% | Rimonabant Hydrochloride | ESD-881909-50MG |
| Cas.: 15866-90-7 | Purity: ≥98% | Incyclinide | ESD-881910-1MG |
| Cas.: 15866-90-7 | Purity: ≥98% | Incyclinide | ESD-881910-5MG |
| Cas.: 158642-42-3 | Purity: 95% | Yixingensin | ESD-881911-5MG |
| Cas.: 158628-80-9 | Purity: 95% | tert-Butyl 6-bromospiro[indene-1,4′-piperidine]-1′-carboxylate | ESD-881912-250MG |
| Cas.: 158628-80-9 | Purity: 95% | tert-Butyl 6-bromospiro[indene-1,4′-piperidine]-1′-carboxylate | ESD-881912-1G |
| Cas.: 1585-68-8 | Purity: 95% | Catalpalactone | ESD-881913-1MG |
| Cas.: 158500-59-5 | Purity: 96% | Cnidioside B methyl ester | ESD-881914-5MG |
| Cas.: 158475-79-7 | Purity: 98% | Nucleoprotein 396-404 | ESD-881915-1MG |
| Cas.: 158475-79-7 | Purity: 98% | Nucleoprotein 396-404 | ESD-881915-5MG |
| Cas.: 1584713-87-0 | Purity: ≥99% | BMS-983970 | ESD-881916-2MG |
| Cas.: 1584713-87-0 | Purity: ≥99% | BMS-983970 | ESD-881916-5MG |
| Cas.: 1584236-34-9 | Purity: 97% | Demethyl calyciphylline A | ESD-881917-5MG |
| Cas.: 158364-59-1 | Purity: 98% | pumaprazole | ESD-881918-1MG |
| Cas.: 158364-59-1 | Purity: 98% | pumaprazole | ESD-881918-5MG |
| Cas.: 158353-15-2 | Purity: ≥97% | Pyraclonil | ESD-881919-5MG |
| Cas.: 158353-15-2 | Purity: ≥97% | Pyraclonil | ESD-881919-10MG |
| Cas.: 15823-04-8 | Purity: 98% | Methyl 3-(4-methoxyphenyl)propanoate | ESD-881920-1G |
| Cas.: 1581270-11-2 | Purity: ≥99% | RIP2 kinase inhibitor 2 | ESD-881921-1MG |
| Cas.: 1581270-11-2 | Purity: ≥99% | RIP2 kinase inhibitor 2 | ESD-881921-5MG |
| Cas.: 1581248-32-9 | Purity: 97% | 5-Hydroxy-6,7,8-trimethoxycoumarin | ESD-881922-5MG |
| Cas.: 158089-95-3 | Purity: 98% | S-2474 | ESD-881923-1MG |
| Cas.: 158089-95-3 | Purity: 98% | S-2474 | ESD-881923-5MG |
| Cas.: 158001-76-4 | Purity: 98% | Win 58237 | ESD-881924-1MG |
| Cas.: 158001-76-4 | Purity: 98% | Win 58237 | ESD-881924-5MG |
| Cas.: 1579991-63-1 | Purity: ≥98% | Chitinase-IN-2 | ESD-881925-2MG |
| Cas.: 1579991-63-1 | Purity: ≥98% | Chitinase-IN-2 | ESD-881925-5MG |
| Cas.: 1579991-61-9 | Purity: ≥99% | Chitinase-IN-1 | ESD-881926-2MG |
| Cas.: 1579991-61-9 | Purity: ≥99% | Chitinase-IN-1 | ESD-881926-5MG |
| Cas.: 157922-77-5 | Purity: ≥98% | Duocarmycin TM | ESD-881927-5MG |
| Cas.: 157922-77-5 | Purity: ≥98% | Duocarmycin TM | ESD-881927-10MG |
| Cas.: 15790-02-0 | Purity: 98% | Tropodifene | ESD-881928-1MG |
| Cas.: 15790-02-0 | Purity: 98% | Tropodifene | ESD-881928-5MG |
| Cas.: 1578245-44-9 | Purity: ≥99% | BOS-172722 | ESD-881929-1MG |
| Cas.: 1578245-44-9 | Purity: ≥99% | BOS-172722 | ESD-881929-5MG |
| Cas.: 157664-03-4 | Purity: 95% | 7-Xylosyl-10-deacetylbaccatin III | ESD-881930-5MG |
| Cas.: 157659-20-6 | Purity: 98% | Prenylpiperitol | ESD-881931-5MG |
| Cas.: 15763-06-1 | Purity: ≥98% | 1-Methyladenosine | ESD-881932-50MG |
| Cas.: 1575818-46-0 | Purity: ≥99% | PRN694 | ESD-881933-1MG |
| Cas.: 1575818-46-0 | Purity: ≥99% | PRN694 | ESD-881933-5MG |
| Cas.: 1575596-29-0 | Purity: ≥99% | PRN1008 | ESD-881934-5MG |
| Cas.: 1575596-29-0 | Purity: ≥99% | PRN1008 | ESD-881934-10MG |
| Cas.: 157528-81-9 | Purity: 95% | Coronarin D methyl ether | ESD-881935-5MG |
| Cas.: 157-48-2 | Purity: 95% | 1-oxaspiro[2.3]hexane | ESD-881936-1G |
| Cas.: 157-48-2 | Purity: 95% | 1-oxaspiro[2.3]hexane | ESD-881936-2.5G |
| Cas.: 157414-05-6 | Purity: 95% | Taxuspine B | ESD-881937-5MG |
| Cas.: 157341-41-8 | Purity: ≥99% | DMP 777 | ESD-881938-5MG |
| Cas.: 157341-41-8 | Purity: ≥99% | DMP 777 | ESD-881938-10MG |
| Cas.: 15727-65-8 | Purity: ≥99% | 1-Ethynylnaphthalene | ESD-881939-100MG |
| Cas.: 15727-65-8 | Purity: ≥99% | 1-Ethynylnaphthalene | ESD-881939-500MG |
| Cas.: 157263-00-8 | Purity: 98% | L-159282 | ESD-881940-1MG |
| Cas.: 157263-00-8 | Purity: 98% | L-159282 | ESD-881940-5MG |
| Cas.: 1572583-29-9 | Purity: 98% | Teneligliptin hydrobromide hydrate | ESD-881941-10MG |
| Cas.: 1572583-29-9 | Purity: 98% | Teneligliptin hydrobromide hydrate | ESD-881941-50MG |
| Cas.: 1572510-80-5 | Purity: ≥99% | AB-423 | ESD-881942-5MG |
| Cas.: 1572510-80-5 | Purity: ≥99% | AB-423 | ESD-881942-10MG |
| Cas.: 1572510-42-9 | Purity: ≥99% | JNJ-632 | ESD-881943-1MG |
| Cas.: 1572510-42-9 | Purity: ≥99% | JNJ-632 | ESD-881943-5MG |
| Cas.: 157134-53-7 | Purity: 98% | Di-8-ANEPPS | ESD-881944-1MG |
| Cas.: 157134-53-7 | Purity: 98% | Di-8-ANEPPS | ESD-881944-5MG |
| Cas.: 156993-29-2 | Purity: 98% | Wedeliatrilolactone A | ESD-881945-5MG |
| Cas.: 156974-99-1 | Purity: 96% | Isosalicifolin | ESD-881946-5MG |
| Cas.: 15686-97-2 | Purity: 98% | Pyrrolifene | ESD-881947-1MG |
| Cas.: 15686-97-2 | Purity: 98% | Pyrrolifene | ESD-881947-5MG |
| Cas.: 156791-81-0 | Purity: 97% | Iristectorene B | ESD-881948-5MG |
| Cas.: 156767-69-0 | Purity: 95% | 3β-Hydroxyergost-5-en-7-one | ESD-881949-1MG |
| Cas.: 156722-18-8 | Purity: ≥96% | Rostafuroxin | ESD-881950-10MG |
| Cas.: 156722-18-8 | Purity: ≥96% | Rostafuroxin | ESD-881950-50MG |
| Cas.: 156720-75-1 | Purity: 95% | 7,7-dimethyl-6,8-dioxa-2-azaspiro[3.5]nonane | ESD-881951-1G |
| Cas.: 156720-75-1 | Purity: 95% | 7,7-dimethyl-6,8-dioxa-2-azaspiro[3.5]nonane | ESD-881951-2.5G |
| Cas.: 156720-48-8 | Purity: 92% | 7,7-dimethyl-6,8-dioxa-2-thiaspiro[3.5]nonane | ESD-881952-1G |
| Cas.: 156720-48-8 | Purity: 92% | 7,7-dimethyl-6,8-dioxa-2-thiaspiro[3.5]nonane | ESD-881952-2.5G |
| Cas.: 156719-41-4 | Purity: 98% | S-MTC | ESD-881953-5MG |
| Cas.: 156719-41-4 | Purity: 98% | S-MTC | ESD-881953-10MG |
| Cas.: 1566-81-0 | Purity: 98% | NS1652 | ESD-881954-1MG |
| Cas.: 1566-81-0 | Purity: 98% | NS1652 | ESD-881954-5MG |
| Cas.: 156640-23-2 | Purity: 98% | 1,2,5-Trihydroxyxanthone | ESD-881955-5MG |
| Cas.: 156-51-4 | Purity: ≥98% | Phenelzine sulfate | ESD-881956-100MG |
| Cas.: 156-51-4 | Purity: ≥98% | Phenelzine sulfate | ESD-881956-500MG |
| Cas.: 156497-25-5 | Purity: 97% | 7,13-Dideacetyl-9,10-didebenzoyltaxchinin C | ESD-881957-5MG |
| Cas.: 15648-86-9 | Purity: 98% | Myricetin 3-O-galactoside | ESD-881958-5MG |
| Cas.: 1564286-55-0 | Purity: ≥99% | CWHM-12 | ESD-881959-2MG |
| Cas.: 1564286-55-0 | Purity: ≥99% | CWHM-12 | ESD-881959-5MG |
| Cas.: 1564268-08-1 | Purity: ≥99% | BAY1238097 | ESD-881960-5MG |
| Cas.: 1564268-08-1 | Purity: ≥99% | BAY1238097 | ESD-881960-10MG |
| Cas.: 1564265-85-5 | Purity: 96% | 3,4-Seco-3-oxobisabol-10-ene-4,1-olide | ESD-881961-5MG |
| Cas.: 156398-61-7 | Purity: 97% | Ailanthoidol | ESD-881962-5MG |
| Cas.: 156368-84-2 | Purity: 95% | Ehretioside B | ESD-881963-1MG |
| Cas.: 156364-04-4 | Purity: 98% | SX-3228 | ESD-881964-1MG |
| Cas.: 156364-04-4 | Purity: 98% | SX-3228 | ESD-881964-5MG |
| Cas.: 156338-93-1 | Purity: 97% | 11-Anhydro-16-oxoalisol A | ESD-881965-5MG |
| Cas.: 1562492-32-3 | Purity: 93% | Pomegralignan | ESD-881966-5MG |
| Cas.: 156223-05-1 | Purity: ≥99% | GTS-21 dihydrochloride | ESD-881967-5MG |
| Cas.: 156223-05-1 | Purity: ≥99% | GTS-21 dihydrochloride | ESD-881967-10MG |
| Cas.: 1562067-05-3 | Purity: 98% | Banoxantrone D12 | ESD-881968-1MG |
| Cas.: 1562067-05-3 | Purity: 98% | Banoxantrone D12 | ESD-881968-5MG |
| Cas.: 1562066-98-1 | Purity: ≥98% | Banoxantrone D12 dihydrochloride | ESD-881969-1MG |
| Cas.: 1562066-98-1 | Purity: ≥98% | Banoxantrone D12 dihydrochloride | ESD-881969-5MG |
| Cas.: 156162-10-6 | Purity: 98% | Maackiaflavanone | ESD-881970-5MG |
| Cas.: 156161-89-6 | Purity: ≥98% | BQ-788 sodium salt | ESD-881971-1MG |
| Cas.: 156161-89-6 | Purity: ≥98% | BQ-788 sodium salt | ESD-881971-5MG |
| Cas.: 156137-99-4 | Purity: ≥98% | Rapacuronium bromide | ESD-881972-5MG |
| Cas.: 156137-99-4 | Purity: ≥98% | Rapacuronium bromide | ESD-881972-10MG |
| Cas.: 15599-45-8 | Purity: 98% | Symetine | ESD-881973-1MG |
| Cas.: 15599-45-8 | Purity: 98% | Symetine | ESD-881973-5MG |
| Cas.: 155977-87-0 | Purity: 95% | Rabdoternin F | ESD-881974-5MG |
| Cas.: 1559064-13-9 | Purity: 95% | 2-isopropyl-2,6-diazaspiro[3.3]heptane | ESD-881975-250MG |
| Cas.: 1559059-75-4 | Purity: 95% | (spiro[2.5]oct-1-ylmethyl)amine hydrochloride | ESD-881976-1G |
| Cas.: 1559059-75-4 | Purity: 95% | (spiro[2.5]oct-1-ylmethyl)amine hydrochloride | ESD-881976-5G |
| Cas.: 155899-92-6 | Purity: 98% | Strictosidine | ESD-881977-5MG |
| Cas.: 15585-43-0 | Purity: 98% | Rivanicline | ESD-881978-10MG |
| Cas.: 15585-43-0 | Purity: 98% | Rivanicline | ESD-881978-50MG |
| Cas.: 155836-29-6 | Purity: 96% | (-)-Dehydrodiconiferyl alcohol | ESD-881979-5MG |
| Cas.: 1558021-37-6 | Purity: ≥98% | TP0463518 | ESD-881980-5MG |
| Cas.: 1558021-37-6 | Purity: ≥98% | TP0463518 | ESD-881980-10MG |
| Cas.: 155709-41-4 | Purity: 98% | Isomagnolone | ESD-881981-5MG |
| Cas.: 155709-40-3 | Purity: 97% | Simonsinol | ESD-881982-5MG |
| Cas.: 155683-00-4 | Purity: ≥98% | Notoginsenoside Ft1 | ESD-881983-5MG |
| Cas.: 155683-00-4 | Purity: ≥98% | Notoginsenoside Ft1 | ESD-881983-10MG |
| Cas.: 155595-93-0 | Purity: 98% | Dehydroaglaiastatin | ESD-881984-5MG |
| Cas.: 155551-61-4 | Purity: 95% | 3a-Epiburchellin | ESD-881985-5MG |
| Cas.: 155521-46-3 | Purity: ≥98% | Alisol G | ESD-881986-5MG |
| Cas.: 155521-46-3 | Purity: ≥98% | Alisol G | ESD-881986-10MG |
| Cas.: 155521-45-2 | Purity: ≥99% | Alisol F | ESD-881987-5MG |
| Cas.: 155521-45-2 | Purity: ≥99% | Alisol F | ESD-881987-10MG |
| Cas.: 155488-34-9 | Purity: 98% | 1,9-Caryolanediol 9-acetate | ESD-881988-5MG |
| Cas.: 155488-25-8 | Purity: ≥98% | Sograzepide | ESD-881989-5MG |
| Cas.: 155488-25-8 | Purity: ≥98% | Sograzepide | ESD-881989-10MG |
| Cas.: 155485-76-0 | Purity: 98% | Caryolane-1,9β-diol | ESD-881990-5MG |
| Cas.: 155425-87-9 | Purity: 97% | 3′-(4-Ethoxyphenyl)spiro[indoline-3,2′-thiazolidine]-2,4′-dione | ESD-881991-2G |
| Cas.: 155425-87-9 | Purity: 97% | 3′-(4-Ethoxyphenyl)spiro[indoline-3,2′-thiazolidine]-2,4′-dione | ESD-881991-10G |
| Cas.: 155418-97-6 | Purity: 95% | 4,5-Dihydroblumenol A | ESD-881992-1MG |
| Cas.: 155415-08-0 | Purity: 98% | Inogatran | ESD-881993-1MG |
| Cas.: 155415-08-0 | Purity: 98% | Inogatran | ESD-881993-5MG |
| Cas.: 1553977-42-6 | Purity: ≥99% | Btk inhibitor 1 R enantiomer hydrochloride | ESD-881994-2MG |
| Cas.: 1553977-42-6 | Purity: ≥99% | Btk inhibitor 1 R enantiomer hydrochloride | ESD-881994-5MG |
| Cas.: 155348-06-4 | Purity: 97% | p-Menthane-1,3,8-triol | ESD-881995-5MG |
| Cas.: 155347-36-7 | Purity: 98% | Fluconazole hydrate | ESD-881996-100MG |
| Cas.: 155347-36-7 | Purity: 98% | Fluconazole hydrate | ESD-881996-500MG |
| Cas.: 155294-62-5 | Purity: ≥99% | NB-598 Maleate | ESD-881997-2MG |
| Cas.: 155294-62-5 | Purity: ≥99% | NB-598 Maleate | ESD-881997-5MG |
| Cas.: 15527-80-7 | Purity: 96% | Peraksine | ESD-881998-5MG |
| Cas.: 155271-17-3 | Purity: 98% | KF21213 | ESD-881999-1MG |
| Cas.: 155271-17-3 | Purity: 98% | KF21213 | ESD-881999-5MG |
| Cas.: 1552151-99-1 | Purity: 95% | tert-Butyl 2-(4-tert-butylphenyl)-3-oxo-1,4,8-triazaspiro[4.5]dec-1-ene-8-carboxylate | ESD-882000-500MG |
| Cas.: 1552151-99-1 | Purity: 95% | tert-Butyl 2-(4-tert-butylphenyl)-3-oxo-1,4,8-triazaspiro[4.5]dec-1-ene-8-carboxylate | ESD-882000-1G |
| Cas.: 155205-65-5 | Purity: 95% | Methyl 7α,15-dihydroxydehydroabietate | ESD-882001-5MG |
| Cas.: 155205-64-4 | Purity: 98% | 7α,15-Dihydroxydehydroabietic acid | ESD-882002-5MG |
| Cas.: 155178-03-3 | Purity: 96% | Physapruin A | ESD-882003-5MG |
| Cas.: 155148-32-6 | Purity: 98% | Plerixafor octahydrobromide | ESD-882004-5MG |
| Cas.: 155060-48-3 | Purity: 95% | 24,25-Dihydroxycycloartan-3-one | ESD-882005-5MG |
| Cas.: 155051-85-7 | Purity: 97% | 4-Hydroxy-3-(3-methyl-2-butenoyl)-5-(3-methyl-2-butenyl)benzoic acid | ESD-882006-5MG |
| Cas.: 155030-63-0 | Purity: ≥98% | Emodepside | ESD-882007-5MG |
| Cas.: 155030-63-0 | Purity: ≥98% | Emodepside | ESD-882007-10MG |
| Cas.: 1548743-69-6 | Purity: ≥99% | Autotaxin modulator 1 | ESD-882008-2MG |
| Cas.: 1548743-69-6 | Purity: ≥99% | Autotaxin modulator 1 | ESD-882008-5MG |
| Cas.: 15486-33-6 | Purity: 98% | Kaempferol 7,4′-dimethyl ether | ESD-882009-5MG |
| Cas.: 15486-24-5 | Purity: 97% | Eleutheroside C | ESD-882010-1MG |
| Cas.: 154801-30-6 | Purity: 96% | 2-(2′-Hydroxytetracosanoylamino)-octadecane-1,3,4-triol | ESD-882011-5MG |
| Cas.: 154706-44-2 | Purity: 95% | 3-Methoxymollugin | ESD-882012-5MG |
| Cas.: 154566-12-8 | Purity: ≥98% | SB 204990 | ESD-882013-5MG |
| Cas.: 154566-12-8 | Purity: ≥98% | SB 204990 | ESD-882013-10MG |
| Cas.: 154512-46-6 | Purity: 98% | L162441 | ESD-882014-1MG |
| Cas.: 154512-46-6 | Purity: 98% | L162441 | ESD-882014-5MG |
| Cas.: 154495-69-9 | Purity: 95% | 8-Benzyl-2,8-diazaspiro[4.5]decan-3-one | ESD-882015-100MG |
| Cas.: 154495-69-9 | Purity: 95% | 8-Benzyl-2,8-diazaspiro[4.5]decan-3-one | ESD-882015-500MG |
| Cas.: 154495-67-7 | Purity: 95% | 8-methyl-2,8-diazaspiro[4.5]decan-3-one | ESD-882016-1G |
| Cas.: 154495-67-7 | Purity: 95% | 8-methyl-2,8-diazaspiro[4.5]decan-3-one | ESD-882016-5G |
| Cas.: 154461-65-1 | Purity: 95% | Sinapaldehyde glucoside | ESD-882017-5MG |
| Cas.: 154418-16-3 | Purity: 98% | 5,5′-Dimethoxylariciresinol 4-O-glucoside | ESD-882018-5MG |
| Cas.: 154229-21-7 | Purity: ≥99% | D4-abiraterone | ESD-882019-5MG |
| Cas.: 154229-21-7 | Purity: ≥99% | D4-abiraterone | ESD-882019-10MG |
| Cas.: 1542213-00-2 | Purity: ≥99% | NCT-502 | ESD-882020-5MG |
| Cas.: 1542213-00-2 | Purity: ≥99% | NCT-502 | ESD-882020-10MG |
| Cas.: 154-21-2 | Purity: 98% | Lincomycin | ESD-882021-5MG |
| Cas.: 154127-41-0 | Purity: 98% | 2-(3-Methoxypropyl)-4-oxo-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide | ESD-882022-5MG |
| Cas.: 154106-92-0 | Purity: 98% | RPR104632 | ESD-882023-1MG |
| Cas.: 154106-92-0 | Purity: 98% | RPR104632 | ESD-882023-5MG |
| Cas.: 154057-56-4 | Purity: 98% | 3-(Bromomethyl)-2-cyclopropyl-4-(4′-fluorophenyl)quinoline | ESD-882024-5MG |
| Cas.: 15404-80-5 | Purity: 98% | Isonormangostin | ESD-882025-5MG |
| Cas.: 1539314-06-1 | Purity: ≥99% | GSK-2881078 | ESD-882026-2MG |
| Cas.: 1539314-06-1 | Purity: ≥99% | GSK-2881078 | ESD-882026-5MG |
| Cas.: 1539303-03-1 | Purity: 97% | p-Hydroxyphenethyl vanillate | ESD-882027-5MG |
| Cas.: 153874-14-7 | Purity: 98% | S16961 | ESD-882028-1MG |
| Cas.: 153874-14-7 | Purity: 98% | S16961 | ESD-882028-5MG |
| Cas.: 1538593-71-3 | Purity: ≥99% | Piperazine Erastin | ESD-882029-1MG |
| Cas.: 1538359-43-1 | Purity: 95% | 5′-CHLOROSPIRO[CYCLOPROPANE-1,3′-INDOLINE] | ESD-882030-250MG |
| Cas.: 1538359-43-1 | Purity: 95% | 5′-CHLOROSPIRO[CYCLOPROPANE-1,3′-INDOLINE] | ESD-882030-1G |
| Cas.: 153804-05-8 | Purity: 98% | Pratosartan | ESD-882031-1MG |
| Cas.: 153804-05-8 | Purity: 98% | Pratosartan | ESD-882031-5MG |
| Cas.: 153777-70-9 | Purity: 98% | DOTA derivative | ESD-882032-1MG |
| Cas.: 15374-15-9 | Purity: 99% | Dioxopromethazine hydrochloride | ESD-882033-5MG |
| Cas.: 153653-30-6 | Purity: ≥99% | Dofequidar fumarate | ESD-882034-5MG |
| Cas.: 153653-30-6 | Purity: ≥99% | Dofequidar fumarate | ESD-882034-10MG |
| Cas.: 1536200-31-3 | Purity: ≥99% | GNE-9605 | ESD-882035-2MG |
| Cas.: 1536200-31-3 | Purity: ≥99% | GNE-9605 | ESD-882035-5MG |
| Cas.: 1536169-63-7 | Purity: 95% | 5-AZASPIRO[2.3]HEXANE HCL | ESD-882036-250MG |
| Cas.: 1536169-63-7 | Purity: 95% | 5-AZASPIRO[2.3]HEXANE HCL | ESD-882036-1G |
| Cas.: 153483-31-9 | Purity: 97% | Xanthinin | ESD-882037-5MG |
| Cas.: 153437-55-9 | Purity: 98% | WHI-P180 hydrochloride | ESD-882038-2MG |
| Cas.: 153437-55-9 | Purity: 98% | WHI-P180 hydrochloride | ESD-882038-5MG |
| Cas.: 1534358-79-6 | Purity: ≥98% | COH000 | ESD-882039-5MG |
| Cas.: 1534358-79-6 | Purity: ≥98% | COH000 | ESD-882039-10MG |
| Cas.: 153415-46-4 | Purity: 95% | Taxcultine | ESD-882040-5MG |
| Cas.: 153415-45-3 | Purity: 98% | Taxol C | ESD-882041-5MG |
| Cas.: 153381-68-1 | Purity: 98% | 7-Epi-docetaxel | ESD-882042-1MG |
| Cas.: 153381-68-1 | Purity: 98% | 7-Epi-docetaxel | ESD-882042-10MG |
| Cas.: 153355-70-5 | Purity: Analysis control, 98% | Ginkgolide K | ESD-882043-5MG |
| Cas.: 1533426-72-0 | Purity: ≥99% | SCR7 | ESD-882044-5MG |
| Cas.: 1533426-72-0 | Purity: ≥99% | SCR7 | ESD-882044-10MG |
| Cas.: 1532593-30-8 | Purity: ≥98% | ML355 | ESD-882045-2MG |
| Cas.: 1532593-30-8 | Purity: ≥98% | ML355 | ESD-882045-5MG |
| Cas.: 1532533-69-9 | Purity: ≥99% | Umbralisib R-enantiomer | ESD-882046-2MG |
| Cas.: 1532533-69-9 | Purity: ≥99% | Umbralisib R-enantiomer | ESD-882046-5MG |
| Cas.: 153229-31-3 | Purity: 97% | Taxayunnansin A | ESD-882047-5MG |
| Cas.: 153168-05-9 | Purity: ≥99% | Pleconaril | ESD-882048-5MG |
| Cas.: 153168-05-9 | Purity: ≥99% | Pleconaril | ESD-882048-10MG |
| Cas.: 1531634-31-7 | Purity: ≥99% | AF38469 | ESD-882049-2MG |
| Cas.: 1531634-31-7 | Purity: ≥99% | AF38469 | ESD-882049-5MG |
| Cas.: 153083-53-5 | Purity: 98% | N-Methyltaxol C | ESD-882050-5MG |
| Cas.: 15302-15-5 | Purity: ≥98% | Etosalamide | ESD-882051-10MG |
| Cas.: 153012-37-4 | Purity: 98% | Precursor of cefcapene diisopropylanmine salt | ESD-882052-5MG |
| Cas.: 15297-92-4 | Purity: 97% | Dehydro-α-lapachone | ESD-882053-5MG |
| Cas.: 1529775-08-3 | Purity: 96% | Guajadial F | ESD-882054-5MG |
| Cas.: 1529775-06-1 | Purity: 95% | Guajadial E | ESD-882055-5MG |
| Cas.: 1529775-04-9 | Purity: 95% | Guajadial D | ESD-882056-5MG |
| Cas.: 1529775-02-7 | Purity: 95% | Guajadial C | ESD-882057-5MG |
| Cas.: 152918-26-8 | Purity: ≥99% | AB-MECA | ESD-882058-1MG |
| Cas.: 152918-26-8 | Purity: ≥99% | AB-MECA | ESD-882058-5MG |
| Cas.: 152886-85-6 | Purity: 98% | U91356 | ESD-882059-1MG |
| Cas.: 152886-85-6 | Purity: 98% | U91356 | ESD-882059-5MG |
| Cas.: 1528745-88-1 | Purity: 98% | Chartarlactam A | ESD-882060-5MG |
| Cas.: 152831-36-2 | Purity: ≥99% | NE 10790 | ESD-882061-5MG |
| Cas.: 152831-36-2 | Purity: ≥99% | NE 10790 | ESD-882061-10MG |
| Cas.: 152811-62-6 | Purity: ≥98% | Piboserod | ESD-882062-10MG |
| Cas.: 152811-62-6 | Purity: ≥98% | Piboserod | ESD-882062-50MG |
| Cas.: 152802-84-1 | Purity: 98% | KRN4884 | ESD-882063-1MG |
| Cas.: 152802-84-1 | Purity: 98% | KRN4884 | ESD-882063-5MG |
| Cas.: 152784-32-2 | Purity: 95% | Puerol A | ESD-882064-5MG |
| Cas.: 152721-37-4 | Purity: ≥98% | EF-5 | ESD-882065-1MG |
| Cas.: 152721-37-4 | Purity: ≥98% | EF-5 | ESD-882065-5MG |
| Cas.: 152685-91-1 | Purity: 97% | Cimiside B | ESD-882066-5MG |
| Cas.: 152685-85-3 | Purity: ≥99% | Hemorphin-7 | ESD-882067-1MG |
| Cas.: 152685-85-3 | Purity: ≥99% | Hemorphin-7 | ESD-882067-5MG |
| Cas.: 152684-53-2 | Purity: ≥98% | TLK117 | ESD-882068-5MG |
| Cas.: 152684-53-2 | Purity: ≥98% | TLK117 | ESD-882068-10MG |
| Cas.: 15266-35-0 | Purity: 98% | Dihydroevocarpine | ESD-882069-5MG |
| Cas.: 152633-54-0 | Purity: 98% | Win-62005 | ESD-882070-1MG |
| Cas.: 152633-54-0 | Purity: 98% | Win-62005 | ESD-882070-5MG |
| Cas.: 152-62-5 | Purity: ≥99% | Dydrogesterone | ESD-882071-10MG |
| Cas.: 152-62-5 | Purity: ≥99% | Dydrogesterone | ESD-882071-25MG |
| Cas.: 152480-82-5 | Purity: 95% | 2′,7′-Dicyano-spiro[fluorene-9,9′-xanthene] | ESD-882072-500MG |
| Cas.: 152464-78-3 | Purity: 98% | Leachianone G | ESD-882073-5MG |
| Cas.: 1523618-29-2 | Purity: 95% | 5-Oxa-2-aza-spiro[3·4]octane oxalate (2:1) | ESD-882074-1MG |
| Cas.: 1523617-88-0 | Purity: 95% | 2-Azaspiro[4.4]nonane hemioxalate | ESD-882075-100MG |
| Cas.: 1523617-88-0 | Purity: 95% | 2-Azaspiro[4.4]nonane hemioxalate | ESD-882075-500MG |
| Cas.: 1523571-81-4 | Purity: 95% | 6-Aza-spiro[3·4]octane oxalate | ESD-882076-1G |
| Cas.: 1523571-10-9 | Purity: 97% | tert-butyl 1,6-diazaspiro[3 3]heptane-1-carboxylate hemioxalate | ESD-882077-1G |
| Cas.: 1523570-96-8 | Purity: 95% | 2-Oxa-6-azaspiro[3·4]octane hemioxalate | ESD-882078-1G |
| Cas.: 1523404-29-6 | Purity: ≥99% | Vps34-IN-2 | ESD-882079-1MG |
| Cas.: 1523404-29-6 | Purity: ≥99% | Vps34-IN-2 | ESD-882079-5MG |
| Cas.: 152317-89-0 | Purity: 98% | Alniditan | ESD-882080-1MG |
| Cas.: 152317-89-0 | Purity: 98% | Alniditan | ESD-882080-5MG |
| Cas.: 1523068-91-8 | Purity: 95% | 6′-METHOXYSPIRO[CYCLOPROPANE-1,3′-INDOLINE] | ESD-882081-250MG |
| Cas.: 1523068-91-8 | Purity: 95% | 6′-METHOXYSPIRO[CYCLOPROPANE-1,3′-INDOLINE] | ESD-882081-1G |
| Cas.: 152286-31-2 | Purity: 98% | Amyloid β-Protein 10-20 | ESD-882082-1MG |
| Cas.: 152286-31-2 | Purity: 98% | Amyloid β-Protein 10-20 | ESD-882082-5MG |
| Cas.: 152273-12-6 | Purity: ≥99% | U93631 | ESD-882083-5MG |
| Cas.: 152273-12-6 | Purity: ≥99% | U93631 | ESD-882083-10MG |
| Cas.: 152253-67-3 | Purity: 97% | mupinensisone | ESD-882084-5MG |
| Cas.: 152243-70-4 | Purity: 95% | Uncargenin C | ESD-882085-5MG |
| Cas.: 152204-32-5 | Purity: 95% | Phomaligol A | ESD-882086-5MG |
| Cas.: 1522004-70-1 | Purity: 95% | Aphadilactone C | ESD-882087-5MG |
| Cas.: 1522004-68-7 | Purity: 95% | Aphadilactone B | ESD-882088-5MG |
| Cas.: 152175-76-3 | Purity: 95% | Forrestin A | ESD-882089-1MG |
| Cas.: 1521-41-1 | Purity: 95% | 3,4-Dimethoxybenzamide | ESD-882090-1MG |
| Cas.: 1521197-43-2 | Purity: 98% | 2-Chloro-11-cyclopentyl-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one | ESD-882091-5MG |
| Cas.: 152110-17-3 | Purity: 98% | Teuclatriol | ESD-882092-5MG |
| Cas.: 152041-27-5 | Purity: 98% | Dehydroacerogenin C | ESD-882093-5MG |
| Cas.: 151823-14-2 | Purity: ≥98% | Sapacitabine | ESD-882094-5MG |
| Cas.: 151823-14-2 | Purity: ≥98% | Sapacitabine | ESD-882094-10MG |
| Cas.: 15176-29-1 | Purity: ≥99% | Edoxudine | ESD-882095-50MG |
| Cas.: 15176-29-1 | Purity: ≥99% | Edoxudine | ESD-882095-100MG |
| Cas.: 151731-50-9 | Purity: 97% | 2,2-Dimethyl-8-prenylchromene-6-carboxylic acid | ESD-882096-5MG |
| Cas.: 151720-43-3 | Purity: ≥98% | Oxamflatin | ESD-882097-1MG |
| Cas.: 151720-43-3 | Purity: ≥98% | Oxamflatin | ESD-882097-5MG |
| Cas.: 151705-84-9 | Purity: 98% | LCMV gp33-41 | ESD-882099-1MG |
| Cas.: 151705-84-9 | Purity: 98% | LCMV gp33-41 | ESD-882099-5MG |
| Cas.: 1516896-09-5 | Purity: ≥97% | PDE10-IN-1 | ESD-882100-2MG |
| Cas.: 1516896-09-5 | Purity: ≥97% | PDE10-IN-1 | ESD-882100-5MG |
| Cas.: 151649-34-2 | Purity: 97% | 3-O-Methylgancaonin P | ESD-882101-5MG |
| Cas.: 1515855-97-6 | Purity: ≥98% | JJKK 048 | ESD-882102-5MG |
| Cas.: 1515855-97-6 | Purity: ≥98% | JJKK 048 | ESD-882102-10MG |
| Cas.: 151563-36-9 | Purity: 95% | 10-Epideuclatriol | ESD-882103-5MG |
| Cas.: 151561-88-5 | Purity: 98% | ent-3-Oxokauran-17-oic acid | ESD-882104-5MG |
| Cas.: 1514888-56-2 | Purity: ≥99% | S1p receptor agonist 1 | ESD-882105-1MG |
| Cas.: 1514888-56-2 | Purity: ≥99% | S1p receptor agonist 1 | ESD-882105-5MG |
| Cas.: 1514669-21-6 | Purity: 95% | Swietemahalactone | ESD-882106-5MG |
| Cas.: 151455-26-4 | Purity: 96% | 3′,3”’-Biapigenin | ESD-882107-5MG |
| Cas.: 151455-25-3 | Purity: 97% | 2”,3”-Dihydro-3′,3”’-biapigenin | ESD-882108-5MG |
| Cas.: 151455-10-6 | Purity: 97% | 2”-OEp-Coumaroylafzelin | ESD-882109-5MG |
| Cas.: 1513879-21-4 | Purity: ≥99% | BQR-695 | ESD-882110-2MG |
| Cas.: 1513879-21-4 | Purity: ≥99% | BQR-695 | ESD-882110-5MG |
| Cas.: 1513879-19-0 | Purity: ≥99% | KDU691 | ESD-882111-5MG |
| Cas.: 1513879-19-0 | Purity: ≥99% | KDU691 | ESD-882111-10MG |
| Cas.: 1513857-77-6 | Purity: ≥98% | pemigatinib | ESD-882112-5MG |
| Cas.: 1513857-77-6 | Purity: ≥98% | pemigatinib | ESD-882112-10MG |
| Cas.: 151358-48-4 | Purity: ≥99% | DIM-C-pPhCO2Me | ESD-882113-5MG |
| Cas.: 151358-48-4 | Purity: ≥99% | DIM-C-pPhCO2Me | ESD-882113-10MG |
| Cas.: 151334-06-4 | Purity: 95% | 3-Op-Coumaroyloleanolic acid | ESD-882114-1MG |
| Cas.: 151227-08-6 | Purity: 98% | AP521 | ESD-882115-1MG |
| Cas.: 151227-08-6 | Purity: 98% | AP521 | ESD-882115-5MG |
| Cas.: 151200-50-9 | Purity: 98% | Borapetoside F | ESD-882116-5MG |
| Cas.: 151200-49-6 | Purity: 95% | Borapetoside E | ESD-882117-5MG |
| Cas.: 151200-48-5 | Purity: 95% | Borapetoside D | ESD-882118-5MG |
| Cas.: 151165-96-7 | Purity: 98% | S-8921 | ESD-882119-1MG |
| Cas.: 151165-96-7 | Purity: 98% | S-8921 | ESD-882119-5MG |
| Cas.: 151135-64-7 | Purity: 98% | 4′-Hydroxy-2,4-dimethoxychalcone | ESD-882120-5MG |
| Cas.: 151121-39-0 | Purity: 95% | 8-(6-Hydroperoxy-3,7-dimethylocta-2,7-dienyloxy)psoralen | ESD-882121-5MG |
| Cas.: 1511-16-6 | Purity: 98% | Haloperidol hydrochloride | ESD-882122-100MG |
| Cas.: 1511-16-6 | Purity: 98% | Haloperidol hydrochloride | ESD-882122-500MG |
| Cas.: 1510829-06-7 | Purity: ≥99% | Vecabrutinib | ESD-882123-5MG |
| Cas.: 1510829-06-7 | Purity: ≥99% | Vecabrutinib | ESD-882123-10MG |
| Cas.: 151038-96-9 | Purity: 98% | MC-DOXHZN | ESD-882124-2MG |
| Cas.: 151038-96-9 | Purity: 98% | MC-DOXHZN | ESD-882124-5MG |
| Cas.: 15097-74-2 | Purity: 95% | 2,4,4′-Trihydroxydihydrochalcone | ESD-882125-5MG |
| Cas.: 1508-76-5 | Purity: ≥99% | Procyclidine hydrochloride | ESD-882126-100MG |
| Cas.: 15085-71-9 | Purity: 98% | Micromelin | ESD-882127-5MG |
| Cas.: 1508250-72-3 | Purity: 98% | Nazartinib mesylate | ESD-882128-1MG |
| Cas.: 1508250-72-3 | Purity: 98% | Nazartinib mesylate | ESD-882128-5MG |
| Cas.: 150821-16-2 | Purity: 98% | 2α,3α,24-Trihydroxyolean-12-en-28-oic acid | ESD-882129-5MG |
| Cas.: 150821-03-7 | Purity: ≥99% | Pranlukast hemihydrate | ESD-882130-50MG |
| Cas.: 150821-03-7 | Purity: ≥99% | Pranlukast hemihydrate | ESD-882130-100MG |
| Cas.: 150779-71-8 | Purity: 98% | SDZ281-977 | ESD-882131-1MG |
| Cas.: 150779-71-8 | Purity: 98% | SDZ281-977 | ESD-882131-5MG |
| Cas.: 150725-87-4 | Purity: 98% | Ro 46-2005 | ESD-882132-1MG |
| Cas.: 150725-87-4 | Purity: 98% | Ro 46-2005 | ESD-882132-5MG |
| Cas.: 15071-56-4 | Purity: 98% | 5-Methoxycanthin-6-one | ESD-882133-5MG |
| Cas.: 150710-72-8 | Purity: 98% | Calyxamine B | ESD-882134-5MG |
| Cas.: 150671-04-8 | Purity: 98% | Ceratotoxin A | ESD-882135-1MG |
| Cas.: 150671-04-8 | Purity: 98% | Ceratotoxin A | ESD-882135-5MG |
| Cas.: 1505857-33-9 | Purity: 95% | 7′-CHLOROSPIRO[CYCLOPROPANE-1,3′-INDOLINE] | ESD-882136-1G |
| Cas.: 150566-71-5 | Purity: ≥99% | Levamlodipine besylate | ESD-882137-10MG |
| Cas.: 150566-71-5 | Purity: ≥99% | Levamlodipine besylate | ESD-882137-50MG |
| Cas.: 1505484-82-1 | Purity: ≥99% | Nemorexant | ESD-882138-1MG |
| Cas.: 1505484-82-1 | Purity: ≥99% | Nemorexant | ESD-882138-5MG |
| Cas.: 1505453-59-7 | Purity: ≥99% | BET bromodomain inhibitor | ESD-882139-5MG |
| Cas.: 1505453-59-7 | Purity: ≥99% | BET bromodomain inhibitor | ESD-882139-10MG |
| Cas.: 150543-61-6 | Purity: 95% | 5-[(tert-Butoxy)carbonyl]-5-azaspiro[2.4]heptane-1-carboxylic acid | ESD-882140-1G |
| Cas.: 150543-61-6 | Purity: 95% | 5-[(tert-Butoxy)carbonyl]-5-azaspiro[2.4]heptane-1-carboxylic acid | ESD-882140-5G |
| Cas.: 15051-81-7 | Purity: 95% | epi-Eudesmol | ESD-882141-1MG |
| Cas.: 150452-18-9 | Purity: 98% | ER21355 | ESD-882142-1MG |
| Cas.: 150452-18-9 | Purity: 98% | ER21355 | ESD-882142-5MG |
| Cas.: 150417-90-6 | Purity: ≥98% | GC7 Sulfate | ESD-882143-1MG |
| Cas.: 150417-90-6 | Purity: ≥98% | GC7 Sulfate | ESD-882143-5MG |
| Cas.: 150378-17-9 | Purity: 98% | Indinavir | ESD-882144-10MG |
| Cas.: 150378-17-9 | Purity: 98% | Indinavir | ESD-882144-50MG |
| Cas.: 150374-95-1 | Purity: 98% | Sivelestat sodium | ESD-882145-10MG |
| Cas.: 150374-95-1 | Purity: 98% | Sivelestat sodium | ESD-882145-50MG |
| Cas.: 150333-85-0 | Purity: 95% | threo-7-O-Methylguaiacylglycerol β-coniferyl ether | ESD-882146-5MG |
| Cas.: 1502655-48-2 | Purity: 98% | Ledipasvir (diacetone) | ESD-882147-2MG |
| Cas.: 1502655-48-2 | Purity: 98% | Ledipasvir (diacetone) | ESD-882147-5MG |
| Cas.: 1502654-87-6 | Purity: ≥98% | Ledipasvir D-tartrate | ESD-882148-2MG |
| Cas.: 1502654-87-6 | Purity: ≥98% | Ledipasvir D-tartrate | ESD-882148-5MG |
| Cas.: 150258-84-7 | Purity: 97% | 3,5,3′-Trihydroxystilbene | ESD-882149-5MG |
| Cas.: 150206-05-6 | Purity: 95% | 5-(((2,5-Dioxopyrrolidin-1-yl)oxy)carbonyl)-3-oxo-3H-spiro-[isobenzofuran-1,9′-xanthene]-3′,6′-diyl diacetate | ESD-882150-250MG |
| Cas.: 150206-05-6 | Purity: 95% | 5-(((2,5-Dioxopyrrolidin-1-yl)oxy)carbonyl)-3-oxo-3H-spiro-[isobenzofuran-1,9′-xanthene]-3′,6′-diyl diacetate | ESD-882150-1G |
| Cas.: 1501943-08-3 | Purity: 95% | Trigothysoid N | ESD-882151-5MG |
| Cas.: 150150-61-1 | Purity: 95% | 11,13-Dihydroivalin | ESD-882152-1MG |
| Cas.: 150148-81-5 | Purity: 97% | Strictosidinic acid | ESD-882153-5MG |
| Cas.: 150080-09-4 | Purity: ≥98% | Talabostat mesylate | ESD-882154-5MG |
| Cas.: 150080-09-4 | Purity: ≥98% | Talabostat mesylate | ESD-882154-10MG |
| Cas.: 150058-27-8 | Purity: 98% | Methyl 2-ethoxybenzimidazole-7-carboxylate | ESD-882155-5MG |
| Cas.: 150033-85-5 | Purity: 97% | Cycloshizukaol A | ESD-882156-5MG |
| Cas.: 149998-39-0 | Purity: 95% | Gelomuloside B | ESD-882157-5MG |
| Cas.: 149998-38-9 | Purity: 95% | Gelomuloside A | ESD-882158-5MG |
| Cas.: 1499946-35-8 | Purity: 98% | 5-O-Methyldalbergiphenol | ESD-882159-5MG |
| Cas.: 149979-74-8 | Purity: 98% | Terbogrel | ESD-882160-1MG |
| Cas.: 149979-74-8 | Purity: 98% | Terbogrel | ESD-882160-5MG |
| Cas.: 149968-26-3 | Purity: 98% | Elisartan | ESD-882161-1MG |
| Cas.: 149968-26-3 | Purity: 98% | Elisartan | ESD-882161-5MG |
| Cas.: 149908-53-2 | Purity: 98% | Azimilide | ESD-882162-5MG |
| Cas.: 149908-53-2 | Purity: 98% | Azimilide | ESD-882162-10MG |
| Cas.: 149888-94-8 | Purity: ≥98% | Azimilide Dihydrochloride | ESD-882163-5MG |
| Cas.: 149888-94-8 | Purity: ≥98% | Azimilide Dihydrochloride | ESD-882163-10MG |
| Cas.: 149877-41-8 | Purity: ≥99% | Bifenazate | ESD-882164-100MG |
| Cas.: 149877-41-8 | Purity: ≥99% | Bifenazate | ESD-882164-500MG |
| Cas.: 14982-11-7 | Purity: 98% | Homoeriodictyol 7-O-glucoside | ESD-882165-5MG |
| Cas.: 149751-81-5 | Purity: 98% | Tereticornate A | ESD-882166-5MG |
| Cas.: 149709-63-7 | Purity: ≥98% | (2S,4S)-Sacubitril | ESD-882167-1MG |
| Cas.: 149709-63-7 | Purity: ≥98% | (2S,4S)-Sacubitril | ESD-882167-5MG |
| Cas.: 149709-44-4 | Purity: ≥99% | Sacubitrilat | ESD-882168-2MG |
| Cas.: 149709-44-4 | Purity: ≥99% | Sacubitrilat | ESD-882168-5MG |
| Cas.: 149691-31-6 | Purity: 97% | Stachybotrolide | ESD-882169-5MG |
| Cas.: 1496581-76-0 | Purity: ≥99% | GNE-3511 | ESD-882171-1MG |
| Cas.: 1496581-76-0 | Purity: ≥99% | GNE-3511 | ESD-882171-5MG |
| Cas.: 1496552-51-2 | Purity: ≥98% | Sofosbuvir impurity K | ESD-882172-1MG |
| Cas.: 1496552-51-2 | Purity: ≥98% | Sofosbuvir impurity K | ESD-882172-5MG |
| Cas.: 1496552-28-3 | Purity: 98% | Sofosbuvir impurity C | ESD-882173-1MG |
| Cas.: 1496552-28-3 | Purity: 98% | Sofosbuvir impurity C | ESD-882173-5MG |
| Cas.: 1496552-16-9 | Purity: ≥99% | Sofosbuvir impurity A | ESD-882174-1MG |
| Cas.: 1496552-16-9 | Purity: ≥99% | Sofosbuvir impurity A | ESD-882174-5MG |
| Cas.: 14965-20-9 | Purity: 98% | Chrysosplenol D | ESD-882175-5MG |
| Cas.: 149598-71-0 | Purity: 97% | Stachybotramide | ESD-882176-5MG |
| Cas.: 14957-38-1 | Purity: 98% | Marmin | ESD-882177-5MG |
| Cas.: 1494675-86-3 | Purity: ≥99% | TBA-7371 | ESD-882178-2MG |
| Cas.: 1494675-86-3 | Purity: ≥99% | TBA-7371 | ESD-882178-5MG |
| Cas.: 149415-62-3 | Purity: 97% | Traxillaside | ESD-882179-5MG |
| Cas.: 149402-51-7 | Purity: ≥98% | HPPH | ESD-882180-5MG |
| Cas.: 149402-51-7 | Purity: ≥98% | HPPH | ESD-882180-10MG |
| Cas.: 149400-88-4 | Purity: 98% | Sardomozide | ESD-882181-5MG |
| Cas.: 149400-88-4 | Purity: 98% | Sardomozide | ESD-882181-10MG |
| Cas.: 149385-65-9 | Purity: 98% | β-Amyloid 31-35 | ESD-882182-1MG |
| Cas.: 149385-65-9 | Purity: 98% | β-Amyloid 31-35 | ESD-882182-5MG |
| Cas.: 1493762-74-5 | Purity: ≥98% | BM635 | ESD-882183-1MG |
| Cas.: 1493762-74-5 | Purity: ≥98% | BM635 | ESD-882183-5MG |
| Cas.: 1492952-76-7 | Purity: ≥98% | Asciminib | ESD-882184-1MG |
| Cas.: 1492952-76-7 | Purity: ≥98% | Asciminib | ESD-882184-5MG |
| Cas.: 149281-19-6 | Purity: 98% | CGP-53153 | ESD-882185-1MG |
| Cas.: 149281-19-6 | Purity: 98% | CGP-53153 | ESD-882185-5MG |
| Cas.: 149252-87-9 | Purity: 95% | 1-Dehydroxy-23-deoxojessic acid | ESD-882186-5MG |
| Cas.: 149250-48-6 | Purity: 98% | De-4′-O-methylyangambin | ESD-882187-5MG |
| Cas.: 149249-32-1 | Purity: 98% | Neotripterifordin | ESD-882188-5MG |
| Cas.: 149184-19-0 | Purity: 95% | irenolone | ESD-882189-5MG |
| Cas.: 149-16-6 | Purity: ≥99% | Butacaine | ESD-882190-100MG |
| Cas.: 149155-45-3 | Purity: 98% | CREBtide | ESD-882191-1MG |
| Cas.: 149155-45-3 | Purity: 98% | CREBtide | ESD-882191-5MG |
| Cas.: 1491152-26-1 | Purity: 98% | mDPR-Val-Cit-PAB-MMAE | ESD-882192-1MG |
| Cas.: 1491152-26-1 | Purity: 98% | mDPR-Val-Cit-PAB-MMAE | ESD-882192-5MG |
| Cas.: 148927-23-5 | Purity: 98% | MF 5137 | ESD-882193-1MG |
| Cas.: 148927-23-5 | Purity: 98% | MF 5137 | ESD-882193-5MG |
| Cas.: 148901-68-2 | Purity: 98% | 3-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl-2-propenal | ESD-882194-5MG |
| Cas.: 148899-14-3 | Purity: 95% | 5-nitrospiro[1,3-benzodioxole-2,1′-cyclopentane] | ESD-882195-1G |
| Cas.: 1488363-78-5 | Purity: ≥99% | Adomeglivant | ESD-882196-2MG |
| Cas.: 1488363-78-5 | Purity: ≥99% | Adomeglivant | ESD-882196-5MG |
| Cas.: 1488354-15-9 | Purity: ≥99% | Fulacimstat | ESD-882197-5MG |
| Cas.: 1488354-15-9 | Purity: ≥99% | Fulacimstat | ESD-882197-10MG |
| Cas.: 14882-94-1 | Purity: 98% | Rutamarin | ESD-882198-5MG |
| Cas.: 1487360-85-9 | Purity: 98% | Cyclosporin A-Derivative 1 | ESD-882199-1MG |
| Cas.: 1487360-85-9 | Purity: 98% | Cyclosporin A-Derivative 1 | ESD-882199-5MG |
| Cas.: 148-72-1 | Purity: 98% | Pilocarpine nitrate | ESD-882200-100MG |
| Cas.: 1486-70-0 | Purity: 98% | 3-O-Methylquercetin | ESD-882201-5MG |
| Cas.: 1486-69-7 | Purity: 95% | 3-O-Methylquercetin tetraacetate | ESD-882202-1MG |
| Cas.: 14858-07-2 | Purity: 97% | 3β,5α-Dihydroxyergosta-7,22-dien-6-one | ESD-882203-5MG |
| Cas.: 148554-65-8 | Purity: 98% | Seco Rapamycin sodium salt | ESD-882204-1MG |
| Cas.: 148554-65-8 | Purity: 98% | Seco Rapamycin sodium salt | ESD-882204-5MG |
| Cas.: 148409-36-3 | Purity: 98% | (+)-Matairesinol | ESD-882205-5MG |
| Cas.: 148396-36-5 | Purity: 98% | Fradafiban | ESD-882206-1MG |
| Cas.: 148396-36-5 | Purity: 98% | Fradafiban | ESD-882206-5MG |
| Cas.: 148291-65-0 | Purity: 98% | LY210073 | ESD-882207-1MG |
| Cas.: 148291-65-0 | Purity: 98% | LY210073 | ESD-882207-5MG |
| Cas.: 148274-76-4 | Purity: 98% | MG 1 | ESD-882208-1MG |
| Cas.: 148274-76-4 | Purity: 98% | MG 1 | ESD-882208-5MG |
| Cas.: 1482500-76-4 | Purity: ≥98% | ML-290 | ESD-882209-5MG |
| Cas.: 1482500-76-4 | Purity: ≥98% | ML-290 | ESD-882209-10MG |
| Cas.: 1481-99-8 | Purity: 95% | SPIRO[5.5]UNDECANE-2,4-DIONE | ESD-882210-1G |
| Cas.: 1481-99-8 | Purity: 95% | SPIRO[5.5]UNDECANE-2,4-DIONE | ESD-882210-5G |
| Cas.: 148044-47-7 | Purity: 95% | 25-Hydroxycycloart-23-en-3-one | ESD-882211-5MG |
| Cas.: 148044-44-4 | Purity: 98% | 1-(3-(1-Hydroxy-3-methylbutyl)-4-methoxyphenyl)ethan-1-one | ESD-882212-5MG |
| Cas.: 147976-35-0 | Purity: 95% | Isokadsurenin D | ESD-882214-5MG |
| Cas.: 14796-24-8 | Purity: 98% | Cinperene | ESD-882215-1MG |
| Cas.: 14796-24-8 | Purity: 98% | Cinperene | ESD-882215-5MG |
| Cas.: 147850-78-0 | Purity: 98% | Filic-3-en-25-al | ESD-882216-5MG |
| Cas.: 14782-19-5 | Purity: 98% | INO5042 | ESD-882217-1MG |
| Cas.: 14782-19-5 | Purity: 98% | INO5042 | ESD-882217-5MG |
| Cas.: 147821-57-6 | Purity: 98% | Niazinin | ESD-882218-5MG |
| Cas.: 147821-49-6 | Purity: 98% | Niazimicin | ESD-882219-5MG |
| Cas.: 147770-06-7 | Purity: 98% | Repaglinide ethyl ester | ESD-882220-5MG |
| Cas.: 147764-93-0 | Purity: 98% | Jasamplexoside A | ESD-882221-5MG |
| Cas.: 1477458-14-2 | Purity: 90% | 2′-Bromospiro[fluorene-9,9′-xanthene] | ESD-882222-250MG |
| Cas.: 1477458-14-2 | Purity: 90% | 2′-Bromospiro[fluorene-9,9′-xanthene] | ESD-882222-1G |
| Cas.: 147742-02-7 | Purity: 95% | Jasamplexoside C | ESD-882223-5MG |
| Cas.: 147714-71-4 | Purity: 95% | 6-O-(3”,4”-Dimethoxycinnamoyl)catalpol | ESD-882224-1MG |
| Cas.: 1476777-06-6 | Purity: ≥99% | Niraparib metabolite M1 | ESD-882225-1MG |
| Cas.: 1476777-06-6 | Purity: ≥99% | Niraparib metabolite M1 | ESD-882225-5MG |
| Cas.: 147663-91-0 | Purity: 95% | Magnolianin | ESD-882226-5MG |
| Cas.: 147657-22-5 | Purity: ≥99% | Calcipotriol monohydrate | ESD-882227-5MG |
| Cas.: 147657-22-5 | Purity: ≥99% | Calcipotriol monohydrate | ESD-882227-10MG |
| Cas.: 147611-02-7 | Purity: 95% | Benzyl 2-amino-7-azaspiro[3.5]nonane-7-carboxylate | ESD-882228-1G |
| Cas.: 147611-02-7 | Purity: 95% | Benzyl 2-amino-7-azaspiro[3.5]nonane-7-carboxylate | ESD-882228-5G |
| Cas.: 147610-98-8 | Purity: 95% | 7-Cbz-2-oxo-7-aza-spiro[3.5]nonane | ESD-882229-1G |
| Cas.: 147536-97-8 | Purity: ≥99% | Bosentan | ESD-882230-50MG |
| Cas.: 147536-97-8 | Purity: ≥99% | Bosentan | ESD-882230-100MG |
| Cas.: 147517-06-4 | Purity: 95% | Thunberginol C | ESD-882231-1MG |
| Cas.: 14748-94-8 | Purity: 98% | Aminaftone | ESD-882232-1MG |
| Cas.: 14748-94-8 | Purity: 98% | Aminaftone | ESD-882232-5MG |
| Cas.: 147419-93-0 | Purity: 98% | Ginsenoside Rg6 | ESD-882233-5MG |
| Cas.: 147419-93-0 | Purity: 98% | Ginsenoside Rg6 | ESD-882233-10MG |
| Cas.: 147372-85-8 | Purity: 95% | Spiro[chroman-2,4′-piperidine] | ESD-882234-1G |
| Cas.: 1473450-62-2 | Purity: ≥99% | NITD-349 | ESD-882235-5MG |
| Cas.: 1473450-62-2 | Purity: ≥99% | NITD-349 | ESD-882235-10MG |
| Cas.: 147340-43-0 | Purity: 98% | MHP 133 | ESD-882236-1MG |
| Cas.: 147340-43-0 | Purity: 98% | MHP 133 | ESD-882236-5MG |
| Cas.: 1472797-69-5 | Purity: ≥99% | FF-10101 | ESD-882237-5MG |
| Cas.: 1472797-69-5 | Purity: ≥99% | FF-10101 | ESD-882237-10MG |
| Cas.: 1472795-20-2 | Purity: ≥96% | KRCA-0008 | ESD-882238-5MG |
| Cas.: 1472795-20-2 | Purity: ≥96% | KRCA-0008 | ESD-882238-10MG |
| Cas.: 1472624-85-3 | Purity: ≥99% | 7ACC2 | ESD-882239-2MG |
| Cas.: 1472624-85-3 | Purity: ≥99% | 7ACC2 | ESD-882239-5MG |
| Cas.: 147254-64-6 | Purity: ≥99% | Ranirestat | ESD-882240-5MG |
| Cas.: 147254-64-6 | Purity: ≥99% | Ranirestat | ESD-882240-10MG |
| Cas.: 147221-93-0 | Purity: ≥98% | Delavirdine mesylate | ESD-882241-10MG |
| Cas.: 147221-93-0 | Purity: ≥98% | Delavirdine mesylate | ESD-882241-50MG |
| Cas.: 147200-03-1 | Purity: 98% | N-6-Methyl-7,7-dioxo-2-sulfamoyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-4-yl]acetamide | ESD-882242-5MG |
| Cas.: 147116-67-4 | Purity: ≥99% | Maropitant | ESD-882243-2MG |
| Cas.: 147116-67-4 | Purity: ≥99% | Maropitant | ESD-882243-5MG |
| Cas.: 147086-79-1 | Purity: 98% | 5,6-Dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-one | ESD-882244-5MG |
| Cas.: 147059-46-9 | Purity: 98% | Rocaglaol | ESD-882245-5MG |
| Cas.: 1470374-22-1 | Purity: ≥99% | TAK-448 acetate | ESD-882246-1MG |
| Cas.: 1470374-22-1 | Purity: ≥99% | TAK-448 acetate | ESD-882246-5MG |
| Cas.: 147030-01-1 | Purity: ≥99% | Quiflapon sodium | ESD-882247-5MG |
| Cas.: 147030-01-1 | Purity: ≥99% | Quiflapon sodium | ESD-882247-10MG |
| Cas.: 147027-10-9 | Purity: 98% | Menthyl-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1,3]oxathiolane-2-carboxylic acid | ESD-882248-5MG |
| Cas.: 1469988-75-7 | Purity: ≥99% | QL47 | ESD-882249-2MG |
| Cas.: 1469988-75-7 | Purity: ≥99% | QL47 | ESD-882249-5MG |
| Cas.: 146949-21-5 | Purity: ≥98% | Pocapavir | ESD-882250-5MG |
| Cas.: 146949-21-5 | Purity: ≥98% | Pocapavir | ESD-882250-10MG |
| Cas.: 14694-15-6 | Purity: 97% | Codaphniphylline | ESD-882251-5MG |
| Cas.: 146918-26-5 | Purity: 98% | Bisdemethoxyboehmenan | ESD-882252-5MG |
| Cas.: 146905-24-0 | Purity: 98% | 1,2-Diacetoxy-4,7,8-trihydroxy-3-(4-hydroxyphenyl)dibenzofuran | ESD-882253-5MG |
| Cas.: 146900-55-2 | Purity: 97% | Triptobenzene H | ESD-882254-5MG |
| Cas.: 14686-65-8 | Purity: 98% | 1,5-Dihydroxyxanthone | ESD-882255-5MG |
| Cas.: 14679-73-3 | Purity: 98% | Todralazine | ESD-882256-100MG |
| Cas.: 1467093-03-3 | Purity: ≥99% | Adavivint | ESD-882257-5MG |
| Cas.: 1467093-03-3 | Purity: ≥99% | Adavivint | ESD-882257-10MG |
| Cas.: 1467083-10-8 | Purity: 95% | Daphnicyclidin I | ESD-882258-5MG |
| Cas.: 1467083-09-5 | Purity: 95% | Hybridaphniphylline B | ESD-882259-5MG |
| Cas.: 1467083-07-3 | Purity: 95% | Hybridaphniphylline A | ESD-882260-5MG |
| Cas.: 146578-99-6 | Purity: 98% | 2-Cyclopropyl-3-[(diphenylphosphinyl)methyl]-4-(4-fluorophenyl)quinoline | ESD-882261-5MG |
| Cas.: 14653-77-1 | Purity: ≥98% | WR-1065 dihydrochloride | ESD-882262-5MG |
| Cas.: 14653-77-1 | Purity: ≥98% | WR-1065 dihydrochloride | ESD-882262-10MG |
| Cas.: 1465017-87-1 | Purity: 98% | UPF-648 sodium salt | ESD-882263-2MG |
| Cas.: 1465017-87-1 | Purity: 98% | UPF-648 sodium salt | ESD-882263-5MG |
| Cas.: 14643-66-4 | Purity: ≥99% | Coproporphyrin III | ESD-882264-1MG |
| Cas.: 146422-58-4 | Purity: 98% | CDD0102 | ESD-882265-1MG |
| Cas.: 146422-58-4 | Purity: 98% | CDD0102 | ESD-882265-5MG |
| Cas.: 1464151-33-4 | Purity: ≥99% | ETC-206 | ESD-882266-5MG |
| Cas.: 1464151-33-4 | Purity: ≥99% | ETC-206 | ESD-882266-10MG |
| Cas.: 146408-78-8 | Purity: 97% | Desmethylrocaglamide | ESD-882267-5MG |
| Cas.: 1463-48-5 | Purity: 95% | 8-Benzyl-2,8-diazaspiro[4.5]decane-1,3-dione | ESD-882268-1G |
| Cas.: 1462249-75-7 | Purity: ≥98% | PFK-158 | ESD-882269-5MG |
| Cas.: 1462249-75-7 | Purity: ≥98% | PFK-158 | ESD-882269-10MG |
| Cas.: 146204-42-4 | Purity: ≥99% | BM212 | ESD-882270-1MG |
| Cas.: 146204-42-4 | Purity: ≥99% | BM212 | ESD-882270-5MG |
| Cas.: 1461714-90-8 | Purity: 95% | 7′-FLUOROSPIRO[CYCLOPROPANE-1,3′-INDOLINE] | ESD-882271-1G |
| Cas.: 1461714-36-2 | Purity: 95% | 5′-METHYLSPIRO[CYCLOPROPANE-1,3′-INDOLINE] | ESD-882272-250MG |
| Cas.: 1461714-36-2 | Purity: 95% | 5′-METHYLSPIRO[CYCLOPROPANE-1,3′-INDOLINE] | ESD-882272-1G |
| Cas.: 14599-48-5 | Purity: 98% | Cycloart-23-ene-3β,25-diol | ESD-882273-5MG |
| Cas.: 1459784-57-6 | Purity: 98% | Jasminoid A | ESD-882274-5MG |
| Cas.: 1459687-96-7 | Purity: ≥99% | GJ103 sodium salt | ESD-882275-2MG |
| Cas.: 1459687-96-7 | Purity: ≥99% | GJ103 sodium salt | ESD-882275-5MG |
| Cas.: 145821-57-4 | Purity: 98% | Tiagabine hydrochloride hydrate | ESD-882276-10MG |
| Cas.: 145821-57-4 | Purity: 98% | Tiagabine hydrochloride hydrate | ESD-882276-50MG |
| Cas.: 145781-92-6 | Purity: ≥99% | Goserelin acetate | ESD-882277-5MG |
| Cas.: 145781-92-6 | Purity: ≥99% | Goserelin acetate | ESD-882277-10MG |
| Cas.: 145733-36-4 | Purity: ≥99% | Tasosartan | ESD-882278-5MG |
| Cas.: 145733-36-4 | Purity: ≥99% | Tasosartan | ESD-882278-10MG |
| Cas.: 1456872-74-4 | Purity: 98% | PL553 | ESD-882279-5MG |
| Cas.: 1456872-74-4 | Purity: 98% | PL553 | ESD-882279-10MG |
| Cas.: 1456858-58-4 | Purity: ≥98% | HG-9-91-01 | ESD-882280-2MG |
| Cas.: 1456858-58-4 | Purity: ≥98% | HG-9-91-01 | ESD-882280-5MG |
| Cas.: 1456598-64-3 | Purity: 95% | 2′-O-Benzoylpaeoniflorin | ESD-882281-5MG |
| Cas.: 1456551-16-8 | Purity: ≥99% | JG-98 | ESD-882282-5MG |
| Cas.: 1456551-16-8 | Purity: ≥99% | JG-98 | ESD-882282-10MG |
| Cas.: 145643-96-5 | Purity: 98% | Cyclocommunol | ESD-882283-5MG |
| Cas.: 145643-15-8 | Purity: 98% | SC-52012 | ESD-882284-1MG |
| Cas.: 145643-15-8 | Purity: 98% | SC-52012 | ESD-882284-5MG |
| Cas.: 145-63-1 | Purity: 98% | Suramin | ESD-882285-50MG |
| Cas.: 145600-69-7 | Purity: 98% | AD 0261 | ESD-882286-1MG |
| Cas.: 145600-69-7 | Purity: 98% | AD 0261 | ESD-882286-5MG |
| Cas.: 145544-91-8 | Purity: 96% | Eucamalol | ESD-882287-5MG |
| Cas.: 145523-71-3 | Purity: 97% | 1,7-Dimethoxy-2,3-methylenedioxyxanthone | ESD-882288-5MG |
| Cas.: 145514-62-1 | Purity: 98% | Boc-3-Phenyliserine | ESD-882289-5MG |
| Cas.: 1454925-59-7 | Purity: ≥99% | NXT629 | ESD-882290-5MG |
| Cas.: 1454925-59-7 | Purity: ≥99% | NXT629 | ESD-882290-10MG |
| Cas.: 1454909-15-9 | Purity: 95% | 1-(Trifluoromethyl)-2-oxa-6-azaspiro[3·3]heptane hemioxalate | ESD-882291-250MG |
| Cas.: 1454843-78-7 | Purity: 95% | (R)-5-(TERT-BUTOXYCARBONYL)-5-AZASPIRO[2.4]HEPTANE-6-CARBOXYLIC ACID | ESD-882292-1G |
| Cas.: 1454843-77-6 | Purity: 95% | 5-(TERT-BUTOXYCARBONYL)-5-AZASPIRO[2.4]HEPTANE-6-CARBOXYLIC ACID | ESD-882293-1G |
| Cas.: 1454843-77-6 | Purity: 95% | 5-(TERT-BUTOXYCARBONYL)-5-AZASPIRO[2.4]HEPTANE-6-CARBOXYLIC ACID | ESD-882293-5G |
| Cas.: 1454619-70-5 | Purity: 97% | Furano(2″,3″:7,6)-4′-hydroxyflavanone | ESD-882294-5MG |
| Cas.: 1454619-14-7 | Purity: ≥95% | PU-WS13 | ESD-882295-5MG |
| Cas.: 1454619-14-7 | Purity: ≥95% | PU-WS13 | ESD-882295-10MG |
| Cas.: 1454288-88-0 | Purity: ≥99% | Rovazolac | ESD-882296-5MG |
| Cas.: 1454288-88-0 | Purity: ≥99% | Rovazolac | ESD-882296-10MG |
| Cas.: 145400-03-9 | Purity: 96% | Homalomenol A | ESD-882297-5MG |
| Cas.: 145400-02-8 | Purity: 98% | Eudesmane-1β,4β,7α-triol | ESD-882298-5MG |
| Cas.: 145399-99-1 | Purity: 98% | 3′,3”’-Binaringenin | ESD-882299-5MG |
| Cas.: 145382-68-9 | Purity: 97% | Sideroxylonal A | ESD-882300-5MG |
| Cas.: 145337-55-9 | Purity: 98% | Ro 31-9790 | ESD-882301-1MG |
| Cas.: 145337-55-9 | Purity: 98% | Ro 31-9790 | ESD-882301-5MG |
| Cas.: 1453208-66-6 | Purity: ≥99% | ASP5878 | ESD-882302-5MG |
| Cas.: 1453208-66-6 | Purity: ≥99% | ASP5878 | ESD-882302-10MG |
| Cas.: 14531-47-6 | Purity: 95% | Bergenin pentaacetate | ESD-882304-5MG |
| Cas.: 1453097-13-6 | Purity: ≥99% | HUHS015 | ESD-882305-1MG |
| Cas.: 1453097-13-6 | Purity: ≥99% | HUHS015 | ESD-882305-5MG |
| Cas.: 1452487-93-2 | Purity: 97% | Diarylcomosol III | ESD-882306-5MG |
| Cas.: 1452398-07-0 | Purity: 95% | Sahandol | ESD-882307-5MG |
| Cas.: 145237-05-4 | Purity: 98% | Delgrandine | ESD-882308-5MG |
| Cas.: 1451993-15-9 | Purity: ≥98% | VU0467154 | ESD-882309-5MG |
| Cas.: 1451993-15-9 | Purity: ≥98% | VU0467154 | ESD-882309-10MG |
| Cas.: 145163-97-9 | Purity: 95% | 3β-Hydroxyporiferast-5-en-7-one | ESD-882310-1MG |
| Cas.: 145122-55-0 | Purity: 95% | 6,9-Diaza-spiro[4.5]decane dihydrochloride | ESD-882311-1G |
| Cas.: 145122-55-0 | Purity: 95% | 6,9-Diaza-spiro[4.5]decane dihydrochloride | ESD-882311-5G |
| Cas.: 145103-37-3 | Purity: 97% | Filicenol B | ESD-882312-5MG |
| Cas.: 1450929-77-7 | Purity: ≥98% | LHF-535 | ESD-882313-5MG |
| Cas.: 1450929-77-7 | Purity: ≥98% | LHF-535 | ESD-882313-10MG |
| Cas.: 1450881-55-6 | Purity: ≥97% | SAR-20347 | ESD-882314-5MG |
| Cas.: 1450881-55-6 | Purity: ≥97% | SAR-20347 | ESD-882314-10MG |
| Cas.: 1450833-55-2 | Purity: ≥99% | TAK-243 | ESD-882315-5MG |
| Cas.: 1450833-55-2 | Purity: ≥99% | TAK-243 | ESD-882315-10MG |
| Cas.: 14504-73-5 | Purity: 98% | Tritoqualine | ESD-882316-1MG |
| Cas.: 14504-73-5 | Purity: 98% | Tritoqualine | ESD-882316-5MG |
| Cas.: 145033-48-3 | Purity: 95% | Digalactosyldiacylglycerol | ESD-882317-5MG |
| Cas.: 1449779-49-0 | Purity: ≥95% | DGAT1-IN-1 | ESD-882318-2MG |
| Cas.: 1449779-49-0 | Purity: ≥95% | DGAT1-IN-1 | ESD-882318-5MG |
| Cas.: 1449598-06-4 | Purity: ≥99% | RG7800 | ESD-882319-5MG |
| Cas.: 1449598-06-4 | Purity: ≥99% | RG7800 | ESD-882319-10MG |
| Cas.: 1449597-34-5 | Purity: ≥99% | SMN-C3 | ESD-882320-5MG |
| Cas.: 1449597-34-5 | Purity: ≥99% | SMN-C3 | ESD-882320-10MG |
| Cas.: 1449578-65-7 | Purity: ≥99% | AZ82 | ESD-882321-5MG |
| Cas.: 1449384-21-7 | Purity: 95% | Boeravinone O | ESD-882322-1MG |
| Cas.: 1449382-91-5 | Purity: 98% | Chlojaponilactone B | ESD-882323-5MG |
| Cas.: 1449317-74-1 | Purity: 95% | 9′-Bromospiro(fluorene-9,7′-dibenzo(c,h)acridine)-5′-one | ESD-882324-250MG |
| Cas.: 1449277-10-4 | Purity: ≥99% | GNE-495 | ESD-882325-1MG |
| Cas.: 1449277-10-4 | Purity: ≥99% | GNE-495 | ESD-882325-5MG |
| Cas.: 1449240-68-9 | Purity: ≥99% | K145 hydrochloride | ESD-882326-5MG |
| Cas.: 1449240-68-9 | Purity: ≥99% | K145 hydrochloride | ESD-882326-10MG |
| Cas.: 1449236-96-7 | Purity: ≥97% | NMS-859 | ESD-882327-2MG |
| Cas.: 1449236-96-7 | Purity: ≥97% | NMS-859 | ESD-882327-5MG |
| Cas.: 1449228-40-3 | Purity: ≥99% | Senexin B | ESD-882328-1MG |
| Cas.: 1449228-40-3 | Purity: ≥99% | Senexin B | ESD-882328-5MG |
| Cas.: 1449-09-8 | Purity: 92% | 24-Methylenecycloartan-3β-ol | ESD-882329-5MG |
| Cas.: 1449-08-7 | Purity: 92% | 24-Methylenecycloartanone | ESD-882330-5MG |
| Cas.: 1449-06-5 | Purity: 98% | 21-Episerratenediol | ESD-882331-5MG |
| Cas.: 1448895-09-7 | Purity: ≥99% | ML314 | ESD-882332-2MG |
| Cas.: 1448895-09-7 | Purity: ≥99% | ML314 | ESD-882332-5MG |
| Cas.: 1448855-03-5 | Purity: 95% | 2′,4′-Dihydro-1’H-spiro[oxane-4,3′-quinoline] | ESD-882333-1G |
| Cas.: 144881-21-0 | Purity: 95% | 4′,9,9′-Trihydroxy-3′-methoxy- 3,7′-epoxy-4,8′-oxyneolignan | ESD-882334-1MG |
| Cas.: 144881-19-6 | Purity: 97% | Junipediol B | ESD-882335-5MG |
| Cas.: 1448754-43-5 | Purity: ≥99% | Eleclazine hydrochloride | ESD-882336-1MG |
| Cas.: 1448754-43-5 | Purity: ≥99% | Eleclazine hydrochloride | ESD-882336-5MG |
| Cas.: 144868-43-9 | Purity: 98% | Garjasmin | ESD-882337-5MG |
| Cas.: 1448667-05-7 | Purity: 97% | Alpiniarpene A | ESD-882338-5MG |
| Cas.: 1448525-91-4 | Purity: 98% | S55746 hydrochloride | ESD-882339-5MG |
| Cas.: 1448525-91-4 | Purity: 98% | S55746 hydrochloride | ESD-882339-10MG |
| Cas.: 1448440-52-5 | Purity: ≥95% | SP-13786 | ESD-882340-2MG |
| Cas.: 1448440-52-5 | Purity: ≥95% | SP-13786 | ESD-882340-5MG |
| Cas.: 1448346-38-0 | Purity: 98% | Albendazole sulfoxide D3 | ESD-882341-1MG |
| Cas.: 1448346-38-0 | Purity: 98% | Albendazole sulfoxide D3 | ESD-882341-5MG |
| Cas.: 1448237-05-5 | Purity: ≥98% | Naquotinib mesylate | ESD-882342-1MG |
| Cas.: 1448237-05-5 | Purity: ≥98% | Naquotinib mesylate | ESD-882342-5MG |
| Cas.: 1448189-80-7 | Purity: ≥99% | (S,R,S)-AHPC hydrochloride | ESD-882343-100MG |
| Cas.: 1448189-80-7 | Purity: ≥99% | (S,R,S)-AHPC hydrochloride | ESD-882343-500MG |
| Cas.: 1448188-57-5 | Purity: ≥98% | VL285 | ESD-882344-5MG |
| Cas.: 1448188-57-5 | Purity: ≥98% | VL285 | ESD-882344-10MG |
| Cas.: 144809-28-9 | Purity: 98% | 5-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)benzylidene)thiazolidine-2,4-dione | ESD-882345-5MG |
| Cas.: 1448046-14-7 | Purity: 95% | 6-oxaspiro[4.5]dec-9-ylamine hydrochloride | ESD-882346-1G |
| Cas.: 1448046-14-7 | Purity: 95% | 6-oxaspiro[4.5]dec-9-ylamine hydrochloride | ESD-882346-2.5G |
| Cas.: 1448030-48-5 | Purity: 95% | 2′-fluoro-4′,5′-dihydrospiro[piperidine-4,7′-thieno[2,3-c]pyran] hydrochloride | ESD-882347-1G |
| Cas.: 1448030-48-5 | Purity: 95% | 2′-fluoro-4′,5′-dihydrospiro[piperidine-4,7′-thieno[2,3-c]pyran] hydrochloride | ESD-882347-2.5G |
| Cas.: 1447967-93-2 | Purity: 95% | 9′-(Pyren-1-yl)-spiro[fluorene-9,7′-dibenzo[c,h]acridine]-5′-one | ESD-882348-250MG |
| Cas.: 1447943-53-4 | Purity: 95% | 6,6-Difluorospiro[2.5]octane-1-carboxylic acid | ESD-882349-250MG |
| Cas.: 1447943-53-4 | Purity: 95% | 6,6-Difluorospiro[2.5]octane-1-carboxylic acid | ESD-882349-1G |
| Cas.: 144765-80-0 | Purity: 95% | Brachynoside heptaacetate | ESD-882350-1MG |
| Cas.: 144756-71-8 | Purity: 98% | SL910102 | ESD-882351-1MG |
| Cas.: 144756-71-8 | Purity: 98% | SL910102 | ESD-882351-5MG |
| Cas.: 144-74-1 | Purity: ≥99% | Sulfathiazole sodium | ESD-882352-500MG |
| Cas.: 144-74-1 | Purity: ≥99% | Sulfathiazole sodium | ESD-882352-1G |
| Cas.: 144735-57-9 | Purity: 98% | 2-(4-Hydroxy-3-methoxyphenyl)-7-methoxy-5-benzofuranpropanol | ESD-882353-5MG |
| Cas.: 144702-26-1 | Purity: 98% | Telmisartan tert-butyl ester | ESD-882354-5MG |
| Cas.: 1446817-84-0 | Purity: ≥99% | ABX-1431 | ESD-882355-5MG |
| Cas.: 1446817-84-0 | Purity: ≥99% | ABX-1431 | ESD-882355-10MG |
| Cas.: 14464-90-5 | Purity: 98% | Lyoniresinol | ESD-882356-5MG |
| Cas.: 144629-84-5 | Purity: 95% | 22-Hydroxy-3-oxoolean-12-en-29-oic acid | ESD-882357-1MG |
| Cas.: 1446182-94-0 | Purity: ≥99% | CUDC-427 | ESD-882358-2MG |
| Cas.: 1446182-94-0 | Purity: ≥99% | CUDC-427 | ESD-882358-5MG |
| Cas.: 1445952-33-9 | Purity: 98% | Kanshone H | ESD-882359-5MG |
| Cas.: 1445952-30-6 | Purity: 96% | Nardoeudesmol A | ESD-882360-5MG |
| Cas.: 14459-29-1 | Purity: ≥98% | Hematoporphyrin | ESD-882361-100MG |
| Cas.: 1445879-21-9 | Purity: ≥99% | GSK2837808A | ESD-882362-2MG |
| Cas.: 1445879-21-9 | Purity: ≥99% | GSK2837808A | ESD-882362-5MG |
| Cas.: 1445846-30-9 | Purity: ≥99% | GPR84 antagonist 8 | ESD-882363-5MG |
| Cas.: 1445846-30-9 | Purity: ≥99% | GPR84 antagonist 8 | ESD-882363-10MG |
| Cas.: 1445655-59-3 | Purity: 95% | 6-Chloro-1,2-dihydrospiro[indole-3,4′-piperidine]-2-one | ESD-882364-1G |
| Cas.: 1445603-41-7 | Purity: 95% | tert-Butyl6-chloro-2-oxo-1,2-dihydrospiro[indole-3,4′-piperidine]-1′-carboxylate | ESD-882365-1G |
| Cas.: 1445379-92-9 | Purity: ≥99% | ALS-8112 | ESD-882366-1MG |
| Cas.: 1445379-92-9 | Purity: ≥99% | ALS-8112 | ESD-882366-5MG |
| Cas.: 144510-96-3 | Purity: 98% | Pixantrone | ESD-882367-10MG |
| Cas.: 144510-96-3 | Purity: 98% | Pixantrone | ESD-882367-50MG |
| Cas.: 144446-23-1 | Purity: 95% | β-Aflatrem | ESD-882368-5MG |
| Cas.: 144429-71-0 | Purity: 95% | Goniodiol 8-acetate | ESD-882369-5MG |
| Cas.: 144429-67-4 | Purity: 98% | Aflavarin | ESD-882370-5MG |
| Cas.: 144424-80-6 | Purity: 98% | 3-O-(E)-p-Coumaroylbetulin | ESD-882371-5MG |
| Cas.: 1444103-30-3 | Purity: 95% | 3-methoxy-2-methylspiro[3.3]heptan-1-amine | ESD-882372-1G |
| Cas.: 14440-40-5 | Purity: 98% | Canophyllal | ESD-882373-5MG |
| Cas.: 1444025-85-7 | Purity: 95% | 9-amino-6-oxa-2$l^{6}-thiaspiro[4.5]decane-2,2-dione hydrochloride | ESD-882374-1G |
| Cas.: 144398-34-5 | Purity: 95% | 8-(7-Hydroxy-3,7-dimethyl-2,5-octadienyloxy)psoralen | ESD-882375-1MG |
| Cas.: 1443983-36-5 | Purity: 98% | GDC-0927 Racemate | ESD-882376-5MG |
| Cas.: 1443983-36-5 | Purity: 98% | GDC-0927 Racemate | ESD-882376-10MG |
| Cas.: 1443530-05-9 | Purity: ≥99% | Rogaratinib | ESD-882377-1MG |
| Cas.: 1443530-05-9 | Purity: ≥99% | Rogaratinib | ESD-882377-5MG |
| Cas.: 1443460-91-0 | Purity: ≥99% | GSK2838232 | ESD-882378-5MG |
| Cas.: 1443460-91-0 | Purity: ≥99% | GSK2838232 | ESD-882378-10MG |
| Cas.: 1443421-84-8 | Purity: 97% | Nemoralisin C | ESD-882379-5MG |
| Cas.: 1443373-17-8 | Purity: ≥98% | AM-2099 | ESD-882380-2MG |
| Cas.: 1443373-17-8 | Purity: ≥98% | AM-2099 | ESD-882380-5MG |
| Cas.: 1443218-16-3 | Purity: 95% | Trilepisflavan | ESD-882381-5MG |
| Cas.: 1443138-53-1 | Purity: ≥98% | GSK2200150A | ESD-882382-5MG |
| Cas.: 1443138-53-1 | Purity: ≥98% | GSK2200150A | ESD-882382-10MG |
| Cas.: 144313-54-2 | Purity: 98% | Valorphin | ESD-882383-5MG |
| Cas.: 144313-54-2 | Purity: 98% | Valorphin | ESD-882383-10MG |
| Cas.: 144282-41-7 | Purity: 95% | (S)-7-Amino-5-benzyl-4-oxo-5-azaspiro[2.4]heptane | ESD-882384-250MG |
| Cas.: 144282-41-7 | Purity: 95% | (S)-7-Amino-5-benzyl-4-oxo-5-azaspiro[2.4]heptane | ESD-882384-1G |
| Cas.: 1442684-77-6 | Purity: ≥99% | AM-2394 | ESD-882385-5MG |
| Cas.: 1442684-77-6 | Purity: ≥99% | AM-2394 | ESD-882385-10MG |
| Cas.: 144223-70-1 | Purity: 98% | Dehydroadynerigenin glucosyldigitaloside | ESD-882386-5MG |
| Cas.: 144189-71-9 | Purity: 98% | β-Amyloid 22-35 | ESD-882387-1MG |
| Cas.: 144189-71-9 | Purity: 98% | β-Amyloid 22-35 | ESD-882387-5MG |
| Cas.: 14417-88-0 | Purity: 98% | Melinamide | ESD-882388-1MG |
| Cas.: 14417-88-0 | Purity: 98% | Melinamide | ESD-882388-5MG |
| Cas.: 1441674-54-9 | Purity: ≥99% | Ledipasvir (acetone) | ESD-882389-2MG |
| Cas.: 1441674-54-9 | Purity: ≥99% | Ledipasvir (acetone) | ESD-882389-5MG |
| Cas.: 144106-78-5 | Purity: 97% | 1-Methyleffusol | ESD-882390-5MG |
| Cas.: 144049-72-9 | Purity: 96% | 6-O-Syringoylajugol | ESD-882391-5MG |
| Cas.: 1439908-06-1 | Purity: 95% | tert-butyl 8-(2-ethylbutyl)-1-oxa-8-azaspiro[4.5]dec-3-ylcarbamate | ESD-882392-50MG |
| Cas.: 1439908-06-1 | Purity: 95% | tert-butyl 8-(2-ethylbutyl)-1-oxa-8-azaspiro[4.5]dec-3-ylcarbamate | ESD-882392-250MG |
| Cas.: 1439902-99-4 | Purity: 95% | 5′-Fluoro-2′,4′-dihydro-1’H-spiro[oxane-4,3′-quinoline] | ESD-882393-1G |
| Cas.: 1439902-64-3 | Purity: 95% | 1,7-Diazaspiro[4.4]nonan-2-one hydrochloride | ESD-882394-1G |
| Cas.: 1439902-51-8 | Purity: 95% | 6′-Fluoro-2′,4′-dihydro-1’H-spiro[piperidine-4,3′-quinoline]-2′-one hydrochlorid | ESD-882395-1G |
| Cas.: 1439902-30-3 | Purity: 95% | 7′-Fluoro-2′,4′-dihydro-1’H-spiro[oxane-4,3′-quinoline] | ESD-882396-1G |
| Cas.: 1439902-17-6 | Purity: 95% | 8′-Fluoro-2′,4′-dihydro-1’H-spiro[oxane-4,3′-quinoline] | ESD-882397-1G |
| Cas.: 1439900-44-3 | Purity: 95% | tert-Butyl 8′-fluoro-2′,4′-dihydro-1’H-spiro[piperidine-4,3′-quinoline]-1-carbox | ESD-882398-1G |
| Cas.: 1439899-53-2 | Purity: 95% | tert-Butyl 6′-fluoro-2′-oxo-2′,4′-dihydro-1’H-spiro[piperidine-4,3′-quinoline]-1-carboxylate | ESD-882399-1G |
| Cas.: 1439899-37-2 | Purity: 95% | 6′-Fluoro-2′,4′-dihydro-1’H-spiro[oxane-4,3′-quinoline] | ESD-882400-1G |
| Cas.: 1439898-04-0 | Purity: 95% | 8′-Fuoro-2′,4′-dihydro-1’H-spiro[piperidine-4,3′-quinoline]-2′-one hydrochloride | ESD-882401-1G |
| Cas.: 1439897-97-8 | Purity: 95% | 4-Oxa-1,9-diazaspiro[5.5]undecane dihydrochloride | ESD-882402-250MG |
| Cas.: 1439897-97-8 | Purity: 95% | 4-Oxa-1,9-diazaspiro[5.5]undecane dihydrochloride | ESD-882402-1G |
| Cas.: 1439897-52-5 | Purity: 95% | tert-Butyl 6′-fluoro-2′,4′-dihydro-1’H-spiro[piperidine-4,3′-quinoline]-1-carbox | ESD-882403-1G |
| Cas.: 1439896-71-5 | Purity: 95% | Benzyl 1,8-diazaspiro[5.5]undecane-8-carboxylate hydrochloride | ESD-882404-1G |
| Cas.: 1439896-66-8 | Purity: 95% | tert-Butyl N-{6-oxaspiro[2.5]octan-1-yl}carbamate | ESD-882405-1G |
| Cas.: 1439896-33-9 | Purity: 95% | tert-Butyl 8′-fluoro-2′-oxo-2′,4′-dihydro-1’H-spiro[piperidine-4,3′-quinoline]-1-carboxylate | ESD-882406-1G |
| Cas.: 14397-69-4 | Purity: 96% | Jaceidin triacetate | ESD-882407-5MG |
| Cas.: 143901-35-3 | Purity: ≥98% | Aglafoline | ESD-882408-5MG |
| Cas.: 143901-35-3 | Purity: ≥98% | Aglafoline | ESD-882408-10MG |
| Cas.: 1438-62-6 | Purity: 98% | 13-Epimanool | ESD-882409-5MG |
| Cas.: 143851-98-3 | Purity: ≥98% | Elacridar hydrochloride | ESD-882410-10MG |
| Cas.: 143851-98-3 | Purity: ≥98% | Elacridar hydrochloride | ESD-882410-50MG |
| Cas.: 1438492-26-2 | Purity: ≥98% | Ciraparantag | ESD-882411-1MG |
| Cas.: 1438492-26-2 | Purity: ≥98% | Ciraparantag | ESD-882411-5MG |
| Cas.: 1438391-30-0 | Purity: ≥99% | CC-401 hydrochloride | ESD-882412-2MG |
| Cas.: 1438391-30-0 | Purity: ≥99% | CC-401 hydrochloride | ESD-882412-5MG |
| Cas.: 143839-02-5 | Purity: 95% | 2α,24-Dihydroxyursolic acid | ESD-882413-1MG |
| Cas.: 1438241-18-9 | Purity: 95% | 2-Oxaspiro[3.3]heptane-6-methamine | ESD-882414-2.5MG |
| Cas.: 1438241-18-9 | Purity: 95% | 2-Oxaspiro[3.3]heptane-6-methamine | ESD-882414-5MG |
| Cas.: 143815-99-0 | Purity: 95% | 22-Dehydroclerosterol glucoside | ESD-882415-1MG |
| Cas.: 143807-66-3 | Purity: ≥99% | Chromafenozide | ESD-882416-10MG |
| Cas.: 143807-66-3 | Purity: ≥99% | Chromafenozide | ESD-882416-50MG |
| Cas.: 143773-52-8 | Purity: 95% | 3-O-Coumaroylasiatic acid | ESD-882417-5MG |
| Cas.: 143724-69-0 | Purity: 97% | Kaempferol 3,4′,7-triacetate | ESD-882418-5MG |
| Cas.: 143692-48-2 | Purity: ≥99% | GYKI53655 hydrochloride | ESD-882419-5MG |
| Cas.: 143692-48-2 | Purity: ≥99% | GYKI53655 hydrochloride | ESD-882419-10MG |
| Cas.: 1436861-97-0 | Purity: 98% | Zidebactam | ESD-882420-5MG |
| Cas.: 1436861-97-0 | Purity: 98% | Zidebactam | ESD-882420-10MG |
| Cas.: 1436391-86-4 | Purity: ≥99% | PF-06380101 | ESD-882421-1MG |
| Cas.: 1436391-86-4 | Purity: ≥99% | PF-06380101 | ESD-882421-5MG |
| Cas.: 14362-31-3 | Purity: ≥99% | Chlorcyclizine hydrochloride | ESD-882422-100MG |
| Cas.: 14362-31-3 | Purity: ≥99% | Chlorcyclizine hydrochloride | ESD-882422-200MG |
| Cas.: 143615-00-3 | Purity: 98% | (2R,3S)-3-Phenyliserine ethyl ester | ESD-882423-5MG |
| Cas.: 143601-07-4 | Purity: 95% | Acuminatin | ESD-882424-5MG |
| Cas.: 1435934-25-0 | Purity: ≥99% | A 419259 trihydrochloride | ESD-882425-5MG |
| Cas.: 1435934-25-0 | Purity: ≥99% | A 419259 trihydrochloride | ESD-882425-10MG |
| Cas.: 143584-75-2 | Purity: ≥98% | S-methyl-KE-298 | ESD-882426-1MG |
| Cas.: 143584-75-2 | Purity: ≥98% | S-methyl-KE-298 | ESD-882426-5MG |
| Cas.: 1435786-04-1 | Purity: ≥98% | Rapastinel Trifluoroacetate | ESD-882427-1MG |
| Cas.: 1435786-04-1 | Purity: ≥98% | Rapastinel Trifluoroacetate | ESD-882427-5MG |
| Cas.: 14357-08-5 | Purity: ≥99% | N6-Ethyladenosine | ESD-882428-10MG |
| Cas.: 14357-08-5 | Purity: ≥99% | N6-Ethyladenosine | ESD-882428-50MG |
| Cas.: 14356-51-5 | Purity: 98% | Virgatic acid | ESD-882429-5MG |
| Cas.: 143558-00-3 | Purity: 98% | Rocuronium | ESD-882430-10MG |
| Cas.: 143558-00-3 | Purity: 98% | Rocuronium | ESD-882430-50MG |
| Cas.: 1435467-38-1 | Purity: ≥99% | PF-1355 | ESD-882431-5MG |
| Cas.: 1435467-38-1 | Purity: ≥99% | PF-1355 | ESD-882431-10MG |
| Cas.: 1435467-37-0 | Purity: ≥99% | PF-06282999 | ESD-882432-1MG |
| Cas.: 1435467-37-0 | Purity: ≥99% | PF-06282999 | ESD-882432-5MG |
| Cas.: 1435192-04-3 | Purity: ≥99% | NCGC00247743 | ESD-882433-5MG |
| Cas.: 1435192-04-3 | Purity: ≥99% | NCGC00247743 | ESD-882433-10MG |
| Cas.: 143519-04-4 | Purity: 95% | 3-Acetoxy-24-hydroxydamara-20,25-diene | ESD-882434-5MG |
| Cas.: 14348-16-4 | Purity: 98% | Poriol | ESD-882436-5MG |
| Cas.: 1434639-57-2 | Purity: ≥98% | ND-646 | ESD-882437-1MG |
| Cas.: 1434639-57-2 | Purity: ≥98% | ND-646 | ESD-882437-5MG |
| Cas.: 143413-49-4 | Purity: 98% | ALX 40-4C | ESD-882438-1MG |
| Cas.: 143413-49-4 | Purity: 98% | ALX 40-4C | ESD-882438-5MG |
| Cas.: 143360-00-3 | Purity: ≥98% | SMIP004 | ESD-882439-2MG |
| Cas.: 143360-00-3 | Purity: ≥98% | SMIP004 | ESD-882439-5MG |
| Cas.: 1433497-19-8 | Purity: ≥98% | LY2955303 | ESD-882440-5MG |
| Cas.: 1433497-19-8 | Purity: ≥98% | LY2955303 | ESD-882440-10MG |
| Cas.: 1433286-70-4 | Purity: ≥98% | CREB inhibitor (666-15) | ESD882441-5MG |
| Cas.: 1433286-70-4 | Purity: ≥98% | CREB inhibitor (666-15) | ESD882441-10MG |
| Cas.: 143306-64-3 | Purity: 95% | TERT-BUTYL 8-OXO-5-AZASPIRO[2.5]OCTANE-5-CARBOXYLATE | ESD-882442-1G |
| Cas.: 143306-64-3 | Purity: 95% | TERT-BUTYL 8-OXO-5-AZASPIRO[2.5]OCTANE-5-CARBOXYLATE | ESD-882442-5G |
| Cas.: 1432681-94-1 | Purity: 95% | N-cyclopropyl-N-methyl-6-azaspiro[2.5]octane-1-carboxamide hydrochloride | ESD-882443-5MG |
| Cas.: 1432681-94-1 | Purity: 95% | N-cyclopropyl-N-methyl-6-azaspiro[2.5]octane-1-carboxamide hydrochloride | ESD-882443-10MG |
| Cas.: 1432681-74-7 | Purity: 95% | 8-methyl-3-oxa-1-azaspiro[4.5]decan-2-one | ESD-882444-10MG |
| Cas.: 1432681-74-7 | Purity: 95% | 8-methyl-3-oxa-1-azaspiro[4.5]decan-2-one | ESD-882444-50MG |
| Cas.: 1432681-19-0 | Purity: 95% | 1-(pyrrolidine-1-carbonyl)-6-azaspiro[2.5]octane hydrochloride | ESD-882445-5MG |
| Cas.: 1432681-19-0 | Purity: 95% | 1-(pyrrolidine-1-carbonyl)-6-azaspiro[2.5]octane hydrochloride | ESD-882445-10MG |
| Cas.: 1432679-85-0 | Purity: 95% | 1-methyl-1,8-diazaspiro[4.5]decane dihydrochloride | ESD-882446-25MG |
| Cas.: 1432679-84-9 | Purity: 95% | 4′,4′-dimethyl-3′,4′-dihydro-2’H-spiro[cyclopropane-1,1′-naphthalene]-3-ylmethanamine hydrochloride | ESD-882447-5MG |
| Cas.: 1432679-84-9 | Purity: 95% | 4′,4′-dimethyl-3′,4′-dihydro-2’H-spiro[cyclopropane-1,1′-naphthalene]-3-ylmethanamine hydrochloride | ESD-882447-10MG |
| Cas.: 1432679-83-8 | Purity: 95% | 1-(4-methylpiperazine-1-carbonyl)-6-azaspiro[2.5]octane dihydrochloride | ESD-882448-2.5MG |
| Cas.: 1432679-83-8 | Purity: 95% | 1-(4-methylpiperazine-1-carbonyl)-6-azaspiro[2.5]octane dihydrochloride | ESD-882448-5MG |
| Cas.: 1432678-98-2 | Purity: 95% | 1-(piperidine-1-carbonyl)-6-azaspiro[2.5]octane hydrochloride | ESD-882449-5MG |
| Cas.: 1432678-98-2 | Purity: 95% | 1-(piperidine-1-carbonyl)-6-azaspiro[2.5]octane hydrochloride | ESD-882449-10MG |
| Cas.: 143236-04-8 | Purity: 97% | (-)-Isolariciresinol 9′-O-glucoside | ESD-882450-5MG |
| Cas.: 143236-02-6 | Purity: 98% | (-)-Lyoniresinol 9′-O-glucoside | ESD-882451-5MG |
| Cas.: 143212-60-6 | Purity: 96% | Dehydroadynerigenin β-neritrioside | ESD-882452-5MG |
| Cas.: 143207-76-5 | Purity: 95% | (Z)-3-Hydroxy-5-methoxystilbene | ESD-882453-1MG |
| Cas.: 1432075-68-7 | Purity: 95% | 7-Geranyloxy-5-methoxycoumarin | ESD-882454-5MG |
| Cas.: 1432064-69-1 | Purity: 98% | 10-O-Acetylisocalamendiol | ESD-882455-5MG |
| Cas.: 1432063-63-2 | Purity: 98% | 6-O-Acetylcoriatin | ESD-882456-5MG |
| Cas.: 1432063-35-8 | Purity: 98% | 8-Isomulberrin hydrate | ESD-882457-5MG |
| Cas.: 1432062-53-7 | Purity: 98% | 3-(3-Hydroxy-3-methylbutanyl)-2,4,6-trihydroxybenzophenone | ESD-882458-5MG |
| Cas.: 1432058-90-6 | Purity: 95% | 10-Acetoxyscandine | ESD-882459-5MG |
| Cas.: 1432057-74-3 | Purity: 97% | Catalponol methylthiomethyl ether | ESD-882460-5MG |
| Cas.: 1432057-64-1 | Purity: 98% | Nyasicol 1,2-acetonide | ESD-882461-5MG |
| Cas.: 143205-42-9 | Purity: ≥99% | NIM811 | ESD-882462-1MG |
| Cas.: 143205-42-9 | Purity: ≥99% | NIM811 | ESD-882462-5MG |
| Cas.: 1431868-60-8 | Purity: 95% | 6-Boc-1,6-diazaspiro[3.3]heptane hemioxalate | ESD-882463-100MG |
| Cas.: 1431866-33-9 | Purity: 98% | WEHI-539 | ESD-882464-2MG |
| Cas.: 1431866-33-9 | Purity: 98% | WEHI-539 | ESD-882464-5MG |
| Cas.: 1431698-47-3 | Purity: ≥99% | KN-92 hydrochloride | ESD-882465-2MG |
| Cas.: 1431698-47-3 | Purity: ≥99% | KN-92 hydrochloride | ESD-882465-5MG |
| Cas.: 1431698-10-0 | Purity: ≥99% | OTSSP167 hydrochloride | ESD-882466-2MG |
| Cas.: 1431698-10-0 | Purity: ≥99% | OTSSP167 hydrochloride | ESD-882466-5MG |
| Cas.: 1431697-96-9 | Purity: ≥99% | CCT241533 hydrochloride | ESD-882467-2MG |
| Cas.: 1431697-96-9 | Purity: ≥99% | CCT241533 hydrochloride | ESD-882467-5MG |
| Cas.: 1431697-90-3 | Purity: ≥98% | SB-408124 Hydrochloride | ESD-882468-5MG |
| Cas.: 1431697-90-3 | Purity: ≥98% | SB-408124 Hydrochloride | ESD-882468-10MG |
| Cas.: 1431697-86-7 | Purity: ≥99% | AT7867 dihydrochloride | ESD-882469-2MG |
| Cas.: 1431697-86-7 | Purity: ≥99% | AT7867 dihydrochloride | ESD-882469-5MG |
| Cas.: 1431697-85-6 | Purity: ≥98% | AT7519 trifluoroacetate | ESD-882470-5MG |
| Cas.: 1431697-85-6 | Purity: ≥98% | AT7519 trifluoroacetate | ESD-882470-10MG |
| Cas.: 1431697-84-5 | Purity: ≥98% | gamma-secretase modulator 3 | ESD-882471-10MG |
| Cas.: 1431697-84-5 | Purity: ≥98% | gamma-secretase modulator 3 | ESD-882471-100MG |
| Cas.: 1431697-78-7 | Purity: ≥99% | CAL-130 Hydrochloride | ESD-882472-2MG |
| Cas.: 1431697-78-7 | Purity: ≥99% | CAL-130 Hydrochloride | ESD-882472-5MG |
| Cas.: 1431697-74-3 | Purity: 98% | CAL-130 | ESD-882473-2MG |
| Cas.: 1431697-74-3 | Purity: 98% | CAL-130 | ESD-882473-5MG |
| Cas.: 143165-32-6 | Purity: 95% | 3-(1,4-Dioxaspiro[4.5]dec-7-en-8-yl)-1H-indole | ESD-882474-10MG |
| Cas.: 143165-32-6 | Purity: 95% | 3-(1,4-Dioxaspiro[4.5]dec-7-en-8-yl)-1H-indole | ESD-882474-50MG |
| Cas.: 1431525-23-3 | Purity: ≥98% | BMX-IN-1 | ESD-882475-2MG |
| Cas.: 1431525-23-3 | Purity: ≥98% | BMX-IN-1 | ESD-882475-5MG |
| Cas.: 143120-46-1 | Purity: 98% | Neotuberostemonine | ESD-882476-5MG |
| Cas.: 143032-85-3 | Purity: ≥97% | 1alpha-Hydroxy VD4 | ESD-882477-1MG |
| Cas.: 1430218-51-1 | Purity: ≥98% | VI 16832 | ESD-882478-1MG |
| Cas.: 1430218-51-1 | Purity: ≥98% | VI 16832 | ESD-882478-5MG |
| Cas.: 1430213-30-1 | Purity: ≥99% | ML216 | ESD-882479-5MG |
| Cas.: 1430213-30-1 | Purity: ≥99% | ML216 | ESD-882479-10MG |
| Cas.: 1430208-73-3 | Purity: ≥99% | 1A-116 | ESD-882480-5MG |
| Cas.: 1430208-73-3 | Purity: ≥99% | 1A-116 | ESD-882480-10MG |
| Cas.: 1429882-07-4 | Purity: ≥99% | MRX-2843 | ESD-882481-1MG |
| Cas.: 1429882-07-4 | Purity: ≥99% | MRX-2843 | ESD-882481-5MG |
| Cas.: 142975-81-3 | Purity: 95% | 2′,7′-Dichloro-3′,6′-dihydroxy-3-oxo-3H-spiro-[isobenzofuran-1,9′-xanthene]-5-carboxylic acid | ESD-882482-250MG |
| Cas.: 142975-81-3 | Purity: 95% | 2′,7′-Dichloro-3′,6′-dihydroxy-3-oxo-3H-spiro-[isobenzofuran-1,9′-xanthene]-5-carboxylic acid | ESD-882482-1G |
| Cas.: 1429624-84-9 | Purity: ≥98% | PI4KIIIbeta-IN-9 | ESD-882483-1MG |
| Cas.: 1429624-84-9 | Purity: ≥98% | PI4KIIIbeta-IN-9 | ESD-882483-5MG |
| Cas.: 1429617-90-2 | Purity: ≥98% | DDR1-IN-2 | ESD-882484-5MG |
| Cas.: 1429617-90-2 | Purity: ≥98% | DDR1-IN-2 | ESD-882484-10MG |
| Cas.: 1429515-59-2 | Purity: ≥98% | FN-1501 | ESD-882485-5MG |
| Cas.: 1429515-59-2 | Purity: ≥98% | FN-1501 | ESD-882485-10MG |
| Cas.: 142950-86-5 | Purity: 95% | Triptoquinone A | ESD-882486-5MG |
| Cas.: 142937-50-6 | Purity: 98% | Triptoquinone B | ESD-882487-5MG |
| Cas.: 1429239-98-4 | Purity: ≥98% | CB1-IN-1 | ESD-882488-5MG |
| Cas.: 1429239-98-4 | Purity: ≥98% | CB1-IN-1 | ESD-882488-10MG |
| Cas.: 1429192-00-6 | Purity: ≥98% | Retro-2 cycl | ESD-882489-5MG |
| Cas.: 1429192-00-6 | Purity: ≥98% | Retro-2 cycl | ESD-882489-10MG |
| Cas.: 1429180-08-4 | Purity: ≥98% | Mutant IDH1 inhibitor | ESD-882490-2MG |
| Cas.: 1429180-08-4 | Purity: ≥98% | Mutant IDH1 inhibitor | ESD-882490-5MG |
| Cas.: 1429176-69-1 | Purity: ≥98% | Mutant IDH1-IN-2 | ESD-882491-5MG |
| Cas.: 1429176-69-1 | Purity: ≥98% | Mutant IDH1-IN-2 | ESD-882491-10MG |
| Cas.: 1428935-60-7 | Purity: ≥99% | Durvalumab | ESD-882492-1MG |
| Cas.: 1428935-60-7 | Purity: ≥99% | Durvalumab | ESD-882492-5MG |
| Cas.: 142891-14-3 | Purity: 97% | 8α-Methacryloyloxy-13-ethoxyvernojalcanolide | ESD-882493-5MG |
| Cas.: 1428774-45-1 | Purity: ≥98% | PF-06459988 | ESD-882494-5MG |
| Cas.: 1428774-45-1 | Purity: ≥98% | PF-06459988 | ESD-882494-10MG |
| Cas.: 1428729-63-8 | Purity: ≥98% | RIG-1 modulator 1 | ESD-882495-1MG |
| Cas.: 1428729-63-8 | Purity: ≥98% | RIG-1 modulator 1 | ESD-882495-5MG |
| Cas.: 1428729-56-9 | Purity: ≥98% | KIN1148 | ESD-882496-1MG |
| Cas.: 1428729-56-9 | Purity: ≥98% | KIN1148 | ESD-882496-5MG |
| Cas.: 1428569-85-0 | Purity: ≥99% | GDC-0339 | ESD-882497-2MG |
| Cas.: 1428569-85-0 | Purity: ≥99% | GDC-0339 | ESD-882497-5MG |
| Cas.: 142846-95-5 | Purity: 95% | Clausine D | ESD-882498-1MG |
| Cas.: 1428234-37-0 | Purity: 95% | 1′,3′-Dihydrospiro?kcyclopropane-1,2′-pyrazolo[3,2-b][1,3]oxazine?l-6′-carboxyli | ESD-882499-1G |
| Cas.: 1428234-33-6 | Purity: 95% | 1′,3′-Dihydrospiro(cyclopropane-1,2′-pyrazolo[3,2-b][1,3]oxazine)-5′-carboxylic acid | ESD-882500-1G |
| Cas.: 142763-37-9 | Purity: 95% | 3,4-Didehydrosapriparaquione | ESD-882501-5MG |
| Cas.: 1427514-87-1 | Purity: 95% | (S)-TETRAHYDROSPIRO[CYCLOPROPANE-1,1′-OXAZOLO[3,4-A]PYRAZIN]-3′(5’H)-ONE HCL | ESD-882502-250MG |
| Cas.: 1427514-87-1 | Purity: 95% | (S)-TETRAHYDROSPIRO[CYCLOPROPANE-1,1′-OXAZOLO[3,4-A]PYRAZIN]-3′(5’H)-ONE HCL | ESD-882502-1G |
| Cas.: 142750-47-8 | Purity: 97% | Glabratine | ESD-882503-5MG |
| Cas.: 1427498-29-0 | Purity: 95% | 6′-methoxy-2′,3′-dihydrospiro[cyclopropane-1,1′-indene]-3-amine | ESD-882504-1G |
| Cas.: 1427381-02-9 | Purity: 95% | 3-methoxy-2-methylspiro[3.3]heptan-1-one | ESD-882506-5MG |
| Cas.: 1427381-02-9 | Purity: 95% | 3-methoxy-2-methylspiro[3.3]heptan-1-one | ESD-882506-50MG |
| Cas.: 1427380-79-7 | Purity: 95% | 1-(pipidin-1-ylmethyl)-6-azaspiro[2.5]octane dihydrochloride | ESD-882507-5MG |
| Cas.: 1427380-79-7 | Purity: 95% | 1-(pipidin-1-ylmethyl)-6-azaspiro[2.5]octane dihydrochloride | ESD-882507-10MG |
| Cas.: 1427380-49-1 | Purity: 95% | 4′,4′-dimethyl-3′,4′-dihydro-2’H-spiro[cyclopropane-1,1′-naphthalene]-3-amine hydrochloride | ESD-882508-1G |
| Cas.: 1427379-37-0 | Purity: 95% | {6-azaspiro[2.5]octan-1-ylmethyl}(cyclopropylmethyl)amine dihydrochloride | ESD-882509-1G |
| Cas.: 1427379-10-9 | Purity: 95% | 9-methyl-6-azaspiro[3.5]nonane | ESD-882510-5MG |
| Cas.: 1427379-10-9 | Purity: 95% | 9-methyl-6-azaspiro[3.5]nonane | ESD-882510-10MG |
| Cas.: 1427378-94-6 | Purity: 95% | 8-oxa-1-azaspiro[4.5]decane hydrochloride | ESD-882511-5MG |
| Cas.: 1427378-94-6 | Purity: 95% | 8-oxa-1-azaspiro[4.5]decane hydrochloride | ESD-882511-10MG |
| Cas.: 1427378-72-0 | Purity: 95% | 4-oxaspiro[bicyclo[3.2.0]heptane-6,1′-cyclopentane]-7-amine | ESD-882512-5MG |
| Cas.: 1427378-72-0 | Purity: 95% | 4-oxaspiro[bicyclo[3.2.0]heptane-6,1′-cyclopentane]-7-amine | ESD-882512-10MG |
| Cas.: 1427378-59-3 | Purity: 95% | 6′-methoxy-2′,3′-dihydrospiro[cyclopropane-1,1′-indene]-3-amine hydrochloride | ESD-882513-1G |
| Cas.: 1427359-47-4 | Purity: 95% | 5-Oxa-2-azaspiro[3.5]nonane oxalate | ESD-882514-250MG |
| Cas.: 1427359-47-4 | Purity: 95% | 5-Oxa-2-azaspiro[3.5]nonane oxalate | ESD-882514-1G |
| Cas.: 1427358-97-1 | Purity: 95% | 1-Thia-6-azaspiro[3·3]heptane 1,1-dioxide hydrochloride | ESD-882515-250MG |
| Cas.: 1427358-97-1 | Purity: 95% | 1-Thia-6-azaspiro[3·3]heptane 1,1-dioxide hydrochloride | ESD-882515-500MG |
| Cas.: 142698-60-0 | Purity: 98% | Macrocarpal B | ESD-882516-5MG |
| Cas.: 1426944-49-1 | Purity: ≥98% | HBX 19818 | ESD-882517-2MG |
| Cas.: 1426944-49-1 | Purity: ≥98% | HBX 19818 | ESD-882517-5MG |
| Cas.: 1426698-88-5 | Purity: ≥99% | Parsaclisib | ESD-882518-5MG |
| Cas.: 1426698-88-5 | Purity: ≥99% | Parsaclisib | ESD-882518-10MG |
| Cas.: 142648-47-3 | Purity: 98% | Anti-Heart Failure Agent 1 | ESD-882519-1MG |
| Cas.: 142648-47-3 | Purity: 98% | Anti-Heart Failure Agent 1 | ESD-882519-5MG |
| Cas.: 142647-71-0 | Purity: 93% | Macrocarpal D | ESD-882520-5MG |
| Cas.: 142628-54-4 | Purity: 96% | Macrocarpal E | ESD-882521-5MG |
| Cas.: 142628-53-3 | Purity: 97% | Macrocarpal C | ESD-882522-5MG |
| Cas.: 14260-99-2 | Purity: 98% | Daphylloside | ESD-882523-5MG |
| Cas.: 14260-99-2 | Purity: 98% | Daphylloside | ESD-882523-10MG |
| Cas.: 142606-55-1 | Purity: 98% | p2Ca | ESD-882524-1MG |
| Cas.: 142606-55-1 | Purity: 98% | p2Ca | ESD-882524-5MG |
| Cas.: 1426059-89-3 | Purity: 97% | 1,7-Bis(4-hydroxyphenyl)-5-hydroxyhept-1-en-3-one | ESD-882525-5MG |
| Cas.: 142569-99-1 | Purity: 98% | IRL-1620 | ESD-882526-500ΜG |
| Cas.: 142569-99-1 | Purity: 98% | IRL-1620 | ESD-882526-1MG |
| Cas.: 142566-61-8 | Purity: 98% | Calanolide E | ESD-882527-5MG |
| Cas.: 142561-10-2 | Purity: 95% | Glyasperin D | ESD-882528-5MG |
| Cas.: 14255-87-9 | Purity: ≥98% | Parbendazole | ESD-882529-10MG |
| Cas.: 14255-87-9 | Purity: ≥98% | Parbendazole | ESD-882529-25MG |
| Cas.: 142557-61-7 | Purity: ≥98% | A-484954 | ESD-882530-5MG |
| Cas.: 142557-61-7 | Purity: ≥98% | A-484954 | ESD-882530-10MG |
| Cas.: 142546-15-4 | Purity: 97% | Sageone | ESD-882531-5MG |
| Cas.: 142543-30-4 | Purity: 98% | ent-13,16β,17-Trihydroxykauran-19-oic acid | ESD-882532-5MG |
| Cas.: 142542-89-0 | Purity: 98% | Cimidahurinine | ESD-882533-5MG |
| Cas.: 1425-10-1 | Purity: 98% | 19-Nortestosterone acetate | ESD-882534-5MG |
| Cas.: 142479-62-7 | Purity: 98% | Gluten Exorphin C | ESD-882535-1MG |
| Cas.: 142479-62-7 | Purity: 98% | Gluten Exorphin C | ESD-882535-5MG |
| Cas.: 142477-34-7 | Purity: 98% | 5-HT1A modulator 1 | ESD-882536-1MG |
| Cas.: 142477-34-7 | Purity: 98% | 5-HT1A modulator 1 | ESD-882536-5MG |
| Cas.: 142474-52-0 | Purity: 98% | Glyasperin A | ESD-882537-5MG |
| Cas.: 1424386-32-2 | Purity: 95% | 4-oxaspiro[bicyclo[3.2.0]heptane-6,1′-cyclobutane]-7-amine | ESD-882538-5MG |
| Cas.: 1424386-32-2 | Purity: 95% | 4-oxaspiro[bicyclo[3.2.0]heptane-6,1′-cyclobutane]-7-amine | ESD-882538-10MG |
| Cas.: 1423941-23-4 | Purity: 95% | 1-{1,4-diazaspiro[5.5]undecan-1-yl}ethan-1-one | ESD-882539-1MG |
| Cas.: 1423809-64-6 | Purity: 95% | 7α-Hydroxy-4,11-cadinadiene-3,8-dione | ESD-882540-5MG |
| Cas.: 1423715-37-0 | Purity: ≥98% | Seclidemstat | ESD-882541-1MG |
| Cas.: 1423715-37-0 | Purity: ≥98% | Seclidemstat | ESD-882541-5MG |
| Cas.: 142344-87-4 | Purity: 98% | GP531 | ESD-882542-1MG |
| Cas.: 142344-87-4 | Purity: 98% | GP531 | ESD-882542-5MG |
| Cas.: 142326-59-8 | Purity: ≥99% | L-701324 | ESD-882543-10MG |
| Cas.: 142326-59-8 | Purity: ≥99% | L-701324 | ESD-882543-50MG |
| Cas.: 1423186-80-4 | Purity: ≥98% | GSK2983559 active metabolite | ESD-882544-1MG |
| Cas.: 1423186-80-4 | Purity: ≥98% | GSK2983559 active metabolite | ESD-882544-5MG |
| Cas.: 1423070-40-9 | Purity: 95% | 5-BENZYL 1-ETHYL 5-AZASPIRO[2.3]HEXANE-1,5-DICARBOXYLATE | ESD-882545-1G |
| Cas.: 1423033-43-5 | Purity: 95% | methyl 6-cyano-2-oxaspiro[3.3]heptane-6-carboxylate | ESD-882546-10MG |
| Cas.: 1423033-43-5 | Purity: 95% | methyl 6-cyano-2-oxaspiro[3.3]heptane-6-carboxylate | ESD-882546-50MG |
| Cas.: 1423032-49-8 | Purity: 95% | 4-oxspiro[bicyclo[3.2.0]heptane-6,1′-cyclopentane]-7-ol | ESD-882547-1G |
| Cas.: 1423031-10-0 | Purity: 95% | 6-bromo-1,4,8-trioxaspiro[4.5]decane | ESD-882548-1MG |
| Cas.: 1423031-01-9 | Purity: 95% | spiro[oxirane-2,8′-pentacyclo[5.4.0.0^{2,6}.0^{3,10}.0^{5,9}]undecane] | ESD-882549-5MG |
| Cas.: 1423031-01-9 | Purity: 95% | spiro[oxirane-2,8′-pentacyclo[5.4.0.0^{2,6}.0^{3,10}.0^{5,9}]undecane] | ESD-882549-10MG |
| Cas.: 1423030-97-0 | Purity: 95% | 2′,3′-dihydrospiro[cyclopropane-1,1′-indene]-3-amine hydrochloride | ESD-882550-50MG |
| Cas.: 1423028-41-4 | Purity: 95% | 4-oxaspiro[bicyclo[3.2.0]heptane-6,1′-cyclobutane]-7-ol | ESD-882551-10MG |
| Cas.: 1423028-41-4 | Purity: 95% | 4-oxaspiro[bicyclo[3.2.0]heptane-6,1′-cyclobutane]-7-ol | ESD-882551-50MG |
| Cas.: 1423028-28-7 | Purity: 95% | 4-oxspiro[bicyclo[3.2.0]heptane-6,1′-cyclopentane]-7-one | ESD-882552-1G |
| Cas.: 1423027-48-8 | Purity: 95% | 2-oxo-1,2-dihydrospiro[indole-3,3′-pyrrolidine]-4′-carbonitrile hydrochloride | ESD-882553-10MG |
| Cas.: 1423027-48-8 | Purity: 95% | 2-oxo-1,2-dihydrospiro[indole-3,3′-pyrrolidine]-4′-carbonitrile hydrochloride | ESD-882553-50MG |
| Cas.: 1423026-67-8 | Purity: 95% | 4-oxaspiro[bicyclo[3.2.0]heptane-6,1′-cyclobutane]-7-one | ESD-882554-1G |
| Cas.: 1423026-09-8 | Purity: 95% | 1-azaspiro[4.5]decane hydrochloride | ESD-882555-1G |
| Cas.: 142299-73-8 | Purity: 95% | Teuvincenone H | ESD-882556-1MG |
| Cas.: 142279-42-3 | Purity: 98% | Shizukaol D | ESD-882557-5MG |
| Cas.: 142279-41-2 | Purity: 95% | Shizukaol C | ESD-882558-5MG |
| Cas.: 142279-40-1 | Purity: 96% | Shizukaol B | ESD-882559-5MG |
| Cas.: 142273-44-7 | Purity: 95% | 8-Fluoro-1,4-dioxaspiro[4.5]dec-7-ene | ESD-882560-1G |
| Cas.: 142273-44-7 | Purity: 95% | 8-Fluoro-1,4-dioxaspiro[4.5]dec-7-ene | ESD-882560-5G |
| Cas.: 1422554-34-4 | Purity: ≥99% | BET-IN-1 | ESD-882561-1MG |
| Cas.: 1422554-34-4 | Purity: ≥99% | BET-IN-1 | ESD-882561-5MG |
| Cas.: 1422535-52-1 | Purity: ≥98% | T-3775440 hydrochloride | ESD-882562-5MG |
| Cas.: 1422535-52-1 | Purity: ≥98% | T-3775440 hydrochloride | ESD-882562-10MG |
| Cas.: 1422506-53-3 | Purity: 96% | Rauvotetraphylline E | ESD-882563-5MG |
| Cas.: 1422506-52-2 | Purity: 95% | Rauvotetraphylline D | ESD-882564-1MG |
| Cas.: 1422506-51-1 | Purity: 96% | Rauvotetraphylline C | ESD-882565-5MG |
| Cas.: 1422506-50-0 | Purity: 97% | Rauvotetraphylline B | ESD-882566-5MG |
| Cas.: 1422506-49-7 | Purity: 96% | Rauvotetraphylline A | ESD-882567-5MG |
| Cas.: 1422496-61-4 | Purity: 95% | TERT-BUTYL 2-OXA-6-AZASPIRO[3.4]OCTAN-8-YLCARBAMATE | ESD-882568-250MG |
| Cas.: 1422496-61-4 | Purity: 95% | TERT-BUTYL 2-OXA-6-AZASPIRO[3.4]OCTAN-8-YLCARBAMATE | ESD-882568-1G |
| Cas.: 142227-49-4 | Purity: 98% | Carvedilol metabolite 4-Hydroxyphenyl Carvedilol | ESD-882569-2MG |
| Cas.: 142227-49-4 | Purity: 98% | Carvedilol metabolite 4-Hydroxyphenyl Carvedilol | ESD-882569-5MG |
| Cas.: 1422144-42-0 | Purity: ≥99% | Netarsudil mesylate | ESD-882570-2MG |
| Cas.: 1422144-42-0 | Purity: ≥99% | Netarsudil mesylate | ESD-882570-5MG |
| Cas.: 142203-64-3 | Purity: 98% | Taxumairol B | ESD-882571-5MG |
| Cas.: 1421866-48-9 | Purity: ≥99% | Apimostinel | ESD-882572-5MG |
| Cas.: 1421866-48-9 | Purity: ≥99% | Apimostinel | ESD-882572-10MG |
| Cas.: 1421693-22-2 | Purity: ≥99% | CDKI-73 | ESD-882573-2MG |
| Cas.: 1421693-22-2 | Purity: ≥99% | CDKI-73 | ESD-882573-5MG |
| Cas.: 1421603-46-4 | Purity: 95% | 9-ethyl-1,4-dioxa-7-azaspiro[4.4]nonane | ESD-882574-10MG |
| Cas.: 1421603-46-4 | Purity: 95% | 9-ethyl-1,4-dioxa-7-azaspiro[4.4]nonane | ESD-882574-50MG |
| Cas.: 1421601-82-2 | Purity: 95% | 2-{7,7-dimethyl-2,4-dioxo-1,3-diazaspiro[4.5]decan-3-yl}acetic acid | ESD-882575-1G |
| Cas.: 1421601-02-6 | Purity: 95% | 6-oxa-2-thiaspiro[4.5]decan-9-amine | ESD-882576-10MG |
| Cas.: 1421601-02-6 | Purity: 95% | 6-oxa-2-thiaspiro[4.5]decan-9-amine | ESD-882576-50MG |
| Cas.: 1421373-99-0 | Purity: 98% | AZ7550 | ESD-882577-5MG |
| Cas.: 1421373-99-0 | Purity: 98% | AZ7550 | ESD-882577-10MG |
| Cas.: 1421373-62-7 | Purity: ≥98% | Mutant EGFR inhibitor | ESD-882578-2MG |
| Cas.: 1421373-62-7 | Purity: ≥98% | Mutant EGFR inhibitor | ESD-882578-5MG |
| Cas.: 1421372-66-8 | Purity: ≥99% | Mutated EGFR-IN-1 | ESD-882579-2MG |
| Cas.: 1421372-66-8 | Purity: ≥99% | Mutated EGFR-IN-1 | ESD-882579-5MG |
| Cas.: 1421372-18-0 | Purity: 95% | 5-METHYL-2,5-DIAZASPIRO[3.4]OCTANE 2HCL | ESD-882580-250MG |
| Cas.: 1421372-18-0 | Purity: 95% | 5-METHYL-2,5-DIAZASPIRO[3.4]OCTANE 2HCL | ESD-882580-1G |
| Cas.: 1420880-41-6 | Purity: 98% | Olmesartan D4 | ESD-882581-1MG |
| Cas.: 1420880-41-6 | Purity: 98% | Olmesartan D4 | ESD-882581-5MG |
| Cas.: 1420367-28-7 | Purity: ≥99% | Lp-PLA2-IN-1 | ESD-882582-1MG |
| Cas.: 1420367-28-7 | Purity: ≥99% | Lp-PLA2-IN-1 | ESD-882582-5MG |
| Cas.: 141979-19-3 | Purity: 98% | 16-Hydroxycleroda-3,13-dien-15,16-olide | ESD-882583-5MG |
| Cas.: 141973-41-3 | Purity: 96% | 14-Deoxy-11,12-didehydroandrographiside | ESD-882584-5MG |
| Cas.: 141947-42-4 | Purity: 95% | Ginsenoyne K | ESD-882585-1MG |
| Cas.: 1419101-54-4 | Purity: 95% | 6-Boc-2-hydroxy-6-azaspiro[3.5]nonane | ESD-882587-1G |
| Cas.: 1419101-47-5 | Purity: 95% | 5-Aza-spiro[3·5]nonane hydrochloride | ESD-882588-1G |
| Cas.: 1419101-45-3 | Purity: 95% | 6,6-DIFLUOROSPIRO[3.3]HEPTANE-2-CARBOXYLIC ACID | ESD-882589-1G |
| Cas.: 1419101-45-3 | Purity: 95% | 6,6-DIFLUOROSPIRO[3.3]HEPTANE-2-CARBOXYLIC ACID | ESD-882589-5G |
| Cas.: 141887-34-5 | Purity: 98% | A81988 | ESD-882590-1MG |
| Cas.: 141887-34-5 | Purity: 98% | A81988 | ESD-882590-5MG |
| Cas.: 1418741-86-2 | Purity: ≥99% | UNC1079 | ESD-882591-1MG |
| Cas.: 1418741-86-2 | Purity: ≥99% | UNC1079 | ESD-882591-5MG |
| Cas.: 1418274-28-8 | Purity: ≥99% | Cilofexor | ESD-882592-5MG |
| Cas.: 1418274-28-8 | Purity: ≥99% | Cilofexor | ESD-882592-10MG |
| Cas.: 1418150-06-7 | Purity: 95% | Minaxin C | ESD-882593-5MG |
| Cas.: 1417997-93-3 | Purity: ≥99% | HDAC8-IN-1 | ESD-882594-5MG |
| Cas.: 1417997-93-3 | Purity: ≥99% | HDAC8-IN-1 | ESD-882594-10MG |
| Cas.: 141799-76-0 | Purity: 98% | E-5324 | ESD-882595-1MG |
| Cas.: 141799-76-0 | Purity: 98% | E-5324 | ESD-882595-5MG |
| Cas.: 1417887-91-2 | Purity: 97% | Stauntosaponin A | ESD-882596-5MG |
| Cas.: 1417805-15-2 | Purity: 95% | Albatrelin A | ESD-882597-5MG |
| Cas.: 1417633-09-0 | Purity: 95% | 7-Oxa-2-azaspiro[3.5]nonane hydrochloride | ESD-882598-1G |
| Cas.: 1417633-09-0 | Purity: 95% | 7-Oxa-2-azaspiro[3.5]nonane hydrochloride | ESD-882598-5G |
| Cas.: 1417567-64-6 | Purity: 95% | 1-Azaspiro[4.4]nonane hydrochloride | ESD-882599-1G |
| Cas.: 1417567-64-6 | Purity: 95% | 1-Azaspiro[4.4]nonane hydrochloride | ESD-882599-5G |
| Cas.: 1417301-86-0 | Purity: 95% | 2,8-diazaspiro[4.5]decan-3-one dihydrochloride | ESD-882600-1G |
| Cas.: 1417301-86-0 | Purity: 95% | 2,8-diazaspiro[4.5]decan-3-one dihydrochloride | ESD-882600-5G |
| Cas.: 1417162-36-7 | Purity: ≥99% | RI-2 | ESD-882601-2MG |
| Cas.: 1417162-36-7 | Purity: ≥99% | RI-2 | ESD-882601-5MG |
| Cas.: 141702-36-5 | Purity: ≥96% | Faropenem daloxate | ESD-882602-10MG |
| Cas.: 141702-36-5 | Purity: ≥96% | Faropenem daloxate | ESD-882602-100MG |
| Cas.: 141685-53-2 | Purity: 98% | Thrombin Receptor Activator for Peptide 5 TRAP-5 | ESD-882603-1MG |
| Cas.: 141685-53-2 | Purity: 98% | Thrombin Receptor Activator for Peptide 5 TRAP-5 | ESD-882603-5MG |
| Cas.: 1416561-90-4 | Purity: ≥95% | O-Propargyl-Puromycin | ESD-882604-500ΜG |
| Cas.: 1416561-90-4 | Purity: ≥95% | O-Propargyl-Puromycin | ESD-882604-1MG |
| Cas.: 1416439-08-1 | Purity: 95% | 2-AMINOSPIRO[3.3]HEPTANE HCL | ESD-882605-1G |
| Cas.: 1416439-08-1 | Purity: 95% | 2-AMINOSPIRO[3.3]HEPTANE HCL | ESD-882605-5G |
| Cas.: 1416438-78-2 | Purity: 95% | SPIRO[CYCLOPROPANE-1,3′-PYRROLO[2,3-B]PYRIDIN]-2′(1’H)-ONE | ESD-882606-1G |
| Cas.: 1416438-78-2 | Purity: 95% | SPIRO[CYCLOPROPANE-1,3′-PYRROLO[2,3-B]PYRIDIN]-2′(1’H)-ONE | ESD-882606-5G |
| Cas.: 1416323-16-4 | Purity: 95% | 2-Oxaspiro[3.5]nonane-7-carboxylic acid | ESD-882607-1G |
| Cas.: 1416323-16-4 | Purity: 95% | 2-Oxaspiro[3.5]nonane-7-carboxylic acid | ESD-882607-2.5G |
| Cas.: 1416153-62-2 | Purity: ≥99% | SR9238 | ESD-882608-5MG |
| Cas.: 1416153-62-2 | Purity: ≥99% | SR9238 | ESD-882608-10MG |
| Cas.: 1416133-89-5 | Purity: ≥99% | JW 642 | ESD-882609-5MG |
| Cas.: 1416133-89-5 | Purity: ≥99% | JW 642 | ESD-882609-10MG |
| Cas.: 1415925-18-6 | Purity: ≥99% | GSK2795039 | ESD-882610-1MG |
| Cas.: 1415925-18-6 | Purity: ≥99% | GSK2795039 | ESD-882610-5MG |
| Cas.: 1415834-63-7 | Purity: ≥99% | CPDA | ESD-882611-5MG |
| Cas.: 1415834-63-7 | Purity: ≥99% | CPDA | ESD-882611-10MG |
| Cas.: 1415795-51-5 | Purity: 95% | Angustin B | ESD-882612-5MG |
| Cas.: 1415795-50-4 | Purity: 98% | Angustin A | ESD-882613-5MG |
| Cas.: 1415637-72-7 | Purity: ≥98% | PF-05085727 | ESD-882614-5MG |
| Cas.: 1415637-72-7 | Purity: ≥98% | PF-05085727 | ESD-882614-10MG |
| Cas.: 1415608-33-1 | Purity: 95% | 2-Thia-6-azaspiro[3.3]heptane 2,2-dioxide hemioxalate | ESD-882615-250MG |
| Cas.: 1415564-68-9 | Purity: ≥98% | ST-836 hydrochloride | ESD-882616-5MG |
| Cas.: 1415564-68-9 | Purity: ≥98% | ST-836 hydrochloride | ESD-882616-10MG |
| Cas.: 1415562-83-2 | Purity: ≥98% | PF-543 Citrate | ESD-882617-5MG |
| Cas.: 1415562-83-2 | Purity: ≥98% | PF-543 Citrate | ESD-882617-10MG |
| Cas.: 1415560-64-3 | Purity: ≥98% | GSK 256066 Trifluoroacetate | ESD-882618-5MG |
| Cas.: 1415560-64-3 | Purity: ≥98% | GSK 256066 Trifluoroacetate | ESD-882618-10MG |
| Cas.: 1415559-43-1 | Purity: ≥95% | CDK9-IN-1 | ESD-882619-5MG |
| Cas.: 1415559-43-1 | Purity: ≥95% | CDK9-IN-1 | ESD-882619-10MG |
| Cas.: 1415559-41-9 | Purity: ≥98% | MK-8245 Trifluoroacetate | ESD-882620-5MG |
| Cas.: 1415559-41-9 | Purity: ≥98% | MK-8245 Trifluoroacetate | ESD-882620-10MG |
| Cas.: 1415555-92-8 | Purity: 95% | 2-Thia-6-azaspiro[3·3]heptane 2,2-dioxide oxalate | ESD-882621-250MG |
| Cas.: 1415396-42-7 | Purity: 95% | 1-Benzyl-1,7-diazaspiro[3,5]nonan-2-one hemioxalate | ESD-882622-100MG |
| Cas.: 1415396-42-7 | Purity: 95% | 1-Benzyl-1,7-diazaspiro[3,5]nonan-2-one hemioxalate | ESD-882622-500MG |
| Cas.: 1415379-56-4 | Purity: 98% | T807 | ESD-882623-1MG |
| Cas.: 1415379-56-4 | Purity: 98% | T807 | ESD-882623-5MG |
| Cas.: 1415246-68-2 | Purity: ≥99% | MMAF Hydrochloride | ESD-882624-2MG |
| Cas.: 1415246-68-2 | Purity: ≥99% | MMAF Hydrochloride | ESD-882624-5MG |
| Cas.: 1414963-82-8 | Purity: ≥99% | NK-252 | ESD-882625-5MG |
| Cas.: 1414963-82-8 | Purity: ≥99% | NK-252 | ESD-882625-10MG |
| Cas.: 1414958-13-6 | Purity: 95% | 6-AMINO-2-AZA-SPIRO[3.3]HEPTANE-2-CARBOXYLIC ACID TERT-BUTYL ESTER HCL | ESD-882626-50MG |
| Cas.: 1414958-13-6 | Purity: 95% | 6-AMINO-2-AZA-SPIRO[3.3]HEPTANE-2-CARBOXYLIC ACID TERT-BUTYL ESTER HCL | ESD-882626-1G |
| Cas.: 1414885-16-7 | Purity: 95% | 7-Aza-spiro[3·5]nonane hydrochloride | ESD-882627-1G |
| Cas.: 1414883-82-1 | Purity: 92% | Rauvoyunine B | ESD-882628-5MG |
| Cas.: 1414883-81-0 | Purity: 95% | Rauvoyunine A | ESD-882629-1MG |
| Cas.: 1414811-15-6 | Purity: 98% | FMK-MEA | ESD-882630-5MG |
| Cas.: 1414811-15-6 | Purity: 98% | FMK-MEA | ESD-882630-10MG |
| Cas.: 1414513-75-9 | Purity: 95% | 6-Phenyl-2-oxa-spiro[3.3]heptane-6-carbonitrile | ESD-882631-1G |
| Cas.: 1414513-75-9 | Purity: 95% | 6-Phenyl-2-oxa-spiro[3.3]heptane-6-carbonitrile | ESD-882631-5G |
| Cas.: 1414455-03-0 | Purity: 97% | Guajadial B | ESD-882632-5MG |
| Cas.: 1413843-71-6 | Purity: 98% | Orobanchyl acetate | ESD-882633-5MG |
| Cas.: 141374-81-4 | Purity: 98% | Tarazepide | ESD-882634-1MG |
| Cas.: 141374-81-4 | Purity: 98% | Tarazepide | ESD-882634-5MG |
| Cas.: 141335-10-6 | Purity: 98% | LCB-2853 | ESD-882635-1MG |
| Cas.: 141335-10-6 | Purity: 98% | LCB-2853 | ESD-882635-5MG |
| Cas.: 141286-78-4 | Purity: ≥98% | PEPA | ESD-882636-5MG |
| Cas.: 141286-78-4 | Purity: ≥98% | PEPA | ESD-882636-10MG |
| Cas.: 1412458-61-7 | Purity: ≥99% | Asenapine hydrochloride | ESD-882637-10MG |
| Cas.: 1412458-61-7 | Purity: ≥99% | Asenapine hydrochloride | ESD-882637-50MG |
| Cas.: 1412418-47-3 | Purity: ≥97% | Btk inhibitor 1 | ESD-882638-2MG |
| Cas.: 1412418-47-3 | Purity: ≥97% | Btk inhibitor 1 | ESD-882638-5MG |
| Cas.: 141237-50-5 | Purity: 98% | HIV-1 Rev 34-50 | ESD-882639-500ΜG |
| Cas.: 141237-50-5 | Purity: 98% | HIV-1 Rev 34-50 | ESD-882639-1MG |
| Cas.: 1411977-95-1 | Purity: ≥95% | Acetylene-linker-Val-Cit-PABC-MMAE | ESD-882640-1MG |
| Cas.: 1411977-95-1 | Purity: ≥95% | Acetylene-linker-Val-Cit-PABC-MMAE | ESD-882640-5MG |
| Cas.: 1411629-26-9 | Purity: 95% | Epiguajadial B | ESD-882641-5MG |
| Cas.: 141120-33-4 | Purity: 95% | 1,4-Dioxa-spiro[4.5]dec-8-yl methanesulfonate | ESD-882642-1G |
| Cas.: 141120-33-4 | Purity: 95% | 1,4-Dioxa-spiro[4.5]dec-8-yl methanesulfonate | ESD-882642-5G |
| Cas.: 141117-12-6 | Purity: ≥98% | Celgosivir hydrochloride | ESD-882643-1MG |
| Cas.: 141117-12-6 | Purity: ≥98% | Celgosivir hydrochloride | ESD-882643-5MG |
| Cas.: 141064-23-5 | Purity: ≥99% | Xanomeline oxalate | ESD-882644-5MG |
| Cas.: 141064-23-5 | Purity: ≥99% | Xanomeline oxalate | ESD-882644-10MG |
| Cas.: 14103-09-4 | Purity: 98% | 1-Hydroxy-2,3,4,7-tetramethoxyxanthone | ESD-882645-5MG |
| Cas.: 1408311-12-5 | Purity: 97% | 1-Hydroxymethyl-β-carboline glucoside | ESD-882646-5MG |
| Cas.: 1408076-43-6 | Purity: 95% | tert-Butyl 3-oxo-1-oxa-6-azaspiro-[3.4]octane-6-carboxylate | ESD-882647-50MG |
| Cas.: 1408076-43-6 | Purity: 95% | tert-Butyl 3-oxo-1-oxa-6-azaspiro-[3.4]octane-6-carboxylate | ESD-882647-250MG |
| Cas.: 1408076-15-2 | Purity: 95% | 7-Boc-1-oxa-3-oxo-7-azaspiro[3.5]nonane | ESD-882648-10MG |
| Cas.: 1408076-15-2 | Purity: 95% | 7-Boc-1-oxa-3-oxo-7-azaspiro[3.5]nonane | ESD-882648-50MG |
| Cas.: 1408076-09-4 | Purity: 95% | 7-oxa-2-azaspiro[3·5]nonane oxalate (2:1) | ESD-882649-1G |
| Cas.: 1408076-07-2 | Purity: 95% | 5-Boc-2,5-diazaspiro[3.5]nonane oxalate | ESD-882650-250MG |
| Cas.: 1408076-07-2 | Purity: 95% | 5-Boc-2,5-diazaspiro[3.5]nonane oxalate | ESD-882650-1G |
| Cas.: 1408075-68-2 | Purity: 95% | 8-Oxa-2-aza-spiro[4.5]decane oxalate | ESD-882651-1G |
| Cas.: 1408075-68-2 | Purity: 95% | 8-Oxa-2-aza-spiro[4.5]decane oxalate | ESD-882651-5G |
| Cas.: 1408075-19-3 | Purity: 95% | TERT-BUTYL 7-AMINO-2-AZASPIRO[3.5]NONANE-2-CARBOXYLATE | ESD-882652-250MG |
| Cas.: 1408075-19-3 | Purity: 95% | TERT-BUTYL 7-AMINO-2-AZASPIRO[3.5]NONANE-2-CARBOXYLATE | ESD-882652-1G |
| Cas.: 1408075-17-1 | Purity: 95% | 8-Boc-1,8-diazaspiro[4.5]decane oxalate | ESD-882653-1G |
| Cas.: 1408075-00-2 | Purity: 97% | 2-Oxa-6-azaspiro[3.4]octane oxalate | ESD-882654-1G |
| Cas.: 1407522-01-3 | Purity: 95% | tert-Butyl 2,6-diazaspiro[4.5]decane-6-carboxylate hydrochloride | ESD-882655-500MG |
| Cas.: 140701-70-8 | Purity: 97% | 16-Oxolyclanitin-29-yl p-coumarate | ESD-882656-5MG |
| Cas.: 140701-69-5 | Purity: 98% | Scandine Nb-oxide | ESD-882657-5MG |
| Cas.: 140700-63-6 | Purity: 98% | 4-Aza-5androstan-1-ene- 3-one-17carboxylic acid | ESD-882658-5MG |
| Cas.: 140686-92-6 | Purity: ≥98% | N-563 | ESD-882659-1MG |
| Cas.: 140686-92-6 | Purity: ≥98% | N-563 | ESD-882659-5MG |
| Cas.: 140678-14-4 | Purity: ≥95% | Mangafodipir trisodium | ESD-882660-1MG |
| Cas.: 140678-14-4 | Purity: ≥95% | Mangafodipir trisodium | ESD-882660-5MG |
| Cas.: 140671-07-4 | Purity: 97% | Gnetifolin E | ESD-882661-5MG |
| Cas.: 140669-89-2 | Purity: 95% | Kadsurenin D | ESD-882662-5MG |
| Cas.: 140646-80-6 | Purity: 98% | MCI826 | ESD-882663-1MG |
| Cas.: 140646-80-6 | Purity: 98% | MCI826 | ESD-882663-5MG |
| Cas.: 140631-27-2 | Purity: 95% | 12-Hydroxyjasmonic acid | ESD-882664-5MG |
| Cas.: 1405-97-6 | Purity: 98% | Gramicidin | ESD-882665-50MG |
| Cas.: 14050-92-1 | Purity: 96% | Methyl chanofruticosinate | ESD-882666-5MG |
| Cas.: 14050-90-9 | Purity: 95% | 1,2-Methylenedioxy-3,10,11-trimethoxynoraporphine | ESD-882667-5MG |
| Cas.: 140447-22-9 | Purity: 85% | Ergosterol peroxide glucoside | ESD-882668-5MG |
| Cas.: 140447-14-9 | Purity: 95% | 11-Hydroxyjasmonic acid | ESD-882669-1MG |
| Cas.: 1404437-62-2 | Purity: ≥99% | ML281 | ESD-882670-5MG |
| Cas.: 1404437-62-2 | Purity: ≥99% | ML281 | ESD-882670-10MG |
| Cas.: 1404231-34-0 | Purity: 98% | ON 146040 | ESD-882671-2MG |
| Cas.: 1404231-34-0 | Purity: 98% | ON 146040 | ESD-882671-5MG |
| Cas.: 1404095-34-6 | Purity: ≥99% | CCT244747 | ESD-882672-2MG |
| Cas.: 1404095-34-6 | Purity: ≥99% | CCT244747 | ESD-882672-5MG |
| Cas.: 1403766-77-7 | Purity: 98% | 2-Methyl-7-azaspiro[3.5]nonan-2-ol | ESD-882673-250MG |
| Cas.: 1403766-77-7 | Purity: 98% | 2-Methyl-7-azaspiro[3.5]nonan-2-ol | ESD-882673-1G |
| Cas.: 1403766-69-7 | Purity: 95% | 5-Azaspiro[3.4]octane oxalate | ESD-882674-1G |
| Cas.: 1403766-68-6 | Purity: 95% | tert-Butyl 2-(aminomethyl)-1-oxa-7-azaspiro[3.5]nonane-7-carboxylate | ESD-882675-10MG |
| Cas.: 1403766-68-6 | Purity: 95% | tert-Butyl 2-(aminomethyl)-1-oxa-7-azaspiro[3.5]nonane-7-carboxylate | ESD-882675-50MG |
| Cas.: 1403566-81-3 | Purity: 95% | 5′-CHLOROSPIRO[CYCLOPROPANE-1,3′-INDOLIN]-2′-ONE | ESD-882676-1G |
| Cas.: 1403564-65-7 | Purity: 95% | 7′-CHLOROSPIRO[CYCLOPROPANE-1,3′-INDOLIN]-2′-ONE | ESD-882677-1G |
| Cas.: 14031-37-9 | Purity: 93% | Squalene-2,3-diol | ESD-882678-1MG |
| Cas.: 14028-97-8 | Purity: 97% | N-Methyllindcarpine | ESD-882679-5MG |
| Cas.: 1402837-79-9 | Purity: ≥99% | IDO-IN-5 | ESD-882680-1MG |
| Cas.: 1402837-79-9 | Purity: ≥99% | IDO-IN-5 | ESD-882680-5MG |
| Cas.: 1402837-78-8 | Purity: ≥99% | Navoximod | ESD-882681-1MG |
| Cas.: 1402837-78-8 | Purity: ≥99% | Navoximod | ESD-882681-5MG |
| Cas.: 1402837-77-7 | Purity: ≥99% | IDO-IN-8 | ESD-882682-1MG |
| Cas.: 1402837-77-7 | Purity: ≥99% | IDO-IN-8 | ESD-882682-5MG |
| Cas.: 1402837-76-6 | Purity: ≥99% | IDO-IN-6 | ESD-882683-1MG |
| Cas.: 1402837-76-6 | Purity: ≥99% | IDO-IN-6 | ESD-882683-5MG |
| Cas.: 1402821-41-3 | Purity: ≥99% | GV-58 | ESD-882684-1MG |
| Cas.: 1402821-41-3 | Purity: ≥99% | GV-58 | ESD-882684-5MG |
| Cas.: 1402727-29-0 | Purity: ≥98% | PE859 | ESD-882685-1MG |
| Cas.: 1402727-29-0 | Purity: ≥98% | PE859 | ESD-882685-5MG |
| Cas.: 1402709-93-6 | Purity: ≥99% | CCT241736 | ESD-882686-5MG |
| Cas.: 1402709-93-6 | Purity: ≥99% | CCT241736 | ESD-882686-10MG |
| Cas.: 1402612-64-9 | Purity: 98% | KT203 | ESD-882687-5MG |
| Cas.: 1402612-64-9 | Purity: 98% | KT203 | ESD-882687-10MG |
| Cas.: 1402612-62-7 | Purity: 98% | KT182 | ESD-882688-5MG |
| Cas.: 1402612-62-7 | Purity: 98% | KT182 | ESD-882688-10MG |
| Cas.: 1402608-02-9 | Purity: ≥99% | BAY1125976 | ESD-882689-2MG |
| Cas.: 1402608-02-9 | Purity: ≥99% | BAY1125976 | ESD-882689-5MG |
| Cas.: 1402233-02-6 | Purity: 95% | 7′-Fluoro-2′,4′-dihydro-1’H-spiro[piperidine-4,3′-quinoline]-2′-one hydrochlorid | ESD-882690-1G |
| Cas.: 1402232-95-4 | Purity: 95% | tert-Butyl 5′-fluoro-2′,4′-dihydro-1’H-spiro[piperidine-4,3′-quinoline]-1-carbox | ESD-882691-1G |
| Cas.: 1402232-86-3 | Purity: 95% | 5′-Fluoro-2′,4′-dihydro-1’H-spiro[piperidine-4,3′-quinoline]-2′-one hydrochlorid | ESD-882692-1G |
| Cas.: 1402232-78-3 | Purity: 95% | tert-Butyl 5′-fluoro-2′-oxo-2′,4′-dihydro-1’H-spiro[piperidine-4,3′-quinoline]-1-carboxylate | ESD-882693-1G |
| Cas.: 1402232-58-9 | Purity: 95% | 1,9-Dioxa-4-azaspiro[5.5]undecan-3-one | ESD-882694-1G |
| Cas.: 1402232-57-8 | Purity: 95% | Benzyl 1-oxa-4,9-diazaspiro[5.5]undecane-4-carboxylate hydrochloride | ESD-882695-1G |
| Cas.: 1402232-51-2 | Purity: 95% | 1-Oxa-4,9-diazaspiro[5.5]undecan-3-one hydrochloride | ESD-882696-1G |
| Cas.: 1402067-84-8 | Purity: 98% | Eupalinolide I | ESD-882697-5MG |
| Cas.: 1402066-95-8 | Purity: 95% | Psiguadial D | ESD-882698-5MG |
| Cas.: 1401963-17-4 | Purity: 98% | Vc-MMAD | ESD-882699-1MG |
| Cas.: 1401963-17-4 | Purity: 98% | Vc-MMAD | ESD-882699-5MG |
| Cas.: 1401963-15-2 | Purity: ≥98% | Mc-MMAD | ESD-882700-1MG |
| Cas.: 1401963-15-2 | Purity: ≥98% | Mc-MMAD | ESD-882700-5MG |
| Cas.: 14017-71-1 | Purity: 95% | (-)-Praeruptorin A | ESD-882701-5MG |
| Cas.: 1401708-83-5 | Purity: ≥98% | Dihexa | ESD-882702-2MG |
| Cas.: 1401618-51-6 | Purity: 95% | Negundonorin A | ESD-882703-1MG |
| Cas.: 140147-77-9 | Purity: ≥99% | Epimedin A1 | ESD-882704-5MG |
| Cas.: 140147-77-9 | Purity: ≥99% | Epimedin A1 | ESD-882704-10MG |
| Cas.: 1401463-54-4 | Purity: ≥95% | BAN ORL 24 | ESD-882705-10MG |
| Cas.: 1401463-54-4 | Purity: ≥95% | BAN ORL 24 | ESD-882705-50MG |
| Cas.: 1401419-90-6 | Purity: 95% | Pterisolic acid F | ESD-882706-5MG |
| Cas.: 1401419-89-3 | Purity: 95% | Pterisolic acid E | ESD-882707-5MG |
| Cas.: 1401419-88-2 | Purity: 97% | Pterisolic acid D | ESD-882708-5MG |
| Cas.: 1401419-87-1 | Purity: 98% | Pterisolic acid C | ESD-882709-5MG |
| Cas.: 1401419-86-0 | Purity: 95% | Pterisolic acid B | ESD-882710-1MG |
| Cas.: 1401419-85-9 | Purity: 98% | Pterisolic acid A | ESD-882711-5MG |
| Cas.: 140129-22-2 | Purity: 95% | 15,16-Dihydroxyoctadeca-9Z,12Z-dienoic acid | ESD-882712-5MG |
| Cas.: 1401242-74-7 | Purity: ≥98% | ML277 | ESD-882713-5MG |
| Cas.: 1401242-74-7 | Purity: ≥98% | ML277 | ESD-882713-10MG |
| Cas.: 1401-20-3 | Purity: 98% | Safflower yellow | ESD-882714-50MG |
| Cas.: 1401093-57-9 | Purity: 95% | 3′-Hydroxygynuramide II | ESD-882715-5MG |
| Cas.: 1401090-53-6 | Purity: ≥99% | Ibiglustat | ESD-882716-2MG |
| Cas.: 1401090-53-6 | Purity: ≥99% | Ibiglustat | ESD-882716-5MG |
| Cas.: 1401034-19-2 | Purity: ≥98% | AMG 925 HCl | ESD-882717-5MG |
| Cas.: 1401034-19-2 | Purity: ≥98% | AMG 925 HCl | ESD-882717-10MG |
| Cas.: 1401028-25-8 | Purity: 98% | Oliceridine (Racemate) | ESD-882718-2MG |
| Cas.: 1401028-25-8 | Purity: 98% | Oliceridine (Racemate) | ESD-882718-5MG |
| Cas.: 1401026-78-5 | Purity: 95% | 2-(9-(PYRIDIN-2-YL)-6-OXASPIRO[4.5]DECAN-9-YL)ETHANAMINE | ESD-882719-250MG |
| Cas.: 1401026-78-5 | Purity: 95% | 2-(9-(PYRIDIN-2-YL)-6-OXASPIRO[4.5]DECAN-9-YL)ETHANAMINE | ESD-882719-1G |
| Cas.: 1400764-62-6 | Purity: 95% | tert-Butyl 2-azaspiro[3.3]heptan-6-ylcarbamate hemioxalate | ESD-882720-250MG |
| Cas.: 1400764-62-6 | Purity: 95% | tert-Butyl 2-azaspiro[3.3]heptan-6-ylcarbamate hemioxalate | ESD-882720-1G |
| Cas.: 14004-35-4 | Purity: 95% | Eucalyptin acetate | ESD-882721-1MG |
| Cas.: 139968-49-3 | Purity: ≥96% | Metaflumizone | ESD-882722-100MG |
| Cas.: 139968-49-3 | Purity: ≥96% | Metaflumizone | ESD-882722-500MG |
| Cas.: 139954-00-0 | Purity: 98% | Palbinone | ESD-882723-5MG |
| Cas.: 1399-49-1 | Purity: 95% | Globularin | ESD-882724-5MG |
| Cas.: 139906-49-3 | Purity: 98% | Alpinone 3-acetate | ESD-882725-5MG |
| Cas.: 1399049-43-4 | Purity: 96% | Drahebenine | ESD-882726-5MG |
| Cas.: 139892-53-8 | Purity: 95% | (R)-2-(Chloromethyl)-1,4-dioxaspiro[4.5]decane | ESD-882727-250MG |
| Cas.: 139892-53-8 | Purity: 95% | (R)-2-(Chloromethyl)-1,4-dioxaspiro[4.5]decane | ESD-882727-1G |
| Cas.: 1398609-80-7 | Purity: 95% | tert-Butyl 5′-bromo-3’H-spiro[azetidine-3,1′-isobenzofuran]-1-carboxylate | ESD-882728-1G |
| Cas.: 1398609-39-6 | Purity: ≥99% | Sarolaner | ESD-882729-5MG |
| Cas.: 1398609-39-6 | Purity: ≥99% | Sarolaner | ESD-882729-10MG |
| Cas.: 1398568-47-2 | Purity: 98% | Milademetan | ESD-882730-1MG |
| Cas.: 1398568-47-2 | Purity: 98% | Milademetan | ESD-882730-5MG |
| Cas.: 1398507-72-6 | Purity: 97% | (S)-7-AMINO-5-(4-METHOXYBENZYL)-5-AZASPIRO[2.4]HEPTAN-4-ONE | ESD-882731-250MG |
| Cas.: 1398507-72-6 | Purity: 97% | (S)-7-AMINO-5-(4-METHOXYBENZYL)-5-AZASPIRO[2.4]HEPTAN-4-ONE | ESD-882731-1G |
| Cas.: 1398504-23-8 | Purity: 95% | 7-BENZOYL-2,7-DIAZASPIRO[3.5]NONANE | ESD-882732-1MG |
| Cas.: 1398044-45-5 | Purity: 98% | Piribedil D8 | ESD-882733-1MG |
| Cas.: 1398044-45-5 | Purity: 98% | Piribedil D8 | ESD-882733-5MG |
| Cas.: 1397922-61-0 | Purity: ≥98% | Pyrotinib dimaleate | ESD-882734-1MG |
| Cas.: 1397922-61-0 | Purity: ≥98% | Pyrotinib dimaleate | ESD-882734-5MG |
| Cas.: 139726-40-2 | Purity: 97% | Sibiricose A1 | ESD-882735-5MG |
| Cas.: 139726-35-5 | Purity: 95% | Tenuifoliside A | ESD-882736-5MG |
| Cas.: 139726-30-0 | Purity: 98% | Isodunnianol | ESD-882737-5MG |
| Cas.: 139726-29-7 | Purity: 98% | Dunnianol | ESD-882738-5MG |
| Cas.: 139713-81-8 | Purity: 98% | Yunnanxane | ESD-882739-5MG |
| Cas.: 139682-36-3 | Purity: 98% | Gardenine | ESD-882740-5MG |
| Cas.: 139667-74-6 | Purity: ≥98% | CGP52432 | ESD-882741-5MG |
| Cas.: 139667-74-6 | Purity: ≥98% | CGP52432 | ESD-882741-10MG |
| Cas.: 1396337-04-4 | Purity: ≥99% | Auglurant | ESD-882742-5MG |
| Cas.: 1396337-04-4 | Purity: ≥99% | Auglurant | ESD-882742-10MG |
| Cas.: 13956-52-0 | Purity: 98% | Serratriol | ESD-882743-5MG |
| Cas.: 13956-51-9 | Purity: 98% | Lycoclavanol | ESD-882744-5MG |
| Cas.: 1395347-24-6 | Purity: ≥99% | ISA-2011B | ESD-882746-1MG |
| Cas.: 1395347-24-6 | Purity: ≥99% | ISA-2011B | ESD-882746-5MG |
| Cas.: 139524-58-6 | Purity: 95% | 8-(BENZYLOXYCARBONYL)-1,4-DIOXA-8-AZASPIRO[4.5]DECANE | ESD-882747-1G |
| Cas.: 139524-58-6 | Purity: 95% | 8-(BENZYLOXYCARBONYL)-1,4-DIOXA-8-AZASPIRO[4.5]DECANE | ESD-882747-5G |
| Cas.: 1395048-49-3 | Purity: 98% | M-110 | ESD-882748-5MG |
| Cas.: 1394854-52-4 | Purity: ≥98% | GSK-J2 | ESD-882749-10MG |
| Cas.: 1394854-52-4 | Purity: ≥98% | GSK-J2 | ESD-882749-50MG |
| Cas.: 1394840-24-4 | Purity: 95% | 2-Benzyl-2,6-diazaspiro[3.3]heptane oxalate | ESD-882750-250MG |
| Cas.: 1394820-77-9 | Purity: ≥99% | Ningetinib Tosylate | ESD-882751-2MG |
| Cas.: 1394820-77-9 | Purity: ≥99% | Ningetinib Tosylate | ESD-882751-5MG |
| Cas.: 1394820-69-9 | Purity: ≥98% | Ningetinib | ESD-882752-2MG |
| Cas.: 1394820-69-9 | Purity: ≥98% | Ningetinib | ESD-882752-5MG |
| Cas.: 139481-69-9 | Purity: 98% | Candesartan methyl ester | ESD-882753-5MG |
| Cas.: 139481-58-6 | Purity: 98% | Candesartan ethyl ester | ESD-882754-5MG |
| Cas.: 139481-28-0 | Purity: 98% | Methyl 2-(((2′-cyano-[1,1′-biphenyl]-4-yl)methyl)amino)-3-nitrobenzoate | ESD-882755-5MG |
| Cas.: 1394631-64-1 | Purity: 95% | 6,6,8,8-tetramethyl-7-oxa-1,3-diazaspiro[4.4]nonane-2,4-dione | ESD-882756-10MG |
| Cas.: 1394631-64-1 | Purity: 95% | 6,6,8,8-tetramethyl-7-oxa-1,3-diazaspiro[4.4]nonane-2,4-dione | ESD-882756-50MG |
| Cas.: 1394371-71-1 | Purity: ≥98% | MK8722 | ESD-882757-5MG |
| Cas.: 1394371-71-1 | Purity: ≥98% | MK8722 | ESD-882757-10MG |
| Cas.: 1394319-56-2 | Purity: 95% | 1-Boc-1,6-diazaspiro[3·3]heptane oxalate | ESD-882758-1G |
| Cas.: 1394306-58-1 | Purity: 95% | 5-oxa-7-azaspiro[2.5]octan-6-one | ESD-882759-1G |
| Cas.: 1394306-58-1 | Purity: 95% | 5-oxa-7-azaspiro[2.5]octan-6-one | ESD-882759-5G |
| Cas.: 1394306-54-7 | Purity: 95% | 5-methyl-5,7-diazaspiro[2.5]octan-6-one | ESD-882760-1G |
| Cas.: 1394306-54-7 | Purity: 95% | 5-methyl-5,7-diazaspiro[2.5]octan-6-one | ESD-882760-5G |
| Cas.: 1394157-34-6 | Purity: ≥98% | Sofosbuvir impurity N | ESD-882761-1MG |
| Cas.: 1394157-34-6 | Purity: ≥98% | Sofosbuvir impurity N | ESD-882761-5MG |
| Cas.: 1394156-45-6 | Purity: 98% | 8α-Hydroxyhirsutinolide | ESD-882762-5MG |
| Cas.: 1394042-20-6 | Purity: 95% | 3-ethoxy-N-methylspiro[3.3]heptan-1-amine hydrochloride | ESD-882763-10MG |
| Cas.: 1394042-20-6 | Purity: 95% | 3-ethoxy-N-methylspiro[3.3]heptan-1-amine hydrochloride | ESD-882763-50MG |
| Cas.: 1394041-68-9 | Purity: 95% | 3-ethoxyspiro[3.3]heptan-1-ol | ESD-882764-10MG |
| Cas.: 1394041-68-9 | Purity: 95% | 3-ethoxyspiro[3.3]heptan-1-ol | ESD-882764-50MG |
| Cas.: 1394040-84-6 | Purity: 95% | 1,9-dioxaspiro[5.5]undec-4-ylamine hydrochloride | ESD-882765-1G |
| Cas.: 1394040-84-6 | Purity: 95% | 1,9-dioxaspiro[5.5]undec-4-ylamine hydrochloride | ESD-882765-5G |
| Cas.: 1394040-37-9 | Purity: 95% | 3′,4′-dihydro-2’H-spiro[cyclopropane-1,1′-naphthalene]-3-ylmethanamine hydrochloride | ESD-882766-5MG |
| Cas.: 1394040-37-9 | Purity: 95% | 3′,4′-dihydro-2’H-spiro[cyclopropane-1,1′-naphthalene]-3-ylmethanamine hydrochloride | ESD-882766-10MG |
| Cas.: 1394033-54-5 | Purity: ≥99% | PF-05180999 | ESD-882767-5MG |
| Cas.: 1394033-54-5 | Purity: ≥99% | PF-05180999 | ESD-882767-10MG |
| Cas.: 139401-45-9 | Purity: 98% | CP-96486 | ESD-882768-1MG |
| Cas.: 139401-45-9 | Purity: 98% | CP-96486 | ESD-882768-5MG |
| Cas.: 1394003-64-5 | Purity: 95% | 5-BENZYL-5-AZASPIRO[2.4]HEPTAN-4-ONE | ESD-882769-1G |
| Cas.: 1394003-64-5 | Purity: 95% | 5-BENZYL-5-AZASPIRO[2.4]HEPTAN-4-ONE | ESD-882769-5G |
| Cas.: 1393450-96-8 | Purity: 95% | SPIRO[3.5]NONAN-7-OL | ESD-882770-250MG |
